note_id,name,subject_id,hadm_id,text,service
10003400-DS-13,Deanna Cuthill,10003400,26090619," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Hematuria with supratherapeutic INR
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
 This is a ___ ___ Female with a PMH significant for chronic 
persistent atrial fibrillation (on anticoagulation), essential 
hypertension, obesity, IgG multiple myeloma (started C28 of 
Lenalidomide ___ who presents from clinic with recent 
hematuria and evidence of a supratherapeutic INR.  
.  
The patient presented for a routine ___ clinic visit 
on ___ and was found to have an INR of 10.7 and there was 
concern for gross hematuria for several days. She was instructed 
to take Vitamin K 5 mg PO x 1 an hold her Coumadin, and she was 
to proceed to the ___ ED. On ___ her INR was 2.6.  
.  
Of note, the patient also has a recent history of neck pain 
since ___ which has been managed by her PCP. There was no 
inciting event or trauma. She described vague posterior neck 
pain that is intermittent and achy, worse with flexion and 
relieved with rest. She denies weakness, numbness or tingling in 
her upper extremities. She was prescribed warm compresses and 
Tramadol 50 mg PO Q6H for pain control. Since starting the 
Tramadol, she had noted episodes of dizziness and 
lightheadedness with ambulation. She felt the need to support 
herself with railing and started utilizing a cane more 
frequently. She denies lower extremity weakness or paresthesias. 
Her only medication changes was the Tramadol. She has no chest 
pain or trouble breathing. She denies nausea, emesis or 
abdominal pain. She has no headaches, vision changes. She denies 
trauma or recent falls. No true syncope events or LOC were 
noted. She denies vertiginous symptoms, tinnitus or hearing 
loss. Overall, with discontinuation of the Tramadol, her 
symptoms improved - thus her PCP felt this was the precipitant 
of her ___ complaints.  
.  
In the ___ ED, initial VS 97.3 ___ 16 99% RA. 
Laboratory studies were notable for a WBC 3.9 (ANC > 1500), HCT 
34.8%, PLT 322. INR was 9.6. Creatinine 1.0. Troponin < 0.01. 
Lactate 2.1. A U/A showed 21 WBCs, 4 RBCs with moderate 
bacteria. An EKG demonstrated A.fib @ 127, LAD/NI and 
___. A CXR was without focal consolidation 
or effusion. She received Ceftriaxone 1 gram IV x 1 and 
Lopressor 5 mg IV x 1 followed by Metoprolol tartrate 100 mg PO 
x 1 in the ED given evidence of rapid ventricular response to 
the ___.  
.  
On arrival to the floor, she is mentating well and has minimal 
complaints.  

 
Past Medical History:
Atrial Fibrillation: Persistent, Chronic, on Coumadin
Multiple Myeloma: described below
HTN
Obesity
Fibroids s/p TAH

ONCOLOGIC HISTORY: Presented with anemia in ___. 
Further testing demonstrated an ___ of approximately 3.3 
g/dL, IgG was 5800 mg/dL. Eventually, the patient was referred 
to Hematology, IgG increased to 7100 mg/dL at the start of 
treatment. Bone marrow biopsy revealed 60% of her bone marrow 
occupied by plasma cells, cytogenetics demonstrated 
translocation of chromosomes 11 and 14, also monosomy 13. 
Skeletal survey was negative. Initial beta 2 microglobulin was 
4.08.

___ - C1 ___  
___ - pneumonia, leukopenia admission to ___  
___ - severe back pain, L3 vertebral compression fracture  
___ - resumed Revlimid at 15 mg with Dexamethasone 20 mg 
weekly; started Zometa every 3 months  
___ - more pronounced leukopenia  
___ - C19 ___ was down to 0.6 
g/dL), reduced Revlimid to 10 mg daily because of neutropenia  
___ - back to Revlimid 15 mg given ___ increase to 0.8 
g/dL  
___ - C27 ___  
___ - started Biaxin  
___ - C31 ___ 
# Afib: found incidentally in ___
# htn
# s/p CCY
# s/p TAH for fibroids
 
Social History:
___
Family History:
Her parents died in their ___ or ___ of ""old age.""  Her parents
and multiple siblings have hypertension.  There is no family 
history of significant arrhythmia or premature coronary disease.
 
Physical Exam:
PHYSICAL EXAM on admission:  
VITALS: 97.6 112 131/84 18 100% RA  
GENERAL: Appears in no acute distress. Alert and interactive. 
Well nourished appearing female.  
HEENT: Normocephalic, atraumatic. EOMI. PERRL. Nares clear. 
Mucous membranes moist.  
NECK: supple without lymphadenopathy. JVD not elevated. Thyroid 
barely palpable.  
___: Irregularly irregular rhythm, without murmurs, rubs or 
gallops. S1 and S2 normal.  
RESP: Decreased breath sounds at bases with faint inspiratory 
crackles at bases. No wheezing, rhonchi. Stable inspiratory 
effort.  
ABD: soft, ___, with normoactive bowel 
sounds. No palpable masses or peritoneal signs.  
EXTR: no cyanosis, clubbing or edema, 2+ peripheral pulses  
NEURO: CN ___ intact throughout. Alert and oriented x 3. DTRs 
2+ throughout, strength ___ bilaterally, sensation grossly 
intact. Gait deferred.  

Physical Exam on discharge:
AFebrile ___  ___  ___ sat 99% on RA
Gen: NAD, lying in bed
HEENT: moist mucosa
CV: irregularly irregular, normal rate, no murmur
Pulm: few crackles at bases, no wheezes, good air movement
Abd: NT, ND, soft
Ext: no peripheral edema
Skin: no skin lesions noted 

 
Pertinent Results:
___ 05:34AM BLOOD ___ 
___ Plt ___
___ 05:34AM BLOOD ___ 
___
___ 05:34AM BLOOD ___ ___
___ 06:15AM BLOOD ___ ___
___ 10:25PM BLOOD ___ ___
___ 05:34AM BLOOD ___
___ 11:40PM URINE ___ Sp ___
___ 11:40PM URINE ___  ___ 
___
___ 11:40PM URINE ___ 
___

CXR:
The lungs are well expanded and clear.  Mild cephalization of 
the pulmonary
vessels is unchanged.  The cardiac silhouette is enlarged.  The 
mediastinal
silhouette and hilar contours are normal.  No pleural effusion 
or pneumothorax
is present.
 
IMPRESSION:
 
Moderate, unchanged cardiomegaly. No edema.
 
Brief Hospital Course:
___ with a PMH significant for chronic persistent atrial 
fibrillation (on anticoagulation), HTN, obesity, IgG multiple 
myeloma (started C28 of Lenalidomide ___ who presents from 
clinic with reported recent hematuria and evidence of a 
supratherapeutic INR in the setting of anticoagulation.

# Supratherapeutic INR/Coagulopathy - Likely due to use of 
tramadol over past 2 weeks for neck pain. INR was 2.6 on 
___. Coumadin managed by the ___. INR 
noted to be 10.7 in clinic on ___ (previously 2.6 in ___. 
Of note patient started on clarithromycin to increase the 
potency of her chemotherapy regimen in ___ and has not 
had INR issues in the past with this drug. She seems compliant 
with her medications. She had no clinical evidence of bleeding. 
Her U/A has 4 RBCs and she has no gross hematuria. No neurologic 
deficits or mental clouding to suggest ICH or bleeding. 
- no acute indication for FFP given no active bleeding concerns  

- received Vitamin K 5 mg PO x 1 with improvement in INR   
- held coumadin in hospital and recommended coumadin 2.5mg po 
qHS on ___ followed by 5mg po for ___ per ___ 
___ at ___ where patient followed. 
Patient will have INR drawn on ___.
  
# AFib: Chronic, persistent, w/ episodic RVR. Clinic visits 
noted HR has been in the ___ bpm range at baseline per 
Atrius records. Has previously utilized Digoxin for rate 
control, but now remains on Metoprolol for ___ blockade. In 
the ED, had evidence of A.fib with persistent RVR - she had 
skipped afternoon dosing of Metoprolol. On arrival to floor, HR 
stabilized with oral Metoprolol home dosing.  
- rate control: continued home Metoprolol tartrate 100 mg PO TID 
 
- rhythm control: deferred  
- anticoagulation: held given supratherapeutic INR    
 
# Asymptomatic Bacteruira - Reports no dysuria or hematuria. U/A 
on admission demonstrating 21 WBCs and moderate bacteria without 
epithelial cells; no ___ or nitrites. Received IV Ceftriaxone 1 g 
in the ED prior to admission. Her picture is more consistent 
with asymptomatic bacteruria. Afebrile. Leukopenic without 
neutropenia.  
- Did not continue antibiotics 
- no signs of infection 
- f/u urine cx : NGTD for 24+ hr

# IgG Multiple Myeloma- Presented with anemia in ___. 
Further testing demonstrated an ___ of approximately 3.3 
g/dL, IgG was 5800 mg/dL. Eventually, the patient was referred 
to Hematology, IgG increased to 7100 mg/dL at the start of 
treatment. Bone marrow biopsy revealed 60% of her bone marrow 
occupied by plasma cells, cytogenetics demonstrated 
translocation of chromosomes 11 and 14, also monosomy 13. 
Skeletal survey was negative. Now on cycle 28 (as of ___ of 
Lenalidomide with weekly Dexamethasone and Biaxin per Oncology. 
___ > 1500 on admission.  
- discussed patient with ___ attending Dr. ___
- continued C28 of Lenalidomide 15 mg PO daily (discuss with 
pharmacy)  
- continued Biaxin and held Dexamethasone dosing  
- bone metabolism - will continue Zometa every ___ (due 
___  
- trended ___: ___ 1500+  
 
# HTN - Stable on home regimen.
- continued home Lisinopril 20 mg PO daily  
- continued home Amlodipine 2.5 mg PO daily  
- continued home Metoprolol tartrate 100 mg PO TID  
- continued home Lasix 40 mg PO daily  

# Microscopic hematuria:  In the setting of high INR.  Please 
repeat UA on follow up.  Referral to urology recommended if 
persists.
 
# FEN/GI - Cardiac healthy diet, IVF and electrolyte repletion 
prn  
# COMMUNICATION - ___ (husband) - ___  
# CODE STATUS - FULL CODE (confirmed with patient)  
# Dispo: D/C'd to home with husband; ___ did not recommend any 
home services.

Transitional Issues:
- Follow up microhematuria with U/A via PCP
- ___ INR with appropriate coumadin adjustment via ___ 
___

 
Medications on Admission:
Preadmission medications listed are correct and complete.  
Information was obtained from Patient.
1. ___ 10 *NF* (potassium chloride) 10 mEq Oral DAILY 
2. Warfarin 5 mg PO DAILY16 
except ___ pills on ___ and ___ when INR is low 
3. Amlodipine 2.5 mg PO DAILY 
4. Vitamin D 1000 UNIT PO DAILY 
5. Furosemide 40 mg PO DAILY 
6. Lisinopril 20 mg PO DAILY 
7. Metoprolol Tartrate 100 mg PO TID 
8. Lenalidomide 15 mg PO DAILY 
9. Clarithromycin 250 mg PO DAILY 
10. Zometa *NF* (zoledronic acid;<br>zoledronic 
___ 4 mg/5 mL Injection every 3 months 
11. Dexamethasone 20 mg PO 1X/WEEK (MO) 

 
Discharge Medications:
1. Amlodipine 2.5 mg PO DAILY 
2. Clarithromycin 250 mg PO DAILY 
3. Furosemide 40 mg PO DAILY 
4. Lisinopril 20 mg PO DAILY 
5. Metoprolol Tartrate 100 mg PO TID 
6. Vitamin D 1000 UNIT PO DAILY 
7. Lenalidomide 15 mg PO DAILY 
8. ___ 10 *NF* (potassium chloride) 10 mEq ORAL DAILY 
9. Dexamethasone 20 mg PO 1X/WEEK (MO) 
10. Zoledronic Acid *NF* (zoledronic acid;<br>zoledronic 
___ 4 mg/5 mL INJECTION EVERY 3 MONTHS 
11. Warfarin 5 mg PO DAILY16 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
Elevated INR

Secondary Diagnosis:
Atrial Fibrillation CHADS Score 2
Multiple Myeloma

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
It was a pleasure taking care of you at ___ 
___.  You were admitted to the hospital for an 
elevated INR that is now coming down to normal.  You had no 
signs of bleeding and your blood pressure and heart rate were 
normal once we restarted your home dose of metoprolol.  Your INR 
is normal at 2.4 and the goal is to keep it between ___.  You 
will have your INR drawn on ___ and it will continue 
to be managed by ___.  We feel that you are 
ready for discharge and can continue to have your other medical 
conditions managed by your outpatient provider. Tonight, please 
take 2.5mg (one half of your normal dose). Please resume you 
normal dose of 5mg tomorrow and ___. Close follow up 
for your coumadin and INR is very important. Please stop taking 
your tramadol at home, because we believe this was increasing 
your INR to dangerous levels.

Please have urinalysis performed on a urine sample at next 
primary care visit, and follow up with Urology is blood is found 
in the urine. While you were here, there was no blood in your 
urine, but you reportedly did in the past.

Weigh yourself every morning, call your primary care provider if 
weight goes up more than 3 lbs.
 
Followup Instructions:
___
",MEDICINE
10003400-DS-14,Deanna Cuthill,10003400,29483621," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
BRBPR 
 
Major Surgical or Invasive Procedure:
___ Colonoscopy
___ Exam under anesthesia with a ___ biopsy

 
History of Present Illness:
Ms. ___ is a ___ year-old woman with AFib on coumadin, 
myeloma, HTN, and obesity who who presents to ___ ED with 
BRBPR.  
At baseline, the patient has 1 bowel movement a day that is 
soft/hard. Approximately 1 week ago, the patient had 3 days of 
constipation in the setting of not taking home stool softeners. 
Her next bowel movement occurred with significant straining, 
followed by significant pain with defecation and bright red 
blood staining in the toilet bowel. Since then, the patient has 
had continued abdominal cramping, pain with defecation and 
bright red blood in the toilet bowel with slight soft brown 
stool. Due to the fear of pain associated with BMs, the patient 
has stopped eating for the last ___ days, only taking in ""some 
broth."" In this setting, she endorses some increased weakness 
and 1 episode of dark stools (""looked like spinach"") but 
otherwise denies fever, chills, chest pain, SOB, abdominal pain. 
 

In the ED initial vitals were 99.9 86 142/92 18 100%RA. Labs 
were significant for Chem-10 with Cr 1.2 (baseline Cr 1.___ 
___ and hypophos to P 1.2, CBC with stable anemia H/H 
___ (baseline Hct ___, Trop 0.01, lactate 2.5, UA with 
few bacteria, 73 WBC, 57 RBC, large leuk, neg nitrites. 30 
minutes after arrival to ED, the patient triggered for 
hypotension to sBP 90/71. The patient was bolused 3L NS with 
imrpvoement in sBP to low 100s. No other 
medications/interventions in the ED. The patient is now admitted 
to Medicine for further monitoring. Vitals prior to transfer 
were 99.1 108 102/68 18 100% RA.  

On the floor, VS 98.9 112/56 106 20 99%RA and patient reports 
that she feels somewhat improved from a weakness standpoint but 
continues to have pain in the rectal region.  
 
Past Medical History:
Hypertension  
Atrial fibrillation on coumadin  
Obesity  
Myeloma    
Osteoarthritis of right knee  
CKD stage 3 (baseline Cr 1.4) 
UPJ obstruction s/p stent placement ___ c/b persistent 
Klebsiella bacteruria  
? Perirectal cyst drainage in 1980s 
 
Social History:
___
Family History:
Her parents died in their ___ or ___ of ""old age.""  Her parents 
and multiple siblings have hypertension.  There is no family 
history of significant arrhythmia or premature coronary disease.
 
Physical Exam:
ADMISSION PHYSICAL EXAM
Vitals: 98.9 112/56 106 20 99%RA  
GENERAL: Elderly woman, lying in bed, NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, dry MM, good 
dentition  
NECK: Supple neck, no JVD  
CARDIAC: RRR, S1/S2, faint SEM, no gallops or rubs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: Nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly  
RECTAL: Hyperpigmentation surrounding rectal area, no visible 
external hemorrhoid. Area internal to sphincter with friable 
mucosa, trace brown stool slightly streaked with blood 
(guaiac+), and fissure in posterior midline  
EXTREMITIES: Trace edema, no cyanosis, clubbing, moving all 4 
extremities with purpose  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  

DISCHARGE PHYSICAL EXAM
Vitals: 98.4  122/66  93  18  100%
GENERAL: Elderly woman, appears comfortable, bundled in blankets
CARDIAC: RRR, S1/S2, faint SEM, no gallops or rubs  
LUNG: CTAB
ABDOMEN: Soft, no tenderness to palpation, but hard mass 
appreciated in lower abdomen    
EXTREMITIES: Trace edema, no cyanosis, clubbing, moving all 4 
extremities with purpose   
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes
 
Pertinent Results:
ADMISSION LABS:
___ 04:35PM BLOOD WBC-4.1 RBC-3.72* Hgb-11.0* Hct-32.5* 
MCV-87 MCH-29.5 MCHC-33.8 RDW-20.8* Plt ___
___ 04:35PM BLOOD Neuts-69.2 Lymphs-16.1* Monos-12.3* 
Eos-2.1 Baso-0.3
___ 04:35PM BLOOD ___ PTT-20.7* ___
___ 04:35PM BLOOD Glucose-92 UreaN-17 Creat-1.2* Na-144 
K-4.1 Cl-106 HCO3-25 AnGap-17
___ 04:35PM BLOOD cTropnT-0.01
___ 04:35PM BLOOD Calcium-8.2* Phos-1.2*# Mg-1.8
___ 04:44PM BLOOD Lactate-2.5*

INTERVAL LABS:

___ 05:45AM BLOOD Ret Aut-1.0*
___ 06:50AM BLOOD VitB12-597
___ 05:45AM BLOOD Folate-6.1
___ 05:30AM BLOOD calTIBC-165* Ferritn-423* TRF-127*
___ 05:45AM BLOOD PEP-AWAITING F IgG-485* IgA-65* IgM-20* 
IFE-PND
___ 05:45AM BLOOD CEA-20*

MICROBIOLOGY:

Time Taken Not Noted     Log-In Date/Time: ___ 8:34 pm
      URINE      TAKEN FROM ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH FECAL
      CONTAMINATION. 

___ 7:30 pm URINE      Source: ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 

RADIOLOGY:
___ KUB
IMPRESSION:  
No bowel obstruction.  Moderate amount of colonic stool.  No 
free air. 

___ MRI Pelvis
IMPRESSION:  
1.  Right anal mass encompassing the right aspect of the 
internal sphincter, extending approximately 7 cm into the lower 
rectum with suspected invasion through the left anterior aspect 
of the external sphincter into the mesorectal fat. 
2.  Small hematoma along the left aspect of the hysterectomy 
vaginal cuff. 

___ CT Abd/Pelvis
IMPRESSION: 
1. Anal carcinoma is not well characterized on this CT 
examination therefore see MRI done same day for further 
characterization. 
2. The right kidney is lobulated with areas of thinned cortex. 
There is 
proximal ureteral dilation with double-J stent and abnormal 
appearance of the bladder, likely postsurgical.  Please 
correlate with patient's surgical history. No hydronephrosis is 
noted. 
3. Heterogeneous liver attenuation without focal lesions, please 
correlate with liver function tests. 
4. Compression fracture of the superior endplate of L2 and L3 of 
indeterminate age, although sclerosis at L2 suggests chronicity. 


___ CT Chest
IMPRESSION:  
Motion limited exam. 
No evidence of pulmonary metastases. 
Small bilateral layering non-hemorrhagic pleural effusions. 
Dilated main pulmonary artery suggests pulmonary arterial 
hypertension. 
Thyroid nodules measuring up to 1.5 cm in the isthmus warrant 
dedicated 
ultrasound for further evaluation. 
Moderate cardiomegaly with predominantly biatrial enlargement. 

PATHOLOGY:
SURGICAL PATHOLOGY REPORT - Final
PATHOLOGIC DIAGNOSIS:
1. Perianal lesion, biopsy:
-Mucinous adenocarcinoma; see note.
2. Perianal lesion, biopsy:
-Mucinous adenocarcinoma; see note.
-Note: The tumor shows patchy signet-ring differentiation 
consistent a high-grade tumor. Tumor cells are positive for CK7 
(patchy), CK20, and CDX-2. The differential diagnosis includes 
primary anal adenocarcinoma and primary rectal adenocarcinoma 
with secondary involvement of the anus.

DISCHARGE LABS:

___ 10:50AM BLOOD WBC-2.5* RBC-3.02* Hgb-9.0* Hct-26.8* 
MCV-89 MCH-29.7 MCHC-33.4 RDW-20.4* Plt ___
___ 10:50AM BLOOD ___ PTT-30.3 ___
___ 10:50AM BLOOD Glucose-122* UreaN-8 Creat-0.9 Na-142 
K-3.4 Cl-108 HCO3-24 AnGap-13
___ 10:50AM BLOOD Calcium-8.5 Phos-1.6* Mg-2.___ with AFib on coumadin, myeloma, HTN, and obesity who who 
presents to ___ ED with BRBPR found to have newly diagnosed 
anal adenocarcinoma.

# Anal adenocarcinoma: Patient initially presented with a 
history of changes in bowel habits and some bright red blood per 
rectum. Initial concern was for anal fissure, but after being 
seen by GI, they recommended evaluation by Colon and Rectal 
Surgery. They agreed that her lesion was concerning for 
malignancy, so she underwent EUS/biopsy with colorectal surgery 
___, which revealed lesion concerning for anal squamous cell 
caricnoma. Baseline CEA 20. Staging scans showed local disease 
without suspicious regional LAD, and no distant mets. She also 
underwent colonoscopy which showed no evidence of disease beyond 
the known anal/rectal lesion.

# Anal/rectal pain: Patient's pain was controlled initially with 
tylenol and dilaudid, then transitioned to tylenol and 
oxycodone. She was placed on an aggressive bowel regimen to keep 
her bowel movements soft so as not to cause additional pain. Her 
bowel regimen included docusate, colace and miralax, as well as 
being advised to increase and regulate her fiber intake. She was 
also given nitroglycerin 0.02% cream, 2% lidocaine ointment, 
Tuck's ointment and perineum care recommendations from wound 
care nursing.

# Pancytopenia: Patient with downtrending thrombocytopenia, also 
with neutropenia and stable anemia noted on admission. She was 
midly neutropenic. This was thought to be a combination of 
lenalidomide effect combined with anemia of chronic disease. No 
bony metastases were seen on initial cancer staging to implicate 
bone marrow spread. Heme/Onc consult from ___ recommended that 
this be followed as an outpatient but did not require inpatient 
work-up.

# IgG Myeloma: Patient with longstanding IgG MM, followed by 
___ Oncology for which she is on lenolidamide days ___ of 28 
days and dexamethasone 1x/week on weeks when she takes 
lenolidamide. The patient completed her last 3 weeks of Revlamid 
___. Also received Zometa ___. 
Lenolidamide/dexamethasone was held while patient was admitted 
due to risk of poor wound healing from biopsy. She was seen by 
Heme/Onc Consult from ___ who recommended following her 
pancytopenia and following up with her oncologist, Dr. ___ 
___ as an outpatient.

# Asymptomatic bacteruria: Patient has a history of chronic 
Klebsiella bacteriuria as a complication of UPJ obstruction s/p 
stent placement in ___. Patient was asymptopmatic from this 
during her hospitalization. She was monitored for active 
symptoms of UTI. 

# AFib on coumadin: Stable during admission. Did require 
adminsitration of FFP before biopsy and colonoscopy with FFP. 
Otherwise, was continued on home metoprolol, diliazem and 
warfarin. 

# Hypertension: Was relatively hypotensive initially, which 
prompted the team to hold lasix. Near the end of her hosptial 
course, she began to endorse some leg swelling, so we restarted 
furosemide ___. She was continued on diltiazem and 
metoprolol for the duration of her hospital stay as per above.

# CKD Stage 3: Cr 1.2 on admission, within recent baseline of 
1.4. Down to 0.9 at discharge.

TRANSITIONAL ISSUES:
- Patient is not being discharged on Bactrim since she is not 
currently taking dexamethasone.
- Patient should follow-up with Dr. ___ as an outpatient who can 
then refer to Dr. ___ Colon & Rectal Surgery 
Multidisciplinary follow-up.
- Continue bowel regimen to prevent constipation and subsequent 
painful bowel movements
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Lenalidomide 15 mg PO DAILY ON DAYS ___. Dexamethasone 20 mg PO 1X/WEEK (TH) on weeks taking 
lenalidomide 
3. Clarithromycin 250 mg PO DAILY 
4. Diltiazem Extended-Release 120 mg PO DAILY 
5. Metoprolol Tartrate 100 mg PO TID 
6. Vitamin D 1000 UNIT PO DAILY 
7. Potassium Chloride 20 mEq PO DAILY 
8. Furosemide 80 mg PO DAILY 
9. Warfarin 2.5 mg PO DAILY16 

 
Discharge Medications:
1. Diltiazem Extended-Release 120 mg PO DAILY 
2. Metoprolol Tartrate 100 mg PO TID 
3. Potassium Chloride 20 mEq PO DAILY 
4. Vitamin D 1000 UNIT PO DAILY 
5. Warfarin 2.5 mg PO DAILY16 
6. Acetaminophen 325-650 mg PO Q6H:PRN pain 
7. Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg ___ capsule(s) by mouth Twice daily 
Disp #*30 Capsule Refills:*0
8. nitroglycerin 0.2 % rectal QID 
Please apply to anorectal area after bowel movements as needed.  

RX *nitroglycerin [Rectiv] 0.4 % (w/w) 1 ointment(s) rectally 
four times a day Refills:*0
9. Psyllium 1 PKT PO DAILY 
RX *psyllium  1 packet(s) by mouth Daily Disp #*30 Packet 
Refills:*0
10. Senna 8.6 mg PO BID 
RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp 
#*60 Tablet Refills:*0
11. Tucks Hemorrhoidal Oint 1% 1 Appl PR SIX TIMES DAILY PRN 
Anorectal pain 
RX *pramoxine-mineral oil-zinc [Tucks] 1 %-12.5 % 1 ointment(s) 
rectally four times a day Refills:*0
12. Dexamethasone 20 mg PO 1X/WEEK (TH) on weeks taking 
lenalidomide 
13. Furosemide 80 mg PO DAILY 
14. Lenalidomide 15 mg PO DAILY ON DAYS ___. Polyethylene Glycol 17 g PO DAILY 
RX *polyethylene glycol 3350 [Miralax] 17 gram/dose 1 TSBP by 
mouth Daily Refills:*0
16. Lidocaine Jelly 2% 1 Appl TP BID 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Anal adenocarcinoma
Hypotension
Atrial fibrillation
Multiple Myeloma
pancytopenia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you during your recent stay at 
___. You were admitted after seeing some blood in your stool 
and because your blood pressure was low.

Upon further investgiation, you were found to have a mass around 
your anus that was biopsied by colorectal surgery and 
unfortuantely found to represent a cancer. You had some scans 
done to see if the cancer had spread, which it has not. You 
underwent a colonoscopy as well to look at the rest of your 
colon, which did not show any additional lesions.

You should make sure to eat lots of fiber to keep your bowel 
movements regular and use stool softeners to keep them soft. 
Avoid straining when you are having a bowel movement. Use the 
medications, ointments and suppositories prescribed to help with 
your pain. 

Please follow-up with your doctors as below. You should 
follow-up with Dr. ___ also with Colon & Rectal Surgery in 
their ___ where you will see different 
kinds of doctors to ___ up with a plan for the next steps.

It was a pleasure taking care of you. We wish you the best!
- Your ___ Care Team
 
Followup Instructions:
___
",MEDICINE
10003400-DS-15,Deanna Cuthill,10003400,26467376," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
afib with rvr
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Mrs ___ is a ___ with obesity, atrial fibrillation on 
coumadin, CKD III (recent baseline 0.88-1.1), UPJ obstruction 
s/p stent placement ___ c/b persistent Klebsiella bacteruria, 
chronic multiple myeloma,  and adenocarcinoma of anal canal dx 
___ who presents with atrial fibrillation with rapid 
ventricular response. 

Pt was seen by PCP ___, ___, for pre-op visit re: 
cystoscopy and right ureteral stent exchange. She presented with 
complaints of fatigue, inability to stand due to pain in legs, 
and bilateral leg swelling. Metoprolol had been hold at nursing 
home due to intermittent hypotension. EKG in office showed AF 
with RVR in 140s and she was sent to the ED. 
 
In the ED, initial VS were 98.3 157 115/81 18   
Exam significant for  
Labs significant for Cr 1.2, (baseline .9), phos 1.7, WBC 3.8, 
Hb 9.6, INR of 6.5, and troponin of 0.02.
Imaging significant for normal CXR.  
Initially received 5 mg IV metoprolol tartrate, 50 mg metoprolol 
tartrate PO, and 1L NS. Due to persistent tachycardia to the 
130s, she received an additional 5 mg IV metoprolol x2 then 
diltiazem 10 mg IV.
 
Transfer VS were 98.6 ___ 16 100% RA. On arrival to the 
floor, patient reports that she has been feeling tired, 
lightheaded and dizzy for several weeks. She has also had 
bilateral leg pain both at rest and exacerbated with weight 
bearing. She has also had decreased PO intake and describes dry 
mouth. She also describes dysuria, but no frequency or flank 
pain. She denies fevers and night sweats, but admits to feeling 
cold. 
 
REVIEW OF SYSTEMS:  
Denies fever, night sweats, headache, vision changes, 
rhinorrhea, congestion, sore throat, cough, shortness of breath, 
chest pain, abdominal pain, nausea, vomiting, diarrhea, 
constipation, BRBPR, melena, hematochezia, or hematuria.  
All other 10-system review negative in detail
 
Past Medical History:
Hypertension  
Atrial fibrillation on coumadin  
Obesity  
Myeloma    
Osteoarthritis of right knee  
UPJ obstruction s/p stent placement ___ c/b persistent 
Klebsiella bacteruria  
Anal adenocarcinoma (dx ___ without evidence of metastatic 
dz
? Perirectal cyst drainage in ___ 

 
Social History:
___
Family History:
Her parents died in their ___ or ___ of ""old age.""  Her parents 
and multiple siblings have hypertension.  There is no family 
history of significant arrhythmia or premature coronary disease.
 
Physical Exam:
ADMISSION EXAM:
VS:  98.9 112 18 112/61 100RA
Tele: irreg irreg 100s 
GENERAL: NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclerae, pink conjunctivae, 
patent nares, poor dentition, dry oral mucosa
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: irregulary irregularm no murmurs, gallops, or rubs.  no 
carotid bruits  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly, no CVA tenderness  
EXTREMITIES: No cyanosis or clubbing; Diffuse anasarca, BLE > 
BLE. 2+ pitting edema in BLE to knee. Bilateral knees edematous, 
but non erythematous.   
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact (with the exception of mild left side of 
mouth droop). Strength:
RUE flexor/extensors ___
LUE rlexor/extensors ___
RLE knee extensor ___
LLE knee extensor ___
Unable to elicit bilateral patellar reflexes; Downward babinkski 
bilat  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  

DISCHARGE EXAM:
VS Tm 98 18 ___ 100RA
Tele: irreg 100s, excursions to 130s
IO: 24h 1140/inc + 5 BMs (small)
GENERAL: NAD  
HEENT: AT/NC, EOMI, anicteric sclerae, pink conjunctivae, patent 
nares, poor dentition
NECK: nontender supple neck, no LAD, no JVD 
CHEST: right-sided portacath accessed, bandage c/d/i, no 
induration/ttp 
CARDIAC: irregulary irregular, no murmurs, gallops, or rubs.  no 
carotid bruits  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly 
EXTREMITIES: No cyanosis or clubbing; Diffuse anasarca, BLE > 
BUE. 2+ pitting edema in BLE to knee, improved since admission. 
Bilateral knees edematous, but non erythematous.   
PULSES: 2+ DP pulses bilaterally  

 
Pertinent Results:
ADMISSION LABS:
---------------
___ 01:30PM BLOOD WBC-3.8*# RBC-3.39* Hgb-9.6* Hct-29.4* 
MCV-87 MCH-28.3 MCHC-32.6 RDW-19.4* Plt ___
___ 01:30PM BLOOD Neuts-77.1* Lymphs-14.1* Monos-8.4 
Eos-0.4 Baso-0.1
___ 01:30PM BLOOD ___ PTT-35.9 ___
___ 01:30PM BLOOD Glucose-105* UreaN-18 Creat-1.2* Na-137 
K-4.1 Cl-100 HCO3-23 AnGap-18
___ 01:30PM BLOOD cTropnT-0.02*
___ 01:30PM BLOOD Albumin-3.0* Calcium-8.1* Phos-1.7* 
Mg-1.9
___ 01:56PM BLOOD Lactate-2.6*

PERTINENT LABS:
---------------
___ 01:30PM BLOOD CK(CPK)-77
___ 09:10PM BLOOD cTropnT-0.01
___ 04:46AM BLOOD Cortsol-30.5*
___ 09:24PM BLOOD Lactate-1.2
___ 10:59PM URINE Color-DkAmb Appear-Cloudy Sp ___
___ 10:59PM URINE Blood-MOD Nitrite-NEG Protein-600 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG
___ 10:59PM URINE RBC-67* WBC->182* Bacteri-MANY Yeast-MOD 
Epi-7
___ 10:33AM URINE Color-Yellow Appear-Cloudy Sp ___
___ 10:33AM URINE Blood-MOD Nitrite-NEG Protein-600 
Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG
___ 10:33AM URINE RBC-46* WBC->182* Bacteri-MOD Yeast-FEW 
Epi-25

MICROBIOLOGY:
-------------
BLOOD CULTURE ___: Negative
URINE CULTURE ___: YEAST ___, org/ml
URINE CULTURE ___: YEAST ___, org/ml
STOOL C. DIF TOXIN ___: POSITIVE
URINE CULTURE ___: YEAST ___, org/ml

DISCHARGE LABS:
---------------
___ 05:55AM BLOOD WBC-3.5* RBC-2.81* Hgb-8.1* Hct-24.6* 
MCV-88 MCH-28.7 MCHC-32.7 RDW-19.8* Plt ___
___ 05:55AM BLOOD Glucose-159* UreaN-21* Creat-0.9 Na-138 
K-4.1 Cl-109* HCO3-22 AnGap-11
___ 05:55AM BLOOD Calcium-7.7* Phos-2.7 Mg-2.0

STUDIES:
--------
___ CXR: IMPRESSION: No acute cardiopulmonary abnormality. 
 
Brief Hospital Course:
___ PMHx obesity, atrial fibrillation on coumadin, CKD III 
(baseline 1.4) and chronic multiple myeloma and adenocarcinoma 
of anal canal (dx'ed ___ presenting for AFib with RVR.

ACUTE ISSUES:
-------------
# Atrial fibrillation with RVR: Pt presented initially with RVR 
in the 140s. Most likely in the setting of B-blocker and CCB 
being held due to hypotension. C. diff infection (see below) 
most likely contributing to hypotension. Pt received IV 
metoprolol and IV diltiazem in ED and was started on PO 
metoprolol/diltiazem on floor. She was also fluid resuscitated. 
Patient discharged with control of afib with RVR with PO metop 
and diltiazem at home doses. INR was supratherapeutic and 
coumadin was held (see below). 

# Hypotension: Per nursing home, she had intermittent 
hypotension requiring  discontinuation of her metoprolol and 
diltiazem. Most likely secondary to decreased PO intake/loose 
stools from C.diff infection. Adrenal insufficiency secondary to 
chronic steroid use in the setting of infection was ruled out 
with AM cortisol (30). 

# Funguria, bacteruria: Pt initially reported dysuria and UA x2 
showed large leuks/bacteria/yeast. Despite being contaminated, 
due to symptoms of dysuria, she was initially treated with IV 
CTX. Urine cultures eventually grew only yeast, prompting 
discontinuation of CTX. She was no longer symptomatic at this 
time, and she had no CVA tenderness or systemic symptoms of 
infection. She had a foley place initially for urine output 
monitoring, however, this was removed. Funguria will be treated 
with fluconazole for total 7 days of therapy. 

# C.difficile infection: Although no recent history of 
antibiotics, patient immunosuppressed and at rehabilitation 
facility. She was initially started on PO metronidazole on 
___, but this was changed to PO vanc, given that she is 
immunosuppresed and falls into the severe category. ___, 
___.

# Coagulopathy: INR on admission was 6.5. Most likely secondary 
to decreased PO ntake and exacerbated antibiotics. No active 
signs of bleeding. Once INR reached 7.8, she was given 2.5 mg PO 
vitamin K. She received additional 2.5 mg PO vitamin K on 
___. Coumadin was held on discharge.  

# Acute on chronic CKD (stage 3): Cr 1.2 (baseline 0.8-1.1). 
Most likely secondary to decreased PO intake and decreased 
cardiac output from afib with RVR. Creatinine improved with IVF.

# Lower extremity edema: Multi-factorial. Most likely venous 
stasis vs diastolic heart failure, especially in the setting of 
afib with RVR, vs hypoalbuminemia. Pa/lateral film in ED showed 
no cardiomegaly or pulmonary vascualar congestion to suggest 
decompensated systolic heart failure. Pt on furosemide at home. 
Albumin was 3.0. Furosemide held on admission due to ___. Edema 
was managed with pneumatic boots. Furosemide was restarted at 40 
mg on discharge. 

# UPJ obstruction s/p stent placement ___ c/b persistent 
Klebsiella bacteruria: Pt scheduled for stent replacement soon. 
She had no CVA tenderness on exam and creatinine was stable 
after IVF. Pt was scheduled to have stent replaced on ___, 
but procedure was cancelled due to supratherapeutic INR. Per 
Urology, pt's INR needs to be <3.0 and she will need this 
procedure in the next ___ months. 

# Troponinemia: Most likely strain from RVR vs decreased 
clearance in the setting of ___. Peaked at 0.02 before 
downtrending.

# Hyperlactatemia: Lactate 2.6 on admission. Most likely 
secondary to dehydration versus ineffective cardiac output from 
RVR. Peaked at 2.6 before downtrending.

CHRONIC ISSUES:
---------------
# Weakness: She had generalized total body weakness, with the 
lower extremities worse than upper extremities. Also with the 
left ___ greater than right ___. No documented previous CVA 
to which asymmetry can be attributed. Most likely deconditioning 
and myopathy from dexamethasone, versus myositis or 
cerebrovascular event, both thought unlikely. CK was within 
normal limits. ___ worked with patient and she was discharged 
back to rehab.

# Leg pain: Most likely osteoarthritis. She does not have 
diabetes to suggest neuropathy. She continued home oxycodone 10 
mg qHS.

# Pancytopenia: Patient with stable neutropenia, anemia, 
thrombocytopenia improved from prior, thought to be secondary to 
lenalidomide as well as anemia of chronic disease.

# Anal adenocarcinoma: Diagnosed recently in ___. T2N0M0. 
Staging scans showed local disease without suspicious regional 
LAD, and no distant mets. Baseline CEA 20. Has plans for 
colorectal surgeon Dr. ___ diverting ostomy. S/p port 
placement in ___. Plans for chemo/radiation. Updated 
oncologist.

# Anorectal pain: Her bowel regimen included docusate, colace 
and miralax, as well as being advised to increase and regulate 
her fiber intake. She was also given nitroglycerin 0.02% cream, 
2% lidocaine ointment, Tuck's ointment and perineum care 
recommendations from wound care nursing. Bowel regimen was held 
in the setting of loose stools. 

# IgG myeloma: Patient with longstanding IgG MM, followed by 
___ Oncology for which she is on lenolidamide days ___ of 28 
days and dexamethasone 1x/week on weeks when she takes 
lenolidamide. The patient completed her last 3 weeks of Revlamid 
___. Also received Zometa ___. 
Lenolidamide/dexamethasone was held during admission due to 
infection. 

TRANSITIONAL ISSUES:
--------------------
- C.diff infection, Severe: Needs PO vancomycin 125mg PO QID 
until ___ for total 14 day treatment course.
- Funguria: Three urine cultures grew >100,000 cfu/ml of yeast. 
She was started on fluconazole treatment, per her Urologist. D1 
= ___, D7 = ___.
- Ureteral stent replacement: Was scheduled for replacement on 
___, but cancelled due to supratherapeutic INR. Her stent 
can be replaced when her INR is therapeutic (2.0 - 3.0). When 
therapeutic, please call her Urologist Dr. ___ to schedule a 
stent replacement. She will also see him on ___.
- Supratherapeutic INR: Will need daily INR checks to follow INR 
until therapeutic so Coumadin may be restarted. If uptrending 
x72hours, consider 2.5mg PO vitamin K (in the absence of normal 
gut flora due to C. diff infection).
- Diastolic heart failure: Patient restarted on lower dose of 
furosemide 40 mg. Uptitrate as necessary based on volume status 
and kidney function.
- Myeloma: Revlamid/dexamethasone held during admission and on 
discharge. Please call her Oncologist Dr. ___ to discuss 
restarting on ___.
- Rectal adenocarcinoma: Stool softeners should be held until 
frequency and consistency of BM normalizes.

# Emergency Contact/HCP: ___ (son) ___ and 
___ (son) ___ 
# CODE: FULL, confirmed
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Docusate Sodium 100 mg PO BID 
2. Polyethylene Glycol 17 g PO DAILY 
3. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with 
sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 
4. Senna 8.6 mg PO BID 
5. Diltiazem Extended-Release 120 mg PO DAILY 
6. Furosemide 80 mg PO DAILY 
7. Metoprolol Tartrate 100 mg PO TID 
8. Potassium Chloride 20 mEq PO DAILY 
9. Vitamin D 1000 UNIT PO DAILY 
10. Lenalidomide 15 mg PO   DAILY 
11. Dexamethasone 20 mg PO ASDIR 
12. Warfarin 3 mg PO DAILY16 
 
Discharge Medications:
1. Diltiazem Extended-Release 120 mg PO DAILY 
2. Furosemide 40 mg PO DAILY 
3. Metoprolol Tartrate 100 mg PO TID 
Hold for HR<55 or SBP<90 
4. Vitamin D 1000 UNIT PO DAILY 
5. Fluconazole 200 mg PO Q24H Duration: 7 Days 
Last day = ___ 
6. Vancomycin Oral Liquid ___ mg PO Q6H 
Day 14 = ___ 
7. Docusate Sodium 100 mg PO BID 
Hold for loose stools 
8. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with 
sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 
Hold for loose stools.  
9. Polyethylene Glycol 17 g PO DAILY 
Hold for loose stools 
10. Potassium Chloride 20 mEq PO DAILY 
11. Senna 8.6 mg PO BID 
Hold for loose stools. 
 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnoses: 
-atrial fibrillation with rapid ventricular response
-c.difficile infection, severe

Secondary diagnoses:
-multiple myeloma
-rectal adenocarcinoma
-pancytopenia
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear ___,

___ was a pleasure taking care of you at the ___ 
___. You were admitted for a fast heart 
rate. We treated this with intravenous medications, and then 
restarted your home medications. You were also found to have an 
infection of your colon called C.difficile. You will need to 
continue antibiotics by mouth for this. 

Your INR (measure of how thin your blood is from warfarin) is 
still elevated. Your rehab will measure this and restart 
warfarin when appropriate.

Please remember to weigh yourself every morning, and speak to 
your MD if your weight rises by more than 3lbs.

On behalf of your ___ team, 
We wish you a speedy recovery!
 
Followup Instructions:
___
",MEDICINE
10003400-DS-16,Deanna Cuthill,10003400,27296885," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
ALTERED MENTAL STATUS
 
Major Surgical or Invasive Procedure:
NONE
 
History of Present Illness:
Ms. ___ is a ___ year-old woman a ___ significant for AFib on 
coumadin, UPJ obstruction s/p stent placement in ___ c/b 
chronic Klebsiella bacturia, IgG myeloma on lenolidamide, and 
recently diagnosed adenocarcinoma of the anal canal who presents 
with altered mental status. Of note, patient is currently unable 
to relay any of her medical information (only response to 
questions is ""I don't know""). As such, much of medical 
information is obtained from medical records. Per ED note, the 
patient was brought in from ___. Her 
family reports that that she has had AMS for the last ___ days. 
to the point that she does not recognize her family members and 
does not know where she is. Upon arrival to ___ ED, initial VS 
97.7 91 111/68 16 100%. Labs notable for Chem-7 wnl, P2.0, LFTS 
wnl, Alb 2.8, CBC with pancytopenia 2.8>9.1<140, coags with INR 
3.6. UA positive with large leuk, neg nitrites, 137 WBC, few 
bacteria. CXR without cardiopulmonary process. Pateint was 
administered 500cc LR, ceftriaxone 1g x1. She is now admitted to 
medicine for further management. Vitals prior to transfer 98 88 
140/80 18 100% RA.  
On the floor, initial VS 97.7 110/57 72 18 98%RA. The patient in 
lying in bed NAD but her only response to questions are ""I don't 
know.""  
 
Past Medical History:
Hypertension  
Atrial fibrillation on coumadin  
Obesity  
Myeloma    
Osteoarthritis of right knee  
UPJ obstruction s/p stent placement ___ c/b persistent 
Klebsiella bacteruria  
Anal adenocarcinoma (dx ___ 
? Perirectal cyst drainage in 1980s 

 
Social History:
___
Family History:
Her parents died in their ___ or ___ of ""old age.""  Her parents 
and multiple siblings have hypertension. Sibling with 
Alzheimer's disease. No family history of significant arrhythmia 
or premature coronary disease.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
Vitals: 97.7 110/57 72 18 98%RA  
GENERAL: Elderly woman, lying in bed, NAD  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM  
NECK: nontender supple neck, no LAD, no JVD  
CARDIAC: Irregularly irregular, +S1/S2, no murmurs, gallops, or 
rubs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly. Anus with friable 
mucosa.  
EXTREMITIES: 2 piting edema up through shins bilaterally, no 
cyanosis or clubbing  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII and motor grossly intact intact  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes  
 
DISCHARGE PHYSICAL EXAM:
Vitals: 99.0 (99.0) 119/71 (100-120/50-80) 85 (60-90) 18 100%RA
I/O: 1140/inc
Weight: 86.7 kg
GENERAL: elderly woman lying in bed in NAD.  
HEENT: AT/NC, EOMI, PERRL, anicteric sclera
CARDIAC: irregularly irregular, +S1/S2, no murmurs
LUNG: CTAB, no wheezes, mild crackles, breathing comfortably
ABDOMEN: non-distended, +BS, non-tender in all quadrants, no 
rebound/guarding  
EXTREMITIES: 2+ piting edema to shins bilaterally
NEURO: CN II-XII grossly intact, AA+O X 3. did not know day of 
the week. uncooperative with other cognitive questions
SKIN: warm and well perfused, no rashes  

 
Pertinent Results:
ADMISSION LABS
=============================
___ 05:30PM   WBC-2.8* RBC-3.31* HGB-9.1* HCT-28.6* MCV-87 
MCH-27.4 MCHC-31.6 RDW-20.8*
___ 05:30PM   NEUTS-71.7* LYMPHS-17.9* MONOS-8.5 EOS-1.6 
BASOS-0.2
___ 05:30PM   PLT COUNT-140*
___ 05:30PM   ___ PTT-35.1 ___
___ 05:30PM   ALT(SGPT)-16 AST(SGOT)-20 ALK PHOS-83 TOT 
BILI-0.6
___ 05:30PM   LIPASE-24
___ 05:30PM   GLUCOSE-99 UREA N-6 CREAT-0.6 SODIUM-141 
POTASSIUM-3.3 CHLORIDE-104 TOTAL CO2-31 ANION GAP-9
___ 04:40PM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-30 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-8.0 
LEUK-LG
___ 04:40PM URINE  RBC-12* WBC-137* BACTERIA-FEW YEAST-NONE 
EPI-1

PERTINANT LABS
==============================
___ 05:01AM BLOOD ___
___ 05:47AM BLOOD ___ PTT-33.4 ___
___ 05:47AM BLOOD VitB12-471
___ 05:47AM BLOOD TSH-2.6

DISCHARGE LABS
==============================
___ 05:19AM BLOOD WBC-3.1* RBC-2.90* Hgb-8.1* Hct-25.4* 
MCV-88 MCH-28.1 MCHC-32.0 RDW-20.5* Plt ___
___ 05:19AM BLOOD ___ PTT-35.6 ___
___ 05:19AM BLOOD Glucose-95 UreaN-5* Creat-0.6 Na-142 
K-3.6 Cl-108 HCO3-27 AnGap-11
___ 05:19AM BLOOD Calcium-7.8* Phos-1.8* Mg-1.9

IMAGING
==============================
CXR (___):
No evidence of acute cardiopulmonary disease.

Head CT w/o contrast (___):
1. No acute intracranial abnormality. 
2. Please note MRI of the brain is more sensitive for the 
evaluation of acute infarct. 
3. Atrophy and probable small vessel ischemic changes as 
described. 
4. 15 mm right posterior neck probable dermal inclusion cyst as 
described. Recommend clinical correlation and correlation with 
direct examination.

MICROBIOLOGY
==============================
URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION.
BLOOD CULTURE x 2: NGTD 
 
Brief Hospital Course:
___ with AFib on coumadin, UPJ obstruction s/p stent placement 
in ___ c/b chronic Klebsiella bacturia, IgG myeloma on 
lenolidamide, and recently diagnosed adenocarcinoma of the anal 
canal who presents with altered mental status.

# Subacute congitive decline: Patient presenting from assisted 
living facility with several days of progressive AMS. On 
admission was A+O X 1 without focal deficits but quickly 
improved to orientation x3. Differential included infectious 
etiology (ie UTI), mild dementia per family report or subacute 
hemorrhage given supratherapeutic INRs. NCHCT obtained on 
___ and showed no acute intracranial abnormality. 
Initially covered with ABX for possible to be UTI (see below) 
but ABX stopped with urine culture unrevealing. TSH and B12 WNL. 
Given hx of rectal adenocarcinoma, considered potential brain 
metastasis, however with no localizing symptoms and low burden 
malignancy so head MRI was deferred. Please arrange 
neurocognitive work-up to exclude dementia vs 
depression/pseudodementia as outpatient given mental status 
largely notable for apathy and pt being withdrawn with 
relatively good attention and orientation which makes an acute 
encephalopathy less likely.
.
# Pyuria: Patient has a history of chronic Klebsiella 
bacteriuria as a complication of UPJ obstruction s/p stent 
placement in ___. Seen previously by ID who recommended not 
treating unless symptoms. Given that she presented with altered 
mental status, she was started on ceftriaxone. However, urine 
culture on ___ returned with mixed flora and CTX stopped.  
.
# Anal adenocarcinoma: Diagnosed recently in ___. T2N0M0. 
Staging scans showed local disease without suspicious regional 
LAD, and no distant mets. Baseline CEA 20. Has plans for 
colorectal surgeon Dr. ___ diverting ostomy. Home bowel 
regimen of metamucil, senna, colace was continued.
.
# AFib: CHADS = 2. Patient was rate-controlled during 
hospitalization. INR 3.6 on admission. Home warfarin was held 
given supratherapeutic INR. Rate-control agents with home 
diltiazem and metoprolol was also continued. Warfarin restarted 
at lower dose on ___.
.
# Hypertension: Normotensive. Home BB/CCB and furosemide were 
continued.  
.
# CKD Stage 3: Baseline Cr 0.8-1.1, currently 0.6.  
.
# IgG Myeloma: Patient with longstanding IgG MM, followed by 
___ Oncology. 
.
TRANSITIONAL ISSUES:
========================
-will benefit from neurocognitive evaluation to further 
elucidate possibility of dementia
-would also assess for pseudodementia/depression with psychiatry 
evaluation
-will need to discuss with outpatient oncologist re: Revalmid 
therapy
-pt requires motivation from staff for participation in ___ 
activities. Please promote OOB to chair for all meals and 
encourage PO intake.
-f/u with colorectal surgeon (Dr. ___ for mgmt of anal 
adenocarcinoma
-full code
-contact ___ (son) ___ and ___ (son) 
___ 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Diltiazem Extended-Release 120 mg PO DAILY 
2. Furosemide 40 mg PO DAILY 
3. Metoprolol Tartrate 100 mg PO TID 
4. Vitamin D 1000 UNIT PO DAILY 
5. Docusate Sodium 100 mg PO BID 
6. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with 
sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 
7. Polyethylene Glycol 17 g PO DAILY 
8. Potassium Chloride 20 mEq PO DAILY 
9. Senna 8.6 mg PO BID 

 
Discharge Medications:
1. Diltiazem Extended-Release 120 mg PO DAILY 
2. Docusate Sodium 100 mg PO BID 
3. Furosemide 40 mg PO DAILY 
4. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with 
sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 
5. Metoprolol Tartrate 100 mg PO TID 
Hold for HR<55 or SBP<90   
6. Polyethylene Glycol 17 g PO DAILY 
7. Senna 8.6 mg PO BID 
8. Vitamin D 1000 UNIT PO DAILY 
9. Warfarin 1 mg PO DAILY16 
10. Potassium Chloride 20 mEq PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis: Subacute Encephalopathy 
Secondary Diagnosis: Atrial Fibrillation, Anal Adenocarcinoma, 
Hypertension, CKD Stage 3

 
Discharge Condition:
Mental Status: Clear and Coherent.
Level of Consciousness: Alert and interactive - usually.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at ___. You were admitted 
for confusion. You were initially put on antibiotics, but your 
urine culture did not how infection and these medications were 
stopped. Other tests including blood tests and a CAT scan of 
your brain were reassuring. Your mental status remained at 
baseline throughout your hospitalization and you will need 
further testing as an outpatient to further define your 
cognition. 

Please follow-up with the appointments listed below and take 
your medications as instructed below.

Best wishes,
Your ___ Team
 
Followup Instructions:
___
",MEDICINE
10003400-DS-17,Deanna Cuthill,10003400,22390287," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
rectal pain
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
Mrs. ___ is a ___ w/ anal mucinous adenocarcinoma not yet on
chemo, AFib on coumadin, UPJ obstruction s/p stent placement in
___ c/b chronic Klebsiella bacturia, IgG myeloma on
lenolidamide, currently residing at ___, who is referred from clinic by her primary
oncologist for rectal pain and expedited management of her 
rectal
ca.

She had reportedly mentioned worsening rectal pain over the past
several days as well as bright red blood on the tissue paper. 
She
denies melanotic stools. 

She had labs checked at the outpatient office today which showed
Hct of 29.3, which is roughly baseline. Because of her lack of
follow through but interest to pursue surgery, she was directly
admitted for pain control and surgical evaluation. 

ED: VS ___ HR 106-124, BP 107/76-136/82, RR 15, 100% RA. 
Received
5 mg IV morphine. Initial labs in ___ ED showed Hct of 15, but
was 27.7 when rechecked. Before the recheck, GI was consulted 
for
a possible GI bleed and plan was to admit to ICU. She received 5
mg IV Vit K. However in absence of frank melanotic stools with a
H/H that was baseline just several hours prior to admission, the
low Hg was suspected to be erroroneous and on recheck Hct 27.7.

She was evaluated by colorectal surgery who recommended
""admission to medicine for appropriate oncologic evaluation and
pain management. We recommend she be evaluated by radiation
oncology for short course pre-op radiation, followed by
proctectomy and end colostomy.""

REVIEW OF SYSTEMS:
10 point ROS reviewed in detail and negative except for what is
mentioned above in HPI

 
Past Medical History:
PAST ONCOLOGIC HISTORY:

#ANAL ADENOCA: Per Dr. ___: Admitted to ___ ___ for
BRBPR. Found to have anal adenocarcinoma, T2N0 based on MRI and
CT. Seen by Dr ___ in the hospital from surgery but has
been noncompliant with f/u with her despite multiple outreaches
from her office.

#MM: ___ woman who presented with anemia in ___.  Further testing demonstrated an M-spike of
approximately 3.3 g/dL, IgG was 5800 mg/dL.  Eventually, the
patient was referred to Hematology, IgG increased to 7100mg/dL 
at
the start of treatment.  Initial Hematology consult was ___.  Bone marrow biopsy revealed 60% of her bone marrow
occupied by plasma cells, cytogenetics demonstrated 
translocation
of chromosomes 11 and 14, also monosomy 13.  Skeletal survey was
negative.  Initial beta 2 microglobulin was 4.08, she started
cycle 1 of Revlimid and dexamethasone on ___, 
Revlimid
at 25 mg.  She was admitted to ___ on ___,
with pneumonia, she was also coagulopathic and quite leukopenic. 

She was discharged on ___.  On
___, she presented with severe back pain, and she has
sustained a compression fracture of L3 vertebra.  Her white 
blood
cell count was still low, the Revlimid was held, and restarted 
on
___ at a lower dose of 15 mg, in combination with
weekly dexamethasone at 20 mg.  She was started on Zometa.  The
patient did well on this lower dose of Revlimid with a nice
improvement in her IgG and M-spike, M-spike going down to 1.0
g/dL by ___, and her IgG going into the normal range 
at
the same time, she continued on Revlimid 15 mg every days ___,
with weekly dexamethasone at 20 mg, repeated every month, with
Zometa every 3 months, for quite some time, although by ___, the patient was becoming more leukopenic.  At the start of
cycle 19 of Revlimid and dexamethasone, in ___, the
M-spike was down to 0.6 g/dL, and the Revlimid was reduced to 10
mg per day because of severe neutropenia.  Unfortunately by
___ timeframe, the M-spike started to creep up, to 0.8
g/dL fairly consistently through the ___, and by 
___, at her ___ cycle of Revlimid and dexamethasone, the
M-spike increased to 0.9 g/dL. She was increased to Rev 15 mg 
and
her counts are holding. She reports she missed a month of Rev 
due
to her hospitalization in ___                      Cycle #27 Rev 15mg -Dex
___    Clinic appt start Biaxin
___                      Cycle #28 Rev-Dex
___    Clinic appt reviewed labs M-spike 0.8g/dL
___                      Cycle #29 Rev-Dex
___                      Admitted for hematuria, elevated INR
attributed to Ultram-warfarin interaction
___    Clinic appt Zometa, on cycle #29
___    Cycle #30 Rev-Dex
___    Cycle #31-- decided to continue without a clinic 
appt,
she was having a great time visiting family in ___
___  Cycle #31 day #19
___  Cycle #32
___  Cycle #33 and Zometa
___  Cycle #34 start on ___ end ___. 
___    Cycle #35 start ___ end ___.  M-spike 0.9g/dL
___    Cycle #36, start ___ or ___, Zometa, end ___. 
M-spike 0.8g/dL
___    Cycle ___ M-spike 0.9g/dL.  Now ___ years on 
Rev-dex
(first cycle was ___    Cycle ___ M-spike 0.9g/dL IgG stable.  Start Rev ___
___ finish ___                      See me in clinic before cycle #39
start ___ finish ___                      See me in clinic, Zometa, cycle #40
will start ___ ( I am out of office ___
___    Admitted ___ obstructive uropathy and
enterococcal UTI discharged ___ to rehab
___                      ___ 
discharged
___    Touched base by phone, hold Revlimid until next 
follow
up
___                      Cycle #41 start ___ end ___    Stent change scheduled
___                      Cycle #42 planned start
___    Zometa, Previously followed in hem/onc by Dr 
___ today to establish care with me.
___    Cycle 44
___    Cycle 45, zometa
___      Cycle 46
___      Cycle 47, zometa
___         Cycle 48 Rev
___      Cycle 49 rev, zometa
___      Cycle 50 rev
___    Cycle 51 rev
___    Anal cancer - adeno diagnosed

PAST MEDICAL HISTORY:
Hypertension  
Atrial fibrillation on coumadin  
Obesity  
Myeloma    
Osteoarthritis of right knee  
UPJ obstruction s/p stent placement ___ c/b persistent 
Klebsiella bacteruria  
Anal adenocarcinoma (dx ___ 
? Perirectal cyst drainage in ___ 

PSH: 
___ - EUA, biopsy of ___ lesion
___ - cystoscopy and R ureteral stent exchange
___ - lap CCY
Hysterectomy
___ - unknown ___ procedure

 
Social History:
___
Family History:
Her parents died in their ___ or ___ of ""old age.""  Her parents 
and multiple siblings have hypertension. Sibling with 
Alzheimer's disease. No family history of significant arrhythmia 
or premature coronary disease.
 
Physical Exam:
ADMIT PHYSICAL EXAM:
General:  NAD elderly frail female resting in bed comfortably
sleeping
VITAL SIGNS: ___ 120/80 95 20 99% RA
HEENT:  MMM, no OP lesions, no cervical or supraclavicular
adenopathy
CV:  ___, NL S1S2 no S3S4 No MRG
PULM:  CTAB, No ___
ABD:  BS+, soft, NTND, no palpable masses or HSM
LIMBS: WWP, 2+ pitting ___ to the proximal leg, no tremors
SKIN:  No rashes on the extremities
NEURO:  Grossly normal, oriented to person/place/date/time but
had some difficulty with months of year backwards, easily
distractable, though process logical 
RECTAL: PER COLORECTAL SURGERY: ""Rectal: large plaque-like 
lesion
arising from right superolateral portion of anus, extending
nearly circumferentially around the anus and into the anal 
canal;
internal extension of the lesion palpable approximately 3cm
internally; able to digitally pass lesion without e/o
obstruction; small amount of red blood on glove after exam""

DISCHARGE PHYSICAL EXAM:
VITAL SIGNS: 98.2  130/78  104  18  98%RA
HEENT:  MMM, no OP lesions, no cervical or supraclavicular
adenopathy
CV:  irregular irregular nl rate, NL S1S2 no S3S4 No MRG
PULM:  CTAB, No ___
ABD:  BS+, soft, NTND, no palpable masses or HSM
LIMBS: WWP, no lower extremity edema, no tremors.  
SKIN:  No rashes on the extremities
NEURO:  ___ strength throughout no tremor/asterixis,aware of 
person, place, year but not full date. answers appropriately and 
follows commands. sensation intact to light touch. 
Rectal: ulcerated circumferential anorectal mass w/ oozing

 
Pertinent Results:
ADMISSION LABS:
___ 01:45PM BLOOD WBC-4.3 RBC-1.73*# Hgb-5.0*# Hct-15.0*# 
MCV-87 MCH-28.7 MCHC-33.0 RDW-19.1* Plt ___
___ 01:45PM BLOOD Neuts-66.5 ___ Monos-14.5* 
Eos-0.3 Baso-0.1
___ 01:45PM BLOOD ___ PTT-32.0 ___
___ 01:45PM BLOOD Glucose-90 UreaN-20 Creat-0.7 Na-140 
K-3.7 Cl-107 HCO3-25 AnGap-12
___ 01:45PM BLOOD ALT-24 AST-21 AlkPhos-81 TotBili-0.5
___ 01:45PM BLOOD Albumin-2.9*

DISCHARGE LABS:
___ 06:09AM BLOOD WBC-3.7* RBC-2.90* Hgb-8.6* Hct-26.1* 
MCV-90 MCH-29.7 MCHC-32.9 RDW-20.2* Plt ___
___ 06:09AM BLOOD Glucose-140* UreaN-12 Creat-0.7 Na-141 
K-4.1 Cl-110* HCO3-24 AnGap-11
___ 06:09AM BLOOD ALT-14 AST-13 AlkPhos-78 TotBili-0.2
___ 06:09AM BLOOD Calcium-7.9* Phos-1.9* Mg-1.9

IMAGING:
MRI pelvis ___: IMPRESSION:   
Interval growth of the previously demonstrated distal rectal 
tumor, with inferior anal extension and mucinous 
differentiation, now extending further beyond of the right 
posterior external anal sphincter and into the subcutaneous 
tissues of the right buttock.  The rectal tumor extends beyond 
the muscularis propria into the mesorectal fat posteriorly on 
the left, abutting the levator ani muscle and mesorectal fascia 
without obvious involvement. This constitutes tumor stage T3.   
No identified definitively pathologic lymphadenopathy. 
  
CXR ___: Slight worsening of mild pulmonary vascular congestion 
in the setting of stable moderate cardiomegaly. No evidence of
pneumonia.

 
Brief Hospital Course:
Mrs. ___ is a ___ w/ anal mucinous adenocarcinoma not yet 
treated, AFib, UPJ obstruction s/p stent placement in ___ c/b 
chronic Klebsiella bacturia, IgG myeloma on lenolidamide, 
currently residing at ___ since 
___, who is admitted from clinic by her primary oncologist, 
Dr. ___ rectal pain and expedited treatment. Also w/ blood 
loss anemia on admission.

#Anal Mucinous Adenocarcinoma 
Diagnosed in ___. Restaging ___ shows T4 disease extending 
beyond the anal verge, progressing through external muscle of 
anal sphincter, progression from 3 months ago.
-- plan for 5 fractions per Drs. ___ on thurs 
___ w/ first session ___ cancelled due to machine 
malfunction, resumed ___ and completed ___. 
-- pt evaluated by Dr. ___/ colorectal surgery with plans 
for surgical resection proctectomy and end colostomy on ___, 
one week following completion of radiation. 
-- pt received ostomy teaching during her stay

#Rectal Pain - ___ above
-- cont metamucil, senna, colace, prn miralax/bisacodyl
-- pain control w/ oxycodone prn and tylenol 

#Rectal bleeding - persistent hematochezia ___ mass/oozing. no 
large vol bleeding. stopped lovenox. Anticipate ongoing oozing 
until surgery but improved w/ radiation and stopping 
anticoagulation. 

#Blood loss anemia/ACD - Recent Ferritin and TIBC suggest anemia 
of chronic inflammation but recent rectal bleeding and low HCT 
on admission concerning for acute blood loss. HCT 15 in ED on 
admission likely spurious as Hgb was 9 at ___ earlier that day 
and on repeat in ED HCT 27. 
- Normal TSH and b12
- Hgb gradually downtrending ___ bleeding. Was given 1U PRBC on 
___ for Hgb 8.6 in anticipation of slow oozing over next week 
prior to surgery 

#Hypophosphatemia - poor PO vs GI loss while on bowel regimen vs 
lasix effect. remained low despite PO phos x 3 days so stopped 
lasix.  PTH secondarily
elevated. vitD borderline low will increase to 2000U. Phos 1.9 
day of discharge repleted with 500mg

#AFib
#HTN
CHADS2Vasc at least4, coumadin reversed in ED out of initial 
concern for GI bleed, was transitioned to lovenox. 
- plan was to cont lovenox perioperatively as needs bridge prior 
to surgery-- however held in setting of worsening rectal 
bleeding, risk of bleeding in short term felt to outweigh risk 
of stroke. off lovenox since ___
-- cont home dilt and metoprolol, decreased dilt dose as BP in 
low 100s-120s 

# Neutropenia - resolved. likely ___ revlamid, we are holding 
revlamid perioperatively for now per primary oncologist. No 
fevers

#CKDIII - renal function is good on arrival but reportedly 
carries this diagnosis, likely prior myeloma kidney
-- avoid nephrotoxins

#IgG Myeloma
IgG kappa, ISS stage II, Durie-Salmon stage II (IgG greater than 
5 g).  ___. On Rev-Dex, stable History of vertebral 
compression fracture ___. Last skeletal survey in ___ neg.
-- holding revlamid while hospitalized and perioperative per 
outpt onc but cont qthurs 20mg po dex
-- Zometa given in ___. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Diltiazem Extended-Release 120 mg PO DAILY 
2. Furosemide 20 mg PO DAILY 
3. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk (with 
sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral Daily 
4. Senna 8.6 mg PO DAILY:PRN constipation 
5. Vitamin D 1000 UNIT PO DAILY 
6. Warfarin 2.5 mg PO DAILY16 
7. Potassium Chloride 20 mEq PO DAILY 
8. OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN severe pain 
9. Bisacodyl ___AILY:PRN constipation 
10. Acetaminophen 650 mg PO Q6H:PRN pain 
11. Fleet Enema ___AILY:PRN constipation if bisacodyl 
ineffective 
12. OxycoDONE (Immediate Release)  10 mg PO QHS 
13. Calcium 600 with Vitamin D3 (calcium carbonate-vitamin D3) 
600 mg(1,500mg) -400 unit oral BID 
14. Metoprolol Succinate XL 100 mg PO BID 
15. Lenalidomide 15 mg PO DAILY myeloma 
16. Ascorbic Acid ___ mg PO DAILY 
17. Zinc Sulfate 220 mg PO DAILY 
18. Citalopram 10 mg PO DAILY 
19. Dexamethasone 4 mg PO 1X/WEEK (TH) on ___ while on 
revlimid 

 
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H:PRN pain 
2. Bisacodyl ___AILY:PRN constipation 
3. Citalopram 10 mg PO DAILY 
4. Dexamethasone 4 mg PO 1X/WEEK (TH) on ___ while on 
revlimid 
5. Metoprolol Succinate XL 100 mg PO BID 
6. OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN severe pain 
RX *oxycodone 10 mg 1 tablet(s) by mouth every 6 hours Disp #*60 
Tablet Refills:*0
7. OxycoDONE (Immediate Release)  10 mg PO QHS 
RX *oxycodone 15 mg 1 tablet(s) by mouth at bedtime Disp #*60 
Tablet Refills:*0
8. Senna 8.6 mg PO DAILY:PRN constipation 
9. Vitamin D 1000 UNIT PO DAILY 
10. Aquaphor Ointment 1 Appl TP QID:PRN apply daily and then prn 
after each bowel movement 
11. Ascorbic Acid ___ mg PO DAILY 
12. Calcium 600 with Vitamin D3 (calcium carbonate-vitamin D3) 
600 mg(1,500mg) -400 unit oral BID 
13. Diltiazem Extended-Release 120 mg PO DAILY 
14. Docusate Sodium 200 mg PO BID 
15. Metamucil Fiber Singles (psyllium husk (aspartame)) 3.4 gm 
ORAL DAILY 
16. Omeprazole 20 mg PO DAILY 
17. Polyethylene Glycol 17 g PO DAILY:PRN constipation 
please give if no bowel movement in 24 hr period 
18. Metamucil (psyllium;<br>psyllium husk;<br>psyllium husk 
(with sugar);<br>psyllium seed (sugar)) 3.4 gram/12 gram oral 
Daily 
19. Potassium Chloride 20 mEq PO DAILY 
20. Zinc Sulfate 220 mg PO DAILY 
21. Multivitamins ___ 1 TAB PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Rectal cancer
Rectal bleeding
Rectal pain
Blood loss anemia
Hypophosphatemia (low phosphate)

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms ___ it was a pleasure caring for you during your stay at 
___.  You were hospitalized with worsening pain due to the 
rectal mass.  You also had some rectal bleeding. You completed 5 
radiation treatments to the rectum with plans for surgical 
removal of the mass.  Your coumadin was stopped both due to 
bleeding and in anticipation of surgery.  Your lasix was also 
stopped due to low phosphate. This can be resumed after surgery 
if needed.  You also received a blood transfusion for anemia. 
 
Followup Instructions:
___
",MEDICINE
10003400-DS-19,Deanna Cuthill,10003400,23559586," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Sacral ulcer
 
Major Surgical or Invasive Procedure:
Uretropelvic junction stent replacement
Intubation
PICC line placement
Right Chest tube placement
 
History of Present Illness:
Ms. ___ is a ___ year-old woman a PMH significant for AFib on 
coumadin, UPJ obstruction s/p stent placement in ___ c/b 
chronic Klebsiella bacturia, IgG myeloma on lenolidamide, and 
adenocarcinoma of the anal canal (followed by Dr. ___ 
admitted to ___ for evaluation of anemia (Hgb 8.6) 
with course complicated by atrial fibrillation with RVR 
requiring ICU admission for dilt gtt, Acute of chronic kidney 
injury osteomyelitis from sacral decubitus ucler who was 
transferred to ___ for debridement of sacral ulcer.  
  In the ED she developed afib with RVR with hypotension where 
she briefly required a dilt gtt. She was then transferred to the 
floor. 
  Hospital course thus far has included an MRI without 
osteomyelitis, abdominal distension w/ NGT placement draining 
bilious contents, CBI and urology procedure for evaluation of 
hematuria. She underwent cystoscopy ___ to exchange ureteral 
stent and found purulence behind stent. There was no etiology of 
hematuria seen. She was started on vanc and zosyn and kept on 
fluconazole started pre-procedure.  Culture significant for 
___ albicans and MDR pseudomonas SN to Gentamicin which was 
held ___ ___.
 Following cystoscopy, were unable to extubate and couldn't get 
off pressors. Per report, black colored liquid was coming out of 
NGT.  
 
Required FICU transfer
FICU Course Significant for: Extubation and starting on tube 
feeding.
Was restabilized and discharged from the FICU where CT Torso 
revealed
New retroperitoneal soft tissue mass encasing the aorta and 
common iliac vessels in comparison to the ___ 
examination. The mass abuts the second and third portion of the 
duodenum and pancreatic head.  Suspected involvement of the 
pancreatic head and distal CBD with new intra and extrahepatic 
bile duct dilation.  
Encasement of both ureters, with new left and worsened right 
moderate hydronephrosis in comparison to the ___  
  Transferred to ___ where course was complicated by hypotension 
and worsening of anemia in the setting of gross hematuria. Her 
VS were 85/Doppler and HR of high ___. She received one unit 
prbc at the time of initial assessment and 2nd unit being hung.

Prior to transfer: hung 2nd unit prbc (first at about 3). 
-Obtained ABG.
-Guiac positive

On arrival to the CCU, pt in respiratory distress with shallow 
breathing.  Intermittently responsive, able to follow some 
commands.  Felt ""ok"" but increasingly somnolent.
 
Past Medical History:
PAST ONCOLOGIC HISTORY:

#ANAL ADENOCA: Per Dr. ___: Admitted to ___ ___ for
BRBPR. Found to have anal adenocarcinoma, T2N0 based on MRI and
CT. Seen by Dr ___ in the hospital from surgery but has
been noncompliant with f/u with her despite multiple outreaches
from her office.

#MM: ___ woman who presented with anemia in ___.  Further testing demonstrated an M-spike of
approximately 3.3 g/dL, IgG was 5800 mg/dL.  Eventually, the
patient was referred to Hematology, IgG increased to 7100mg/dL 
at
the start of treatment.  Initial Hematology consult was ___.  Bone marrow biopsy revealed 60% of her bone marrow
occupied by plasma cells, cytogenetics demonstrated 
translocation
of chromosomes 11 and 14, also monosomy 13.  Skeletal survey was
negative.  Initial beta 2 microglobulin was 4.08, she started
cycle 1 of Revlimid and dexamethasone on ___, 
Revlimid
at 25 mg.  She was admitted to ___ on ___,
with pneumonia, she was also coagulopathic and quite leukopenic. 

She was discharged on ___.  On
___, she presented with severe back pain, and she has
sustained a compression fracture of L3 vertebra.  Her white 
blood
cell count was still low, the Revlimid was held, and restarted 
on
___ at a lower dose of 15 mg, in combination with
weekly dexamethasone at 20 mg.  She was started on Zometa.  The
patient did well on this lower dose of Revlimid with a nice
improvement in her IgG and M-spike, M-spike going down to 1.0
g/dL by ___, and her IgG going into the normal range 
at
the same time, she continued on Revlimid 15 mg every days ___,
with weekly dexamethasone at 20 mg, repeated every month, with
Zometa every 3 months, for quite some time, although by ___, the patient was becoming more leukopenic.  At the start of
cycle 19 of Revlimid and dexamethasone, in ___, the
M-spike was down to 0.6 g/dL, and the Revlimid was reduced to 10
mg per day because of severe neutropenia.  Unfortunately by
___ timeframe, the M-spike started to creep up, to 0.8
g/dL fairly consistently through the ___, and by 
___, at her ___ cycle of Revlimid and dexamethasone, the
M-spike increased to 0.9 g/dL. She was increased to Rev 15 mg 
and
her counts are holding. She reports she missed a month of Rev 
due
to her hospitalization in ___                      Cycle #27 Rev 15mg -Dex
___    Clinic appt start Biaxin
___                      Cycle #28 Rev-Dex
___    Clinic appt reviewed labs M-spike 0.8g/dL
___                      Cycle #29 Rev-Dex
___                      Admitted for hematuria, elevated INR
attributed to Ultram-warfarin interaction
___    Clinic appt Zometa, on cycle #29
___    Cycle #30 Rev-Dex
___    Cycle #31-- decided to continue without a clinic 
appt,
she was having a great time visiting family in ___
___  Cycle #31 day #19
___  Cycle #32
___  Cycle #33 and Zometa
___  Cycle #34 start on ___ end ___. 
___    Cycle #35 start ___ end ___.  M-spike 0.9g/dL
___    Cycle #36, start ___ or ___, Zometa, end ___. 
M-spike 0.8g/dL
___    Cycle ___ M-spike 0.9g/dL.  Now ___ years on 
Rev-dex
(first cycle was ___    Cycle ___ M-spike 0.9g/dL IgG stable.  Start Rev ___
___ finish ___                      See me in clinic before cycle #39
start ___ finish ___                      See me in clinic, Zometa, cycle #40
will start ___ ( I am out of office ___
___    Admitted ___ obstructive uropathy and
enterococcal UTI discharged ___ to rehab
___                      ___ 
discharged
___    Touched base by phone, hold Revlimid until next 
follow
up
___                      Cycle #41 start ___ end ___    Stent change scheduled
___                      Cycle #42 planned start
___    Zometa, Previously followed in hem/onc by Dr 
___ today to establish care with me.
___    Cycle 44
___    Cycle 45, zometa
___      Cycle 46
___      Cycle 47, zometa
___         Cycle 48 Rev
___      Cycle 49 rev, zometa
___      Cycle 50 rev
___    Cycle 51 rev
___    Anal cancer - adeno diagnosed

PAST MEDICAL HISTORY:
Hypertension  
Atrial fibrillation on coumadin  
Obesity  
Myeloma    
Osteoarthritis of right knee  
UPJ obstruction s/p stent placement ___ c/b persistent 
Klebsiella bacteruria  
Anal adenocarcinoma (dx ___ 
? Perirectal cyst drainage in 1980s 

PSH: 
___ - EUA, biopsy of ___ lesion
___ - cystoscopy and R ureteral stent exchange
___ - lap CCY
Hysterectomy
___ - unknown ___ procedure

 
Social History:
___
Family History:
Her parents died in their ___ or ___ of ""old age.""  Her parents 
and multiple siblings have hypertension. Sibling with 
Alzheimer's disease. No family history of significant arrhythmia 
or premature coronary disease.

 
Physical Exam:
Admission Physical Exam:
 Vitals: 97.8 120/77 118 20 100RA  
 GENERAL: Elderly woman, lying in bed, NAD  
 HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM  
 NECK: nontender supple neck, no LAD, no JVD  
 CARDIAC: Irregularly irregular, +S1/S2, no murmurs, gallops, or 
rubs  
 LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
 ABDOMEN: nondistended, +BS, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly. Anus with friable 
mucosa. Ostomy in place  
 EXTREMITIES: 2 piting edema up through shins bilaterally, no 
cyanosis or clubbing  
 PULSES: 2+ DP pulses bilaterally  
 NEURO: CN II-XII and motor grossly intact intact  
 SKIN: warm and well perfused, no excoriations or lesions, no 
rashes

Discharge Physical Exam:
deceased
 
Pertinent Results:
Admission Labs:
---------------
___ 04:38AM BLOOD WBC-4.3 RBC-2.88* Hgb-8.6* Hct-25.9* 
MCV-90 MCH-29.9 MCHC-33.2 RDW-15.9* RDWSD-52.1* Plt ___
___ 04:38AM BLOOD Neuts-53 Bands-0 Lymphs-14* Monos-25* 
Eos-3 Baso-0 ___ Metas-2* Myelos-3* AbsNeut-2.28 
AbsLymp-0.60* AbsMono-1.08* AbsEos-0.13 AbsBaso-0.00*
___ 04:38AM BLOOD Hypochr-2+ Anisocy-NORMAL Poiklo-NORMAL 
Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 04:38AM BLOOD ___ PTT-27.0 ___
___ 04:38AM BLOOD Glucose-101* UreaN-35* Creat-2.0*# Na-134 
K-4.9 Cl-98 HCO3-27 AnGap-14
___ 04:38AM BLOOD ALT-6 AST-18 LD(LDH)-182 AlkPhos-75 
TotBili-0.4
___ 04:38AM BLOOD Albumin-2.4* Calcium-8.1* Phos-3.6 Mg-2.1
___ 04:38AM BLOOD Vanco-14.6

IMAGES:  
-------
___ CXR
Port-A-Cath catheter tip is at the level of the right 
ventricular outflow tract.  The double tube has been removed.  
There is substantial distension of the stomach that might 
potentially benefit from the NG tube insertion.  What appears to 
be a E ureteral stent is partially imaged. Bilateral pleural 
effusions, right more than left are present. Vascular congestion 
is noted, borderline with mild interstitial pulmonary edema. 

___ KUB
1. A right double J stent projects over the expected location of 
the right renal pelvis and bladder.  The stent is unchanged in 
position since ___. 
2. The stomach is distended with air. 

___ TTE
The left atrium is moderately dilated. Left ventricular wall 
thicknesses and cavity size are normal. Regional left 
ventricular wall motion is normal. Overall left ventricular 
systolic function is low normal (LVEF 50-55%). The estimated 
cardiac index is normal (>=2.5L/min/m2). Tissue Doppler imaging 
suggests a normal left ventricular filling pressure 
(PCWP<12mmHg). The right ventricular cavity is mildly dilated 
with normal free wall contractility. The aortic valve leaflets 
(3) are mildly thickened but aortic stenosis is not present. 
Trace aortic regurgitation is seen. The mitral valve leaflets 
are structurally normal. There is no mitral valve prolapse. Mild 
to moderate (___) mitral regurgitation is seen. There is mild 
to moderate pulmonary artery systolic hypertension. There is no 
pericardial effusion. 

Compared with the prior study (images reviewed) of ___, the 
findings are similar.  

___ Renal US
1.  Moderate hydronephrosis and cortical thinning on the right.  
Mild 
hydronephrosis on the left.  These findings are unchanged from 
CT ___. 
2.  A large pleural effusion is unchanged from ___. 

___ CXR
As compared to the previous radiograph, the right sided J-stent 
is unchanged. The previously severe gastric over distension has 
further increased in severity and is now massive. 

___ CXR
As compared to ___, the patient has received a new 
nasogastric tube.  The tube is located in the middle parts of 
the stomach.  The previous overinflation of the stomach is no 
longer present.  The lung volumes remain low.  Moderate 
cardiomegaly.  Moderate bilateral areas of atelectasis and mild 
to moderate right pleural effusion. 

___ MRI Sacrum
PND - preliminary read is no osteomylelitis

Discharge Labs: N/A
---------------
 
Brief Hospital Course:
Ms. ___ is a ___ year-old woman a PMH significant for AFib on 
coumadin, UPJ obstruction s/p stent placement in ___ c/b 
chronic Klebsiella bacturia, IgG myeloma on lenolidamide, and 
adenocarcinoma of the anal canal (followed by Dr. ___ 
admitted to ___ for evaluation of anemia (Hgb 8.6) with 
course complicated by atrial fibrillation with RVR requiring ICU 
admission for dilt gtt, Acute of chronic kidney injury, 
?osteomyelitis from sacral decubitus ulcer now transferred to 
___ for debridement of sacral ulcer.  Became hypotensive and 
quite anemic on the floor with H/H of ___ and was transferred 
to the MICU ___. 
  She peacefully passed away with her family and family pastor 
present in the room at ___ on ___. 
 
#Hypercarbic respiratory failure: The pt consistently required 
nasal cannula up to 6 L while on the floor. This was thought to 
be due to volume overload and increased work of breathing. While 
in the CCU pt became more lethargic and an ABG showed 
hypercarbic respiratory failure.  She was intubated by 
anesthesia.  CXR showed large bilateral pleural effusions and 
she was grossly anasarcic.  IP placed a right chest tube to 
drain the effusion which showed that it was malignant with 
cytology showing adenocarcinoma.  She was extubated successfully 
on ___ and was weaned down to room air thereafter.  She was 
able to be comfortable on room air for the rest of her 
admission.

# Encephalopathy: although the pt's mental status had noticed to 
be declining on the floor, she was still able to answer 
appropriately. After extubation, the pt was noted to be very 
lethargic and minimally responsive. EEG was done which showed 
triphasic waves consistent with an encephalopathy. The pt was 
trialed on Ativan and Keppra. Her mental status remained very 
poor in spite of continued Keppra.  Neuro signed off after head 
imaging was unrevealing.  Mental status continued to wax and 
wane through the rest of her time. 

# Stage IV surgical dehiscence: Patient had correction of 
abdominoperineal resection defect with a right vertical rectus 
abdominis muscular cutaneous flap in ___ following 
resection of anal cancer. She presented to the hospital with 
stage IV, MRSA + sacral ulcer with concern for osteomyelitis, as 
wound probes to bone. CT scan with no mention of sacral 
osteomyelitis. GI deferred to plastics as they did flap surgery. 
Plastics does not recommend surgical intervention at this time. 
MRI shows no signs of osteomyelitis. This wound remained stable 
during her hospital course. 

# ___: Baseline Creatinine 0.8. Creatinine on admission was 2.1 
in setting of diuresis but also possible hypotension from afib 
with RVR. Pt is grossly volume overloaded with hypoalbumenemia. 
Concern for prerenal vs. intrinsic with possible multiple 
myeloma involvement vs obstructive. Creatinine remains above 2.0 
today. Renal consulted and believed that her ___ was 
predominantly secondary to obstruction. After stent exchange by 
urology ___, renal function improved with a Cr to 1.5 with IV 
fluids and remained stable. 
 
# Gastric Distension: Patient developed nausea and 1 episode of 
vomiting ___ with increasing distention. And xray ___ 
showed significant gastric distension. NG tube was placed and 
>1L was drawn off. Patient's reported symptomatic improvement. 
Patient continued to have ostomy output throughout episode. No 
mass appreciated on exam though obese abdomen. Patient not on 
narcotic medication. On ___, NG tube was clamped without 
recurrence of distention, patient denies nausea or distension. 
Unable to get CT abd due to poor kidney function, but got OSH CT 
read by our radiologists. It was notable for new retroperitoneal 
mass encasing aorta throughout abdomen. It is touching and 
possibly invading ___ and ___ portion of duodenum, potentially 
explaining gastric obstruction symptoms. Invades pancreatic 
head, explaining ductal dilatation. Also surrounding common 
iliac vessels, and both ureters (hydronephrosis worse since 
___. Speech and swallow was consulted who said the pt 
should be strict NPO. Tube feeds were started.  

# Tube feeds: On ___ Ms. ___ was no longer tolerating 
her tube feeds due to very high residuals.  Tube feeds were 
stopped and she was given nutrition with D5NS at 75/hr.  ___ 
attempted to place the Dobhoff tube post-pyloric but they were 
unable to pass the tube through the pylorus and noted contrast 
barely trickles through ___ obstruction. In family meetings the 
family was informed that the feeding tube could not be advanced, 
and that other options such as TPN would likely harm the pt more 
than help her because of her risk for bloodstream infection and 
metabolic derangements.  

# Metastatic anal adenocarcinoma: large retroperitoneal mass 
compressing the abdomen and constricting the aorta at the level 
of the iliacs noted on CT from OSH, thought to be metastasis 
from her known anal adenocarcinoma. Per onc, not a candidate for 
chemotherapy, so likely not worth biopsying even though 
definitive diagnosis would not otherwise be reached. Recommend 
getting palliative care involved and having goals of care 
discussion with family.  First family meeting was ___ and 
son, ___, wanted us to do everything we could to help Ms. 
___. This continued to be a theme during her hospital stay, 
and several meetings were held with the family to discuss goals 
of care.  On ___ it was decided to switch to focusing on her 
comfort only.

# Volume overload: Likely from diastolic heart failure but will 
need to rule out hypoalbuminemic state, and cirrhosis. Patient 
with gross volume overload with 2+ ___ edema, bilateral effusions 
and CT with anasarca on abdominal imaging.  TTE unchanged from 
previous with EF 55% and no gross valvular dysfunction. TSH 
elevated, T4 WNLs. Patient given albumin ___ with good 
response.  However, patient still significantly overloaded.  On 
___ she was anuric and hypotensive despite having 
significant lower extremity and abdominal edema.  She was 
transferred to the MICU on this day.  While in the MICU she was 
stabilized and pressors were downtitrated.  Poor response to 
Lasix alone but given Lasix and Chlorothiazide with good UOP.  
 
# Hematuria: Unclear cause but patient was on anticoagulation. 
Concern would be primarily for tumor infiltration. Hematuria 
intermittent, but seems to recur during transport. Potential 
mechanical irritation. Patient continues to pass dime sized 
clots. Stent exchange done ___ by urology, with improvement in 
her hematuria.  Hematuria with clots returned on ___.  
Urology recommended CBI which was started ___.  She had 
CBI intermittently throughout her stay to relieve foley 
obstructions. 
 
# Normocytic Anemia: Hgb at ___ 8.6. No evidence of 
bleeding. She does have stage III CKD. MCV within normal range 
and iron studies not particularly suggestive of iron deficiency 
anemia with ferritin of 781. Folate level of 7.4 and B12 of 411. 
Concern could possibly be for chronic low grade bleed from gut 
or hematuria. (transfused evening of ___.  Hgb remained 
stable in the 7's until ___ when H/H dropped to ___.  
This same day she triggered for hypotension of 86/Doppler.  As 
she was anuric at this  time there was concern of intraabdominal 
bleeding and was one of the indications for MICU transfer.  Pt 
had episode of gross hematuria requiring CBI and pRBC 
transfusion for BP control.  Pt required Vasopressin and 
Phenylephrine while in the MICU but was able to be weaned off.  
She required intermittent pRBC transfusions during her time in 
the MICU.
 
# AFib on coumadin: CHADS 2 of 3. Hemodynamically unstable with 
RVR upon arrival, but controlled with diltiazem and metoprolol.  
She remained in AFib during her hospital stay.  Due to her 
hematuria and dropping H/H, blood pressure medications and 
ultimately SQH were discontinued on ___.   Pt put on an 
esmolol gtt as she had afib with RVR into the 130s on her first 
day in the ICU. She was taken off the esmolol drip and 
thereafter controlled with IV metoprolol and achieved good 
control on PO metoprolol with heart rates in the ___. 

# Hypertension: Currently normotensive.  See above for issues 
with hypotension and reason for MICU transfer ___. 
 
# IgG Myeloma: Patient with longstanding IgG MM, followed by 
___ Oncology. Currently not on revlimid or dexamethasone. 
Kappa:lamba increase, but can be seen in kidney disease.  Atrius 
oncology followed patient throughout hospital stay.

====================
TRANSITIONAL ISSUES:
====================
- Family Bereavement Counseling 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen (Liquid) 1000 mg PO TID 
2. Diltiazem 30 mg PO QID 
3. Heparin Flush (10 units/ml) 5 mL IV DAILY and PRN, line flush 

4. Artificial Tears ___ DROP BOTH EYES PRN Dry eyes 
5. Heparin Flush (100 units/ml) 5 mL IV PRN DE-ACCESSING port 
6. TraMADOL (Ultram) 25 mg PO Q6H:PRN pain 
7. Dexamethasone 4 mg PO 1X/WEEK (TH) 
8. Calcium Carbonate 500 mg PO BID:PRN heart burn 
9. Collagenase Ointment 1 Appl TP DAILY 
10. Escitalopram Oxalate 5 mg PO DAILY 
11. Metoprolol Succinate XL 200 mg PO DAILY 
12. Mirtazapine 7.5 mg PO QHS 
13. Pantoprazole 40 mg PO Q24H 
14. Furosemide 80 mg PO DAILY 

 
Discharge Medications:
N/A
 
Discharge Disposition:
Expired
 
Discharge Diagnosis:
Patient Expired 
 
Discharge Condition:
Patient Expired

 
Discharge Instructions:
Patient Expired
 
Followup Instructions:
___
",MEDICINE
10003502-DS-3,Elizabeth Marquez,10003502,21671572," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Nifedipine Er / Amitriptyline / Prilosec Otc / Terazosin / 
Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide
 
Attending: ___
 
Chief Complaint:
failure to thrive
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is an ___ year old ___ speaking woman sent in 
by her PCP for further management of multiple issues, chiefly 
gait instability, headaches, and poor PO intake.
.
At baseline, Ms. ___ ambulates with a walker. She does 
report several falls over the last year, last more than one 
month prior to today's visit. She denies any loss of 
consciousness of prodromal symptoms such as chest discomfort or 
palpitations. No focal weakness, sensory loss, or tremor.
.
Of note, she has not been eating well due to a poor appetite. 
She denies any abdominal pain, nausea, vomiting, diarrhea, 
melena or hematochezia. No other bleeding. Her only other new 
medication has been restarting lisinopril within the last month.
.
Her headaches have been an issue for her over the last year. She 
describes these as originating from her right ear and extending 
over her scalp. They are intermittent and somewhat responsive to 
tylenol. No associated visual complaints, n/v, jaw or tongue 
claudication. She thinks the headaches are related to her 
chronic right ear problems (extensively worked up by ENT).
.
In the ED, initial vs were: 97.2 55 166/47 18 97. Patient c/o 
headaches x ___ year. Guiac negative. CXR unremarkable, EKG showed 
sinus brady unchanged from before. No orthostatics checked. 
Patient was given 500cc of saline. Vitals prior to transfer 96.3 
57 174/52 18, 100% 2L NC.
.
On the floor, her headache is ___ in intensity. She has no 
other major complaints. 
 
Past Medical History:
HTN
Hyperlipidemia
CAD
Headaches
Nephrolithiasis
Cataracts
Otitis media
Syncope ?sick sinus syndrome
s/p CCY 
 
Social History:
___
Family History:
Mother deceased at age ___ from breast cancer.
Father deceased at age ___. Son deceased at age ___ from heart
attack. 
 
Physical Exam:
Vitals 97.3 54 146/58 18 100% on RA
HEENT NC/AT, PEARL, EOMI, dry MM. Right TM with small amount of 
white ?exudate, left TM with ?perforation
Neck Supple, no JVD
Pulm Lungs clear bilaterally, no rales or wheezing
CV Bradycardic S1 S2 soft systolic murmur at apex
Abd Soft nontender +bowel sounds. Guiac negative in ER.
Extrem Warm no edema palpable distal pulses
Derm Skin warm, no rash
Neuro Alert, answering appropriately, attentive. CN ___, 
strength, and sensation to light touch intact. No tremor, no 
cogwheeling. No dysmetria. Initially patient refused to stand up 
because feeling dizzy. Next AM, gait revealed short steps, no 
shuffling w/ walker, negative Romberg's
 
Pertinent Results:
Labs on admission:

___ 08:00PM   GLUCOSE-103* UREA N-16 CREAT-1.0 SODIUM-127* 
POTASSIUM-4.7 CHLORIDE-92* TOTAL CO2-26 ANION GAP-14
___ 08:00PM   TOT PROT-5.8* ALBUMIN-3.9 GLOBULIN-1.9* 
CALCIUM-10.7*
___ 12:05PM   WBC-5.0 RBC-3.72* HGB-9.9* HCT-30.2* MCV-81* 
MCH-26.7* MCHC-33.0 RDW-16.2*
___ 12:05PM   NEUTS-73.2* ___ MONOS-6.6 EOS-0.8 
BASOS-0.3
___ 12:05PM   PLT COUNT-161
___ 12:05PM   TSH-2.0
___ 12:05PM   VIT B12-468
___ 12:05PM   CALCIUM-10.4* PHOSPHATE-2.6* MAGNESIUM-1.8
___ 12:05PM   ALT(SGPT)-13 AST(SGOT)-17 ALK PHOS-59 TOT 
BILI-0.4
___ 02:44PM URINE  U-PEP-NEGATIVE F
___ 01:26PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG

Micro:
URINE CULTURE (Final ___:    <10,000 organisms/ml. 

Reports:
CXR: IMPRESSION: No acute cardiopulmonary abnormality.

ECG:
Sinus bradycardia. The P-R interval is prolonged. Left axis 
deviation.
There is non-specific intraventricular conduction delay. There 
are Q waves
in the lateral leads consistent with prior myocardial 
infarction. Left
ventricular hypertrophy with associated ST-T wave changes, 
although ischemia or myocardial infarction cannot be excluded. 
Compared to the previous tracing right bundle-branch block is no 
longer present.

Repeat Ecg:
Sinus bradycardia with prominent sinus arrhythmia. The P-R 
interval is
prolonged. Left axis deviation. Non-specific intraventricular 
conduction
delay. There are Q waves in the lateral leads consistent with 
prior myocardial infarction. Left ventricular hypertrophy with 
associated ST-T wave changes, although ischemia or myocardial 
infarction cannot be excluded. Compared to the previous tracing 
there is no significant change.
 
Brief Hospital Course:
Ms. ___ is a ___ year old woman with history of falls, 
chronic headaches, and poor oral intake who is admitted for 
failure to thrive.
.
* Gait instability
This is probably multifactorial. Dehydration was a significant 
factor upon admission. Her hyponatremia, likely hypovolemic in 
etiology, may also have been relevant to her overall sense of 
weakness. Though she was admitted with concern for possible 
Parkinsons, she does not have any clear exam findings to suggest 
this such as tremor or cogwheeling. NPH is worth considering, 
but seems less likely. There may be a vestibular component of 
her gait instability as well, especially given her multiple ENT 
procedures. She has outpatient neurology follow-up scheduled. A 
cardiac contribution was considered given her history of prior 
syncope with question of sick sinus syndrome. After fluid 
resuscitation, patient no longer orthostatic and Na trending up. 
She was evaluated by physical therapy who felt that it was safe 
for her to go home with physical therapy. 

.
* Hyponatremia
By history, likely hypovolemic in etiology and improving on 
discharge. HCTZ could be contributory, and was held on discharge 
as patient appeared euvolemic with good BP control off the HCTZ. 
 Patient stated her appetite was better on discharge (possible 
hyponatremia was contributing).

.
* Bradycardia
Prior cardiac workup raised question of sick sinus syndrome, and 
patient had bradycardic rate, <2 second pauses on tele. TSH was 
within normal limits. Outpatient cardiology follow-up is 
scheduled with Dr. ___.
.
# Noncardiac Chest pain
On evening of admission, patient c/o left sided stabbing pain 
under her rib, worse when she pressed on it and also following a 
meal. No N/V/SOB/diaphoresis/radiation. She was ruled out for MI 
with serial unchanged ECGs, two sets negative CE. Her pain 
resolved with maalox and tylenol and did not return.

.
* Headaches
Appears to be consistent with her chronic headache syndrome, 
thought to be cervical in etiology by neurology. History less 
suggestive of other etiologies such as migraine, tension, or 
even temporal arteritis (but ESR was 3). Continued soft cervical 
collar at night per neuro recs. Pain resolved with tylenol.

.
* Anemia
Seen by ___ as an outpatient, felt to be related to CRI and 
some degree of iron deficiency. Gets regular epo and iron 
infusions. No history of recent gross bleeding.
 B12, folate, retic, RBC morph, SPEP/UPEP all wnl. No guaiac 
positive stools during hospitalization.
.
* Hypertension
In setting of dehydration, held ACEI and HCTZ. HCTZ held on 
discharge as above. SBP's in 130's at time of discharge. In 
outpatient setting might consider adding amlodipine. She did not 
have a true allergy to CCBs, only peripheral edema.
.
* CAD. Continued ASA and statin. Not on BB as outpatient, and 
continued to hold as she was mildly bradycardic.

 
Medications on Admission:
Hydrochlorothiazide 12.5 mg on ___,
and ___ only. Oxybutynin 5 mg at night, Protonix 40 mg daily,
simvastatin 10 mg daily, aspirin 81 mg daily, Colace 400 mg
daily, multivitamin with iron daily.
 
Discharge Medications:
1. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
2. Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day): Hold for loose stools.  
5. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
6. Oxybutynin Chloride 5 mg Tab,Sust Rel Osmotic Push 24hr Sig: 
One (1) Tab,Sust Rel Osmotic Push 24hr PO once a day.  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
1. Dehydration
2. Gait instability
3. Failure to thrive
4. Noncardiac chest pain

SECONDARY DIAGNOSES:
Hypertension
Hyperlipidemia
Coronary artery disease
Chronic headaches
Nephrolithiasis
Cataracts

 
Discharge Condition:
Mental Status:Clear and coherent
Level of Consciousness:Alert and interactive
Activity Status:Ambulatory - requires assistance or aid (walker 
or cane)

 
Discharge Instructions:
You were admitted to the hospital on ___ with balance 
difficulty and dehydration. You were given intravenous fluids 
with improvement. You were seen by the physical therapists who 
recommended that you continue working with physical therapy at 
home in order to work on your strength and balance. You were 
also having chest pain, but this resolved with maalox and your 
heart tests were normal.

STOP taking hydrochlorothiazide. None of your other medications 
were changed.
 
Followup Instructions:
___
",MEDICINE
10003502-DS-4,Elizabeth Marquez,10003502,29460260," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Nifedipine Er / Amitriptyline / Prilosec Otc / Terazosin / 
Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide
 
Attending: ___.
 
Chief Complaint:
presyncope s/p fall
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
Ms. ___ is an ___ year old ___ speaking woman who 
presents after a fall.  History was obtained through ___ 
interpreter. 
The patient reports feeling unwell 1 day PTA, with no specific 
complaints, but with general fatigue, baseline chronic headache. 
  She describes bending over to pick up a napkin. Upon standing 
up, she felt dizzy and like she was about to fall backwards. She 
quickly plopped down on her behind to prevent herself from 
falling. At that point, she felt her heart racing and had some 
difficulty catching her breath. She found she was unable to get 
up, and her husband ___ help her. They called EMS. 
.  
At baseline, Ms. ___ ambulates with a walker. She does 
report several falls over the last year, but much less 
frequently since using walker. She denies any loss of 
consciousness of prodromal symptoms such as chest discomfort or 
palpitations. No focal weakness, sensory loss, or tremor.  
Patient also c/o leg swelling, worse over past 2 months, left 
greater than right. Her legs look normal in the AM, but become 
swollen as the day progresses. She was told to try compression 
stockings, but needs a Rx. She has not gained any weight, and 
she sleeps lying flat. 
.
Of note, she has started taking HCTZ again in the past few days 
on her own, since she thought it might help with her leg 
swelling. She drinks ___ glasses water/day and c/o urinary 
frequency with occasional incontinence because of not making it 
to BR in time. She feels she is eating well, but cannot gain any 
weight. Drinking Ensures.
 
Past Medical History:
HTN
Hyperlipidemia
CAD s/p MI in ___
Headaches
Nephrolithiasis
Cataracts
Otitis media
Syncope ?sick sinus syndrome
s/p CCY 
 
Social History:
___
Family History:
Mother deceased at age ___ from breast cancer.
Father deceased at age ___. Son deceased at age ___ from heart
attack. 
 
Physical Exam:
Vitals 97.1 52 130/58 18 100% on RA  
HEENT NC/AT  
Neck Supple, no JVD  
Pulm Lungs clear bilaterally, no rales or wheezing  
CV Bradycardic S1 S2 soft systolic murmur at apex  
Abd Soft nontender +bowel sounds.    
Extrem Warm, palpable distal pulses, 1+ pedal edema
Derm Skin warm, no rash  
Neuro Alert, answering appropriately, attentive. CN ___, 
strength, and sensation to light touch intact. No tremor, no 
cogwheeling. No dysmetria. Babinkski downgoing.
 
Pertinent Results:
ADMISSION LABS:
___ 06:20PM BLOOD WBC-5.1 RBC-3.17* Hgb-9.4* Hct-27.8* 
MCV-88 MCH-29.7 MCHC-34.0 RDW-14.2 Plt ___
___ 06:20PM BLOOD Neuts-73.5* ___ Monos-5.1 Eos-2.3 
Baso-0.3
___ 06:20PM BLOOD Plt ___
___ 06:20PM BLOOD Glucose-95 UreaN-28* Creat-1.0 Na-128* 
K-4.5 Cl-95* HCO3-24 AnGap-14
___ 06:40AM BLOOD TotProt-5.2* Calcium-10.3 Phos-3.2 Mg-1.8
___ 12:55AM BLOOD Albumin-3.7
___ 06:20PM BLOOD Osmolal-278
.
CARDIAC BIOMARKERS
___ 06:20PM BLOOD CK(CPK)-92
___ 12:55AM BLOOD CK(CPK)-85
___ 06:40AM BLOOD CK(CPK)-76
___ 06:20PM BLOOD cTropnT-0.02*
___ 12:55AM BLOOD CK-MB-NotDone cTropnT-0.02*
___ 06:40AM BLOOD CK-MB-NotDone cTropnT-<0.01
.
DISCHARGE LABS:
___ 06:40AM BLOOD Glucose-80 UreaN-21* Creat-0.9 Na-135 
K-4.3 Cl-100 HCO3-28 AnGap-11
.
SPEP PENDING
URINE CX PENDING
.
IMAGING
L-SPINE PLAIN FILMS:
Minimal anterolisthesis of L4 upon L5 and minimal retrolisthesis 

of L1 upon L2, of indetermiante age. Recommend clinical 
correlation for point tenderness. No acute fracture seen. 
Degenerative changes of the lumbar spine. 
.
CXR:
Right lower lobe granuloma is stable since ___. 
Flattening of the diaphragms and hyperinflation of the lungs is 
compatible with COPD. The aorta is calcified and tortuous. Heart 
is borderline in size. Degenerative changes of the spine are 
noted. 

 
Brief Hospital Course:
___ yo ___ speaking F with CAD, chronic ear infection who 
presents with presyncope and fall at home.  
.  
# Presyncope: Likely orthostasis in setting of HCTZ use and 
possible mild dehydration. Hyponatremia may have also 
contributed. Patient ruled out for MI. Neurological exam had no 
focal deficits. There was no evidence of infection, however 
urine cx was pending at discharge. Patient has bradycardia ___ 
SSS, but this is a chronic issue and patient is asymptomatic 
with bradycardia on the floor, and responded appropriately to 
exercise.  No events on tele. Patient was not orthostatic after 
receiving gentle IVF. Physical therapy consult cleared patient 
for independent ambulation with walker. 
HCTZ was discontinued. Patient will have her BP monitored off 
this medication by her PCP, and may require a replacement 
medication. Amitrityline was another candidate for causing 
confusion and falls, however patient has noted benefit from this 
in terms of headaches. If falls continue, could consider 
stopping Amitrityline as well. 
. 
# Hyponatremia: Patient has h/o hyponatremia in setting of HCTZ, 
possibly with mild SIADH component as well (since Na did not 
completely normalize when taken off of HCTZ). Patient had brain 
MRI as outpatient which showed only moderate microvascular 
disease, which is unlikely to explain hyponatremia. Patient does 
have evidence of COPD on CXR, but no other intrathoracic 
pathology to cause SIADH. Urine osm were intermediate, so no 
clear SIADH picture. 
Patient did start taking HCTZ taking on her own over the last 
few days for leg swelling. This likely accounted for worsened 
hyponatremia at admission. After holding the HCTZ, giving IVF, 
and encouraging POs, sodium was in normal range.   
Patient was instructed not to take HCTZ, and to instead use 
compression stockings for leg edema. 
.
# Lower extremity edema: This was very consistent with chronic 
venous insufficiency. Patient describes swelling that only 
occurs over the course of the day, and improves with rest and 
elevation. She has not been wearing compression stockings. 
Otherwise patient had no evidence of volume overload on exam. 
She is at risk for CHF given CAD and past MI, and should 
continue to weight herself daily.
.  
# Sick sinus syndrome: Followed by Dr ___ as 
outpatient. No need for pacemaker given appropriate response to 
exercise. This episode is highly unlikely to be cardiac in 
etiology. Sinus bradycardia on tele. Asymptomatic.  
.
# L gluteal pain: No fracture noted on L-spine films. Likely 
soft tissue trauma from fall.    
.   
# Hypercalcemia: Borderline and chronic, with mildly elevated 
PTH in past. This degree is very unlikely to be causing 
symptoms.    
.  
# Anemia: Hct 28 in baseline range.   
.  
# HTN:  continue lisinopril.  
.  
# Hyperlipidemia: continue statin   
.  
#: Headaches: chronic, likely related to chronic ear 
infections/mastoiditis.   
.  
# Otitis media: Right ear chronically infected. Per report, has 
used ear dropts. Patient does not complain of worsening 
pain/symptoms in her ear.    

 
Medications on Admission:
HCTZ (D/Ced but now taking again)
Amitryptiline 10 mg PO QHS (restarted for headaches in ___  
Pantoprazole 40 mg PO Q24H  
Simvastatin 10 mg PO DAILY  
Aspirin 81 mg PO DAILY (Daily)  
Docusate Sodium 100 mg PO BID  
Multivitamin PO DAILY  
Lisinopril 10 mg PO daily  
diclofenac
fluticasone nasal spray
 
Discharge Medications:
1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO once a 
day.  
2. Senna 8.6 mg Tablet Sig: Two (2) Tablet PO once a day as 
needed for constipation.  
3. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).  
4. Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
5. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
6. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
7. Fluticasone 50 mcg/Actuation Spray, Suspension Sig: One (1) 
Spray Nasal DAILY (Daily).  
8. Amitriptyline 10 mg Tablet Sig: One (1) Tablet PO at bedtime. 
 
9. Aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  
10. compression stockings
2 pairs compression stockings
11. Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO once a 
day as needed for pain.  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
primary:
presyncope
hyponatremia
.
secondary:
sick sinus syndrome
coronary artery disease

 
Discharge Condition:
Mental Status: Clear and coherent
Level of Consciousness: Alert and interactive
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane)

 
Discharge Instructions:
It was a pleasure taking care of you. You were admitted for an 
episode of dizziness and falling. You had been taking HCTZ, a 
diuretic which can lead to dehydration and low sodium levels in 
your blood. Your sodium level was low, and improved before you 
left the hospital. You were treated with intravenous fluids and 
the HCTZ was stopped. You did well with physical therapy and 
your heart rate and blood pressure were normal. 
.
You also had leg swelling. This is caused by chronic venous 
insufficiency, which means that the valves in your veins get 
leaky over time and cause blood to pool in your legs. The 
treatment for this is elevating your legs and wearing 
compression stockings. 
.
The following changes were made to your medications
- STOP taking HCTZ
 
Followup Instructions:
___
",MEDICINE
10003502-DS-5,Elizabeth Marquez,10003502,23352834," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
nifedipine / Amitriptyline / Prilosec OTC / Terazosin / 
Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide
 
Attending: ___.
 
Chief Complaint:
Nausea, Vomiting
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ year old ___ speaking female with HTN, CAD s/p MI, HL, 
and vascular cognitive impairment who presents with nausea and 
vomiting.  
.  
She reports feeling well yesterday. At 2:30AM this morning, she 
awoke with the acute onset of nausea and vomiting. She describes 
nonbloody nonbilious vomit x3. Her family called EMS and she had 
another episode in the ED. Denies abd pain, diarrhea, 
constipation, or blood in stool/vomit. Denies dysuria. She has 
had no recent changes in her appetite and yesterday she states 
that was in her normal state of health. Denies recent changes in 
food intake (although did eat fish soup that was three days old 
yesterday).  
.  
In the ED, initial vitals were 97.3 64 159/84 16 100%. She was 
given zofran and no IVF. Labs were notable for a lipase of 88, 
alk phos 108, Hct 35.4 (from baseline of ___, troponin <0.01, 
Ca ___. Most recent vitals 98.3 74 115/47 16 98%RA.  
.  
On the floor, the patient denies nausea, abdominal pain. She 
does have a mild stuffy nose that she states is chronic. She 
denies cough, SOB, myalgias or fatigue. 

 
Past Medical History:
HTN
Hyperlipidemia
CAD s/p MI in ___
Headaches
Nephrolithiasis
Cataracts
Otitis media
Syncope ?sick sinus syndrome
s/p CCY 
 
Social History:
___
Family History:
Mother deceased at age ___ from breast cancer.
Father deceased at age ___. Son deceased at age ___ from heart
attack. 
 
Physical Exam:
Admission Exam:
Vitals: 100.0 152/60 78 18 99% RA; patient not orthostatic
GA: AOx3, NAD  
HEENT: PERRLA. MMM. no LAD. no JVD. neck supple.  
Cards: PMI palpable at ___ IC space. No RVH. RRR S1/S2 heard. 
no murmurs/gallops/rubs.  
Pulm: Mild crackles in bases bilaterally. Otherwise clear with 
good air movement.
Abd: soft, NT, +BS. no g/rt. neg HSM. neg ___ sign.  
Extremities: wwp, no edema. DPs, PTs 2+.  
Neuro/Psych: CNs II-XII intact. ___ strength in U/L extremities. 
DTRs 2+ ___ (biceps, achilles, patellar). sensation intact to LT, 
pain, temperature, vibration, proprioception. cerebellar fxn 
intact (FTN, HTS). gait WNL. 

Discharge Exam:
Vitals: 97.1 134/50 64 16 97% RA
GA: AOx3, NAD  
HEENT: PERRLA. MMM. no LAD. no JVD. neck supple.  
Cards: PMI palpable at ___ IC space. No RVH. RRR S1/S2 heard. 
no murmurs/gallops/rubs.  
Pulm: Mild crackles in bases bilaterally. Otherwise clear with 
good air movement.
Abd: soft, NT, +BS. no g/rt. neg HSM. neg ___ sign.  
Extremities: wwp, no edema. DPs, PTs 2+. 

 
Pertinent Results:
Admission Labs:
___ 06:25AM   GLUCOSE-116* UREA N-39* CREAT-1.1 SODIUM-138 
POTASSIUM-3.8 CHLORIDE-99 TOTAL CO2-28 ANION GAP-15
___ 06:25AM   ALT(SGPT)-14 AST(SGOT)-28 ALK PHOS-108* TOT 
BILI-0.4
___ 06:25AM   LIPASE-88*
___ 06:25AM   ALBUMIN-4.7 CALCIUM-10.6* PHOSPHATE-3.0 
MAGNESIUM-2.2
___ 06:25AM   WBC-10.4# RBC-4.47# HGB-11.8* HCT-35.4* 
MCV-79*# MCH-26.3*# MCHC-33.2 RDW-15.6*
___ 06:25AM   NEUTS-93.2* LYMPHS-4.3* MONOS-2.1 EOS-0.5 
BASOS-0

Discharge Labs:
___ 08:05AM BLOOD WBC-3.5* RBC-3.54* Hgb-9.3* Hct-28.1* 
MCV-79* MCH-26.3* MCHC-33.2 RDW-15.6* Plt ___
___ 08:05AM BLOOD Glucose-84 UreaN-23* Creat-0.9 Na-138 
K-3.7 Cl-109* HCO3-22 AnGap-11
___ 08:05AM BLOOD ALT-16 AST-29 LD(LDH)-167 AlkPhos-69 
TotBili-0.2
___ 08:05AM BLOOD Lipase-31
___ 08:05AM BLOOD Calcium-9.1 Phos-2.2* Mg-2.0

Microbiology:
___ 10:30AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 
LEUK-NEG

___ 6:50 pm Influenza A/B by ___
      Source: Nasopharyngeal swab. 

                            **FINAL REPORT ___

   DIRECT INFLUENZA A ANTIGEN TEST (Final ___: 
      Negative for Influenza A. 

   DIRECT INFLUENZA B ANTIGEN TEST (Final ___: 
      Negative for Influenza B. 

___ 7:18 pm STOOL     CONSISTENCY: WATERY      Source: 
Stool. 

                            **FINAL REPORT ___

   FECAL CULTURE (Final ___:    NO SALMONELLA OR SHIGELLA 
FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

Imaging:
CXR: FINDINGS: There is no pneumonia. There is no pleural 
effusion or 
pneumothorax. There is mild cardiomegaly with a left ventricular 

configuration. A right lower lobe granuloma is stable since 
___.  
The thoracic aorta is tortuous. Hilar silhouettes are within 
normal limits. 
  
IMPRESSION: 
1. No pneumonia. 
2. Stable mild cardiomegaly with a left ventricular 
configuration. 

 
Brief Hospital Course:
___ year old ___ speaking female with HTN, CAD s/p MI, HL, 
and vascular cognitive impairment who presented with nausea and 
vomiting. 
.
#. Nausea/Vomiting: The patient likely had a viral 
gastroenteritis and she continued to have mild nausea with some 
vomiting while inpatient. She was cleared by physical therapy 
and was able to tolerate POs before discharge.
.
She was also tested for influenza while here given some nasal 
congestion with the above symptoms. Pre test suspicion for this 
was low given that she did not have myalgias or other systemic 
symtpoms. The test was negative.
.
We also considered mild pancreatitis given an elevation in her 
lipase upon admission. This decreased on the second day of 
admission and remained normal and the patient tolerated POs well 
before discharge. Therefore, pancreatitis was thought to be 
unlikely.

#. Chronic Pain/Vascular Parkinsonism: Continued Amitriptyline.
.
#. HTN:  Continued Lisinopril, Lasix.
  
#. Dyslipidemia: Continued Simvastatin 
.  
#. s/p MI in ___: Continued aspirin, lisinopril and 
simvastatin. 
.  
#. Sick sinus syndrome: Followed by Dr. ___, pacemaker 
felt to be unnecessary given appropriate response of 
asymptomatic bradycardia to exertion.
.  
#. Chronic anemia:  Thought to be secondary to renal failure. 
Followed by Dr. ___ in Infectious ___, and treated with 
biweekly injections of Aranesp 200 micrograms. 
.
#  Chronic nasal congestion: Continued Fluticasone

 
Medications on Admission:
AMITRIPTYLINE - 20 mg Tablet QHS
FLUTICASONE - 50 mcg Spray, Suspension - 2 sprays each nostril 
qpm
FUROSEMIDE - 20 mg Tablet - 1 Tablet(s) by mouth qam
LISINOPRIL - 40 mg Tablet - 1 Tablet(s) by mouth qam
PANTOPRAZOLE [PROTONIX] - 40 mg Tablet, Delayed Release (E.C.) - 
one Tablet(s) by mouth once a day
POTASSIUM CHLORIDE - 10 mEq Tab Sust.Rel. Particle/Crystal - 1 
Tab(s) by mouth qam
SIMVASTATIN - 10 mg Tablet - 1 Tablet(s) by mouth once a day
ACETAMINOPHEN - 325 mg Tablet - 2 Tablet(s) by mouth twice a day 
as needed for neck pain avoid regular use
ASPIRIN - 81 mg Tablet, Delayed Release daily
DOCUSATE SODIUM - 400 mg Capsule daily
MULTIVITAMIN WITH IRON-MINERAL daily
___ ___ (laxative)

 
Discharge Medications:
1. amitriptyline 10 mg Tablet Sig: Two (2) Tablet PO HS (at 
bedtime) as needed for sleep.  
2. fluticasone 50 mcg/Actuation Spray, Suspension Sig: Two (2) 
Spray Nasal DAILY (Daily).  
3. Lasix 20 mg Tablet Sig: One (1) Tablet PO once a day.  
4. lisinopril 40 mg Tablet Sig: One (1) Tablet PO once a day.  
5. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO once a day.  
6. potassium chloride 10 mEq Capsule, Sustained Release Sig: One 
(1) Capsule, Sustained Release PO once a day.  
7. simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
8. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO BID;prn as 
needed for pain, fever.  
9. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
10. docusate sodium 100 mg Capsule Sig: Four (4) Capsule PO once 
a day.  
11. multivitamin,tx-minerals     Tablet Sig: One (1) Tablet PO 
DAILY (Daily).  
12. Zofran 4 mg Tablet Sig: One (1) Tablet PO once a day as 
needed for nausea.
Disp:*2 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Gastroenteritis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory 

 
Discharge Instructions:
Ms. ___,
It was a pleasure to take care of you in the hospital. You came 
in with nausea and vomiting and this subsided while you were in 
the hospital. We checked you for influenza and pancreatitis but 
both were negative. We think that you likely had a viral 
gastroenteritis.
.
We did not make any changes to your medications. You should make 
sure that you eat if you can and drink lots of fluids.
.
Please return to the emergency room if your symptoms worsen.
.
Please followup with Dr. ___ as listed below. 
 
Followup Instructions:
___
",MEDICINE
10003502-DS-6,Elizabeth Marquez,10003502,29391916," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
nifedipine / Amitriptyline / Prilosec OTC / Terazosin / 
Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide / 
spironolactone
 
Attending: ___.
 
Chief Complaint:
""feeling unwell"", Admitted for bradycardia
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ ___ speaking HTN, CAD s/p MI, HL, and vascular cognitive 
impairment, hx of afib on pradaxa presenting with feeling 
'unwell' x2 days; states that she had brief chest discomfort 
yesterday which passed spontaneously. Headache which was 
baseline now gone. Vomited in triage, now denies nausea. No abd 
pain. No bloody stools. No vision changes. No shortness of 
breath. No urinary sx.  

Her spironolactone which was recently added by her PCP to treat 
her symptoms of right sided heart failure (pleural effusion seen 
on CXR, pedal edema) was discontinued by her PCP given her 
hyponatremia.  
It was noted previously that she has sinus bradycardia and 
probable sick sinus syndrome and therefore her CAD was not 
treated by BB. 

Prior cardiology note indicates that the patient has evidence of 

intrinsic sinus node disease.  

___ it was noted that she has aflutter/afib and after 
discussion with the patient it was decided to start her on 
dabigatran 75 mg twice daily given her age, fragility and 
slightly reduced GFR per PCP ___.  

In the ED, initial VS were: T 98.3 HR 59 BP 178/59 RR 18 Sat99% 
2L.  
EKG in the ED revealed bradycardia with afib and no ischemic 
changes. She was heme negative DRE with brown stool. Her labs 
were notable for PTT: 48.5, INR: 1.2, H/H ___, Cr 1, Na 125 
(Na 128-132 since ___ with episodic hyponatremia prior to 
___ K 5.1. Tpn < 0.01 x1. In the ED she received 1L NS. CT 
head without contrast showed no acute process per prelim report. 
CXR showed pulmonary vascular congestion with small left pleural 
effusion, decreased 
since ___ and mild cardiomegaly. UA was not 
suggestive of UTI. She was noted to be going in and out of heart 
block in high 30___ shortly after arrival while in the ED.  

Vitals prior to transfer to floor were: HR 61 BP 115/47 RR 18 
Sat 100%.  
 
On arrival to the floor, patient having difficult time 
understanding ___ phone translation due to hearing aid 
malfunction. Does not appear in distress. Complaining of RLE 
discomfort.
 
Past Medical History:
HTN
Hyperlipidemia
CAD s/p MI in ___
Headaches
Nephrolithiasis
Cataracts
Otitis media
Syncope ?sick sinus syndrome
s/p CCY 
 
Social History:
___
Family History:
Mother deceased at age ___ from breast cancer.
Father deceased at age ___. Son deceased at age ___ from heart
attack. 
 
Physical Exam:
ADMISSION
VS - Temp F 97.7, BP 139/45, HR 54 (retaken by me at ___), R28, 
O2-sat 100% RA  
GENERAL - NAD
NECK - no JVD, no carotid bruits  
LUNGS - Good air movement. R basilar crackles.
HEART - bradycardic at 44, ___ systolic murmur loudest at ___
ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no 
rebound/guarding  
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, 
DPs), hip pain  
SKIN - no rashes or lesions  
LYMPH - no cervical, axillary, or inguinal LAD  
NEURO - awake, A&Ox3

DISCHARGE
VS - 97.7 162/72 64 20 100RA
Tele: rate ___, recurrent pauses lasting up to 2.6 seconds
GENERAL - NAD
NECK - no JVD, no carotid bruits  
LUNGS - Good air movement. R basilar crackles.
HEART - bradycardic at ___, ___ systolic murmur loudest at ___
ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no 
rebound/guarding  
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, 
DPs), hip pain  
SKIN - no rashes or lesions  
LYMPH - no cervical, axillary, or inguinal LAD  
NEURO - awake, A&Ox3
 
Pertinent Results:
ADMISSION

___ 01:20AM BLOOD WBC-6.2 RBC-3.81* Hgb-11.3* Hct-32.9* 
MCV-86 MCH-29.7 MCHC-34.4 RDW-13.3 Plt ___
___ 01:20AM BLOOD ___ PTT-48.5* ___
___ 01:20AM BLOOD Glucose-107* UreaN-21* Creat-1.0 Na-120* 
K-5.9* Cl-89* HCO3-21* AnGap-16
___ 03:00AM BLOOD Calcium-10.0 Phos-2.6* Mg-1.7

DISCHARGE

___ 07:25AM BLOOD WBC-5.0 RBC-3.69* Hgb-10.7* Hct-32.0* 
MCV-87 MCH-28.9 MCHC-33.3 RDW-13.4 Plt ___
___ 06:34AM BLOOD Glucose-77 UreaN-26* Creat-1.0 Na-129* 
K-4.9 Cl-95* HCO3-25 AnGap-14
___ 06:34AM BLOOD Calcium-10.0 Phos-3.0 Mg-1.___RIEF HOSPTIAL COURSE AND ACTIVE ISSUE (BRADYCARDIA)
___ ___ speaking HTN, CAD s/p MI, HL, and vascular cognitive 
impairment, hx of afib on pradaxa presenting with feeling 
'unwell'. Noted to be bradycardic to ___ in ED. In-house had 
episodic bradycardia to ___. On telemetry this appeared to be 
aflutter with variable block (2:1 block all the way to 8:1 
block). Pt asymptomatic during these episodes. Per discussion 
with Dr. ___ (o/p cardiologist), patient likely has enough 
intrinsic nodal disease that diltiazem is not needed for rate 
control for flutter, so home diltiazem 180mg held. Patient 
continued to have episodes of bradycardia, but these were fewer 
in number. For blood pressure control patient started on 
amlodipine 5mg.

OTHER ACTIVE ISSUES
# Hyponatremia: Patient's sodium noted to be 120 on admission. 
Without treatment trended spontaneously up to 129 on discharge.

# HTN: Continued on lisinopril 40 mg daily. Given that diltizem 
was held, we started patient on amlodipine 5mg for lack of nodal 
blockading effects. Patient's blood pressure on discharge was 
running high in 150s-160s. 

# Lumbar radiculopathy: continued home lidocaine patch and 
amitryptiline. 
# Pleural effusion: In house did not have hypoxia. CXR showed 
decrease in size from prior in ___. 
# HL: cont pravastatin 10 mg daily  
# CAD s/p MI:  Continued Pravastatin, and ASA. No BB given given 
given bradycardia.
# GERD: stable. Cont protonix 40 daily

TRANSITIONAL ISSUES
# o/p lab draw on ___, results will be faxed to Dr. ___ 
followup at appointment on ___.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amitriptyline 10 mg PO HS 
2. Dabigatran Etexilate 75 mg PO BID 
3. Diltiazem Extended-Release 180 mg PO DAILY 
4. Fluticasone Propionate NASAL 2 SPRY NU QPM 
5. Lisinopril 40 mg PO DAILY 
6. Pantoprazole 40 mg PO Q24H 
7. Pravastatin 10 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Docusate Sodium 400 mg PO DAILY 
10. Multivitamins W/minerals 1 TAB PO DAILY 
11. Lidocaine 5% Patch 1 PTCH TD DAILY 
RLE pain 

 
Discharge Medications:
1. Amitriptyline 10 mg PO HS 
2. Aspirin 81 mg PO DAILY 
3. Dabigatran Etexilate 75 mg PO BID 
4. Fluticasone Propionate NASAL 2 SPRY NU QPM 
5. Lidocaine 5% Patch 1 PTCH TD DAILY 
RLE pain 
6. Lisinopril 40 mg PO DAILY 
7. Multivitamins W/minerals 1 TAB PO DAILY 
8. Pantoprazole 40 mg PO Q24H 
9. Pravastatin 10 mg PO DAILY 
10. Docusate Sodium 400 mg PO DAILY 
11. Amlodipine 5 mg PO DAILY 
RX *amlodipine 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0
12. Outpatient Lab Work
Please draw Chem 7, Ca, Mg, Phos on ___ and fax to ___ 
___ MD at ___

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis
Atrial Flutter with variable heart block (2:1 up to 8:1)

Secondary diganosis
Hyponatremia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure participating in your care. You came to the 
Emergency Room feeling ill, but were not able to fully explain 
what was making you feel unwell. While in the Emergency Room, we 
found that your heart rate was low. We did an EKG (an electrical 
map of the heart) to better characterize this slow rhythm. The 
EKG was not markedly different from the ones you had previously. 
We monitored you and you had slow heart rates often while you 
were in the hospital. These episodes did not correlate to your 
symptoms.

We held one of your heart medicines, the Diltiazem, because this 
can block the conduction of impulses through your heart and 
contribute to this slow heart rate. 

At the same time, we found that your sodium is a little bit low. 
 This improved over the course of your stay.

Please STOP Diltiazem
Please START Amlodipine 5mg daily.  This is for your blood 
pressure.
 
Followup Instructions:
___
",MEDICINE
10003502-DS-7,Elizabeth Marquez,10003502,20459702," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
nifedipine / Amitriptyline / Prilosec OTC / Terazosin / 
Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide / 
spironolactone
 
Attending: ___
 
Chief Complaint:
Nausea
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Ms. ___ is an ___ with atrial fibrillation/flutter on 
dabigatran, coronary artery disease, diastolic heart failure 
(LVEF 60% in ___, hypertension/hyperlipidemia, and vascular 
dementia who presents with nausea and headache. She is 
___ only, and collateral information is obtained 
from her sister ___. According to her sister, she was in her 
usual state of health until days to a week prior to admission, 
when she developed nausea, initially without vomiting, with 
onset of frequent nonbloody, nonbilious emesis on the night 
prior to admission. She also experienced intermittent diffuse 
headaches, consistent with chronic of unclear etiology, over the 
same period. At least as far as her sister is aware, she has not 
experienced fevers/chills, chest pain/palpitations, cough, nasal 
congestion/rhinorrhea, sore throat, shortness of breath at 
rest/on exertion, difficulty lying flat, abdominal pain, loose 
stools, hematuria/dysuria, or myalgias. She has not been exposed 
to sick contacts or made any dietary changes. Her sister does 
indicate that her appetite has been poor for some time, leading 
to unintentional weight loss (""lots"") over a ___ period. She 
experiences chronic intermittent peripheral edema.

Of note, she was admitted most recently from ___ for 
episodic asymptomatic bradycardia to ___ attributed to atrial 
flutter with variable (2:1 to 8:1) block. Home diltiazem was 
held, given degree of intrinsic nodal disease, and amlodipine 
was initiated along with preexisting lisinopril for blood 
pressure control, with pressures of 150s-160s systolic by the 
time of discharge. More recently, ___ found a 2-lb weight gain 
(133 lbs, up from 131 lbs at baseline) in association with 
bilateral pitting edema, right > left, on ___, at which time 
patient denied shortness of breath. Spironolactone was initiated 
by her PCP ___ ___ for symptomatic diastolic heart failure, 
including peripheral edema and pleural effusions, but was 
discontinued within weeks due to hyponatremia; she reportedly 
has become hyponatremic on other diuretics in the past. She has 
no home oxygen requirement.  
 
In the ED, initial vital signs were as follows: 97.2 112 170/76 
15 100% 3L. Admission labs were notable for Hct of 33.7 
(consistent with baseline), platelets of 142 (consistent with 
baseline), and proBNP of 3220 (no priors available). CXR 
revealed bilateral pleural effusions, cardiomegaly and mild 
edema suggesting fluid overload, and possible underlying 
consolidation. She received acetaminophen 650mg x1, ceftriaxone 
1g x1, azithromycin 500mg x1, and furosemide 40mg x1, with 
1100cc UOP. Vital signs at transfer were as follows: 98.4 70 
165/83 18 100%. 

On arrival to the floor, patient reports that she is not in 
pain. Further discussion is difficult due to language barrier. 
 
Past Medical History:
Hypertension/hyperlipidemia
Coronary artery disease complicated by myocardial infarction 
Atrial fibrillation/flutter
Diastolic heart failure (LVEF 60% in ___
Vascular dementia
Headaches
Nephrolithiasis
Cataracts
Otitis media
Syncope/possible sick sinus syndrome
Status post cholecystectomy
Gastroesophageal reflux
Hyponatremia
Anemia
Lumbar radiculopathy
 
Social History:
___
Family History:
Mother deceased at ___ yo from breast cancer. Father deceased at 
___ yo. Son deceased at ___ yo from heart attack. 
 
Physical Exam:
On admission: 
VS 97.4 140/P 62 18 96
GEN Alert, oriented, no acute distress
HEENT NCAT MMM EOMI sclera anicteric, OP clear, left-sided 
hearing loss
NECK supple, no JVD, no LAD
PULM Good aeration, CTAB no wheezes, rales, ronchi
CV RRR normal S1/S2, no mrg
ABD soft NT ND normoactive bowel sounds, no r/g
EXT WWP 2+ pulses palpable bilaterally, trace pitting edema 
bilaterally
NEURO CNs2-12 intact, motor function grossly normal
SKIN no ulcers or lesions

DISCHARGE:
I/O: 200po/incontinent of urine
 NAD, AAO speaking ___
 mucosa moist and pink
 RRR, no m/r/g
 CTAB
 BS+, soft, NT, ND
 no ___ pretibial edema
 
Pertinent Results:
___ 10:15AM BLOOD WBC-6.4 RBC-3.64* Hgb-11.1* Hct-33.7* 
MCV-93 MCH-30.6 MCHC-33.1 RDW-14.1 Plt ___
___ 08:09AM BLOOD WBC-4.9 RBC-3.45* Hgb-10.6* Hct-31.5* 
MCV-91 MCH-30.6 MCHC-33.6 RDW-14.2 Plt ___
___ 09:35AM BLOOD WBC-5.6 RBC-3.99* Hgb-11.3* Hct-35.7* 
MCV-89 MCH-28.3 MCHC-31.6 RDW-13.6 Plt ___
___ 07:33AM BLOOD WBC-5.6 RBC-3.60* Hgb-10.5* Hct-33.1* 
MCV-92 MCH-29.3 MCHC-31.9 RDW-14.1 Plt ___
___ 08:10AM BLOOD WBC-5.6 RBC-3.55* Hgb-10.6* Hct-32.5* 
MCV-92 MCH-29.9 MCHC-32.7 RDW-14.1 Plt ___
___ 10:15AM BLOOD Neuts-84.3* Lymphs-10.6* Monos-3.4 
Eos-1.4 Baso-0.4
___ 10:15AM BLOOD Glucose-113* UreaN-19 Creat-1.0 Na-135 
K-4.2 Cl-99 HCO3-25 AnGap-15
___ 08:09AM BLOOD Glucose-88 UreaN-18 Creat-1.0 Na-138 
K-4.0 Cl-101 HCO3-32 AnGap-9
___ 09:35AM BLOOD Glucose-104* UreaN-18 Creat-1.0 Na-141 
K-3.8 Cl-99 HCO3-27 AnGap-19
___ 07:33AM BLOOD Glucose-98 UreaN-23* Creat-1.2* Na-141 
K-4.2 Cl-101 HCO3-32 AnGap-12
___ 08:10AM BLOOD Glucose-102* UreaN-26* Creat-1.2* Na-138 
K-3.9 Cl-100 HCO3-32 AnGap-10
___ 10:15AM BLOOD CK-MB-5 cTropnT-0.07* proBNP-3220*
___ 08:09AM BLOOD CK-MB-5 cTropnT-0.11*
___ 04:20PM BLOOD CK-MB-4 cTropnT-0.09*
___ 01:03AM BLOOD CK-MB-4 cTropnT-0.09*
___ 09:35AM BLOOD cTropnT-0.06*
___ 09:35AM BLOOD cTropnT-0.06*
___ 04:20PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ 05:35PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG

TTE ___:
The left atrium is mildly dilated. There is moderate symmetric 
left ventricular hypertrophy. The left ventricular cavity size 
is normal. Regional left ventricular wall motion is normal. 
Overall left ventricular systolic function is normal (LVEF>55%). 
Right ventricular chamber size and free wall motion are normal. 
The aortic valve leaflets are moderately thickened. There is 
mild aortic valve stenosis (valve area 1.2-1.9cm2). Mild (1+) 
aortic regurgitation is seen. The mitral valve leaflets are 
mildly thickened. Moderate (2+) mitral regurgitation is seen, 
but may be underestimated due to Coanda effect and acoustic 
shadowing from the mitral annulus calcification. The estimated 
pulmonary artery systolic pressure is normal. There is a small 
pericardial effusion. 

IMPRESSION: Moderate symmetric LVH with normal global and 
regional biventricular systolic function. Mild aortic stenosis. 
Mild aortic regurgitation. At least moderate mitral 
regurgitation.

 
Brief Hospital Course:
Hospitalization Summary: 
Ms. ___ is an ___ yo ___ F with atrial 
fibrillation/flutter on dabigatran, coronary artery disease, 
diastolic heart failure (LVEF 60% in ___, 
hypertension/hyperlipidemia, and vascular dementia who presented 
with nausea and headache and was found to be in acute-on-chronic 
diastolic heart failure in the setting of NSTEMI.

Active Issues:
#NSTEMI: Although viral infection was suspected initially on the 
basis of history of nausea/vomiting obtained from her sister, 
revised history of nausea without vomiting in the absence of 
sick contacts obtained from the patient via interpreter raised 
concern for acute coronary syndrome, with nausea representing 
anginal equivalent. While admission EKG was negative for acute 
ischemic changes, subsequent EKG on hospital day 2 demonstrated 
new T wave inversions in II, III, aVF, and V3-V6 in association 
with rising troponinemia of 0.07 to 0.11. She received 81mg 
aspirin x4 and atorvastatin 80mg, and home Pradaxa was held in 
favor of a heparin drip. She was transferred from medicine to 
___ for further management. On ___, troponins peaked at 0.11 
and then downtrended. MBs were flat. BNP was elevated to 3220 
and it was thought the the primary pathology was CHF causing 
heart strain and troponin leak. Heparin gtt was discontinued 
after 48 hrs and dabigatran was restarted. Aspirin was increased 
to 325 mg qday and statin to atorvastatin 80 mg qday. 

#Acute-on-chronic diastolic heart failure: She was found to be 
in acute-on-chronic heart failure on admission, with clinical 
signs of volume overload, moderate bilateral pleural effusions 
and mild pulmonary edema on admission CXR, and elevated proBNP = 
3220. Although transiently hypoxic with 3-L supplemental oxygen 
requirement in the ED, she was on room air by the time of 
arrival to the floor, with approximately 2-L urine output to 
40mg IV Lasix in the ED. She was diuresed with 20- 40 mg IV 
lasix daily thereafter. She was to be discharged on ___ but had 
an episode of DOE while ambulating to the bathroom. CXR showed 
CHF and she was kept for further diuresis. Diuretic regimen on 
discharge was 20mg QD.  She has close f/u with PCP 1 week after 
discharge for volume status assessment and further titration of 
diuretics as necessary.  In addition she will be discharged with 
21 hours of service and ___ with instruction for daily weights 
and communication with PCP if weights increase.

Inactive Issues:
#Atrial fibrillation/flutter: She has a history of atrial 
fibrillation and flutter, including recent admission for 
bradycardia attributed to atrial flutter with variable block. 
Admission EKG revealed normal sinus rhythm, and she remained in 
sinus rhythm on telemetry. Home dabigatran was administerd 
initially, but subsequently held as above in the setting of 
NSTEMI. Dabigatran 75 mg BID was restarted prior to discharge. 

#Hypertension: Home lisinopril was continued. She remained 
hypertensive in-house and due to multiple drug allergies, imdur 
60 mg was started in addition.  She continued with isolated 
hypertension in the very early morning but was normotensive 
throughout the day after medication administration so no further 
changes were made.

#Hyperlipidemia: Home pravastatin was held in favor of 
atorvastatin as above.

#Anemia/thrombocytopenia: Hematocrit and platelets were 33.7 and 
142, respectively, on admission, consistent with recent 
baseline. She remained hemodynamically stable without signs of 
active bleeding.

#Gastroesophageal reflux: Home pantoprazole was continued. 

Transitional Issues: 
- monitoring of volume status and titration of diuretic 
according to weights/kidney function
- atorvastatin was increased to 80 mg and aspirin to 325 mg, 
which can be downtitrated per cardiology

 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Dabigatran Etexilate 75 mg PO BID 
3. Fluticasone Propionate NASAL 2 SPRY NU QPM 
4. Lidocaine 5% Patch 1 PTCH TD DAILY 
RLE pain 
5. Lisinopril 40 mg PO DAILY 
6. Multivitamins W/minerals 1 TAB PO DAILY 
7. Pantoprazole 40 mg PO Q24H 
8. Pravastatin 10 mg PO DAILY 
9. Docusate Sodium 100 mg PO HS 
___ hold for loose stool 
10. Acetaminophen 1000 mg PO Q8H:PRN pain 
Please ___ before giving for fever 
11. Docusate Sodium 100 mg PO DAILY:PRN constipation 
12. Senna 1 TAB PO DAILY:PRN constipation 

 
Discharge Medications:
1. Acetaminophen 500 mg PO Q6H:PRN pain 
2. Aspirin 325 mg PO DAILY 
RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*3
3. Docusate Sodium 100 mg PO BID 
4. Fluticasone Propionate NASAL 2 SPRY NU QPM 
5. Lidocaine 5% Patch 1 PTCH TD DAILY 
RLE pain 
6. Lisinopril 40 mg PO DAILY 
7. Multivitamins W/minerals 1 TAB PO DAILY 
8. Pantoprazole 40 mg PO Q24H 
9. Senna 1 TAB PO DAILY:PRN constipation 
10. Atorvastatin 80 mg PO DAILY 
RX *atorvastatin 80 mg 1 tablet(s) by mouth daily at night Disp 
#*30 Tablet Refills:*3
11. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
RX *isosorbide mononitrate 60 mg 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*3
12. Dabigatran Etexilate 75 mg PO BID 
13. Furosemide 20 mg PO DAILY 
RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*3

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary: 
Acute diastolic CHF exacerbation
NSTEMI
Hypertension

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
It was a pleasure caring for you at ___ 
___. You were admitted for a headache and for nausea. 
You were found to have too much fluid in your body (heart 
failure) and this was causing stress to your heart. We treated 
you with diuretics and with medications to improve the blood 
flow to your heart. Your blood pressure was also found to be too 
high so we added a new blood pressure medication. 
 
Followup Instructions:
___
",MEDICINE
10003502-DS-8,Elizabeth Marquez,10003502,26475031," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
nifedipine / Amitriptyline / Prilosec OTC / Terazosin / 
Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide / 
spironolactone
 
Attending: ___
 
Chief Complaint:
?syncope
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
 ___, ___ only, with atrial fibrillation/flutter on 
dabigatran, coronary artery disease, diastolic heart failure 
(LVEF 60% in ___, hypertension, hyperlipidemia, ?SSS, and 
vascular dementia who was discharged yesterday from the ___ 
service after an admission for headache and nausea/vomiting 
found to have CHF with demand ischemia (trop 0.11 peak).  She 
was discharged with 4 new medications (imdur 60 for blood 
pressure, atorvastatin 80 and aspirin 325 for CAD, lasix 20 for 
CHF) which she picked up at her pharmacy. 

Per report from her sister: ___ hour after pt was discharged 
home, she had an episode of unresponsiveness at 5:30p last eve 
that lasted approximately 7 minutes. Sister describes pt 
appearance during this episode as having her tongue hanging out 
and had urinary incontinence. Her mentation returned to baseline 
after approximately 7 minutes.

Per the patient (with a translator): she does not remember 
passing out.  States she felt ""unwell"" but cannot tell me more.  
Does not remember if she took her medications or not (new or 
otherwise) but did have them picked up from the pharmacy.  Does 
not remember a prodrome or the actual event of ""syncope"".  No 
cp/sob/palps, currently no complaints and is hungry.

In the ED, initial vitals were: 98.2 65 130/53 28 98% RA.
 
Past Medical History:
Hypertension/hyperlipidemia
Coronary artery disease complicated by myocardial infarction 
Atrial fibrillation/flutter
Diastolic heart failure (LVEF 60% in ___
Vascular dementia
Headaches
Nephrolithiasis
Cataracts
Otitis media
Syncope/possible sick sinus syndrome
Status post cholecystectomy
Gastroesophageal reflux
Hyponatremia
Anemia
Lumbar radiculopathy
 
Social History:
___
Family History:
Mother deceased at ___ yo from breast cancer. Father deceased at 
___ yo. Son deceased at ___ yo from heart attack. 
 
Physical Exam:
PHYSICAL EXAMINATION:  
VS: 97.5 161/67 62 20 96%RA  
GEN Alert, oriented, no acute distress
HEENT NCAT MMM EOMI sclera anicteric, OP clear, left-sided 
hearing loss
NECK supple, no JVD, no LAD
PULM Good aeration, CTAB no wheezes, rales, ronchi
CV RRR normal S1/S2, no mrg
ABD soft NT ND normoactive bowel sounds, no r/g
EXT WWP 2+ pulses palpable bilaterally, trace pitting edema 
bilaterally
NEURO CNs2-12 intact, motor function grossly normal
SKIN no ulcers or lesions
 
Pertinent Results:
___ 08:10AM BLOOD WBC-5.6 RBC-3.55* Hgb-10.6* Hct-32.5* 
MCV-92 MCH-29.9 MCHC-32.7 RDW-14.1 Plt ___
___ 12:17PM BLOOD WBC-6.7 RBC-3.79* Hgb-11.2* Hct-34.3* 
MCV-91 MCH-29.5 MCHC-32.7 RDW-13.7 Plt ___
___ 08:10AM BLOOD Glucose-102* UreaN-26* Creat-1.2* Na-138 
K-3.9 Cl-100 HCO3-32 AnGap-10
___ 12:17PM BLOOD Glucose-175* UreaN-27* Creat-1.3* Na-137 
K-4.7 Cl-98 HCO3-26 AnGap-18
___ 05:56AM BLOOD Glucose-90 UreaN-25* Creat-1.2* Na-140 
K-4.0 Cl-102 HCO3-30 AnGap-12
___ 12:17PM BLOOD ___ 12:17PM BLOOD cTropnT-0.07*
___ 08:10AM BLOOD Calcium-10.2 Phos-3.6 Mg-2.2

CXR ___:
IMPRESSION: 
Persistent small bilateral effusions, larger on the left which 
have decreased in size.  Decreased pulmonary vascular 
congestion.  No evidence of superimposed acute cardiopulmonary 
process. 

CT Head ___:
IMPRESSION: 
No evidence of acute intracranial process. 

 
Brief Hospital Course:
___ hx atrial fibrillation/flutter on dabigatran, coronary 
artery disease, diastolic heart failure (LVEF 60% in ___, 
hypertension, hyperlipidemia, ?SSS, and vascular dementia who 
presents 12 hours post-discharge with possible syncope.

#Syncope: unclear etiology, tele with aflutter and 4:1 
conduction earlier now with sinus and occasional sinus pauses.  
Has had recent admissions for similar episodes of ""feeling 
unwell"" with and without syncope, attributed to her intrinsic 
nodal disease.  EKG unchanged, enzymes flat. ?whether her 
syncopal event was a sinus conversion pause.  Due to the 
recurrent and progressive nature of her symptoms, and her lack 
of support at home and concern that the next event could be 
terminal, she was discharged to a LTAC with plan to continue on 
telemetry for ___ weeks to capture any event.

#CHF: euvolemic upon admission and discharge.  Continued 
aspirin, lisinopril, lasix 20mg qday.  Might need further 
titration of her diuretics pending volume status.

#CAD: continued aspirin, atorvastatin, imdur.  No chest pain.  
EKG without changes, enzymes flat.

#HTN: started imdur on last admission.  Noted that when taken 
both at the same time in the AM she had BPs in the 100s 
transiently; this was changed to lisinopril HS and imdur AM.

#Afib/flutter: not symptomatic.  No rate control due to 
intrinsic nodal disease.  On dabigatran 75 BID.

Transitional Issues:
- evaluation for any syncopal event and review of telemetry
- daily weights and volume assessment
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 500 mg PO Q6H:PRN pain 
2. Aspirin 325 mg PO DAILY 
3. Docusate Sodium 100 mg PO BID 
4. Fluticasone Propionate NASAL 2 SPRY NU QPM 
5. Lidocaine 5% Patch 1 PTCH TD DAILY 
RLE pain 
6. Lisinopril 40 mg PO DAILY 
7. Multivitamins W/minerals 1 TAB PO DAILY 
8. Pantoprazole 40 mg PO Q24H 
9. Senna 1 TAB PO DAILY:PRN constipation 
10. Atorvastatin 80 mg PO DAILY 
11. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
12. Dabigatran Etexilate 75 mg PO BID 
13. Furosemide 20 mg PO DAILY 

 
Discharge Medications:
1. Acetaminophen 500 mg PO Q6H:PRN pain 
2. Aspirin 325 mg PO DAILY 
3. Atorvastatin 80 mg PO DAILY 
4. Dabigatran Etexilate 75 mg PO BID 
5. Docusate Sodium 100 mg PO BID 
6. Fluticasone Propionate NASAL 2 SPRY NU QPM 
7. Furosemide 20 mg PO DAILY 
8. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 
9. Lidocaine 5% Patch 1 PTCH TD DAILY 
RLE pain 
10. Lisinopril 40 mg PO HS 
11. Multivitamins W/minerals 1 TAB PO DAILY 
12. Pantoprazole 40 mg PO Q24H 
13. Senna 1 TAB PO DAILY:PRN constipation 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Acute: syncope

Chronic: 
coronary artery disease, 
Chronic diastolic congestive heart failure, 
atrial fibrillation/flutter, 
possible sick sinus syndrome

 
Discharge Condition:
Mental Status: Confused - sometimes.  ___ speaking only.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
You were admitted for a fainting spell.  We are not sure what 
caused this episode, however it is possible that your heart is 
not beating properly.  We were unable to capture any of these 
episodes on our monitors, so we are sending you to a ___ 
facility that can monitor your heart rate in case these episodes 
happen again.

 
Followup Instructions:
___
",MEDICINE
10003502-DS-9,Elizabeth Marquez,10003502,29011269," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
nifedipine / Amitriptyline / Prilosec OTC / Terazosin / 
Amlodipine / Atenolol / Oxybutynin / Hydrochlorothiazide / 
spironolactone / furosemide
 
Attending: ___.
 
Chief Complaint:
Fall, bradycardia.
 
Major Surgical or Invasive Procedure:
None.
 
History of Present Illness:
___ YO F w/ PMH significant for CAD, mild AS, afib/flutter on 
dabigatran, HFpEF, HTN, HLD, chronic hyponatremia, who presents 
after a fall at her nursing home.  

Pt unable to provide history, but per nursing home and OSH 
notes, in early AM on ___, pt fell and was discovered by nursing 
home RN. RN at that time noted that pt was confused and 
lethargic. HR at that time per report was in the ___. EMS was 
activated and pt brought to OSH ER. En route, EMS report 
indicates that heart rates were labile, but there are no EKG 
strips and unclear if pt received any cardiac medications. At 
OSH ER, pt's EKG revealed bradycardia to 20 with ventricular 
escape and no signs of atrial activity. The pt was then given 1 
mg of atropine with no effect and then transcutaneously paced 
for 1 hour. She was then noted to have HRs in the ___ and atrial 
activity. She was then transferred to ___ for possible PPM. 

Here at ___, noted to be intermittently lethargic and poorly 
responsive. CT head and neck negative. EP was consulted for 
possible PPM and initially recommended admission to ___, 
deferred PPM for the time being. She continued to be 
intermittently bradycardic to the ___ in the ED, but given that 
she has a history of previous bradycardia and has been 
asymptomatic with her episodes, she was felt to be stable for 
the floor. However, after this she had increasing respiratory 
distress requiring a NRB. Due to this she was admitted to the 
CCU. Received Lasix 60mg IV x1.
 
 Of note, pt's HCP reports that she had been more altered over 
the last week in the setting of higher doses of seroquel that 
the nursing home had started for increased agitation.  

In the ED initial vitals were: 98.3, HR 90, 142/73, 18, 93% RA  
EKG:  
Labs/studies notable for: Na 140, K 4.6, Cl 98 HCO3 35 BUN 58 Cr 
1.2 glu 125, WBC 7 Hct 34.8 AST 219 ALT 178 Trop 0.05 ___: 14.8 
PTT: 42.4 INR: 1.4 AGap=12 BNP 2900 Lactate 1.5. ABG: 
___

On arrival to the CCU: Awake but not answering questions. Pt 
does not speak ___, per report. On NRB. 
 
Past Medical History:
1. CARDIAC RISK FACTORS
- Hypertension
- Dyslipidemia
2. CARDIAC HISTORY
- CAD (100% LAD occlusion). MI ___ year ago. Unclear history of 
PCI.
- Afib/flutter on dabigatran 
- Mild aortic stenosis
3. OTHER PAST MEDICAL HISTORY 
- Chronic hyponatremia  
- Dementia

 
Social History:
___
Family History:
Mother deceased at ___ yo from breast cancer. Father deceased at 
___ yo. Son deceased at ___ yo from heart attack. 
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
VS: T 97.6 BP 132/103 HR 80 RR 21 O2 SAT 100% NRB
GENERAL: Ill appearing. Not answering questions. 
HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI. 
Conjunctiva were pink. No pallor or cyanosis of the oral mucosa. 
No xanthelasma.
NECK: Supple. JVP unable to assess due to restlessness.
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. Irregularly irregular. Normal S1, S2. II/VI systolic 
murmur at R sternal border. 
LUNGS: No chest wall deformities or tenderness. Tachypneic but 
withoug increased work of breathing. Faint crackles.
ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No 
splenomegaly.
EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or 
peripheral edema.
SKIN: No significant skin lesions or rashes.
PULSES: Distal pulses palpable and symmetric.

DISCHARGE PHYSICAL

VS: T 97.6 BP 144/75 HR 54 RR 22 O2 SAT 92% 2 L NC 

GENERAL: Skinny, somewhat anxious. Oriented to self only.  
HEENT: Normocephalic atraumatic. Sclera anicteric. PERRL. EOMI. 
Conjunctiva were pink. No pallor or cyanosis of the oral mucosa. 
No xanthelasma.
NECK: Supple. JVP unable to assess due to restlessness.
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. Irregularly irregular. Normal S1, S2. II/VI systolic 
murmur at R sternal border. 
LUNGS: No chest wall deformities or tenderness. Tachypneic no 
signs respiratory distress. Lungs clear to auscultation 
bilaterally. 
ABDOMEN: Soft, non-tender, non-distended. No hepatomegaly. No 
splenomegaly.
EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or 
peripheral edema.
SKIN: No significant skin lesions or rashes.
PULSES: Distal pulses palpable and symmetric.
 
Pertinent Results:
ADMISSION LABS:
___ 12:45PM BLOOD WBC-10.0 RBC-3.55* Hgb-10.5* Hct-34.8 
MCV-98 MCH-29.6 MCHC-30.2* RDW-13.1 RDWSD-46.9* Plt ___
___ 12:45PM BLOOD Neuts-87.3* Lymphs-5.0* Monos-7.0 
Eos-0.0* Baso-0.2 Im ___ AbsNeut-8.76* AbsLymp-0.50* 
AbsMono-0.70 AbsEos-0.00* AbsBaso-0.02
___ 12:45PM BLOOD ___ PTT-42.4* ___
___ 12:45PM BLOOD Glucose-125* UreaN-58* Creat-1.2* Na-140 
K-4.6 Cl-98 HCO3-35* AnGap-12
___ 12:45PM BLOOD proBNP-2915*
___ 12:45PM BLOOD cTropnT-0.05*
___ 05:51AM BLOOD CK-MB-9 cTropnT-0.13*
___ 05:51AM BLOOD Calcium-10.1 Phos-4.6* Mg-2.5
___ 08:10PM BLOOD ___ pO2-23* pCO2-79* pH-7.29* 
calTCO2-40* Base XS-6
___ 12:52PM BLOOD Lactate-1.5

PERTINENT RESULTS:
___ 12:45PM BLOOD cTropnT-0.05*
___ 05:51AM BLOOD CK-MB-9 cTropnT-0.13*
___ 12:52PM BLOOD Lactate-1.5
___ 11:47PM BLOOD Lactate-1.0
___ 06:04AM BLOOD Lactate-2.9*

DISCHARGE LABS:

___ 05:51AM BLOOD WBC-7.8 RBC-3.90 Hgb-11.3 Hct-37.7 MCV-97 
MCH-29.0 MCHC-30.0* RDW-13.2 RDWSD-46.2 Plt ___
___ 05:51AM BLOOD ___ PTT-36.7* ___
___ 05:51AM BLOOD Glucose-89 UreaN-56* Creat-1.2* Na-141 
K-4.1 Cl-97 HCO3-31 AnGap-17
___ 05:51AM BLOOD CK-MB-9 cTropnT-0.13*

IMAGING:
CHEST XRAY ___: Large right and moderate left pleural 
effusions and severe bibasilar atelectasis are unchanged.  
Cardiac silhouette is obscured. No pneumothorax. Pulmonary edema 
is mild, obscured radiographically by overlying abnormalities. 

MICROBIOLOGY:
None.

 
Brief Hospital Course:
Ms. ___ is ___ year old female with a past medical history 
significant for CAD, mild AS, afib/flutter on dabigatran, HTN, 
HLD, chronic hyponatremia, who presented to ___ on transfer 
from OSH after a fall and headstrike when subsequently found to 
be bradycardic to the ___. She was transferred here externally 
paced and was seen by our EP physicians. After discussion with 
patient's healthcare proxy, it was decided not to purse 
pacemaker placement and to withdraw external pacemaker. She 
initially became profoundly bradycardic from ___ beats per 
minute but stabilized to the ___ overnight. She was made 
DNR/DNI/DNH and sent back to senior living facility 
hemodynamically stable. Of note CT head at outside facility was 
negative. 

TRANSITIONAL ISSUES
====================
- Per discussion with patient's sister, ___, 
patient was made DNH in addition to her DNR/DNI. She will need a 
new MOLST signed by her sister and the doctors at ___ 
___
- She will also need a palliative care consult with possible 
escalation to hospice care as needed.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Artificial Tears ___ DROP BOTH EYES BID 
2. Aspirin 81 mg PO DAILY 
3. Dabigatran Etexilate 75 mg PO BID 
4. Vitamin D ___ UNIT PO EVERY 3 WEEKS 
5. Escitalopram Oxalate 15 mg PO DAILY 
6. Losartan Potassium 37.5 mg PO DAILY 
7. QUEtiapine Fumarate 12.5 mg PO QHS 
8. Senna 17.2 mg PO QHS 
9. Sodium Chloride Nasal ___ SPRY NU BID:PRN congestion 
10. Torsemide 60 mg PO DAILY 
11. OxyCODONE (Immediate Release) 2.5 mg PO QAM 
12. LORazepam 0.5 mg PO Q6H:PRN anxiety 
13. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 

 
Discharge Medications:
1.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
2.  Artificial Tears ___ DROP BOTH EYES BID  
3.  Dabigatran Etexilate 75 mg PO BID  
4.  Escitalopram Oxalate 15 mg PO DAILY  
5.  LORazepam 0.5 mg PO Q6H:PRN anxiety  
6.  Losartan Potassium 37.5 mg PO DAILY  
7.  OxyCODONE (Immediate Release) 2.5 mg PO QAM  
8.  QUEtiapine Fumarate 12.5 mg PO QHS  
9.  Senna 17.2 mg PO QHS  
10.  Sodium Chloride Nasal ___ SPRY NU BID:PRN congestion  
11.  Torsemide 60 mg PO DAILY  
12.  Vitamin D ___ UNIT PO EVERY 3 WEEKS  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Bradycardia

 
Discharge Condition:
Mental Status: Confused - always.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at ___.

Why was I here?
- You originally went to another hospital because you fell and 
hit your head.
- You were found to have a very slow heart rate and transferred 
here to ___ for further management

What was done while I was in the hospital?
- A CT scan of your head and neck at the outside hospital was 
done and was normal.
- You were transferred here with an external pacemaker to bring 
your heart rate up but we eventually decided to withdraw this 
device. 
- You were seen by our electrophysiologists, who did not decided 
to put in a pacemaker at this time.

What should I do when I get home?
- Take your old medications as prescribed.

All the best,

Your ___ team
 
Followup Instructions:
___
",MEDICINE
10003637-DS-19,Robert Saavedra,10003637,22082422," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
lisinopril
 
Attending: ___.
 
Chief Complaint:
Hypotension
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ hx of ischemic cardiomyopathy sent from ___ clinic 
when his BP was noted to be systolic ___. Patient reports that 
at 9am his vision was a little blurry and he felt diffusely weak 
and tired, the subjective feelings completely resolved prior to 
admission. He states he had been taking his blood pressure 
medication regularly and drinking only about one small bottle of 
water daily. He reports over the last year his blood pressure 
has been regularly with systolic in the ___. He denies fevers or 
recent illness. Had perirectal abscess drained in ___, site 
looked well at evaluation today in clinic. No chest pain, 
palpitations, or cough. No abd pain/n/v/d/urinary symptoms.  
 
 In the ED, initial vitals were: HR 82 BP79/42 RR16 SaO298% RA  
 Exam notable for  
 Labs notable for BNP 5890, Cr 2.8, WBC 13.4  
 Imaging notable for ___ CXR: No acute cardiopulmonary 
abnormality.  
 Patient was given: 500 cc IVF  
 Decision was made to admit for hypotension and ___  
 Vitals prior to transfer: HR 73 BP101/57 RR20 SaO2 100% RA  
 On the floor, Patient was resting comfortably in bed and 
asymptomatic.  
 
 ROS:  
 (+) Per HPI  
 (-) Denies fever, chills, night sweats.  
 Denies headache, sinus tenderness, rhinorrhea or congestion. 
Denies cough, shortness of breath. Denies chest pain or 
tightness, palpitations. Denies nausea, vomiting, diarrhea, 
constipation or abdominal pain. No recent change in bowel or 
bladder habits. No dysuria. Denies arthralgias or myalgias.  
 
Past Medical History:
*Cards: HTN, HLD, CAD c/b MI s/p PCI/stent and CABG, CHF with 
reduced EF (LVEF 27%), Single lead ICD pacemaker
*Neuro: L MCA ischemic stroke 
*GI: Perirectal abscess s/p I&D (___), Anal 
fistula, s/p EUA, ___ placement 
 
Social History:
___
Family History:
Noncontributory
 
Physical Exam:
ADMISSION EXAM: 
Vital Signs: T97.9 PO, BP97/50, HR60 RR16 SaO2: 100% RA  
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, 
neck supple, JVP not elevated, no LAD  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
Abdomen: Soft, non-tender, non-distended, bowel sounds present, 
no organomegaly, no rebound or guarding  
GU: No foley  
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: CNII-XII intact, ___ strength upper/lower extremities, 
grossly normal sensation 

DISCHARGE EXAM: 
Vital Signs: Tmax 98.2 T97.4 BP 102/67 HR 71 RR 18 O2 100%RA
General: No acute distress 
HEENT: Sclera anicteric, conjunctiva without injection. PERRLA. 
Oropharynx clear with MMM. Neck supple, no JVP elevation. 
Lungs: Clear to auscultation bilaterally with no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops. Left-sided AICD.   
Abdomen: Soft, non-tender, non-distended. Bowel sounds present 
with no renal bruits. No rebound tenderness or guarding, no 
organomegaly, no pulsatile mass.    
Ext: Warm, well perfused with no cyanosis of the toes or 
fingers. No calf tenderness or edema.
Skin: Without rashes or lesions on gross exam. Tattoos over the 
forearm bilaterally.  
Neuro: Alert and oriented. Face symmetric. Speech is fluent and 
logical with no evidence of dysarthria. Moves all extremities 
purposefully. 

 
Pertinent Results:
ADMISSION LABS: 
___ 02:05PM   WBC-13.4*# RBC-4.11*# HGB-12.1*# HCT-35.6*# 
MCV-87 MCH-29.4 MCHC-34.0 RDW-14.0 RDWSD-43.9
___ 02:05PM   NEUTS-72.3* LYMPHS-13.0* MONOS-12.7 EOS-1.2 
BASOS-0.4 IM ___ AbsNeut-9.68* AbsLymp-1.74 AbsMono-1.70* 
AbsEos-0.16 AbsBaso-0.05
___ 02:05PM   PLT COUNT-223
___ 02:21PM   ___ PTT-34.1 ___
___ 02:05PM   GLUCOSE-143* UREA N-78* CREAT-2.8*# 
SODIUM-133 POTASSIUM-3.7 CHLORIDE-89* TOTAL CO2-23 ANION GAP-25*
___ 02:05PM   CALCIUM-10.4* PHOSPHATE-4.6* MAGNESIUM-2.4
___ 02:05PM   CK(CPK)-59
___ 02:05PM   cTropnT-0.04*
___ 02:05PM   CK-MB-2 proBNP-5890*
___ 07:30PM URINE  HOURS-RANDOM
___ 07:30PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 07:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 
LEUK-NEG
___ 07:30PM URINE  RBC-<1 WBC-2 BACTERIA-FEW YEAST-NONE 
EPI-0
___:30PM URINE  MUCOUS-RARE
___ 07:30PM URINE  HYALINE-13*

DISCHARGE LABS: 
___ 07:35AM BLOOD WBC-7.7 RBC-3.84* Hgb-11.3* Hct-33.8* 
MCV-88 MCH-29.4 MCHC-33.4 RDW-14.1 RDWSD-44.8 Plt ___
___ 07:35AM BLOOD Plt ___
___ 07:35AM BLOOD ___ PTT-34.7 ___
___ 07:35AM BLOOD Glucose-105* UreaN-91* Creat-2.6* Na-134 
K-3.5 Cl-91* HCO3-25 AnGap-22*
___ 03:14PM BLOOD Glucose-96 UreaN-84* Creat-1.8* Na-134 
K-3.4 Cl-95* HCO3-22 AnGap-20
___ 07:35AM BLOOD CK-MB-4 cTropnT-0.03*
___ 07:35AM BLOOD Calcium-9.6 Phos-5.1* Mg-2.6
___ 03:14PM BLOOD Digoxin-0.2*

DIAGNOSTICS:
ECHO (CHA ___
CONCLUSIONS   
1. LV ejection fraction is 27%.   
2. The apical portion of the anterior wall and the LV apex are 
akinetic.   
3. The left atrium is mildly dilated.   
4. There is mild-to-moderate mitral regurgitation.   
5. Estimated RV systolic pressure is moderately elevated at 55 
mmHg.   
6. Compared to the previous echo of ___, there is no 
significant change.

CXR ___
FINDINGS:  
Patient is status post median sternotomy and CABG. Left-sided 
AICD is noted with single lead terminating in the right 
ventricle.  Heart size is normal. Mediastinal and hilar contours 
are normal. Lungs are clear. No pleural effusion or 
pneumothorax. No acute osseous abnormalities are detected. 
IMPRESSION: No acute cardiopulmonary abnormality. 

 
Brief Hospital Course:
___ M with h/o ischemic cardiomyopathy (s/p PCI/stent, CABG, 
ICD pacemaker) c/b systolic CHF (LVEF 27%), L MCA stroke, and 
perirectal abscess who presents with hypotension and new ___ in 
the setting fluid restriction while taking multiple diuretics 
and anti-hypertensives. 

#Hypotension: Pt presented with a baseline SBP in ___ over past 
year, was fluid restricting given history of pulmonary edema, 
presented with SBP in 60-70s in ED. After 500cc fluid bolus, SBP 
returned to baseline and pt was asymptomatic. Patient was not 
orthostatic. Bolused additional 1L NS. Hypotension seemed likely 
attributable to self fluid restriction in the setting of 
multiple diuretic and anti-hypertensive medications. Losartan, 
Spironolactone, Carvedilol and Torsemide were held on discharge. 
Patient was instructed to schedule primary care to have 
follow-up of his laboratory values.

___: Rise in pt's Cr to 2.8 from baseline of 1.1 with 
associated BUN/Cr >20. UA was unremarkable. Pt was maintaining 
UOP, w/ no history to suggest post-renal obstruction. Elevated 
pro-BNP suggestive of ventricular overload c/w history of 
ischemic cardiomyopathy, possible cardiorenal contribution to 
___. Overall findings were pre-renal ___, likely ___ decreased 
effective circulating volume in the setting of hypotension and 
fluid restriction in pt with underlying ischemic cardiomyopathy. 
He responded well to 1.5L IVFs, with a creatinine of 1.8 at time 
of discharge. He was instructed to improve his PO intake to 1.5L 
per day (has hx of CHF exacerbations). Antihypertensives were 
held at time of discharge. 

#Hyperphosphatemia: Phos to 5.1 on ___. Likely ___ renal 
insufficiency. He was given a low phosphate diet for one day.

#Normocytic Anemia: H/H down to 11.3/33.8 on ___ AM. Had low 
suspicion for hemolysis or acute blood loss. Was thought to be 
likely dilutional after fluids and was consistent with pt's 
normal range.

RESOLVED ISSUES: 
#Leukocytosis: Patient presented with transient leukocytosis, 
which downtrended to wnl ___ AM, likely ___ acute stress 
reaction. CXR/UA was not concerning for infection. Further 
infectious workup was not pursued.

CHRONIC ISSUES: 
#Ischemic Cardiomyopathy: s/p L ICD placement. No evidence of 
volume overload on exam ___. Losartan, Spironolactone, 
Torsemide, Carvedilol in were held in the setting of hypotension 
and ___, and also held on discharge.
#Hypertension: Losartan, Spironolactone, Torsemide, Carvedilol 
were held as above. 
#Hyperlipidemia: atorvastatin was continued without issue.
#History of MCA stroke: continued home warfarin without issue.

TRANSITIONAL ISSUES:
-patient was instructed to drink 1.5 L of fluid per day
-patient's home antihypertensives were held at time of 
discharge.
-patient was instructed to follow-up with his PCP within one 
week
-patient may benefit from a repeat Na, K, Cl, bicarb, BUN, Cr at 
time of follow-up
-consideration of when to restart home antihypertensives can be 
considered at follow-up.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Warfarin 4 mg PO DAILY16 
3. Atorvastatin 80 mg PO QPM 
4. Carvedilol 12.5 mg PO BID 
5. Digoxin 0.125 mg PO DAILY 
6. Ferrous Sulfate uncertain mg PO DAILY 
7. Losartan Potassium 25 mg PO DAILY 
8. Spironolactone 25 mg PO DAILY 
9. Torsemide 20 mg PO BID 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY  
2.  Atorvastatin 80 mg PO QPM  
3.  Digoxin 0.125 mg PO DAILY  
4.  Ferrous Sulfate uncertain mg PO DAILY  
5.  Warfarin 4 mg PO DAILY16  
6. HELD- Carvedilol 12.5 mg PO BID  This medication was held. Do 
not restart Carvedilol until following up with your primary care 
doctor
7. HELD- Losartan Potassium 25 mg PO DAILY  This medication was 
held. Do not restart Losartan Potassium until following up with 
your primary care doctor
8. HELD- Spironolactone 25 mg PO DAILY  This medication was 
held. Do not restart Spironolactone until following up with your 
primary care doctor
9. HELD- Torsemide 20 mg PO BID  This medication was held. Do 
not restart Torsemide until following up with your primary care 
doctor

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
-------------------
Hypotension
___

Secondary Diagnosis
Congestive Heart Failure

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to the hospital when it was discovered that 
you had low blood pressures and evidence of kidney injury after 
having reduced fluid intake while still taking your 
antihypertensives. You were evaluated with bloodwork and 
imaging, and given intravenous fluids. Your blood pressure 
medications were held and we have not restarted these on 
discharge from the hospital.

Please follow-up with your primary care doctor with ___ visit in 
the next week before resuming your home antihypertensives. 
Please continue to drink 1.5L of fluids per day.

It was a pleasure to be involved with your care!
-___ Team
 
Followup Instructions:
___
",MEDICINE
10003637-DS-20,Robert Saavedra,10003637,28484061," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
lisinopril
 
Attending: ___
 
Major Surgical or Invasive Procedure:
___: Right heart catheterization
___: Anal exam under anesthesia with anal fistuolotomy
___: Bronchoscopy with EBUS and lymph node biopsies
attach
 
Pertinent Results:
ADMISSION LABS:
===============
___ 05:49PM BLOOD WBC-9.0 RBC-3.71* Hgb-11.3* Hct-34.3* 
MCV-93 MCH-30.5 MCHC-32.9 RDW-16.9* RDWSD-56.8* Plt ___
___ 05:49PM BLOOD Glucose-112* UreaN-69* Creat-1.9* Na-140 
K-4.5 Cl-102 HCO3-24 AnGap-14
___ 05:49PM BLOOD Calcium-10.1 Phos-3.3 Mg-2.3 Iron-65

PERTINENT INTERVAL LABS:
========================
___ 05:49PM BLOOD calTIBC-300 Ferritn-246 TRF-231

MICRO:
======
___ 11:12 am BRONCHOALVEOLAR LAVAGE      RIGHT LOWER LOBE. 

   GRAM STAIN (Final ___: 
      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      3+  ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). 
      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI. 
                                    ___ CLUSTERS. 
      This is a concentrated smear made by cytospin method, 
please refer to
      hematology for a quantitative white blood cell count, if 
applicable. 
      SMEAR REVIEWED; RESULTS CONFIRMED. 

   RESPIRATORY CULTURE (Final ___: 
      10,000-100,000 CFU/mL Commensal Respiratory Flora. 

   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. 

   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. 

   POTASSIUM HYDROXIDE PREPARATION (Final ___: 
      Test cancelled by laboratory. 
      PATIENT CREDITED. 
      This is a low yield procedure based on our ___ 
studies. 
      if pulmonary Histoplasmosis, Coccidioidomycosis, 
Blastomycosis,
      Aspergillosis or Mucormycosis is strongly suspected, 
contact the
      Microbiology Laboratory (___). 

   ACID FAST CULTURE (Pending): 

___ 11:44 am TISSUE      MEDIASTINAL LYMPH NODE. 

   GRAM STAIN (Final ___: 
      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      NO MICROORGANISMS SEEN. 

   TISSUE (Preliminary):    RESULTS PENDING. 

   ANAEROBIC CULTURE (Preliminary): 

   ACID FAST SMEAR (Final ___: 
      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. 

   ACID FAST CULTURE (Preliminary): 

   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. 

   POTASSIUM HYDROXIDE PREPARATION (Preliminary): 

STUDIES:
========
___: CT chest w/o contrast
Mediastinal and hilar lymphadenopathy could be reactive ___ 
nature or sequela of the evident prior granulomatous infection, 
however, a lymphoproliferative disorder such as lymphoma cannot 
be excluded.  A PET-CT scan is recommended for further 
assessment. 
Moderate cardiomegaly with associated extensive coronary artery 
atherosclerotic disease and CABG postsurgical changes.  
Moderate pulmonary edema. 

___: Right heart cath
 Normal right heart filling pressure. Mildly elevated left 
heart filling pressure.
 Mild pulmonary hypertension (mPA 24mmHg) with hemodynamic 
features consistent with
predominant post-capillary PH (TPG 8, DPG 3, PVR 1.35 ___.
 Normal systemic blood pressure and SVR.
 Normal cardiac output/index as estimated by both the indirect 
Fick method and by thermodilution.

DISCHARGE LABS:
===============
___ 07:33AM BLOOD WBC-8.8 RBC-2.92* Hgb-9.0* Hct-28.1* 
MCV-96 MCH-30.8 MCHC-32.0 RDW-17.9* RDWSD-62.1* Plt ___
___ 07:33AM BLOOD Glucose-102* UreaN-53* Creat-2.1* Na-139 
K-4.4 Cl-101 HCO3-22 AnGap-16
___ 07:33AM BLOOD Calcium-9.2 Phos-3.4 Mg-2.0
 
Brief Hospital Course:
PATIENT SUMMARY:
================
Mr. ___ is a ___ with CAD/MI s/p PCIs and CABG ___, HFrEF
(EF 28%) s/p ___ ICD ___ and cardiomems ___,
pAF on apixaban, HTN, DLD, prior L MCA CVA, CKD, and recurrent
perirectal abscesses who presented as direct admit from home for
heparin gtt bridge for planned procedures including RHC and anal
fistulotomy. Chest CT was also performed which demonstrated 
enlarged lymph nodes, now s/p bronchoscopy with biopsies. He was 
actively diuresed for slight volume overload until euvolemic and 
then discharged on his home diuretic regimen. 

# CORONARIES: Unknown; needs repeat stress
___ RHC: RA 5, PA ___ (24), PCWP 16 CO 5.89 CI 2.92 SVR 1005
# PUMP: TTE ___ showed ___. IVS 1.0, PW 1.0. LVEDD 6.1, LVEF
___. RV normal size/function. No AS/AR. 1+ MR. ___+ TR. Mild
pHTN. 
# RHYTHM: NSR w/ non-specific intraventricular delay

TRANSITIONAL ISSUES:
====================
Discharge Weight: 195.8 lbs
Discharge Creatinine: 2.1
Discharge diuretic: Home torsemide 60mg BID

[ ] Tooth extraction: According to OMFS, it is appropriate to 
continue apixaban prior to outpatient extraction. If his primary 
dentist has concerns, he can be referred to our oral surgeons by 
calling ___. Recommend not holding apixaban for given 
his prior stroke.
[ ] Stress testing: Recommend another CPET (cardiopulmonary 
stress test) now that he is euvolemic and optimized. 
[ ] Interventional pulmonology: Pt will follow up with IP ___ 2 
weeks, where he will review the results from his 
bronchoscopy/biopsy. 
[ ] Cardiology: Outpatient notes had said his spironolactone was 
increased from 25mg to 50mg PO daily but patient only reports 
taking 25mg per day. He was continued on 25mg daily of 
spironolactone while inpatient.

ACTIVE ISSUES: 
============== 
# Chronic HFrEF s/p ICD and cardiomems (EF ___ 
History of dilated ischemic cardiomyopathy, ___ Class II, EDW 
previously documented as 185-187lbs, but likely closer to 
190-195lbs given relatively dry RHC at this weight. On 
presentation he was well compensated. RHC was performed while 
inpatient which had largely normal pressures and it was 
discovered that his cardiomems was not calibrated correctly and 
still is reporting falsely elevated numbers. He had a few days 
off diuretics due to NPO status for procedures and mild 
hypotension, then restarted on his home dosing at discharge. He 
previously had a CPET that demonstrated poor function. This 
should be repeated now that he is optimized to reassess his need 
for LVAD/transplant.
- PRELOAD: Torsemide 60mg PO BID 
- AFTERLOAD: Entresto 97-103mg PO BID, Carvedilol 12.5/18.75mg 
PO BID
- NHBK: Spironolactone 25mg PO daily, Carvedilol as above
- Ionotrope: Digoxin 0.125mcg PO daily
- ICD: s/p ___ ICD placement ___ ___ 
- Transplant/VAD: undergoing workup

# Transplant workup
Evaluation for advanced therapies for VAD/transplant started 
___.
- Dental/OMFS were consulted for teeth removal. He was found to 
have no acute dental infections requiring intervention. 
Therefore, extractions were not performed during this admission. 
Dental/OMFS recommended pursuing extraction of mobile tooth #9 
as an outpatient with an outpatient dentist with no need to hold 
apixaban. If there are concerns from his primary dentist, he can 
be referred to our outpatient ___ clinic for extraction. 
- Underwent right heart catheterization on ___ which 
demonstrated only mildly elevated filling pressures including a 
mildly elevated PASP, which is significantly improved from 
prior. Vasodilator study was not performed given low pulmonary 
pressures. 
- CT chest was performed as part of workup, found asymmetric 
pulmonary edema (R>L) and enlarged mediastinal/hilar lymph 
nodes. Given these findings, IP was consulted and he underwent 
bronchoscopy w/ EBUS and lymph node biopsies on ___. Per 
pulmonology, unclear etiology of the lymph nodes. Initially 
thought to be just pulmonary edema but RHC showed he was fairly 
euvolemic. Other possibilities include prior granulomatous 
disease or, less likely, lymphoma.

# Perianal fistula
Initially presented ___ s/p multiple exams under anesthesia, 
I&D, most recently ___ abscess was drained and malecot 
catheter placed. Evaluated by ___ ___ ___ clinic after 
referral from cardiology for pre-transplant evaluation. They 
noted no evidence of abscess but recommended exam under 
anesthesia with management of fistula ___ ano. He underwent anal 
fistulotomy with colorectal surgery on ___. The procedure was 
without complications and he had a cutting ___ placed that 
will remain until outpatient follow up. 
- Outpatient CRS follow up on ___. At that visit they will 
schedule further follow up with Dr. ___.

CHRONIC ISSUES: 
============== 
# CAD c/b MI s/p PCI and subsequent CABG
- Continued ASA 81mg
- Continued atorvastatin 80mg 

# Paroxysmal atrial fibrillation
# Hx CVA 
- Continued ASA 81, atorvastatin 80
- Continued carvedilol, digoxin per above
- Resumed home apixaban 5mg BID

# History of GI bleed
- Continued omeprazole

# ___ on CKD stage ___ 
B/l 1.3-1.6. Cr 1.9 on admission, had been up to 2.2 as
outpatient. Fluctuated throughout admission, 2.1 on discharge, 
which may be new baseline. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Sacubitril-Valsartan (97mg-103mg) 1 TAB PO BID 
2. Allopurinol ___ mg PO DAILY 
3. Atorvastatin 80 mg PO QPM 
4. CARVedilol 12.5 mg PO BID 
5. CARVedilol 6.25 mg PO QPM 
6. Digoxin 0.125 mg PO DAILY 
7. Omeprazole 40 mg PO BID 
8. Spironolactone 25 mg PO DAILY 
9. Torsemide 60 mg PO BID 
10. Apixaban 5 mg PO BID 
11. Aspirin 81 mg PO DAILY 

 
Discharge Medications:
1.  Allopurinol ___ mg PO DAILY  
2.  Apixaban 5 mg PO BID  
3.  Aspirin 81 mg PO DAILY  
4.  Atorvastatin 80 mg PO QPM  
5.  CARVedilol 12.5 mg PO BID  
6.  CARVedilol 6.25 mg PO QPM  
7.  Digoxin 0.125 mg PO DAILY  
8.  Omeprazole 40 mg PO BID  
9.  Sacubitril-Valsartan (97mg-103mg) 1 TAB PO BID  
10.  Spironolactone 25 mg PO DAILY  
11.  Torsemide 60 mg PO BID  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Chronic heart failure with reduced ejection fraction
Paroxysmal atrial fibrillation
Perianal fistula
Mediastinal/hilar lymphadenopathy

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,   

You were admitted to the hospital for heparin (a blood thinner 
similar to the apixaban you take at home) while getting multiple 
procedures done. Please see below for more information on your 
hospitalization. It was a pleasure participating ___ your care!  
 
What happened while you were ___ the hospital?  
-  We held your apixaban and started you on a heparin drip for 
continued anticoagulation for your atrial fibrillation
-  You underwent multiple procedures while you were 
hospitalized; this includes a right heart catheterization, an 
anal fistulotomy, and a bronchoscopy with lymph node biopsies
-  We gave you a little extra diuretics while you were ___ the 
hospital to help keep fluid off you. 

What should you do after leaving the hospital?  
- Please take your medications as listed below and follow up at 
the listed appointments. We have made NO changes to your 
medications.
 - You have an appointment with the lung doctors ___ ___. They 
will go over the results of your biopsy then.
- Your weight at discharge is 195.8 lbs. Please weigh yourself 
today at home and use this as your new baseline.  
- Please weigh yourself every day ___ the morning. Call your 
doctor if your weight goes up or down by more than 3 lbs ___ one 
day or 5 lb ___ one week

We wish you the best! 
 
- Your ___ Healthcare Team  

 
Followup Instructions:
___
",MEDICINE
10003731-DS-2,Pearl Johnson,10003731,23646008," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Penicillins / Bactrim / Doxycycline / Sulfa(Sulfonamide 
Antibiotics)
 
Attending: ___.
 
Chief Complaint:
cellulitis 
 
Major Surgical or Invasive Procedure:
needle aspiration of subcutaneous hematoma

 
History of Present Illness:
___ with A. fib on rivaroxaban, hypertension, and venous stasis 
presents with 7 days of increasing erythema on the left leg.  
One week ago, patient was walking down stairs and struck her 
left shin on a metal plant holder. Two days ago she noticed some 
erythema in her lower left leg and went to an urgent care and 
was placed on clindamycin. Over the last couple days the 
erythema had increased and she was seen by her PCP on ___ and 
again on ___. At that time, erythema was noted to expand 
beyond the marked edges, and she was advised to be admitted for 
IV antibiotics, but she declined. On the day of presentation, 
patient's erythema extended even further which prompted her to 
come to the emergency department. Patient denies any fevers, 
chest pain, shortness of breath, nausea or vomiting. There has 
not been any purulent drainage from the leg.  
In the ED intial vitals were: T 98.3 HR 88 BP 157/86 RR 16 Sat 
99%. Labs were significant for lactate of 2, K of 3.4, Cr 1.1, 
BUN 21, INR 1.3, PTT 40. Patient was given tylenol and IV 
vancomycin 1 gram x1. Blood cultured were drawn and pending.  
On the floor, patient states that her leg pain is improved and 
she has no other acute complaints at this time.  
 
Review of Systems:  
(+) per HPI. 10-point ROS conducted and otherwise negative.  

 
Past Medical History:
venous insufficiency in lower extremities  
Paroxysmal a-fib on rivaroxaban for anticoagulation  
CKD w/ baseline creatinine 1.2 - eGFR 45-50  
HTN  
obesity  
Depression  
GERD  
HSV  
rosacea  
sleep disorder  
PCOS  
H. pylori by EGD biopsy in ___  

 
Social History:
___
Family History:
Sister: DVTs  
Father: a-fib. CVA  
Mother: vascular disease  

 
Physical Exam:
On Admission:
Vitals - 98.2 160/80 76 18 97%RA  
GENERAL: NAD. Well-appearing. Very pleasant.  
HEENT: AT/NC, EOMI, PERRL  
CARDIAC: irregularly irregular rhythma, ___ SEM heard best at 
LUSB  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, obese  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact. No focal deficits  
SKIN: Large area of erythema extending across left anterior shin 
and ___ surface of left foot. Area of erythema is 
extending beyond previously marked lines. This area is warm to 
touch and tender to palpation. No areas of fluctuance or 
purulence. No calf tenderness. Right leg w/o any significant 
skin changes.  

On Discharge:
97.5 142/84 70 18 100%RA  
GENERAL: NAD. Well-appearing.  
HEENT: AT/NC  
CARDIAC: rrr, no murmurs  
LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, +BS, nontender in all quadrants, obese  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact. No focal deficits  
SKIN: erythema improving w/in pen marks. Small fluid collection 
ant shin  
 
 

 
Pertinent Results:
On Admission:
___ 08:40AM   GLUCOSE-102* UREA N-15 CREAT-0.9 SODIUM-144 
POTASSIUM-3.6 CHLORIDE-101 TOTAL CO2-32 ANION GAP-15
___ 08:40AM   WBC-6.8 RBC-4.48 HGB-14.2 HCT-42.0 MCV-94 
MCH-31.6 MCHC-33.7 RDW-12.4
___ 08:40AM   PLT COUNT-279
___ 08:40AM   ___ PTT-38.4* ___
___ 09:00PM   LACTATE-2.0
___ 08:46PM   GLUCOSE-133* UREA N-21* CREAT-1.1 SODIUM-140 
POTASSIUM-3.4 CHLORIDE-99 TOTAL CO2-31 ANION GAP-13
___ 08:46PM   WBC-8.7 RBC-4.51 HGB-14.1 HCT-43.6 MCV-97 
MCH-31.2 MCHC-32.3 RDW-13.0
___ 08:46PM   NEUTS-69.8 ___ MONOS-4.7 EOS-1.6 
BASOS-1.2
___ 08:46PM   PLT COUNT-317
___ 08:46PM   ___ PTT-40.0* ___

On Discharge:
___ 08:15AM BLOOD WBC-5.6 RBC-4.40 Hgb-14.4 Hct-42.3 MCV-96 
MCH-32.6* MCHC-34.0 RDW-12.6 Plt ___
___ 08:15AM BLOOD Glucose-114* UreaN-13 Creat-0.8 Na-143 
K-4.1 Cl-106 HCO3-27 AnGap-14

Imaging:
lower extremity ultrasound ___:
1.  No evidence of deep venous thrombosis in the left lower 
extremity veins. 

2.  Subcutaneous edema in the area of redness in the mid to 
distal left shin. 

Microbiology:

Left Shin Fluid Aspiration ___ 1:57 pm SWAB      Source: left shin ABSCESS. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
      NO MICROORGANISMS SEEN. 

   WOUND CULTURE (Final ___:    NO GROWTH. 

   ANAEROBIC CULTURE (Final ___:    NO GROWTH. 

Blood Culture ___ x 2: no growth
 
Brief Hospital Course:
Ms. ___ is a ___ year old woman with A. fib on rivaroxaban, 
hypertension, and venous stasis who presented with left leg 
cellulitis that had not improved on PO clindamycin, admitted for 
IV antibiotics.
 
ACTIVE ISSUE: 
# Cellulitis: 
She presented with a large area of erythema extending across her 
left anterior shin and ___ surface of left foot. The 
area of erythema extended beyond previously marked lines. It was 
warm to the touch and tender to palpation. She had one area of 
fluctuance noted on her anterior shin which was aspirated and 
found to be a hematoma; fluid culture of the aspirated fluid was 
negative for growth. DVT was ruled out with ultrasound. She was 
treated with vancomycin and her symptoms and erythema improved. 
Given her multiple medication allergies and previous failure on 
clindamycin, she was discharged on linezolid to complete 
treatment of her cellulitis outpatient. 

CHRONIC/INACTIVE ISSUES:
# Paroxysmal Afib: continued metoprolol and rivaroxaban. Rate 
controlled.  
# HTN: continued home losartan, metoprolol, and HCTZ  
# Depression/sleep disorder: continued aderral, lamotrigine and 
risperidone  
 
TRANSITIONAL ISSUES:
- Code: Full (confirmed with patient)  
- Emergency Contact:  
HCP ___ (friend) ___.  
Alternative: ___ (brother) ___  

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Adderall XR (dextroamphetamine-amphetamine) 40 mg oral daily 
2. Hydrochlorothiazide 25 mg PO DAILY 
3. LaMOTrigine 300 mg PO HS 
4. Losartan Potassium 50 mg PO DAILY 
5. Metoprolol Tartrate 25 mg PO BID 
6. Rivaroxaban 20 mg PO DAILY 
7. Acetaminophen 325-650 mg PO Q6H:PRN pain 
8. Multivitamins 1 TAB PO DAILY 
9. Docusate Sodium 100 mg PO BID 

 
Discharge Medications:
1. Linezolid ___ mg PO Q12H Duration: 10 Days 
RX *linezolid [Zyvox] 600 mg 1 tablet(s) by mouth twice a day 
Disp #*20 Tablet Refills:*0
2. Acetaminophen 325-650 mg PO Q6H:PRN pain 
3. Docusate Sodium 100 mg PO BID 
4. Hydrochlorothiazide 25 mg PO DAILY 
5. LaMOTrigine 300 mg PO HS 
6. Losartan Potassium 50 mg PO DAILY 
7. Metoprolol Tartrate 25 mg PO BID 
8. Multivitamins 1 TAB PO DAILY 
9. Rivaroxaban 20 mg PO DAILY 
10. Adderall XR (dextroamphetamine-amphetamine) 40 mg ORAL DAILY 


 
Discharge Disposition:
Home
 
Discharge Diagnosis:
cellulitis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure meeting you during your hospitalization at 
___. You were admitted with cellulitis for IV antibiotics. 
Your infection improved with IV vancomycin. You will be 
discharged on linezolid to continue to treat the infection. 
While taking this antibiotic, you will need to follow a low 
tyramine diet. Please take your medication as prescribed and 
follow up with your doctor.

Sincerely, 
Your ___ Team 
 
Followup Instructions:
___
",MEDICINE
10003757-DS-14,Sulema Williams,10003757,26829618," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Sulfa (Sulfonamide Antibiotics) / nitrofurantoin
 
Attending: ___.
 
Chief Complaint:
Fall from wheelchair
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ female with a history of peripheral vascular 
disease, hypertension, coronary artery disease, emphysema, 
pelvic fracture s/p hip replacement  presents to the ED after a 
fall and a head CT from OSH showing ___ for neurosurgery 
evaluation.

Patient was in her usual state of health until today when she 
fell from her wheelchair at home. Patient has a laceration to 
her forehead. Per report from outside hospital, patient was 
getting up from her wheelchair when she tripped and fell forward 
hitting her head. Patient denies any chest pain and there is no 
nausea or vomiting

 
Past Medical History:
Past medical history:
- Peripheral vascular disease
- Hypertension
- Coronary artery disease
- Emphysema 
- Pelvic fracture 

Past surgical history:
- Right hip replacement
 
Social History:
___
Family History:
NC
 
Physical Exam:
ADMISSION:
Vital signs: reviewed
General: alert and oriented x3, cooperative, speaks in full
sentences 
HEENT: EOMI PERLA, left periorbital ecchymosis, left forehead
laceration sutured by ED team. Neck supple.
Pulmonary: clear to auscultation bilaterally
Cardiovascular: regular rate and rhythm, no murmurs
Abdomen: soft, nontedner, nondistended.
Extremities: warm and well perfussed. Normal ___ 2+

DISCHARGE
Vitals: 97.5 122/58R Lying 87 18 95 Ra  
Gen: Calm, alert, NAD
HEENT: Ecchymosis surrounding the left eye, improving, no
conjunctival hemorrhage
CV: RRR, ___ harsh systolic murmur with radiation to the 
carotids
Resp: Lungs clear to auscultation bilaterally, no w/r/r
Abd: Soft, NTND
Ext: warm, no edema, L calf > R calf 
MSK: ecchymosis of L shoulder, mild ttp and with movement, large
hematoma on lateral L hip/buttock
Neuro: alert, oriented to self and place, not date
 
Pertinent Results:
ADMISSION:
___ 10:30PM BLOOD WBC-23.6* RBC-2.90* Hgb-9.4* Hct-29.5* 
MCV-102* MCH-32.4* MCHC-31.9* RDW-15.0 RDWSD-55.3* Plt ___
___ 10:30PM BLOOD Neuts-79.6* Lymphs-8.2* Monos-10.3 
Eos-0.6* Baso-0.5 Im ___ AbsNeut-18.76* AbsLymp-1.92 
AbsMono-2.42* AbsEos-0.15 AbsBaso-0.12*
___ 10:30PM BLOOD ___ PTT-25.3 ___
___ 10:30PM BLOOD Glucose-134* UreaN-16 Creat-0.5 Na-136 
K-4.7 Cl-98 HCO3-26 AnGap-12
___ 10:44AM BLOOD Calcium-8.0* Phos-3.4 Mg-1.6

DISCHARGE:
___ 05:57AM BLOOD WBC-9.9 RBC-2.42* Hgb-7.7* Hct-24.8* 
MCV-103* MCH-31.8 MCHC-31.0* RDW-17.2* RDWSD-61.1* Plt ___

MICRO:
___ BLOOD CULTURE Blood Culture, 
Routine-PENDING EMERGENCY WARD 
___ BLOOD CULTURE Blood Culture, 
Routine-PENDING 
___ 1:52 am URINE

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      ESCHERICHIA COLI.    >100,000 CFU/mL. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------     8 S
AMPICILLIN/SULBACTAM--     4 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S

IMAGING
___ CT C/A/P:
1. Severe T12 compression fracture with slight retropulsion of 
the superior T2 endplate, indeterminate age. 
2. Multiple fractures of posterior and lateral ___ ribs, 
some of which demonstrate developing callus, suggesting subacute 
chronicity. 
3. Acute appearing right L1 transverse process fracture, and 
probable T10 and T11 spinous process fractures. 
4. Status post aortic bifemoral bypass with complete occlusion 
of right bypass graft. 
5. 3.5 cm fluid collection encasing the left bypass graft in the 
left lower quadrant, likely representing a seroma. 
6. Apparent filling defect in the left common femoral vein, 
likely mixing 
artifact.  However, ultrasound is recommended to evaluate for 
possible DVT. 
7. UIP pattern of pulmonary fibrosis in the bilateral lung 
bases. 
8. Diverticulosis without evidence of acute diverticulitis. 
9. 4.2 cm abdominal aortic aneurysm at the level of the aortic 
hiatus. 

___ L ___:
IMPRESSION:  
No evidence of deep venous thrombosis in the left lower 
extremity veins. 

___ CT head:
1. Mild left frontal subarachnoid hemorrhage. No prior studies 
available for comparison. 
2. Presumed arachnoid cyst in the left middle cranial fossa. 

___ TTE:
The left atrial volume index is normal. There is no evidence for 
an atrial septal defect by 2D/color Doppler.
The estimated right atrial pressure is ___ mmHg. There is mild 
(non-obstructive) hypertrophy of the basal
septum with a normal cavity size. There is normal regional left 
ventricular systolic function. Global left
ventricular systolic function is normal. The visually estimated 
left ventricular ejection fraction is 60%. Left
ventricular cardiac index is normal (>2.5L/min/m2) No 
ventricular septal defect is seen. There is no resting
left ventricular outflow tract gradient. Normal right 
ventricular cavity size with normal free wall motion. The
aortic sinus diameter is normal with normal ascending aorta 
diameter. The aortic arch diameter is normal.
There are simple atheroma in the abdominal aorta. The aortic 
valve leaflets (3) are mildly thickened. There is
moderate aortic valve stenosis (valve area 1.0-1.5 cm2). There 
is no aortic regurgitation. The mitral leaflets
are mildly thickened with no mitral valve prolapse. There is 
moderate mitral annular calcification. There is no
mitral valve stenosis. There is mild [1+] mitral regurgitation. 
Due to acoustic shadowing, the severity of mitral
regurgitation could be UNDERestimated. The tricuspid valve 
leaflets appear structurally normal. There is trivial
tricuspid regurgitation. The estimated pulmonary artery systolic 
pressure is normal. There is no pericardial
effusion.
IMPRESSION: Adequate image quality. Moderate low gradient aortic 
stenosis. Normal biventricular systolic
function.

___ XR shoulder/humerus:
1. No fracture or dislocation. 
2. Multiple focal lucencies in the left humeral shaft could 
reflect osteopenia but raise concern for multiple myeloma or 
diffuse metastatic disease, which could be further evaluated 
with MRI, SPEP, and UPEP. 
3. Moderate to severe degenerative changes of the 
acromioclavicular 
glenohumeral joints. 

 
Brief Hospital Course:
___ is an ___ with history of dementia, PAD, HTN, 
CAD, COPD, prior pelvic fracture s/p hip replacement who 
presented to an OSH with an unwitnessed fall and was transferred 
to ___ due to CT head showing SAH. Transferred to the medicine 
service for encephalopathy. 

# Encephalopathy, toxic/metabolic: Patient was acutely altered 
on admission with waxing and waning mental status consistent 
with delirium on baseline of mild dementia. Found to have 
symptomatic UTI which was a like contributor as well as 
pain/trauma from her fall. She was started on antibiotics and 
improved back to baseline.

# Small left frontal traumatic SAH: Sustained in her fall. She 
had repeat head CT that showed stability. She was evaluated by 
neurosurgery who felt no surgical intervention was needed. Her 
home aspirin and prophylactic subcutaneous heparin were started 
on ___. Her goal blood pressure was under 160 and was maintained 
throughout her hospitalization. Per neurosurgery she did not 
need seizure prophylaxis and did not need neurosurgery follow up 
as an outpatient. Sutures were placed for her head laceration 
and can be removed on ___. 
 
# T12 compression fracture
# L1 transverse fracture: Per orthospine, likely chronic and 
unrelated to recent fall. She worked with ___ who recommended 
rehab. She is weight bearing as tolerated and ROM as tolerated. 
She should follow up with spine clinic 2 weeks after discharge. 
Pain control was with lidocaine patch and Tylenol. Her home 
tramadol was restarted on discharge at reduced dose.  

# Fall: She suffered an unwitnessed fall and had poor memory of 
the event. She is on a number of medications that could 
pre-dispose to falls including multiple antihypertensives (and 
had positive orthostatics in-house) and sedating/pain 
mediations. Symptomatic UTI likely contributer as well. A TTE 
revealed moderate AS. Telemetry revealed rare short runs of 
self-terminating SVT. Low suspicion overall for cardiac cause of 
her fall. Her antihypertensives were held with acceptable blood 
pressures throughout (SBPs < 160). Her tramadol and gabapentin 
(which had been newly started/uptitrated) were also held. 
Tramadol was restarted at a lower dose on the day of discharge 
and well tolerated.
 
# Urinary tract infection: patient with urinary frequency and 
pansensitive E coli in her urine culture. She was treated with 
ceftriaxone starting ___ and discharged with one day of 
cefpodoxime to complete a ___nemia: She was found to be anemic on admission around 7s with 
a small drop to 6.4 for which she received 1U pRBC with 
appropriate increase. Her H/H remained stable thereafter. Per 
her family she has chronic anemia. She may have element of MDS 
as she has borderline thrombocytopenia as well. She has a 
hip/buttock hematoma that remained stable. Iron studies showed 
an elevated ferritin and normal Fe, consistent with ACD. 

TRANSITIONAL ISSUES:
[] Patient discharged on cefpodoxime for 400 mg q12h for one day 
to complete a 5 day course of antibiotics for UTI
[] Patient with sutures in place; can be removed ___
[] Patient found to be anemic with unknown baseline; if not 
previously evaluated could consider further work up
[] Xray of the L humerus revealed: ""Multiple focal lucencies in 
the left humeral shaft could reflect osteopenia but raise 
concern for multiple myeloma or diffuse metastatic disease, 
which could be further evaluated with MRI, SPEP, and UPEP.""
[] Patients antihypertensives (atenolol and lisinopril) were 
stopped on admission due to fall and orthostatic hypotension. If 
she develops hypertension, can consider restarting.
[] Patient started on metoprolol succinate 25 mg daily for 
cardiac protection as atenolol was stopped
[] Patient's tramadol was decreased to 50 mg TID PRN
[] Patient's gabapentin was held on discharge

**The patient was seen and examined today and is stable for 
discharge. Greater than 30 minutes were spent on discharge 
coordination and counseling.**
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Atenolol 25 mg PO DAILY 
3. Atorvastatin 40 mg PO QPM 
4. Calcium 500 + D (calcium carbonate-vitamin D3) 500 
mg(1,250mg) -200 unit oral DAILY 
5. Docusate Sodium 100 mg PO BID 
6. Donepezil 5 mg PO QHS 
7. Bisacodyl ___AILY:PRN constipation 
8. DULoxetine 60 mg PO DAILY 
9. Florastor (Saccharomyces boulardii) 250 mg oral BID 
10. Gabapentin 100 mg PO QHS 
11. Lisinopril 10 mg PO DAILY 
12. Loratadine 10 mg PO DAILY 
13. Milk of Magnesia 30 mL PO PRN constipation 
14. Multivitamins 1 TAB PO DAILY 
15. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 
16. Omeprazole 20 mg PO BID 
17. Senna 17.2 mg PO BID 
18. TraMADol 100 mg PO TID 
19. Acetaminophen 1000 mg PO Q8H 
20. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
21. Ondansetron 4 mg PO Q8H:PRN nausea 

 
Discharge Medications:
1.  Cefpodoxime Proxetil 400 mg PO Q12H Duration: 2 Doses 
Give on ___.  Metoprolol Succinate XL 25 mg PO DAILY  
3.  TraMADol 50 mg PO TID:PRN Pain - Moderate  
4.  Acetaminophen 1000 mg PO Q8H  
5.  Aspirin 81 mg PO DAILY  
6.  Atorvastatin 40 mg PO QPM  
7.  Bisacodyl ___AILY:PRN constipation  
8.  Calcium 500 + D (calcium carbonate-vitamin D3) 500 
mg(1,250mg) -200 unit oral DAILY  
9.  Docusate Sodium 100 mg PO BID  
10.  Donepezil 5 mg PO QHS  
11.  DULoxetine 60 mg PO DAILY  
12.  Florastor (Saccharomyces boulardii) 250 mg oral BID  
13.  Loratadine 10 mg PO DAILY  
14.  Milk of Magnesia 30 mL PO PRN constipation  
15.  Multivitamins 1 TAB PO DAILY  
16.  Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain  
17.  Omeprazole 20 mg PO BID  
18.  Ondansetron 4 mg PO Q8H:PRN nausea  
19.  Senna 17.2 mg PO BID  
20. HELD- Gabapentin 100 mg PO QHS  This medication was held. Do 
not restart Gabapentin until talking with your PCP
21. HELD- Lisinopril 10 mg PO DAILY  This medication was held. 
Do not restart Lisinopril until talking with your PCP

 
___:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Small left frontal SAH
T12 compression fracture
Urinary tract infection
Acute right L1 transverse process fracture and T10/T11 spinous 
process fractures. 

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

You were admitted to the hospital after you fell and hit your 
head. You had a bleed in your brain but did not need surgery. 
You were found to have a small fracture in one of the small 
bones in your back but this was thought to have been present 
before you fell. You will follow up with spine doctors after ___ 
leave the hospital for this. You also hit your arm and hip but 
did not have any broken bones. 

You were found to have a urinary tract infection and treated 
with antibiotics. This may have contributed to your fall. You 
also were found to have low blood pressure when you stand up, so 
your blood pressure medications stopped. You can discuss 
restarting them with your primary care doctor.

You were found to be anemic (to have low blood counts) and got a 
blood transfusion. Your blood counts were stable after this. You 
may need further evaluation of your anemia by your primary care 
doctor unless this has already been done.

It was a pleasure participating in your care. We wish you all 
the best in the future!

Sincerely,

Your ___ team

 
Followup Instructions:
___
",MEDICINE
10004235-DS-21,Harold Neighbors,10004235,24181354," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
 Persistent hypotension and s/p cardiac arrest

 
Major Surgical or Invasive Procedure:
___ ERCP
CVVH
Mechanical ventillation

 
History of Present Illness:
___ history w/ PMH of HTN and autism who presents as a transfer 
from OSH s/p cardiac arrest. He reportedly had 2 days of 
lethargy and malaise and diarrhea at home. He had an episode of 
syncope at home when walking down the stairs (SOB prior per 
mother). When EMS arrived, pt was agitated but awake but became 
unresponsive and was pulseless on arrival to the ___ ED. 
For PEA arrest, he received CPR, atropine, and epi with ROSC. He 
then became hypotensive w/asystole received Ca, bicarb, epi, and 
CPR. Also had episode of VTACH s/p shock in OSH. OSH labs were 
notable for eo's of 5.8 on diff, lactate 9.4, INR 1.75, Cr 8.2, 
and FSBG of 58. He had a right femoral CVL placed, received 3L 
of fluid, and was uptitrated to 3 pressors of levo/epi/neo. He 
received no abx, 1 amp of glucose, and was transferred to ___ 
for further management.

He arrived to ___ on max does of norepi, epi and phenylephrine 
gtts. He was unresponsive but s/p NMB (rocuronium at 11:30 AM) 
en route via Medflight. His labs were notable for WBC 24.0 (12% 
bands), H/H 11.9/36.0, PLT 31, INR 1.3, BUN/Cr 83/8.3, ALT 114, 
AST 143, CK 5097, AP 337, TB 5.4, Lipase 61, CK MB 20, Uric acid 
17.7, Phos 8.3, calcium 7.4, Cortisol 66.9, negative UA, 
negative serum and urine tox screens. His initial blood gas was 
7.00/___/72. Lactate was 4.0 and free Ca was 1.01. Blood and 
urine cultures were sent. Imaging was notable for CXR with 
pulmonary edema, CT head with no acute bleed but subtle 
subcortical white matter hypodensity in the right frontal lobe, 
CT c-spine without acute fracture, and CTA chest and abdomen 
with no PE, type I choledochal cyst, 3.5 cm heterogeneous, 
potentially enhancing left renal lesion concerning for neoplasm, 
and ill-defined segment VII with hypodense liver lesion. A 
bedside echo showed a hyperdynamic heart. He received 150 
bicarb, vanc/zosyn, tamiflu, azithromycin, and was loaded with 
amiodarone for persistent tachycardia and AF. He was 
temperature-controlled for normothermia and reached 37oc by 3:40 
___. He was admitted to the MICU for further management.

On admission to the MICU, the patient's VS were: . He was noted 
to be in AF with RVR. In speaking with the patient's mother, the 
patient only takes medications given to him by her. His only 
regular medications are atenolol and protonix. He takes 
indomethacin and colchicine as needed, and last dose was 5 days 
ago. Because of not feeling well over the past few days, his 
mother reported that the patient took 2 capsules of keflex 
yesterday, but was not taking a prescribed antibiotic course.
 

 
Past Medical History:
Autism  
HTN
?Gout  

 
Social History:
___
Family History:
 No known history of sudden cardiac death.

 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
Vitals- T: 98.1, BP: 112/65, P: 134, O2: 94% on CMV on Vt 550, 
RR 24, 8 PEEP.
GENERAL: Intubated, not sedated
HEENT: Icteric sclera, dry MMM, oropharynx clear  
NECK: supple, JVP elevated, no LAD  
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding, no organomegaly  
EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
NEURO: Not alert, not oriented, opens eyes to pain and voice, 
but does not withdraw to pain. Intact pupillary reflex, negative 
corneals, negative cough/gag. No spontaneous movements of limbs.

Discharge physical:
Vitals: Tm 101.3; Tc 99.7;  HR 121;  BP 99/59;  RR 39;  SaO2 97 
on 2L
General: Somulent male lying comfortably in bed. Tachypneic but 
nonlabored breathing
HEENT: Sclera anicteric, MMM, oropharynx clear
Neck: supple, left IJ line in place
Lungs: Clear to auscultation anteriorly and laterally
CV: Tachycardic but regular rate, normal S1 + S2, no murmurs, 
rubs, gallops
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema
Skin: No rashes or lesions
Neuro: Somulent, but arousable. Responds to some yes/no 
questions. Follows simple commands

 
Pertinent Results:
INITIAL LABS: 
___ 12:40PM   WBC-24.0* RBC-4.21* HGB-11.9* HCT-36.0* 
MCV-86 MCH-28.3 MCHC-33.1 RDW-16.4*
___ 12:40PM   NEUTS-67 BANDS-12* LYMPHS-9* MONOS-5 EOS-0 
BASOS-0 ___ METAS-4* MYELOS-3* NUC RBCS-1*
___ 12:40PM   ___ PTT-35.9 ___
___ 12:40PM   ___
___ 12:40PM   GLUCOSE-174* LACTATE-4.0* NA+-137 K+-4.1 
CL--108
___ 12:40PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG 
bnzodzpn-NEG barbitrt-NEG tricyclic-NEG
___ 12:40PM   CORTISOL-66.9*
___ 12:40PM   CALCIUM-7.4* PHOSPHATE-8.3* MAGNESIUM-2.2 
URIC ACID-17.7*
___ 12:40PM   LIPASE-61*
___ 12:40PM   CK-MB-20* MB INDX-0.4
___ 01:15PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG 
cocaine-NEG amphetmn-NEG mthdone-NEG
___ 05:41PM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-NORMAL 
MACROCYT-NORMAL MICROCYT-1+ POLYCHROM-NORMAL
___ 05:41PM   HAPTOGLOB-279*
___ 05:41PM   LD(LDH)-486* DIR BILI-4.8*
___ 05:41PM   GLUCOSE-425* UREA N-87* CREAT-7.9* 
SODIUM-132* POTASSIUM-4.3 CHLORIDE-96 TOTAL CO2-14* ANION 
GAP-26*

STUDIES
==========================================================
___ EEG IMPRESSION: This is an abnormal continuous ICU 
monitoring study because of a discontinuous background 
throughout the recording, characterized by ___ Hz theta 
frequency activity with admixed delta activity and occasional 
suppressions, consistent with a moderate to several 
encephalopathy. Background reactivity is present as seen during 
bedside examination when a more continuous and higher voltage 
theta frequency activity is observed. There are no definite 
epileptiform discharges or electrographic seizures. Note is made 
of an irregular cardiac rhythm throughout the recording with an 
average heart rate of 70 to 130 bpm on a single channel EKG. 

___ ECG Baseline artifact. Sinus tachycardia. Non-diagnostic Q 
waves in leads I and aVL. Borderline intraventricular conduction 
delay of the left bundle-branch block type. ST-T wave 
abnormalities. No previous tracing available for comparison. 
Clinical correlation is suggested. TRACING ___ CXR IMPRESSION: 1. Widened mediastinum may reflect low lung 
volumes and supine positioning, however mediastinal great vessel 
injury cannot be excluded. If concern exists, recommend chest 
CTA. 2. Pulmonary vascular congestion and probable mild 
pulmonary edema. 3. Bibasilar atelectasis. 4. ET tube with tip 6 
cm above carina. Enteric tube with tip projecting over stomach 
fundus. 

___ CT SPINE 1. No acute fracture or malalignment. 2. 
Heterogeneously enlarged left thyroid gland with punctate 
calcification suggestive of a goiter. Consider thyroid 
ultrasound if the patient has not had one previously if the 
patient's condition stabilizes. 3. Mild pulmonary edema. 

___ CT HEAD W/O CONTRAST IMPRESSION: 1. No acute intracranial 
hemorrhage or mass effect. 2. Subtle subcortical white matter 
hypodensity in the right frontal lobe which is nonspecific, 
potentially related to chronic small vessel infarction, but can 
also be seen with vasculitis, demyelination, or infection. This 
can be further assessed with MRI. 

___ CTA CHEST AND ABDOMEN IMPRESSION: 1. No evidence of 
pulmonary embolism to the segmental level. 2. Fusiform dilation 
to 53 mm of the extrahepatic common hepatic and common bile duct 
as well as the cystic duct, compatible with type I choledochal 
cyst. Hyperdense anti-dependent material within the gallbladder 
lumen may represent sludge, however underlying mass lesion is 
also of concern. Recommend non-urgent MRCP for further 
evaluation of biliary system and gallbladder when clinically 
appropriate. 3. A 3.5 cm heterogeneous, potentially enhancing 
left renal lesion, concerning for neoplasm. Patent ipsilateral 
renal vein. This could be further evaluated at the time of 
followup MRI/MRCP. 4. Ill-defined segment VII hypodense liver 
lesion. Attention on followup imaging. 5. Possible non-displaced 
sternal fracture. 6. Appropriately-positioned ET tube and 
enteric tube. 7. Mild pulmonary edema which is most conspicuous 
in the lung apices. Bibasilar atelectasis. 8. Mildly 
heterogeneous thyroid is partially imaged. 

___ ECHO The left atrium is elongated. No atrial septal defect 
is seen by 2D or color Doppler. Left ventricular wall 
thicknesses are normal. The left ventricular cavity is mildly 
dilated. There is severe global left ventricular hypokinesis 
(LVEF = 25 %). No masses or thrombi are seen in the left 
ventricle. There is no ventricular septal defect. The right 
ventricular cavity is dilated with depressed free wall 
contractility. The diameters of aorta at the sinus, ascending 
and arch levels are normal. The aortic valve leaflets (3) appear 
structurally normal with good leaflet excursion and no aortic 
stenosis or aortic regurgitation. The mitral valve appears 
structurally normal with trivial mitral regurgitation. There is 
moderate pulmonary artery systolic hypertension. There is no 
pericardial effusion. 

___ CXR IMPRESSION: 1. Slight interval worsening of vascular 
congestion and mild pulmonary edema. Additionally, the heart 
appears slightly larger. 2. High position of the endotracheal 
tube, 7 cm from the carina. Advance 2-3 cm for more secure 
placement. 

___ CXR IMPRESSION: Subtle new confluent opacity in the right 
perihilar region,? related to subtle progression of CHF 
findings. Otherwise, I doubt significant interval change. 
Attention to this area on followup films is requested. 

ERCP report
___ 
Impression: Bulging of the major papilla 
Biliary dilation compatible with cholydocal cyst. 
A 5cm by ___ straight plastic biliary stent was placed 
successfully. Brisk drainage of cloudy bile and contrast from 
the biliary tree was noted endoscopically and fluoroscopically.  
 
Otherwise normal ercp to third part of the duodenum 

___ CXR IMPRESSION:  
In comparison with the study of ___, the monitoring and 
support devices are essentially unchanged. The patient has taken 
a somewhat better inspiration. Nevertheless, there is 
enlargement of the cardiac silhouette with bibasilar 
opacifications. 

MICRO:
___ 12:40 pm BLOOD CULTURE

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___: 
      ESCHERICHIA COLI.    FINAL SENSITIVITIES. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 
         TYPING FOR E.COLI 0157:H7 REQUESTED BY ___ ___ 
___. 
         NEGATIVE FOR E.COLI SEROGROUP 0157:H7 BY LATEX 
AGGLUTINATION TEST. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------     8 S
AMPICILLIN/SULBACTAM--   <=2 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S

   Anaerobic Bottle Gram Stain (Final ___: 
      Reported to and read back by ___ @ 0354 ON ___. 

      GRAM NEGATIVE ROD(S). 

   Aerobic Bottle Gram Stain (Final ___:    GRAM NEGATIVE 
ROD(S). 

Subsequent blood cultures negative

LABS ON DISCHARGE
___ 04:38AM BLOOD WBC-12.4* RBC-3.16* Hgb-8.7* Hct-27.2* 
MCV-86 MCH-27.4 MCHC-31.9 RDW-17.6* Plt ___
___ 04:38AM BLOOD ___ PTT-26.9 ___
___ 04:38AM BLOOD Glucose-94 UreaN-32* Creat-1.2 Na-144 
K-4.1 Cl-116* HCO3-17* AnGap-15
___ 04:38AM BLOOD ALT-32 AST-29 AlkPhos-164* TotBili-1.4
___ 04:38AM BLOOD Calcium-8.1* Phos-4.1 Mg-1.___ history HTN and autism who presents as a transfer from OSH 
s/p PEA arrest, septic shock on 3 pressors, and ___.

ACUTE ISSUES:
# PEA arrest: Unclear precipitant, but most likely metabolic 
derangement in the setting of diarrhea, leading to bicarbonate 
losses and consequential hypokalemia, acidosis, and hypovolemia 
driving an arrhythmia. While he had shortness of breath, hypoxia 
does not seen likely. Bedside echo did not show any evidence of 
tamponade and CXR/CT did not show evidence of tension 
pneumothorax. EKG and echo also did not support ACS. Serum tox 
does not favor a toxin ingestion.  He was maintained at strict 
normothermia for 48 hours. 

# Septic Shock: Patient presented in septic shock.  Source most 
likely cholangitis. Hypotension was refractory to volume 
resussitation and was required 3 pressors. Patient was found to 
have cholangitis and E. coli bacteremia which was treated as 
below. 

# AF with RVR: Patient presented with new onset afib with RVR. 
the pt has no history of AF. Tachycardia is likely induced by 
the use of multiple pressors, especially epinephrine. Due to 
patients hypotension he was loaded with amiodarone and 
transitioned to PO amiodarone. He then receieved dilt and then 
verapamil for additional attempts at rate control. He was in 
sinus rhythm on floor transfer. Started on coumadin 3mg on ___. 
Cardiology was consulted and recommended discontinuing 
amiodarone and verapamil and starting the patient on metoprolol 
and an ACEI. Metoprolol was started and titrated to 150mg upon 
discharge. He was not started on lisinopril 5mg as his renal 
function had just recovered. Patient should start lisinopril on 
___. 

# ___: Pt likely has some CKD at baseline, as Cr in ___ was 
1.7. Rapid rise in Cr unlikely to occur suddednly in setting of 
septic shock.  Urine microscopy with many muddy brown casts, 
unsuprising given his arrest and severe septic shock.  With 
prolonged dehydration and cardiac arrest, likely pre-renal 
azotemia developed into ATN. His uric acid level of 17.7 is very 
elevated and makes uric acid nephropathy possible and uric acid 
cystals were seen on urine microscopy. Per mother, took ___ 
and indomethacin for perhaps a few days prior to this event. 
Because of volume overload and low urine output patient was 
treated with continuous renal replacement therapy which was 
continued until ___. His renal function continued to improve, 
and he should be started on ACEI for heart failure on ___, in 
order to give his kidneys time to recover. On discharge, he 
appeared to be in post-ATN diuresis, so patient should be 
encouraged to keep hydrated with careful monitoring of I/O after 
discharge. 

# Respiratory failure: Not ARDS. Likely ___ cardiac arrest and 
acidosis. Pt initally had severe metabolic acidosis and 
permitted to hyperventilate to compensate.  Due to patients 
kidney injury and aggressive fluid resussitation. TTE showed EF 
25%, global hypokinesis, unclear chronicity. 

# Cholangitis and E. coli bacteremia:  Elevated LFTs in the 
setting of dilated CBD on imaging with choledochal cyst was 
suggestive of underlying cholangitis. ERCP findings included 
Cloudy bile, no frank pus. Ampulla was found to have with edema 
and erythema, possibly site of obstruction. ___ CBD stent placed 
in CBD, good bile flow after placement. Patient improved rapidly 
after ERCP and should continue ceftriaxone and flagyl until 
___. He will need surgery and ERCP follow-up for cyst removal 
and stent removal. 
 
# Thrombocytopenia: Unlikely a consumptive process as fibrinogen 
elevated and INR only midly elevated, making DIC unlikely. Heme 
was consulted to rule out TTP in setting of liver and renal 
dysfunction. Ehrlichia/anaplasmosis was negative. 
Thrombocytopenia was likely due to sepsis, and recovered quickly 
after source control for cholangitis. 

# Hyperglycemia: Pt had low FSBG on presentation at OSH and 
received 1 amp. He then became hyperglycemic in setting of 
sepsis and required insulin drip during that time.

TRANSITIONAL ISSUES:
- Please start lisinopril 5mg on ___ if kidney function 
stable. Patient needs ACEI for likely acute heart failure, 
however needs a week prior to starting due to ___. 
-Patient in post-ATN diuresis. Encourage PO intake, monitor I/O 
and blood pressures to make sure he is not dehydrated. 
- Patient started on warfarin on ___ at 3mg due to concurrent 
use of flagyl. It was increased to 5mg on ___. Please monitor 
INR.
-Scheduled for appointments with surgery, ERCP, urology (concern 
for renal mass), and cardiology. 
- Does not need renal follow-up, but please schedule if kidney 
function worse or if metabolic acidosis does not resolve.
-Per cardiology, will continue warfarin, metoprolol, and 
lisinopril until his follow-up appointment. At that time, he 
will need repeat echo to assess LV function and may need an 
event monitor to determine whether he is still having episodes 
of A-fib.
- Recent CT scan showed a ""3.5 cm heterogeneous, potentially 
enhancing left renal lesion, concerning for neoplasm"". Warrants 
further evaluation by Urology once he recovers 
- Outpatient surgery f/u for choledochal cyst resection 
- ERCP f/u to take out stent 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atenolol 50 mg PO DAILY 
2. Pantoprazole 40 mg PO Q24H 
3. Colchicine 0.6-1.2 mg PO BID:PRN pain 
4. Diazepam 5 mg PO QHS:PRN insomnia 
5. Sertraline 50 mg PO DAILY:PRN anxiety 
6. Indomethacin 25 mg PO TID:PRN pain 

 
Discharge Medications:
1. CeftriaXONE 2 gm IV Q24H 
2. Colchicine 0.6-1.2 mg PO BID:PRN pain 
3. Diazepam 5 mg PO QHS:PRN insomnia 
4. Pantoprazole 40 mg PO Q24H 
5. Sertraline 50 mg PO DAILY:PRN anxiety 
6. MetRONIDAZOLE (FLagyl) 500 mg PO TID 
7. Warfarin 5 mg PO DAILY16 
8. Metoprolol Succinate XL 200 mg PO DAILY 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary diagnosis:
Septic shock due to cholangitis

Secondary diagnoses:
Paroxysmal atrial fibrillation
___ on CKD
Systolic heart failure
Thrombocytopenia
Anemia
Respiratory failure

 
Discharge Condition:
Mental Status: patient attentive and able to answer limited 
questions
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure caring for you at ___. You were admitted 
with weakness and diarrhea and were found to have an infection 
in your abdomen. You also experienced an event where your heart 
stopped and you were very ill afterwards. Your symptoms 
gradually improved with antibiotics and a procedure to place a 
stent in the duct your gallbladder drains into, and we gave you 
medication to control your heart rate. Our cardiology team saw 
you and started you on several new medications to protect your 
heart. You will need to go to rehab to regain your strength and 
will need to see several specialists, listed below, after you 
leave the hospital. Please follow-up with your appointments as 
listed below.

Please note that your CT scan showed a mass in your kidney which 
should be evaluated by Urology as an outpatient, as there is 
concern this could be a cancer. You will also need surgery to 
remove the cyst around your gallbladder to prevent future events 
like this from occurring. You also need to follow-up with 
cardiology to reassess your heart function and adjust your 
medications.

Take care, and we wish you the best.

Sincerely,
Your ___ medicine team
 
Followup Instructions:
___
",MEDICINE
10004322-DS-21,Cory Goodman,10004322,28755331," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
multiple falls at group home
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Mr. ___ is a ___ year old male with a h/o psychosis admitted 
for falls over the past two days. Patient himself claims that 
people have been pushing him to the ground and beating him up. 
He denies blacking out or having palpitations or dizziness 
before the fall. Importantly, conversations with supervisor of 
the group home ___ ___ reveal that he has 
had some mechanical falls, but they were likely not result of 
being pushed.  Per ___, Mr. ___ has been more lethargic 
than usual. Also, she says that Mr. ___ administers his own 
medication without supervision and may not have been compliant 
in the past few weeks. 
Of note, pt did report ""urine hurting"" in the ED, which he later 
denied.  He also complained of tooth pain on bottom jaw where he 
has a chronically split tooth and cavity. Also lower bilateral 
abdominal pain. No back pain. Some recent constipation with last 
bowel movement 2 days ago. Frequently strains. No blood. No 
other focal symptoms. 
In the ED, initial VS were 106/65 hr 100 rr 18 sat 97/ra. He 
received 2LNS. Head CT, CXR, pelvis and lumbar spine films in 
the ED were negative. 

 
Past Medical History:
Psychosis 
Diabetes 
COPD 

 
Social History:
___
Family History:
Unknown to patient.
 
Physical Exam:
ADMISSION PHYSICAL EXAM: 
VS: 98.1 117/62 97 18 96RA 
GENERAL: disheveled male, appears stated age, NAD, odd affect 
HEENT: Middle lower jaw with cracked tooth that is tender to 
palpation. No pus or swelling at the area. No areas of 
bruising/hematoma of chin/jaw. PERRL, EOMI, MMM 
LUNGS - CTA bilat, no r/rh/wh, good air movement 
HEART - RRR, no MRG, nl S1-S2 
ABDOMEN - Soft, mild tenderness to palpation of lower abdomen 
(right and lower), +BS 
EXTREMITIES - no c/c/e, 2+ peripheral pulses 
NEURO - A&Ox1, CNs II-XII grossly intact, muscle strength ___ 
throughout, sensation grossly intact throughout, gait not 
assessed 

DISCHARGE PHYSICAL EXAM:
PHYSICAL EXAM: 
VS: 98.4 135/70 78 16 98RA 
GENERAL: disheveled male, appears stated age, NAD, odd affect 
HEENT: Middle lower jaw with cracked tooth that is tender to 
palpation. No pus or swelling at the area. No areas of 
bruising/hematoma of chin/jaw. MMM 
LUNGS - CTAB
HEART - RRR, no MRG, nl S1-S2 
ABDOMEN - Soft, NTND +BS 
EXTREMITIES - no c/c/e, 2+ peripheral pulses 
NEURO - A&Ox1, CNs II-XII grossly intact, muscle strength ___ 
throughout, sensation grossly intact throughout, gait not 
assessed 

 
Pertinent Results:
ADMISSION LABS:
___ 03:40PM BLOOD WBC-17.7* RBC-4.73 Hgb-13.7* Hct-40.2 
MCV-85 MCH-29.0 MCHC-34.2 RDW-14.0 Plt ___
___ 03:40PM BLOOD Neuts-85.7* Lymphs-8.9* Monos-5.2 Eos-0 
Baso-0.3
___ 03:40PM BLOOD Glucose-274* UreaN-22* Creat-1.0 Na-134 
K-4.4 Cl-96 HCO3-24 AnGap-18
___ 03:40PM BLOOD ALT-23 AST-28 AlkPhos-159* TotBili-0.5
___ 03:40PM BLOOD Lipase-32
___ 03:40PM BLOOD cTropnT-<0.01
___ 06:10AM BLOOD CK-MB-1 cTropnT-<0.01
___ 06:10AM BLOOD Calcium-9.1 Phos-3.8 Mg-2.0
___ 03:40PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 05:37PM BLOOD Lactate-2.4*
===========================================

DISCHARGE LABS:
___ 06:00AM BLOOD WBC-10.3 RBC-4.14* Hgb-12.1* Hct-35.3* 
MCV-85 MCH-29.2 MCHC-34.2 RDW-14.3 Plt ___
___ 06:00AM BLOOD Glucose-122* UreaN-16 Creat-0.9 Na-138 
K-3.8 Cl-100 HCO3-28 AnGap-14
___ 06:00AM BLOOD Calcium-9.6 Phos-5.0* Mg-2.2

===========================================

URINE:
___ 10:00PM URINE Color-Yellow Appear-Clear Sp ___
___ 10:00PM URINE Blood-NEG Nitrite-NEG Protein-30 
Glucose-1000 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-NEG
___ 10:00PM URINE RBC-0 WBC-2 Bacteri-FEW Yeast-NONE Epi-<1
URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 
COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL 
CONTAMINATION. 

===========================================

Blood cultures: negative for 48hours

===========================================

IMAGING from ___:
CXR: Supine AP portable view of the chest provided. Lung volumes 
are low. No definite consolidation or supine evidence of 
effusion or pneumothorax. The cardiomediastinal silhouette 
appears grossly within normal limits. No definite displaced rib 
fracture is seen. 

X-Ray Pelvis/Lumbar Spine: No fracture or malalignment in the 
lumbar spine. Intact appearance of the bony pelvis 

Non-Contrast Head CT: There is no evidence of acute hemorrhage, 
edema, mass, mass effect, or acute territorial infarction.  The 
ventricles and sulci are mildly prominent consistent with 
age-related atrophy.  There are mild periventricular and 
subcortical white matter hypodensities consistent with the 
sequela of chronic small vessel ischemic disease.  The 
visualized paranasal sinuses and mastoid air cells are well 
aerated.  No fracture. IMPRESSION: No acute intracranial process 


EKG: sinus, NA/NI, no acute ischemia 
===========================================

 
Brief Hospital Course:
___ with h/o psychosis admitted because of multiple falls, also 
vague complaints of abdominal discomfort and burning with 
urination.  

# S/P Mechanical Fall: Patient is poor historian and reports 
being pushed. Collateral info from group home, supports 
behavioral changes and mechanical fall. Story surrounding fall 
not consistent with syncope. Furthermore trops negative x2, EKG 
without changes. Telemetry monitoring without events.  No 
episodes of fall while inpatient.  He was able to walk with ___ 
with use of a cane. ___ recommended further therapy in his group 
home. 

# Psychosis: Per collateral info, prior to admission he was more 
lethargic than usual.  There was question of medication 
compliance as he administers his own meds independently.  He was 
continued on his home medications (CLozapine) and was 
interactive and appropriate during his admission.  Mental status 
returned to baseline (per collateral information).
  
#Dysuria: On presentation, he gave an inconsistent history of 
discomfort with urination. UA not convincing of UTI and urine 
culture only with genital flora contamination.  He was not 
treated with antibiotics.  No longer complained of pain with 
urination.  
 
CHRONIC ISSUES:  
# Diabetes:  He is typically on metformin and Lantus 70 units 
qam. He was started on Lantus 50 units qam and titrated up only 
to Lantus 55units daily with good effect.  He was discharged 
home on 55units qam to prevent possibility of hypoglycemia.  He 
was also restarted on metformin.   

#COPD: stable, he continued his home meds (fluticasone and 
tiotropium inhaler)  
  
# He was continued on the following home meds: 
-ranitidine 150mg BID  
-Aspirin 81mg po daily  
-Lisinopril 5mg po daily  
-Gemfibrozil 600 mg PO BID  
 
TRANSITIONAL ISSUES:
-He was discharged back home to the ___ Home
-Full Code
-___ for ___ 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Docusate Sodium 100 mg PO BID 
2. Clozapine 200 mg PO BID 
3. Clozapine 75 mg PO HS 
in addition to 200mg BID 
4. Ranitidine 150 mg PO BID 
5. MetFORMIN (Glucophage) 1000 mg PO BID 
6. Aspirin 81 mg PO DAILY 
7. Lisinopril 5 mg PO DAILY 
hold for SBP < 100 
8. Gemfibrozil 600 mg PO BID 
9. Acetaminophen 650 mg PO Q6H:PRN pain 
10. Fluticasone Propionate 110mcg 2 PUFF IH BID 
11. Tiotropium Bromide 1 CAP IH DAILY 
12. Glargine 70 Units Breakfast

 
Discharge Medications:
1. Acetaminophen 650 mg PO Q6H:PRN pain 
2. Aspirin 81 mg PO DAILY 
3. Clozapine 200 mg PO BID 
4. Clozapine 75 mg PO HS 
in addition to 200mg BID 
5. Docusate Sodium 100 mg PO BID 
6. Fluticasone Propionate 110mcg 2 PUFF IH BID 
7. Gemfibrozil 600 mg PO BID 
8. Glargine 55 Units Breakfast
Insulin SC Sliding Scale using HUM Insulin
9. Lisinopril 5 mg PO DAILY 
hold for SBP < 100 
10. Ranitidine 150 mg PO BID 
11. Tiotropium Bromide 1 CAP IH DAILY 
12. MetFORMIN (Glucophage) 1000 mg PO BID 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary: mechanical fall
Secondary: 
psychosis, diabetes, COPD.

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr. ___,

It was our pleasure to care for you at ___.  You were admitted 
for a fall and question of confusion.  Your mental status 
improved during your hospitalization and you were treated with 
your home antipsychotic medications.  We had our physical 
therapists see you in the hospital and they determined that you 
would benefit from continued physical therapy assesment and care 
in your group home.  
 
Followup Instructions:
___
",MEDICINE
10004322-DS-22,Cory Goodman,10004322,22602599," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
WEAKNESS
 
Major Surgical or Invasive Procedure:
N/A
 
History of Present Illness:
___ is a ___ year-old M (poor historian) with a PMH of
psychosis, mechanical falls with negative syncope w/u in ___,
T2DM (last HbA1c unknown, on metformin and insulin), and COPD
(last FEV1 unknown), who presents with a 2-week history of
weakness and cough with sputum production. 

He was in his usual state of health until 2 weeks ago, when he
began to feel weak and short of breath. Of note, he has had
similar episodes in the past that last for several days and said
directly that ""this feels like pneumonia to me."" This was
associated with a frequent cough productive of yellow-green
sputum and anorexia with poor PO intake. He denies hemoptysis,
fevers, chills, and night sweats. He denies orthopnea and PND. 
He
denies nausea, vomiting, diarrhea, constipation, hematochezia,
melena, dysuria, and hematuria. Yesterday, he experienced
worsening lightheadedness and he had frequent episodes of
tripping. He denies falls, LOC, or head strike with these
episodes.   

This morning, he had an episode of chest pain that was
midsternal, sharp, and pleuritic without radiation into the arm
or neck or worsened SOB. Concurrently, he was too weak to rise
from his chair. Last FSG 138. Given his weakness and worsening
respiratory status, he presented to the ED. 

___ ED
--------
+ Initial Vitals:  
 97.5 91 126/81 17 100% RA 

+ Exam was notable for: 
 Dry MM, R tonsillar fullness. No focality to pulmonary exam. 
 
+ Labs were significant for:
 BUN 33, Cr 1.5, AGAP 21
 WBC 13, Hgb 12.4, Plt 341
 Trop <0.01

+ Imaging:
- CT head showed no acute process.
- CXR showed streaky posteroinferior left lobe opacity may
reflect atelectasis, though infection cannot be entirely
excluded.
- EKG showed NSR, rate 90.

+ Interventions: 1L IVF, azithromycin 500mg IV x1, CTX 1g x1.

+ Vitals Prior to Transfer: 
 97.9 84 132/78 17 99% RA 

Currently, he continues to have a cough with intermittent sputum
production. His appetite has returned and he was eating dinner 
at
the time of the exam. He denies any other complaints. 
  
 
Past Medical History:
1. Paranoid schizophrenia, well-controlled on Clozaril  
- Previous auditory and visual hallucinations, none ""for awhile""
per patient
2. Mechanical falls with negative syncope workup (___)
3. T2DM (last HbA1c 7.1 in ___
4. COPD (last FEV1 unknown)
 
 
Social History:
___
Family History:
Unknown to patient. 
 
Physical Exam:
ADMISSION PHYSICAL EXAM
VS:  T 97.7 BP 137/80 HR 98 RR 20 SaO2 100% RA Wt 78.88kg 
GEN: Man appearing older than stated age, alert, lying in bed
watching TV, no acute distress.   
HEENT: Dry MM, anicteric sclerae, no conjunctival pallor. +R
tonsillar fullness.  
NECK: Supple without LAD. 
PULM: Globally decreased breath sounds with intermittent
expiratory wheeze, no rhonchi or rales, symmetric air movement,
no increased work of breathing. 
COR: RRR (+)S1/S2 no m/r/g  
ABD: Soft, non-tender, non-distended, +bowel sounds. 
EXTREM: Warm, well-perfused, no edema. +2 ___ pulses. 
NEURO: A&Ox3. CN II-XII grossly intact, motor function grossly
normal. Diminished sensation in bilateral distal ___ (although
difficult to pinpoint given intermittent compliance with the
exam).  

DISCHARGE PHYSICAL EXAM
VS: 97.2 141/86 83 18 97 RA   
Orthostatics ___:
 154/77 82 (lying)
 143/78 90 (sitting)
 120/86 97 (standing) 
GEN: Elderly gentleman lying in bed, arousable but falls asleep 
quickly, NAD.
HEENT: Chapped lips, anicteric sclerae. Multiple missing teeth 
of front lower jaw.
NECK: Supple without LAD. 
PULM: Breath sounds clearer than ___ bilaterally but general 
poor air movement decreased, intermittent expiratory wheeze, no 
increased work of breathing. No egophony. 
COR: RRR (+)S1/S2 no m/r/g, heart sounds distant.   
ABD: Soft, non-tender, non-distended, +bowel sounds. 
EXTREM: Warm, well-perfused, no edema. +2 ___ pulses. 
No e/o diabetic foot ulcers.
NEURO: Refused to answer orientation Qs this AM. Gait deferred.
 
Pertinent Results:
ADMISSION LABS
------------------

___ 12:30PM BLOOD WBC-13.0* RBC-4.26* Hgb-12.4* Hct-36.5* 
MCV-86 MCH-29.1 MCHC-34.0 RDW-13.8 RDWSD-42.5 Plt ___
___ 12:30PM BLOOD Neuts-77.3* Lymphs-16.1* Monos-5.3 
Eos-0.5* Baso-0.2 Im ___ AbsNeut-10.01* AbsLymp-2.08 
AbsMono-0.69 AbsEos-0.06 AbsBaso-0.03
___ 12:30PM BLOOD Glucose-139* UreaN-33* Creat-1.5* Na-136 
K-4.2 Cl-97 HCO3-22 AnGap-21*

OTHER LABS
------------------
___ 06:55AM BLOOD Cortsol-13.0
___ 06:33AM BLOOD Triglyc-379* HDL-25 CHOL/HD-8.8 
LDLcalc-120
___ 07:25AM BLOOD WBC-7.2 RBC-3.77* Hgb-10.9* Hct-32.7* 
MCV-87 MCH-28.9 MCHC-33.3 RDW-13.9 RDWSD-43.2 Plt ___
___ 06:33AM BLOOD %HbA1c-7.1* eAG-157*
___ 06:33AM BLOOD Triglyc-379* HDL-25 CHOL/HD-8.8 
LDLcalc-120
___ 06:33AM BLOOD HBsAg-Negative HBsAb-Negative IgM 
HBc-Negative
___ 06:33AM BLOOD HIV Ab-Negative
___ 06:33AM BLOOD HCV Ab-Negative
___ 10:07AM BLOOD ___ pO2-195* pCO2-33* pH-7.43 
calTCO2-23 Base XS-0
___ 12:30PM BLOOD cTropnT-<0.01

DISCHARGE LABS
___ 06:13AM BLOOD WBC-9.3 RBC-4.19* Hgb-11.9* Hct-36.5* 
MCV-87 MCH-28.4 MCHC-32.6 RDW-13.7 RDWSD-43.2 Plt ___
___ 06:13AM BLOOD Glucose-114* UreaN-16 Creat-1.1 Na-137 
K-4.3 Cl-99 HCO3-21* AnGap-21*

IMAGING
---------
+ CXR (___)
Streaky left lobe opacity may reflect atelectasis, though
infection cannot be entirely excluded. 

+ CT Head (___)
No acute intracranial abnormalities.  Specifically, no evidence
of intra-axial or extra-axial hemorrhage. 

+ EKG (___)
 NSR, rate 90

 
Brief Hospital Course:
___ is a ___ year-old M (poor historian) with a PMH of 
psychosis, mechanical falls with negative syncope w/u in ___, 
T2DM (last HbA1c 7.1 in ___, on metformin and insulin), and 
COPD (last FEV1 unknown), who presents with a 2-week history of 
weakness and cough with sputum production concerning for CAP as 
well as orthostatic hypotension. 

# Cough: Likely CAP given leukocytosis (13k), malaise, sputum 
production, and LLL infiltrate on CXR. Never met SIRS criteria 
during hospitalization. He always saturated well on RA with no 
evidence of increased work of breathing. SputumCx indeterminate, 
urine legionella negative. He received a 5-day course of 
antibiotics with ceftriaxone/azithromycin (___). On 
discharge, he was feeling significantly better with no 
complaints of cough. 

# Dizziness/Weakness: The patient presented with orthostatic 
hypotension thought secondary hypovolemia in the setting of poor 
PO intake, given positive orthostatics and BUN/Cr > 20:1 
suggestive of dehydration. Patient relies on cane at home. ECG 
NSR, trops neg. CT Head with no acute process. Electrolytes WNL. 
Despite brisk fluid resuscitation and now likely euvolemic 
status, orthostatics remain positive and he has a persistent 
unsteady gait. Underlying etiology unclear, possibly autonomic 
dysfunction ___ DM versus medication (on clozapine). Per 
outpatient psychiatrist Dr. ___ has been on the same dose 
of clozapine for ___ years. Adrenal insufficiency unlikely as 
___ AM cortisol level 13.0. ___ evaluated him on ___ and 
recommended rehab. On discharge, his orthostatic vital signs 
remained positive and he continued to require assistance with 
walking. He was initiated on fludrocortisone 0.1mg QD on ___ 
with some symptom relief. 

# ___: Likely due to hypovolemia in the setting of poor PO 
intake given BUN/Cr > 20:1. Last baseline 0.95 in ___. We 
gave him IVF as above with resolution of his ___ to Cr 0.9. On 
discharge, his BUN/Cr were ___.

# Prior IVDU: Patient reports prior history of heroin use and 
""other drugs."" He gave consent for HIV testing. HIV, HepB, HepC 
were all negative. 

CHRONIC ISSUES: 
===============
# Psychosis: Continued clozapine. 
# Diabetes: RISS, held home metformin. Repeat HbA1c 7.2. FSGs 
120s-180s here. No evidence of diabetic foot ulcers. 
# COPD: Continued home fluticasone and tiotropium inhaler. 
# GERD: Continued home ranitidine. 
# CAD: Continued home ASA. 
# HTN: Held home lisinopril given orthostatic hypotension. 
# HL: Continued home gemfibrozil. Total Chol 221 Triglycerides 
379* elevated. HDL low at 25. Chol/HD 8.8, LDL calc 120. 

TRANSITIONAL ISSUES
=================== 
# Fludrocortisone: The patient was initiated on Fluricil on ___ 
at 0.1mg daily. This can be uptitrated at a rate of 0.1mg per 
week to a maximum of 0.3mg daily. 

# Transthoracic echo: The patient was scheduled for an 
outpatient echo. ECHO office will call patient to make 
appointment. He should follow up with a cardiologist to review 
the results.

# Nutrition: The patient arrived with evidence of dehydration. 
Please ensure that he is reminded to drink water and other 
fluids throughout the day, especially if he is feeling ill. 

# Former IVDU: HIV, HepC, HepB found to be negative on this 
admission. No evidence of active IVDU.

# ? Diabetic neuropathy: The patient intermittently reported 
reduced sensation and proprioception in bilateral distal 
extremities. His HbA1c was 7.2 on admission, which is mildly 
elevated. His orthostatic hypotension may also be an effect of 
autonomic neuropathy. His primary care physician should 
reevaluate this at their next appointment. 

# Orthostatic hypotension: He will be scheduled for an 
outpatient follow-up appointment with neurology to evaluate for 
potential causes of autonomic neuropathy. If negative, his 
psychiatrist should consider redosing of his clozapine to 
minimize potential side effects. His primary care physician 
should continue to work closely with him to ensure his diabetes 
mellitus is being treated adequately. 

# Blood cultures: Negative since ___, final result pending at 
discharge. If any growth observed, the patient will be notified. 


# Lipid panel: Total Chol 221 Triglycerides 379* elevated. HDL 
low at 25. Chol/HD 8.8, LDL calc 120. He should have a repeat 
lipid panel performed with his primary care physician and 
consider alternative agents/dosing to better manage his low HDL 
and high triglycerides.

===========================
# CODE STATUS: Full (unconfirmed) 
# CONTACT: ___ ___ or ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN pain 
2. Aspirin 81 mg PO DAILY 
3. Clozapine 200 mg PO BID 
4. Clozapine 75 mg PO HS 
5. Docusate Sodium 100 mg PO BID 
6. Fluticasone Propionate 110mcg 2 PUFF IH BID 
7. Gemfibrozil 600 mg PO BID 
8. Lisinopril 5 mg PO DAILY 
9. Ranitidine 150 mg PO BID 
10. Tiotropium Bromide 1 CAP IH DAILY 
11. MetFORMIN (Glucophage) 1000 mg PO BID 
12. Detemir 32 Units Breakfast
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN pain 
2. Aspirin 81 mg PO DAILY 
3. Clozapine 200 mg PO BID 
4. Clozapine 75 mg PO HS 
5. Docusate Sodium 100 mg PO BID 
6. Fluticasone Propionate 110mcg 2 PUFF IH BID 
7. Gemfibrozil 600 mg PO BID 
8. Lisinopril 5 mg PO DAILY 
9. Ranitidine 150 mg PO BID 
10. Tiotropium Bromide 1 CAP IH DAILY 
11. MetFORMIN (Glucophage) 1000 mg PO BID 
12. Detemir 32 Units Breakfast

 
Discharge Medications:
1.  Fludrocortisone Acetate 0.1 mg PO DAILY hypotension  
2.  Acetaminophen 650 mg PO Q6H:PRN pain  
3.  Aspirin 81 mg PO DAILY  
4.  Clozapine 200 mg PO BID  
5.  Clozapine 75 mg PO HS  
6.  Docusate Sodium 100 mg PO BID  
7.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
8.  Gemfibrozil 600 mg PO BID  
9.  Detemir 32 Units Breakfast 
10.  MetFORMIN (Glucophage) 1000 mg PO BID  
11.  Ranitidine 150 mg PO BID  
12.  Tiotropium Bromide 1 CAP IH DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES:
COMMUNITY-ACQUIRED PNEUMONIA 
DEHYDRATION 
ACUTE KIDNEY INJURY 
ORTHOSTATIC HYPOTENSION 

SECONDARY DIAGNOSES:
TYPE II DIABETES MELLITUS
HYPERTENSION
HYPERLIPIDEMIA
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
PARANOID SCHIZOPHRENIA 
CORONARY ARTERY DISEASE 
GASTROESOPHAGEAL REFLUX DISORDER 

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to the hospital for weakness and cough. We 
found that you had a pneumonia (infection of the lungs) and gave 
you antibiotics. We also found that you were very dehydrated and 
gave you IV fluids. Our physical therapists also evaluated you 
and decided you were strong enough to go home. 

You will need to continue your antibiotics until _____. It is 
very important not to stop your antibiotics early as this can 
lead to repeated or worse infections. 

Please make sure to drink enough water (at least 8 cups a day) 
and eat three meals a day. 

It was a pleasure taking care of you, and we hope you continue 
to feel better.

Sincerely,
Your Team at ___
 
Followup Instructions:
___
",MEDICINE
10004322-DS-23,Cory Goodman,10004322,20356134," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Altered Mental Status
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ is a ___ year old male with history of 
schizophrenia with most recent ED visit ___, COPD, DM, 
mechanical falls most recently in ___ and s/p negative 
syncope workup in ___, history of urinary retention s/p 
indwelling foley in ___, admission in ___ for sepsis 
from pneumonia, presenting with complaints of fever and altered 
mental status.

___ presented to the ED from his group home after reportedly 
being febrile yesterday. The group home care staff changed his 
foley yesterday and noted that he his mental status was altered 
this morning.

Seen in ___ on ___ by Dr. ___ 
for evaluation of need for chronic foley which was placed in 
late ___ after ___ presented to the ED after a fall and 
was found to be in ___ (prior to this, he had no problems 
voiding) and have obstructive uropathy. Noted to have a 
hypersensitive bladder with normal compliance, terminal detrusor 
overactivity, no obstruction, and was able to empty bladder 
completely despite over activity. The plan was to leave the 
foley catheter out and monitor PVRs ___ times daily with foley 
re-insertion if PVR>400-450cc and to continue tamsulosin.

In the ED, initial vital signs were: T99.1 HR112 BP91/58 RR16 
SaO2 95% on RA
- Exam notable for: lethargy, arousable only to pain, oriented 
x1
- Labs were notable for: 
1) Chem 10 -
134|94|28
---------<159
4.2|20|1.5
2) CBC - 27.3>10.5/32.5<376
Diff - 85.6%, 4.5%, Monos 8.7%
3) LFTs - ALP 167 (ALT 5, AST 14, Tbili 0.5, Alb 3.8)
4) U/A - hazy appearance with large leuks (WBC>182), small 
amount of blood (RBC>10), Few bacteria, Negative Nitrites, 30 
Proteins
5) FluAPCR and FluBPCR - negative
6) Lactate - 1.6
7) Blood cx - pnd
8) Urine cx - pnd
- Studies performed include:
1) CT C-spine w/o contrast: No acute fracture or malalignment of 
the cervical spine. 
2) NCHCT: No acute intracranial process
3) CXR: No acute cardiopulmonary process. No focal consolidation 
to suggest pneumonia. 
- Patient was given:
1) IV NS 
2) Ceftriaxone 2 gm
- Vitals on transfer: 
___, 99.2F, HR111(106-113), BP135/67 (91-135/55-67), RR25 
(___), SaO2 100% on RA

Upon arrival to the floor, the patient was somnolent but 
arousable, oriented to name only. History could not be completed 
as patient could not answer questions.   
 
REVIEW OF SYSTEMS:  
(+) per HPI  
(-) chills, night sweats, headache, vision changes, rhinorrhea, 
congestion, sore throat, cough, shortness of breath, chest pain, 
abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, 
melena, hematochezia, dysuria, hematuria.  
 
Past Medical History:
1. Paranoid schizophrenia, well-controlled on Clozaril  
- Previous auditory and visual hallucinations, none ""for awhile""
per patient
2. Mechanical falls with negative syncope workup (___)
3. T2DM (last HbA1c 7.1 in ___
4. COPD (last FEV1 unknown)
5. GERD/Reflux Esophagitis
6. CAD
7. HTN
8. Hyperlipidemia
 
Social History:
___
Family History:
Unknown to patient
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
VS: 98.9, 109bpm, BP129/66, RR18, SaO2 96% on RA
GENERAL: A&Ox1 (name only), somnolent, responsive to voice and 
gentle touch but quickly falls asleep, unable to answer 
questions comprehensibly
HEENT: Normocephalic, atraumatic.  Pupils equal (3mm), round, 
and unreactive bilaterally.  No conjunctival pallor or 
injection, sclera anicteric and without injection.  Moist mucous 
membranes, good dentition.  Oropharynx is clear.
NECK: Thyroid is normal in size and texture, no nodules.  No 
cervical lymphadenopathy.
CARDIAC: Regular rhythm, normal rate, no murmurs/rubs/gallops.  
No JVD.
LUNGS: Clear to auscultation bilaterally w/appropriate breath 
sounds appreciated in all fields.  No wheezes, rhonchi or rales. 

BACK: Skin. no spinous process tenderness. no CVA tenderness. 
ABDOMEN:  Normal bowels sounds, non distended, non-tender to 
deep palpation in all four quadrants though difficult to assess 
given patient's altered sensorium. Tympanic to percussion.  No 
organomegaly. well-healed mid-line incision measuring ___ inches
EXTREMITIES: No clubbing, cyanosis, or edema, no sign of 
atrophy/hypertrophy. Pulses DP/Radial 2+ bilaterally.
SKIN: No evidence of ulcers, rash or lesions suspicious for 
malignancy
NEUROLOGIC: could not complete due to lack of patient 
cooperation

DISCHARGE PHYSICAL EXAM:
========================
VS: 98.0PO, Tmax 98.1, 156/79 (149-156/79-87), 83 (71-85), 18, 
SaO2 95% on RA 
GENERAL: A&Ox2 (name and place), able to engage in conversation 
and keep eyes open
HEENT: Normocephalic, atraumatic.  Pupils equal (3mm), round, 
and unreactive bilaterally.  No conjunctival pallor or 
injection, sclera anicteric and without injection.  Moist mucous 
membranes, good dentition.  Oropharynx is clear.
NECK: Thyroid is normal in size and texture, no nodules.  No 
cervical lymphadenopathy.
CARDIAC: Regular rhythm, normal rate, no murmurs/rubs/gallops.  
No JVD.
LUNGS: Clear to auscultation bilaterally w/appropriate breath 
sounds appreciated in all fields.  No wheezes, rhonchi or rales. 

BACK: Skin. no spinous process tenderness. no CVA tenderness. 
ABDOMEN:  Normal bowels sounds, soft, non-tender/non-distended. 
Tympanic to percussion.  No organomegaly. well-healed mid-line 
incision measuring ___ inches
EXTREMITIES: No clubbing, cyanosis, or edema, no sign of 
atrophy/hypertrophy. Pulses DP/Radial 2+ bilaterally.
SKIN: No evidence of ulcers, rash or lesions suspicious for 
malignancy
NEUROLOGIC: could not complete due to lack of patient 
cooperation

 
Pertinent Results:
ADMISSION LABS:
===============
___ 12:54PM   PLT SMR-NORMAL PLT COUNT-376
___ 12:54PM   HYPOCHROM-NORMAL ANISOCYT-NORMAL 
POIKILOCY-OCCASIONAL MACROCYT-NORMAL MICROCYT-NORMAL 
POLYCHROM-NORMAL OVALOCYT-OCCASIONAL
___ 12:54PM   NEUTS-85.6* LYMPHS-4.5* MONOS-8.7 EOS-0.0* 
BASOS-0.2 IM ___ AbsNeut-23.37*# AbsLymp-1.23 AbsMono-2.36* 
AbsEos-0.00* AbsBaso-0.05
___ 12:54PM   WBC-27.3*# RBC-3.75* HGB-10.5* HCT-32.5* 
MCV-87 MCH-28.0 MCHC-32.3 RDW-14.2 RDWSD-44.6
___ 12:54PM   ALBUMIN-3.8
___ 12:54PM   ALT(SGPT)-5 AST(SGOT)-14 ALK PHOS-167* TOT 
BILI-0.5
___ 12:54PM   estGFR-Using this
___ 12:54PM   GLUCOSE-159* UREA N-28* CREAT-1.5* SODIUM-134 
POTASSIUM-4.2 CHLORIDE-94* TOTAL CO2-20* ANION GAP-24*
___ 01:19PM   LACTATE-1.6
___ 01:53PM OTHER BODY FLUID  FluAPCR-NEGATIVE 
FluBPCR-NEGATIVE
___ 03:00PM URINE  MUCOUS-RARE
___ 03:00PM URINE  HYALINE-4*
___ 03:00PM URINE  RBC-10* WBC->182* BACTERIA-FEW 
YEAST-NONE EPI-<1
___ 03:00PM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-30 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 
LEUK-LG
___ 03:00PM URINE  COLOR-Yellow APPEAR-Hazy SP ___
___ 03:00PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG 
oxycodn-NEG
___ 03:00PM URINE  UHOLD-HOLD
___ 03:00PM URINE  HOURS-RANDOM
___ 09:32PM   PLT COUNT-334
___ 09:32PM   WBC-19.8* RBC-3.39* HGB-9.4* HCT-29.7* MCV-88 
MCH-27.7 MCHC-31.6* RDW-14.5 RDWSD-46.8*
___ 09:32PM   GLUCOSE-123* UREA N-24* CREAT-1.2 SODIUM-139 
POTASSIUM-3.7 CHLORIDE-101 TOTAL CO2-21* ANION GAP-21*

DISCHARGE/PERTINENT LABS:
=========================
___ 07:05AM BLOOD WBC-8.9 RBC-3.32* Hgb-9.2* Hct-27.7* 
MCV-83 MCH-27.7 MCHC-33.2 RDW-13.9 RDWSD-42.4 Plt ___
___ 07:05AM BLOOD Glucose-118* UreaN-6 Creat-0.6 Na-140 
K-3.5 Cl-101 HCO3-24 AnGap-19
___ 07:00AM BLOOD ___ PTT-35.2 ___
___ 07:00AM BLOOD ALT-6 AST-14 LD(LDH)-176 AlkPhos-127 
TotBili-0.4
___ 07:05AM BLOOD Calcium-8.5 Phos-2.5* Mg-1.7

MICROBIOLOGY:
==============
___ 3:00 pm URINE

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      ESCHERICHIA COLI.    10,000-100,000 CFU/mL. 
         Fosfomycin Susceptibility testing requested by ___. ___ 
___
         (___) ON ___.  FOSFOMYCIN = 24MM = SUSCEPTIBLE. 
         FOSFOMYCIN sensitivity testing performed by ___ 
___. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMIKACIN--------------     8 S
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--  =>32 R
CEFAZOLIN-------------  =>64 R
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------  =>64 R
CIPROFLOXACIN---------   =>4 R
GENTAMICIN------------  =>16 R
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
TOBRAMYCIN------------  =>16 R
TRIMETHOPRIM/SULFA----  =>16 R

IMAGING:
========
___ Imaging ABDOMEN (SUPINE & ERECT)
Nonobstructive bowel gas pattern in the stomach, small bowel and 
colon.  No evidence of pneumoperitoneum. 

___ Imaging CHEST (SINGLE VIEW)
No acute cardiopulmonary process.  No focal consolidation to 
suggest 
pneumonia. 
      
___-SPINE W/O CONTRAST
No acute fracture or malalignment of the cervical spine.

___ Imaging CT HEAD W/O CONTRAST 
No acute intracranial process.
 
Brief Hospital Course:
Mr. ___ is a ___ man with history of paranoid 
schizophrenia, COPD, Type 2 DM, urinary retention s/p indwelling 
foley catheter placement in ___, who presented from his 
group home with report of 1 day of fever prior to admission and 
altered mental status on the day of presentation to the ED 
(___). 

# Altered mental status/catheter associated urinary tract 
infection:
Patient hemodynamically stable on admission, but drowsy and not 
oriented. Afebrile, but WBC count of 27. Urinalysis consistent 
with infection in the setting of indwelling foley catheter. Head 
and neck imaging without acute abnormalities. He was without 
headaches, photophobia, or neck stiffness to suggest 
meningoencephalitis. Patient initially started on ceftriaxone; 
however, urine culture revealed ESBL E. coli resistant to 
ceftriaxone. Patient switched to meropenem, which he received 
from ___ to ___. Patient was switched to fosfomycin (1 dose) 
on discharge to complete a full antibiotic course. Foley 
catheter was replaced.

# Acute kidney injury:
Patient also noted to have acute kidney injury with Cr 1.5, 
likely prerenal in etiology, that resolved with IV fluids. Cr on 
discharge 1.0.

# Paranoid schizophrenia:
Patient's clozapine was held on admission, given altered mental 
status. He was seen by the psychiatry service for assistance 
with management. Clozapine was resumed at the suggestion of 
psychiatry at 100mg PO QHS, with plan for outpatient uptitration 
by primary psychiatrist.

# Normocytic anemia: 
He was found to have Hgb of 8.8-10.5 as compared to most recent 
baseline of 11.8. He was without signs of overt bleeding. There 
was low suspicion for hemolysis in the setting of normal TBili 
and lack of schistocytes on manual smear.

# Abdominal pain:
He experienced transient abdominal pain with benign abdomen, 
possibly related to urinary tract infection, though not 
specifically suprapubic. KUB was without signs of obstruction or 
perforation. Abdominal pain resolved prior to discharge.

# T2DM
He received long-acting insulin with sliding scale as needed. 
Home metformin was held throughout admission and resumed at 
discharge.

# COPD
Home fluticasone and tiotropium inhaler were held throughout 
admission and resumed at discharge.

# GERD/Reflux esophagitis
He received omeprazole in place of home ranitidine in the 
inpatient setting.

# CAD
Home ASA was continued.

# Hyperlipidemia
Home gemfibrozil was held throughout admission and resumed at 
discharge.

# Orthostatic hypotension 
Home fludrocortisone was continued.

TRANSITIONAL ISSUES:
====================
# Patient's clozapine was stopped on admission and restarted at 
100mg PO QHS by recommendation from psychiatry. Patient should 
follow up with outpatient psychiatrist for uptitration.
# Patient was found to have anemia with Hgb of 9.2. He should 
have a follow-up CBC with differential within 1 week and should 
be worked-up for iron-deficiency or other causes anemia if not 
improved; downtrending monocyte count, likely elevated on 
admission in the setting of infection, also should be ensured.
# Follow-up of coagulation studies to ensure downtrending INR 
(elevated to 1.4 on this admission likely in the setting of 
infection and poor PO intake, without overt signs of DIC) also 
advised.
# Patient found to have 10 RBC on urinalysis on this admission, 
likely in the setting of urinary tract infection; please assess 
for resolution of hematuria following resolution of urinary 
tract infection, though may be confounded if ongoing foley 
catheter needed.
# Patient should follow up with urology for foley catheter care 
and to assess whether ongoing foley catheter is needed. 
Appointment was made for ___.

# CODE: Full
# CONTACT: ___ (___) 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Fludrocortisone Acetate 0.1 mg PO DAILY hypotension 
2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
3. Aspirin 81 mg PO DAILY 
4. Clozapine 200 mg PO BID 
5. Clozapine 75 mg PO QHS 
6. Docusate Sodium 100 mg PO BID 
7. Fluticasone Propionate 110mcg 2 PUFF IH BID 
8. Gemfibrozil 600 mg PO BID 
9. Levemir (insulin detemir) 32 units  subcutaneous BREAKFAST 
10. MetFORMIN (Glucophage) 1000 mg PO BID 
11. Ranitidine 150 mg PO BID 
12. Tiotropium Bromide 1 CAP IH DAILY 

 
Discharge Medications:
1.  Clozapine 100 mg PO QHS  
2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
3.  Aspirin 81 mg PO DAILY  
4.  Docusate Sodium 100 mg PO BID  
5.  Fludrocortisone Acetate 0.1 mg PO DAILY hypotension  
6.  Fluticasone Propionate 110mcg 2 PUFF IH BID  
7.  Gemfibrozil 600 mg PO BID  
8.  Levemir (insulin detemir) 32 units  subcutaneous BREAKFAST  
9.  MetFORMIN (Glucophage) 1000 mg PO BID  
10.  Ranitidine 150 mg PO BID  
11.  Tiotropium Bromide 1 CAP IH DAILY  
12. HELD- Clozapine 200 mg PO BID  This medication was held. Do 
not restart Clozapine until until you see your psychiatrist

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES:
==================
Toxic Metabolic Encephalopathy
Catheter-associated UTI
Acute Kidney Injury

SECONDARY DIAGNOSES:
====================
Paranoid Schizophrenia
Type 2 Diabetes
COPD

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you. You were admitted to the 
___ because you were confused 
and had a fever. You were found to have a urinary tract 
infection and you were started on IV antibiotics and your mental 
status improved significantly. Your Clozaril was also stopped 
and restarted at a lower dose because of your confusion.

You should follow-up with your PCP and outpatient psychiatrist 
within ___ weeks of discharge.

Wishing you a speedy recovery,
___ Care Team
 
Followup Instructions:
___
",MEDICINE
10004401-DS-22,William Armstrong,10004401,21085166," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol
 
Attending: ___.
 
Chief Complaint:
___
 
Major Surgical or Invasive Procedure:
Esophagogastroduodenoscopy

 
History of Present Illness:
This is an ___ year old man with past medical history significant 
for CAD s/p bare metal stents x2 in ___, systolic dysfunction 
(EF 35%), chronic atrial fibrillation on warfarin, VF arrest 
status pos pacemaker and ICD placement, and rectal cancer s/p 
resection who presented with melena.  Ten days prior to 
presentation, he began to notice that the stools in his ostomy 
bag were dark. The color was not frankly black, but darker than 
usual. He denied nausea, vomiting, hematemesis, pain after 
meals, epigastric pain, abdominal pain, constipation, or 
diarrhea.  He did aknowledge chronic dysphagia that had been 
persistent for many years.  He also denied syncope, 
lightheadedness, shortness of breath, and chest pain.  On the 
day of admission, he presented to his PCP's office with the 
complaint of black stools, and those stools were found to be 
grossly guaiac positive. Hence, he was admitted for further 
work-up.  Of note, the patient had a colonoscopy approximately 
eight days prior to presentation for follow-up of his colon 
cancer.  This study was essentially normal.  
  
On the presentation to the ED the patient continued to deny 
complaints and was hemodynamically stable. He received 
pantoprazole 40 mg IV and had IV access established with two 
large bore IV's.  He was then admitted to the floor.   
  
<b><u>Review of Systems:</b></U>
He claims a ___ weight loss over the last week, but denies 
watery stools or increased urine output.  He has mild dyspnea on 
exertion that has increased over the last month. He denies chest 
pain, SOB, diaphresis, night sweats, fevers, chills. 

 
Past Medical History:
-CAD s/p bare metal stent x2 in ___  
-Hypertension  
-Systolic dysfunction (EF 35%)  
-Dual chamber pacemaker 
-h/o VF s/p ICD for secondary prevention  
-Chronic atrial fibrillation  
-Rectal cancer s/p neoadjuvant chemotherapy, resection and 
adjuvant chemotherapy for positive LNs found at surgery  
-BPH  
-h/o stroke in ___ with residual R hand dysthesia  
-Cervical spondylosis  
-Sleep apnea on CPAP  

 
Social History:
___
Family History:
Father died of an MI in his ___, Mother died of a PE in her ___, 
twin sister died of colitis age ___, no family h/o colon, 
breast, uterine, or ovarian CA  

 
Physical Exam:
On presentation:
VS: Tc:97.3 Tm:98.8 BP:122-138/64-72 ___ RR:20 95%RA  
Gen: NAD
HEENT: PERRL, EOMI, OP clear, dry mucous membranes, no apparent 
JVD  
Cor: distant heart sounds, RRR, nl S1S2, no murmurs, rubs, 
gallops  
Pulm: CTAB anteriorly and posteriorly
Abd: well-healed abdominal scars, no erythema or irritation by 
ostomy site, no ostomy output, normoactive BS, NT, ND, No HSM
Ext: chronic venous stasis changes, no edema, warm 

On discharge vital signs were T 99.4, BP 120/70, HR 69, RR 20, 
96% on RA.  Exam not notably changed from presentation and was 
basically benign.
 
Pertinent Results:
<b><u>LABORATORY RESULTS</B></U>
On Presentation:
WBC-4.3 RBC-2.94*# Hgb-8.4*# Hct-26.1*# MCV-89 Plt ___
----Neuts-68.1 Lymphs-16.9* Monos-12.9* Eos-1.6 Baso-0.3
___ PTT-31.0 ___
Glucose-161* UreaN-26* Creat-1.4* Na-138 K-4.0 Cl-101 HCO3-27 

On discharge:
WBC-3.0* RBC-2.83* Hgb-8.1* Hct-25.2* MCV-89 Plt ___ PTT-31.0 ___
Glucose-103 UreaN-13 Creat-1.0 Na-137 K-4.3 Cl-108 HCO3-21* 
AnGap-12

Other Results:
Hct Trend:
26.1-23.3-23.5-25.7-25.5-25.5-28.9-25.2

<B><U>OTHER STUDIES</B></U>
EGD ___:
Impression: Erythema and erosion in the stomach body compatible 
with erosive gastritis
Erythema in the first part of the duodenum compatible with mild 
duodenitis
Polyp in the fundus
Otherwise normal EGD to third part of the duodenum
 
Brief Hospital Course:
___ yo man with chronic atrial fibrillation on coumadin, CAD s/p 
stents on plavix and aspirin, and history of rectal cancer s/p 
resection and ostomy reconstruction, presents with anemia and 
dark stools.  
 
1) Anemia/GI bleed: On presentation the patient was anemic with 
melena, but he was hemodynamically stable and relatively 
asymptomatic.  Hematocrit on presentation was 26.1 so he was not 
immediately transfused, but he did have large bore IV's inserted 
and received fluid boluses.  He was also started on BID PPI 
therapy and his anticoagulants (aspirin, clopidogrel, and 
warfarin) were held.  His second hematocrit had dropped to 23.3, 
but as there was not a great deal of stool or blood in his 
ostomy bag this was presumed to be more consistent with dilution 
than continued brisk bleeding.  Still, at that time transfusion 
was offered, but the patient was quite reluctant and as he 
continued to be hemodynamically stable and asymptomatic 
transfusion was held.  As the day progressed hematocrit rose 
back to 25 and remained stable throughout the rest of his 
hospitalization.  Gastroenterology was consulted on the day 
after presentation and planned to take the patient for EGD after 
allowing the INR to fall for a day.  Unfortunately, the INR 
remained elevated, but at that point gastroenterology elected to 
proceed with EGD with a plan not to do any interventions unless 
their was overt, active bleeding.  On EGD the patient had 
gastritis and duodenitis but no ulcers or obvious other sources 
of bleeding.  ___, no intervention was performed and the patient 
was discharged on BID PPI and with a reduced anticoagulant 
regimen to follow up in GI clinic.  Stools at discharge were 
non-melenic.  Hematocrit was greater than 25.    

2) CAD s/p BMS ___: The patient has history of coronary artery 
disease and had bare metal stents placed in ___.  
Nevertheless, he never had chest pain or other signs of active 
ischemia.  His aspirin and clopidogrel were held on presentation 
due to concern for active bleeding.  At discharge he was 
restarted on warfarin and aspirin but as it was greater than one 
year out from his stent placement it was considered safe to hold 
clopidogrel at discharge in order to decrease the number of 
anticoagulants the patient was taking.  The patient's 
cardiologist, Dr ___, was made aware of this decision and 
thought it was reasonable.  

3)Systolic Heart Failure: The patient has an EF of 35% by 
previous echocardiograms but never showed signs of acute volume 
overload or evidenced dyspnea in the hospital.  Initially, his 
aspirin, beta blocker, ACE inhibitor, and diuretic were held in 
the context of potentially active bleeding and concern about 
hemodynamic stability.  These were all restarted prior to 
discharge.  

4)HTN: The patient has a history of hypertension but was never 
frankly hypertensive in the hospital.  His anti-hypertensives 
were initially held in the hospital and then restarted as 
described in the previous problem point.  

5)Chronic atrial fibrillation: The patient is on metoprolol for 
rate control and warfarin for stroke prevention.  His rate 
remained relatively well controlled even when metoprolol was 
being held. His warfarin was held on presentation but restarted 
after his procedure.  His INR never became subtherapeutic.  He 
will follow up with his PCP for further INR monitoring. 

As the patient was systemically anticoagulated no further DVT 
prophylaxis was given.  He was on BID PPI for GI bleed.  He 
tolerated a full diet prior to discharge.  He was full code. 

 
Medications on Admission:
Clopidogrel 75 daily  
Aspirin 325 daily  
Warfarin (goal INR ___  
Furosemide 40 daily  
Lisinopril 5 daily  
Metoprolol succinate 25 daily  
Amitryptiline  

 
Discharge Medications:
1. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

2. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  
3. Furosemide 20 mg Tablet Sig: One (1) Tablet PO QPM.  
4. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO twice a day for 4 weeks: 
Please take until you see Dr. ___.
Disp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*0*
5. Amitriptyline 25 mg Tablet Sig: Two (2) Tablet PO HS (at 
bedtime).  
6. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) 
Tablet, Delayed Release (E.C.) PO once a day.  
7. Warfarin 2 mg Tablet Sig: One (1) Tablet PO twice a week 
___ and ___: Please restart warfarin on previous dosage 
schedule.  .  
8. Outpatient Lab Work
INR check on ___.  
9. Warfarin 2 mg Tablet Sig: Two (2) Tablet PO 5X/week 
(TWThSaSu): Resume warfarin on preivous schedule.  
10. Furosemide 40 mg Tablet Sig: One (1) Tablet PO QAM.  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
--------------------
Acute blood loss anemia
Gastritis with bleeding in setting of multiple anti-coagulants
.
Secondary Diagnoses:
--------------------
Coronary Artery Disease
Chronic Systolic Heart Failure
Hypertension

 
Discharge Condition:
Good, tolerating PO's, with asymptomatic anemia and Hct stable 
>24 hours.  

 
Discharge Instructions:
You were admitted to the hospital because you were bleeding into 
your gastrointestinal tract so that blood was showing up in your 
colostomy bag.  The GI specialists passed a camera into your 
stomach (endoscopy) and saw some irritation of the lining of 
your stomach called gastritis.  We will medically manage this by 
giving you the acid blocking medicine (proton pump inhibitor) 
and by decreasing the number of medications you are on that 
encourage bleeding.  You will follow up in the GI clinic as 
well.  As your blood counts were stable we are now discharging 
you to complete your recovery at home.  

Your medications have been changed.  Your CLOPIDOGREL (PLAVIX) 
has been stopped; this was discussed with your cardiologist who 
agreed;  as you are now far enough out from your stent placement 
that this medication is not necessary.  
You have also been started on the proton pump inhibitor for 
blocking stomach acid.  This medication is called PANTOPRAZOLE 
(PROTONIX).  Please continue to take all other medications as 
prescribed.  We recommend you avoid alcohol for the next few 
weeks as your stomach lining heals.  

Please keep all scheduled follow-up appointments as these are 
important to help manage your health.  You will also need to 
have your INR rechecked next week as you were off this 
medication in the hospital and your dose will need to be 
re-titrated.  

Please call your doctor or go to the Emergency Room if you have 
fever>101, chest pain, shortness of breath, further black or red 
material in your ostomy bag, intractable nausea/vomiting, 
lightheadedness, fainting, or other concerning changes to your 
health.

Regarding your heart failure, you should weigh yourself every 
morning and contact your doctor if your weight changes > 3 lbs 
over the course of 24 hours.  Please limit your salt intake to 2 
gms/day.  
 
Followup Instructions:
___
",MEDICINE
10004401-DS-23,William Armstrong,10004401,25753439," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol
 
Attending: ___.
 
Chief Complaint:
Hand cramping.
 
Major Surgical or Invasive Procedure:
EGD

 
History of Present Illness:
___ yo man with ischemic cardiomyopathy, HTN, A fib on coumadin, 
h/o gastritis who was admitted for anemia and guaiac positive 
stools.  Of note, his PMD in early ___ had noted worsening 
anemia and had stopped ASA and coumadin x 1 week and started 
omeprazole. Also for evaluation of this bili was checked and 
mildly elevated at 2.3, direct 0.9, hapto 111.  His hct remained 
stable with negative stool guaiacs at that time so asa and 
coumadin were restarted.  Of note, has also gone to his 
cardiologist who started torsemide (dose reduced 1 week ago).  
The pt initially presented to the ED with muscle spasms, cramps 
bilateral hands and lower extremities for the past week, worse 
at night but bothersome to the point that he has had difficulty 
driving due to pain. He states the pain is relieved by running 
it under warm water. He did not take pain meds for the pain and 
has never had anything like this before. He did not take the 
torsemide today, and has no muscle cramps today (currently pain 
free). He notes melena for the past few days at home, which is 
unusual, but no bright red blood in ostomy output, he denies 
abdominal pain, nausea, vomitting, constipation, diarrhea, cp, 
sob, palpitations, sob, cough, fevers, chills, dysuria, 
hematuria. He notes ___ edema for the past ___ weeks despite 
stable wieght (168) and bleeding from cracks in dry skin on his 
hands. 

In the ED: VS: 99.1 71 110/43 16 99% on RA.

ROS: 10 point review of systems negative except as noted above.
 
Past Medical History:
-CAD s/p bare metal stent x2 in ___
-Hypertension  
-Ischemic cardiomyopathy Systolic dysfunction (EF 35%-40% ___  

-Dual chamber pacemaker 
-h/o VF s/p ICD for secondary prevention  
-Chronic atrial fibrillation  
-Rectal cancer s/p neoadjuvant chemotherapy, resection and 
adjuvant chemotherapy for positive LNs found at surgery  
-BPH  
-h/o stroke in ___ with residual R hand dysthesia  
-Cervical spondylosis  
-Sleep apnea, only uses CPAP intermittently  
-h/o gastritis ___ year ago
-insomnia, has been using chamomile tea and melatonin with 
minimal relief
 
Social History:
___
Family History:
Father died of an MI in his ___, Mother died of a PE in her ___, 
twin sister died of colitis age ___, no family h/o colon, 
breast, uterine, or ovarian CA  

 
Physical Exam:
VS: T 96.6 HR 72 BP 110/59 RR 19 Sat 100% RA
Gen: Well appearing elderly man in NAD
Eye: extra-occular movements intact, pupils equal round, 
reactive to light, sclera anicteric, not injected, no exudates
ENT: mucus membranes moist, no ulcerations or exudates
Neck: no thyromegally, JVD: 7cm
Cardiovascular: regular rate and rhythm, normal s1, s2, III/VI 
HSM at apex, no rubs or gallops
Respiratory: Clear to auscultation bilaterally, no wheezes, 
rales or rhonchi
Abd: Soft, non tender, non distended, no heptosplenomegally, 
bowel sounds present, ostomy bag in place, draining dark stool
Extremities: 2+ PE to mid calf bilaterally, no cyanosis, 
clubbing, joint swelling
Neurological: Alert and oriented x3, CN II-XII intact, normal 
attention, sensation normal, speech fluent
Integument: Dry skin on hands with scattered fissurees, 
otherwise warm, moist, no rash or ulceration  
Psychiatric: appropriate, pleasant, not anxious
Hematologic: no cervical or supraclavicular LAD
 
Pertinent Results:
CBC: 4.4 > 8.5/27.9 < 215 (baseline hct ___
Chem: 133 | 99 | 34 < 139
      5.4 | 24 | 1.5
Ca 9.1, Mg 2.5, Phos 3.5
INR 1.8
PTT 35
BNP 2825
ALT 35 AST 64 LD 352 ALK PHOS 121 TOT BILI 1.3 DIR BILI 0.6 
INDIR BIL 0.7

ECG: V paced (69), no acute st-t changes, unchanged from prior.

CT Chest/Abd: ___
1. Stable appearance of the liver, with a stable small enhancing 
focus in the left lobe, which may reflect a hemangioma, but is 
incompletely characterized.  No new lesion identified. 
2. Status post abdominoperineal resection of the rectum, with 
end-colostomy in the left lower quadrant, without evidence of 
recurrent disease. 
3. Stable perastomal hernia containing loops of small bowel 
without obstruction. 
4. Cholelithiasis. 

EGD ___: Erythema and erosion in the stomach body 
compatible with erosive gastritis. Erythema in the first part of 
the duodenum compatible with mild duodenitis. Polyp in the 
fundus. Otherwise normal EGD to third part of the duodenum.
 
Brief Hospital Course:
___ with h/o CHF p/w GI bleeding.   
.
Primary Diagnosis: 285.1 ANEMIA, ACUTE BLOOD LOSS  
Secondary Diagnosis: 578.9 BLEEDING, GASTROINTESTINAL NOS  
EGD demonstrated Angioectasia in the Distal duodenal bulb and 
stomach body with no active bleeding, but signs of recent 
bleeding.  ASA was held and INR was already below theraputic 
range at 1.7. No intervention was done to the angioectasias b/c 
of elevated INR. The patient's HCT fell to 25.8. He was given 1 
U RBC's with appropriate increase in HCT. He will return on 
___ to have an elective EGD with likley cauterization of the 
angioectasia with Dr. ___. INR to be drawn the ___ 
before the procedure. To continue to hold ASA and coumadin until 
further notice. PPI increased. 
.
Secondary Diagnosis: 414.01 CAD, NATIVE VESSEL  
BB continued. ASA held as above.
.
Secondary Diagnosis: 428.20 HEART FAILURE, (A3) CHRONIC SYSTOLIC 
 
Patient having cramps on torsemide, changed back to lasix 20 
bid. instructed to continue daily weights. Lytes in 1 week. 
.
Secondary Diagnosis: 401.1 HYPERTENSION, BENIGN  
on BB/ACEI
.
Secondary Diagnosis: 530.11 GASTROESOPHAGEAL REFLUX DISEASE 
(GERD)  
PPI as above.
.
Secondary Diagnosis: 585.3 CHRONIC KIDNEY DISEASE, STAGE III 
(___)  
stable
 
Medications on Admission:
MVI daily
ASA 81mg daily
Torsemide 20mg BID
Klor-Con 20mEQ daily
Omepraole 20mg daily
Toprol XL 25mg daily
Lisinopril 5mg daily
Amitryptiline 50mg qhs
coumadin: 1mg mwf, 2mg sstr
melatonin 2mg hs prn insomnia
 
Discharge Medications:
1. Outpatient Lab Work
INR prior to EGD with gastroenterology. to be run STAT for 
procedure.
2. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  
3. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

4. Amitriptyline 25 mg Tablet Sig: Two (2) Tablet PO HS (at 
bedtime).  
5. Furosemide 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
6. Omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO twice a day.
Disp:*60 Capsule, Delayed Release(E.C.)(s)* Refills:*2*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis: 285.1 ANEMIA, ACUTE BLOOD LOSS  
Secondary Diagnosis: 427.31 ATRIAL FIBRILLATION  
Secondary Diagnosis: 414.01 CAD, NATIVE VESSEL  
Secondary Diagnosis: 578.9 BLEEDING, GASTROINTESTINAL NOS  
Secondary Diagnosis: 428.20 HEART FAILURE, (A3) CHRONIC SYSTOLIC 
 
Secondary Diagnosis: 401.1 HYPERTENSION, BENIGN  
Secondary Diagnosis: 530.11 GASTROESOPHAGEAL REFLUX DISEASE 
(GERD)  
Secondary Diagnosis: 585.3 CHRONIC KIDNEY DISEASE, STAGE III 
(___)  
Secondary Diagnosis: 153.9 MALIGNANT NEOPLASM, COLON  

 
Discharge Condition:
Mental Status:Clear and coherent
Level of Consciousness:Alert and interactive
Activity Status:Ambulatory - Independent

 
Discharge Instructions:
As we discussed you were admitted with a bleed in your stomach 
or proximal small intestine. The bleeding has stopped, but we 
would recommend that you discontinue your aspirin and coumadin 
until you follow up with your outpaient doctors. We have made 
plans for you to see Dr. ___. You will need to arrive 1 
hour before the appointment time and eat nothing after midnight 
prior to arrival. You will also need to come that morning to the 
lab at ___ and have your blood work drawn prior to the 
procedure. Please provide them with the prescription for this 
included in your discharge paperwork. We have also increased the 
dose of your Prilosec(omeprazole) to a higher dose twice a day. 
Dr. ___ will let you know whether to continue at this dose 
or not.
********************
We have changed your torsemide back to lasix so please weigh 
yourself every morning, call your cardiologist if weight goes up 
more than 3 lbs. We recommend that you see your cardiologist or 
primary care doctor in the next week as this medication may need 
to be adjusted and you will have to have your blood electrolytes 
drawn with the next lasix dose.
We have also asked our staff to reschedule your appointment with 
Dr. ___. 
 
Followup Instructions:
___
",MEDICINE
10004401-DS-24,William Armstrong,10004401,28679787," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol
 
Attending: ___.
 
Chief Complaint:
melana
 
Major Surgical or Invasive Procedure:
EGD 
 
History of Present Illness:
___ with h/o CHF and GIB. Patient was discharged 1 day PTA for 
GI bleeding. See the discharge summary for that admission for 
details. In brief, the patient had angioectasia that required 
cauterization after his INR was 1.5 or less which was done 
today. The procedure was uncomplicated, but they noted a 
significant amount of fresh blood in his stomach and his HCT was 
25. He was admitted for observation. Of note, the patient was 
having symptoms of shortness of breath later today before the 
procedure when walking up there stairs. This was not present 
after discharge. No CP, palp, melena, hematemsis, or abd pain. 

ROS:a complete ROS was obtained and negative except for those 
mentioned above. 
 
Past Medical History:
-CAD s/p bare metal stent x2 in ___
-Hypertension  
-Ischemic cardiomyopathy Systolic dysfunction (EF 35%-40% ___  

-Dual chamber pacemaker 
-h/o VF s/p ICD for secondary prevention  
-Chronic atrial fibrillation  
-Rectal cancer s/p neoadjuvant chemotherapy, resection and 
adjuvant chemotherapy for positive LNs found at surgery  
-BPH  
-h/o stroke in ___ with residual R hand dysthesia  
-Cervical spondylosis  
-Sleep apnea, only uses CPAP intermittently  
-h/o gastritis ___ year ago
-insomnia, has been using chamomile tea and melatonin with 
minimal relief
 
Social History:
___
Family History:
Father died of an MI in his ___, Mother died of a PE in her ___, 
twin sister died of colitis age ___, no family h/o colon, 
breast, uterine, or ovarian CA  

 
Physical Exam:
96.6 98/58 70 20 98RA
NAD, awake, alert, oriented x 3
OP clear, conjunctiva w/o pallor
RRR, nml S1 S2, has II/VI holosystolic murmer at apex
lungs clear bilaterally
abd soft NT, ostomy wnl
___ warm, well perfused with 1+ ___ edema bilaterally
strength and sensation intact throughout
 
Pertinent Results:
___ 02:05PM   HCT-25.5*
___ 10:15AM   SODIUM-132* POTASSIUM-4.6 CHLORIDE-100 TOTAL 
CO2-24 ANION GAP-13
___ 10:15AM   CALCIUM-8.5 PHOSPHATE-3.6 MAGNESIUM-2.2
___ 10:15AM   ___
 
Brief Hospital Course:
___ with h/o CHF p/w GI bleeding.   
.
Primary Diagnosis: 285.1 ANEMIA, ACUTE BLOOD LOSS  
Secondary Diagnosis: 578.9 BLEEDING, GASTROINTESTINAL NOS  
The patient was electively admitted for an EGD(see HPI) that 
demonstrated there had been active bleeding in the stomach. 
Cauterization of the angioectasia was performed with achievement 
of hemostasis. The patient was given 1 U RBC's for symptomatic 
anemia with appropriate HCT increased to 30. He was discharged 
the following day without any evidence of bleeding.  He will 
continue PPI bid, holding ASA/Coumadin until f/u with PCP in the 
middle of next week to have his HCT checked.
.
Secondary Diagnosis: 414.01 CAD, NATIVE VESSEL  
BB continued. ASA held as above.
.
Secondary Diagnosis: 428.20 HEART FAILURE, (A3) CHRONIC SYSTOLIC 

Patient was discharged on lasix, but by exam he appears a bit 
more volume up. ___ have been from blood, IVF, and holding 
diuretics on last admission. Gave 1 dose IV lasix with blood 
with good effect. He was discharged on lasix 40 qAM and 20qPM(a 
previous dosing for him) with f/u lytes in 5 days.
.
Secondary Diagnosis: 401.1 HYPERTENSION, BENIGN  
on BB/ACEI
.
Secondary Diagnosis: 530.11 GASTROESOPHAGEAL REFLUX DISEASE 
(GERD)  
PPI as above.
.
Secondary Diagnosis: 585.3 CHRONIC KIDNEY DISEASE, STAGE III 
(___)  
stable

 
Medications on Admission:
2. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  
3. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

4. Amitriptyline 25 mg Tablet Sig: Two (2) Tablet PO HS (at 
bedtime).  
5. Furosemide 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a 

day).  
6. Omeprazole 40 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO twice a day.
Disp:*60 Capsule, Delayed Release(E.C.)(s)* Refills:*2*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis: 285.1 ANEMIA, ACUTE BLOOD LOSS  Secondary 
Diagnosis: 427.31 ATRIAL FIBRILLATION  
Secondary Diagnosis: 414.01 CAD, NATIVE VESSEL  
Secondary Diagnosis: 578.9 BLEEDING, GASTROINTESTINAL NOS  
Secondary Diagnosis: 401.1 HYPERTENSION, BENIGN  
Secondary Diagnosis: 530.11 GASTROESOPHAGEAL REFLUX DISEASE 
(GERD)  
Secondary Diagnosis: 585.3 CHRONIC KIDNEY DISEASE, STAGE III 
(___)  
Secondary Diagnosis: 153.9 MALIGNANT NEOPLASM, COLON  
Secondary Diagnosis: 428.23 HEART FAILURE, (A2) ACUTE ON CHRONIC 
SYSTOLIC  

 
Discharge Condition:
Mental Status:Clear and coherent
Level of Consciousness:Alert and interactive
Activity Status:Ambulatory - Independent

 
Discharge Instructions:
As we discussed, you were admitted for bleeding in your stomach. 
An intervention was performed to stop that bleeding and your 
blood counts have been stable. As before, please be aware of the 
signs and symptoms of bleeding and call your doctor or return to 
the ER if these occur. Please continue the omeprazole at the 
higher dose. We have also increased the dose of your lasix to 40 
in the morning and 20 at night. Please weigh yourself every 
morning, call MD if weight goes up more than 3 lbs. Please do 
not take your aspirin or coumadin until directed by your doctor.
 
Followup Instructions:
___
",MEDICINE
10004401-DS-25,William Armstrong,10004401,26164209," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol / Torsemide
 
Attending: ___.
 
Chief Complaint:
Mechanical fall
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Mr ___ is an ___ year old man with a PMH significant for 
CAD, CHF, AFIB, and chronic balance issues who states that he 
was going down the stairs at his friends house and tripped and 
fell. He denies feeling light-headed, having palpitations, 
losing consciousness or feeling his legs give way, and that he 
simply ""tripped."" He did not lose control of his bladder or 
bowels, and beleives that he hit his back and his head on the 
way down. Two neighbors tried to help them up, but couldnt 
because they ""weren't very strong.""
.
They called EMS who brought him to the ED. In the ED he was 
evaluated for injuries and underwent CT of the C-spine as well 
as plain films of the T-spine, and L-spine, and a CXR. Notably 
found was a T11 fracture. He was also found to be hyponatremic 
to 129 then 126 on repeat labs. He was found to be in acute 
renal faillure and admitted to medicine.
.
Of note he has been recently aggressively diuresed, which has 
been dialed back, but his daugther notes he has lost ""a lot"" of 
weight.
.
Currently, he is hungry and thirsty and complaining only of calf 
cramps, which would go away if ""he could just stand up""
.
ROS: Denies fever, chills, night sweats, headache, vision 
changes, rhinorrhea, congestion, sore throat, cough, shortness 
of breath, chest pain, abdominal pain, nausea, vomiting, 
diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, 
hematuria. 
 
Past Medical History:
-CAD s/p bare metal stent x2 in ___
-Hypertension  
-Ischemic cardiomyopathy Systolic dysfunction (EF 35%-40% ___  

-Dual chamber pacemaker 
-h/o VF s/p ICD for secondary prevention  
-Chronic atrial fibrillation  
-Rectal cancer s/p neoadjuvant chemotherapy, resection and 
adjuvant chemotherapy for positive LNs found at surgery  
-BPH  
-h/o stroke in ___ with residual R hand dysthesia  
-Cervical spondylosis  
-Sleep apnea, only uses CPAP intermittently  
-h/o gastritis ___ year ago
-insomnia, has been using chamomile tea and melatonin with 
minimal relief
 
Social History:
___
Family History:
Father died of an MI in his ___, Mother died of a PE in her ___, 
twin sister died of colitis age ___, no family h/o colon, 
breast, uterine, or ovarian CA  

 
Physical Exam:
Vitals - T:97.8 / BP:120/60 / HR:71 / RR:___ sat:97%
.
GENERAL: Chronicly ill appearring elderly gentleman in NAD, 
sitting comfortably in bedside chair
HEENT: Moist MM, PERRL, EOMI
CHEST: Sparse crackles, good air movement, NO SPINAL TENDERNESS
CV: s1s2, holosystolic murmur heard best at the axilla
ABD: Soft, NT, ND, clean intact ostomy site noted
EXT: Dry, healing skin tear over right shin, no edema
NEURO: CN II-XII intact
 
Pertinent Results:
Admitting Labs:
___ 01:40PM BLOOD WBC-4.4 RBC-4.05* Hgb-10.3* Hct-34.0* 
MCV-84 MCH-25.5* MCHC-30.4* RDW-20.8* Plt ___
___ 01:40PM BLOOD Neuts-63 Bands-1 Lymphs-10* Monos-22* 
Eos-0 Baso-0 Atyps-1* Metas-3* Myelos-0
___ 01:40PM BLOOD Hypochr-1+ Anisocy-NORMAL Poiklo-1+ 
Macrocy-NORMAL Microcy-OCCASIONAL Polychr-OCCASIONAL 
Ovalocy-OCCASIONAL Schisto-OCCASIONAL Burr-1+ Tear Dr-OCCASIONAL
___ 01:40PM BLOOD ___
___ 01:40PM BLOOD UreaN-57* Creat-2.0* Na-129* K-5.3* 
Cl-91* HCO3-23 AnGap-20
___ 01:40PM BLOOD ALT-36 AST-47* CK(CPK)-93 AlkPhos-98 
TotBili-1.9*
___ 01:40PM BLOOD CK-MB-5 cTropnT-0.03*
___ 04:15PM BLOOD CK-MB-5 cTropnT-0.02*
___ 04:15PM BLOOD cTropnT-0.02*
___ 02:10AM BLOOD CK-MB-7 cTropnT-0.01
___ 05:15AM BLOOD CK-MB-7 cTropnT-0.01
___ 01:40PM BLOOD Calcium-9.4
___ 01:40PM BLOOD Hapto-121

Other Studies:
___ 4:15 pm URINE     Site: CLEAN CATCH

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 

___ 04:15PM URINE Color-Yellow Appear-Clear Sp ___
___ 04:15PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG
___ 04:15PM URINE Hours-RANDOM UreaN-456 Creat-58 Na-37 
K-61 Cl-45
___ 04:15PM URINE Osmolal-368
.
** Head CT (___)
FINDINGS: There is no acute hemorrhage, edema, mass effect, or 
infarct. The
ventricles and sulci are enlarged, consistent with age-related 
atrophy.
Chronic infarcts are noted in the right thalamus and left 
cerebellum.
Additional supratentorial and periventricular white matter 
hypodensities are consistent with small vessel ischemic disease. 
Calcifications are noted in the bilateral cavernous carotid and 
vertebral arteries.
 
Again seen is mild mucosal thickening and a mucous retention 
cyst in the left maxillary sinus, as well as some thickening in 
the right ethmoid sinus. The remaining paranasal sinuses and 
mastoid air cells are clear. Diffuse osseous demineralization is 
present. There are no fractures.
 
IMPRESSION: No acute intracranial process. Chronic atrophy and 
old infarcts.
.
CT of C-Spine (___)
FINDINGS: There are no acute fractures. There is multilevel 
degenerative
disease of the cervical spine with osteophyte formation, disc 
space narrowing, subchondral cystic changes, and vertebral 
compression deformities at multiple levels, most marked from 
C5-C7. Multiple posterior disc-osteophyte complexes are present, 
without significant impingement of the thecal sac outline. There 
is moderate-to-severe facet and uncovertebral joint hypertrophy 
at virtually all levels, most severe at C3 and C4 on the right, 
with significant foraminal stenosis.
 
Note is made of partial fusion of the right first and second 
ribs.
 
The thyroid gland is heterogeneous, with a 5-mm hypodense nodule 
in the left lobe (3:76).
 
Left subclavian venous catheter courses in expected position.
 
IMPRESSION: No fractures. Cervical spine DJD.
.
Xray L spine PA/LA (___)
IMPRESSION: No evidence of acute fracture or malalignment. 
Multilevel
degenerative changes.
.
Xray T spine (___)
IMPRESSION: Extensive degenerative disease. There is a superior 
endplate
compression of likely T11. Morphology suggests chronicity and no 
definite
posterior retropulsion is noted. If clinical symptoms are 
referable to this
region, consider cross-sectional exam for more sensitive 
evaluation.
.
Discharge Labs:
___ 05:15AM BLOOD WBC-5.0 RBC-3.83* Hgb-9.6* Hct-30.5* 
MCV-80* MCH-25.1* MCHC-31.6 RDW-21.2* Plt ___
___ 05:15AM BLOOD Plt ___
___ 05:15AM BLOOD ___ PTT-37.0* ___
___ 02:35PM BLOOD Na-126* K-5.0 Cl-93*
___ 05:15AM BLOOD Calcium-8.6 Phos-3.7 Mg-2.___. Mechanical Fall:
Mr. ___ was admitted after a mechanical fall while going 
down the stairs. A CT scan of his head and C-spine neck, as well 
as xrays of the T and L spine were obtained. The T spine xray 
showed and old fracture at T11. The orthopedic spine service 
consulted on the patient and did not feel as if further workup 
was needed unless he developed severely worsening symptoms 
related to his spine. While in the hospital any acute back pain 
was controlled with oxycodone and valium. 
. 
2. Acute Renal failure with Hyponatremia
This believed to be due to dehydration ___ to over diuresis (pt 
was on furosemide and spironolactone as an outpt and reported 
significant recent weight loss). Pt was given IV fluids and 
diuretics were stopped in the hospital. He quickly felt better 
and his symptoms of unsteadiness and fatigue improved. Sodium 
levels stayed mildly low at 126 but creatinine quickly improved. 
Patient was advised to hold his diuretics for at least 24hrs 
after discharge.

3. EKG changes:
Pt had a very difficult EKG to interpret ___ to being paced and 
having some old bundle branch block abnormalities. Cardiology 
had been contacted while patient was in ER and indicated no 
intervention. Pt was ruled out for ACS with 3 sets of cardiac 
markers and placed on telemetry until this was done. Their was a 
mild elevation in initial troponin value but it did not increase 
and was attributed to the acute renal insufficiency. 

On discharge patient was instructed to hold his two diuretics 
for 24hrs and to monitor his dry weights closely and daily.
 
Medications on Admission:
FUROSEMIDE - 60qAM, 40qPM
LISINOPRIL - 2.5 mg Tablet once a day
METOPROLOL SUCCINATE [TOPROL XL] - 25 daily
OMEPRAZOLE - 20 mg Capsule, 1 Capsule(s) by mouth daily
TEDS STOCKINGS - 1 PAIR - WEAR DAILY TO PREVENT ANKLE SWELLING
WARFARIN - ___ MWF. 1 TTHSASU
Spironalactone 25mg daily
KCL 20meq daily.
 
Discharge Medications:
1. Lisinopril 2.5 mg Tablet Sig: One (1) Tablet PO once a day.  
2. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO once a day.  
3. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
4. Warfarin 2 mg Tablet Sig: One (1) Tablet PO 3X/WEEK 
(___).  
5. Warfarin 1 mg Tablet Sig: One (1) Tablet PO 4X/WEEK 
(___).  
6. Spironolactone 25 mg Tablet Sig: One (1) Tablet PO once a 
day: hold for 24 hours after hospital discharge.     
.  
7. Lasix 40 mg Tablet Sig: One (1) Tablet PO twice a day: hold 
for 24 hours after hospital discharge.  
8. Outpatient Lab Work
Please check labs including patients Na and renal function 
within ___ days of being discharged from the hospital. Please 
send results to patient's PCP.
Name: ___.
Phone: ___
Fax: ___

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Mechanical Fall
Acute Renal Failure
Hyponatermia

Secondary:
CAD 
Hypertension  
systolic CHF  
Chronic atrial fibrillation  
BPH  

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
It was a pleasure taking care of you while you were in the 
hospital.  You were admitted after a fall and had CT-scan of 
your head and neck.  You also had x-rays of your back.  The 
x-ray of your back showed an old fracture at T11.  You were seen 
by the spine specialist and did not feel there was further 
workup needed unless you developed worsening pain, numbness, 
tingling or other neurologic symptoms.

You were also found to be dehydrated likely secondary to your 
diuretics.  We gave you some IV fluids and held your water 
pills.  You felt better and symptoms improved.  You should hold 
your lasix & spironolactone for 24hrs and then restart them.  
You need to follow-up with your PCP and cardiologist.  You will 
also have your sodium and renal function checked via lab draw 
tomorrow and have the labs faxed to your PCP, ___.

The following changes were made to you medications:
1) Please hold your lasix and spironolactone for 24 hours.  You 
will have labs drawn tomorrow in the morning. Please follow-up 
with Dr. ___ your lab work prior to restarting 
tomorrow.  Call his office and ask whether your sodium level is 
better and whether you can restart your lasix 40mg twice a day. 

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___
",MEDICINE
10004401-DS-26,William Armstrong,10004401,28154772," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol / Torsemide
 
Attending: ___.
 
Chief Complaint:
fatigue
 
Major Surgical or Invasive Procedure:
Upper Endoscopy

 
History of Present Illness:
___ year old gentleman with PMH including CAD s/p stenting of OM 
in ___ following cardiac arrest, s/p dual chamber ICD, dilated 
cardiomyopathy with last LVEF of 40% (___), atrial 
tachycardia/fibrillation on coumadin, rectal cancer s/p chemo 
radiation and surgery in ___, colostomy, s/p stroke in ___ 
with right hand dysthesia who was reffered by his PCP due to 
progressive fatigue and ___ Hct.
.
Patient endorses mild dyspnea on exertion, says he can walk upto 
100 feet with walker and up ___ steps w/o stopping. He is 
comfortable at rest.  He has been chronically fatigue, but is 
moreso over the last ___ months without any acute deterioration. 
He denies any dark stools or BRBPR, hematemesis, chest pain, 
palpitations. He does endorse stable orthopnea X2, nocturiaX 4, 
w/o PND. he has chronic leg swelliung w/o recent change.  He was 
evaluated by his PCP, who sent him to the ED due to concern for 
slowly ___ hematocrit.  
.
he has history of prior GI bleed ___ angiectasia in the duodenum 
___ which was cauterized by EGD, 

.  
In the ED, initial vs were: T 98.8 P 68 BP 104/44 R18 O2 96%sat. 
 Guiac was negative.  Labs notable for hematocrit of 24.7, with 
baseline hct ___.  Patient was transfered to the ward for 
further care.  
.  
On the floor, patient is w/o complaints
.  
Review of sytems:  
(+) Per HPI  
. Patient had some dry cough recently for two-three weeks which 
reolsved a few days ago. He denies URT complaints or febrile 
illness. 
(-) Denies fever, chills, night sweats. Denies headache, sinus 
tenderness, rhinorrhea or congestion. Denied chest pain or 
tightness, palpitations. Denied nausea, vomiting, diarrhea, 
constipation or abdominal pain. No recent change in bowel or 
bladder habits. No dysuria. Denied arthralgias or myalgias.  
.  

 
Past Medical History:
  
- history of ventricular tachycardia
- dilated cardiomyopathy with EF 35-40%
- CAD s/p stenting of the OM in ___ following cardiac arrest; 
s/p dual chamber ICD in ___
- chronic systolic CHF
- atrial tachycardia
- atrial fibrillation
- rectal cancer s/p chemo radiation and surgery in ___
- GI bleed ___ angiectasia in the duodenum ___
- CVA in ___ with right hand dysthesia
- prior mechanical falls
- depression
.  

 
Social History:
___
Family History:
 Father: died in ___ from MI.  Mother: died in ___ from PE.  
Twin sister: died of colitis at age ___.  No family history of 
colon, breast, uterine, or ovarian cancer.
 
Physical Exam:
Physical Exam:  
Vitals: T:96.0 BP:104/55 P:69 R: 25. O2% 95%2L   
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear  
Neck: supple, JVD to Jaw with pos HJR, no LAD  
Lungs: Some central ronchi which clear with cough, no crackles 
Clear no wheezes  
CV: RRR, S1, Split S2, soft SM at apex and LLSB w/o radiation, 
no rubs/gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, liver edge palpated 3cm under 
rib line. No ascitis. Colostomy LLQ. 
Ext: WWP, severe stasis dermaitis bil ___, no signs of DVT. Bil 
+3 pitting edema. 
Neuro: no gross deficit

 
Pertinent Results:
Admission Labs:
.  

___ 04:57PM BLOOD WBC-5.4 RBC-3.39* Hgb-7.9* Hct-25.8* 
MCV-76* MCH-23.2* MCHC-30.5* RDW-20.9* Plt ___
___ 04:30PM BLOOD Neuts-63 Bands-0 ___ Monos-15* 
Eos-1 Baso-1 ___ Myelos-0
___ 04:57PM BLOOD ___
___ 04:30PM BLOOD Ret Aut-3.6*
___ 04:30PM BLOOD Glucose-102* UreaN-32* Creat-1.7* Na-130* 
K-5.1 Cl-98 HCO3-22 AnGap-15
___ 04:30PM BLOOD ALT-23 AST-75* LD(LDH)-483* CK(CPK)-103 
AlkPhos-127 TotBili-1.9* DirBili-0.8* IndBili-1.1
___ 04:30PM BLOOD CK-MB-2 cTropnT-0.03* proBNP-4846*
___ 04:57PM BLOOD Iron-38*
___ 04:57PM BLOOD calTIBC-467 VitB12-1816* Folate->20 
Ferritn-74 TRF-359
.
___ 03:51PM URINE Color-Yellow Appear-Clear Sp ___
___ 03:51PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-8* pH-7.0 Leuks-NEG

Micro: 
___ BLOOD CULTURE Blood Culture, Routine-PENDING 
INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-PENDING 
INPATIENT 
.
Celiac Serology:
___ 07:55AM BLOOD IgA-130
___ 07:55AM BLOOD tTG-IgA-2 antiDGP-0
.
Discharge labs:
.
.  

___ 07:00AM BLOOD WBC-4.4 RBC-3.89* Hgb-9.3* Hct-30.4* 
MCV-78* MCH-24.0* MCHC-30.8* RDW-20.8* Plt ___
___ 07:00AM BLOOD Glucose-91 UreaN-24* Creat-1.1 Na-134 
K-3.7 Cl-98 HCO3-23 AnGap-17
___ 07:00AM BLOOD LD(LDH)-307* TotBili-3.6* DirBili-1.2* 
IndBili-2.4
___ 07:00AM BLOOD Calcium-8.5 Phos-2.8 Mg-1.9
___ 07:00AM BLOOD Hapto-153
.
Images:  
.  
EKG ___: A-V paced rhythm with ventricular premature beat. 
Since the previous tracing of ___ no significant change. 
.
CXR ___ unchanged w/lead tips in the expected 
location of the right atrium and right ventricle. Cardiomegaly 
is again noted with mild pulmonary vascular congestion. Trace 
pleural effusions cannot be excluded. There is no definite sign 
of pneumonia or pneumothorax. Bony structures appear grossly 
intact.  There is a mild dextroscoliosis of the T-spine. 
IMPRESSION: Cardiomegaly. Mild congestion. 
.
GI endoscopy:
.
.
Echo: ___: LVEF= 40 %.moderate mitral regurgitation. Mild 
global left ventricular hypokinesis. Moderate right ventricular 
dilation,

 
Brief Hospital Course:
___ year old gentleman with PMH including CAD s/p stenting,  dual 
chamber ICD, CHF LVEF of 40% mod MR, TR (___), atrial 
tach/fib on coumadin, s/p chemo + Rad + left coloectomy for 
rectal CA, h/o upper GIB from duodenal ectazia who was reffered 
by his PCP due to progressive fatigue and ___ Hct.
.
# Anemia: Mr. ___ had slowly ___ Hct prior to 
his admission w/o overt bleeding. On admission found to have 
microcytic anemia with Hct 24.7 and Retic. Index of 1.1%. 
Thought to be multifactorial d/t iron deficiency, CRF, Chronic 
disease. Concern for hemolysis was also raised (See ""Jaundice"" 
below). B12 and Folate were not deficient. Iron was low with 
Ferrittin at low end of normal range. He was hemodynamically 
stable throught his stay. Despite guiac negative stools history 
was concerning for potential sources of GI bleed including  s/p 
UGIB from duodenal ectasia and s/p rectal cancer. He underwent 
EGD which was normal. The patient declined colonoscopy at this 
time. Celiac serology was negative. He recieved a total of 3 
units of PRBC. Hct at discharge was 30.4 His coumadin was 
continued as he did not have signs of major bleeding. Omeprazole 
dose was reduced from 40mg BID to 20mg QD per normal EGD. Iron 
supplementation was started. He will require close monitoring of 
his Hct in the out-patient setting and further anemia workup 
including outpatient colonoscopy, UPEP, SPEP as well as 
hematology consultation for possible hemolysis. 
.
# CHF exacerbation. Mr. ___ has dilated cardiomyopathy 
with EF 40% per echo ___. He was clinically fluid overoladed on 
admission, likely ___ to decompensated HF in the setting of 
anemia. He was kept on his home doses of PO furosamide and 
recieved adittional IV furosamide dosing as well as PRBC for his 
anemia. Lisinopril, spironolacton and Metoprolol were continued. 
He had good urine output with this and his fluid status 
significantly improved to euvolumia at discharge. He will 
continue to follow-up with his outpatient cardiologist.  
.
# Jaundice: The patient was noticed to be Jaundiced and was 
found to have hyperbilirubinemia. Urobiilnogen + spoke against 
obstructive process. Raised LDH++ was concerning for hemolysis, 
but haptoglobin was normal and direct and indirect coombs 
testing was negative, no schistocytes were noted on smear. He 
does have chronic transamintis which is thought to be due to 
congested liver ___ to right heart failure. Worsening of liver 
congestion in the setting of decompensated heart failure may be 
the underlying cause of Jaundice. ___ syndrome is unlikely 
as he has no history of prior episodes of Jaundice. Trending of 
LFT's and further work-up should continue in the out-patient 
setting. Hematology consultation was arranged for work-up of 
possible hemolysis.   
.
# Acute on chronic renal failure: Admission Cr 1.7 up from 1.3 
at baseline, likely pre-renal failure in the setting of 
decompensated heart failure. Cr subsequently trended down to 
base-line with treatment of HF. Renal functions should be 
followed up in the out-patient setting. 

# Fever: Mr. ___ had a ___ temprature spike 
during a blood transfusion. Work-up for transfusion reaction was 
not concerning. Blood cultures were so far negative. He did have 
a cough but CXR was not concerning for pneumonia. UA was 
negative. He subsequently remained afebrile and had no 
leukocytosis. 
.  
# Atrial Fibrillation: patient is paced by dual chamber ICD. 
Rate control with BB and anticoagulatation with Warfaine were 
continued. His INR on discharge was 1.7. He will continue INR 
monitoring and warfarin dose adjustment in the out-patient 
setting.  
. 
# CAD: Patient is s/p stenting of the OM in ___ following 
cardiac arrest; His home medication regimen does not include 
aspirin and statin. He will continue follow up with his 
out-patient cardiologist. Initiation of aspirin and statin for 
seondary prevention should be considered. 
 
Medications on Admission:
- lisinopril 2.5mg PO daily
- warfarin PO 1mg TTSS, ___ MWF
- CPAP - prescribed but doesn't use it
- toprol XL 25mg PO daily
- triamcinolone cream applied topically BID to legs
- omeprazole 40mg PO BID
- lasix 60mg PO BID
- spironolactone 25mg PO daily
- KCL ___ daily

.  
Allergies:  
- penicillin
- streptomycin
- erythromycin
- auriomycin
- atenolol

 
Discharge Medications:
1. Toprol XL 25 mg Tablet Sustained Release 24 hr Sig: One (1) 
Tablet Sustained Release 24 hr PO once a day.  
2. triamcinolone acetonide 0.025 % Cream Sig: One (1) Appl 
Topical BID (2 times a day).  
3. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.
Disp:*30 Capsule, Delayed Release(E.C.)(s)* Refills:*0*
4. spironolactone 25 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
5. lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).  
6. warfarin 2 mg Tablet Sig: One (1) Tablet PO 3X/WEEK 
(___).  
7. warfarin 1 mg Tablet Sig: One (1) Tablet PO 4X/WEEK 
(___).  
8. potassium chloride 20 mEq Tab Sust.Rel. Particle/Crystal Sig: 
One (1) Tab Sust.Rel. Particle/Crystal PO ONCE (Once) for 1 
doses.  
9. furosemide 20 mg Tablet Sig: Three (3) Tablet PO BID (2 times 
a day).  
10. iron 325 mg (65 mg Iron) Capsule, Sustained Release Sig: One 
(1) Capsule, Sustained Release PO once a day.
Disp:*30 Capsule, Sustained Release(s)* Refills:*0*
11. Vitamin C 500 mg Tablet Sig: One (1) Tablet PO once a day: 
take with iron tablet.
Disp:*30 Tablet(s)* Refills:*2*
12. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day: 
continue while taking iron; hold for loose stools.
Disp:*60 Capsule(s)* Refills:*2*
13. senna 8.6 mg Capsule Sig: One (1) Capsule PO twice a day: 
take while on iron tablets; hold for loose stools.
Disp:*60 Capsule(s)* Refills:*2*
14. Outpatient Lab Work
Please check CBC at PCP's appointment on ___.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
anemia
iron deficiency
suspected hemolysis
heart failure exacerbation

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
You were admitted due to fatigue and shortness of breath. You 
were found to have anemia (low number of read blood cells) and 
worsening heart failure. We suspected bleeding from the 
intestine. You underwent upper endoscopy which did not 
demonstrate a source of bleeding in the upper part of your 
intestinal tract. You will need to undergo lower endoscopy 
(colonoscopy) to look for bleeding from the lower intestine. You 
were treated with medication to increase the amount of urine and 
decrease the accumulation of fluid in your body. You were also 
given blood units to treat your anemia. 
.
The following changes were made to your medications:
.
# Omeprazole 40 mg tablet was changed to omeprazole 20 mg 
tablet. Please take one tablet ONCE daily. 
.
# Iron 325mg tablet was added. Please take one tablet once 
daily. Please take with vitamin C and colace/senna stool 
softeners to avoid constipation.
.
Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___
",MEDICINE
10004401-DS-28,William Armstrong,10004401,28128182," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol / Torsemide / Heparin Agents
 
Attending: ___
 
___ Complaint:
Bloody sputum for 5 days, post-bronchoscopy respiratory distress
 
Major Surgical or Invasive Procedure:
___: Bronchoscopy - only suction trauma visualized, no source 
of bleeding found.

 
History of Present Illness:
Mr. ___ is a very pleasant ___ y/o male with a h/o colon 
cancer s/p resection and radiation, CAD s/p stents, systolic CHF 
with EF 40-45%, dilated cardiomyopathy, afib, h/o cardiac arrest 
and complete heart block now with pacer/AICD, and history of GI 
bleed secondary to duodenal telangiectasia who is here from 
rehab following evaluation of blood in his respiratory 
secretions.  
.
Mr. ___ had a lengthy, complex, and recent admission to 
the TICU which is summarized in brief. He had a fall on ___, 
leading to multiple rib fractures. He had L ___ rib frx, R 
___ rib frx, L hemothorax decompressed by pigtail catheter, 
and a L distal clavicle fracture. He was given a tracheostomy 
and PEG tube after failed extubation and reintubation.
.  
In rehab, the patient was noted to have blood tinged secretions 
via his trach. A bronschoscopy was performed and reportedly saw 
bleeding inside of his trachea with poor visualization. He was 
transfused 2 unit pRBC and was transferred to ___. Here, the 
patient reports no resp distress. His wife stated that the pt 
has been stable with no change in his respiration.
.
He underwent a bronchoscopy with our ___ group on ___, which 
did not find an etiology of the bleed. Only suction trauma was 
seen. Of note, he was receiving intermittent lasix and IVF for 
hypernatremia prior to bronchoscopy. Post-procedure, he was 
noted to be mildly tachypnic with RR ___ and was satting 88% on 
15L NC. As such, he was transferred to the medical ICU for 
closer monitoring. Of note, he is typically on 50% FIO2 with his 
trach mask.

 
Past Medical History:
rectal cancer s/p removal and radiation ijn ___  
CAD s/p stents  
Complete heart block (now with pacer)  
afib  
h/o cardiac arrest (now with AICD)  
systolic CHF (EF 40-45%)  
fall with multiple rib fractures (___)  
GI bleed
 
Social History:
___
Family History:
Father died in ___ from MI. Mother died in ___ from PE. No 
family history of colon, breast, uterine, or ovarian cancer. No 
family history of seizures. 
 
Physical Exam:
VS: T 101, BP:111/49, HR: 70, RR:19, O2:95% on 50% FiO2  
General: NAD, resting comfortably and sleeping, arousable with 
mild stimuli from sleep, no labored breathing
HEENT: NC, AT, no blood at trach opening or in oropharynx, MMM  
Neck: no JVD, no LAD
Lungs: rhonchi throughout, diminished sounds at the bases
Heart: RRR, no M/R/G
Abdomen: soft, nontender, nondistended, normoactive bowel 
sounds, PEG and ostomy in place, ostomy has brown stool
Skin: dry, hyperpigmentation of distal ___ bilaterally; LUE seems 
to be more swollen than RUE 
Ext: bilateral lower extremities wrapped in dressing
NEURO: Coherent but sluggish, has episodic confusion. Can 
verbalize some words through mask. CN II-XII intact, no motor or 
sensory deficits on screening exam.
At discharge: same as above except 
Gen: Arousable to verbal stimuli
HEENT: clear/tan secretions at trach site
Ext: LUE with swelling
 
Pertinent Results:
___ 02:15PM BLOOD WBC-10.4 RBC-3.05* Hgb-9.1* Hct-28.8* 
MCV-95 MCH-29.9 MCHC-31.6 RDW-19.7* Plt ___
___ 03:00AM BLOOD WBC-3.8* RBC-2.68* Hgb-8.0* Hct-25.5* 
MCV-95 MCH-29.7 MCHC-31.2 RDW-17.1* Plt ___
___ 02:15PM BLOOD Neuts-80.6* Bands-0 Lymphs-8.4* Monos-9.6 
Eos-0.6 Baso-0.6
___ 02:15PM BLOOD Hypochr-2+ Anisocy-2+ Poiklo-1+ 
Macrocy-2+ Microcy-NORMAL Polychr-NORMAL Ovalocy-OCCASIONAL 
Burr-OCCASIONAL Stipple-OCCASIONAL
___ 02:15PM BLOOD ___ PTT-30.5 ___
___ 05:37AM BLOOD ___ PTT-29.6 ___
___ 02:15PM BLOOD Glucose-138* UreaN-63* Creat-1.1 Na-150* 
K-4.8 Cl-108 HCO3-33* AnGap-14
___ 03:00AM BLOOD Glucose-130* UreaN-36* Creat-0.9 Na-141 
K-5.1 Cl-105 HCO3-32 AnGap-9
___ 02:15PM BLOOD ALT-43* AST-38 AlkPhos-151* TotBili-1.0
___ 02:15PM BLOOD Lipase-523*
___ 02:15PM BLOOD proBNP-7598*
___ 03:00AM BLOOD Calcium-8.2* Phos-2.8 Mg-2.4
___ 04:36PM BLOOD Type-ART Rates-/32 FiO2-100 pO2-60* 
pCO2-48* pH-7.47* calTCO2-36* Base XS-9 Intubat-NOT INTUBA 
Comment-TRACH MASK
___ 02:22PM BLOOD Lactate-1.1
.
Microbiology:
___ Blood Cx: No growth
___ Urine Cx: No growth
___ Sputum Cx: Staph aureus coag +, sensitive to levofloxacin
___ MRSA nasal screen: negative
.
Imaging:
___ LUE doppler: No evidence of deep venous thrombosis in the 
left upper extremity.
___ CXR: Slightly rotated positioning. A tracheostomy tube is in 
place. A left-sided dual-lead pacemaker is in place, with lead 
tips over right atrium and right ventricle.  There is moderately 
severe cardiomegaly, with left lower lobe collapse and/or 
consolidation. There is upper zone redistribution and diffuse 
vascular blurring, suggestive of mild CHF. There is focal patchy 
opacity in the left mid zone, which could reflect atelectasis or 
a pneumonic infiltrate. There is a small left and possible 
minimal right effusion. Minimal atelectasis right base. The hila 
are enlarged. 

 
Brief Hospital Course:
Mr. ___ is a ___ y/o male with colon cancer s/p resection 
and radiation, CAD s/p stents, systolic CHF with EF 40-45%, 
dilated cardiomyopathy, afib, h/o cardiac arrest and complete 
heart block now with pacer/AICD, and history of GI bleed 
secondary to duodenal telangiectasia who is here from rehab for 
hemoptysis. Of note, he had lengthy TICU hospitalization for L 
___ rib fractures, R ___ rib fractures, a L hemothorax, a L 
dist clavicle fracture, and he is s/p trach and peg.
.
# Hemoptysis: Mr. ___ was noted to have blood tinged 
secretions via his trach. An OSH bronschoscopy was performed and 
reportedly saw bleeding inside the trachea with poor 
visualization. He was transfused 2 units of pRBC and transferred 
to ___. Here, he reported no resp distress. He is status post 
bronchoscopy with our pulmonary team on ___, which did not find 
an etiology of the bleed. Only suction trauma was seen, and this 
may be the primary etiology of his bloody tracheal secretions. 
While the cause of his hemoptysis remains uncertain, his 
hematocrits have remained stable and there are no signs of 
continuing hemoptysis or active bleeding. Chemical DVT ppx was 
held at time of discharge after he was HIT positive and given 
risk of bleeding with suction trauma.
.
# Respiratory distress: His respiratory distress has 
currentlyimproved. Post bronchoscopy, he was noted to be mildly 
tachypnic with RR ___ and was 88% on 15L NC. A CXR showed 
worsening pulmonary edema, and he received lasix with 
improvement in PACU. He was transferred to the MICU for closer 
monitoring. Of note, he was receiving intermittent lasix and an 
IVF bolus prior to bronchoscopy. He is typically on 50% FIO2 
with his trach mask. He was weaned from the ventilator, and was 
continued on albuterol MDIs. He was also treated with vancomycin 
and cefepime for HCAP, until his sputum Cx grew coag-positive 
staph sensitive to levofloxacin. He was started on an 8-day 
course of levofloxacin 750mg qday, of which the last dose will 
be on ___. Lasix 40mg PO daily was restarted on day of 
discharge. This should be titrated as needed.
-We recommend keeping the patient on the ventilator (MMV) 
overnight to decrease his work of breathing.
.
# Fever: The patient p/w low grade fever/temperature post 
bronchoscopy. His fever curve was trended, and cultures were 
sent. His urine and blood cultures showed no growth, while his 
sputum culture grew coag-positive staph as mentioned above. He 
was continued on levofloxacin.
.
# Anemia: His anemia was stable after 2u pRBC prior to transfer, 
and his hematocrits remained stable. There was no further need 
for transfusion.
.
# Asymetric swelling of LUE: His LUE was cooler than the RUE and 
more swollen than the right, but still had good pulses. Although 
his wife stated that his LUE has always been swollen, a doppler 
of the LUE was obtained which showed no evidence of DVT. The 
swelling appears to have reduced, although it still remains more 
swollen than the RUE. 
.
# Acute on chronic systolic CHF (40-45%): The initial physical 
exam showed leg edema and his chest x-ray suggest mild CHF. He 
was given 20mg of lasix in the PACU, and further diuresis was 
not undertaken in the ICU. He was started on Lasix 40mg PO daily 
(Previous home dose) on day of discharge. This should continue 
to be monitored. He was given free water flushes through his G 
tube for hypernatremia, which resolved during his stay.  
.
# Low platelet count: His platelets fell from 273 on admission 
to 107 prior to discharge. This drop was consistent with 
heparin-induced thrombocytopenia, for which his heparin was 
discontinued. This was confirmed as his heparin antibody from 
___ was positive. His PLT count on ___ is 111. He was put on 
pneumoboots for DVT prophylaxis given risk of bleeding with 
suction.
-He should not be given heparin.
.
# Hypernatremia: As above, he was given free water flushes for 
correction of his hypernatremia, which appears to have resolved. 
Free water flushes were continued at time of discharge.
.  
# Oral candidiasis: PO fluconazole was stopped prior to 
discharge.
.
Only evidence of bleed is suection trauma in L maintstem 
bronchus, needs to come back in 6 week from ___ for rpt 
bronch
 
Medications on Admission:
acetaminophen 975mg PO Q8H  
carvedilol 3.125mg PO BID  
Citalopram 20mg PO daily  
docusate 100mg PO BID  
ferrous sulfate 300mg PO daily  
fluconazole 100mg PO Q12H  
folic acid 1 mg po daily  
lasix 40mg PO daily  
gabapentin 300mg PO Q12H  
heparin 5000U SC Q12H  
lisinopril 2.5mg PO daily  
MVI daily  
omeprazole 20mg PO daily  
protein supplement daily  
albuterol inhaler 4 puffs Q2H prn wheezing  
simethicone 80mg PO Q8Hprn  
oxycodone ___ po q4h prn  

 
Discharge Medications:
1. acetaminophen 650 mg Tablet Sig: One (1) Tablet PO every 
eight (8) hours as needed for pain.  
2. acetaminophen 325 mg Tablet Sig: One (1) Tablet PO every 
eight (8) hours as needed for pain.  
3. carvedilol 3.125 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  
4. citalopram 20 mg Tablet Sig: One (1) Tablet PO once a day.  
5. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) milliliters 
PO BID (2 times a day).  
6. ferrous sulfate 325 mg (65 mg iron) Tablet Sig: One (1) 
Tablet PO once a day.  
7. folic acid 1 mg Tablet Sig: One (1) Tablet PO once a day.  
8. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  
9. gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q12H (every 
12 hours).  
10. lisinopril 2.5 mg Tablet Sig: One (1) Tablet PO once a day.  

11. multivitamin     Tablet Sig: One (1) Tablet PO once a day.  
12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  
13. protein supplement     Packet Sig: One (1)  PO once a day.  
14. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
Four (4) Puff Inhalation q2hr as needed for SOB.  
15. simethicone 80 mg Tablet Sig: One (1) Tablet PO every eight 
(8) hours.  
16. oxycodone 5 mg/5 mL Solution Sig: ___  PO Q4H (every 4 
hours) as needed for tracheal pain.  
17. levofloxacin 750 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily) for 2 days: Pt needs one dose on ___ and one dose on ___ 
(in order to complete 8day course, day 1 was ___.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Respiratory distress, now improved.
Tracheostomy requiring ventilation
Pneumonia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Lethargic but arousable.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
You initially came from your rehab after receiving a 
bronchoscopy to evaluate your bloody sputum that you had had for 
5 days. You received another bronchoscopy on ___, which did not 
show any obvious source of bleeding. Afterwards, you had a fast 
breathing rate and low oxygen saturation, so you were monitored 
in the ICU. You received antibiotics for suspected pneumonia and 
were on a ventilator machine at night. Your breathing and 
overall status has improved, and you can be discharged to your 
rehab in order to begin regaining your strength.

You were found to have an antibody against heparin products and 
should avoid getting any further heparin products.

The following changes were made to your medications:
New: Levofloxacin 750mg daily, for 2 more days (dose on ___ and 
___
Discontinued: Fluconazole, Heparin

Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___
",MEDICINE
10004401-DS-29,William Armstrong,10004401,22869003," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol / Torsemide / Heparin Agents
 
Attending: ___.
 
Chief Complaint:
Respiratory Distress, Hypotension
 
Major Surgical or Invasive Procedure:
Right internal jugular (CVL) (discontinued) 
Arterial line (discontinued)
PICC (placed ___
 
History of Present Illness:
___ year old male with multiple co-morbidities, including rectal 
cancer s/p resection and radiation in ___, coronary artery 
disease s/p stents, systolic CHF, dilated cardiomyopathy, atrial 
fibrillation, history of cardiac arrest and complete heart blood 
s/p AICD/pacemaker, recent trach/peg who presented with 
respiratory distress, fevers and hypotension. The patient 
desaturated one day before admission to 85% at ___ 
although improved to 92% with suctioning out copious amounts of 
thick yellow, brown secretions. Per his wife and daughter, he 
had been doing well with the trach, often having it capped in 
the last week - up until ___ days ago when he needed to be on 
the vent more frequently. He reportedly had a fever to ___ 
yesterday and 102.0 today at rehab and had a CXR performed there 
showing LLL pneumonia; he was treated with Vancomycin 1 gram X1 
there.
.
On arrival to the ___ ___, the patient was being bagged by EMS 
upon arrival, hypotensive to SBP80s, not tachypneic, never 
febrile, satting stably on his trach settings. He was mentating 
well, complaining only of buttocks pain (stable) and answering 
questions appropriately. CXR ___ similar to priors and he was 
treated with Levofloxacin and Cefepime. Given persistent 
hypotension SBP80s and decreased UOP ___ hours) despite 
1.5L IVF, a RIJ CVL was placed and levophed started at 0.06. He 
also had a midline IV from before and 18 gauge PIV. His troponin 
was 0.11 so he was also given aspirin 325mg. VS on transfer to 
MICU: Afebrile, HR70, BP86/40, RR16, 95% on PEEP5, FiO2 60%, 
TV500.
.
Upon arrival to the MICU, the patient was resting comfortably in 
bed. 
.
Review of systems:  
(+) Per HPI  
(-) Denies headache, sinus tenderness, congestion. Denies chest 
pain, chest pressure, palpitations, or weakness. Denies nausea, 
vomiting, diarrhea, constipation, abdominal pain, or changes in 
bowel habits. 

 
Past Medical History:
- Rectal cancer s/p excision and XRT (___)
- CAD s/p stents  
- Complete heart block s/p pacemaker 
- h/o cardiac arrest (now with AICD)  
- Afib 
- Systolic CHF (EF 40-45%)  
- s/p Fall with multiple rib fractures (___)  
- h/o GI bleed
 
Social History:
___
Family History:
Father died in ___ from MI. Mother died in ___ from PE. No 
family history of colon, breast, uterine, or ovarian cancer. No 
family history of seizures. 
 
Physical Exam:
Admission Exam:
Vitals: T: Afebrile BP: 105/47 P: 61 R: 13 O2: 100%   
General: oriented, no acute distress, sleepy
HEENT: Sclera anicteric, MMM, oropharynx clear  
Neck: Supple, RIJ CVL
Lungs: Diffusely rhonchorous, rales; no wheezes 
CV: RRR, ___ holosystolic murmur heard best over apex with 
dulling of S1 and S2 over apex. Otherwise S1 S2 clear and of 
good quality over rest of precordium.
Abdomen: Soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding; ostomy bag in place  
GU: three way irrigation foley 
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema; dry stasis changes on bilateral lower extremities  
  
Discharge Exam: 
VS 98.9 73 133/69 24 95% trach collar 50%F1O2   
General Appearance: No acute distress, breathing comfortably on 
trach collar.
HEENT: PERRL, Conjunctiva pale, Normocephalic, Poor dentition
Cardiovascular: RRR, ___ holosystolic murmur heard best over 
Respiratory:  mild rhonchi throughout all lung fields with 
occasional expiratory wheezes
Abdominal: Soft, non-tender, colostomy, PEG, + BS 
Extremities: Bilateral ___ edema L>R, Chronic skin changes over 
bilateral ___ suggestive of chronic venous stasis, right knee 
tender to palpation 
Skin:  Warm, well perfused
Neurologic: Attentive, Follows simple commands, Responds to: 
Verbal stimuli, Movement: Purposeful, Tone: Normal, localizes 
pain. Able to point out letters on chart for communicating, 
appropriate

 
Pertinent Results:
Blood Counts
___ 08:00AM BLOOD WBC-28.2*# RBC-2.71* Hgb-7.9* Hct-24.0* 
MCV-88 MCH-29.1 MCHC-33.1 RDW-16.6* Plt ___
___ 02:30PM BLOOD WBC-11.6* RBC-3.00* Hgb-8.8* Hct-26.6* 
MCV-89 MCH-29.3 MCHC-33.1 RDW-16.6* Plt ___
___ 02:53AM BLOOD WBC-8.0 RBC-2.81* Hgb-8.3* Hct-25.0* 
MCV-89 MCH-29.4 MCHC-33.0 RDW-16.1* Plt Ct-80*

Electrolytes
___ 08:00AM BLOOD Glucose-139* UreaN-45* Creat-1.5* Na-136 
K-5.0 Cl-99 HCO3-29 AnGap-13
___ 02:57AM BLOOD Glucose-106* UreaN-50* Creat-1.3* Na-138 
K-4.4 Cl-107 HCO3-25 AnGap-10
___ 02:53AM BLOOD Glucose-144* UreaN-48* Creat-1.2 Na-139 
K-4.3 Cl-103 HCO3-29 AnGap-11

 
Brief Hospital Course:
HOSPITAL COURSE
___ PMHx rectal cancer s/p resection and XRT w ostomy, systolic 
CHF (LVEF40-45%), recent trach/peg who presented with 
respiratory distress, found to have a pnuemonia, with blood and 
sputum cultures growing out MRSA, now improved to baseline 
respiratory status being discharged to ___ on 2 week course of 
IV antibioitics
.
ACTIVE
# Healthcare Associated Pnuemonia and MRSA Bacteremia - Patient 
presented with increasing O2 requirements, leukocytosis and 
hypotension; CXR demonstrated LLL PNA; accompanying elevated 
Lactate, High SvO2 (93%), hypotension and tachycardia suggested 
sepsis; blood and sputum cultures grew out MRSA.  Patient was 
initially fluid resuscitated and briefly required vasopressors.  
He was treated with vancomycin (initially with cefepime and 
levofloxacin as well, which were stopped based upon culture 
data).  Patient respiratory status improved, and patient was 
able to be weaned off vent to trach collar.  Given MRSA 
bacteremia, patient had PICC line changed and underwent TTE that 
did not demonstrate signs of valvular lesions; patient was 
planned for 2 week course with IV vancomycin.  
.
# Sacral decubitus ulcer: Significant, likely stage IV.  
Appropriate wound care was provided and his pain regimen was 
increased to Oxycodone to ___ mg q4 PRN for pain which 
successfully curbed decubitus pain.
.
# Coronary artery disease: Stable, continued carvedilol; held 
lisinopril given hypotension and will need to be restarted; 
started ASA (had been held previously given history of GI 
bleeds).  
.
# Afib: CHADS4, but off anticoagulation ___ hemothorax ___.  
Discussed with primary cardiologist who recommended considering 
restarting coumadin as outpatient. 

INACTIVE
# Anemia - Continued iron supplementation
.
# Systolic CHF: EF 40-45%, continued lasix
.  
Transitional Issues:
- Patient is full code
- Will need primary care doctors to discuss ___ as 
outpatient
- Continue vancomycin for 2 weeks total course
 
Medications on Admission:
Medications (per D/C summary and ___ records): 
* Acetaminophen 650mg q8 hours PRN pain 
* Acetaminophen 325mg q8 hours PRN pain 
* Lidocaine patch X2 
* Trazodone 25mg qHS 
* Carvedilol 3.125mg twice daily 
* Citalopram 20mg daily 
* Docusate 10mL twice daily 
* Ferrous sulfate 325mg elixir daily 
* Folate 1mg daily 
* Lasix 40mg daily 
* Gabapentin 300mg twice daily 
* Lisinopril 2.5mg daily 
* Multivitamin daily 
* Omeprazole 20mg 
* Protein supplements daily 
* Albuterol HFA inhaler 
* Simethicone 80mg every 8 hours 
* Oxycodone 5 every four hours PRN tracheal pain, dressing 
changes
* Miconazole powrder qHS 
* Levofloxacin 750mg daily, completed course ___ 
* Gentamicin nebulizer 80mg q12 hours nebulizer

 
Discharge Medications:
1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 
4 hours) as needed for pain.  
2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: 
One (1) Adhesive Patch, Medicated Topical DAILY (Daily): 12 
hours on, 12 hours off.  
3. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as 
needed for insomnia.  
4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
5. docusate sodium 50 mg/5 mL Liquid Sig: Ten (10) mL PO BID (2 
times a day).  
6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: One (1) 
dose PO DAILY (Daily).  
7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

8. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
Two (2) Puff Inhalation Q4H (every 4 hours) as needed for sob, 
wheeze.  
11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, 
Chewable PO TID (3 times a day).  
12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS 
(at bedtime).  
13. oxycodone 5 mg Tablet Sig: ___ Tablets PO every four (4) 
hours as needed for pain: Hold for Sedation or RR<12.  
14. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
15. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  
16. Please change and care for lines per nursing routine
17. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO twice a 
day.  
18. vancomycin 750 mg Recon Soln Sig: One (1) solution 
Intravenous twice a day for 24 days.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY
Healthcare Associated Pneumonia
Staph Bacteremia

SECONDARY
Systolic CHF 
Atrial Fibrillation

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Lethargic but arousable.
Activity Status: Bedbound.

 
Discharge Instructions:
Mr. ___--

It was a pleasure treating you at ___. You were admitted with 
difficulty breathing and low blood pressure.  You were found to 
have a pneumonia and an infection in your blood. You were 
treated with antibiotics and improved.  You will need to 
continue your antibiotics for 2 weeks total.
  
The following changes to your medications were made:
- STARTED vancomycin (continue until ___
- STARTED aspirin
- STOPPED inhaled gentamycin
 
Followup Instructions:
___
",MEDICINE
10004401-DS-30,William Armstrong,10004401,27939719," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol / Torsemide / Heparin Agents
 
Attending: ___.
 
Chief Complaint:
Bleeding from colostomy and foley 

 
Major Surgical or Invasive Procedure:
none 
 
History of Present Illness:
___ year old male with multiple co-morbidities including rectal 
cancer s/p resection and radiation in ___ now with colostomy, 
coronary artery disease s/p stents, systolic CHF, dilated 
cardiomyopathy, atrial fibrillation not on coumadin, cardiac 
arrest and complete heart block s/p AICD/pacemaker, recent 
trach/peg after prolonged hospitalization for rib 
fractures/flail chest s/p fall who presents with large amount of 
bleeding from colostomy and Foley. The patient also endorsed 
increased shortness of breath, weakness and fatigue. The patient 
had been recently admitted ___ to the ___ MICU for 
pneumonia and MRSA bacteremia/sepsis and had been discharged on 
Vancomycin and baby aspirin (for his atrial fibrillation and 
coronary artery disease).
.
In the ___ ED, initial vital signs were: Afebrile, HR70, 
BP107/53, RR24, 91% on trach vent. Given his tender abdomen, 
there was initial concern for an intrabdominal event. 
ACS/General Surgery was consulted and CT abdomen/pelvis was 
performed. As the imaging was negative, there were no acute 
surgical concerns; ACS recommended tagged RBC if he continued to 
bleed. GI was also consulted and recommended two units pRBC for 
Hct 22, IV PPI initiation. The patient also underwent PEG lavage 
which was clear but was passing small amounts of maroon colored 
stools. There was also initial concern for DIC but labs not 
suggestive of this (the patient has history of heparin induced 
thrombocytopenia but platelets normal). The patient has had 
hematuria in the past, with three-way foley in place.  
.
Upon arrival to the MICU, the patient was resting comfortably in 
bed with trach/PEG, endorsing fatigue and abdominal pain. Per 
the patient's wife, the patient looked good on discharge two 
days ago but seemed under the weather on arrival to ___ 
___. When she saw him at 6pm yesterday evening, he was stable 
without signs of bleeding. 
.  
Review of systems:  
(+) Per HPI  
(-) Denies fever, headache, cough, shortness of breath, or 
wheezing. Denies chest pain, chest pressure, palpitations, or 
weakness. Denies nausea, vomiting. 

 
Past Medical History:
- Rectal cancer s/p excision and XRT (___)
- CAD s/p stents (?___)
- CVA in ___ with residual right hand dysthesia
- Complete heart block s/p pacemaker 
- h/o cardiac arrest (now with AICD) 
- GI bleed secondary to angiectasias in the duodenum (___) 
s/p cauterization via EGD 
- Atrial fibrillation
- Systolic CHF (EF 40-45%)  
- s/p Fall with multiple rib fractures (___)  
- MICU admission ___ for hemoptysis, bleeding from 
trach
- Abdominoperineal resection ___ w/ ___

 
Social History:
___
Family History:
Father died in ___ from ___. Mother died in ___ from PE. No 
family history of colon, breast, uterine, or ovarian cancer. No 
family history of seizures
 
Physical Exam:
ADMISSION:  
Vitals: T: 98.9 BP: 115/54 P: 71 R: 16 O2: 99%  (FiO2 35%, Tv 
450, RR12, PEEP5)
General: Alert, oriented, no acute distress, pale, breathing 
comfortably via trach  
HEENT: PERRL, pale conjunctiva, normocephalic, poor dentition, 
clear oropharynx   
Neck: Soft, supple, trach in place with minimal secretions  
Lungs: Mild rhonchi in all lung fields, no wheezing/rales; mild 
bibasilar crackels 
CV: Regular rate and rhythm, normal S1 + S2, no rubs or gallops, 
___ holosystolic murmur 
Abdomen: Soft, non-tender, non-distended, positive bowel sounds, 
no rebound tenderness or guarding, maroon streaked stool in 
colostomy 
GU: Three way foley with dark pink urine in collection bag
Ext: Warm, well perfused, +pulses, bilateral upper extremity 
edema, L>R; bilateral anterior shin hemosiderin changes
. 
DISCHARGE:
VS: 98.7 70 111/49 17 96% (Pressure Support 12, PEEP 5, FiO2 
35%)
General: Comfortable, no acute distress
HEENT: PERRL, EOMI, MMM, poor dentition
Cardiovascular: RRR, II/VI systolic murmur
Respiratory / Chest: CTA bilaterally, no wheezes/rales/ronchi
Abdominal: Soft, nontender/nondistended, naBS, ostomy c/d/i 
Extremities: WWP, 2+ lower extremity edema, 2+ upper extremity 
edema L>R (chronic), ___ pulses
Neurologic: Attentive, moving all extremities
 
Pertinent Results:
Blood Counts
___ 10:15PM BLOOD WBC-8.1 RBC-2.55* Hgb-7.3* Hct-22.4* 
MCV-88 MCH-28.7 MCHC-32.6 RDW-16.3* Plt ___
___ 01:56AM BLOOD WBC-8.0 RBC-3.06* Hgb-9.2*# Hct-26.3* 
MCV-86 MCH-29.9 MCHC-34.8 RDW-16.5* Plt ___
___ 04:39AM BLOOD WBC-6.9 RBC-3.06* Hgb-8.9* Hct-26.6* 
MCV-87 MCH-29.0 MCHC-33.5 RDW-16.6* Plt ___

Chemistry
___ 10:15PM BLOOD Glucose-108* UreaN-49* Creat-1.1 Na-139 
K-4.0 Cl-103 HCO3-29 AnGap-11

ABx 
___ 06:51AM BLOOD Vanco-24.2*
.
IMAGING:
___ CXR:
IMPRESSION: Blunting of the left costophrenic angle and left 
base opacities consistent with left pleural effusion with 
overlying atelectasis, underlying consolidation cannot be 
entirely excluded. Cardiomegaly and prominent right hilum again 
seen. Mild pulmonary vascular congestion, improved.
.
CT ABD and PELVIS:
1. Ascites is new since most recent exams dating back to ___, 
likely 
correlating with diffuse anasarca. 
2. Slight increase in size of 9-mm enhancing left liver lobe 
lesion which is incompletely characterized on this exam. This 
might be a flash filling 
hemangioma or focal nodular hyperplasia. No other acute 
intra-abdominal 
process. If more definitive characterization is desired, 
multiphasic CT of 
the liver could be considered. 
.
 
Brief Hospital Course:
HOSPITAL COURSE
___ M PMHx CAD s/p stenting, systolic CHF (EF40-45%), atrial 
fibrillation, recent hospitalization for MRSA bacteremia of 
respiratory source, who represented from ___ with hematuria and 
blood in colostomy bag, thought to be secondary to recent 
initiation of ASA, now resolved after holding ASA, 
hemodynamically stable x multiple days, being discharged to 
___.
.
ACTIVE
# Blood in Ostomy: Patient w/ history of UGIB secondary to 
angiectasias in the duodenum who presented w/ trace blood in his 
ostomy; patient remaining hemodynamically stable w/ PEG lavage 
negative; Trace blood in his colostomy bag suggests lower GI 
bleed; given temporal relationship to initiation of ASA, this 
was felt to most likely be an exacerbation of underlying issue; 
bleeding resolved with holding of ASA.  He received 2 units of 
pRBC on the day of admission.  His hemoglobin/hematocrit was 
thereafter stable.  Patient/family have declined scoping at this 
time but may be amenable to this as an outpatient (of note, 
colonoscopy in ___ was normal).  Continued patient's home 
omeprazole; held ASA (see below).  His cardiologist was notified 
because the patient is now no longer on aspirin or coumadin, but 
bleeding risk strongly outweighs stroke risk at this time.  
Patient will need to readdress issue of colonoscopy as an 
outpatient with outpatient providers.  Scheduled follow up with 
Dr. ___ on ___.  Please call Dr. ___ office to see if 
can get EGD sooner.
.
# Hematuria: Patient with a history of hematuria of uncertain 
etiology who presents w recurrence of bleeding, thought to be 
secondary recent initiation of ASA; holding of ASA resolved 
bleeding issue; patient will need to have outpatient follow-up 
with urology for discussion of cystoscopy; (appt was not yet 
scheduled).  PATIENT WITH FIRM FOLEY CATHETER WITH 30CC balloon. 
 Sending extra replacements with the patient.  Please be aware 
if removing.

.
# MRSA bacteremia: Pt w recent admission notable for MRSA 
bacteremia w/o TTE evidence of valvular involvement; continued 
vancomycin treatment course (last day is ___ level was 
supratherapeutic during this hospitalization; adjusted dosing to 
500mg BID.  Patient will need Vancomycin trough on morning of 
___ and adjust dose as necessary. 
.
# Chronic Diastolic CHF: Patient w EF 55-60% (___) 
appearing fluid overloaded on admission; restarted patient's 
home diuresis with good urine output.  Continued home 
carvedilol.  Continued to hold lisinopril (had been held during 
recent admission) given normotensive without.  Could consider 
restarting as outpatient if he became hypertensive.  
.
# Sacral decubitus ulcer: Stage IV, significant. Appropriate 
wound care.  Continued oxycodone, lidocaine. Patient became 
loopy receiving oxycodone 5mg Q4H.  Is written for ___ 
Q4H:PRN for pain, but will need to be assessed prior to 
medication to make sure not continuing to get loopy.  Please 
assess at ___ and continue to turn the patient regularly 
minimizing weight bearing to that area.
.
# Atrial fibrillation: CHADS4 but off 
anticoagulation/antiplatelet secondary to history of GI bleeds, 
hemothorax in ___. Given bleeding on this admission he will 
likely be a poor candidate for ASA in the future.  Alerted 
outpatient cardiologist Dr. ___ this issue.  He 
has follow up with Dr. ___ on ___ and we will contact him 
as well on the day of discharge.   
.
TRANSITIONAL
- PATIENT WITH FIRM FOLEY CATHETER WITH 30CC balloon.  Sending 
extra replacements with the patient.  Please be aware if 
removing.
- Scheduled for follow-up with cardiologist 
- Scheduled follow up with gastroenterologist, please call to 
see if can get EGD sooner than schedule appt.
- If has continued hematuria, will need urology follow up for 
cystoscopy.  
- Continue vancomycin for MRSA bactermia until ___, next 
traough needs to be morning of ___.  Goal level ___.  
- Wean off vent to trach mask, plan to diurese to dry weight to 
aid in weaning process
- Holding lisinopril given stable, BP, but can restart if 
becomes hypertensive.
 
Medications on Admission:
* Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H PRN 
* Lidocaine 5 %(700 mg/patch) daily 
* Trazodone 25 mg Tablet qHS
* Citalopram 20 mg daily
* Docusate 10mL twice daily 
* Ferrous sulfate 300mg daily 
* Folic acid 1mg daily 
* Multivitamin daily 
* Omeprazole 20 mg daily 
* Albuterol inhaler 2 puffs q4 hours PRN 
* Simethicone 80mg three times daily 
* Miconazole nitrate 2% powder qHS 
* Oxycodone ___ q4 hours PRN 
* Aspirin 81mg daily 
* Lasix 40mg daily 
* Carvedilol 6.25mg twice daily 
* Vancomycin 750mg twice daily X 13 more days 
 
Discharge Medications:
1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 
4 hours) as needed for pain.  
2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: 
One (1) Adhesive Patch, Medicated Topical DAILY (Daily): 12 
hours on and 12 hours off.  
3. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as 
needed for insomnia.  
4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
5. docusate sodium 50 mg/5 mL Liquid Sig: One (1)  PO BID (2 
times a day): Hold for loose stools.  
6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: One (1)  
PO DAILY (Daily).  
7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

8. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
Two (2) Puff Inhalation Q4H (every 4 hours) as needed for sob, 
wheeze.  
11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, 
Chewable PO TID (3 times a day).  
12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS 
(at bedtime).  
13. oxycodone 5 mg Tablet Sig: ___ Tablets PO Q4H (every 4 
hours) as needed for pain: PLease evaluate pt and hold for 
RR<12, sedation or if the patient appears loopy.  
14. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a day.  
15. vancomycin 500 mg Recon Soln Sig: One (1) Recon Soln 
Intravenous Q 12H (Every 12 Hours) for 11 days: 500mg started on 
___, please get trough morning of ___.  
16. psyllium     Packet Sig: One (1) Packet PO TID (3 times a 
day) as needed for low ostomy output: low ostomy output.  
17. sucralfate 1 gram Tablet Sig: One (1) Tablet PO QID (4 times 
a day).  
18. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day).  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis:
GI bleed
.
Secondary Diagnosis:
CAD
A-fib 
s/p cardiac arrest and AICD pacemaker

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
You are being dishcarged from ___ 
___.  You were re-admitted to the hospital for bleeding from 
your ostomy as well as your Foley catheter.  We felt this was 
because your aspiring was continued.  We held your aspirin, gave 
you one unit of blood and you have been doing well since.  You 
will go back to the ___ and will have follow up with GI and 
Cardiology for further management of these issues.

The following medication was STOPPED:
Aspirin 81mg Daily
.
Please continue to HOLD lisinopril 2.5mg PO Daily
Weigh yourself every morning, call MD if weight goes up more 
than 3 lbs.
 
Followup Instructions:
___
",MEDICINE
10004401-DS-31,William Armstrong,10004401,23920883," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol / Torsemide / Heparin Agents
 
Attending: ___.
 
Chief Complaint:
Bacteremia
 
Major Surgical or Invasive Procedure:
Transesophagealechocardiogram
 
History of Present Illness:
___ year old male with h/o CAD s/p stenting, systolic CHF 
(EF40-45%), atrial fibrillation, h/o cardiac arrest with heart 
block s/p AICD/pacemaker, trach/PEG, recent MRSA bacteremia, and 
recent MICU admission for hematuria and GI bleed who presents 
with fevers and baceteria.

He was recently admitted ___ for pneumonia and MRSA 
bacteremia and sepsis.  Discharged on IV vancomycin which he has 
been on since.  He was then readmitted ___ to ___ for 
hematuria and blood from his colostomy bag felt to be secondary 
to recent aspirin initiation.  He was discharged to ___ 
___.

He has had persistent fevers with Tm 101.5 and positive MRSA 
blood cultures at rehab.  Denies cough, cold symptoms, nausea, 
or vomiting.  Has had diarrhea over the last several days.  
Denies CP or SOB.   His family reports that he was doing poorly 
a few days ago but has turned around in the past few days.  
Denies increasing secretions and he is vent-dependent.

In the ED, initial vitals were 98.8 70 120/52 96%.  He is being 
admitted to the MICU for an endocarditis workup given history of 
positive blood cultures.  Currently, he reports feeling tired 
but otherwise okay.  Complains of pain in his back and his legs.

Review of systems:  
(+) Per HPI  
(-) Denies chills, night sweats, recent weight loss or gain. 
Denies headache, sinus tenderness, rhinorrhea or congestion. 
Denies cough, shortness of breath, or wheezing. Denies chest 
pain, chest pressure, palpitations, or weakness. Denies nausea, 
vomiting, constipation, abdominal pain, or changes in bowel 
habits. Denies dysuria, frequency, or urgency. Denies 
arthralgias or myalgias. Denies rashes or skin changes.
 
Past Medical History:
Rectal cancer s/p excision and XRT (___)
CAD s/p stents (?___)
CVA in ___ with residual right hand dysthesia
Complete heart block s/p pacemaker 
H/o cardiac arrest (now with AICD) 
GI bleed secondary to angiectasias in the duodenum (___) s/p 
cauterization via EGD 
Atrial fibrillation, not on coumadin
Systolic CHF (EF 40-45%)  
S/p Fall with multiple rib fractures (___)  
MICU admission ___ for hemoptysis, bleeding from 
trach
Abdominoperineal resection ___ w/ ___

 
Social History:
___
Family History:
Father died in ___ from MI. Mother died in ___ from PE. No 
family history of colon, breast, uterine, or ovarian cancer. No 
family history of seizures.
 
Physical Exam:
On Admission:
Vitals: 97.7 70 108/49 18 100% AC 500x12, PEEP 5, FiO2 35%
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, trach in place 
with clear/white secretions
Neck: supple, no LAD  
Lungs: Coarse rales at bases, no wheezes  
CV: Regular rate and rhythm, normal S1 + S2, III/VI systolic 
murmur at apex
Abdomen: soft, non-tender, distended, ostomy in place, bowel 
sounds present, no rebound tenderness or guarding
GU: Foley in place
Skin: 3cm sacral decub without surrounding erythema.  PICC in 
place on right arm, only mild redness at insertion.
Ext: Warm, well perfused with 2+ pitting edema, ulcerations on 
bilateral shins

On discharge:
General: Alert, oriented, no acute distress
HEENT: Sclera anicteric, MMM, oropharynx clear, trach in place
Neck: Supple, no LAD
Lungs: Coarse rales at bases, no wheezes  
CV: Regular rate and rhythm, normal S1 + S2, III/VI systolic 
murmur at apex
Abdomen: Soft, non-tender, distended, ostomy in place, bowel 
sounds present, no rebound tenderness or guarding
GU: Foley in place
Skin: 3cm sacral decub without surrounding erythema.  PICC in 
place on left.
Ext: Significant ulcerations on bilateral shins, some pain and 
swelling of both knees that is stable
 
Pertinent Results:
Admission Labs:
___ 04:15PM   WBC-8.9 RBC-2.79* HGB-8.0* HCT-24.2* MCV-87 
MCH-28.8 MCHC-33.3 RDW-15.8*
___ 04:15PM   NEUTS-80.3* LYMPHS-9.0* MONOS-9.9 EOS-0.5 
BASOS-0.2
___ 04:15PM   PLT COUNT-168
___ 04:15PM   ___ PTT-30.4 ___
___ 04:15PM   LIPASE-69*
___ 04:15PM   ALT(SGPT)-26 AST(SGOT)-96* ALK PHOS-266* TOT 
BILI-1.1
___ 04:15PM   GLUCOSE-127* UREA N-70* CREAT-1.7* SODIUM-134 
POTASSIUM-4.3 CHLORIDE-99 TOTAL CO2-27 ANION GAP-12
___ 05:00PM   COMMENTS-GREEN TOP 

___ 4:15 pm BLOOD CULTURE
Blood Culture, Routine (Final ___: 
      STAPH AUREUS COAG +.    FINAL SENSITIVITIES. 
                              SENSITIVITIES: MIC expressed in 
MCG/ML
                             STAPH AUREUS COAG +
CLINDAMYCIN-----------   =>8 R
ERYTHROMYCIN----------   =>8 R
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------   =>8 R
OXACILLIN-------------   =>4 R
RIFAMPIN-------------- <=0.5 S
TETRACYCLINE----------     2 S
TRIMETHOPRIM/SULFA---- <=0.5 S
VANCOMYCIN------------ <=0.5 S

___ 4:15 pm URINE     Site: CATHETER
   URINE CULTURE (Final ___: 
      PSEUDOMONAS AERUGINOSA.    >100,000 ORGANISMS/ML.. 
         Piperacillin/Tazobactam sensitivity testing performed 
by ___
         ___.
                              SENSITIVITIES: MIC expressed in 
MCG/ML
                             PSEUDOMONAS AERUGINOSA
                             |   
CEFEPIME--------------    16 I
CEFTAZIDIME-----------    32 R
CIPROFLOXACIN---------   =>4 R
GENTAMICIN------------     8 I
MEROPENEM-------------  =>16 R
PIPERACILLIN/TAZO-----       R
TOBRAMYCIN------------   <=1 S

___ 4:00 pm SWAB      Source: decubitus ulcer. 
   GRAM STAIN (Final ___: 
      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
      1+    (<1 per 1000X FIELD):   GRAM NEGATIVE ROD(S). 
   WOUND CULTURE (Final ___: 
      PSEUDOMONAS AERUGINOSA.    SPARSE GROWTH. 
         Piperacillin/Tazobactam sensitivity testing performed 
by ___
         ___. 
      ENTEROCOCCUS SP..    SPARSE GROWTH. 
                              SENSITIVITIES: MIC expressed in 
MCG/ML                             PSEUDOMONAS AERUGINOSA
                             |          ENTEROCOCCUS SP.
                             |          |   
AMPICILLIN------------              <=2 S
CEFEPIME--------------    32 R
CEFTAZIDIME-----------  =>64 R
CIPROFLOXACIN---------   =>4 R
GENTAMICIN------------     8 I
LINEZOLID-------------                1 S
MEROPENEM-------------     8 I
PENICILLIN G----------                8 S
PIPERACILLIN/TAZO-----       R
TOBRAMYCIN------------   <=1 S
VANCOMYCIN------------             =>32 R

___ 2:51 pm URINE      Source: Catheter. 
   URINE CULTURE (Final ___: 
      PSEUDOMONAS AERUGINOSA.    >100,000 ORGANISMS/ML.. 
         Piperacillin/Tazobactam sensitivity testing performed 
by ___
         ___. 
      KLEBSIELLA PNEUMONIAE.    10,000-100,000 ORGANISMS/ML.. 
         Piperacillin/tazobactam sensitivity testing available 
on request. 
                              SENSITIVITIES: MIC expressed in 
MCG/ML
                             PSEUDOMONAS AERUGINOSA
                             |          KLEBSIELLA PNEUMONIAE
                             |          |   
AMPICILLIN/SULBACTAM--               16 I
CEFAZOLIN-------------             =>64 R
CEFEPIME--------------    16 I        2 S
CEFTAZIDIME-----------    16 I     =>64 R
CEFTRIAXONE-----------               16 R
CIPROFLOXACIN---------   =>4 R      =>4 R
GENTAMICIN------------     8 I      <=1 S
MEROPENEM-------------     8 I   <=0.25 S
NITROFURANTOIN--------            =>512 R
PIPERACILLIN/TAZO-----       R
TOBRAMYCIN------------   <=1 S     =>16 R
TRIMETHOPRIM/SULFA----              <=1 S

___ 3:54 am BLOOD CULTURE      Source: Line-midline. 
   Blood Culture, Routine (Final ___:    NO GROWTH. 

___ 3:00 am BLOOD CULTURE      FROM MIDLINE. 
   Blood Culture, Routine (Final ___:    NO GROWTH.

___ 3:51 am BLOOD CULTURE: Pending 

___ 3:51 am BLOOD CULTURE: Pending

Studies:

CXR ___: No significant change from ___ radiograph, with 
cardiomegaly, pulmonary vascular congestion and bilateral 
pleural effusions again noted.  Left lower lobe opacity is 
compatible with atelectasis and/or pneumonia. 

TTE ___: The left atrium is moderately dilated. The left 
atrium is elongated. The right atrium is moderately dilated. 
There is mild symmetric left ventricular hypertrophy with normal 
cavity size. The right ventricular cavity is moderately dilated 
There is abnormal septal motion/position consistent with right 
ventricular pressure/volume overload. The ascending aorta is 
mildly dilated. The aortic valve leaflets (3) are mildly 
thickened but aortic stenosis is not present. No masses or 
vegetations are seen on the aortic valve. Trace aortic 
regurgitation is seen. The mitral valve leaflets are mildly 
thickened. No mass or vegetation is seen on the mitral valve. An 
eccentric, posteriorly directed jet of Moderate (2+) mitral 
regurgitation is seen. Due to the eccentric nature of the 
regurgitant jet, its severity may be significantly 
underestimated (Coanda effect). Moderate [2+] tricuspid 
regurgitation is seen. There is mild pulmonary artery systolic 
hypertension. There is no pericardial effusion. Compared with 
the prior study dated ___ (images reviewed), the degree of 
pulmonary pressures is much lower (likely underestimated as the 
IVC was not well visualized). No vegetations or abscesses 
visualized.

TEE ___: No vegetations seen on the cardiac leaflets. No mass 
or vegetation seen on the cardiac wires. Simple atheroma aortic 
arch. At least moderate in severity eccentric mitral 
regurgitation. Moderate tricuspid regurgitation. Mild to 
moderate pulmonary artery systolic hypertension.  

BLE Ultrasound ___: Limited study demonstrates no evidence 
of right or left lower extremity DVT. 

CXR ___: As compared to the previous radiograph, the 
position of the 
tracheostomy tube and of the pacemaker wires is unchanged. 
Unchanged moderate cardiomegaly with bilateral areas of 
atelectasis and substantial enlargement of the vascular 
structures at the lung hilus. Unchanged moderate pulmonary 
edema. No newly appeared focal parenchymal opacities. 

WBC scan ___: 1. Splenomegaly. 2. No focal source of 
infection localized.

Bilateral UE ultrasound ___: No evidence of upper extremity 
deep venous thrombosis.

Labs prior to discharge:
___ 02:57AM BLOOD WBC-7.1 RBC-2.89* Hgb-8.1* Hct-24.9* 
MCV-86 MCH-28.0 MCHC-32.5 RDW-15.8* Plt ___
___ 02:57AM BLOOD Neuts-75.9* Lymphs-11.7* Monos-10.6 
Eos-1.2 Baso-0.5
___ 02:57AM BLOOD Glucose-154* UreaN-49* Creat-1.4* Na-135 
K-3.5 Cl-96 HCO3-29 AnGap-14
___ 02:57AM BLOOD Calcium-8.2* Phos-3.3 Mg-2.1
___ 11:06AM BLOOD Tobra-1.9*
___ 09:00PM BLOOD Tobra-2.5*
___ 04:03AM BLOOD Vanco-21.5*
___ 07:50PM BLOOD Vanco-21.7*
___ 02:07PM BLOOD ___ Temp-37.4 Rates-/35 Tidal V-309 
PEEP-5 FiO2-50 pO2-48* pCO2-42 pH-7.48* calTCO2-32* Base XS-6 
Intubat-INTUBATED Vent-SPONTANEOU
 
Brief Hospital Course:
Primary Reason for Hospitalization: Mr. ___ is a ___ year 
old male with h/o CAD s/p stenting, systolic CHF (EF40-45%), 
atrial fibrillation, h/o cardiac arrest with heart block s/p 
AICD/pacemaker, trach/PEG, and recent ICU admission with GI 
bleed, hematuria, and MRSA bacteremia, who presented from rehab 
with fevers and persistent MRSA bacteremia while on vancomycin.

#. MRSA Bacteremia: The source of the patient's persistent 
bacteremia was not found. He grew MRSA from multiple blood 
cultures at rehab and also on initial presentation despite 
appropriate vancomycin troughs. Multiple sources of persistent 
seeding were considered. He had a TTE and TEE which were both 
negative for vegetations and did not show any involvement of his 
pacer leads. A tagged WBC scan was performed to look for occult 
focus of infection which was negative. An upper extremity 
ultrasound was also performed to look for possible infected clot 
but was negative. His PICC line which had been recently replaced 
at ___ was removed. A new one was not placed until he 
had negative blood cultures.  He was continued on vancomycin and 
dosing was changed to 1g q48h.  Further blood cultures were 
negative.   Ultimately it was felt he likely has an endovascular 
source but it was not found during this hospitalization.  He 
should be continued on IV vancomycin for 6 weeks from the date 
of his last positive blood culture, with last day ___.

#. Pseudomonas and Klebsiella UTI: Given that he has an 
indwelling foley it was suspected that this might be 
colonization however his cultures were positive even after 
changing his foley. He was found to have pseudomonas in his 
urine as well as wound culture.  It was multidrug resistant 
pseudomonas and he was treated with tobramycin for a seven day 
course.  He needs one more dose of tobramycin 320mg IV x 1 when 
trough < 1.  He also grew multidrug resistant klebsiella in his 
urine and was started on a 7 day course of cefepime with last 
day ___. 

#. Fevers: He had fevers on admission felt to be related to his 
MRSA bacteremia.  Other cultures returned positive as above.  He 
also had a knee arthrocentesis which was not consistent with 
septic arthritis.  His PICC was changed after a 24 hour line 
holiday.  He was ruled out for C diff.

#. Acute renal failure: BUN/creatinine elevated to 70/1.7 on 
admission felt to be related to ongoing infection and poor 
forward floor from chronic systolic CHF.  His creatinine slowly 
improved with diuresis.

#. Chronic respiratory failure: He was continued on mechanical 
ventilation during this admission and was unable to be weaned to 
trach mask for any length of time.  This was felt to be related 
to chronic respiratory fatigue in addition to substantial 
pulmonary edema.  Diuresis was difficult due to his large 
obligate fluid intake, but was eventually acheived with lasix 
80mg IV q6h plus metolazone 2.5mg po bid.  His metolazone may 
need to be decreased over the next several days if he is 
overdiuresed as he was on average 1L negative on this regimen 
for the few days prior to discharge.  On the day of discharge, 
he was on pressure support ___, PEEP 5, FiO2 50% with TV in the 
300's.

#. Anemia: His hematocrit remained stable in the low 20's during 
this admission.

#. Chronic Diastolic CHF: Has EF 55%. He was continued on his 
home carvedilol.  His lisinopril has been on hold indefinitely 
and was not restarted due to renal failure.  He was diuresed 
with IV lasix and metolazone as above and will need his 
creatinine and electrolytes monitored closely with ongoing 
diuresis.

#. Sacral decubitus ulcer: Stage IV.  He was started on a 
fentanyl patch and continued on prn oxycodone for pain control.

#. Atrial fibrillation: His heart rate and blood pressure 
remained stable during this admission.  He is off 
anticoagulation due to h/o GI bleeding and hemothorax.  He was 
continued on carvedilol. 

#. Wound care: He was evaluated by the wound care team who 
recommended the following:
1. Follow pressure ulcer guidelines. First Step for fluid 
management. Turn q 2 hours.
2. Cleanse wounds with commercial wound cleanser. Pat dry.
3. Apply Aquacel ag to sacrum wound, cover with 4x4's and soft 
sorb dressing, secure with Medipore tape. Change daily.
4. BLE ulcerations - cover with Adaptic dressing, place 4x4 and 
wrap with Kerlix. Secure with paper tape.
5. No tape on skin.
6. Mid upper back ulcer - Apply Mepilex 4x4 and change q3 days.
7. Mid lower back ulcer - apply DuoDerm wound gel to bed to 
assist with autolytic debridement of yellow slough. Cover with 
Mepilex 4x4 dressing, and change q 3 days.
8. Apply Critic Aid clear skin barrier ointment to scrotal 
tissue to protect from fluid exposure daily. Elevate scrotum to 
assess with edema.
9. Waffles bilateral feet.
10. Apply aloe vesta ointment to dry intact skin daily.
11. Support nutrition and hydration.

TRANSITIONAL ISSUES:
- Monitor I/O's closely and check electrolytes closely given 
large doses of lasix and metolazone.  ___ need to back off on 
metalazone if signs of overdiuresis.  However, would continue to 
aim for -500cc daily I/O balance.
- Needs tobramycin trough drawn ___ AM.  Give tobramycin 
320mg IV x 1 when trough is <1.0.
- Continue vancomycin until ___ for MRSA bacteremia.  
Should have trough measured intermittently to assess for 
appropriate dosing.
- Needs 2 more days of cefepime treatment
- Continue ventilator weaning and trach collar trials if 
possible.  Diuresis should help with this.
- Please draw weekly labs: CBC/diff, chem-7, LFTs and fax to 
Infectious disease R.Ns. at ___.  All questions 
regarding outpatient antibiotics should be directed to the 
infectious disease R.Ns. at ___ or to on call MD in 
when clinic is closed
 
Medications on Admission:
Acetaminophen 650mg po q4h prn pain
Lidocaine patch 5% TD daily
Trazodone 25mg po qhs prn insomnia
Citalopram 20mg po daily
Docusate 50mg po bid
Ferrous sulfate 300mg po daily
Folic acid 1mg po daily
Multivitamin 1 tab po daily
Omeprazole 20mg po daily
Albuterol sulfate 90mcg q4h prn SOB/wheeze
Simethicone 80mg po tid
Miconazole nitrate 2% application qhs
Oxycodone ___ po q4h prn pain
Lasix 40mg po daily
Vancomycin 500mg IV q12h 
Psyllium one packet po tid
Sucralfate 1gram po qid
Carvedilol 6.25mg po bid
 
Discharge Medications:
1. acetaminophen 650 mg/20.3 mL Solution Sig: Six Hundred Fifty 
(650) mg PO Q6H (every 6 hours) as needed for pain, fever.  
2. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: 
One (1) Adhesive Patch, Medicated Topical DAILY (Daily).  
3. trazodone 50 mg Tablet Sig: ___ Tablet PO at bedtime as 
needed for insomnia.  
4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
5. docusate sodium 50 mg/5 mL Liquid Sig: One Hundred (100) mg 
PO twice a day: Hold for loose stools.  
6. ferrous sulfate 300 mg (60 mg iron)/5 mL Liquid Sig: Three 
Hundred (300) mg PO once a day.  
7. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

8. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
9. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  
10. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: 
___ Puffs Inhalation Q4H (every 4 hours) as needed for sob, 
wheeze.  
11. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, 
Chewable PO TID (3 times a day).  
12. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical HS 
(at bedtime) as needed for rash.  
13. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 
hours) as needed for pain.  
14. fentanyl 12 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr 
Transdermal Q72H (every 72 hours).  
15. psyllium     Packet Sig: One (1) Packet PO TID (3 times a 
day).  
16. sucralfate 1 gram Tablet Sig: One (1) Tablet PO QID (4 times 
a day).  
17. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO BID (2 
times a day): Hold for SBP<100, HR<55.  
18. cefepime 1 gram Recon Soln Sig: One (1) gram Injection Q24H 
(every 24 hours) for 2 days: Last day ___.  
19. vancomycin in D5W 1 gram/200 mL Piggyback Sig: One (1) gram 
Intravenous q48h: Until ___.  
20. furosemide 10 mg/mL Solution Sig: Eighty (80) mg Injection 
Q6H (every 6 hours).  
21. metolazone 2.5 mg Tablet Sig: One (1) Tablet PO BID (2 times 
a day): 30 minutes prior to Lasix dose.  
22. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  
23. tobramycin sulfate 40 mg/mL Solution Sig: Three Hundred 
Twenty (320) mg Injection ONCE (Once) for 1 doses: Give one dose 
of 320mg when trough level < 1.0.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis:
MRSA bacteremia
Klebsiella and pseudomonas UTI
Chronic diastolic congestive heart failure
Respiratory failure

Secondary Diagnosis:
Coronary Artery Disease
Atrial fibrillation

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Lethargic but arousable.
Activity Status: Bedbound.

 
Discharge Instructions:
You were admitted to the hospital due to persistent fevers and a 
bacterial infection in your blood.  You underwent multiple 
studies to evaluate the source of your infection.  It does not 
appear that your heart valves or your pacemaker are infected.  
You were treated with antibiotics for your bloodstream 
infection, as well as urinary and wound infections.  We also 
tried to give you diuretics to help your breathing.

Changes to your medications:
Increased docusate to 100mg po bid
Increased albuterol to ___ puffs q4h prn SOB/wheeze
Start fentanyl patch 12mcg/hr TD q72h
Start cefepime 1g IV q24h for 2 more days, last day ___
Change vancomycin to 1g q48h, last day ___
Change furosemide to 80mg IV q6h
Add metolazone to 2.5mg po bid, 30 mins prior to lasix dose
Add tobramycin, needs one more dose of 320mg when trough ___

You should be weighed every day and the providers at rehab 
should be notified if your weight goes up by more than 3 pounds.
 
Followup Instructions:
___
",MEDICINE
10004401-DS-32,William Armstrong,10004401,26488315," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol / Torsemide / Heparin Agents
 
Attending: ___
 
___ Complaint:
fevers, vomiting, AMS

 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
History of Present Illness:  Mr. ___ is an ___ male with 
history of CAD s/p stenting, CHF (EF 55%), Afib, prior cardiac 
arrest and heart block s/p pacer/AICD placement, chronic trach, 
and recent MRSA bacteremia on vancomycin who presents from rehab 
with a one day history of fevers and vomiting, as well as AMS.  
Patient has had several recent admissions, including admission 
from ___ for PNA and MRSA bacteremia/sepsis.  Was 
discharged to rehab on vanco, readmitted ___ for hematuria 
and GI bleed (blood in ostomy bag), and again readmitted 
___ with persistent fevers and positive MRSA blood 
cultures.  Source of MRSA bacteremia was unclear, and work-up 
during that time included TTE/TEE negative for vegetations on 
valves and cardiac pacer leads, and negative tagged WBC scan.  
PICC was removed and replaced.  Patient discharged on planned 6 
week course of vanco through ___.  Hospital course also 
notable for pseudomonas and klebsiella UTI, treated with 7 day 
courses of cefepime and tobramycin.  Patient had Foley changed 
during that admission.  Was discharged back to ___ 
___.  
.
Since discharge, has been noted to have worsening renal function 
requiring nephrology consult, and in this setting his diuretic 
regimen was held.  Also had increasing SOB requiring pulmonary 
consult, with change in vent settings from pressure support to 
AC mode.  Has had recurrent GI bleed requiring transfusion of 2 
units pRBCs on ___, and has been continued on PPI, 
sucralfate, and iron supplementation.  Per report, usually 
responds to wife, but was less responsive over past ___ days.  
On day of admission had several episodes of vomiting, and per 
wife was febrile to 101.  Sent to ED for further evaluation. 
.
In the ED, initial VS were: 98.2 69 106/51 20 95% assist 
control.  Labs notable for leukocytosis (WBC 14.2) with 
neutrophil predominance, Hct 26.3 (stable), Na 127, Cr 3.5 
(baseline 1.4), lactate 1.2.  UA suggestive of recurrent UTI.  
CXR showed moderate pulmonary edema with bilateral pleural 
effusions, and was similar to recent prior studies.  Given LUE 
edema, ultrasound obtained which was negative for DVT.  Patient 
received vancomycin and cefepime.  Also got ASA given elevated 
trop of 0.2.  ECG showed paced rhythm.  Patient had 1L NS hung 
prior to transfer.  VS prior to transfer 100.0 70, 112/82, 15, 
99%.  
.  
On arrival to the MICU, patient nods yes when asked if he is in 
pain, but he cannot localize the pain.  Appears comfortable when 
resting in bed, though uncomfortable when examined.
.

 
Past Medical History:
Rectal cancer s/p excision and XRT (___)
CAD s/p stents (?___)
CVA in ___ with residual right hand dysthesia
Complete heart block s/p pacemaker 
H/o cardiac arrest (now with AICD) 
GI bleed secondary to angiectasias in the duodenum (___) s/p 
cauterization via EGD 
Atrial fibrillation, not on coumadin
Systolic CHF (EF 40-45%)  
S/p Fall with multiple rib fractures (___)  
MICU admission ___ for hemoptysis, bleeding from 
trach
Abdominoperineal resection ___ w/ ___

 
Social History:
___
Family History:
Father died in ___ from MI. Mother died in ___ from PE. No 
family history of colon, breast, uterine, or ovarian cancer. No 
family history of seizures.
 
Physical Exam:
ADMISSION EXAM:
General: easily arousable to voice, frequently falls to sleep, 
oriented to person and place, unable to assess if oriented to 
time (could not interpret patient's answer), appears comfortable 
at rest 
HEENT: PERRL, EOMI, sclera anicteric, dry MM, oropharynx clear  
Neck: supple, JVP 8-9cm, trach in place
CV: RRR, normal S1 + S2, II/VI holosystolic murmur loudest at 
apex and radiating to axilla
Lungs: bilateral rhonchi with scattered crackles, no wheezing
Abdomen: bowel sounds present, soft, mildly distended, diffuse 
mild  tenderness to palpation, suprapubic tenderness, ostomy bag 
in place GU: foley in place
Ext: slighty cool, 2+ pulses, venous stasis changes, 2+ edema to 
knees bilaterally   

DISCHARGE EXAM
HEENT: PERRL, EOMI, sclera anicteric, dry MM, oropharynx clear  
Neck: supple, JVP 8-9cm, trach in place
CV: RRR, normal S1 + S2, II/VI holosystolic murmur loudest at 
apex and radiating to axilla
Lungs: bilateral rhonchi with scattered crackles, no wheezing
Abdomen: bowel sounds present, soft, mildly distended, diffuse 
mild  tenderness to palpation, suprapubic tenderness, ostomy bag 
in place GU: foley in place
Ext: slighty cool, 2+ pulses, venous stasis changes, 2+ edema to 
knees bilaterally

 
Pertinent Results:
ADMISSION LABS
___ 06:25PM BLOOD WBC-14.2*# RBC-3.15* Hgb-8.9* Hct-26.3* 
MCV-83 MCH-28.2 MCHC-33.8 RDW-15.4 Plt ___
___ 06:25PM BLOOD Neuts-82.8* Lymphs-6.4* Monos-10.2 
Eos-0.3 Baso-0.4
___ 06:25PM BLOOD ___ PTT-35.8* ___
___ 06:25PM BLOOD Glucose-108* UreaN-117* Creat-3.5*# 
Na-127* K-4.5 Cl-85* HCO3-28 AnGap-19
___ 06:25PM BLOOD ALT-52* AST-65* AlkPhos-258* TotBili-1.7*
___ 02:26AM BLOOD Albumin-2.8* Calcium-8.4 Phos-3.5 Mg-2.2

DISCHARGE LABS
___ 03:32AM BLOOD WBC-4.9 RBC-2.90* Hgb-8.2* Hct-25.5* 
MCV-88 MCH-28.2 MCHC-32.0 RDW-16.2* Plt ___
___ 12:11AM BLOOD ___ PTT-36.1* ___
___ 03:32AM BLOOD Glucose-74 UreaN-96* Creat-2.7* Na-140 
K-3.7 Cl-102 HCO3-23 AnGap-19
___ 03:02AM BLOOD CK(CPK)-21*
___ 03:32AM BLOOD Calcium-8.4 Phos-4.9* Mg-2.0

MICROBIOLOGY
___ BLood Culture
   STAPH AUREUS COAG +
                             |   
CLINDAMYCIN-----------   =>8 R
DAPTOMYCIN------------       S
ERYTHROMYCIN----------   =>8 R
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------   =>8 R
OXACILLIN-------------   =>4 R
RIFAMPIN-------------- <=0.5 S
TETRACYCLINE----------     2 S
TRIMETHOPRIM/SULFA---- <=0.5 S
VANCOMYCIN------------ <=0.5 S

___ Urine Culture
   URINE CULTURE (Final ___: 
      ENTEROCOCCUS SP..    >100,000 ORGANISMS/ML.. 
         Sensitivity testing performed by Sensititre. 
         Daptomycin = 1 MCG /ML. 
      YEAST.    10,000-100,000 ORGANISMS/ML.. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ENTEROCOCCUS SP.
                             |   
AMPICILLIN------------     1 S
DAPTOMYCIN------------       S
LINEZOLID-------------     1 S
TETRACYCLINE----------  =>32 R
VANCOMYCIN------------  >256 R

___ Sputum culture
___ 7:00 pm SPUTUM      Source: Endotracheal. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      THIS IS A CORRECTED REPORT ___ AT 3:00 ___. 
      Reported to and read back by ___. 
      >25 PMNs and <10 epithelial cells/100X field. 
      4+   (>10 per 1000X FIELD):   GRAM NEGATIVE ROD(S). 
      ___ PREVIOUSLY REPORTED AS. 
      <10 PMNs and >10 epithelial cells/100X field. 
      4+   (>10 per 1000X FIELD):   GRAM NEGATIVE ROD(S). 

   RESPIRATORY CULTURE (Final ___: 
      Commensal Respiratory Flora Absent. 
      PSEUDOMONAS AERUGINOSA.    HEAVY GROWTH. 
         Piperacillin/Tazobactam sensitivity testing performed 
by ___
         ___. 
      KLEBSIELLA PNEUMONIAE.    SPARSE GROWTH. 
         Piperacillin/tazobactam sensitivity testing available 
on request. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             PSEUDOMONAS AERUGINOSA
                             |          KLEBSIELLA PNEUMONIAE
                             |          |   
AMPICILLIN/SULBACTAM--             =>32 R
CEFAZOLIN-------------             =>64 R
CEFEPIME--------------    16 I      <=1 S
CEFTAZIDIME-----------    32 R     =>64 R
CEFTRIAXONE-----------               16 R
CIPROFLOXACIN---------   =>4 R      =>4 R
GENTAMICIN------------     8 I        2 S
MEROPENEM-------------     8 I   <=0.25 S
PIPERACILLIN/TAZO-----       R
TOBRAMYCIN------------   <=1 S     =>16 R
TRIMETHOPRIM/SULFA----              <=1 S

___ Sputum
Time Taken Not Noted     Log-In Date/Time: ___ 2:50 am
      SPUTUM

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      >25 PMNs and <10 epithelial cells/100X field. 
      NO MICROORGANISMS SEEN. 

   RESPIRATORY CULTURE (Final ___: 
      RARE GROWTH Commensal Respiratory Flora. 
      STAPH AUREUS COAG +.    RARE GROWTH. 
         Oxacillin RESISTANT Staphylococci MUST be reported as 
also
         RESISTANT to other penicillins, cephalosporins, 
carbacephems,
         carbapenems, and beta-lactamase inhibitor combinations. 

         Rifampin should not be used alone for therapy. 
         This isolate is presumed to be resistant to clindamycin 
based on
         the detection of inducible resistance . 
      YEAST.    SPARSE GROWTH. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             STAPH AUREUS COAG +
                             |   
CLINDAMYCIN-----------       R
ERYTHROMYCIN----------   =>8 R
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------   =>8 R
OXACILLIN-------------   =>4 R
RIFAMPIN-------------- <=0.5 S
TETRACYCLINE----------   <=1 S
TRIMETHOPRIM/SULFA---- <=0.5 S
VANCOMYCIN------------ <=0.5 S

___ Urine Culture
___ 12:29 pm URINE      Source: Catheter. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      YEAST.    10,000-100,000 ORGANISMS/ML.. 

___ RUQ US
RIGHT UPPER QUADRANT ULTRASOUND: The liver is normal in 
echotexture without focal lesions. There is no intrahepatic or 
extrahepatic biliary ductal dilatation. The normal CBD measures 
5 mm in diameter. Again noted is a large gallstone, measuring 
2.7 cm, in the non-fully distended gallbladder. The gallbladder 
wall is mildly thickened measuring up to 5 mm, nonspecific. 
There is normal hepatopetal portal venous flow. The enlarged 
spleen measures up to 16.6 cm. The visualized IVC, aorta and 
pancreas are grossly unremarkable.  Trace ascites is noted.  
  
IMPRESSION: 
1. Known cholelithiasis. 
2. Mildly thickened gallbladder wall, unchanged and 
non-specific, could be 
seen in right heart failure, hypoalbuminemia or other liver 
disease. No 
ultrasound findings to suggest acute cholecystitis. 
3. Splenomegaly. 

___ LUE US
IMPRESSION: No DVT left upper extremity with a left basilic PICC 
in place.

___ G-tube check
REASON FOR EXAMINATION: Evaluation of the percutaneous 
gastrostomy tube with bleeding and leakage throughout the tube.  
AP radiograph of the abdomen after injection of contrast 
material through the percutaneous gastrostomy is noted. The 
contrast material is demonstrated in the stomach as well as in 
the duodenum and jejunum. No definitive evidence of 
extravasation is noted. If clinically warranted, correlation 
with cross-sectional imaging might be considered. 
  
Wound Care recomendations: Recommendations:

1. Follow pressure ulcer guidelines. Atmos Air. Turn q 2 hours.
2. Cleanse wounds with commercial wound cleanser. Pat dry.
3. Apply Aquacel ag to sacrum wound, cover with 4x4's and 
   Soft sorb dressing, secure with Medipore tape. Change daily.
4. LLE anterior excoriation - cover with Adaptic dressing, place 

   4x4,and wrap with Kerlix. Secure with paper tape. Change 
   daily.
5. No tape on skin.
6. Left Trochanter - apply Mepilex 4x4 to site, and change 
   q3 days.
7. Cleanse scrotum and perineum area with Aloe Vesta foam 
   cleanser daily. Pat dry.
8. Apply Critic Aid clear skin barrier ointment to scrotal 
tissue
   to protect from fluid exposure daily. Elevate scrotum to
   assist with edema.
9. Waffles bilateral feet.
10. Apply Aquaphor ointment to dry intact skin daily from 
    pharmacy daily.

Ostomy Care:  LLQ, ___, red, flush, os at center, 
mucocutaneous junction
intact, peristomal skin intact with large parastomal hernia.  
Pouched with ___ Sura one piece drainable, ___ # 
___, ___ # ___. No-sting barrier wipe, ___ # ___, ___ # 
___. Nursing staff to change pouch q ___ and ___ while 
her.

 
Brief Hospital Course:
___ male with extensive cardiac PMH, recent MRSA bacteremia, 
trach on chronic mechanical ventilation, and chronic foley 
catheter with recent pseudomonal/klebsiella UTI, who presents 
now from rehab with fever, leukocytosis, vomiting, and AMS in 
setting enterococcus and yeast UTI, ___, MRSA bacteremia, 
hematochezia, and Stage 4 sacral decubitus ulcer.
.
ACUTE ISSUES
#. MRSA Bacteremia:  Pt had recurrent MRSA bacteremia in the 
settting of vancomycin treatment.  We are particularly concerned 
about endocarditis from ICD given the refractory nature.  
However, removal of instrumentation is not an option per patietn 
and family wishes.  Source of infection include sacral 
decubitous ulcer, UTI, ventilation.  Pt does not have 
leukocytosis or fever.  Chronic colonization likely.  Complete 
bacterial clearance is unlikely in this setting.  
OUTPATIENT ISSUES
- START Daptomycin indefinitely
- PICC line in place, routine care
.
#. GIB: Pt presented with HCT drop and Bright red blood through 
ostomy.  He received a total of 3 units pRBC blood transfusion. 
We temporarily stopped tube feeding the setting of GIB, and 
discontinued his aspirin.  His HCT has been stable in the past 
48 hours without transfusion.  GI has been consulted, and did 
not feel that the benefit of osteostomy-scope outweighs its 
risk.
OUTPATIENT ISSUES
- CONTINUE tube feeding as scheduled
- STOP aspirin and anti-platelets forever. 
- START pantoprazole 40 mg iv bid
- CONTINUE ferrous sulfate, sucrafate
.
#. ___: Pt presented with elevated Cr to 3.5 on admission with 
anuria.  There was muddy brown cast on urine sedimentation, 
concerning for ATN in the setting of sepsis and tobramycin 
exposure.  We gave him gentle fluid challenge, and his urine 
output recovered shortly afterwards.  His creatinine decreased 
to 2.7 on the day of discharge.  This may or may not ever go 
back down to his previous baseline.  Regardless, he's not anuric 
and patient and family have refused initiation of dialysis.
OUTPATIENT ISSUES
- AVOID nephrotoxic medication
- DISCONTINUE Lisinopril
.
#. Hematuria and UTI:  Pt has indwelling foley catheter and 
presented with hematuria and positive UA.  Urine culture was 
notable for VRE, fungus.  We treated him with meropenem and 
fluconazole while he was in the MICU.  He received bladder 
irrigation for hematuria.  His hematuria resolved on the day of 
discharge.  Pt was asymptomatic from his UTI.  We felt it is 
impossible to completely treat his UTI.  We decided to 
withdrawal treatment for now to minimize the hepatic and renal 
drug intoxication.
.
#. Decubitus ulcer: Pt has a Stage 4 decubitus ulcer over sacrum 
and left thigh.  The pain from decubitous ulcer is his major 
concern while he was here.  He was seen by wound care.  They 
advise supportive care.
OUTPATIENT ISSUES
- Pleae CHANGE BODY POSITION every 2 hours
- Please provide adequate pain management with lidocaine patch, 
fentanyl, oxycodone.
.
#. Positive sputum culture: Pt has trach tube.  His sputum 
culture grew multiresistant klebsiella and pseudomonas.  Pt 
remained afebrile, no leukocytosis, left shift or increased 
sputum production.  We felt the complete irradiation was unlikey 
given his current clinical status and suspect he has permanent 
colonization.
.  
CHRONIC ISSUES
#. Chronic dCHF: Pt has diastolic CHF.  We continued his 
beta-blocker for the need of rate control.  We held his 
lisinopril in an hope of protecting his current kidney function. 
 We held his aspirin in the setting of GI bleeding.  We felt 
that active treatment for his CHF is less of a priority.
OUTPATIENT ISSUES
- DISCONTINUED Aspirin and all antiplatelet drugs
- DISCONTINUED Lisinopril
.
#. Atrial fibrillation: Pt is AV paced on telemetry. Not on 
anticoagulation given history of GI bleeding.  Rate controlled 
with carvedilol.
OUTPATIENT ISSUES
- Per our EP recommendation, they can disable the defibrillator 
function, while still keep AV pacing, if there is a need in the 
change of goal of care.  
.
# Depression: Continue citalopram.
.
TRANSITIONAL ISSUES
Pt declared a code status of DNR/DNI.  Extensive discussion has 
occurred between family and care provider team on goal of care.  
In general, our understanding is that family would like 
continued conservative treatment, with no invasive procedure, 
including the use of pressors.  We have conveyed clearly to the 
family that clinical improvement is unlikely in the current 
situation.  Pt's family expressed concerns that patient has not 
been getting enough comfort care (ie skin, wound, pain).
.
The wife has expressed continued frustration with being 
transferred back and forth from rehab to the hospital.  We 
assured her that the care provided to him at rehab is very good. 
 In general, we'd try to limit the number of unecessary 
hospitalizations.  We explained to the family, with the son 
present in the room, that the patient's condition is stable, but 
ultimately is declining.  We explicity told them that things are 
probably as good as they'll ever be, and that in the future he 
will have a slow and steady decline.  We are limited in 
interventions that can be done here in hospital and have 
conveyed that to his family.   
.
.

 
Medications on Admission:
Acetylcysteine 100mg TID intratracheal
Carvedilol 6.25mg BID
Citalopram 20mg daily
Docusate sodium 100mg BID
Ferrous sulfate elixir 325mg daily
Folic acid 1mg daily
Lidocaine patch daily
MVI daily
Omeprazole 20mg daily
Simethicone 80mg BID
Sucralfate 1gm TID
Fentanyl 12mcg patch Q72hrs
Acetaminophen 650mg Q6H prn pain
Albuterol inhaler 2 puffs Q4H prn SOB
Psyllium 1 teaspoon TID
Oxycodone 5mg Q4H prn pain 

 
Discharge Medications:
OxycoDONE (Immediate Release)  ___ mg PO/NG Q4H:PRN pain hold 
for sedation or RR <12  
Citrate ___ mcg IV Q4H:PRN dressing changes 
Albuterol Inhaler 6 PUFF IH Q4H:PRN shortness of breath, 
wheezing 
Pantoprazole 40 mg IV Q12H
Daptomycin 540 mg IV Q48H 
Acetaminophen (Liquid) 650 mg PO/NG Q6H:PRN pain  
Fentanyl Patch 12 mcg/hr TP Q72H last changed ___ @ 12:45
Sucralfate 1 gm PO/NG TID
Simethicone 80 mg PO/NG TID
Multivitamins 1 TAB PO/NG DAILY
Lidocaine 5% Patch 1 PTCH TD DAILY
FoLIC Acid 1 mg PO/NG DAILY
Ferrous Sulfate (Liquid) 300 mg PO/NG DAILY
Docusate Sodium (Liquid) 100 mg PO/NG BID
Citalopram 20 mg PO/NG DAILY  
Carvedilol 6.25 mg PO/NG BID
MVI daily
Psyllium 1 teaspoon TID
Acetylcysteine 100mg TID intratracheal

Pt was administered the flu vaccine ___
 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
MRSA bacteremia with likely pacemaker colonization, multiple 
decubitus ulcers, ventilator dependence, acute kidney injury, 
gastrointestinal bleeding, urinary tract infection, chronic 
congestive heart failure.
 
Discharge Condition:
fair
 
Discharge Instructions:
Mr. ___,

It was a pleasure taking care of you in the intensive care unit. 
 As you know, the blood stream infection is probably chronic and 
it would basically be impossible to cure of you that.  We 
believe that your pacemaker is colonized with the bacteria, and 
it would be impossible to remove it.  You also have a urinary 
tract infection, and you were bleeding somewhere in your 
intestines.  Fortunately the bleeding stopped.  You also have a 
chronic heart failure, which you are aware.  Your kidney 
insufficiency may resolve, but it may not.  

You were also administered the flu vaccine while you were here.

 
Followup Instructions:
___
",MEDICINE
10004401-DS-33,William Armstrong,10004401,25777141," 
Name:  ___              Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Erythromycin Base / Streptomycin / Citric Acid / 
Atenolol / Torsemide / Heparin Agents
 
Attending: ___
 
Chief Complaint:
Bacteremia/ Bleeding from G tube site 

 
Major Surgical or Invasive Procedure:
Endoscopy x3: Performed by Dr. ___ on ___ and 
___

 
History of Present Illness:
___ year old male per omr with history of CAD s/p stenting, CHF 
(EF 55%), Afib, prior cardiac arrest and heart block s/p 
pacer/AICD placement, chronic trach, and recent MRSA bacteremia 
transitioned from vancomycin to daptomycin presenting from rehab 
facility with continued bacteremia and bleeding around G-tube 
site. 
.
Briefly patient was doing well until ___ when he suffered a 
fall that caused multiple fractures. He was hospitalized and 
intubated and subsequently trached. He was transferred to rehab 
where he spent a good deal of time with multiple readmissions 
for various infections and chronic GI Bleeds. In ___ was 
admitted to ___ for PNA and found to have MRSa bacteremia. Was 
dicharged on Vancomycin. Was readmitted later that month for a 
GI bleed. ___ was deferred ___ to family wishes and 
comorbidites. He was discharged again to ___. 
Surveilece cultures remained positive and he was readmitted for 
infectious work up. TTE, TEE and tagged WBC scan were all 
negative for ocult infectious source. On that admission he was 
diagnosed with concurrent Pseudomonas and Klebsiella UTI and 
treated with Meropenam. Given his persistent MRSA bacteremia he 
was switched from Vancomycin to daptomycin. 
.
Over the last several days he has been febrile with intermittent 
AMS. Blood cultures are persistently positive. Per notes form 
his PCP and discussions with the family, he is being admitted 
for evaluation for ICD lead explantation and for managment of 
fevers.
.
With regards to the bleedign at the G-tube site, the nursing 
staff at the rehabilitation facility noted oozing of blood from 
around the G-tube site. There was no bleeding at the lumen of 
the site. The patient remained normotensive. He remained normal 
mental status. The G-tube was clear and patent. There were no 
exacerbating or relieving factors. There was no known preceding 
trauma to the G-tube.
.
In the ED, initial VS were:  88 130/70   99% 15L
.
FAST positive but hemodynamic stable
CT abd non-con: simple fluid in the abdomen and pelvis, but no 
evidence for hematoma. left ventral wall hernia containing 
non-obstructed loops of bowel.   
.  
On arrival to the MICU, he was alert and cooperative and 
following commands.

 
Past Medical History:
Rectal cancer s/p excision and XRT (___)
CAD s/p stents (?___)
CVA in ___ with residual right hand dysthesia
Complete heart block s/p pacemaker 
H/o cardiac arrest (now with AICD) 
GI bleed secondary to angiectasias in the duodenum (___) s/p 
cauterization via EGD 
Atrial fibrillation, not on coumadin
Systolic CHF (EF 40-45%)  
S/p Fall with multiple rib fractures (___)  
MICU admission ___ for hemoptysis, bleeding from 
trach
Abdominoperineal resection ___ ___/ ___

 
Social History:
___
Family History:
Father died in ___ from ___. Mother died in ___ from PE. No 
family history of colon, breast, uterine, or ovarian cancer. No 
family history of seizures.
 
Physical Exam:
Admission Exam:
General: Alert, no acute distress  
HEENT: Trached NC AT  
Neck: trach in place
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Coarse bilateral breath sounds  
Abdomen: soft, non-tender, non-distended, bowel sounds present 
Ostomy in place 
GU: Foley in place 
Ext: WWP 3+ pitting edema to theknees with bilateral venous 
stasis changes. 

 
Pertinent Results:
___ 04:15PM   ___ PTT-38.5* ___
___ 04:15PM   PLT COUNT-110*
___ 04:15PM   NEUTS-82.7* LYMPHS-10.0* MONOS-6.5 EOS-0.5 
BASOS-0.2
___ 04:15PM   WBC-17.4*# RBC-3.50* HGB-9.7* HCT-30.0* 
MCV-86 MCH-27.6 MCHC-32.2 RDW-17.0*
___ 04:15PM   CALCIUM-8.4 PHOSPHATE-3.3# MAGNESIUM-1.9
___ 04:15PM   estGFR-Using this
___ 04:15PM   GLUCOSE-130* UREA N-88* CREAT-1.9* SODIUM-141 
POTASSIUM-3.9 CHLORIDE-104 TOTAL CO2-25 ANION GAP-16
___ 04:24PM   GLUCOSE-123* LACTATE-2.1* NA+-140 K+-3.7 
CL--105 TCO2-26
___ 04:24PM   COMMENTS-GREEN TOP
___ 07:14PM   TYPE-ART PO2-60* PCO2-34* PH-7.51* TOTAL 
CO2-28 BASE XS-3
___ 07:42PM URINE  WBCCLUMP-MOD MUCOUS-OCC
___ 07:42PM URINE  AMORPH-OCC
___ 07:42PM URINE  RBC-47* WBC->182* BACTERIA-MANY 
YEAST-FEW EPI-0
___ 07:42PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-30 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 
LEUK-LG
___ 07:42PM URINE  COLOR-Red APPEAR-Cloudy SP ___
.
CT ABDDOMEN AND PELVIS Study Date of ___ 5:01 ___ 
MPRESSION: 
.  
1. Diffuse anasarca with small to moderate amount of ascites 
within the abdomen and pelvis, but no evidence for hemorrhage. 
2. Moderate bilateral pleural effusions which have increased 
since the most recent examination. Small pericardial effusion, 
increased. 
3. Cholelithiasis without evidence for cholecystitis. 
4. Parastomal hernia containing nonobstructed, nondilated loops 
of small bowel. 
5. Prostatic hypertrophy. 
6. 15-mm hyperdense left upper pole renal lesion which is 
unchanged and may represent a hemorrhagic cyst. This can be 
further assessed with MRI if clinically indicated (as prior 
renal ultrasound from ___ did not demonstrate any 
abnormality within this area). 
.  
The study and the report were reviewed by the staff radiologist. 

.
.  
EKG: AV paced at 70 
.
AP CHEST 1:43 P.M. ON ___. 
  
HISTORY: New right subclavian line. 
  
IMPRESSION: AP chest compared to ___ through ___ 
at 10:45 
a.m.: 
  
Tip of the new right subclavian line ends low in the SVC. There 
is no change 
in the small-to-moderate right pleural effusion and no 
pneumothorax or 
mediastinal widening to suggest complications of line insertion. 
Severe 
cardiomegaly is longstanding. Pulmonary vascular engorgement and 
bibasilar 
atelectasis are unchanged. Tracheostomy tube is midline. 
Transvenous right 
atrial and right ventricular pacer defibrillator leads are in 
their expected 
locations, unchanged. No pneumothorax. 
.
___ 1:18 am BLOOD CULTURE     Site: ARM
      Source: Venipuncture. 

   Blood Culture, Routine (Preliminary): 
      STAPH AUREUS COAG +.    FINAL SENSITIVITIES. 
         Oxacillin RESISTANT Staphylococci MUST be reported as 
also
         RESISTANT to other penicillins, cephalosporins, 
carbacephems,
         carbapenems, and beta-lactamase inhibitor combinations. 

         Rifampin should not be used alone for therapy. 
         Consultations with ID are recommended for all blood 
cultures
         positive for Staphylococcus aureus and ___ species. 

         VANCOMYCIN Sensitivity testing confirmed by Sensititre. 


                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             STAPH AUREUS COAG +
                             |   
CLINDAMYCIN-----------   =>8 R
ERYTHROMYCIN----------   =>8 R
GENTAMICIN------------     1 S
LEVOFLOXACIN----------   =>8 R
OXACILLIN-------------   =>4 R
RIFAMPIN-------------- <=0.5 S
TETRACYCLINE----------     2 S
TRIMETHOPRIM/SULFA---- <=0.5 S
VANCOMYCIN------------     2 S

   Anaerobic Bottle Gram Stain (Final ___: 
      Reported to and read back by ___. ___ ON ___ AT 
0515. 
      GRAM POSITIVE COCCI IN PAIRS AND CLUSTERS.
.
___ 3:45 am URINE      Source: Catheter. 

   URINE CULTURE (Preliminary): 
      KLEBSIELLA PNEUMONIAE.    >100,000 ORGANISMS/ML.. 
         Piperacillin/tazobactam sensitivity testing available 
on request. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 
      PSEUDOMONAS AERUGINOSA.    10,000-100,000 ORGANISMS/ML.. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             KLEBSIELLA PNEUMONIAE
                             |          PSEUDOMONAS AERUGINOSA
                             |          |   
AMPICILLIN/SULBACTAM--  =>32 R
CEFAZOLIN-------------  =>64 R
CEFEPIME--------------   <=1 S       16 I
CEFTAZIDIME-----------  =>64 R        4 S
CEFTRIAXONE-----------    16 R
CIPROFLOXACIN---------   =>4 R      =>4 R
GENTAMICIN------------   <=1 S        8 I
MEROPENEM-------------<=0.25 S     =>16 R
NITROFURANTOIN-------- =>512 R
TOBRAMYCIN------------  =>16 R      <=1 S
TRIMETHOPRIM/SULFA----   <=1 S
 
Brief Hospital Course:
___ YOM with MMP most notable of which inclue persistent MRSA 
bacteremia of unknown source, recurrent MDR UTI's, PNA, chronic 
renal failure presented with fevers, MRSA bacteremia, UTI and 
UGIB. 
.
# Brief Hospital course: Patient was initially admitted for 
infectious w/u due to fevers, and was found to have MRSA 
bacteremia (chronic, likely ___ seeding of ICD), and 
Klebsiella/Pseudomonas UTI.  These were treated with IV 
vancomycin and meropenem.  He subsequently developed bleeding at 
his G-tube site as well as increased dark output from ostomy 
bag.  His hct trend was: 30 (___) -> 28 (___) -> 25 (___) 
-> 22 (___).  He was transfused 1 unit pRBC.  Hct ___ was 18 
and bleeding persisted.  GI and surgery were consulted.  He was 
given reglan, and started on ppi iv bid.  GI performed 3 EGDs 
that large amounts of blood and an ulcer with visible vessel 
around peg insertion site; An initial attempt at clipping the 
ulcer caused bright red blood, confirming that this was likely 
the cause of the patient's recent bleed. 10cc of epinephrine 
were injected around the ulcer. 2 clips were applied around the 
ulcer with hemostasis successfully achieved. The PEG was 
removed.  Because of his chronic MRSA bacteremia (thought likely 
___ ICD seeding), TPN was not an option and family felt that a 
feeding tube would cause him too much discomfort.  The 
palliative care team was consulted for assistance with the 
family's decision-making regarding goals of care.  The family 
ultimately felt that his current quality of life was not 
consistent with what he would have wanted based on remarks he 
had made in the past.  They elected to change his goals of care 
to comfort-measures only.  On HD#9 he passed away with family at 
bedside.  Family declined autopsy.
 
Medications on Admission:
Tylenol ___  q4h PRN
Acetylcysteine 100mg TID
Citalopram 20 mg QD
Daptomycin 500mg Q 48h
Docusate 100mg BID
Ferrous Sulfate 325mg QD
Lidocaine patch 
Metoprolol 12.5mg BIDSimethicone 80mg TID
Sucralfate 1 Gram TID with meals
Fentanyl patch 12 mcg Q 3Days (Last applied ___
Albuterol inhaler 2 puffs Q 6hours
Oxycodone 5mg QHS
COMPAZINE 5MG q 8 HOURS
Psyllium seed 1 tsp TID

 
Discharge Disposition:
Expired
 
Facility:
___
 
Discharge Diagnosis:
Anemia due to upper GI bleed
Bacteremia
Urinary tract infection

 
Discharge Condition:
Deceased

 
Discharge Instructions:
N/A
 
Followup Instructions:
___
",MEDICINE
10004457-DS-10,Bradley Souers,10004457,28723315," 
Name:  ___.             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Tetracycline Analogues / Amoxicillin / IV Dye, 
Iodine Containing Contrast Media / Lactose
 
Attending: ___
 
Chief Complaint:
Abnormal Stress Test, New AI
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Mr. ___ is a ___ with a hx of CAD (s/p DES to LAD in 
___ 
who presented today for a routine stress echo (ordered by his 
PCP) and was found to have evidence of inducible ischemia and 
severe aortic insuficiency. The patient was in his usual state 
of health prior to the stress test. He retired from his 
___ job of ___ years just 3 days ago. While on the 
treadmill the patient developed left shoulder pain (similar to 
previous anginal pains) and ST changes on EKG. Echocardiography 
revealed 4+ aortic regurgitation (patient was noted to be 1+ on 
last echo in ___. After getting off the treadmill the pain 
went away and he felt back to baseline. The patient has 
otherwise been asymptomatic. He exercises 3 times per week and 
will notice faint chest pain only with maximal exercise. He 
denies shortness of breath, PND, lower extremity edema and 
orthopnea. He has not noticed any fevers, chills, night sweats, 
or weight loss. 

After the stress test the patient was sent straight to the ED. 
In the ED he had an EKG which reportedly showed no ischemic 
changes. He had a CTA chest which was negative for aortic 
dissection. He was then admitted to the cardiology service for 
further management. 

Currently the patient is asymptomatic although he is 
considerably distressed by this new diagnosis. 
 
REVIEW OF SYSTEMS  
On review of systems, he denies any prior history of deep venous 
thrombosis, pulmonary embolism, bleeding at the time of surgery, 
 cough, hemoptysis, black stools or red stools. He denies recent 
fevers, chills or rigors. He denies exertional buttock or calf 
pain. All of the other review of systems were negative.  
 
Cardiac review of systems is notable for absence of dyspnea on 
exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, 
palpitations, syncope or presyncope.  

 
Past Medical History:
CAD (s/p DES to LAD in ___ 
Prostate cancer s/p prostatectomy ___
Hodgkin's Lymphoma ___ s/p splenectomy, chemotherapy and
radiation,
Gout
Tonsillectomy
Spontaneous subarachnoid hemorrhage ___, treated conservatively 

Hemorrhoids
Herpes zoster and simplex
Hyperlipidemia
asthma
peptic ulcer disease

 
Social History:
___
Family History:
Father had an MI at age ___, died at age ___.

 
Physical Exam:
On Admission:
VS- 97.8 157/64 101 18 98% RA 
GENERAL- WDWN in NAD. Oriented x3. Mood, affect appropriate.  
HEENT- NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. 
NECK- Supple with JVP just above clavicle 
CARDIAC- ___ Systolic (heard best at RUSB) and ___ Diastolic 
Murmur (heard best at LLSB).  
LUNGS- CTAB, no crackles, wheezes or rhonchi.  
ABDOMEN- Soft, NTND. No HSM or tenderness. Abd aorta not 
enlarged by palpation. No abdominial bruits.  
EXTREMITIES- No c/c/e. No femoral bruits.  
SKIN- No stasis dermatitis or ulcers
PULSES-  
Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  
Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  
 
Prior to discharge:
VS- 98.1 142/72 97 18 97% RA
GENERAL- WDWN in NAD. Oriented x3. Mood, affect appropriate.  
HEENT- NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. 
NECK- Supple with JVP just above clavicle 
CARDIAC- ___ Systolic (heard best at RUSB) and ___ Diastolic 
Murmur (heard best at ___).  
LUNGS- CTAB, no crackles, wheezes or rhonchi.  
ABDOMEN- Soft, NTND. No HSM or tenderness. Abd aorta not 
enlarged by palpation. No abdominial bruits.  
EXTREMITIES- No c/c/e. No femoral bruits.  
SKIN- No stasis dermatitis or ulcers
PULSES-  
Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  
Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  
 

 
Pertinent Results:
Labs:
============
___ 12:45PM BLOOD WBC-6.1 RBC-4.23* Hgb-13.2* Hct-41.2 
MCV-97 MCH-31.2 MCHC-32.1 RDW-13.8 Plt ___
___ 06:30AM BLOOD WBC-6.5 RBC-4.39* Hgb-13.7* Hct-42.9 
MCV-98 MCH-31.2 MCHC-32.0 RDW-14.2 Plt ___
___ 12:45PM BLOOD ___ PTT-30.4 ___
___ 12:45PM BLOOD Glucose-89 UreaN-23* Creat-0.9 Na-137 
K-4.5 Cl-103 HCO3-27 AnGap-12
___ 06:30AM BLOOD Glucose-92 UreaN-16 Creat-1.0 Na-143 
K-5.1 Cl-105 HCO3-33* AnGap-10
___ 06:30AM BLOOD Calcium-9.2 Phos-3.1 Mg-2.3 Cholest-241*
___ 06:30AM BLOOD Triglyc-199* HDL-56 CHOL/HD-4.3 
LDLcalc-145*
___ 12:45PM BLOOD CRP-1.7
___ 04:54PM BLOOD Lactate-1.4

Imaging:
================
 
CTA chest ___
1. No dissection, acute aortic injury, or pulmonary embolism.
2. Dense aortic arch and coronary artery calcifications
3. 3-mm right lower lobe pulmonary nodule (4:148). If there is 
high risk of cancer, f/u may be obtained at 12 months; 
otherwise, no f/u is necessary.
4. Numerous calcified pleural plaques. 
   
ETT (___) with ECHO:  
Anginal type symptoms with borderline ischemic EKG changes at a 
high cardiac demand and good functional capacity. Resting 
systolic hypertension with blunted hemodynamic response to 
physiologic stress. Echo report sent separately. Patient 
transferred to ED for further evaluation. Dr. ___. 
 
The patient exercised for 8 minutes 45 seconds according to a 
___ treadmill protocol ___ METS) reaching a peak heart rate 
of 129 bpm and a peak blood pressure of 158/56 mmHg. The test 
was stopped because of anginal pain and ST changes (see exercise 
report for details). This level of exercise represents an 
average/good exercise tolerance for age. In response to stress, 
the ECG showed ischemic ST changes in the setting of abnormal 
resting ECG (see exercise report for details). Resting systolic 
hypertension with blunted blood pressure response to stress. 
There was a blunted heart rate response to stress [beta 
blockade]. 
 
Resting images were acquired at a heart rate of 105 bpm and a 
blood pressure of 158/68 mmHg. These demonstrated normal left 
ventricular cavity size and regional/global systolic function. 
Right ventricular free wall motion is normal. There is no 
pericardial effusion. The ascending aorta diameter is normal. No 
dissection flap is suggested by 2D or color flow Doppler (does 
not exclude). Doppler demonstrated severe aortic regurgitation 
and mild mitral regurgitation with no aortic stenosis or 
significant resting LVOT gradient. 
Echo images were acquired within 58 seconds after peak stress at 
heart rates of 125 - 112 bpm. These demonstrated appropriate 
augmentation of all segments. 
 
IMPRESSION: Good functional exercise capacity. Borderline 
ischemic ST changes with 2D echocardiographic evidence of severe 
resting aortic regurgitation and no inducible wall motion 
abnormalities. Blunted heart rate and blood pressure response to 
exercise. Severe aortic regurgitation at rest. Mild mitral 
regurgitation at rest. 
If clinically indicated, a thoracic CT/MR or TEE is suggested to 
evaluate for possible aortic dissection. A TEE would be best 
able to assess the aortic valve for possible vegetations.  

TTE ___:
The left atrium is normal in size. The left ventricular cavity 
size is normal. Regional left ventricular wall motion is normal. 
Overall left ventricular systolic function is normal (LVEF>55%). 
Right ventricular chamber size and free wall motion are normal. 
The aortic valve leaflets are moderately thickened. There is 
mild aortic valve stenosis (valve area 1.2-1.9cm2). Moderate to 
severe (3+) aortic regurgitation is seen. The mitral valve 
leaflets are moderately thickened. Mild (1+) mitral 
regurgitation is seen. There is no pericardial effusion. 

Compared with the prior study (images reviewed) of ___, 
findings are similar.  
 
Brief Hospital Course:
PRIMARY REASON FOR HOSPITALIZATION:
========================================
Mr. ___ is a ___ with a hx of CAD (s/p DES to LAD in 
___ who presented for a routine stress echo and was found to 
have evidence of inducible ischemia and aortic insuficiency. 
  
ACTIVE ISSUES:
=======================
#) Aortic Insufficiency: Unclear etiology. Dissection was ruled 
out by CTA. There was no root dilation seen on TTE so more 
likely it is valvular in origin. Patient had no clinical signs 
of endocarditis and blood cultures had no growth to date. Most 
likely this is not acute AI given absence of symptoms other than 
during stress test. It is unclear how long it has been 
progressing for however. As for chronic etiologies, patient does 
not have a marfanoid habitus. He did however have a spontaneous 
subarachnoid hemorrhage which may or may not be related. RPR was 
negative. He did have mantle field radiation for Hodgkins in the 
1970s that could theoretically have contributed. On repeat 
echocardiogram patient did not have LV dilatation and EF was 
>60%. Clinically he did not have any signs of heart failure. 
- Since the patient is asymptomatic and appears to be 
compensated there was no urgent need for surgical evaluation. 
The patient was therefore scheduled to follow-up with his 
cardiologist, Dr. ___ to pursue further workup as an 
outpatient. 
- He was started on lisinopril for afterload reduction and 
diltiazem was stopped
  
#) Positive Stress Test/Hx of CAD: Patient had reversible EKG 
changes and anginal symptoms while on treadmill. He is known to 
have coronary artery disease which may have progressed. However 
it may be that he had demand ischemia from his aortic 
insufficiency that was further compounding the problem. There 
were no inducible wall motion abnormalities to suggest a 
significant functional problem. Since the stress test was 
performed for stable angina there is no evidence that PCI would 
have any benefit over medical therapy. Therefore he was 
discharged to follow-up with his cardiologist Dr. ___ 
further evaluation.  
- Could consider left heart cath as outpatient if patient has 
ischemic symptoms or is being evaluated for AVR
- Patient had difficulty tolerating statins because of myalgias 
therefore he will continue Niacin and Omega 3 fatty acids. LDL 
was 145 which is significantly above goal of 70. More aggressive 
LDL control should be discussed at outpatient follow-up with his 
cardiologist. 
- Patient reports that he is not on beta blocker because of 
fatigue
- Continued ASA/Plavix 
  
CHRONIC ISSUES:
===================
#) Asthma: well controlled
- Continued budenoside    
 
TRANSITIONAL ISSUES:
========================
# Patient will follow-up with his cardiologist Dr. ___ 
further workup of his new Aortic Insufficiency, to discuss his 
stress test, and to discuss more aggressive LDL lowering
# CODE STATUS- DNR, Okay to intubate for procedures but would 
not want prolonged intubation.   
# EMERGENCY CONTACT- Ex wife (HCP) ___ ___
 
Medications on Admission:
Preadmission medications listed are correct and complete.  
Information was obtained from PatientwebOMR.
1. testosterone *NF* 1 %(50 mg/5 gram) Transdermal daily 
2. omega-3 fatty acids-vitamin E *NF* 1,000 mg Oral daily 
3. arginine (L-arginine) *NF* 1000 mg Oral BID 
4. lysine *NF* ___ mg Oral TID 
5. Magnesium Citrate 800 mg PO QHS 
6. Guaifenesin 600 mg PO DAILY 
7. Glutamine ___ mg PO BID 
8. Pravastatin 5 mg PO DAILY 
9. phosphatidylcholine (bulk) *NF* 97 % Miscellaneous daily 
10. Nitroglycerin SL 0.3 mg SL PRN chest pain 
11. budesonide *NF* 180 mcg/actuation Inhalation Daily 
12. Glucosamine-Chondroitin Complx *NF* 
___ sod-vit 
C-Mn;<br>glucosamine-chondroit-vit C-Mn) 500-400 mg Oral daily 
13. methylsulfonylmethane *NF* 1,000 mg Oral daily 
14. Clopidogrel 75 mg PO DAILY 
15. selenium *NF* 100 mcg Oral daily 
16. Aspirin 325 mg PO DAILY 
17. Cyanocobalamin 1500 mcg PO DAILY 
18. FoLIC Acid 1.6 mg PO DAILY 
19. Vitamin D 2500 UNIT PO DAILY 
20. Vitamin E 1200 UNIT PO DAILY 
21. Diltiazem Extended-Release 120 mg PO DAILY 
hold for SBP < 100 
22. Niacin SR 500 mg PO BID 

 
Discharge Medications:
1. Aspirin 325 mg PO DAILY 
2. Clopidogrel 75 mg PO DAILY 
3. Niacin SR 500 mg PO BID 
4. Pravastatin 5 mg PO DAILY 
5. Lisinopril 5 mg PO DAILY 
RX *lisinopril 5 mg 1 Tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*2
6. arginine (L-arginine) *NF* 1000 mg Oral BID 
7. Budesonide *NF* 180 mcg/actuation INHALATION DAILY 
8. Cyanocobalamin 1500 mcg PO DAILY 
9. FoLIC Acid 1.6 mg PO DAILY 
10. Glucosamine-Chondroitin Complx *NF* 
___ sod-vit 
C-Mn;<br>glucosamine-chondroit-vit C-Mn) 500-400 mg Oral daily 
11. Glutamine ___ mg PO BID 
12. Guaifenesin 600 mg PO DAILY 
13. lysine *NF* ___ mg Oral TID 
14. Magnesium Citrate 800 mg PO QHS 
15. methylsulfonylmethane *NF* 1,000 mg Oral daily 
16. Nitroglycerin SL 0.3 mg SL PRN chest pain 
17. omega-3 fatty acids-vitamin E *NF* 1,000 mg Oral daily 
18. phosphatidylcholine (bulk) *NF* 97 % Miscellaneous daily 
19. selenium *NF* 100 mcg Oral daily 
20. testosterone *NF* 1 %(50 mg/5 gram) Transdermal daily 
21. Vitamin D 2500 UNIT PO DAILY 
22. Vitamin E 1200 UNIT PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
- Aortic Regurgitation
- Aortic Stenosis
- Coronary Artery Disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Mr. ___, it was a pleasure taking care of you here at 
___. You were admitted to the hospital after you had a stress 
test. Your stress test showed that you had aortic regurgitation. 
You had a CT scan which did not show any urgent problems like 
aortic dissection. At this time we are not entirely certain what 
caused your aortic valve function to worsen. It is important you 
follow-up with your cardiologist Dr. ___ further 
evaluation. 
 
Followup Instructions:
___
",MEDICINE
10004606-DS-20,Etta Taylor,10004606,29242151," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
seizures, abdominal pain
 
Major Surgical or Invasive Procedure:
mechanical intubation
 
History of Present Illness:
Ms. ___ is a ___ woman with HTN who presents with 
seizure. Around ___ on ___, daughter received a text from her 
cousin that the patient was vomiting. The patien't daughter then 
got back from work in the morning of ___ when she found her 
mother sleeping on her R side facing opposite direction. She 
then did a full turn out of bed and fell on the floor face 
first. Per the daughter, the patient had positive head strike on 
the night stand on her way down to the floor. Daughter turned 
her over and saw pt's bottom jaw retracted and top part of mouth 
sticking out, eyes open, arms straight out stiffly. Tongue was 
starting to come out, and pt was ""banging up against the bed."" 
After ___ min, convulsions stopped, and pt developed heavy 
breathing/snoring. Her eyes kind of cracked open but she was not 
responsive to daughter. EMS came and brought her outside, but 
head was flopping around as they were transporting her. When 
they got close to ___, pt started to ""come to"" and kept 
taking off the O2 mask. Seemed to go ""in and out"" of 
consciousness per daughter. She would get intermittently 
agitated, pupils were dilated, and she would have episodes of 
intermittent staring where she did not seem to be registering 
things. No further shaking. Reportedly got 2mg IV Ativan at 
___ and transferred to ___. Once she arrived at ___, the 
patient was complaining of abdominal pain. CT abd/pelvis showed 
acute pancreatitis. Patient was then intubated given her 
agitation and need for diagnostic procedures. LP was completed. 
Nicardipine gtt was initated at OSH for SBP >220. She is now 
admitted to the neuro ICU, remains intubated on nicardipine gtt 
for further workup and management.

Of note, about 1mo ago, pt was sitting with daughter's cousin. 
There was a yell, so daughter went to go find her mother. At 
that time, pt was sitting up with a ""deer caught in headlights 
look."" Cousin who witnessed the episode said that she sat 
upright, then started falling backwards and became stiff. Was 
shaking. Lasted a few seconds, then came out of it. After the 
episode, she said she was thirsty and did not remember the 
episode happening at all. 
 
Per son at bedside, she did have a seizure ___ years ago without 
any clear cause. She was living in ___ alone at that time. 
She was taking a lot of Klonopin, vicodin, and Percocet along 
with antidepressants, so unclear if this was a trigger. He does 
not know any further information about the seizure. Also unclear 
if she ever had strokes before. She had fallen ___ months ago in 
___, but son does not think she had any brain hemorrhages 
from that. She came back to ___ about 5 months ago to live 
with her daughter. Since that time, she has only been taking 
lisinopril. No other pain medications.  Patient's daughter 
denies any further drug use over the past 5 months.

 
Past Medical History:
HTN, DVTs
-internal bleed from small intestine  
- tubes tied  
- plantar wart removed  
- procedure in groin  
- colonoscopies 
 
Social History:
___
Family History:
no history of seizures or strokes 
 
Physical Exam:
===ADMISSION EXAM===
General: agitated, refusing to participate in exam
HEENT: contusions on forehead with a few scrapes
___: tachycardic
Pulmonary: breathing comfortably on RA
Abdomen: Soft, NT, ND
Extremities: Warm, no edema
Neurologic Examination:
- Mental status: awake, agitated, oriented to ___ and ___. Able to name ""thumb"" and ""watch"" and ""green."" Speech is
clear and not dysarthric. No gibberish.
- Cranial Nerves: PERRL 6->5mm brisk. BTT bilaterally. Face
appears symmetric. Looks around the room fully. Unable to 
perform
more dedicated CN exam ___ pt's agitation 
- Motor: moves all extremities spontaneously and equally
- Reflexes: unable to obtain, pt moving too much and is not
relaxing
- Sensory: withdraws to light touch in all extremities
- Coordination: no ataxia when reaching for bed rails or trying
to pull out foley catheter
- Gait: unable to assess

DISCHARGE EXAM
VS: 98.8 PO 100 / 56 53 18 97 RA
GENERAL: Pleasant elderly woman, sitting up in bed, appears
comfortable in no acute distress. Persistent paranoid delusions.
HEENT: Sclerae anicteric, EOMI, moist mucous membranes
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, or
rhonchi. Good inspiratory effort.
HEART: Regular rate and rhythm, normal S1 and S2, no murmurs,
rubs, gallops, or thrills
ABDOMEN: Normal bowel sounds.  Soft, non-distended.  Mild
improving tenderness and hyperesthesia around lap port incision
sites.  No organomegaly.  No rebound tenderness or guarding.
EXTREMITIES: Warm and well perfused.  No clubbing, cyanosis, or
lower extremity edema.
NEURO: A&Ox3, moving all 4 extremities with purpose
 
Pertinent Results:
ADMISSION LABS
___ 12:00PM BLOOD WBC-15.7* RBC-5.35* Hgb-16.2* Hct-48.4* 
MCV-91 MCH-30.3 MCHC-33.5 RDW-13.6 RDWSD-45.3 Plt ___
___ 12:00PM BLOOD Neuts-91.3* Lymphs-3.8* Monos-4.1* 
Eos-0.1* Baso-0.2 Im ___ AbsNeut-14.36* AbsLymp-0.59* 
AbsMono-0.65 AbsEos-0.01* AbsBaso-0.03
___ 12:00PM BLOOD ___ PTT-29.7 ___
___ 12:00PM BLOOD Glucose-228* UreaN-13 Creat-1.3* Na-132* 
K-8.4* Cl-93* HCO3-21* AnGap-18*
___ 06:30PM BLOOD ALT-523* AST-333* AlkPhos-252* 
TotBili-1.7*
___ 06:30PM BLOOD Lipase-1222*
___ 06:30PM BLOOD Calcium-9.6 Phos-2.7 Mg-1.7
___ 12:00PM BLOOD Osmolal-287
___ 12:00PM BLOOD TSH-3.5
___ 12:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 12:11PM BLOOD Lactate-3.4* K-4.5

PERTINENT LABS
___ 01:55PM BLOOD Lactate-1.1
___ 01:45PM BLOOD WBC-10.5* RBC-3.25* Hgb-9.8* Hct-30.3* 
MCV-93 MCH-30.2 MCHC-32.3 RDW-14.4 RDWSD-49.2* Plt ___
___ 05:25AM BLOOD WBC-7.0 RBC-3.04* Hgb-9.1* Hct-28.1* 
MCV-92 MCH-29.9 MCHC-32.4 RDW-14.3 RDWSD-48.3* Plt ___
___ 04:45PM BLOOD Glucose-93 UreaN-5* Creat-0.7 Na-139 
K-3.6 Cl-100 HCO3-24 AnGap-15
___ 09:45AM BLOOD Glucose-144* UreaN-8 Creat-0.9 Na-138 
K-3.7 Cl-100 HCO3-22 AnGap-16
___ 01:36AM BLOOD ALT-177* AST-50* AlkPhos-110* 
Amylase-149* TotBili-0.6
___ 02:32AM BLOOD ALT-139* AST-38 AlkPhos-131* Amylase-302* 
TotBili-0.9
___ 03:58AM BLOOD Lipase-442*
___ 01:36AM BLOOD Lipase-67*
___ 02:32AM BLOOD Lipase-40

DISCHARGE LABS
___ 05:41AM BLOOD WBC-7.0 RBC-2.81* Hgb-8.7* Hct-26.8* 
MCV-95 MCH-31.0 MCHC-32.5 RDW-14.0 RDWSD-48.2* Plt ___
___ 05:41AM BLOOD Glucose-98 UreaN-7 Creat-0.9 Na-140 K-4.4 
Cl-101 HCO3-28 AnGap-11

IMAGING/STUDIES
CT A/P: ___- 1. Mild to moderate intra and extrahepatic 
biliary ductal dilatation with
probable calculus in the distal common bile duct indicative of 
choledocholithiasis.  If needed, MRCP can provide further 
confirmation and assessment.
2. Edematous pancreas with peripancreatic fat stranding and 
fluid most suggestive of acute interstitial edematous 
pancreatitis.  In the setting of probable choledocholithiasis, 
constellation of findings likely indicate gallstone 
pancreatitis.  Correlation with serum amylase and lipase levels 
are
recommended.
3. Cholelithiasis.  Pericholecystic fluid and stranding may be 
secondary to pancreatitis.
4. Extensive atherosclerotic disease with severe stenosis of the 
SMA and right renal artery with resultant atrophy of the right 
kidney.
5. Bilateral nodular adrenal glands which are incompletely 
characterized.
6. 0.5 cm pulmonary nodule in the right upper lobe.  Please see 
recommendations section.

MRI Brain w/ and w/o: ___: 1. Motion limited exam.
2. No evidence for acute infarction.
3. Nonmasslike FLAIR signal abnormality within the right 
posteriorperiventricular white matter, with discontiguous foci 
of cystic encephalomalacia and no evidence for blood products.  
These may represent sequela of prior infarction, demyelination, 
infection, or other insult.
4. Small chronic infarcts in the left cerebellar hemisphere. 
Punctate cortical FLAIR hyperintensity in the right frontal lobe 
may also represent a chronic infarct.
5. Small area of FLAIR hyperintensity and contrast enhancement 
in the right occipital cortex, with associated chronic blood 
products, and with questionable involvement of the adjacent 
sulci.  This may represent a chronic infarct with hemorrhagic 
transformation or sequela of amyloid angiopathy.
6. Small chronic microhemorrhage in the right posterior internal 
capsule, most likely hypertensive.
7. 6 mm round structure in the region of the left petroclival 
confluence, with diagnostic considerations including a 
cholesterol granuloma, another type of lesion, or an aberrant 
blood vessel.  Partial left mastoid air cell opacification.
 
Brief Hospital Course:
================
PATIENT SUMMARY:
================
___ year old woman who presented with generalized tonic-clonic 
seizure in the setting of gallstone pancreatitis who was found 
to have right side renal artery stenosis. Seizures were 
controlled with keppra and patient underwent cholecystectomy and 
patients blood pressure was well controlled with medical 
management.

=============
ACUTE ISSUES:
=============

#Generalized tonic clonic seizures: 
Patient presented after a witnessed generalized tonic-clonic 
seizures. She presented to the emergency room and seizures were 
initially controlled with ativan in the emergency room. 
Neurology followed the patient during this hospitalization for 
workup of seizures. Patient was found to have gallstone induced 
pancreatitis which is believed to have caused seizures in a 
patient with underlying susceptibility given history of CVA. She 
underwent cholecystectomy. Infectious workup was negative. LP 
was preformed which was bland. MRI demonstrated existing 
infarcts, but no evidence of acute infarction or intracranial 
process. The patient was maintained on Keppra 1500 BID and had 
no further seizures during hospitalization. Neurology recommends 
that the patient continue keppra 1500 BID indefinitely until 
potential modification by outpatient neurology in 6 months. If 
there is concern for mild encephalopathy and gait unsteadiness, 
Keppra could be decreased to 1250 mg twice daily prior to 
follow-up. She was started on atorvastatin and aspirin for 
primary prevention of CVA. 

#Renal artery stenosis:
Patient was found to have right sided renal artery stenosis on 
CT during hospitalization. Systolic blood pressure were 
initially 170 systolic. Her blood pressure was controlled with 
nicardipine drip. Vascular surgery evaluated the patient and 
recommended no surgical intervention. She was medically managed 
with oral antihypertensive regime and blood pressure was 
successfully controlled to the 100-160s systolic. she should 
continue lisinopril, amlodapine and labetalol as an outpatient.

#Gallstone pancreatitis 
Patient was found to have choledocolithiasis induced 
pancreatitis. She underwent cholecystectomy and had an 
uneventful postoperative course. Pain was well controlled with 
oral oxycodone in the postoperative period. The patient will 
follow with acute care surgery two weeks after discharge.

===============
CHRONIC ISSUES:
===============
#GERD: Home famotidine was continued

====================
TRANSITIONAL ISSUES:
====================
[ ] Please recheck patient blood pressure and adjust blood 
pressure medications accordingly as an outpatient
[ ] Neurology recommends that the patient continue keppra 1500 
BID indefinitely until potential modification by outpatient 
neurology in 6 months. If there is concern for mild 
encephalopathy and gait unsteadiness, Keppra could be decreased 
to 1250 mg twice daily prior to follow-up. She was started on 
atorvastatin and aspirin for primary prevention of CVA. 
[ ] Follow up with surgery for post-operative check after 
cholecystectomy
[ ] Follow up with new PCP to establish care and also for 
cardiology referral for her known peripheral vascular disease 
for which she was on aspirin and Plavix, but were stopped for GI 
bleeding in ___.
[ ] given recent seizure, patient should not drive until cleared 
by her Neurologist

FULL CODE
HCP daughter ___ ___
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Lisinopril 20 mg PO BID 
2. Famotidine 20 mg PO BID 
3. Acetaminophen 500 mg PO Q12H:PRN Pain - Mild 

 
Discharge Medications:
1.  amLODIPine 10 mg PO DAILY hypertension 
RX *amlodipine [Norvasc] 10 mg 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*0 
2.  Aspirin 81 mg PO DAILY 
RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
3.  Atorvastatin 40 mg PO QPM 
RX *atorvastatin 40 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0 
4.  Labetalol 400 mg PO BID Hypertension 
RX *labetalol 200 mg 2 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
5.  LevETIRAcetam 1500 mg PO Q12H 
RX *levetiracetam 1,000 mg 1.5 tablet(s) by mouth every twelve 
(12) hours Disp #*90 Tablet Refills:*0 
6.  OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Severe 

RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp 
#*8 Tablet Refills:*0 
7.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
8.  Lisinopril 40 mg PO DAILY 
RX *lisinopril 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
9.  Famotidine 20 mg PO BID  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
=================
Primary diagnosis
=================
Generalized tonic-Clonic Seizures
cholecystitis
===================
Secondary diagnosis
===================
Right Renal Artery Stenosis
Hypertension
Gallstone Pancreatitis
Encephalopathy 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
DISCHARGE WORKSHEET INSTRUCTIONS:

Dear Ms. ___,

It was a pleasure caring for you at ___ 
___!

WHY WERE YOU ADMITTED?
You were admitted to the hospital because you had seizures.

WHAT HAPPENED IN THE HOSPITAL?
Your seizures were controlled with medication. You were found to 
have abdominal pain caused by inflammation in your gallbladder 
and pancreas. Your gallbladder was removed and this helped the 
inflammation. We think that your seizures were caused  by the 
inflammation in your gallbladder and pancreas. You were also 
found to have hypertension caused by a partial blockage to the 
artery for your right kidney. You were started on new 
medications to treat your blood pressure and your blood pressure 
improved.

WHAT SHOULD YOU DO AT HOME?
You should continue the new medications for your seizures and 
blood pressure and follow up with the surgeons and neurologist 
at your next scheduled appointment. You also have a primary care 
physician appointment scheduled for you to follow up and 
establish care. You will have to discuss with the new PCP about 
cardiologist referral for your peripheral vascular disease that 
was treated with aspirin, Plavix, and procedures in your lower 
extremity arteries in ___ last year. As you know, your 
Plavix was stopped due to GI bleeding that occurred in ___ 
last year. You need a new cardiologist to continue to manage 
your antiplatelet agents.

Because you had a seizure, please do not drive a car until you 
are cleared by your Neurologist. 

Please work on switching your insurance to ___ so that 
you can continue to get care here. 

Thank you for allowing us be involved in your care, we wish you 
all the best!

Your ___ Team

 
Followup Instructions:
___
",MEDICINE
10004606-DS-21,Etta Taylor,10004606,23517634," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Weakness
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ female with past medical
history notable for hypertension, prior small intestinal bleed
(sounds like distal upper AVM), recent hospitalization for
seizures in the setting of gallstone pancreatitis status post
cholecystectomy who was discharged on ___ who presents to
the hospital with several days of weakness.  She reports that
initially following discharge she was feeling well.  She reports
that after several days at home she started to feel increasingly
fatigued.  She reports that she felt similar to when she was
bleeding in ___ and required the upper GI which found a
likely AVM.  She reports the records from that hospitalization 
or
at ___ in ___.  She reports that at that 
time
her bowel movements were normal.  She reports that on the 
evening
prior to admission she developed diarrhea with black stools.  
She
reports that this is the exact same happened last time she had
the upper GI bleed.  She reports that she continue to feel
further fatigue.  She touch base with her primary care doctor 
who
referred her into the emergency department for further
evaluation.  She also reports that while at home she had a
decreased appetite.  Per her daughter she started to look
increasingly pale.  She became lightheaded and dizzy in the
shower on several occasions.  She also reports that she had
urinary symptoms from around the time she got home.  She reports
that over the last 6 days she has had increased lower abdominal
pain, burning on urination, pressure.  She reports that she 
feels
like it got so bad she decreased her p.o. intake to reduce the
amount that she would have to urinate.  She also reports that 
she
had some blood in the urine.

In the emergency department she was seen and evaluated.  Her
initial vital signs were unremarkable.  She was afebrile with a
heart rate of 81, blood pressure 157/94, respiratory rate of 18. 

Her H&H was notable for 11.3/35.3 which is up from her discharge
hemoglobin and hematocrit of 8.7/26.8.  She had a UA that was
checked which unfortunately contained 9 epithelial cells.  It 
did
have positive nitrates, large leukocyte esterase, greater than
184 white blood cells as well as few bacteria.  She received 1 g
of IV ceftriaxone, 2 L of normal saline, and was admitted to the
medical service for further evaluation and management.  She was
also evaluated by the surgery service while in the emergency
department he felt like if she had anything was likely a slow GI
bleed and would not require acute surgical intervention and 
would
recommend admission to medicine for a GI workup.

ROS: Pertinent positives and negatives as noted in the HPI.  All
other systems were reviewed and are negative. 
 
Past Medical History:
Gallstone pancreatitis status post cholecystectomy ___
Seizures in the setting of the above gallstone pancreatitis
Hypertension due to renal artery stenosis, difficult to control
Prior history of upper GI bleed from a likely AVM
Prior history of DVT no longer on anticoagulation
 
Social History:
___
Family History:
___ and found to be not relevant to this
illness/reason for hospitalization.  She specifically denies any
family history of seizures or strokes.
 
Physical Exam:
ADMISSION EXAM
--------------
VITALS: 98.4 PO 147 / 72 60 18 100 RA 
GENERAL: Alert and in no apparent distress, laying in bed
EYES: Anicteric, pupils equally round
ENT: Ears and nose without visible erythema, masses, or trauma. 
Oropharynx without visible lesion, erythema or exudate
CV: Heart regular, no murmur. No JVD.
RESP: Lungs clear to auscultation with good air movement
bilaterally.  Breathing is non-labored
GI: Abdomen soft, non-distended, tender to palpation over the
suprapubic region.  Laparoscopic cholecystectomy incisions
healing well.  Bowel sounds present.  No HSM.  No CVA tenderness
GU: No suprapubic fullness but significant tenderness to
palpation
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: No rashes or ulcerations noted
NEURO: Alert, oriented, face symmetric, gaze conjugate with 
EOMI,
speech fluent, moves all limbs, sensation to light touch grossly
intact throughout
PSYCH: pleasant, appropriate affect

DISCHARGE EXAM
--------------
VS:  Reviewed
GENERAL: Alert and in no apparent distress, laying in bed
EYES: Anicteric, pupils equally round
CV: Heart regular, no murmur. 
RESP: Lungs clear to auscultation with good air movement
bilaterally.  Breathing is non-labored
GI: Abdomen soft, non-distended, tender to palpation over the
suprapubic region.  Laparoscopic cholecystectomy incisions
healing well.  Bowel sounds present.  
GU: No suprapubic fullness but significant tenderness to
palpation
PSYCH: pleasant, appropriate affect 
 
Pertinent Results:
ADMISSION LABS
--------------
___ 03:46PM BLOOD WBC-10.6*# RBC-3.78*# Hgb-11.5# Hct-35.3# 
MCV-93 MCH-30.4 MCHC-32.6 RDW-14.0 RDWSD-47.6* Plt ___
___ 03:46PM BLOOD Neuts-71.9* Lymphs-17.5* Monos-6.9 
Eos-2.6 Baso-0.7 Im ___ AbsNeut-7.65* AbsLymp-1.86 
AbsMono-0.73 AbsEos-0.28 AbsBaso-0.07
___ 02:22PM BLOOD Glucose-108* UreaN-12 Creat-1.0 Na-145 
K-4.8 Cl-104 HCO3-24 AnGap-17
___ 02:22PM BLOOD ALT-18 AST-17 AlkPhos-121* TotBili-0.5

MICROBIOLOGY
------------
___ 4:55 pm URINE

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT 
WITH SKIN
      AND/OR GENITAL CONTAMINATION. 
      ESCHERICHIA COLI.    >100,000 CFU/mL.  PRESUMPTIVE 
IDENTIFICATION. 
         PREDOMINATING ORGANISM.  INTERPRET RESULTS WITH 
CAUTION. 
         Cefazolin interpretative criteria are based on a dosage 
regimen of
         2g every 8h. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------   <=2 S
AMPICILLIN/SULBACTAM--   <=2 S
CEFAZOLIN-------------   <=4 S
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------   <=1 S
CEFTRIAXONE-----------   <=1 S
CIPROFLOXACIN---------<=0.25 S
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S

DISCHARGE LABS
--------------
___ 08:10AM BLOOD WBC-5.6 RBC-2.92* Hgb-8.9* Hct-27.2* 
MCV-93 MCH-30.5 MCHC-32.7 RDW-13.3 RDWSD-45.4 Plt ___
___ 08:10AM BLOOD Glucose-101* UreaN-11 Creat-1.0 Na-142 
K-4.6 Cl-101 HCO3-30 AnGap-11
___ 07:10AM BLOOD ALT-16 AST-17 AlkPhos-91 TotBili-0.4
___ 07:45AM BLOOD Calcium-9.7 Phos-3.8 Mg-1.7
___ 03:46PM BLOOD calTIBC-411 Ferritn-___-___
___ 02:35PM BLOOD Lactate-1.8

KUB: 
IMPRESSION: 
Normal bowel gas pattern.
 
Brief Hospital Course:
___ female with past medical history notable for 
hypertension, prior small intestinal bleed (sounds like distal 
upper AVM), recent hospitalization for seizures in the setting 
of gallstone pancreatitis status post cholecystectomy who was 
discharged on ___ who presents to the hospital with 
several days of weakness. 

# Possible upper GI bleed
# Gastritis: Patient reported several episodes of black stools, 
but none during admission.  Hemoglobin downtrended over the 
course of admission.  Awaiting records from ___ 
in ___.   GI following patient, but did not plan on 
EGD/colonoscopy.  H. pylori antigen was sent.  She was placed on 
PO pantoprazole, as well as home famotidine and simethicone, 
given complaints of indigestion, as well as antiemetics.

# Urinary tract infection: Patient reported approximately five 
days of urinary tract symptoms with pain on urination, burning 
on urination, and suprapubic fullness.  Pan-sensitive E.coli on 
urine specimen, placed on ceftriaxone and switched to 
ciprofloxacin for 7-day course.  She was also placed on three 
day course of pyridium.

# Weakness: suspect related to UTI and possible slow GI bleed, 
see above.  ___ consulted. She progressed and was able to be 
discharged home. 

#Constipation
Patient noted to constipated likely ___ to opioids and decreased 
mobility. KUB without obstruction. She received bowel regimen. 
She had a bowel movement prior to discharge.

# HTN due to
# RAS: Patient has renal artery stenosis as documented on her 
prior admission.  She has difficult to control blood pressures.  
She was stabilized on a regimen during her prior 
hospitalization.  Continued home antihypertensive regimen of 
amlodipine, labetalol, lisinopril.

# Seizure Disorder: Patient had generalized tonic-clonic seizure 
during her prior hospitalization in the setting of her gallstone 
pancreatitis.  She was seen by neurology during her prior 
hospitalization and is now on antiseizure medication with 
outpatient follow-up.  She was continued on her home Keppra.

# GERD: continued on home famotidine and added PO pantoprazole.

I updated her son and daughter with the plan of care. 

TRANSITIONS OF CARE
-------------------
# Follow-up: patient will follow up with her PCP.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY hypertension 
2. Atorvastatin 40 mg PO QPM 
3. LevETIRAcetam 1500 mg PO Q12H 
4. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 
5. Lisinopril 40 mg PO DAILY 
6. Famotidine 20 mg PO BID 
7. Aspirin 81 mg PO DAILY 
8. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Severe 
9. Labetalol 400 mg PO BID Hypertension 

 
Discharge Medications:
1.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice 
a day Disp #*30 Capsule Refills:*0 
2.  Ondansetron 4 mg PO Q8H 
RX *ondansetron 4 mg 1 tablet(s) by mouth every eight (8) hours 
Disp #*30 Tablet Refills:*0 
3.  OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Severe 

RX *oxycodone 5 mg 1 capsule(s) by mouth every eight (8) hours 
Disp #*6 Capsule Refills:*0 
4.  Pantoprazole 40 mg PO Q12H 
RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp 
#*60 Tablet Refills:*0 
5.  Polyethylene Glycol 17 g PO DAILY 
RX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by 
mouth once a day Disp #*30 Packet Refills:*0 
6.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  
7.  amLODIPine 10 mg PO DAILY hypertension  
8.  Aspirin 81 mg PO DAILY  
9.  Atorvastatin 40 mg PO QPM  
10.  Famotidine 20 mg PO BID  
11.  Labetalol 400 mg PO BID Hypertension  
12.  LevETIRAcetam 1500 mg PO Q12H  
13.  Lisinopril 40 mg PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Urinary tract infection
Gastritis/peptic ulcer

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure caring for you during your recent admission at 
___.  You came for further evaluation of weakness, pain when 
urinating and black stools.  

It is important that you continue to take your medications as 
prescribed and follow up with the appointments listed below.

Please follow up with your PCP ___. 
Please arrange to have you labs checked.

Good luck!
 
Followup Instructions:
___
",MEDICINE
10004606-DS-22,Etta Taylor,10004606,28731738," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
GI bleed
 
Major Surgical or Invasive Procedure:
Endoscopy ___
Capsule Endoscopy ___
 
History of Present Illness:
___ with history of GI bleed with unidentified etiology, 
gallstone pancreatitis requiring lap CCY (course c/b seizures 
thought triggered by pancreatitis and possible prior stroke) who 
presents from home with dark stools, abd pain, dysuria, 
polyuria.
In the ED, initial VS were: 98.5 76 179/62 18 100% RA
Exam notable for:
TTP RLQ, LLQ, suprapubic region
Labs showed:
Hgb 7.9
UA with few bacteria, lg leuk, 2 WBC
Lactate 1.5
Imaging showed:
CTA ABD/PELVIS
1. No evidence of active contrast extravasation into the bowel.
2. Colonic diverticulosis without diverticulitis.
3. Interval increased extrahepatic and central intrahepatic 
biliary dilation is likely due to post cholecystectomy status. 
Correlation with LFTs is Recommended and if there is continued 
concern for biliary obstruction, consider MRCP for further 
assessment.
Patient received:
___ 15:00 IV Morphine Sulfate 4 mg
___ 16:39 IV Esomeprazole sodium 40 mg
___ 17:59 IV Morphine Sulfate 4 mg
___ 20:19 IV Morphine Sulfate 4 mg
___ 21:54 IV CefTRIAXone
___ 22:23 PO/NG Atorvastatin 40 mg
___ 22:23 PO/NG Labetalol 200 mg
___ 22:23 PO LevETIRAcetam 1500 mg
___ 23:30 IV Ondansetron 4 mg ___
***1 unit PRBCs ___ @ 1752***
GI was consulted:
H/H down from discharge at 7.9/24.5. Discharged on ___ at 
8.9/27.2.
Recommend:
- 2 large bore IVs
- Trend CBC q12h
- IV PPI BID
- NPO at midnight
- Transfuse for hgb >7
- Plan for EGD in AM
Transfer VS were: 98.3 67 164/70 16 100% RA
On arrival to the floor, patient reports that she simply does 
not feel well. She has been unable to sleep, feeling weak upon 
standing, melena x 2 days, diffuse abdominal pain, and dysuria. 
She typically knows when she has a UTI, and these symptoms are 
consistent. She denies fevers, weight change, chest pain, 
shortness of breath.
Recently hospitalized ___ for weakness, thought ___ UTI 
and possible slow GI bleed. UTI grew pan-sensitive E coli 
treated with CTX -> ciprofloxacin. H/H trended, H pylori 
serology came back negative, patient did not undergo endoscopy. 
Discharge Hgb 8.9.
REVIEW OF SYSTEMS:
10 point ROS reviewed and negative except as per HPI
 
Past Medical History:
Gallstone pancreatitis status post cholecystectomy ___
Seizures in the setting of the above gallstone pancreatitis
Hypertension due to renal artery stenosis, difficult to control
Prior history of upper GI bleed from a likely AVM
Prior history of DVT no longer on anticoagulation
 
Social History:
___
Family History:
___ and found to be not relevant to this
illness/reason for hospitalization.  She specifically denies any
family history of seizures or strokes.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
VS: 98.2 162/75 63 18 96% RA
GENERAL: NAD
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, 
MMM
NECK: supple, no LAD, no JVD
HEART: RRR, S1/S2, no murmurs, gallops, or rubs
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles
ABDOMEN: slightly TTP diffusely
EXTREMITIES: no cyanosis, clubbing, or edema
PULSES: 2+ DP pulses bilaterally
NEURO: A&Ox3, moving all 4 extremities with purpose
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes

DISCHARGE EXAM:
VS:  98.4 ___
GENERAL: NAD , pale
HEENT: AT/NC, anicteric sclera, pink conjunctiva, MMM  
NECK: supple 
HEART: RRR, S1/S2, no murmurs, gallops, or rubs   
LUNGS: CTAB
ABDOMEN: Soft nondistended, tender over umbilicus, no 
rebound/guarding.
EXTREMITIES: no cyanosis, clubbing, or edema. Warm 
NEURO: A&Ox3, moving all 4 extremities with purpose  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 
PSYCH: Appropriate affect 
 
Pertinent Results:
ADMISSION LABS:
___ 01:49PM BLOOD WBC-7.6 RBC-2.70* Hgb-7.9* Hct-24.5* 
MCV-91 MCH-29.3 MCHC-32.2 RDW-13.2 RDWSD-43.4 Plt ___
___ 01:49PM BLOOD Neuts-58.9 ___ Monos-6.2 Eos-5.4 
Baso-0.4 Im ___ AbsNeut-4.48 AbsLymp-2.19 AbsMono-0.47 
AbsEos-0.41 AbsBaso-0.03
___ 01:49PM BLOOD ___ PTT-30.9 ___
___ 01:49PM BLOOD Glucose-106* UreaN-15 Creat-1.0 Na-143 
K-4.3 Cl-103 HCO3-22 AnGap-18
___ 01:49PM BLOOD ALT-15 AST-15 LD(LDH)-136 AlkPhos-62 
TotBili-0.2
___ 05:05AM BLOOD Calcium-9.4 Phos-4.1 Mg-1.9
___ 02:09PM BLOOD Lactate-1.5

IMAGING:

KUB ___:
1. Enteric capsule in the small bowel of the left lower abdomen 
in similar position to the study 2 days ago.
2. Nonobstructive bowel gas pattern.

KUB ___:
Enteric capsule in the left lower abdomen.

GI Endoscopy ___:
Angioectasias in the body (thermal therapy)
Otherwise normal EGD to third part of the duodenum

CTA ABD/PELVIS ___:
1. No evidence of active contrast extravasation into the bowel.
2. Colonic diverticulosis without diverticulitis.
3. Interval increased extrahepatic and central intrahepatic
biliary dilation is likely due to post cholecystectomy status.
Correlation with LFTs is Recommended and if there is continued
concern for biliary obstruction, consider MRCP for further
assessment.

DISCHARGE LABS:
___ 05:15AM BLOOD WBC-4.8 RBC-2.66* Hgb-7.8* Hct-24.7* 
MCV-93 MCH-29.3 MCHC-31.6* RDW-13.2 RDWSD-44.8 Plt ___
___ 05:00AM BLOOD Glucose-93 UreaN-9 Creat-1.0 Na-144 K-4.7 
Cl-105 HCO3-26 AnGap-13
___ 05:15AM BLOOD ___ PTT-31.1 ___
___ 05:00AM BLOOD ALT-10 AST-9 AlkPhos-55 TotBili-0.3
___ 05:00AM BLOOD Calcium-9.1 Phos-4.2 Mg-2.___ with history of recurrent GIB of unidentified source who 
presents with melena, drop in H/H, and abdominal pain also with 
UTI and GPC bactermia.

#Acute blood loss anemia
#Melena,Upper GI bleeding: suspect recurrence of prior GIB. Has 
had reported extensive workup in past at hospital in ___ 
including capsule study. Required 3 transfusions in ___. No 
endoscopy in our system. Prior thought to be AVM in small bowel. 
EGD showed angiectasias in the body of the stomach. No further 
bleeding while inpatient. Capsule endoscopy ___ was 
complicated by poor transit time through the stomach and poor 
bowel prep. Capsule remained in colon by day of discharge, will 
need visualization in stool or KUB ___ to ensure passage. Will 
need to be repeated as an outpatient.
   
#Staph bacteremia, contaminant:
Coag negative staph and staph hemolyticus growing out of initial 
cultures. Unclear if contaminant however as affecting 2 out of 2 
bottles. Patient without white count or systemic symptoms of 
infection and no further positive cultures. Treated with 
vancomycin until preantibiotic repeat cultures resulted 
negative. Overall thought to be contaminant.
   
#UTI/Dysuria/suprapubic pain: in setting of recent E coli in 
urine, dysuria, and suprapubic tenderness, concern for UTI 
despite equivocal urine. Initial urine culture was contaminated. 
Postvoid residual was 0. Pain was managed with Tylenol and 
oxycodone. S/p ceftriaxone x 3 days for presumed UTI.

#Abdominal pain: Patient had some gassy abdominal pain following 
MoviPrep. Treated with simethicone. She subsequently had 
abdominal pain following jerking with subcu heparin injection; 
abdominal exam benign.

#History of seizure: per neuro notes, thought triggered by 
pancreatitis vs prior stroke. Continued Keppra

#HA: Likely related to SBPs in 190s. Pain management with 
Tylenol/oxycodone. Avoided NSAIDs given GIB. Trialed fioricet. 

#Dizziness, bradycardia: Patient endorsed significant dizziness 
during hospitalization. Was bradycardic to the ___ on home 
labetalol. Labetalol was discontinued and patient was treated 
with IV fluids.

#HTN: HTN to 190s inpatient. Restarted home amlodipine, 
lisinopril. 

#HLD: atorvastatin. Restarted Asa on discharge. 

#Chronic pain in bilateral legs: no longer takes oxycodone at 
home. Not a complaint here. 

#CTA findings of intrahepatic biliary dilation: likely ___ 
post-CCY state. LFTs negative. No RUQ pain. 

TRANSITIONAL ISSUES:
====================
[] Outpatient follow up with Dr. ___ on ___ as already 
scheduled to determine whether EGD for capsule placement is 
needed
[] Titrate antihypertensives 
[] Labetalol was held for bradycardia
[] Needs KUB ___ to ensure passage of capsule 

#CODE: Full (confirmed) 
#CONTACT: ___ (daughter) ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY hypertension 
2. Aspirin 81 mg PO DAILY 
3. Atorvastatin 40 mg PO QPM 
4. LevETIRAcetam 1500 mg PO Q12H 
5. Labetalol 400 mg PO BID Hypertension 
6. Famotidine 20 mg PO BID 
7. Ondansetron 4 mg PO Q8H:PRN nausea 
8. Pantoprazole 40 mg PO Q12H 
9. Lisinopril 40 mg PO DAILY 

 
Discharge Medications:
1.  Simethicone 40-80 mg PO QID:PRN abd pain 
RX *simethicone 80 mg 1 tab by mouth four times a day Disp #*80 
Tablet Refills:*0 
2.  amLODIPine 10 mg PO DAILY hypertension  
3.  Aspirin 81 mg PO DAILY  
4.  Atorvastatin 40 mg PO QPM  
5.  Famotidine 20 mg PO BID  
6.  LevETIRAcetam 1500 mg PO Q12H  
7.  Lisinopril 40 mg PO DAILY  
8.  Ondansetron 4 mg PO Q8H:PRN nausea  
9.  Pantoprazole 40 mg PO Q12H  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Upper GI bleed
UTI
Bacteremia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

You were seen at ___ for gastrointestinal bleed.  You 
underwent an endoscopic procedure that showed a small blood 
vessel abnormality in your stomach.  We suspected that a similar 
abnormality in your small bowel could be the cause of your 
bleed.  We tried to verify this with the capsule endoscopy, 
however the images were of poor quality.  You may need to have 
this capsule study repeated as an outpatient.  You may require 
further transfusions in the future.

You also had some burning pain in her lower abdomen that was 
likely due to a urinary tract infection.  You were treated with 
antibiotics for this.

Your initial blood cultures showed growth of some bacteria.  
Given that you did not have symptoms of a bloodstream infection, 
it is likely that these were a contaminant.  You were treated 
with antibiotics while we waited for these bacterial colonies to 
grow enough to be identified as contaminants from your skin. 

Please take all your medications as prescribed and follow-up at 
your outpatient appointments.

It was a pleasure taking care of you,

Your ___ team
 
Followup Instructions:
___
",MEDICINE
10004606-DS-23,Etta Taylor,10004606,28691361," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Presyncope, Fall
 
Major Surgical or Invasive Procedure:
EGD ___
Capsule endoscopy ___
Colonoscopy ___

 
History of Present Illness:
___ with history of CVA, seizures, upper GI AVM's with chronic 
anemia, HTN, presents after presyncopal fall. 

On ___ she was at home and went to linen closet to grab 
something. Then felt presyncopal, dizzy, warm feeling, and fell 
backwards, hitting her head first against a bedroom door which 
gave way, and then against the floor. No LOC. Daughter came to 
her aid. She did not want to go to the hospital. The next day 
she went to ___. CT head and CT C-spine 
negative for
acute bleed or fracture. Today she went to her GI appointment 
and was referred to ___. Last ___ she reported a seizure 
episode where her arms were shaking and she was in a daze. This 
lasted for a few minutes. Consistent with prior seizures 
episodes.

In the ___, initial VS were:  
- 98.3 77 147/45 19 100% RA 
- Exam: diffuse mild abd tenderness, scant brown stool in rectal
vault +guaiac, 
- Labs: Hgb 7.4, Creatinine 1.1, Lactate 1.3, urine WBC 35, lg
leuk, hazy, few bac
- Imaging: CXR clear. CT A/P no acute process.

On interview she reports acute on chronic ""soreness"" in neck, 
back, hips, for which she takes oxycodone at home. Otherwise no 
acute complaints.
 
REVIEW OF SYSTEMS: 
+tinnitus; all other positives per HPI
otherwise 10 point ROS reviewed and negative except as per HPI  
 
Past Medical History:
- Hypertension
- Renal Artery Stenosis
- Seizures
- CVA
- Gallstone pancreatitis
- Iron deficiency anemia
- AVM's in stomach and duodenum
- Lumbar radiculopathy
- Chronic opioid use, with pain contract
- Hypothyroidism
- Hyperlipidemia
- COPD
- Neuropathic pain
- GERD
- DVT 
 
Social History:
___
Family History:
Mother had dementia.
Father had asbestosis and mesothelioma.

 
Physical Exam:
ADMISSION PHYSICAL
================== 
VS:   98.3  130 / 55  58 18 99 ra 
GENERAL: NAD  
HEENT: PERRL, EOMI, no nystagmus, tongue moist
NECK: +L carotid bruit
HEART: RRR, S1, S2, no murmurs
LUNGS: LCAB
ABDOMEN: s, lower abdominal tenderness
GU: suprapubic tenderness
EXTREMITIES: no edema
NEURO: A&Ox3, moving all 4 extremities with purpose, RLE 
weakness

DISCHARGE PHYSICAL
==================
___ ___ Temp: 97.9 PO BP: 162/62 HR: 56 RR: 18 O2
sat: 97% O2 delivery: Ra  
GENERAL: NAD, sitting in bed
NECK: +bilateral carotid bruits  
HEART: RRR, S1, S2, no murmurs  
PULM: CTABL 
ABDOMEN: soft, mildly distended without tenderness, +BS
EXTREMITIES: warm, 1+ ___ pulses bilaterally, no edema  
NEURO: A&Ox3, no facial asymmetry, moving all 4 extremities with
purpose
 
Pertinent Results:
ADMISSION LABS
==============
___ 05:50PM BLOOD WBC-5.5 RBC-2.49* Hgb-7.4* Hct-22.3* 
MCV-90 MCH-29.7 MCHC-33.2 RDW-15.3 RDWSD-50.4* Plt ___
___ 05:50PM BLOOD Neuts-47.5 ___ Monos-8.9 Eos-7.5* 
Baso-0.5 Im ___ AbsNeut-2.60 AbsLymp-1.94 AbsMono-0.49 
AbsEos-0.41 AbsBaso-0.03
___ 05:50PM BLOOD ___ PTT-34.2 ___
___ 05:50PM BLOOD Glucose-101* UreaN-12 Creat-1.1 Na-138 
K-4.2 Cl-99 HCO3-24 AnGap-15
___ 05:50PM BLOOD ALT-14 AST-13 AlkPhos-43 TotBili-0.3
___ 05:50PM BLOOD Lipase-22
___ 05:50PM BLOOD proBNP-78
___ 05:50PM BLOOD cTropnT-<0.01
___ 05:50PM BLOOD Albumin-4.8 Calcium-9.6 Phos-3.7 Mg-1.8

PERTINENT INTERVAL LABS
=======================
___ 09:10AM BLOOD Calcium-9.4 Phos-4.1 Mg-1.8 Iron-16*
___ 09:10AM BLOOD calTIBC-382 VitB12-318 Folate-14 
Ferritn-14 TRF-294
___ 06:48AM BLOOD TSH-3.6
___ 06:48AM BLOOD Free T4-0.9*

DISCHARGE LABS
==============
___ 05:35AM BLOOD WBC-5.0 RBC-3.62* Hgb-10.7* Hct-34.0 
MCV-94 MCH-29.6 MCHC-31.5* RDW-15.5 RDWSD-53.1* Plt ___
___ 05:35AM BLOOD Glucose-91 UreaN-20 Creat-1.1 Na-144 
K-4.5 Cl-104 HCO3-24 AnGap-16
___ 05:35AM BLOOD Calcium-9.6 Phos-5.0* Mg-2.0

MICROBIOLOGY
============
Urine Culture ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), 
CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION

IMAGING AND STUDIES
===================
___ CXR
AP upright and lateral views of the chest provided.
There is no focal consolidation, effusion, or pneumothorax. The
cardiomediastinal silhouette is normal. Imaged osseous 
structures are intact. 
No free air below the right hemidiaphragm is seen.

___ CT ABD/PEVLIS W CON
1. Colonic diverticulosis without evidence of diverticulitis.  
No signs of
colitis or bowel obstruction.  Normal appendix.
2. Status post cholecystectomy with stable mild prominence of 
the intrahepatic
and extrahepatic biliary tree.
3. Extensive aortoiliac atherosclerotic calcification with 
stents in the
bilateral external iliac arteries which appear patent.
4. Atrophic right kidney.
5. Trace free pelvic fluid, nonspecific.

___ ECHO (TTE)
The left atrial volume index is normal. The estimated right 
atrial pressure is ___ mmHg. Left ventricular wall thickness, 
cavity size and regional/global systolic function are normal 
(LVEF >55%). There is no left ventricular outflow obstruction at 
rest or with Valsalva. There is no ventricular septal defect. 
Right ventricular chamber size and free wall motion are normal. 
The aortic valve leaflets (3) are mildly thickened but aortic 
stenosis is not present. No aortic regurgitation is seen. The 
mitral valve appears structurally normal with trivial mitral 
regurgitation. There is no mitral valve prolapse. The estimated 
pulmonary artery systolic pressure is normal. There is no 
pericardial effusion. 

IMPRESSION: Normal biventricular cavity size and global/regional 
systolic function. No pathological valvular flow identified. No 
structural cause for syncope identified. 

___ CAROTID ULTRASOUND
Moderate-to-marked predominantly heterogeneous soft plaque 
within the
bilateral carotid arteries most profound within the mid ICAs, 
right greater
than left, resulting in hemodynamically significant stenosis 
estimated to be 80-99% bilaterally.

___ EGD
Mucosa suggestive of ___ Esophagus
Erosion in pylorus
Angioectasias in stomach and second part of duodenum (Thermal 
Therapy applied)
Capsule released in duodenum

___ COLONOSCOPY 
Aborted due to high residue material

___ pMIBI
FINDINGS:  There was soft tissue attenuation. 
Left ventricular cavity size is within normal limits. 
Rest and stress perfusion images reveal uniform tracer uptake 
throughout the  left ventricular myocardium. 
  
Gated images reveal normal wall motion. 
The calculated left ventricular ejection fraction is 71%. 
  
IMPRESSION: 1. No evidence of myocardial perfusion defect. 2. 
Normal left 
ventricular cavity size with normal systolic function. 

___ KUB
Endoscopy capsule in the proximal descending colon.

___ KUB
Endoscopy pill capsule has migrated since ___, now 
possibly in the sigmoid colon. 
 
Brief Hospital Course:
___ with history of CVA, seizures, upper GI AVM's with chronic 
anemia, HTN, peripheral vasculopathy, who presented after 
presyncopal fall.  

ACUTE ISSUES 
============
# Acute on Chronic Blood Loss Anemia 
# Upper GI Bleed
Presented with ongoing intermittent melena and known gastric and 
duodenal AVMs per prior EGD's s/p single balloon enteroscopy 
with APC to small bowel AVMs. Stool guaiac positive in ___. 
Required 2u pRBCs during her hospitalization. EGD showed several 
duodenal/gastric AVMs that were cauterized, as well as likely 
___ esophagus. Patient was iron deficient and was given 2 
125mg IV infusions of ferric  gluconate. Patient was continued 
on PPI prophylaxis.

# Seizures
Patient reported that her last seizure 1 week prior to admission 
and involved extremity shaking and AMS that lasted several 
minutes, consistent with previous episodes. Neurology was 
consulted for optimization of her AEDs. EEG was performed and 
the patient was continued on Keppra with plans for outpatient 
followup in neurology clinic. She had no seizures in house.

# Severe, Bilateral Carotid Artery Stenosis
Carotid US done as part of pre-syncope work-up revealed severe 
bilateral carotid artery stenosis (80-99%). She was seen by 
vascular surgery in house, who recommended no urgent treatment. 
This could certainly contribute to pre-syncope, however vascular 
surgery will followup with patient for CEA consideration. 

# Presyncope
Presented 4 days after presyncopal episode at home with fall and 
head trauma. CT head and c-spine were negative at OSH. Signs and 
symptoms not consistent with prior seizures. Initial ddx 
included CNS process (TIA, carotid stenosis), cardiac (had old 
RBBB on EKG, and new LBBB on this admission), orthostasis (had 
previously documented orthostatic hypotension), vasovagal event, 
peripheral vertigo (has tinnitus), or symptomatic anemia. 

# Concern for Cardiac Conduction Disease
Noted patient has HRs usually in ___, even when standing and 
lightheaded. There was concern that she was not adequately 
augmenting her cardiac output with exertion due to conduction 
disease and this blunted response was contributing to her 
pre-syncope. Also noted to initially have RBBB on EKG, but then 
LBBB on EKG done later in the same day (in ___ on presentation). 
Unusual and concerning for conduction disease, so cardiology was 
consulted and beta-blocker (home med) was held. pMIBI revealed 
no overt ischemia and ambulatory telemetry revealed that 
patients heart rates increased to ___. Cardiology felt that this 
was an appropriate response and the patient did not require 
further electrophysiologic evaluation during this 
hospitalization.

# Hypertension
Patient has history of hypertension (renal artery stenosis) with 
orthostatic hypotension. Antihypertensives were held in the 
setting of GI bleed but were restarted once her GI bleed was 
addressed. She was continued on home doses of blood pressure 
medications and was also started on chlorthalidone 12.5mg daily 
for better control.   

# Chronic Back and Neck Pain
Has narcotics contract w PCP for oxycodone 5mg BID since 
___. Review of MassPMP indicates pt also prescribed 
vicodin in OSH ___ three days prior to presentation. Likely that 
pain is exacerbated by recent fall, so increased pain regimen 
while in-house. 

CHRONIC ISSUES
==============
# Neuropathic pain: continued gabapentin 300mg TID. 
# GERD: continued PPI and famotidine. 
# Chronic nausea: continued ondansetron PRN. 

TRANSITIONAL ISSUES
===================
[]Ensure passage of capsule, on discharge KUB ___ noted to be 
in sigmoid colon/rectum. Consider repeat KUB to assess if 
concerned. Per GI, very unlikely to cause obstruction once in 
colon.
[]Labetalol/Beta-Blockade: Recommend avoiding all beta-blockade 
given heart rates in the ___. Patient's labetalol was 
discontinued to avoid negative chronotrope effect
[]Chlorthalidone: titrate dose as needed for adequate blood 
pressure control
[]ASA 81: discharged on ASA 81 given stroke risk in the setting 
of severe carotid disease, if GI bleed recurs, risk/benefit 
should be discussed with patient (okay to hold per inpatient 
cardiology recommendations but neurology would recommend 
continuing)
[]Atorvastatin: increased to 80mg (although less data in 
secondary prevention) due to severe vascular disease
___ esophagus: Noted on EGD. Will have follow up 
endoscopy with plan for biopsy in ___  
[]Labs: Repeat CBC at clinic visit to ensure stability, 
discharge Hgb 9.9
[]Vascular Followup: Has appointment with Dr. ___ ___ for 
CEA evaluation
[]Neurology Followup: Has appointment for further management of 
anti-seizure medications

# Contact/HCP: ___ (daughter) ___  
# Code status: Full, presumed
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY hypertension 
2. Atorvastatin 40 mg PO QPM 
3. LevETIRAcetam 1500 mg PO Q12H 
4. Lisinopril 40 mg PO DAILY 
5. Simethicone 40-80 mg PO QID:PRN abd pain 
6. Famotidine 20 mg PO BID 
7. Ondansetron 4 mg PO Q8H:PRN nausea 
8. Pantoprazole 40 mg PO Q12H 
9. Aspirin 81 mg PO DAILY 
10. Ferrous Sulfate 325 mg PO BID 
11. Ascorbic Acid ___ mg PO BID 
12. OxyCODONE (Immediate Release) 5 mg PO Q12H:PRN BREAKTHROUGH 
PAIN 
13. Labetalol 200 mg PO BID 
14. Gabapentin 300 mg PO TID 
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY hypertension 
2. Atorvastatin 40 mg PO QPM 
3. LevETIRAcetam 1500 mg PO Q12H 
4. Lisinopril 40 mg PO DAILY 
5. Simethicone 40-80 mg PO QID:PRN abd pain 
6. Famotidine 20 mg PO BID 
7. Ondansetron 4 mg PO Q8H:PRN nausea 
8. Pantoprazole 40 mg PO Q12H 
9. Aspirin 81 mg PO DAILY 
10. Ferrous Sulfate 325 mg PO BID 
11. Ascorbic Acid ___ mg PO BID 
12. OxyCODONE (Immediate Release) 5 mg PO Q12H:PRN BREAKTHROUGH 
PAIN 
13. Labetalol 200 mg PO BID 
14. Gabapentin 300 mg PO TID 

 
Discharge Medications:
1.  Bisacodyl 10 mg PO/PR DAILY:PRN constipation 
RX *bisacodyl 5 mg 2 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
2.  Chlorthalidone 12.5 mg PO DAILY 
RX *chlorthalidone 25 mg 0.5 (One half) tablet(s) by mouth daily 
Disp #*30 Tablet Refills:*0 
3.  Docusate Sodium 100 mg PO BID constipation 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily 
Disp #*30 Capsule Refills:*0 
4.  Multivitamins W/minerals 1 TAB PO DAILY 
RX *multivitamin,tx-minerals  1 tablet(s) by mouth once a day 
Disp #*30 Tablet Refills:*0 
5.  Polyethylene Glycol 17 g PO DAILY constipation 
RX *polyethylene glycol 3350 [PEG___] 17 gram/dose 17 g by 
mouth daily Refills:*0 
6.  Senna 8.6 mg PO BID 
RX *sennosides [senna] 8.6 mg 1 by mouth twice a day Disp #*30 
Tablet Refills:*0 
7.  Atorvastatin 80 mg PO QPM 
RX *atorvastatin 80 mg 1 tablet(s) by mouth at nightime Disp 
#*30 Tablet Refills:*0 
8.  amLODIPine 10 mg PO DAILY hypertension  
9.  Ascorbic Acid ___ mg PO BID  
10.  Aspirin 81 mg PO DAILY  
11.  Famotidine 20 mg PO BID  
12.  Ferrous Sulfate 325 mg PO BID  
13.  Gabapentin 300 mg PO TID  
14.  LevETIRAcetam 1500 mg PO Q12H  
15.  Lisinopril 40 mg PO DAILY  
16.  Ondansetron 4 mg PO Q8H:PRN nausea  
17.  OxyCODONE (Immediate Release) 5 mg PO Q12H:PRN BREAKTHROUGH 
PAIN  
18.  Pantoprazole 40 mg PO Q12H  
19.  Simethicone 40-80 mg PO QID:PRN abd pain  
20.Rolling Walker
Please provide rolling walker.
Dx: Seizure Disorder (ICD-9: 780.39)
Prognosis: Good
___: 13 Months

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnoses
=================
Acute on chronic upper GI bleed
Severe, bilateral coronary artery stenosis
Seizure disorder
Orthostatic hypotension

Secondary Diagnoses
===================
Bipolar Disorder
Hepatitis B

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___, 

___ was a pleasure taking care of you in the hospital.

WHY DID YOU COME TO THE HOSPITAL?
-You felt lightheaded and suffered a fall

WHAT HAPPENED TO YOU DURING YOUR HOSPITAL STAY?
-You were given blood to increase your blood counts
-Your bloody bowel movements were evaluated and treated by the 
gastroenterologists
-You were evaluated for seizures by the neurologists and was 
started on a medication to prevent seizures 
-You were found to have severe blockages in both arteries 
supplying blood to brain and need to follow-up with the vascular 
surgeons in vascular surgery clinic to discuss surgical 
correction of these blockages
-Your heart was evaluated by the cardiologists who do not 
recommend any further testing at this time

WHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL?
please take all of your medications as prescribed, details 
below
Please keep all of your appointments as scheduled
-Please keep track of whether you have passed the capsule in 
your bowel movement. If you have not passed the capsule in 2 
days since discharge, you should be seen in clinic by your PCP. 
Please call your PCP right away if you have any symptoms such as 
constipation, vomiting, anorexia, and if you are not passing any 
gas.

We wish you the very best!

Your ___ Care Team
 
Followup Instructions:
___
",MEDICINE
10004720-DS-11,Marvin Drennon,10004720,22081550," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins / Haldol
 
Attending: ___
 
___ Complaint:
s/p cardiac arrest 
 
Major Surgical or Invasive Procedure:
chest thoracostomy tube placement
intubation 
central venous catheter placement
 
History of Present Illness:
___ with PMHx significant for schizophrenia, hypertension and 
anemia who p/w from nursing home with cardiac arrest.

Per EMS, he choked while sitting in his chair eating, found 
slumped over in chair without e/o trauma, turned blue. Found 
cyanotic without pulses. Heimelich productive of large food 
bolus. ROSC ___ s/p CPR and epi x2 and intubated w/ IO placed. 
In ___, became bradycardic transitioning to Asystole 
1330. Given Epi, further CPR, obtained ROSC. His SBP of ___, 
started on levo. 

In ED initial VS: T 34.9 HR 83 BP 111/63 RR 14 100% ra

Exam: Tube in place, some secretions suctioned, No e/o trauma or 
prolonged down time, Psoriatic plaques, 2mm minimally responsive 
pupils, Unresponsive, No spontaneous limb movements
Labs were notable for: wbc 16.1, hgb 12.4, plt 635, Na 134, K 
4.2, cr 0.3, TnT 0.47, AP 164, normal ALT/AST, INR 1.4, ABG 
___, lactate 2.6->1.3

Imaging notable for: NCCTH w/o hemorrhage, CXR w/ possible LLL 
PNA. 

EKG 88 NS NA No STTW changes concerning for ischemia

Patient was given: RIJ placed, given rocuronium 80 mg, 
norepinephrine gtt, midazolam gtt, fentanyl gtt

Consults: Post-arrest response team recommended TTM at 35 
degrees for 24 hours w/ EEG in ICU. TTM was initiated. He 
developed a CTX after the RIJ was placed that required chest 
tube placement.

VS prior to transfer: T 34.9 HR 87 BP 137/76 RR 20 99% RA 

On arrival to the MICU: Patient is intubated and sedated, chest 
tube in place.

 
Past Medical History:
Basal cell carcinoma
Schizophrenia
Anemia
Cataracts
Constipation
Hyponatremia
Tobacco abuse
Osteoporosis
Psoriasis
Actinic keratosis
Dupuytrens
Squamous cell carcinoma
Hypertension
Allergic rhinitis
 
Social History:
___
Family History:
Mother: deceased, old age
Father: prostate cancer
 
Physical Exam:
ADMISSION PHYSICAL EXAM 
============================
VITALS:  Reviewed in metavision.
GENERAL: Intubated and sedated
HEENT: Sclera anicteric, PERRLA, ETT in place
NECK: supple, right CVL
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, 
gallops  
ABD: soft, non-tender, non-distended, bowel sounds present, no 
rebound tenderness or guarding, no organomegaly  
EXT: Cool, well perfused, 2+ pulses, no  edema  
SKIN:  Artic sun in place
 
Pertinent Results:
LABS ON ADMISSION 
==========================
___ 06:38PM   TYPE-CENTRAL VE PO2-40* PCO2-31* PH-7.45 
TOTAL CO2-22 BASE XS-0
___ 06:38PM   LACTATE-1.5
___ 06:38PM   O2 SAT-72
___ 06:10PM   GLUCOSE-182* UREA N-13 CREAT-0.3* SODIUM-134 
POTASSIUM-4.2 CHLORIDE-97 TOTAL CO2-20* ANION GAP-17*
___ 06:10PM   ALT(SGPT)-14 AST(SGOT)-31 CK(CPK)-279 ALK 
PHOS-164* TOT BILI-0.6
___ 06:10PM   ALBUMIN-3.0* CALCIUM-8.5 PHOSPHATE-2.8
___ 06:10PM   NEUTS-86.9* LYMPHS-5.1* MONOS-6.7 EOS-0.1* 
BASOS-0.2 IM ___ AbsNeut-14.01* AbsLymp-0.83* 
AbsMono-1.08* AbsEos-0.01* AbsBaso-0.04
___ 06:10PM   ___ PTT-29.3 ___

PERTIENT LABS 
===============
Trops 
___ 06:10PM BLOOD cTropnT-0.47*
___ 12:30AM BLOOD CK-MB-41* MB Indx-13.4* cTropnT-0.41*
___ 07:32AM BLOOD CK-MB-29* MB Indx-12.0* cTropnT-0.30*
___ 02:29PM BLOOD CK-MB-27* MB Indx-13.6* cTropnT-0.22*

MICRO
===========
BCx ___ pending 

GRAM STAIN (Final ___: 
>25 PMNs and >10 epithelial cells/100X field. 

___  MRSA SCREEN (Final ___:    No MRSA isolated.

IMAGING
==================

___ MRI Head 
Diffusion abnormalities along the cortex of both cerebral 
hemispheres predominantly in the parieto-occipital lobes are 
suggestive of early ischemic brain injury. 

___ LENIs 
1.  Limited examination, but no evidence of deep vein thrombosis 
in the right upper extremity. 
2.  Probable hematoma in the upper inner arm as described.  
Correlate with 
physical examination for chronicity, and advise clinical 
follow-up to ensure resolution over time. 

___ TTE 
The left atrial volume index is normal. Normal left ventricular 
wall thickness, cavity size, and regional/global systolic 
function (biplane LVEF = 64 %). Tissue Doppler imaging suggests 
a normal left ventricular filling pressure (PCWP<12mmHg). Right 
ventricular chamber size and free wall motion are normal. The 
diameters of aorta at the sinus, ascending and arch levels are 
normal. The aortic valve leaflets (?#) appear structurally 
normal with good leaflet excursion. There is no aortic valve 
stenosis. No aortic regurgitation is seen. The mitral valve 
appears structurally normal with trivial mitral regurgitation. 
The estimated pulmonary artery systolic pressure is high normal. 
There is no pericardial effusion. 

 IMPRESSION: Normal biventricular cavity sizes with preserved 
regional and global biventricular systolic function. No valvular 
pathology or pathologic flow identified. No pericardial 
effusion. 

___ EEG 
This is an abnormal ICU continuous video EEG monitoring study 
due to the presence of a burst suppression pattern, indicative 
of a severe ecphalopathy. By the late afternoon, overall 
amplitudes began to diminish, and more prolonged background 
attenuation was seen, with plentiful artifact. By the end of the 
recording, definitive activity of cerebral origin was not 
clearly seen. These findings are indicative of worsening of the 
severe encephalopathy, which could be related to medication 
effects, toxic/metabolic disturbances or progression of 
neurologic injury. There were no clear epileptiform discharges 
or electrographic seizures in this recording. 

___ Shoulder ___ views 
Displaced humeral head fracture corresponding to given history, 
with exact relation of fracture fragments difficult to identify 
given limited included two views. 

___ CXR 
AP portable supine view of the chest.  The endotracheal tube is 
positioned with its tip 3.8 cm above the carina.  There is a 
vague opacity in the right lower lung which could reflect a 
focus of pneumonia though attention on followup advised.  There 
is mild retrocardiac opacity likely atelectasis.  No large 
effusion or pneumothorax is seen.  The cardiomediastinal 
silhouette appears grossly unremarkable.  There is a 
dextroscoliotic curvature of the thoracic spine.  No acute bony 
abnormalities. 
  

 
Brief Hospital Course:
Mr ___ was admitted to the MICU at ___ for post-cardiac 
arrest management. He received 5 rounds of CPR prior to ROSC. 
Unfortunately, despite obtaining ROSC, he suffered a devastating 
brain injury likely ___ anoxia. This was confirmed on MRI as 
well as with consult from the neurology team. After speaking 
with his HCP, we agreed to progress to CMO. He was extubated and 
expired on ___. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 5 mg PO DAILY 
2. Calcium Carbonate 500 mg PO BID 
3. Citalopram 10 mg PO DAILY 
4. Apixaban 5 mg PO BID 
5. OLANZapine 20 mg PO DAILY 
6. Divalproex (DELayed Release) 500 mg PO TID 
7. Ketoconazole Shampoo 1 Appl TP ASDIR 
8. Docusate Sodium 100 mg PO DAILY 
9. Hydrocortisone Cream 2.5% 1 Appl TP BID 

 
Discharge Medications:
Expired 
 
Discharge Disposition:
Expired
 
Discharge Diagnosis:
Expired
 
Discharge Condition:
Expired
 
Discharge Instructions:
N/A
 
Followup Instructions:
___
",MEDICINE
10004749-DS-20,Judie Hamler,10004749,28691602," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Watery diarrhea, LLQ Pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ presenting with epigastic pain and watery diarrea. Pt was in 
her usual state of health until last evening. Pt had a ___ 
burger and ___ for dinner. States she tossed and turned in 
bed overnight and awoke at 6am with worsening abdominal 
bloating. Pt states she first experienced watery diarrhea at 7am 
and had >10 episodes throughout the morning. She states she had 
pain beginging at around 9am. She states the pain is worse in 
LLQ when compared to RLQ. Denies recent travel, no recent fresh 
water ingestion. No other individuals had similar symptoms. No 
fevers, chills.  
.  
In the ED, initial VS 99.6 ___ 16. Exam notable for LLQ 
tenderness and adnexal tenderness without cervical motion 
tenderness, guiac - trace positive. Labs notable for WBC 16.9, 
lactate of 3.1 which improved to 1.4. UCG negative. The pt 
underwent transvaginal u/s (normal ovaries and uterus. no 
evidence of torsion) and a CT scan that was unrevealing. The pt 
was seen by surgery that stated there was no urgent surgical 
need. The pt received IVF, Zofran, Compazine and Dilaudid. 
Vitals prior to transfer were stable.  
.  
On ROS: Denies fever, chills, night sweats, headache, vision 
changes, rhinorrhea, congestion, sore throat, cough, shortness 
of breath, chest pain, abdominal pain, nausea, vomiting, 
constipation, +BRBPR with hx of hemorrhoids, no melena, 
hematochezia, dysuria, hematuria.  

 
Past Medical History:
# Frequent URIs, ?prior PNA  
# asthma (last on steroids ___ year ago)  
# Sinusitis,  
# Seasonal allergies  

 
Social History:
___
Family History:
Her father has a history of asthma.  

 
Physical Exam:
VS: 98.7 123/75 92 20 99RA  
GENERAL: Well-appearing female in NAD, comfortable, appropriate. 
 
HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear.  
NECK: Supple, no thyromegaly, no JVD, no carotid bruits.  
HEART: Tachycardic, RRR, no MRG, nl S1-S2.  
LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored. 
 
ABDOMEN: +Epigastic tenderness LLQ>RLQ. No rebound or guarding. 
+BS. No masses or HSM, no rebound/guarding. Negative ___ 
sign.  
EXTREMITIES: WWP, no c/c/e, 2+ peripheral pulses.  
NEURO: Awake, A&Ox3, CNs II-XII grossly intact, muscle strength 
___ throughout, sensation grossly intact throughout, DTRs 2+ and 
symmetric, cerebellar exam intact, steady gait.  
RECTAL: Normal Tone, Guaiac negative, yellowish stool
 
Pertinent Results:
Admission Labs:
___ 12:50PM   WBC-16.9* RBC-4.75 HGB-14.6 HCT-44.6 MCV-94 
MCH-30.6 MCHC-32.6 RDW-13.2
___ 12:50PM   NEUTS-90* BANDS-0 LYMPHS-8* MONOS-2 EOS-0 
BASOS-0 ___ MYELOS-0
___ 12:50PM   LIPASE-48
___ 12:50PM   ALT(SGPT)-25 AST(SGOT)-21 ALK PHOS-57 TOT 
BILI-0.9
___ 01:00PM   GLUCOSE-95 LACTATE-3.1* NA+-137 K+-3.8 
CL--108 TCO2-17*
___ 01:57PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 
LEUK-NEG
___ 07:00PM   LACTATE-1.___ with hx of seasonal allergies here with 1d hx of watery 
diarrhea and abdominal pain.  She was diagnosed with Clostridium 
difficile-associated diarrhea and treatment with oral 
metronidazole was initiated, to which she responded well. Her 
symptoms had resolved and she was tolerating regular diet at the 
time of discharge.
 
Medications on Admission:
Zantac  
OCP  

 
Discharge Medications:
1. metronidazole 500 mg Tablet Sig: One (1) Tablet PO Q8H (every 
8 hours) as needed for c. difficile for 14 days.
Disp:*33 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Clostridium difficile diarrhea

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted for abdominal pain and diarrhea. You were 
found to have an infection called C. difficile diarrhea. You 
were treated with antibiotics called metronidazole which you 
should continue for a full 14 day course. It is important that 
you finish the full course of antibiotics. Do not consume 
alcohol while taking metronidazole.

You were also evaluated for viral studies which showed....
 
Followup Instructions:
___
",MEDICINE
10004749-DS-21,Judie Hamler,10004749,27481198," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
abdominal pain and diarrhea
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
The patient is a ___ year old female with a history of GERD and 
prior C.diff infecion ___ years ago who presents with right lower 
quadrant abdominal pain.
.
She reports that the pain started when she awoke this morning. 
It is localized to the mid abdomen with radiation to the RLQ. 
She had some associated nausea without vomiting. The abdominal 
pain very similar to the pain with her previous C.diff colitis. 
She presented to her ___ clinic, where there was concern for 
appendicitis. She was also given Acetaminophen 975 mg PO.
.
After arriving in the ED, she began to have diarrhea, about ___ 
episodes. The pain was briefly relieved with defecation. She was 
incontinent of stool at times. There was no bright red blood per 
rectum or melena. She has felt slightly feverish, but did not 
check her temperature. Her appetite has been poor today. She 
denies any vaginal bleeding or discharge.
.
Prior to this morning, she was feeling at her baseline without 
any symptoms. She denies any recent antibiotics. Last week, she 
was on a cruise to ___. She did not have any diarrhea or GI 
symptoms on the trip. She did not drink any unbottled water or 
local food.
.
Initial vitals in ED triage were T 99.7, HR 110, BP 145/84, RR 
16, and SpO2 98% on RA. Exam was notable to RLQ tenderness. 
Pelvic exam showed no CMT or adnexal tenderness. Her CBC was 
notable for WBC 17.6 with N 86.4%. Her chemistry panel showed Cr 
0.7, K 3.4, bicarb 21, and anion gap 14. LFTs were unremarkable 
except for Lipase 61. UCG was negative and UA appeared 
contaminated with WBC 6 and few bacteria, but Epi 18. CT 
abd/pelvis showed several loops of small bowel in the right 
lower quadrant and pelvis with wall edema, minimal surrounding 
fat stranding, and trace free fluid. The appendix was minimally 
hyperemic but only 5-6 mm in diameter, and unlikely to represent 
acute appendicitis.
.
She was given NS ___ ml IV. Stool samples were sent for C.diff 
and bacterial culture. Antibiotics were held pending culture 
results. She received Morphine x3 and Dilaudid 0.5 mg IV x2. She 
continued to have abdominal pain and was admitted to medicine 
for pain control and further workup of her enteritis.
.
Vitals prior to floor transfer were T 99.2, HR 89, BP 119/74, RR 
14, and SPO2 99% on RA. On reaching the floor, she reported 
continued abdominal pain in the periumbilical area with 
radiation to the RLQ. She reported baseline loose stool, but 
that the current diarrhea is abnormal for her.
.
REVIEW OF SYSTEMS:
(+) Per HPI. Mild sore throat and hoarse voice, which she thinks 
is from not drinking anything in the ED. Some slight chills and 
mild fatigue. Recent sunburn while on cruise.
(-) No fevers. No weight loss. No headache, rhinorrhea, or nasal 
congestion. No vertigo, presyncope, syncope, vision changes, 
hearing changes, focal weakness, or paresthesias. No chest pain, 
pressure, palpitations, SOB, cough, or hemoptysis. No dysphagia 
or odynophagia. No melena or BRBPR. No hematuria, dysuria, 
frequency, urgency, incontinence, or discharge. No back, neck, 
joint, or muscle pain. No rashes or concerning skin lesions. No 
easy bleeding or bruising. No depression or anxiety. Review of 
systems was otherwise negative.
 
Past Medical History:
# Asthma -- mild intermittent, rare Albuterol use
# Chronic Sinusitis -- improved after ENT surgery ___ years ago
# GERD -- high dose Omeprazole
# C.diff Colitis (___)
# Migraines -- few per year
# Overweight
 
Social History:
___
Family History:
No famil history of inflammatory bowel disease or GI malignancy.
# Mother: Healthy
# Father: Died at age ___ from asthma exacerbation
# Siblings: Brother who is well
 
Physical Exam:
ADMISSION:
VS: T 98.7, BP 132/81, HR 98, RR 16, SpO2 97% on RA,
Wt 153 lbs, Ht 62 in
Gen: Young female in NAD. Oriented x3. Pleasant, bright affect.
HEENT: Sclera anicteric. PERRL, EOMI. MMM, OP benign.
Neck: JVP not elevated. No concerning cervical lymphadenopathy.
CV: RRR with normal S1, S2. No M/R/G.
Chest: Respiration unlabored, no accessory muscle use. CTAB 
without crackles, wheezes or rhonchi.
Abd: Active bowel sounds. Soft, ND. No organomegaly or masses. 
Tender to palpation in RLQ and periumbilical area. Some rebound 
tenderness, minimal voluntary guarding.
Ext: WWP. Digital cap refill <2 sec. No C/C/E. Distal pulses 
intact radial 2+, DP 2+, ___ 2+.
Skin: No rashes or lesions noted in area of discomfort.
Neuro: CN II-XII grossly intact. Moving all four limbs. Normal 
speech.

DISCHARGE:
VS: 97.9 115/60 88 18 99%RA
Gen: Young female in NAD. Oriented x3. Pleasant, bright affect.
HEENT: Sclera anicteric. MM moist, OP benign.
Neck: JVP not elevated. No concerning cervical lymphadenopathy.
CV: RRR with normal S1, S2. No M/R/G.
Chest: Respiration unlabored, no accessory muscle use. CTAB 
without crackles, wheezes, or rhonchi.
Abd: Active bowel sounds. Soft, ND. No organomegaly or masses. 
Tender to palpation in RLQ and periumbilical area but improved 
from yesterday. no rebound or guarding. psoas, obturatory, and 
___ signs negative
Ext: WWP. Digital cap refill <2 sec. No C/C/E. Distal pulses 
intact radial 2+, DP 2+, ___ 2+.
Skin: No rashes or lesions noted in area of discomfort.
Neuro: CN II-XII grossly intact. Moving all four limbs. Normal 
speech.
 
Pertinent Results:
ADMISSION;

___ 06:10PM BLOOD WBC-17.6*# RBC-4.55# Hgb-14.0 Hct-42.2 
MCV-93 MCH-30.9 MCHC-33.3 RDW-12.7 Plt ___
___ 06:10PM BLOOD Neuts-86.4* Lymphs-8.4* Monos-4.2 Eos-0.5 
Baso-0.5
___ 06:10PM BLOOD Plt ___
___ 08:10AM BLOOD ___ PTT-27.2 ___
___ 06:10PM BLOOD Glucose-88 UreaN-16 Creat-0.7 Na-139 
K-3.4 Cl-104 HCO3-21* AnGap-17
___ 06:10PM BLOOD ALT-19 AST-21 AlkPhos-60 TotBili-0.4
___ 06:10PM BLOOD Albumin-4.6 Calcium-9.5 Phos-2.9 Mg-1.9

OTHER PERTINENT:

___ 08:10AM BLOOD WBC-7.3# RBC-4.04* Hgb-12.4 Hct-38.1 
MCV-94 MCH-30.8 MCHC-32.6 RDW-13.0 Plt ___
___ 08:10AM BLOOD Glucose-90 UreaN-14 Creat-0.6 Na-141 
K-4.1 Cl-111* HCO3-20* AnGap-14
___ 08:10AM BLOOD Calcium-8.6 Phos-2.4* Mg-1.8
___ 05:04PM URINE Color-Yellow Appear-Hazy Sp ___
___ 05:04PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-MOD
___ 05:04PM URINE RBC-1 WBC-6* Bacteri-FEW Yeast-NONE 
Epi-18

MICRO:

___ 5:04 pm STOOL     CONSISTENCY: WATERY      Source: 
Stool. 

                            **FINAL REPORT ___

   C. difficile DNA amplification assay (Final ___: 
      Negative for toxigenic C. difficile by the Illumigene DNA
      amplification assay. 
           (Reference Range-Negative). 

   FECAL CULTURE (Final ___:    NO SALMONELLA OR SHIGELLA 
FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   OVA + PARASITES (Final ___: 
      NO OVA AND PARASITES SEEN. 
      This test does not reliably detect Cryptosporidium, 
Cyclospora or
      Microsporidium. While most cases of Giardia are detected 
by routine
      O+P, the Giardia antigen test may enhance detection when 
organisms
      are rare. 

     FECAL CULTURE - R/O YERSINIA (Final ___:    NO 
YERSINIA FOUND. 

DISCHARGE:

___ 07:59AM BLOOD WBC-8.7 RBC-3.89* Hgb-12.1 Hct-36.4 
MCV-94 MCH-31.1 MCHC-33.3 RDW-12.9 Plt ___
___ 07:59AM BLOOD Glucose-93 UreaN-5* Creat-0.7 Na-138 
K-4.2 Cl-108 HCO3-22 AnGap-12
___ 07:59AM BLOOD Calcium-8.9 Phos-2.7 Mg-2.0

IMAGING:

___ CT ABD/PELVIS:

IMPRESSION:
1.  Enteritis involving several loops of small bowel located in 
the right
lower quadrant of the abdomen and within the pelvis.  
Differential diagnosis
includes infectious, inflammatory, and ischemic etiology.
2.  The appendix is 5-6 mm in diameter, and given the diffuse 
inflammatory
findings, appendicitis is not likely the cause of the patient's 
symptoms.

___ CXR:
FINDINGS:  The lung volumes are normal.  No pleural effusions.  
No parenchymal
abnormalities.  Normal size of the cardiac silhouette.
 
Brief Hospital Course:
The patient is a ___ year old female with a history of GERD and 
prior C.diff infecion ___ years ago who presents with right lower 
quadrant abdominal pain and watery diarrhea.

ACTIVE ISSUES:

# Enteritis/Abdominal Pain: Most likely represents a viral 
enteritis given her associated URI symptoms of voice hoarseness 
and sinus congestion, though her recent cruise to ___ raises 
traveler's diarrhea as also possible but unlikely due to late 
presentation. Appendicitis was considered very unlikely based on 
imaging and prominence of diarrhea. Fortunately C-diff PCR is 
negative. Campylobacter and otther stool studies also negative. 
IBD very unlikely given the acute presentation and lack of alarm 
or systemic symptoms. She receivedI IV fluids, bismuth, and an 
empiric 3-day course of po ciprofloxacin. Her pain was managed 
with tylenol, opioids, and dicyclomine for cramping. She was 
tolerating a light diet prior to time of discharge.

# Leukocytosis: Resolved after IV fluids overnight after 
admission. She had elevated WBC 17.6 with N 86.4% on admission. 
Most likely this is multifactorial from enteritis along with 
hypovolemia and hemoconcentration. Resolved with fluids alone 
without any initial empiric antibiotic coverage.

CHRONIC ISSUES:

# GERD: She takes Omeprazole 40 mg PO BID for GERD symptoms. 
Given her Cdiff history, tapering her PPI as an outpatient would 
be reasonable to consider. Continued Omeprazole 40 mg PO BID for 
now

# Anxiety: Continued home fluoxetine.

TRANSITIONAL ISSUES:
- consider tapering omeprazole as outpatient  if able given 
history of c-diiff
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Omeprazole 40 mg PO BID 
2. Albuterol Inhaler ___ PUFF IH Q4-6H:PRN SOB 
3. Fluoxetine 20 mg PO DAILY 
4. Lorazepam 0.5-1 mg PO BID:PRN anxiety 
5. acetaminophn-isometh-dichloral *NF* 325-65-100 mg Oral 
Q1H:PRN migraine 
up to maximum of 5 tabs in 12 hours 
6. Microgestin Fe ___ (28) *NF* 
(norethindrone-e.estradiol-iron) 1.5-30 mg-mcg Oral DAILY 

 
Discharge Medications:
1. Fluoxetine 20 mg PO DAILY 
2. Microgestin Fe ___ (28) *NF* 
(norethindrone-e.estradiol-iron) 1.5-30 mg-mcg Oral DAILY 
3. Omeprazole 40 mg PO BID 
4. Acetaminophen 1000 mg PO Q8H 
5. DiCYCLOmine 20 mg PO QID 
RX *dicyclomine 20 mg 1 tablet(s) by mouth four times a day Disp 
#*10 Tablet Refills:*0
6. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain 
do not take if drowsy or driving.  Take only if pain persists 
despite taking acetaminophen. 
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours 
Disp #*15 Tablet Refills:*0
7. Albuterol Inhaler ___ PUFF IH Q4-6H:PRN SOB 
8. Lorazepam 0.5-1 mg PO BID:PRN anxiety 
9. Ondansetron 4 mg PO Q8H:PRN nausea 
RX *ondansetron 4 mg 1 tablet,disintegrating(s) by mouth every 
eight (8) hours Disp #*10 Tablet Refills:*0
10. Ciprofloxacin HCl 500 mg PO Q12H Duration: 3 Doses 
take through end of ___ 
RX *ciprofloxacin [Cipro] 500 mg 1 tablet(s) by mouth every 
twelve (12) hours Disp #*3 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
gastroenteritis
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___,

It was a pleasure taking care of you at the ___ 
___.  You were admitted with diarrhea and 
abdominal pain.  We treated you with antibiotics, fluids and 
pain medications, and your symptoms improved.  You were able to 
eat and drink by the time of discharge. 

You will need to continue treatment with antibiotics for a 
further 1 day.  We also gave you medications to contorl pain and 
cramping.  Please followup with your primary care practitioner.  
 
 
Followup Instructions:
___
",MEDICINE
10004955-DS-12,Carole Cawthorne,10004955,27499576," 
Name:  ___                Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
left hip fracture
 
Major Surgical or Invasive Procedure:
None.

 
History of Present Illness:
___ with hx of HTN and Meningioma presents from ___ 
with a fractured right hip while on vacation in ___. The 
patient states that she suffered a mechincal fall while on 
vacation 8 days ago. The pt states she underwent a surgical 
intervention (ORIF) in ___ and has been treat there since 
that time. The patient states she has been unable to bear weight 
since that time. The pt denies fevers, chills, increased lower 
extremity swelling, chest pain or pleuritic pain.  
.  
Upon arrival to the ED intial vitals 98.5 131/74 106 18 98% RA. 
Exam notable for ecchymosis on left ___. Labs notable for BC of 
11.6, Hct 27.2 (baseline mid to high ___. itals prior to 
transfer to the floor 98.8 97 120/57 16 97RA.  
.  
Upon arrival to the floor the patient has no complaints. Denies 
chest pain, pleuritic pain, shortness of breath or increased leg 
swelling.
 
Past Medical History:
# Meningioma - Dx ___ with change in mental status -  
s/p craniotomy ___ with Dr. ___. Remains on Dilantin for  

life. Followed annually by Dr. ___. MRI ___ 
 
___ evidence of recurrence. Bone density being monitored.  
# Hyperparathyroidism: s/p parathyroid adenoma removal (___)  
with Dr. ___ has ___ with Dr. ___. Has  
annual followup with Dr. ___.  
# Hypothyroidism  
# Right nephrolithotomy for treatment of renal staghorn 
calculus.  
___, hx of recurrent kidney stones, previously seen by 
Dr.  
___. CT scan ___ residual stones were  
noted.  
# Hypertension with Renal insufficiency - Cr 1.6.  
# Psoriasis scalp-well controlled with Neutrogena T/Gel once or  

twice weekly.  
# Mild to moderate mitral regurgitation- repeat echocardiogram  
___ MR.  
# Cholelithiasis-asymptomatic  
# Squamous cell carcinoma -anterior chest wall. No recurrence.  
Followed by Dr. ___ at ___ dermatology  
 
Social History:
___
Family History:
Non-Contributory. No known early CAD. 
 
Physical Exam:
Vitals: 98.8 97 120/57 16 97%RA  
Gen: NAD, AOX3  
HEENT: PERRLA, EOMI, MMM, sclera anicteric, not injected, no 
exudates  
Neck: no thyromegally, JVD:  
Cardiovascular: RRR normal s1, s2, no murmurs, rubs or gallops. 
No loud P2 or appreciable RV heave.  
Respiratory: Clear to auscultation bilaterally, no wheezes, 
rales or rhonchi  
Abd: Soft, non-tender, non distended, no heptosplenomegally, 
bowel sounds present, guaiac negative  
Extremities: Left hip with ecchymoses. Surgical site with 
dressing c/d/i. Bilateral ___ stockings. ___ to palpation 
on skin bilaerally. No appreciable cords.  
Neurological: CN II-XII intact, normal attention, sensation 
normal, Integument: Warm, moist, no rash or ulceration  
Psychiatric: appropriate, pleasant, not anxious  
 
Pertinent Results:
___ 08:45PM BLOOD WBC-11.6* RBC-3.00*# Hgb-9.3*# Hct-27.2*# 
MCV-91 MCH-31.1 MCHC-34.3 RDW-18.3* Plt ___
___ 06:00AM BLOOD WBC-7.7 RBC-2.88* Hgb-8.8* Hct-25.9* 
MCV-90 MCH-30.5 MCHC-33.9 RDW-18.1* Plt ___
___ 08:45PM BLOOD ___ PTT-22.1 ___
___ 08:45PM BLOOD Glucose-95 UreaN-23* Creat-1.1 Na-146* 
K-3.6 Cl-109* HCO3-27 AnGap-14
___ 05:50AM BLOOD Iron-41
___ 05:50AM BLOOD calTIBC-187* VitB12-470 Folate-8.7 
Ferritn-98 TRF-144*
___ 06:40PM URINE Blood-NEG Nitrite-NEG Protein-25 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-MOD
___ 06:40PM URINE RBC-0 ___ Bacteri-MOD Yeast-NONE 
___

Discharge:
___ 06:00AM BLOOD WBC-7.7 RBC-2.88* Hgb-8.8* Hct-25.9* 
MCV-90 MCH-30.5 MCHC-33.9 RDW-18.1* Plt ___
___ 06:00AM BLOOD Plt ___
___ 06:00AM BLOOD Glucose-79 UreaN-19 Creat-1.0 Na-142 
K-3.7 Cl-108 HCO3-24 AnGap-14

hip XR (prelim read): No e/o acute fx or hardware 
complication/failure. Increased bony bridging compared to 
___.

 
Brief Hospital Course:
The patient was admitted after returning from ___, as she was 
still having severe hip pain with movement.  X-rays suggested no 
hardware malfunction.  The Orthopedics service was consulted, 
who evaluated the patient and recommended rehabilitation with 
physical therapy.  The patient was also noted to have anemia 
with a hematocrit drop to 27 from the mid-30s approximately 1.5 
months ago.  This was likely due to her fracture, as a hematoma 
was noted on the side of the hip without evidence of expansion 
during the hospitalization.  Her hematocrit remained stable. and 
was 25 at the time of discharge.

Additionally, she was found to have pyuria on urinalysis; 
however, the patient denied dysuria.  For this reason, 
antibiotic treatment was deferred, although this should continue 
to be followded as an outpatient.
 
Medications on Admission:
Phoslo 667mg 2 capsules TID  
Levothyroxine 112mcg PO Daily  
Lisinopril 5mg PO Daily  
Phenytoin 100mg PO TID  
ASA 81mg PO Daily  
Calcium Citrate 250mg PO Daily  
Vitamin D 400mg 
 
Discharge Medications:
1. Levothyroxine 112 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

3. Phenytoin Sodium Extended 100 mg Capsule Sig: One (1) Capsule 
PO Q8H (every 8 hours).  
4. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
5. Calcium Citrate 250 mg Tablet Sig: One (1) Tablet PO once a 
day.  
6. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) 
Tablet PO DAILY (Daily).  
7. Calcium Acetate 667 mg Capsule Sig: Two (2) Capsule PO BID (2 
times a day).  
8. Enoxaparin 30 mg/0.3 mL Syringe Sig: One (1) injection 
Subcutaneous Q12H (every 12 hours).  
9. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 
6 hours).  
10. Oxycodone 5 mg Tablet Sig: One (1) Tablet PO every eight (8) 
hours as needed for pain.  
11. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID 
(2 times a day).  
12. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis:
1. hip fracture

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Out of Bed with assistance to chair or 
wheelchair.

 
Discharge Instructions:
You were seen at ___ after a hip fracture and repair.  You 
were evaluated by our orthopedic surgeons, who requested X-rays 
and then recommended that you undergo intensive physical 
rehabilitation.

You were found to have a low red blood cell count compared to 
two months ago.  We suspect that this was because of your fall 
and surgery, as it appears that you have a blood collection in 
your leg.  We feel that this is stable and you should continue 
to watch this; if you see signs of increased swelling in your 
leg, please call your doctor.

The following medications were changed during this 
hospitalization:
ADDED tylenol for pain control
ADDED oxycodone for pain control
ADDED docusate for constipation
ADDED senna for constipation
 
Followup Instructions:
___
",MEDICINE
10005012-DS-21,Myra Rivers,10005012,28371912," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
Admitted at OSH for SOB
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Mrs. ___ is a very nice and confused ___ year-old woman 
with CAD, HTN, CHF, dyslipidemia, depression, panic attacks and 
renal cell carcinoma who is transfered to the ___ from ___ 
after having a osteolytic lession in T7-T8. Patient presented on 
___ with SOB and delirium from her nursing home. She was 
satting 80% on RA in the nursing home and CXR was compatible 
with CHF and possible PNA (film not available). She received 
levofloxacin 500 mg PO Daily without improvemt. On ___ a 
CXR showed bilateral lower lobe infiltrates and she was started 
on doxycycline without improvement either. Her oxygen 
saturations dropped and she was tachycardic with what it is 
reproted as AFib. She was transfered to the ___ for management 
on ___.
.
She was admitted to the ICU and diuresed 5 L for possible CHF. 
She was weaned of the oxygen and had a respiratory alcalosis 
with metabolic alkalosis with a small A-a gradient, which was 
thought to be due to her COPD. Patient was also diagnosed with 
atrial fibrilation in this last hospitalization. It was made the 
decision to cotninue ASA & Plavix and not anticoagulate due to 
prior bad experiences with coumadin (unclear). She was diuresed 
and betablocked. IT was suggested to stard difoxin 50 mg BID and 
consider cardizem. BNP 1279.1
.
She had a CT scan for evaluation of her RCC? and showed a lytic 
lesion in T7-T8 and was transfered to the ___ for further 
care.
.
Upon further history from the daughter she states that since she 
was originally diagnosed with pneumonia she has not been the 
same. She has been wax and waining. Her anxiety is increased, 
she has short-term memory problems, is disoriented. Her activity 
level has also decreased up to the point in which she is almost 
bed-bound.
 
Past Medical History:
ONCOLOGIC HISTORY:
Renal cell CA: Presentation with diverticulitis. Had finding on 
CT scan of L lower renal pole tumor. Had nephrectomy and path 
showed conventional type renal cell carcinoma with predominantly 
granular/eosinophilic cell type, Grade ___, 3.0 cm, with 
extension into perinephric fat. 1 of 2 LN positive (renal hilum 
node). Margins uninvolved. Had concomitant segmental resection 
of the transverse colon due to narrowing on colonoscopy.
 
PAST MEDICAL HISTORY:
Chronic Obstructive Pulmonary Disease: O2 dependent with Co2 
retention; baseline Co2 ~60 per OSH records
Congestive Heart Failure with EF of 49%
Renal Cell carcinoma as above
T7-T8 lytic lesion
Lumonary nodules thought to be metastatic disease
Delirium
Hypertension  
Hypercholesterolemia  
CRI (baseline 1.3)  
s/p partial colectomy ___ diverticulitis
s/p hysterectomy
s/p rectal dyslpacia
Transverse cholectomy- for non focal diverticulitis  
MI s/p stent placement ___ yrs ago to the RCA in a 99% stenotic 
lesion
Panic attacks  
Depression 
Afib
 
Social History:
___
Family History:
Mother- expired age ___ stomach ca  
Father- expired age ___ leukemia  
Brother- ___ old age  
Son- ___ YO diagnosed with Alzheimers 
Son age ~___ ___ dementia as well
 
Physical Exam:
VITAL SIGNS - Temp 98.1 F, BP 126/56 mmHg, HR 85 BPM, RR 18 X', 
O2-sat 95% 2L NC
<br>
GENERAL - well-appearing woman in NAD, comfortable, appropriate
HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear
NECK - supple, no thyromegaly, no JVD, no carotid bruits
LUNGS - CTA bilat, no r/rh/wh, good air movement, resp 
unlabored, no accessory muscle use
HEART - PMI non-displaced, RRR, no RG, nl S1-S2, SEM in RUSB ___
ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no 
rebound/guarding.
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, 
DPs), right knee is with patela towards the inner part with full 
range of motion
SKIN - no rashes or lesions other than bruises that match with 
prior blood draws
LYMPH - no cervical, axillary, or inguinal LAD
NEURO - awake, A&Ox1 (persoN), CNs II-XII grossly intact, muscle 
strength ___ throughout, sensation grossly intact throughout to 
pain, touch, propioception and temperature, DTRs normal in upper 
extremities and decreased in lower extremities, cerebellar exam 
intact, her minimental was terribly failed and did not complete 
due to lack of completion, but she did not recall any 3 words at 
5 minutes, was not able to write and only said one of the minus 
7s.
 
Pertinent Results:
Labs:
On Admission:
___ 08:00PM   GLUCOSE-159* UREA N-20 CREAT-1.3* SODIUM-138 
POTASSIUM-3.7 CHLORIDE-92* TOTAL CO2-34* ANION GAP-16
___ 08:00PM   ALT(SGPT)-9 AST(SGOT)-20 LD(LDH)-246 ALK 
PHOS-104 TOT BILI-0.4
___ 08:00PM   ALBUMIN-3.6 CALCIUM-8.8 PHOSPHATE-3.9 
MAGNESIUM-2.0
___ 08:00PM   VIT B12-666 FOLATE-8.3
___ 08:00PM   TSH-1.1
___ 08:00PM   WBC-7.3 RBC-3.83* HGB-12.5 HCT-38.5 MCV-101* 
MCH-32.6* MCHC-32.4 RDW-15.0
___ 05:48PM URINE  HOURS-RANDOM UREA N-357 CREAT-40 
SODIUM-39
___ 05:48PM URINE  OSMOLAL-239
___ 05:48PM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 05:48PM URINE  BLOOD-MOD NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-TR
___ 05:48PM URINE  RBC-13* WBC-11* BACTERIA-NONE YEAST-NONE 
EPI-<1
___ 05:48PM URINE  HYALINE-1*
 
Interval Labs:
___ 06:05AM BLOOD CEA-4.4* ___ AFP-1.2 CA125-401*
___ 06:05AM BLOOD CA ___ -PND
___ Urine cx negative
___ Blood cx negative
___ 07:30PM BLOOD Osmolal-277
___ 07:13AM URINE Osmolal-467
___ 07:13AM URINE Hours-RANDOM Creat-37 Na-81
 
Discharge Labs:
___ 06:25AM BLOOD WBC-11.0 RBC-3.99* Hgb-13.0 Hct-39.9 
MCV-100* MCH-32.5* MCHC-32.5 RDW-14.9 Plt ___
___ 06:25AM BLOOD Glucose-116* UreaN-37* Creat-1.2* Na-130* 
K-5.5* Cl-94* HCO3-27 AnGap-15
___ 10:40AM BLOOD Na-131* K-4.4 Cl-95*
 
Imaging:
MRI of spine ___:
Multilevel cervical spondylotic changes are seen from C3 through 
C6. No definite metastatic lesion is seen in the cervical spine. 
Within the thoracic spine, there are metastatic lesions 
involving the posterior vertebral body and the posterior 
elements at T7 and T8. There is substantial epidural disease at 
T7 which encases and displaces the cord anteriorly with mild 
compression. There is no abnormal cord signal at this time. 
There is a metastatic lesion involving the T5 vertebral body on 
the right. Bilateral pleural effusions are seen. Evaluation of 
the lumbar spine demonstrates multilevel spondylosis. No 
definite metastatic lesions seen. Left kidney is not visualized 
and may have been surgically removed. Please clinically 
correlate.
IMPRESSION:
Metastatic disease at T5, T7 and T8. There is epidural tumor at 
T7 which encases the cord and causes mild cord compression.
 
TTE ___: The left atrium is mildly dilated. No atrial septal 
defect is seen by 2D or color Doppler. There is mild symmetric 
left ventricular hypertrophy. There is mild regional left 
ventricular systolic dysfunction with basal inferior and 
infero-lateral akinesis (EF 55%). No masses or thrombi are seen 
in the left ventricle. There is no ventricular septal defect. 
Right ventricular chamber size and free wall motion are normal. 
The aortic valve leaflets (3) are mildly thickened but aortic 
stenosis is not present. Moderate (2+) aortic regurgitation is 
seen. The mitral valve leaflets are mildly thickened. Moderate 
to severe (3+) mitral regurgitation is seen. The tricuspid valve 
leaflets are mildly thickened. There is mild pulmonary artery 
systolic hypertension. There is a trivial/physiologic 
pericardial effusion.
 
MRI head/brain ___:  No evidence of metastatic disease in the 
brain. No acute cranial process is seen.
 
CT abd/pelvis ___ (prelim): No evidence of local disease 
recurrence or distant metastasis. large stool in the 
rectosigmoid region.
 
Brief Hospital Course:
1. AMS: Per discussion with daughter, patient has had 
progressive dementia for months, although daughter was not 
present to comment on deviation from baseline. Her superimposed 
delirium and agitation were likely from benzo withdrawal, as she 
was not initially continued on her outpatient standing lorazepam 
(med list wasn't yet available). With addition of this, and 1mg 
PO haldol at night, she continued to be confused, although was 
much more calm and had no further agitation. Her delirium was 
also managed with pain control (she had very little pain during 
the admission, though) and frequent reorientation and 
reassurance. Infectious workup was negative. She had a brain MRI 
to rule out CVA or metastatic disease, and this was negative.
 
2. Lytic spine lesion: Seen in T5, T7, T8. Also seen was a mass 
surrounding the spinal cord with mild anterior spinal cord 
compression, although with a normal neuro exam. She underwent 3 
sessions of XRT during this admission, and will continue XRT on 
___ and ___ at 2pm to complete a total of 5 sessions. It 
remains unclear if her lesions are metastatic renal carcinoma or 
a new primary, as her renal cell cancer was last treated ___ 
years ago. CT abdomen/pelvis was done to search for a primary, 
or find a site amenable to biopsy as XRT made vertebral biopsy 
not possible. Tumor markers were also sent, but not suggestive 
of a specific diagnosis. After discussion with the patient's 
daughter ___ (to whom the patient deferred all medical 
decisions due to her confusion), it was decided that no further 
workup for a primary site would be performed. Also, it was 
decided that there would be no further attempts at treating the 
patient's malignancy at this time. The patient was on 
dexamethasone, along with insulin sliding scale and bactrim for 
prophylaxis, during this admission. She was discharged on a 
dexamethasone taper, and the bactrim and insulin can be stopped 
once she is off steroids.  Please continue the taper through 
___ as outlined explicitly in her discharge medication list.  
Taper may be modified further upon follow up with 
radiation-oncology.
 
3. Disposition: The patient is to return to her prior skilled 
nursing facility. Her other multiple chronic medical problems 
remained stable and her prior medication regimen was continued. 
Regarding goals of care, the patient's daughter was clear that 
her mother would not want aggressive cancer treatments. She will 
complete her current radiation course and there is no plan for 
further treatment of her malignancy. However, she would be 
amenable to rehospitalization and reconsideration of treatment 
options if an acute problem were to develop. Patient's code 
status is DNR/DNI.
 
Medications on Admission:
Acetaminophen 650mg q4h PRN  
Acidophilus 2 caps BID  
Atrovent inh 2 puffs BID  
Mucinex ___ BID  
Prilosec 20mg daily  
CharcoCaps 260-520mg q4h PRN  
Lidoderm patch daily  
Fleet enema daily PRN  
Milk of magnesia 30ml daily PRN  
Loperamide 4mg PRN  
Aspirin 81mg daily  
Plavix 75mg daily  
Ativan 1mg BID + TID:PRN  
Duonebs q4h PRN  
Vicodin ___ tab q4h PRN  
Premarin cream daily PRN  
Lasix 20 mg PO Daily  
Hyomax-SL 0.125mg q6h PRN  
Colace 200mg daily  
Zocor 40mg daily  
Saliva substitute solution q4h PRN  
Pulmicort 0.25mg/2ml nebs q6h PRN  
Compazine 10mg PO q8h PRN  
Bisacodyl 10mg PR PRN  
Morphine sulfate ER 15 mg PO daily  
Lopressor 25mg TID  
Valtrex ___ daily  
Cymbalta 60mg daily  
Belladonna-phenobarbital 1 tab TID + TID:PRN  
Mirtazapine 15mg QHS  
Trazodone 25mg HS prn  
Oxycodone 5mg QAM  
 
Discharge Medications:
1. Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation 
Q6H (every 6 hours).  
2. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable 
PO DAILY (Daily).  
3. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
4. Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
5. Lorazepam 1 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).  
6. Furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
7. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
8. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID 
(2 times a day).  
9. Duloxetine 60 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO once a day.  
10. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for 
Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours) as 
needed for shortness of breath or wheezing.  
11. Magnesium Hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) 
ML PO Q6H (every 6 hours) as needed for constipation.  
12. Lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).  
13. Insulin Lispro 100 unit/mL Solution Sig: One (1)  
Subcutaneous ASDIR (AS DIRECTED): see attached sliding scale.  
14. Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1)  
Injection TID (3 times a day).  
15. Morphine 15 mg Tablet Sig: One (1) Tablet PO every six (6) 
hours as needed for pain.  
16. Dexamethasone 4 mg Tablet Sig: Two (2) Tablet PO three times 
a day: 8mg tid through ___.  
17. Trimethoprim-Sulfamethoxazole 160-800 mg Tablet Sig: One (1) 
Tablet PO QMOWEFR (___): while on 
dexamethasone.  
18. Senna 8.6 mg Tablet Sig: Two (2) Tablet PO BID (2 times a 
day).  
19. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) 
Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for 
constipation.  
20. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 
hours) as needed for fever or pain.  
21. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
22. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
23. Prochlorperazine Maleate 10 mg Tablet Sig: One (1) Tablet PO 
every eight (8) hours as needed for nausea.  
24. Haloperidol 1 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime).  
25. Docusate Sodium 100 mg Capsule Sig: Two (2) Capsule PO BID 
(2 times a day).  
26. Polyethylene Glycol 3350 100 % Powder Sig: Seventeen (17) g 
PO DAILY (Daily).  
27. Dexamethasone 4 mg Tablet Sig: Two (2) Tablet PO twice a 
day: To start ___ and to be continued through ___.  
28. Dexamethasone 4 mg Tablet Sig: Two (2) Tablet PO once a day: 
To begin ___ and continue through ___.  
29. Dexamethasone 4 mg Tablet Sig: One (1) Tablet PO once a day: 
To start ___ and continue through ___.  
30. Dexamethasone 2 mg Tablet Sig: One (1) Tablet PO once a day: 
To begin ___ and continue through ___ then should be 
discontinued.  
 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Spinal metastasis with unclear primary tumor
Altered mental status
 
Secondary:
History of renal cell carcinoma
Chronic diastolic heart failure
Coronary artery disease
Dementia
 
Discharge Condition:
Stable

 
Discharge Instructions:
You were admitted to ___ due to a tumor that was found in your 
spine and near your spinal cord on an MRI. We are not clear if 
this is from your prior kidney cancer, or is a new cancer. 
However, after discussion with yourself and your daughter, it 
was decided to treat this with radiation, but not to pursue 
aggressive treatment options at this time.
 
Please take all medications as prescribed. We have made many 
minor changes to your medications, and the major changes are as 
follows:
- Changed mirtazipine to haloperidol at night to help 
relaxation.
- Started dexamethasone, a steroid to decrease swelling in your 
spine. You will also take bactrim, an antibiotic, while on this 
medication to prevent infection.
- Started lisinopril for blood pressure.
- Increased lasix to 40mg daily for heart failure.
- Changed metoprolol to 50mg BID for blood pressure.
- Stopped your valtrex as it is unclear that this is needed.
 
If you experience fevers, chills, worsening confusion, 
dizziness, chest pain, trouble breathing, back pain, or any 
other concerning symptoms, please seek medical attention or 
return to the hospital immediately.
 
Followup Instructions:
___
",MEDICINE
10005024-DS-4,Eddie Clinton,10005024,25023471," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
-Flexible sigmoidoscopy ___
-Colonic stent placement ___
 
History of Present Illness:
Mr. ___ is a ___ with history of HCV, etOH use, and 
hypertension who presents upon transfer from ___ 
with abdominal pain and found to have likely metastatic colon 
cancer on CT imaging. The patient reports that he has had dark, 
liquid bowel movements for the past several weeks. He also 
reports crampy lower abdominal pain for the past several days 
which has been worsening. His symptoms have been associated with 
weight loss; the patient reports 40-lbs over just a few weeks. 
Lately, the patient has also noticed some lightheadedness with 
rising with unsteadiness while walking. At ___, 
the patient was noted to have a hematocrit of 34% and sodium of 
118. A CT abdomen showed a rectosigmoid mass with likely 
metastases to the liver and lungs. Given concern for a RLL 
infiltrate, he was given antibiotics for a community-acquired 
pneumonia. Upon transfer to ___ ED, he was found to have a 
further reduced hematocrit after IV fluids.
 
Past Medical History:
Hypertension
Alcohol dependence
Hepatitis C infection
 
Social History:
___
Family History:
Mother without significant illnesses. Father with heart 
condition.
 
Physical Exam:
ADMISSION:
Vitals: 97.4 134/95 104 22 71.2kg  
General: Disheveled appearing, drowsy. No acute distress.  
HEENT: Sclera anicteric. Pale conjunctiva. Pupils equal and 
reactive to light. Poor dentition. Oropharynx clear. Dry mucous 
membranes.  
NECK: Supple.  
Heart: Tachycardic. Regular rate and rhythm. Normal S1, S2. No 
murmurs.  
Lungs: Decreased breath sounds at the bases bilaterally. No 
wheezes, crackles, or rhonchi.  
Abdomen: +BS, soft, nondistended. Tender to palpation diffusely. 
+Hepatomegaly.  
Genitourinary: No foley.  
Extremities: Warm and well perfused. Pulses 2+. No peripheral 
edema.  

DISCHARGE:
Vitals: none
GENERAL: Pale appearing not moving. Not arousable to sternal rub
HEENT: No pupilary or corneal reflex. Pale conjunctiva
CARDIAC: no heart sounds
PULMONARY: No breath sounds
EXTREMITIES: Cool, no pulses. 
NEURO: no corneal, pupilary, gag reflexes. No withdrawal to 
painful stimulus. 
 
Pertinent Results:
ADMISSION LABS:
==============
___ 01:30AM BLOOD WBC-8.0 RBC-3.83* Hgb-10.8* Hct-31.0* 
MCV-81* MCH-28.1 MCHC-34.7 RDW-15.3 Plt ___
___ 06:19AM BLOOD ___ PTT-30.5 ___
___ 01:30AM BLOOD Glucose-93 UreaN-7 Creat-0.4* Na-123* 
K-3.5 Cl-90* HCO3-19* AnGap-18
___ 01:30AM BLOOD ALT-30 AST-64* AlkPhos-364* TotBili-0.7
___ 01:30AM BLOOD Albumin-3.1* Calcium-8.2* Phos-2.6* 
Mg-1.9

IMAGING:
========
CT ABD PLV w/oral Contrast  (___)

IMPRESSION: 
1.  Interval (since ___ placement of a colonic stent,
2.  Circumscribed 10.4 x 7.4mm anterior pelvic fluid collection 
containing small locules of gas, likely an abscess from sigmoid 
tumor perforation. This is amenable to drainage.
2a.  Moderate/large amount of free air, and small amount of free 
fluid within the peritoneum.
3. Extensive lymphadenopathy in the retroperitoneum and porta 
hepatis, which results in narrowing of the origin of the left 
renal vein. Encasement of the splenic vein-SMV confluence and 
bilateral renal arteries is also demonstrated, without 
significant intraluminal narrowing in these vessels.  Normally 
enhancing kidneys on today's study.
4. Innumerable hepatic metastases.
5. Innumerable pulmonary metastases, lungs only partially 
imaged.
6. Moderately-sized bilateral non-hemorrhagic pleural effusions.

___ Flexible sigmoidoscopy
A circumferential mass was encountered at the rectosigmoid 
junction around 15 cm from the anal verge highly suspcious for 
primary colorectal cancer. The colonoscope was unable to 
traverse the stricture which was estimated at around 9mm in 
diameter.The mass was very friable. (biopsy)
Otherwise normal sigmoidoscopy to distal sigmoid colon.

Sigmoidoscopy ___:
Contents: Solid green stool was found in the rectum. No fresh or 
old blood was noted.  A metal stent was found in the rectum. 
There is mild tumor ingrowth into the mid-portion of the stent. 
This area is friable with some bleeding from passage of the 
endoscope - likely source of bleeding.   
Impression: Stent in the rectum
Stool in the rectum
Otherwise normal sigmoidoscopy to splenic flexure 
Recommendations: Stool softners and laxatives as d/w inpatient 
team. 
Oral iron 

CXR ___:
IMPRESSION:    
There is no clear radiographic change over the past 11 days.  
Bilateral 
pleural effusions moderate on the right small on the left and 
callus pulmonary nodules are unchanged. Extent of central 
adenopathy is better revealed by the chest CT scan. 
  
Confluent opacification at the base of the right lung is 
probably atelectasis, pleural mild pneumonia is difficult to 
exclude.  In all other locations there no findings that would 
raise the possibility of pneumonia. 

___ ___:
FINDINGS:  
There is normal compressibility, flow and augmentation of the 
bilateral common femoral, proximal, mid, distal femoral, and 
popliteal veins. Normal color flow and compressibility are 
demonstrated in the posterior tibial and peroneal veins. There 
is normal respiratory variation in the common femoral veins 
bilaterally. No evidence of medial popliteal fossa (___) cyst. 

  
IMPRESSION:  
No evidence of deep venous thrombosis in the bilaterallower 
extremity veins. 

EKG ___: 
Narrow complex tachycardia. Probably sinus tachycardia. Compared 
to the 
previous tracing of ___ the rate has increased. 

CXR ___:
FINDINGS:  
Numerous nodular opacities compatible the patient's metastatic 
disease are again appreciated. In addition, there is worsening 
pulmonary edema as well as a worsening right lower lobe 
infiltrate which could represent pneumonia in the correct 
clinical setting. A right pleural effusion is also increased in 
size. 
  
IMPRESSION:    
Worsening combination of pleural effusion, pulmonary edema and 
possibly 
pneumonia particularly in the right lower lobe. 

CTA CHEST W/ CONTRAST ___:
IMPRESSION:  
1. Partially limited evaluation of the subsegmental pulmonary 
arteries, 
however no evidence of central, lobar, or segmental pulmonary 
embolism. 
2. Since ___, increase in size and number of 
innumerable pulmonary metastases, as well as enlargement of 
bilateral pleural effusions, large on the right and moderate on 
the left. 
3. Partially imaged upper abdomen demonstrates diffuse 
intrahepatic metastasis and considerable upper abdominal 
lymphadenopathy. 

KUB ___:
IMPRESSION:    
1.  Rectal stent overlying the sacrum. 
2. No bowel obstruction. 
3. Likely interval decrease of small right pleural effusion. 

CT ABDOMEN PELVIS W/ CONTRAST ___:
IMPRESSION:  
1.  Interval (since ___ placement of a colonic stent, 
2.  Circumscribed 10.4 x 7.4mm anterior pelvic fluid collection 
containing small locules of gas, likely an abscess from sigmoid 
tumor perforation.   This is amenable to drainage. 
2a.  Moderate/large amount of free air, and small amount of free 
fluid within the peritoneum. 
3. Extensive lymphadenopathy in the retroperitoneum and porta 
hepatis, which results in narrowing of the origin of the left 
renal vein. Encasement of the splenic vein-SMV confluence and 
bilateral renal arteries is also demonstrated, without 
significant intraluminal narrowing in these vessels.  Normally 
enhancing kidneys on today's study. 
4. Innumerable hepatic metastases. 
5. Innumerable pulmonary metastases, lungs only partially 
imaged. 
6. Moderately-sized bilateral non-hemorrhagic pleural effusions 

PATHOLOGY:
==========
___ GI mucosa
PATHOLOGIC DIAGNOSIS:
Sigmoid mass biopsy: Adenocarcinoma, low grade

 
Brief Hospital Course:
Mr. ___ was a ___ with history of HCV and EtOH abuse who 
presented with abdominal pain and melena with imaging concerning 
for metastatic colon cancer.  

ACUTE ISSUES:
=============
# Metastatic colon cancer: Patient presented with weight loss 
for several months with anemia and abdominal pain. Patient 
without prior preventative health care. Imaging from outside 
hospital demonstrated rectosigmoid mass with metastases to the 
liver and lungs. Patient underwent flexible sigmoidoscopy with 
biopsy demonstrating adenocarcinoma. Given near complete 
obstruction Advanced Endoscopy placed a palliative stent. He 
developed diffuse abdominal pain on ___ CT abd showed 
colonic stent perforation. He was not deemed a surgical 
candidate due to his widely metastatic disease. He wished to 
become CMO/DNR/DNI, and expired peacefully on ___. Family 
was notified and declined autopsy. 

# Abdominal Stent Perforation: Experienced diffuse abdominal 
pain on ___, CT abdomen showed perforation ___ stent.  He was 
not felt to be a good surgical candidate due to metastatic 
cancer and poor functional status. He wished to become CMO. 
Vancomycin, Ceftriaxone, and Metronidazole were prescribed to 
improve his abdominal pain and discomfort. 

# Hyponatremia, chronic: Patient presented with sodium of 118 at 
outside hospital The patient was given IV fluids until stable 
sodium level reached at 127. SIADH was thought to be a 
significant component of his hyponatremia, given his extensive 
metastatic disease to his lungs.

# Septicemia: Met sepsis criteria on ___. Thought to be due to 
either hospital-associated pneumonia or GI translocation in the 
setting of stent perforation. He was treated with antibiotics 
until his family was able to visit, then discontinued.

# Hospital-Associated Pneumonia: He developed increased sputum 
production and shortness of breath, and a chest x-ray was 
suggestive of right lower lobe pneumonia. He was treated with 
vancomycin and ceftriaxone.

CHRONIC ISSUES:
===============

# Microcytic anemia: Patient found to have anemia with MCV 79. 
Iron studies demonstrated anemia of chronic disease and also 
likely iron deficient in setting of chronic bleeding from GI 
malignancy. He was started on iron supplementation.

# Transaminitis: Likely secondary to metastatic liver 
involvement vs. EtOH use given elevated AST:ALT ratio.

# Alcohol abuse: Patient reports chronic use of alcohol, 
multiple beers and at least two shots of brandy daily. Has 
continued to drink despite lack of appetite prior to 
hospitalization. During his admission, he had no evidence of 
withdrawal.

# Melena: Patient had melena after stent placement. 
Sigmoidoscopy on ___ showed tumor infiltration into the stent 
with friable, bleeding tissue, which was the likely source of 
his bleeding.

# Hypertension: Held home lisinopril in the setting of low blood 
pressures.

# Hepatitis C: untreated.
 
Medications on Admission:
none
 
Discharge Medications:
none
 
Discharge Disposition:
Expired
 
Discharge Diagnosis:
Primary:
=======
Metastatic colon (adenocarcinoma) cancer
Colonic perforation
Hospital associated pneumonia
Septicemia

Secondary:
==========
Anemia
Hypertension
Hyponatremia
Hepatitis C

 
Discharge Condition:
expired

 
Discharge Instructions:
Dear loved ones of Mr. ___,

It was as pleasure taking part in his care during your 
hospitalization at ___. He wastransferred from ___ 
___ after a CT scan was concerning for colon cancer. A 
biopsy revealed colon cancer with metastases to his liver and 
his lung. He had a stent placed in his colon to relieve his 
abdominal pain. He wasseen by the Oncologists who felt he was 
not a candidate for chemotherapy given his weakness/poor 
functional status. Over his hospitalization  he had pneumonia, 
which was treated with antibiotics. He developed worsening 
abdominal pain and was found to have a perforated colon from the 
stent that was placed. It was a pleasure taking part in his 
care!
 
Followup Instructions:
___
",MEDICINE
10005123-DS-17,Alan Jackson,10005123,24274954," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
post TIPS monitoring
 
Major Surgical or Invasive Procedure:
TIPS ___

 
History of Present Illness:
Mr. ___ is a ___ male with congenital hepatic
fibrosis complicated by portal hypertension and variceal 
bleeding
who presents to the medicine floor s/p TIPS procedure for TIPS
monitoring. 
 
The patient recently presented to the ED on ___ with severe
variceal bleeding requiring blood/plasma transfusion as well as
endoscopic banding of his esophageal/gastric varices. He
ultimately elected to undergo a TIPS placement by ___ on ___.
Per sign out, the TIPS procedure was quite complicated, lasting 
a
total of 6 hours. The HVPG was reduced to 10. His
esophageal/gastric were not embolized though he did receive tPA
for his portal vein thrombosis.

 
Past Medical History:
- Congenital hepatic fibrosis
-- Portal hypertension
-- Gastric and esophageal varices s/p band ligation 
- Hyperlipidemia 
 
Social History:
___
Family History:
non contributory to this admission
 
Physical Exam:
VS: 24 HR Data (last updated ___ @ 1213)
    Temp: 97.9 (Tm 98.5), BP: 133/78 (129-146/75-78), HR: 71
(71-82), RR: 16 (___), O2 sat: 98% (95-98), O2 delivery: RA,
Wt: 203.7 lb/92.4 kg   

GENERAL: well appearing man in no acute distress
HEENT:  anicteric sclera, right neck access site bandaged &
clean. no active bleeding
HEART: RRR, no murmurs, rubs, gallops
LUNGS: clear bilaterally 
ABDOMEN: soft, mildly distended, non-tender to palpation but
subjective discomfort, RUQ dressing c/d/I without surrounding
erythema, drainage, bleeding
EXTREMITIES: wwp, no edema
NEURO: A&Ox3, moving all 4 extremities with purpose, no
asterixis. Able to say months of the year backwards.

 
Pertinent Results:
___ 06:47AM BLOOD WBC-4.2 RBC-3.93* Hgb-11.0* Hct-33.8* 
MCV-86 MCH-28.0 MCHC-32.5 RDW-15.2 RDWSD-47.3* Plt Ct-29*
___ 06:47AM BLOOD Glucose-109* UreaN-15 Creat-1.0 Na-141 
K-3.8 Cl-104 HCO3-23 AnGap-14
___ 06:47AM BLOOD ALT-824* AST-556* LD(LDH)-289* 
AlkPhos-360* TotBili-1.8*

 
Brief Hospital Course:
Mr. ___ is a ___ male with congenital hepatic 
fibrosis complicated by portal hypertension and variceal 
bleeding who presents to the medicine floor for post TIPS 
monitoring. Mild ___ post-op s/p 25gm albumin; otherwise 
uncomplicated course. Surgical wounds stable; dressing clean and 
dry. Patient able to tolerate PO without issue. No evidence of 
hepatic encephalopathy prior to discharge. No further planned 
intervention by ___ this hospitalization; they will see him in 
follow-up in ___ weeks.

TRANSITIONAL ISSUES:
====================
[ ] please obtain repeat LFTs on ___ with results faxed to 
___ (f: ___
[ ] consider repeat hepatitis A and B serologies to ensure 
immunization (non immune as of ___ in ___ records) 
[ ] consider repeat AFP as last AFP in BID system is from ___ 
[ ] please consider stopping lactulose that was continued on 
discharge depending on post-op course regarding HE 

ACTIVE ISSUES
=============
# Congenital Hepatic Fibrosis c/b portal hypertension:
# S/p TIPS ___: 
As above, patient presented in ___ with variceal bleeding 
requiring transfusions and banding of his esophageal/gastric 
varices, now s/p elective TIPS placement on ___ with ___ (10 x 6 
and 10 x 8 R TIPS placed). He has no history of HE or ascites. 
Per ___ team, the TIPS procedure was complicated, lasting 6 
hours. His post-TIPS HVPG is between ___ mmHg (pre-tips HVPG 
not documented). His varices were not embolized though he did 
receive tPA for his portal vein thrombosis. Tentatively may need 
another procedure in the near future. He was discharged on 
lactulose with instructions to titrate to two BMs daily. 
Consider stopping this at his follow-up appointment.

Post-op, his vitals have remained stable. His neck and abdominal 
access sites appear to be healing appropriately. His LFTs are up 
but expected post-op changes, downtrending by discharge. 
Telemetry and foley were dc'd. Patient has been able to urinate 
and has had multiple bowel movements with lactulose. His MELD-NA 
post-op on ___ was 16. Pain control with acetaminophen + 
hot/cold packs. He post-op course was uncomplicated except for a 
mild ___ discussed below which resolved with albumin.

Discharge MELD-NA: 11
Discharge HgB: 11

___
SCR 1.1 --> 1.4 ---> 1.0
Most likely related to NPO prior to procedure and prolonged 
operation. HRS very unlikely has patient has no ascites or 
hepatic hydrothorax (on exam or history of). Urine lytes were 
unremarkable with UNa <20 which is an appropriate response to 
pre-renal dehydration. UA and sediment unremarkable. Discharge 
Creatinine: 1.0

# Thrombocytopenia: 
Plts in the ___, at baseline. Secondary to cirrhosis, 
splenomegaly. SQH was held ___ thrombocytopenia. Patient had no 
e/o bleeding or petichiae during his hospital course. 
Discharge platelets: 29

CHRONIC ISSUES
==============
# Hyperlipidemia:
Continued Pravastatin 40 mg QHS

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Nadolol 40 mg PO DAILY 
2. Pravastatin 40 mg PO QPM 

 
Discharge Medications:
1.  Lactulose 30 mL PO DAILY 
RX *lactulose 10 gram/15 mL (15 mL) 30 ml by mouth once a day 
Disp #*1 Bottle Refills:*2 
2.  Nadolol 40 mg PO DAILY  
3.  Pravastatin 40 mg PO QPM  
4.Outpatient Lab Work
DX: Elevated Liver Enzymes
ICD-10: R94.5
Tests: AST, ALT, ALP, Total Bili, Direct Bili

Please fax results to ___ at ___.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY:
Congenital hepatic fibrosis
Portal hypertension
Cirrhosis

SECONDARY:
History of esophageal and gastric varices

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,  
It was a pleasure taking care of you at the ___ 
___!  

WHY WAS I IN THE HOSPITAL?  
==========================  
- You were admitted because you had a TIPS procedure and needed 
routine monitoring afterwards

WHAT HAPPENED IN THE HOSPITAL?  
==============================  
- You had a TIPS procedure performed
- Post-procedure, your mental status, liver/kidney tests, and 
blood counts were monitored
- You received a medicine to help you have regular bowel 
movements

WHAT SHOULD I DO WHEN I GO HOME?  
================================  
- Be sure to take all your medications and attend all of your 
appointments listed below.
- Take your lactulose enough times daily to have two bowel 
movements every day.
- If you notice black or bloody stool or if you are vomiting 
blood, please go to the ER right away
- Interventional Radiology will call you with an appointment in 
___ weeks. 

Thank you for allowing us to be involved in your care, we wish 
you all the best!  

Your ___ Healthcare Team  

 
Followup Instructions:
___
",MEDICINE
10005123-DS-18,Alan Jackson,10005123,20470681," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
___ Surgical or Invasive Procedure:
___: Redo TIPS
___: Redo TIPS

attach
 
Pertinent Results:
ADMISSION LABS:

___ 07:30AM BLOOD WBC-4.2 RBC-4.29* Hgb-12.1* Hct-37.9* 
MCV-88 MCH-28.2 MCHC-31.9* RDW-14.7 RDWSD-47.1* Plt Ct-63*
___ 07:30AM BLOOD ___
___ 07:30AM BLOOD Plt Ct-63*
___ 06:11PM BLOOD ___
___ 07:30AM BLOOD UreaN-21* Creat-1.0 Na-142 K-4.6 Cl-109* 
HCO3-22 AnGap-11
___ 07:30AM BLOOD ALT-75* AST-88* AlkPhos-487* TotBili-1.0
___ 06:11PM BLOOD Albumin-4.0 Calcium-8.7 Phos-2.7 Mg-1.9

DISCHARGE LABS:
___ 04:54AM BLOOD WBC-5.1 RBC-3.97* Hgb-11.2* Hct-35.4* 
MCV-89 MCH-28.2 MCHC-31.6* RDW-14.7 RDWSD-48.1* Plt Ct-71*
___ 12:07PM BLOOD PTT-83.3*
___ 04:54AM BLOOD Plt Ct-71*
___ 03:22PM BLOOD ___ 04:54AM BLOOD Glucose-95 UreaN-24* Creat-1.0 Na-140 
K-4.4 Cl-109* HCO3-19* AnGap-12
___ 04:54AM BLOOD ALT-501* AST-660* LD(LDH)-696* 
AlkPhos-428* TotBili-2.7*
___ 04:54AM BLOOD Albumin-3.6 Calcium-8.3* Phos-3.0 Mg-1.9

MICRO:
n/a

IMAGING:
___ REDO TIPS 
Successful right internal jugular access with direct 
transjugular intrahepatic portosystemic shunt revision with 
extension of the TIPS cranially. 
  
New direct TIPS aspiration thrombectomy. 
  
Thrombolysis catheter placement through the right IJ sheath for 
overnight 
thrombolysis 

___BD & PELVIS W & W/O 
1. Interval redo TIPS procedure, with persistent thrombus in the 
TIPS shunt.  
The new TIPS shunt lies parallel to the superior most aspect of 
the 
pre-existing stent, with its upper portion approximately 1 cm 
below the 
cavoatrial junction.  The tPA infusion catheter localizes in the 
lower right atrium, with the lowest radiopaque marker overlying 
the lower cavoatrial junction. 
2. There is increased burden of nonocclusive thrombus in the 
main portal vein. 
3. Interval development of trace ascites. 
4. Stable cirrhosis with secondary changes representing the 
sequela of portal hypertension including perisplenic, 
perigastric and periesophageal varices, and splenomegaly. 

___ REDO TIPS 
  
Successful revision of occluded TIPS and thrombosed portal vein 
with a 
postprocedural portosystemic gradient of 11 mm Hg. 
  
Technically successful coronary variceal embolization and 
sclerotherapy. 

 
Brief Hospital Course:
___ male with congenital hepatic fibrosis complicated by 
portal hypertension and variceal bleeding s/p TIPS ___ who 
presented to the MICU s/p TIPS revision with thrombolysis 
complicated by hypoxia. 

ACUTE ISSUES 
======================= 
#Hypoxic respiratory failure: 
Patient developed new oxygen requirement after ___ TIPS revision. 
Unclear if VTE or atelectasis
or just some orthodeoxia but responded to oxygen and remained on 
room air for the majority of his ICU course. 

# Congenital Hepatic Fibrosis c/b portal hypertension and
variceal bleeding:
# S/p TIPS ___ and revision ___
Pt with congenital hepatic fibrosis c/b portal HTN and variceal 
bleeding. TIPS revision complicated by hypoxia. He had a right 
IJ sheath with lysis catheter placed. He underwent CTV with 
persistent thrombus in TIPS shunt. Now s/p revision of occuled 
TIPS and thrombosed portal vein with a postprocedural 
portosystemic gradient of 11 mm Hg. He also had successful 
coronary variceal embolization and sclerotherapy. He was placed 
on a heparin drip post TIPS and transitioned to lovenox on 
discharge.
- GIB/VARICES: EGD ___ which showed scarring at GE junction, 
proximal grade 2 EVs s/p esophageal band ligation x4 and large 
gastric varices. Pt also presented to an outside ED in ___ 
with acute UGIB/variceal bleed. Not able to be banded/embolized; 
considered for future procedure. On nadolol at home which was 
continued while inpatient.
- ASCITES: no history of ascites, not on diuretics, he was not 
overloaded on exam.

#Transminitis
Likely due to liver disease and TIPS procedure

# Thrombocytopenia
Likely ___ to liver disease and sequestration 

CHRONIC ISSUES 
======================= 
# Hyperlipidemia:
- Continued Pravastatin 40 mg QHS 

TRANSITIONAL ISSUES: 
======================= 
[ ] please recheck LFTs in 1 week to ensure downtrending 
[ ] check CBC within 1 week as on anticoagulation and patient 
has bleeding history 
[ ] f/u US of TIPS shunt in 1 week
[ ] continue lovenox for one month 
[ ] follow up with ___ in 1 month 
#CODE STATUS: Presumed FULL 
#CONTACT: ___ - wife - ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Nadolol 40 mg PO DAILY 
2. Pravastatin 40 mg PO QPM 
3. Pantoprazole 40 mg PO Q24H 

 
Discharge Medications:
1.  Enoxaparin Sodium 90 mg SC Q12H  
2.  Nadolol 40 mg PO DAILY  
3.  Pantoprazole 40 mg PO Q24H  
4.  Pravastatin 40 mg PO QPM  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIANGOSIS:
Hypoxic respiratory failure 
Congenital Hepatic Fibrosis c/b portal hypertension and variceal 
bleeding
TIPS occlusion
Portal vein thrombosis occlusion

SECONDARY DIAGNOSIS:
Transaminitis
Thrombocytopenia
Hyperlipidemia 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

WHY WAS I ADMITTED TO THE HOSPITAL?
You were admitted because you had a blood clot in your TIPS and 
your oxygen was low. 

WHAT WAS DONE WHILE I WAS HERE?
We opened up the vessels/TIPS. We started you on a blood 
thinner. We watched your breathing closely. 

WHAT SHOULD I DO NOW?
You should take your medications as instructed. 
You should go to your doctor's appointments as below. 

We wish you the best!
-Your ___ Care Team 
 
Followup Instructions:
___
",MEDICINE
10005368-DS-10,David Carvalho,10005368,24631981," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
amoxicillin / morphine
 
Attending: ___.
 
Chief Complaint:
abdominal ___
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ h/o chronic abdominal ___ attributed to IBS, GERD s/p 
Nissen fundoplication in ___ admitted to ___ surgery 
service with abdominal ___ and now transferred to medicine for 
continued ___ and inability to tolerate PO. Pt is unsure of the 
exact timeline, but in the last 1.5-2 weeks, he has experienced 
both epigastric burning (described as ""felt like swallowing 
nails"") as well as intermittent, sharp RUQ abdominal ___. He 
has had associated nausea but no emesis, bowel movements are at 
his baseline of daily, brown, somewhat loose stools, no dark or 
bloody stools. Denies trauma. Feels ""hot and cold"" lately, but 
no measured fevers, nightsweats or LAD. His IBS ___ is 
typically LLQ ___ which is chronic, but from which he suffers 
""attacks"" ___ times per month. He has a ___ specialist named 
Dr. ___ in ___ who is working with him and 
considering a spinal stimulator for control of his ___. Pt 
became unable to tolerate PO intake 4 days ago and is concerned 
because he estimates that he has lost 14 lbs in the last week. 
Of note, pt also reports multiple ED visits to ___ 
in the last 2 weeks for above complaints as well as an episode 
of ""anaphylactic shock"" involving generalized hives and 
difficulty breathing attributed to recent course of amoxicillin 
for sinusitis for which he was reportedly given prednisone and 
epinephrine at ___. His abdominal ___ workup at 
___ included CT abd, HIDA scan and upper endoscopy, 
all of which were reportedly negative.

Currently, pt is not experiencing epigastric burning, but still 
notes intermittent sharp ___ in his RUQ. He denies depressed 
mood and states that ""life could not be any better,"" given his 
satisfaction with his new job as a ___ at a ___ 
___ the past few months as well as his recent move 
to live with his girlfriend and her parents.
 
 
Past Medical History:
Medical History:
-GERD
-IBS c/b chronic LLQ ___ for which he is followed by a ___ 
specialist Dr. ___ in ___

Surgical History: Laparoscopic ___ Fundoplication (___), 
Endoscopic dilation ___.  Lap removal of abdominal 
cyst ___ (___).
 
Social History:
___
Family History:
MGF- stroke, MI unsure of age
Father- HTN, HLD
""everyone has gallbladder problems""
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
T: 94.5 HR: 92 BP: 135/86 RR: 16 Sat 100% RA
Weight: 130.5  Height: 67. BMI: 20.4
GEN: uncomfortable
CV: RRR, mild tachy
Abd: Soft, nondistended. TTP RUQ and epigastrium
Back: +R CVAT
Ext: No c/c/e

DISCHARGE PHYSICAL EXAM:
Afebrile, normotensive, vital signs stable
General: alert, oriented, no acute distress  
HEENT: sclera anicteric, MMM, oropharynx clear  
Lungs: clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, nontender to palpation,non-distended, bowel 
sounds present, no rebound or guarding, no organomegaly  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: motor function grossly normal 

 
Pertinent Results:
LABS:
=========
___ 06:50PM   GLUCOSE-204* UREA N-21* CREAT-0.9 SODIUM-137 
POTASSIUM-4.5 CHLORIDE-97 TOTAL CO2-22 ANION GAP-23*
___ 06:50PM   ALT(SGPT)-17 AST(SGOT)-14 ALK PHOS-53 TOT 
BILI-0.9
___ 06:50PM   ALBUMIN-4.9 CALCIUM-9.4 PHOSPHATE-3.1 
MAGNESIUM-2.2
___ 06:50PM   WBC-6.2 RBC-5.00 HGB-15.3 HCT-45.8 MCV-92 
MCH-30.5 MCHC-33.3 RDW-13.0
___ 06:50PM   NEUTS-70.5* ___ MONOS-5.3 EOS-1.2 
BASOS-0.8
___ 06:50PM   PLT COUNT-174
___ 07:47AM BLOOD WBC-5.1 RBC-4.97 Hgb-15.1 Hct-44.2 MCV-89 
MCH-30.4 MCHC-34.1 RDW-13.3 Plt ___
___ 07:47AM BLOOD Glucose-64* UreaN-9 Creat-1.2 Na-138 
K-4.3 Cl-98 HCO3-27 AnGap-17
___ 07:00AM BLOOD ALT-15 AST-13 AlkPhos-42 TotBili-0.7
___ 07:00AM BLOOD %HbA1c-5.6 eAG-114
___ 08:03AM BLOOD IgA-103
___ 08:03AM BLOOD tTG-IgA-3
___ 06:50PM BLOOD SULFONYLUREAS-PND

___ 18:50
Test                          Result              Reference 
Range/Units
C-PEPTIDE                     4.07  H             0.80-3.10 
ng/mL

___ 18:50
Test                          Result              Reference 
Range/Units
INSULIN                       27.9  H             2.0-19.6 
uIU/mL 

  

___ 18:50
SULFONYLUREAS
 
Test                          Result              Reference 
Range/Units
ACETOHEXAMIDE                 None Detected       mcg/mL
 
Reporting Limit: 0.30 mcg/mL
 
Synonym(s): Dymelor(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 
Test                          Result              Reference 
Range/Units
CHLORPROPAMIDE                None Detected       mcg/mL
 
Reporting Limit: 0.30 mcg/mL
 
Synonym(s): Diabinese(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 
Test                          Result              Reference 
Range/Units
GLIMEPIRIDE                   None Detected       ng/mL
 
Reporting Limit: 5.0 ng/mL
 
Synonym(s): Amaryl(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 
Test                          Result              Reference 
Range/Units
GLIPIZIDE                     None Detected       mcg/mL
 
Reporting Limit: 0.0050 mcg/mL
 
Synonym(s): Glucotrol(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 
Test                          Result              Reference 
Range/Units
GLYBURIDE                     None Detected       mcg/mL
 
Reporting Limit: 0.0050 mcg/mL
 
Synonym(s): Micronase(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 
Test                          Result              Reference 
Range/Units
NATEGLINIDE                   None Detected       mcg/mL
 
Reporting Limit: 0.050 mcg/mL
 
Synonym(s): Starlix(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 
Test                          Result              Reference 
Range/Units
REPAGLINIDE                   None Detected       mcg/mL
 
Reporting Limit: 0.010 mcg/mL
 
Synonym(s): Prandin(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 
Test                          Result              Reference 
Range/Units
TOLAZAMIDE                    None Detected       mcg/mL
 
Reporting Limit: 0.30 mcg/mL
 
Synonym(s): Tolinase(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 
Test                          Result              Reference 
Range/Units
TOLBUTAMIDE                   None Detected       mcg/mL
 
Reporting Limit: 0.30 mcg/mL
 
Synonym(s): Orinase(R)
Analysis by High Performance Liquid 
Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
 

IMAGING:
========
Portable CXR ___
The lungs are clear without infiltrate. The cardiac and 
mediastinal 
silhouettes are normal. There is minimal right CP angle blunting 
compatible with either a tiny effusion or is small amount of 
pleural thickening the bony thorax appears normal   IMPRESSION:  
Blunting of the right CP angle otherwise normal chest.  

___  Barium Esophagram
The patient is status post ___ fundoplication with surgical 
clips in the left upper abdomen on the initial scout view. The 
distal esophagus is not dilated and appears unremarkable. Barium 
is seen passing freely from the distal esophagus through the 
gastroesophageal junction into the stomach without evidence of 
hold up or leak.
IMPRESSION: Normal appearance of the ___ fundoplication 
without evidence of holdup or leak.

___  LIVER OR GALLBLADDER US
Normal abdominal ultrasound.

___ 08:03AM BLOOD tTG-IgA-___ h/o chronic abdominal ___ attributed to IBS, GERD s/p 
___ fundoplication in ___ admitted to ___ 
service with abdominal ___ and found to have no acute surgical 
issue. He was then transferred to medicine for continued ___ 
and inability to tolerate PO. 

# Acute on chronic abdominal ___: Pt reported intermittent RUQ 
___ distinct from his typical LLQ IBS ___. Unclear etiology, 
but extensive workup at OSH and ___ including LFTs, lipase, 
CBC, TTG IgA, EGD, CT abd, HIDA scan, barium swallow, CXR and 
RUQ u/s negative.   No recent trauma or chest wall tenderness to 
suggest MSK etiology. Symptoms may be due to IBS but given 
inconsistencies in patient's description of symptoms from day to 
day and specific requests for exploratory surgery and narcotic 
___ medications, there is concern for factitious disorder vs 
malingering. Discontinued IV dilaudid that was started on 
admission given lack of clear etiology of ___ beyond known IBS 
and lack of IV med requirement (pt tolerating pills). 
Transitioned to PO tramadol PRN and resumed home ___ regimen 
___. Psychiatry was consulted and felt that patient would 
benefit from longitudinal outpatient therapy. He was observed 
and eventually ___ resolved and he was able to tolerate a 
regular diet. He was discharged with plan for close follow up 
with PCP and his outpatient ___ specialist.

# Epigastric discomfort: Reported intermittent epigastric 
burning. OSH EGD negative, normal post surgical changes s/p 
Nissen on barium swallow. Continued home famotidine and PPI and 
___ resolved. 

# Nausea/Poor PO intake: Questionable h/o 14 lb weight loss in 
week prior to presentation. Pt reported inability to take PO for 
only 4 days, lacked significant systemic symptoms and was well 
appearing on exam. No recent diarrhea or emesis per patient 
report. Patient reported main barrier to PO intake to be 
constant nausea. He was treated symptomatically with ondansetron 
PO. Once he began tolerating PO, he had a very large meal which 
included ___ fries and chocolate cake and reported subsequent 
nausea. He was advised to follow a BRAT diet with small amounts 
of PO intake at a time to avoid exacerbating symptoms.

# Hypoglycemia: Pt reported that he was recently told he is 
diabetic but was not currently taking DM medications per his 
report and A1C this admission was normal. On admission to the 
surgical service, he had symptomatic hypoglycemia to ___ of 
unclear etiology. Fingerstick blood glucose recorded on ___ 
51->142->83. C-peptide and insulin levels were ordered given 
concern for factitious disorder vs malingering, but results were 
non-diagnostic because they were drawn after D50 was 
administered. A sulfonylurea level was added on to his admission 
labs and was negative. Hypoglycemia did not recur.

# H/o anaphylaxis: Pt reported recent episode of hives and 
""throat closing"" with amoxicillin. He plans to seek outpatient 
allergy f/u and was recently prescribed an epi pen. 

TRANSITIONAL ISSUES:
======================
# Acute on chronic abdominal ___: Recommend outpatient ___ 
clinic follow up and longitudinal follow up with a mental health 
provider
# Nausea: Discharged on prn ondansetron and mild diet. Recommend 
outpatient GI follow up if persists.
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Albuterol Inhaler ___ PUFF IH Q6H:PRN sob 
2. Lorazepam 0.5 mg PO HS:PRN insomnia 
3. Pregabalin 200 mg PO BID 
4. TraMADOL (Ultram) 50-100 mg PO Q6H:PRN ___ 
5. Polyethylene Glycol 17 g PO DAILY:PRN constipation 
6. Docusate Sodium 100 mg PO BID 
7. Famotidine 20 mg PO TID 
8. HYDROmorphone (Dilaudid) 2 mg PO Q6H:PRN severe abdominal 
___ 
9. EpiPen 2-Pak (EPINEPHrine) 0.3 mg/0.3 mL (1:1,000) injection 
ONCE PRN anaphylaxis 

 
Discharge Medications:
1. Docusate Sodium 100 mg PO BID 
2. Famotidine 20 mg PO TID 
3. Polyethylene Glycol 17 g PO DAILY:PRN constipation 
4. Pregabalin 300 mg PO BID 
5. TraMADOL (Ultram) 50-100 mg PO Q6H:PRN ___ 
6. Albuterol Inhaler ___ PUFF IH Q6H:PRN sob 
7. EpiPen 2-Pak (EPINEPHrine) 0.3 mg/0.3 mL (1:1,000) injection 
ONCE PRN anaphylaxis 
8. HYDROmorphone (Dilaudid) 2 mg PO Q6H:PRN severe abdominal 
___ 
9. Lorazepam 0.5 mg PO HS:PRN insomnia 
10. Omeprazole 20 mg PO DAILY 
RX *omeprazole 20 mg 1 capsule(s) by mouth Daily Disp #*30 
Capsule Refills:*0
11. Ondansetron ___ mg PO Q4H:PRN nausea 
RX *ondansetron [Zofran ODT] 4 mg ___ tablet(s) by mouth Every 4 
hours Disp #*60 Tablet Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Abdominal ___
Nausea
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Mr. ___,

It was a pleasure participating in your care at ___. You were 
admitted to the hospital for abdominal ___ and nausea. You had 
a thorough evaluation which revealed no specific source for your 
___. Your symptoms gradually improved and you were able to eat 
and drink. It is very important that you eat a mild diet, low in 
fat and dairy in small portions for the next week to avoid 
making your symptoms worse. We have prescribed ondansetron 
(Zofran) for nausea and omeprazole for stomach acid for you to 
take until you see your primary care doctor next week. 

Please follow up with your primary care doctor and ___ 
specialist as scheduled. We believe that you would benefit from 
seeing a counselor or therapist regularly to help cope with your 
chronic ___. 
 
Followup Instructions:
___
",MEDICINE
10005565-DS-3,Diane Bell,10005565,23948843," 
Name:  ___                        Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
Syncope
 
Major Surgical or Invasive Procedure:
none 

 
History of Present Illness:
Ms. ___ is a ___ yo F w/hx of CAD s/p MI, gout, hypothyroidism 
who presented to the ED with syncope.  She had seen her PCP 
today and was standing outside the office when she fainted. She 
first felt a feeling of regurgitation and a bitter taste in her 
mouth, then felt lightheaded and then passed out.She awoke and 
vomited once.  Her pulse was found to be in the ___ and she was 
brought to the ED. The same type of incident occured a few years 
ago but she does not remember what hospital she was admitted to. 
She takes atenolol, however it makes her dizzy and she is 
inconsistent with taking it.She denies any recent medication 
changes. She does say she has been more fatigued in the last ___ 
weeks.
 She was passed out for a few minutes and as per witness reports 
she did not shake, bite her tongue, experience fecal/urinary 
incontinence or experience any motor/sensory abnormalities after 
waking up.She denies any associated chest pain, palpitations, or 
headache. She feels like her exercise tolerance has improved in 
the last couple of months and denies any chest pain or abnormal 
shortness of breath on exertion.  
.  
On review of systems, she denies any prior history of stroke, 
TIA, deep venous thrombosis, pulmonary embolism, bleeding at the 
time of surgery, She someitimes has left upper back and left arm 
pain but says it is related to her gout, cough, hemoptysis, 
black stools or red stools. She denies recent fevers, chills or 
rigors. She denies exertional buttock or calf pain. All of the 
other review of systems were negative.  
.  
Cardiac review of systems is notable for absence of chest pain, 
dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, 
ankle edema, palpitations, syncope or presyncope.  
.  
In the ED, initial vitals were 97.5 37 120/66 16 99%. She 
triggered on arrival for bradycardia of 37.  She was 
asymptomatic and normotensive.  Pacer pads were placed but not 
used.  She was not given Atropine.  She underwent head CT which 
was normal and CXR which was normal.  Vitals prior to transfer: 
afebrile HR 44 BP 102/54 RR 13 99% RA.

 
Past Medical History:
PAST MEDICAL HISTORY:  
1. CARDIAC RISK FACTORS:HTN  
2. CARDIAC HISTORY: Catherization ___ years ago at the ___, 
according to patient she was told it was normal and nothing was 
done.    
3. OTHER PAST MEDICAL HISTORY:
Gout
Hypothyroidism 
CAD
HLD   
.  

 
Social History:
___
Family History:
No family history of early MI, arrhythmia, cardiomyopathies, or 
sudden cardiac death; otherwise non-contributory.  
 
Physical Exam:
VS: T=97.4 BP=127/71 HR=44 RR=18 O2 sat=96% RA   
GENERAL: WDWN female in NAD. Oriented x3. Mood, affect 
appropriate.  
HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were 
pink, no pallor or cyanosis of the oral mucosa. No xanthalesma.  

NECK: Supple, non elevated JVP  
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. RR, soft S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. 
 
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. CTAB, no crackles, 
wheezes or rhonchi.  
ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not 
enlarged by palpation. No abdominial bruits.  
EXTREMITIES: No c/c/e. No femoral bruits.  
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  
PULSES:  
Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  
Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+  

 
Pertinent Results:
Admission Labs 

___ 03:00PM   GLUCOSE-124* UREA N-14 CREAT-0.6 SODIUM-140 
POTASSIUM-3.8 CHLORIDE-100 TOTAL CO2-29 ANION GAP-15
___ 03:00PM   estGFR-Using this
___ 03:00PM   cTropnT-< 0.01
___ 03:00PM   CALCIUM-9.3 PHOSPHATE-2.7 MAGNESIUM-2.2
___ 03:00PM   TSH-2.6
___ 03:00PM   WBC-10.5 RBC-4.22 HGB-13.0 HCT-37.7 MCV-89 
MCH-30.9 MCHC-34.6 RDW-14.2
___ 03:00PM   NEUTS-81.8* LYMPHS-12.0* MONOS-4.1 EOS-1.4 
BASOS-0.6
___ 03:00PM   PLT COUNT-307
.
Discharge Labs 

___ 07:15AM BLOOD WBC-6.9 RBC-4.22 Hgb-12.6 Hct-38.0 MCV-90 
MCH-29.9 MCHC-33.2 RDW-14.3 Plt ___
___ 03:00PM BLOOD WBC-10.5 RBC-4.22 Hgb-13.0 Hct-37.7 
MCV-89 MCH-30.9 MCHC-34.6 RDW-14.2 Plt ___
___ 03:00PM BLOOD Neuts-81.8* Lymphs-12.0* Monos-4.1 
Eos-1.4 Baso-0.6
___ 07:15AM BLOOD Plt ___
___ 03:00PM BLOOD Plt ___
___ 07:15AM BLOOD Glucose-94 UreaN-12 Creat-0.6 Na-143 
K-3.3 Cl-104 HCO3-32 AnGap-10
___ 03:00PM BLOOD estGFR-Using this
___ 03:00PM BLOOD cTropnT-< 0.01
___ 07:15AM BLOOD Calcium-9.2 Phos-3.6 Mg-2.2
___ 03:00PM BLOOD Calcium-9.3 Phos-2.7 Mg-2.2
___ 03:00PM BLOOD TSH-2.6
.
Reports 
CHEST (PORTABLE AP)   Clip # ___   
Reason: eval for infiltrate  
 

 
UNDERLYING MEDICAL CONDITION: 
   ___ year old woman with bradycardia  
REASON FOR THIS EXAMINATION: 
   eval for infiltrate  

 
 
Final Report 
HISTORY: Bradycardia, evaluate for bradycardia. 
  
COMPARISON: ___. 
  
CHEST, SINGLE AP VIEW: The heart is top normal in size, with a 
mildly 
tortuous aorta. The lungs are clear without consolidation or 
edema. No 
pleural effusion or pneumothorax is identified. 
  
IMPRESSION: No acute cardiopulmonary abnormality. 
  
The study and the report were reviewed by the staff radiologist. 

  
 
.
CT HEAD W/O CONTRAST   Clip # ___   
Reason: eval for ICH  
 

 
UNDERLYING MEDICAL CONDITION: 
   ___ year old woman with syncope  
REASON FOR THIS EXAMINATION: 
   eval for ICH  
CONTRAINDICATIONS FOR IV CONTRAST: 
   None. 

 
 
Provisional Findings Impression: ___ WED ___ 6:02 ___ 
No acute intracranial process. 

 
Final Report 
HISTORY: ___ female with syncope. Question intracranial 
hemorrhage. 
  
COMPARISON: None. 
  
TECHNIQUE: Contiguous axial images through the brain were 
acquired without 
intravenous contrast. 
  
FINDINGS: The gray-white matter differentiation is preserved. 
There is no 
evidence of hemorrhage, mass, mass effect, shift of midline 
structures, or  
infarction. The ventricles and sulci are normal in size and 
configuration.  
Periventricular hypodensity adjacent to the frontal horn of the 
right lateral 
ventricle likely represents the sequelae of chronic ischemic 
microvascular 
disease. The calvarium is intact. The visualized paranasal 
sinuses are 
clear. Mild atherosclerotic calcification is noted within the 
cavernous 
carotid arteries bilaterally. 
  
IMPRESSION: 
  
No acute intracranial process. 
 

 
Brief Hospital Course:
Ms. ___ is a ___ yo F w/hx of CAD s/p MI, gout, hypothyroidism 
who presented to the ED with syncope and bradycardia in the 
___.
.  
#Syncope- The patient experienced some reflux of the food she 
had eaten and then felt lightheaded and passed out. She was 
found to have sinus bradycardia on presentation to the E.D. High 
on the differential is symptomatic bradycardia causing 
syncope.Per the patient she has a history of 1 episode of low HR 
causing her to past out a few years ago. The last EKG we have of 
her is in ___ when she was NSR in the ___. She denies having 
palpitations or experiencing lightheadedness on a regular basis, 
however she does say her atenolol makes her lightheaded. 
Vasovagal syncope given regurgitation of her food, and perhaps 
increased abdominal pressure, before passing out was also high 
on the differential. She also has a hx. of hypothyroidism which 
can cause bradycardia. Lower on the differential was seizure 
because of no typical clincial symptoms and PE because she 
denied any SOB and was never found to be tachycardic. Her heart 
rate was in the 40's and the tele showed sinus bradycardia. She 
was asymptomatic.However of note she does say she has been more 
fatigued than usual in the last week or two. We monitored on 
tele.-sinus bradycardia on ___-50.Held nodal blocking agents 
including atenolol and amlodipine during the admission and on 
discharge.She was hemodynamically stable.Checked TSH-2.6.Walked 
the patient and see if her heart rate increases above 60/minand 
####.Restarted HCTZ home dose on discharge, however will 
discontinue atenolol and amlodipine given baseline bradycardia 
and controlled hypertension with systolic blood pressures from 
100-110.Will need reassessment of blood pressure medications as 
outpatient.
.  
# Hypothyroidism- Continued home dose synthroid .Checked TSH-2.6 

.   
#Gout- Was not active, had no joint pains.Held colchicine  given 
no clinically active disease. Continued Allopurinol home dose   
.  
# HTN -Was not hypertensive during the admission, SBP's running 
in the 100- 120's 
Her atenolol was discontinued given her baseline bradycardia and 
her amlodipine was disconinued given her low blood pressures. 
She was discharged only on her home dose 25mg/day 
Hydrochlorthiazide. She will need outpatient follow up for 
titration of blood pressure medications.
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
________________________________________________________________
Outpatient follow up 
-Patient's Blood pressure on admission was between 
105-130/60-80. Her atenolol was discontinued given her baseline 
bradycardia and her amlodipine was disconinued given her low 
blood pressures. She was discharged only on her home dose 
25mg/day Hydrochlorthiazide. She will need outpatient follow up 
for titration of blood pressure medications.
-Please consider outpatient cardiac stress test 
 
Medications on Admission:
Atenolol 50mg PO daily 
Levothyroxine 100 mcg Tab Oral daily
Hydrochlorothiazide 25 mg Tab Oral daily 
Amlodipine 10 mg Tab Oral daily
Crestor 20 mg Tab Oral daily
Allopurinol ___ mg Tab Oral daily
Colchicine 0.6 mg Tab Oral daily
.  

 
Discharge Medications:
1. Rosuvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. Allopurinol ___ mg Tablet Sig: Three (3) Tablet PO DAILY 
(Daily).  
3. Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO 
DAILY (Daily).  
4. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Bradycardia
Syncope
.
Secondary Diagnosis 
HTN 
Hypothyroidism 
Gout  

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
It was a pleasure to care for you as your doctor.
.
You were brought to the hospital because of losing consciousness 
and low heart rate. We carried out several exams and decided you 
needed no intervention at this time. You probably passed out 
because of low heart rate and a natural response to reflux of 
food called vagal response. 
.
We have discontinued some of your blood pressure medications on 
this admission because your blood pressures were well 
controlled. Please take your blood pressures at home and contact 
your primary care physician on future management of your blood 
pressure.
.
We made the following changes to your home medication list: 
STOP Atenolol due to low heart rate
STOP Amlodipine due to low blood pressure

Please talk to your primary doctor next week regarding your 
blood pressure and your medications. 

We continued the rest of your medications you were taking before 
being admitted to the hospital.

Please follow up with the outpatient appointments below: 
 
Followup Instructions:
___
",MEDICINE
10005565-DS-4,Diane Bell,10005565,29140012," 
Name:  ___                        Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Abdominal pain and sycope
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
This is ___ year old lady with a history of CAD, gout, 
hypothyroidism presents to the ___ ED with complaints of 
abdominal pain x 3 hours and syncope.  
.  
She reports she was in her USOH until she had acute onset of 
""achy"" gas like abdominal pain at 18:30 today, non-radiating, 
relieved by bowel movement. She had decreased liquid intake 
earlier in the day, and was out shopping with family and she 
passed out while exiting a car. She was eased to the ground, had 
cyanotic appeaing lips. She did not immediately regain 
consciousness, EMS was called who, according to the husband, 
performed 1 round of CPR, she regained consciousness and was 
brought to the ED. There as no documentation of the 
resuscitation event, no report of medications or cardioversion 
performed.  
.  
Of note she was admitted for a syncope work-up in ___. The ddx 
at that time included a vasovagal event versus symptomatic 
bradycardia. Her heart rate was in the ___ when EMS first 
evaluated her. Her amlodipine and atenolol were stopped and she 
was discharged with PCP ___ and suggestion for outpatient 
stress test. Her thyroid function tests during this admission 
were normal.  
.  
Speaking to the husband who was present during the event, he 
tells me that she was diaphoretic immediately following the 
event, and that her face was cold.  
.  
In the ED, initial VS: 97.6 57 146/75 16. On arrival to the ED, 
she had one large, soft brown, non bloody bowel movement with 
improvement in abdominal pain. She is conversant, neurologically 
intact and reports mild residual abdominal pain. Initial labs 
significant unremarkable liver function tests, chem7 and cbc. A 
troponin <0.01. A moderate demonstrated moderate leukocytes, 
small blood and few bacteria. Her stool was guaic negative. A 
bedside ultrasound was performed to rule out AAA. The aorta 
measured 1.3 x 1.6 in its maximal dimmension. Orthostatics were 
performed and were: 160/90 laying, 150/90 standing. She was 
given a 500cc bolus in the ED. She was started on macrobid ___ 
q12hrs.  
.  
Currently, patient feels well, tells me that she forgot to take 
her pills today  
.  
REVIEW OF SYSTEMS: +rhinorrea for a few days.  
Denies fever, chills, night sweats, headache, vision changes, 
rhinorrhea, congestion, sore throat, cough, shortness of breath, 
chest pain, vomiting, diarrhea, constipation, BRBPR, melena, 
hematochezia, dysuria, hematuria.  

 
Past Medical History:
1. CARDIAC RISK FACTORS:HTN  
2. CARDIAC HISTORY: Catherization ___ years ago at ___, 
according to patient she was told it was normal and nothing was  

done.  
3. OTHER PAST MEDICAL HISTORY:  
Gout  
Hypothyroidism  
CAD  
HLD  

 
Social History:
___
Family History:
No family history of early MI, arrhythmia, cardiomyopathies, or 
sudden cardiac death; otherwise non-contributory.  
 
Physical Exam:
ADMISSION EXAM:
VS - Temp 97.6- HR 55- BP 166/90 - RR 12- 97%RA  
GENERAL - Alert, interactive, well-appearing in NAD  
HEENT - PERRLA, EOMI, sclerae anicteric, MMM, OP clear  
NECK - Supple, no thyromegaly, no JVD, no carotid bruits  
HEART - bradycardic to ___, S1, S2 no murmurs  
LUNGS - CTAB  
ABDOMEN - NABS, soft/NT/ND, no masses or HSM  
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses  
SKIN - no rashes or lesions  
NEURO - awake, A&Ox3, CNs II-XII grossly intact, steady gait  
.
DISCHARGE EXAM:
unchanged
 
Pertinent Results:
ADMISSION LABS:
___ 07:40PM BLOOD WBC-7.0 RBC-4.39 Hgb-13.0 Hct-40.9 MCV-93 
MCH-29.6 MCHC-31.8 RDW-13.0 Plt ___
___ 07:40PM BLOOD WBC-7.0 RBC-4.39 Hgb-13.0 Hct-40.9 MCV-93 
MCH-29.6 MCHC-31.8 RDW-13.0 Plt ___
___ 07:40PM BLOOD Glucose-102* UreaN-20 Creat-0.7 Na-143 
K-4.1 Cl-106 HCO3-27 AnGap-14
___ 07:40PM BLOOD ALT-18 AST-35 AlkPhos-68 TotBili-0.3
.
DISCHARGE LABS:
___ 07:40AM BLOOD WBC-6.6 RBC-4.22 Hgb-12.9 Hct-40.2 MCV-96 
MCH-30.6 MCHC-32.0 RDW-13.4 Plt ___
___ 07:40AM BLOOD Glucose-86 UreaN-12 Creat-0.5 Na-141 
K-3.6 Cl-105 HCO3-27 AnGap-13
.
CARDIAC LABS:
___ 07:40PM BLOOD CK-MB-5 cTropnT-<0.01
___ 07:40AM BLOOD CK-MB-5 cTropnT-<0.01
___ 07:40AM BLOOD CK(CPK)-305*
.
THYROID FUNCTION:
___ 07:40AM BLOOD TSH-8.5*
___ 07:40AM BLOOD Free T4-0.84*
.
NO IMAGING PERFORMED.
.
EKG: Sinus brady at 54bmp, 1st degree AV block. Q wave in III, 
aVF, unchanged from ___SSESSMENT AND PLAN: This is ___ year old lady with a history of 
CAD, gout, hypothyroidism presents to the ___ ED with 
complaints of abdominal pain x 3 hours and syncope.  
.  
ACTIVE ISSUES:
# SYNCOPE: On admission, pt had an unchanged EKG and normal 
troponins x 2, which effectively ruled out an ACS event. She 
denied any loss of bowel of bladder function, no tongue biting 
or post-ictal state to suggest a seizure. She did not experience 
any palpitations or heart racing prior the event, which made an 
arrythemia ___. There was high suspicion that this event 
was secondary to a vasovagal episode, most likely in setting of 
needing to have a bowel movement. Pt also has a history of 
bradycardia with 1st degree AV block which may have been 
contributing factor. The most recent TTE in our system was from 
___, however the patient states that she has had one more 
recently as an outpatient with Dr. ___. Unfortunately, we 
did not have access to this record. The patient has also worn a 
Holter monitor in the past, which she reports revealled no 
events. As part of her work up, TSH was order, which returned 
elevated. Her free T4 was pending at time of discharge. The 
patient was monitored on tele during her admission, which was 
remarkable only for sinus bradycardia. We attempted to get a 
Holter monitor for the patient prior to discharge, however given 
the holiday weekend, this was not possible. We have advised the 
patient to follow up with her PCP and outpatient cardiologist 
this week and recommend another heart monitor.
.  
# ABDOMINAL PAIN: This appears to have resolved with defacation. 
The emergency department considered possible AAA and a bedside 
ultrasound demonstrated 1.3 x 1.6 cm maximal dimmension. Her 
liver funtion tests and lipase were normal. Her stool guaiac was 
negative. Pt remained asymptomatic throughout her admission and 
tolerated PO well with no constipation or diarrhea.  
.  
CHRONIC ISSUES:
# HYPERTNESION: Pt was slightly hypertensive when she arrived on 
the floor with systolic BP 160s. With her medications, her blood 
pressure decreased to 140-150s. She was continued on her 
hydrochlorothiazide. 
.  
# HYPOTHRYOID:  Pt was continued on her home dose of 
levothyroxine 100mcg daily. Her TSH was slightly elevated, and 
her total T4 was pending at time of discharge.
.  
# GOUT:  Pt was continued on her home dose of allopurinol ___ mg 
daily.
.
TRANSITIONAL ISSUES:
# We have recommended that the patient be set up with a Holter 
monitor as an outpatient to monitor for any arrythmias that may 
have contributed to her syncopal episode. We also recommend a 
repeat TTE if she has not had one recently.
.
# Her TSH was slightly elevated, with a free T4 pending at time 
of discharge. This should be followed up as an outpatient, and 
adjusted as necessary.
.
# Pt had a urine culture pending at time of discharge.  
 
Medications on Admission:
1. Rosuvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY  
2. Allopurinol ___ mg Tablet Sig: Three (3) Tablet PO DAILY  
3. Hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO  
4. Levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY 
 
Discharge Medications:
1. rosuvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
2. allopurinol ___ mg Tablet Sig: One (1) Tablet PO once a day.  

3. hydrochlorothiazide 25 mg Tablet Sig: One (1) Tablet PO once 
a day.  
4. levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY:
Syncope

SECONDARY:
bradycardia
1st degree heart block

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at ___ 
___. You were admitted for a fainting episode. We 
kept you on a heart monitor, and did not see any irregular heart 
rhythms other than your known slow heart rate. You had a blood 
test to check for a heart attack which was normal.

We have made no changes to your medications. We recommend that 
you get a heart monitor to wear at home, however we were unable 
to set that up for you today.
 
Followup Instructions:
___
",MEDICINE
10005605-DS-22,Patricia Battle,10005605,21049284," 
Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Tetracycline / Flagyl
 
Attending: ___.
 
Chief Complaint:
lower abd pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ y/o F with HTN, CKD stage III, h/o diverticulitis and 
diverticular abscess, presented originally to the ___ ED on 
___ with 3 days of LLQ pain and constipation. She received a 
CT abd/pelvis, which showed acute diverticulitis with no 
evidence of perforation or fluid collection. There was also a 
large amt of stool seen in the colon with an abrupt transition 
point seen in the caliber of the bowel within the distal sigmoid 
colon, multiple 
prominent left pelvic lymph nodes, noted to be concerning for a 
underlying colonic mass. 

The patient was observed overnight on ___ and discharged on 
___ with stool softeners (colace and Miralax) and oral 
antibiotics (cipro 500 mg BID and clindamycin 300 mg q6h for 10 
days). She had a bowel movement prior to discharge from ED. 
Since then, she has not had any additional bowel movements. She 
was at work today when she developed sudden ___ pain in her 
abd. Due to this, she decided to come to the ED. She usually has 
bowel movements daily but states that since she had been taking 
Zofran (was recently d/c'd from ___ ED in ___ for 
an episode of vertigo), she noted worsening constipation. Denies 
any fever/chills but has had nausea today with no vomiting. 

In the ED, initial vitals were:  98.7 74 174/93 18 98% RA. Labs 
showed normal WBC of 7.3 with 76.8% neutrophils. Electrolytes 
were wnl, lactate 1.3. UA was negative for UTI. UCx and BCx were 
drawn. Rectal exam was performed, which showed minimal stool in 
vault. Patient was not given any medications in the ED. On 
arrival to the floor, the patient's pain had largely resolved, 
remaining at ___ without any pain meds. She denies CP, SOB, HA. 
She denies weight loss and endorses a several pound weight gain. 
Has been tolerating PO without problems but noted some fullness 
yesterday.

Of note, she has had a colonoscopy in ___, which showed 
mod-severe diverticulosis. Also seen were two 4-5 mm sessile 
polyps, one in the cecum and one at 65 cm from the anorectal 
verge. Path revealed Langerhans cell histiocytoma (eosinophilic 
granuloma). 
 
Past Medical History:
- HTN
- CKD stage III
- Anemia
- H/o diverticular abscess ___
- Symptomatic cholelithiasis s/p cholecystectomy ___ 
- DVT in R soleal vein in context of multiple fx ___ after 
being hit by car (US ___ and ___ showed stability)
- Tibial plateau fx in L knee after being hit by car ___
 
Social History:
___
Family History:
Mother - lung cancer
___ uncle - lung cancer
___ aunt - colon cancer
 
Physical Exam:
ADMISSION EXAM
===============
Vitals:  97.5 148/66 75 18 97% RA ___ pain
General: Alert, oriented, no acute distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL  
Neck: Supple, JVP not elevated, no LAD  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
Abdomen: Soft, mildly tender to palpation in lower abd, 
non-distended, bowel sounds present, no organomegaly, no rebound 
or guarding  
GU: No foley  
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: moves all extremities well

DISCHARGE EXAM
==============
Vitals:  T:97.5 HR:75 BP:148/66 RR:18 SaO2:97% RA
General: Alert, sitting up in bed, interactive, no acute 
distress  
HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL 3->2 
directly and consensually  
Neck: Supple, JVP not elevated, no LAD  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
Abdomen: Soft, non-distended. Tender to palpation in left lower 
quadrant, bowel sounds present, no organomegaly, no rebound or 
guarding  
GU: No foley  
Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: AOx3, memory ___ immediate and delayed, speech fluent. 
CNII-XII intact, ___ strength upper/lower extremities, grossly 
normal sensation in face, upper and lower extremities, gait 
narrow based and stable
 
Pertinent Results:
ADMISSION LABS
==============
___ 11:30AM BLOOD WBC-7.3 RBC-4.42 Hgb-13.6 Hct-39.4 MCV-89 
MCH-30.8 MCHC-34.5 RDW-12.8 Plt ___
___ 11:30AM BLOOD Neuts-76.8* Lymphs-16.2* Monos-4.1 
Eos-2.0 Baso-1.0
___ 11:30AM BLOOD Glucose-104* UreaN-23* Creat-1.1 Na-139 
K-3.9 Cl-102 HCO3-23 AnGap-18
___ 11:41AM BLOOD Lactate-1.3

DISCHARGE LABS
==============
___ 08:15AM BLOOD WBC-5.1 RBC-3.88* Hgb-12.0 Hct-34.6* 
MCV-89 MCH-30.8 MCHC-34.6 RDW-13.0 Plt ___
___ 08:15AM BLOOD Glucose-109* UreaN-19 Creat-1.1 Na-140 
K-4.2 Cl-104 HCO3-23 AnGap-17
___ 08:15AM BLOOD Glucose-109* UreaN-19 Creat-1.1 Na-140 
K-4.2 Cl-104 HCO3-23 AnGap-17
___ 08:15AM BLOOD Calcium-9.7 Phos-3.7 Mg-2.2

MICROBIOLOGY
============
 **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 

BCX PENDING
 
Brief Hospital Course:
BRIEF SUMMARY
==============
___ y/o F with HTN, CKD stage III, h/o diverticulitis and 
diverticular abscess, presented originally to the ___ ED on 
___, found to have diverticulitis and constipation and 
discharged on cipro/clinda, now returns with another episode of 
lower abd pain, most likely consistent with known diagnoses.

ACTIVE ISSUES
=============
# Acute, uncomplicated diverticulitis - The patient was recently 
found to have diverticulitis, diagnosed on CT abd/pelvis on 
___ and represented on ___ with similar abdominal pain. 
While patient does have a history of diverticulitis and 
diverticular abscess, this current episode can be considered 
uncomplicated. The patient was afebrile, with normal WBC at 7.3 
and normal lactate. On arrival to the floor, pain had diminished 
from ___ to ___ with no additional pain medication while 
in-house and the patient had a completely benign abdominal exam 
with no concerns for perforation. She was discharged on ___ 
from the ___ ED with a 10-day total course of 
ciprofloxacin/clindamycin (has Flagyl allergy), which she had 
been compliant with. She was continued on this regimen during 
her brief hospitalization and discharged to complete this 10-day 
course, with last dose ___. She tolerated a regular low 
residue diet in the hospital and did not require any additional 
pain medication, so she was discharged on ___. 

# Constipation - The patient presented to the ED on ___ with 
bowel pain and reports of not having had a bowel movement since 
her discharge from the ___ ED on ___. She had a large 
amount of stool seen in the sigmoid colon on CT abd/pelvis on 
___ but no stool in the vault on rectal exam on examination. 
Etiologies included medication-induced, as the patient had been 
taking Zofran at home for dizziness, which could have 
contributed to constipation. Furthermore, there could be an 
obstructive underlying mass (ddx colonic source vs. gyn source) 
given pelvic lymphadenopathy seen on CT abd/pelvis. Last 
colonoscopy was performed ___, which showed sessile polpys that 
were biopsied and revealed Langerhans cell histiocytoma 
(eosinophilic granuloma). The patient was given colace and 
Miralax for relief of constipation and she had two large bowel 
movements prior to discharge on ___ with relief of abdominal 
pain. To further investigate whether there is an underlying 
mass, the patient will need a repeat outpatient colonoscopy in 
___ weeks after her acute episode of diverticulitis has 
resolved. She was discharged on colace/Miralax.

CHRONIC ISSUES
==============
# Stage III CKD - Creatinine of 1.1 on admission, stable. 

# HTN - stable. Continued home amlodipine.

TRANSITIONAL ISSUES
====================
# Patient will need a repeat colonoscopy in ___ weeks to 
evaluate for possible colonic mass given presence of pelvic 
lymph nodes and transition point seen in the sigmoid colon. Both 
patient and PCP are aware.
# Patient will complete 10-day oral antibiotic therapy for 
diverticulitis (ciprofloxacin and clindamycin) as previously 
instructed. Last dose will be ___.

# CODE: Full
# CONTACT: ___ (sister) - ___ (H), ___ (C)
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Amlodipine 5 mg PO DAILY 
2. Multivitamins 1 TAB PO DAILY 
3. Ondansetron 4 mg PO QID:PRN dizziness 
4. Meclizine 25 mg PO Q8H:PRN dizziness 
5. Clindamycin 300 mg PO Q6H 
6. Ciprofloxacin HCl 500 mg PO Q12H 
7. Docusate Sodium 100 mg PO BID 
8. Polyethylene Glycol 17 g PO DAILY 

 
Discharge Medications:
1. Amlodipine 5 mg PO DAILY 
2. Ciprofloxacin HCl 500 mg PO Q12H 
Last day of antibiotics ___. Clindamycin 300 mg PO Q6H 
Last day of antibiotics ___. Docusate Sodium 100 mg PO BID 
5. Multivitamins 1 TAB PO DAILY 
6. Polyethylene Glycol 17 g PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS
=================
# Diverticulitis
# Constipation

SECONDARY DIAGNOSIS
===================
# Hypertension

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you during your hospitalization 
at ___. You were admitted to 
the hospital because you were having worsening abdominal pain 
and constipation. We have given you stool softeners and 
laxatives while you were in the hospital, and this resolved. In 
addition, we continued you on antibiotics (ciprofloxacin and 
clindamycin) for diverticulitis that was previously seen on ___ 
___. You should continue taking these antibiotics as 
previously instructed to complete a 10-day total course of 
antibiotics.

There were some abnormalities that were seen on your CT scan. We 
recommend that you schedule for a colonoscopy in ___ weeks to 
evaluate for a possible mass in your colon that could be 
contibuting to your constipation. 

We wish you the best,
Your ___ Care Team
 
Followup Instructions:
___
",MEDICINE
10005606-DS-18,Henry Hill,10005606,22751751," 
Name:  ___              ___ No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Nausea, Vomiting
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ male, history of cervical fusion in ___, ETOH 
abuse, and HTN presenting with nausea, hematemesis/coffee-ground 
emesis and ? melena.  
 He was in his usual state of health, consuming ___ shot 
glasses per night of ETOH (last night however ___ shots), and 
also using NSAIDS 1600 mg/day and Tylenol ___ mg/day for his 
neck pain after the surgery. On ___, he began having 
intermittent abdominal discomfort with food intake. He also had 
nausea and vomiting, with hematemesis on day prior to 
presentation and 2 episodes of coffee-ground emesis on day of 
presentation. He reports lightheadedness with standing. In the 
ED, noted to have a dark tarry BM with subsequent dizziness.  
 He reports no chest pain, shortness of breath, abdominal pain, 
diarrhea.  
 In ED, vital signs were notable for tachycardia 110s-120s, BP 
130s/70s-80s, satting well on RA. Labs are notable for Hgb 12.9, 
which is above his baseline of ___. He had elevated 
transaminases to 169/257, elevated from prior with normal AP, 
Tbili, and lipase. He has ___ with Cr of 1.2 from baseline of 
0.5 and BUN of 29. Chemistry notable for K 5.0, Cl 82, and anion 
gap of 26. INR was 1.2. GI was consulted and recommended IV PPI, 
NPO, transfusion goal of ___, anti-emetic, and potential EGD. He 
was given NS, pantoprazole, ondansetron, and morphine.  
 
 On arrival to the floor, patient reports severe pain in his 
neck at the site of his recent surgery. Otherwise feels well 
without complaints.  
 
 REVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as 
per HPI  
 
Past Medical History:
ETOH abuse  
HTN  
S/p posterior cervical decompression and fusion ___  
C. diff 
 
Social History:
___
Family History:
No family history of liver disease
 
Physical Exam:
ADMISSION PHYSICAL
==================
VS: 97.7  PO 177 / 92L Lying ___ Ra  
GENERAL: NAD  
HEENT: anicteric sclera, pink conjunctiva, MMM  
NECK: supple, no LAD, no JVD  
HEART: tachycardia, S1/S2, no murmurs, gallops, or rubs  
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: nondistended, nontender in all quadrants, no 
rebound/guarding, no hepatosplenomegaly on exam  
EXTREMITIES: no cyanosis, clubbing, or edema  
PULSES: 2+ DP pulses bilaterally  
NEURO: A&Ox3, moving all 4 extremities with purpose  
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes

DISCHARGE PHYSICAL
==================
___ 0720 Temp: 98.3 PO BP: 107/56 R Lying HR: 67 RR: 16
O2 sat: 97% O2 delivery: Ra  
GENERAL: NAD  
HEENT: anicteric sclera, pink conjunctiva, MMM  
HEART: normal S1/S2, no murmurs, gallops, or rubs  
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles  
ABDOMEN: nondistended, nontender in all quadrants, no
rebound/guarding, no hepatosplenomegaly on exam   
EXTREMITIES: no cyanosis, clubbing, or edema  
PULSES: 2+ DP pulses bilaterally  
NEURO: A&Ox3, moving all 4 extremities with purpose  
SKIN: warm and well perfused, no excoriations or lesions, no
rashes 
 
Pertinent Results:
ADMISSION LABS
==============
___ 04:00PM BLOOD WBC-8.4 RBC-4.51* Hgb-12.9* Hct-38.4* 
MCV-85 MCH-28.6 MCHC-33.6 RDW-16.7* RDWSD-48.5* Plt ___
___ 04:00PM BLOOD Neuts-85.4* Lymphs-7.9* Monos-5.4 
Eos-0.5* Baso-0.4 Im ___ AbsNeut-7.15* AbsLymp-0.66* 
AbsMono-0.45 AbsEos-0.04 AbsBaso-0.03
___ 04:11PM BLOOD ___ PTT-27.5 ___
___ 04:00PM BLOOD Glucose-109* UreaN-29* Creat-1.2 Na-138 
K-5.0 Cl-82* HCO3-30 AnGap-26*
___ 04:00PM BLOOD ALT-169* AST-257* AlkPhos-112 TotBili-0.6
___ 04:00PM BLOOD Lipase-30
___ 04:00PM BLOOD Albumin-4.8 Calcium-11.2* Phos-4.1 Mg-1.6
___ 09:48PM URINE Hours-RANDOM Creat-200 Na-81

PERTINENT LABS
==============
___ 08:57AM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG
___ 08:57AM BLOOD HCV Ab-NEG
___ 01:52PM STOOL HELICOBACTER ANTIGEN DETECTION, STOOL-PND

MICRO
=====
None

STUDIES
=======
US Liver ___. Echogenic liver consistent with steatosis.  Mildly nodular 
suggests
cirrhosis.
2. No cholelithiasis, evidence of cholecystitis, or biliary 
dilation.
3. Patent portal vein.

DISCHARGE LABS
==============
___ 04:47AM BLOOD WBC-3.7* RBC-2.81* Hgb-8.2* Hct-25.3* 
MCV-90 MCH-29.2 MCHC-32.4 RDW-15.6* RDWSD-51.0* Plt Ct-96*
___ 04:47AM BLOOD Glucose-82 UreaN-10 Creat-0.8 Na-141 
K-3.7 Cl-99 HCO3-29 AnGap-13
___ 04:47AM BLOOD Calcium-8.5 Phos-2.5* Mg-2.___ male, history of cervical fusion in ___, ETOH 
abuse, and HTN presenting with hematemesis and coffee-ground 
emesis as well melena concerning for UGIB likely ___ alcoholic 
gastritis vs. esophagitis vs ___ tear.

# UGIB
Patient presented after having two episodes of 
hematemesis/coffee-ground emesis, and then proceeded to have 
large melena in ED. Hgb at presentation was 12.9 but 
subsequently dropped to 9.5 and then 8.9 in the setting of 
getting 2L IVF. Possible etiologies include ___ Tear, 
esophagitis, alcoholic gastritis, and NSAID use. Patient was 
planned to undergo EGD on ___ but unfortunately, given 
spinal fusion, anesthesia felt that it would be safest to 
perform procedure in the OR. Patient was hemodynamically stable 
for 48 hours since admission and had no major changes in his 
hemoglobin. Multiple conversations were had with the patient and 
the inpatient GI team about our preference of having him stay 
and undergo EGD in the OR given possible evidence of cirrhotic 
changes on liver US. Patient preferred to leave due to multiple 
life stressors outside of the hospital (including significant 
work issues with his boss) and the patient's presentation was 
thought to be less concerning for acute variceal bleed. This 
plan was discussed with GI consultants. Patient was educated 
about danger signs that should prompt an immediate return to the 
ED, and otherwise was encouraged to attend his scheduled follow 
up liver clinic where the EGD could be setup as an outpatient.

# ___
Cr was elevated to 1.2 at presentation from baseline 0.5. Likely 
pre-renal in setting of ongoing nausea limiting PO intake and 
vomiting. Patient received 2L IVF and Cr downtrended.

# Cirrhosis
# Transaminitis
Patient's liver enzymes were elevated on admission, AST/ALT 
100s-200s. Baseline abnormal likely due to ongoing alcohol use 
vs. fatty liver disease. He was also found to be leukopenic and 
thrombocytopenic. No stigmata of chronic liver disease on exam. 
RUQ U/S demonstrated stigmata of cirrhosis. Hepatitis serologies 
(HBV, HCV) were obtained and were all negative. Patient was 
started on hepatitis B vaccination series and received the first 
immunization on ___.

# Alcohol abuse
Patient formerly frank ten shots a night every night and drank 
continuously on weekends. He has since cut down and now drinks 
___ shots ___ nights a week. No history of withdrawal seizures 
though did require phenobarb during prior admission. At his 
reduced level of drinking, he did not have withdrawal on this 
admission. 
___ w/ EtOH abuse admitted w/ hematemesis and melena. Imaging 
and labs c/w a new diagnosis of cirrhosis. 
The patient was advised that even though he has cut down his 
drinking, his liver is now much more fragile than before and 
even small amounts of alcohol can cause further damage. He was 
educated on the life-threatening complications of cirrhosis and 
how he may not have any symptoms until it has become too late to 
undo the damage. He verbalized understanding of this, but does 
not feel quite ready to quit drinking. He was educated about 
naltrexone and other resources and agrees to readdress sobriety 
at his follow up visit. 

# H/o cervical fusion in ___
Pain was controlled with Tylenol, tizanadine, gabapentin, and 
oxycodone PRN.

TRANSITIONAL ISSUES
===================
[]EGD: Prompt outpatient EGD is recommended to clarify the cause 
of bleeding. Even if he has no further bleeding, the patient 
still needs to complete an EGD to screen for esophageal varices. 

[]Pending Labs: f/u h pylori stool antigen
[]Hepatology: Close followup in liver clinic given new diagnosis 
of cirrhosis
[]___ Screening: Patient will require q6 month ___ screening 
with abdominal ultrasound
[]Hepatitis B, non-immune: Patient was found to be hepatitis B 
non-immune, received first vaccine on ___, followup with 
course per recommended schedule
[]PPI: Discharged on PPI BID which should be continued until 
patient has GI follow up at ___
[] NO NSAIDS.
[] Continue discussion regarding alcohol cessation. He is 
potentially interested in naltrexone.

#CODE: Full (presumed)
#CONTACT: ___ ___ 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 1000 mg PO Q6H 
2. Gabapentin 300 mg PO Q8H 
3. Tizanidine 4 mg PO TID:PRN neck pain 
4. Ibuprofen 400 mg PO Q6H 

 
Discharge Medications:
1.  FoLIC Acid 1 mg PO DAILY 
RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet 
Refills:*0 
2.  Gabapentin 300 mg PO Q8H  
3.  Multivitamins W/minerals 1 TAB PO DAILY 
RX *multivitamin,tx-minerals [Vitamins and Minerals]  1 
tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 
4.  Omeprazole 40 mg PO BID 
RX *omeprazole 40 mg 1 capsule(s) by mouth twice a day Disp #*60 
Capsule Refills:*0 
5.  Thiamine 200 mg PO DAILY 
RX *thiamine HCl (vitamin B1) 100 mg 1 tablet(s) by mouth daily 
Disp #*30 Tablet Refills:*0 
6.  Tizanidine 4 mg PO TID:PRN neck pain  
7. HELD- Acetaminophen 1000 mg PO Q6H  This medication was held. 
Do not restart Acetaminophen until you really need it, and this 
should be no more than 2 grams per day

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnoses
=================
Upper GI bleed
Alcoholic cirrhosis
___

Secondary Diagnoses
===================
Alcohol abuse
Nicotine dependence

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you in the hospital. 

WHY WERE YOU ADMITTED:
- You were having bloody vomit and dark stools which concerned 
us that you were having a bleed from somewhere in your 
esophagus, stomach, or intestines. 

WHAT HAPPENED IN THE HOSPITAL:
- We gave you fluids
- We took lab tests to see if you were bleeding quickly
- We had the GI doctors ___ by and ___ you, and they 
recommended that you get a procedure in which we look with a 
camera into your stomach. However, because of your neck 
surgeries, this would have to be done in the operating room. You 
decided that you did not want to wait and have this done so you 
were discharged with strict instructions to return if you start 
feeling ANY symptoms or experienced ANY bleeding
- You had imaging that suggested that you had cirrhosis in your 
liver. This needs follow up and further work up and it will be 
extremely important for you to follow up with a liver 
specialist.
- Importantly, you should NOT take any further ibuprofen, advil, 
naproxen, aleve. You should STOP drinking and consider a 
detoxification center.

WHAT SHOULD I DO AFTER LEAVING:
- Please take all of your medications as prescribed including a 
new medication:
  1.) Pantoprazole 40mg twice daily
- Please follow-up with your primary care doctor within the next 
___ weeks to have a repeat blood draw. 
- Please return to the hospital if you develop the following 
signs:
  1.) More bloody or dark vomiting
  2.) More black, tarry stools
  3.) New lightheadedness or shortness of breath

Thank you for allowing us to participate in your care.

Your ___ Team

 
Followup Instructions:
___
",MEDICINE
10005749-DS-15,Theresa Stutzman,10005749,20010003," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
Lower extremity edema  
 
Major Surgical or Invasive Procedure:
Peripherally inserted central venous catheter
 
History of Present Illness:
___ y.o female with pmhx. of polycystic disease s/p bilateral 
native nephrectomies in ___ and then deceased donor renal 
transplant in ___ on Cellcept, Cyclosporine, and Prednisone, 
afib on ASA, type 2 DM, HTN had complicated recent hospital 
course (___) with recurrent pneumonia, exudative 
pleural effusion and infected hepatic cyst requiring ___ drainage 
c/b septic physiology requiring high volume rescuscitation and 
vasopressors, complicated by hyperkalemia and worsening renal 
function, who presented today to ___ clinic for 
second opinion regarding her increasing creatinine. At 
___ clinic she was noted to have significant lower 
extremity edema and pulse of 120 and was directly admitted to 
___. 
.
Of note she was discharged from her last admission at ___ on 
___ and has completed 1 month course of Cipro and Flagyl 
for infected hepatic cyst. She had significant volume overload 
after her large volume resuscitation for sepsis and ultimately 
discharged on lasix 20mg daily howvever this was stopped on 
___. In addition her ___ to be held. She did 
recieve an abdominal CT scan with IV contrast on ___ for 
reevaluation of her hepatic abscess which revealed intervel 
decerase in the size of tghe fluid collection in the right 
hepatic lobe. On ___ her BUN/creat was ___ which was 
elevated from baseline (___). 

On ___ she was admitted again to ___ for hyperkalemia and 
acute renal injury. Her potassium was 6.4 and BUN/Creat ___. 
 She was discharged on ___ with her Lasix continuing to be 
held, her Cipro/flagyl continued for hepatic cyst for 10 more 
days ___ drain removed during this admission) and 
immunosuppressives continued.   
.  
Currently the patient denies any pain. She has been experiencing 
orthopnea and lower extremity edema for ___ weeks. She usually 
weighs approxiamately 120Ibs and now weighs 140Ibs. She denies 
any recent CT studies. She denies any chest pain,cough, fevers, 
chills, palpitations, dizziness, syncope, lower extremity pain 
or dyspnea on exertion. She is ambulatory dependent on a walker 
at baseline. She does endorse decreased urinary output in the 
last 3 weeks but denies any hematuria, dysuria, back/abdominal 
pain, nausea, vomiting, decreased appeptite or confusion.   
.  
.  
ROS: per HPI, denies fever, chills, night sweats, headache, 
vision changes, rhinorrhea, congestion, sore throat, cough, 
shortness of breath, chest pain, abdominal pain, nausea, 
vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, 
dysuria, hematuria. 
 
Past Medical History:
ESRD due to ___ s/p deceased donor renal transplant ___ 
Bilateral naitive nephrectomies in ___ 
Hx of recieving HD via LUE AVF for ___ year prior to transplant 
HTN 
DMt type 2 
Hyperlipidemia 
Recurrent UTI 
Gallstone pancreatitis s/p sphincterotomy 
 
Social History:
___
Family History:
Older sister s/p kidney trasnplant 
Daughter also has ___  
 
Physical Exam:
ADMISSION EXAM
GENERAL: Well appearing ___ yo M/F who appears stated age. 
Comfortable, appropriate and in good humor, oriented X 3   
HEENT: Sclera icteric. PERRL, EOMI.  
NECK: Supple with 10cm JVP  
CARDIAC: PMI located in ___ intercostal space, midclavicular 
line. RRR, S1 S2 clear and of good quality without murmurs, rubs 
or gallops. No S3 or S4 appreciated.  
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use, moving air well and 
symmetrically. CTAB, insp b/l crackles, no wheezes or rhonchi.  
ABDOMEN: NonDistended and Soft, ___ to palpation. 
Dullness to percussion over dependent areas but tympanic 
anteriorly. No HSM or tenderness.  
EXTREMITIES: Warm and well perfused, no clubbing or cyanosis. 2+ 
___ bilaterally to knees. 
 
Pertinent Results:
ADMISSION LABS

___ 07:15PM BLOOD ___ 
___ Plt ___
___ 07:15PM BLOOD ___ 
___
___ 07:15PM BLOOD ___ ___
___ 07:15PM BLOOD ___ 
___
___ 07:15PM BLOOD ___ LD(LDH)-299* ___ 
___
___ 01:10PM BLOOD ___
___ 04:52AM BLOOD ___
___ 04:52AM BLOOD ___
.
DISCHARGE LABS
___ 05:12AM BLOOD ___ 
___ Plt ___
___ 05:12AM BLOOD ___ ___
___ 05:12AM BLOOD ___ 
___
___ 05:12AM BLOOD ___
.
URINE STUDIES

___ 09:49PM URINE ___ Sp ___
___ 09:49PM URINE ___ 
___ 
___ 09:49PM URINE ___ 
___
___ 09:49PM URINE ___
___ 09:49PM URINE ___  
___ 09:49PM URINE ___ 
___
.
MICROBIOLOGY

URINE CULTURE (Final ___: 
      YEAST.    ___ ORGANISMS/ML.. 
.

 CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: 
      Feces negative for C.difficile toxin A & B by EIA. 
           (Reference ___. 
.
___ 4:31 pm STOOL     CONSISTENCY: NOT APPLICABLE
      Source: Stool. 

                            **FINAL REPORT ___

   MICROSPORIDIA STAIN (Final ___:    NO MICROSPORIDIUM 
SEEN. 

   CYCLOSPORA STAIN (Final ___:    NO CYCLOSPORA SEEN. 

   FECAL CULTURE (Final ___: 
      NO ENTERIC GRAM NEGATIVE RODS FOUND. 
      NO SALMONELLA OR SHIGELLA FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   OVA + PARASITES (Final ___: 
      NO OVA AND PARASITES SEEN. 
      This test does not reliably detect Cryptosporidium, 
Cyclospora or
      Microsporidium. While most cases of Giardia are detected 
by routine
      O+P, the Giardia antigen test may enhance detection when 
organisms
      are rare. 

   FECAL CULTURE - R/O VIBRIO (Final ___:    NO VIBRIO 
FOUND. 

   FECAL CULTURE - R/O YERSINIA (Final ___:    NO YERSINIA 
FOUND. 

   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: 
      NO E.COLI 0157:H7 FOUND. 

   Cryptosporidium/Giardia (DFA) (Final ___: 
      NO CRYPTOSPORIDIUM OR GIARDIA SEEN. 

   CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: 
      Feces negative for C.difficile toxin A & B by EIA. 
           (Reference ___. 
.
CMV Viral Load (Final ___: 
      CMV DNA not detected. 
      Performed by PCR. 
      Detection Range: 600 - 100,000 copies/ml. 
      FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC 
PROCEDURES. 
      This test has been validated by the Microbiology 
laboratory at ___. 
.
PARVOVIRUS B19 DNA, QL REAL   Not Detected        Not Detected
TIME PCR 
.
BK Virus DNA, Quantitative ___ PCR
  BK Virus, QN PCR     No DNA Detected                       
<500 copies/mL
STUDIES 
EKG ___
Atrial fibrillation with a rapid ventricular response. 
___ wave changes. Low voltage in the limb leads. 
No previous tracing available for comparison.
.
TTE ___
The left atrium is mildly dilated. Left ventricular wall 
thicknesses and cavity size are normal. Overall left ventricular 
systolic function is severely depressed (LVEF= ___. 
[Intrinsic left ventricular systolic function is likely more 
depressed given the severity of valvular regurgitation.] Right 
ventricular chamber size is normal. with mild global free wall 
hypokinesis. The aortic valve leaflets (3) are mildly thickened 
but aortic stenosis is not present. Trace aortic regurgitation 
is seen. The mitral valve leaflets are mildly thickened. 
Moderate to severe (3+) mitral regurgitation is seen. Moderate 
to severe [3+] tricuspid regurgitation is seen. There is 
moderate pulmonary artery systolic hypertension. [In the setting 
of at least moderate to severe tricuspid regurgitation, the 
estimated pulmonary artery systolic pressure may be 
underestimated due to a very high right atrial pressure.] 
Significant pulmonic regurgitation is seen. There is a small 
pericardial effusion. There is an anterior space which most 
likely represents a prominent fat pad.

IMPRESSION: Severely depressed LV systolic dysfunction with 
anterior/anteroseptal akinesis and hypokinesis of all segments 
bar basal inferior/inferolateral segments. Dilated and depressed 
right ventricle. Moderate to severe mitral regurgitation likely 
due to leaflet tethering. Moderate to severe tricuspid 
regurgitation. At least moderate pulmonary hypertension.
.
Chest Xray ___
Moderate bilateral pleural effusions layer dependently. Cardiac 
silhouette
has a peculiar shape, and a larger than expected component to 
the right of
midline. Whether this is due to cardiomegaly or pericardial 
effusion is
indeterminate. There is no particular distention of either 
pulmonary or
mediastinal vasculature to suggest one or the other. Bibasilar 
atelectasis is relatively mild, and there is no pulmonary edema. 
Aortic contour is normal.
.
___
When compared to the study of ___, there is continued 
enlargement of the
cardiac silhouette with evidence of elevated pulmonary venous 
pressure. The
right heart border is now sharply seen, as is the hemidiaphragm, 
consistent
with substantial decrease in pleural effusion. However, this 
could represent a more erect position of the patient rather than 
significant fluid decrease.
 
There is opacification at the left base consistent with a small 
effusion on
this side.
 
Brief Hospital Course:
___ y.o female with pmhx. of polycystic disease s/p bilateral 
native nephrectomies in ___ and then deceased donor renal 
transplant in ___ on Cellcept, Cyclosporine, and Prednisone, 
afib on ASA, type 2 DM, HTN had complicated recent hospital 
course (___) with recurrent pneumonia, exudative 
pleural effusion and infected hepatic cyst requiring ___ drainage 
c/b septic physiology requiring high volume resuscitation and 
vasopressors, complicated by hyperkalemia and worsening renal 
function, who presented to ___ clinic for second 
opinion regarding her increasing creatinine being admitted for 
volume overload and tachycardia. 
.
#Acute systolic heart failure- Patient was admitted with 
significant lower extremity edema, elevated JVD and pleural 
effusions. A TTE showed a EF of ___ anterior/anteroseptal 
akinesis and hypokinesis as well as moderate to severe mitral 
regurgitation.  She was diuresed with bolus doses of IV lasix 
(40 mg BID) approximately ___ L per day for 4 days.  Her weight 
on admission was 64.8 kg and 59 kg on discharge. She was 
transitioned to oral lasix 40 mg BID.  Cardiology was consulted 
a felt presentation was not complete consistent with ischemic 
cardiomyopathy and possibly reflective of a tachymyopathy.  She 
will however need further imaging with a MIBI or possible 
catheterization as an outpatient. She will also need a repeat 
TTE to evaluate valve and ventricular function now that she is 
no longer volume overloaded. She would likely also benefit from 
initiation as an ACEi as an outpatient when renal function 
improves. 
.
___ creatinine was 1.8 on admission from a baseline 
of 1.2. This was felt to likely reflect poor cardiac forward 
flow leading to hypoperfusion. Patient was diuresed as above 
with improvement in her creatinine to 1.6. Patient will 
___ with transplant nephrology. 
.
#Hepatic Cyst- Patient is status post drainage of cyst and drain 
removal ___. Per Infectious Disease at ___ patient was 
supposed to take 10 more days of Ciprofloxacin and Flagyl. 
However these antibiotics were discontinued at the time of 
admission as the patient had no signs of infection.  She 
remained afebrile with no signs of infection throughout the 
remainder of her hospital course.  
.
#Atrial Fibrilliation- Patient was noted to be in atrial 
fibrillation with rates as high as the 150s. Patient was 
asymptomatic without chest pain or palpitations. TSH was within 
normal limits.  In consultation with cardiology she was started 
on metoprolol tartrate which was titrated upward to 150 mg twice 
a day. This was converted to metoprolol succinate 150 mg BID. 
Rates remained elevated to the ___ and she was started on 
diltiazem with improved rate control.  The patient was only on 
aspirin on admission.  However she was initiated on warfarin at 
the time of discharge. The decision was made not to undertake 
bridging therapy. Patient will ___ in the ___ 
___ clinic for INR monitoring and warfarin dose 
adjustment.  
.  
#Kidney Transplant- Patient was continued on her home 
immunosuppresives, including Cyclosporine, Cell Cept and 
steroids. His BK virus PCR was negative.  Cyclosporine levels 
were appropriate.   
.  
#Thrombocytopenia- Patients platelets were noted to decrease 
from admission platelet count of 140's to the 80's with recovery 
to the 100s. In the differential is HIT and splenic 
sequestration. Heme onc consult has recommended HIT ab and 
various viral PCR's. The HIT antibody was negative. CMV viral 
load was negative. Parvovirus titers were negative and EBV 
titers were pending at the time of discharge.  Reticulocyte 
count was appropriate. Vitamin B12, folate and iron levels were 
within normal limits. Infectious ___ including blood and 
urine cultures were negative. There was no evidence of bleeding. 
The patient will need close monitoring of her platelet count as 
an outpatient. Patient will also need a US to rule out 
splenomegaly.  
.
#DM- Patient was maintained on an insulin sliding scale. Oral 
hypoglycemics were restarted on discharge.
.
TRANSITIONAL ISSUES
- Patient will ___ with transplant nephrology, cardiology 
and with a new ___ PCP
- ___ INR monitoring and dose adjustment was transitioned 
to ___ clinic
- EBV titers were pending at the time of discharge
- Patient will need an US to evaluate for splenomegaly, repeat 
TTE and stress MIBI 
- Patient will need to have her creatinine and platelet count 
monitoring
- Patient was full code throughout this admission

 
Medications on Admission:
Metoprolol Tartrate 12.5 mg TID 
Glipizide 5mg Qd 
Prednisione 5mg Qdaily 
Lorazepam 0.25mg Q12 H PRN agitation 
Cyclosporine 50mg BID 
Mycophenolate Mofetil 500mg BID 
Ciprofloxacin 500mg BID 
Flagyl 500mg TID 
MVI 
 
Discharge Medications:
1. prednisone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  

2. lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 
hours) as needed for insomnia/anxiety .
Disp:*20 Tablet(s)* Refills:*0*
3. metoprolol succinate 50 mg Tablet Extended Release 24 hr Sig: 
Three (3) Tablet Extended Release 24 hr PO BID (2 times a day).
Disp:*180 Tablet Extended Release 24 hr(s)* Refills:*0*
4. mycophenolate mofetil 250 mg Capsule Sig: One (1) Capsule PO 
BID (2 times a day).  
5. multivitamin     Capsule Sig: One (1) Capsule PO once a day.  

6. Coumadin 5 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*2*
7. Diltzac ER 120 mg Capsule, Extended Release Sig: One (1) 
Capsule, Extended Release PO once a day.
Disp:*30 Capsule, Extended Release(s)* Refills:*2*
8. cyclosporine modified 25 mg Capsule Sig: Two (2) Capsule PO 
Q12H (every 12 hours).  
9. furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).
Disp:*60 Tablet(s)* Refills:*2*
10. Outpatient Lab Work
Please have your labs drawn on ___ and have the 
results faxed to ___. Please have chemistry panel, CBC, 
cyclosporine level and INR drawn.

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___:
PRIMARY DIAGNOSIS
Acute on chronic systolic congestive heart failure
Acute on chronic renal failure
Atrial Fibrillation with rapid ventricular response
.
SECONDARY DIAGNOSIS
Status post kidney transplant
Hyperlipidemia
Diabetes
Hypertension 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___,

It was a pleasure participating in your care while you were 
admitted to ___. As you know 
you were admitted because you were having increased swelling in 
your legs and difficulty breathing.  You had an EKG which showed 
your heart was in an abnormal rhythm and going fast. You were 
given medications to improve your heart rate.  You also had an 
ultrasound of your heart called an ECHO which showed your heart 
was not pumping well and one of your heart valves was leaky.  
You were given medication to remove extra fluid. You will need a 
repeat echo as an outpatient. 

We Made the following changes to your medications
1. START Metoprolol Succinate 150 mg twice a day
2. START Diltazem 120 mg once a day 
3. STOP Ciprofloxacin
4. STOP Flagyl 
5. Start Coumadin a blood thinner
6. We decreased your Cell Cept to 250mg twice a day 
7. STOP Glipizide. 
.
Please continue to take the rest of your home medications as you 
were before coming to the hospital. 
.
You will be followed by the ___ clinic at ___ 
associates at ___. Please contact ___ to 
establish when you need lab draws for monitoring of your INR  
(measurement of blood thickness).  
.
Please have your labs drawn on ___ and have the 
results faxed to ___ which is the ___. 
Please have chemistry panel, CBC, cyclosporine level and INR 
drawn.

 
Followup Instructions:
___
",MEDICINE
10005749-DS-16,Theresa Stutzman,10005749,24979738," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___
 
Chief Complaint:
pleuritic chest pain 
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ s/p renal transplant in ___ (unable to obtain IV dye), afib 
on coumadin recently sub-therapeutic, who presents with ___ days 
of pleuritic chest pain under her left breast. She denied any 
pain at rest, dyspnea or lower extremity pain or swelling. She 
was seen at ___ on ___ where she reported a recent car trip to 
___ in the middle of last week ___ach way). Her 
INR was found to be 1.2. She also notes recent exercise which 
she thinks may have contributed to the pain. She currently feels 
at baseline, with no pain. No recent fevers/chills. No chest 
pain or abdominal pain. No shortness of breath.  
- Initial vitals: 98.4 88 145/72 99% RA  
- Labs were notable for UA neg for infection. INR was 1.2. Chem7 
was notable Cr of 1.4, Trop negative. Alb 3.1, AP 133. CBC: 7.9 
/ 10.1 /  
- Studies performed include CXR showing stable small to moderate 
bilateral pleural effusions and stable mild cardiomegaly and 
pulmonary artery enlargement. Bilateral LENIS were negative  
- Patient was given 1mg warfarin  
On the floor patient feels well, no pleuritic pain, no shortness 
of breath.  
Review of Systems:  
(+) per HPI  
(-) fever, chills, night sweats, headache, vision changes, 
rhinorrhea, congestion, sore throat, cough, shortness of breath, 
chest pain, abdominal pain, nausea, vomiting, diarrhea, 
constipation, BRBPR, melena, hematochezia, dysuria, hematuria.
 
Past Medical History:
ATRIAL FIBRILLATION  
CHRONIC KIDNEY DISEASE  
DIABETES TYPE II  
HYPERLIPIDEMIA  
HYPERTENSION  
GALLSTONE PANCREATITIS S/P SPHINCTEROTOMY  
S/P RENAL TRANSPANT  
SYSTOLIC CONGESTIVE HEART FAILURE EF ___  
SHINGLES - FOREHEAD  
DIABETES MELLITUS  
MITRAL REGURGITATION  
URINARY TRACT INFECTION  
RENAL TRANSPLANT ___  
BILATERAL NEPHRECTOMIES ___  
SPHINCTEROTOMY  
BREAST AUGMENTATION
 
Social History:
___
Family History:
Sister RENAL TRANSPLANT
Daughter POLYCYSTIC KIDNEYS
 
Physical Exam:
Physical exam on admission:
=================================
Vitals: 99.1 162/97 96 16 99% RA blood sugar 371  
General: comfortable, in NAD  
HEENT: MMM, PERRL, oropharynx clear  
Neck: supple  
CV: RRR, normal s1 and s2  
Lungs: CTAB  
Abdomen: soft, nontender, nondistended  
Ext: warm, well perfused, no ___ edema  
Neuro: alert and oriented x 3, moving all extremities with 
purpose. CN II-XI intact  

Physical exam on discharge:
=================================
Vitals: 98.5 (101.0) 158/99 86 16 99% RA  
General: comfortable, in NAD 
HEENT:  MMM, PERRL, oropharynx clear
Neck:  supple
CV:  RRR, normal s1 and s2
Lungs:  CTAB
Abdomen:  soft, mild ttp over transplanted kidney in RLQ, no RUQ 
tenderness,  nondistended
Ext:  warm, well perfused, no ___ edema
Neuro: alert and oriented x 3, moving all extremities with 
purpose. CN II-XI intact

 
Pertinent Results:
Labs on admission:
=========================
___ 12:24PM BLOOD WBC-9.8 RBC-3.44* Hgb-10.5* Hct-30.2* 
MCV-88 MCH-30.5 MCHC-34.8 RDW-12.7 RDWSD-40.1 Plt ___
___ 12:24PM BLOOD Neuts-88.4* Lymphs-7.1* Monos-3.8* 
Eos-0.2* Baso-0.1 Im ___ AbsNeut-8.70* AbsLymp-0.70* 
AbsMono-0.37 AbsEos-0.02* AbsBaso-0.01
___ 12:24PM BLOOD ___
___ 12:24PM BLOOD Plt ___
___ 12:24PM BLOOD UreaN-21* Creat-1.2* Na-132* K-4.4 Cl-97 
HCO3-24 AnGap-15
___ 12:24PM BLOOD ALT-15 AST-20
___ 12:24PM BLOOD Lipase-35
___ 12:24PM BLOOD Calcium-9.1
___ 03:30PM BLOOD Albumin-3.1* Calcium-9.0 Phos-2.6*# 
Mg-1.8
___ 02:43PM BLOOD D-Dimer-___*
___ 03:35PM BLOOD Lactate-1.8

Reports:
=========================
IMPRESSION: 
  
1. Multiple liver cysts and tortuous anechoic structures in the 
central liver 
which may represent additional cysts and/or saccular dilation of 
bile ducts, 
several with either intraductal stones or parenchymal 
calcifications.  MRCP is 
suggested for further delineation and to exclude a common 
hepatic duct stone 
or other central cause of apparent biliary dilation, versus 
intrinsic biliary 
dilation such as could be due to ___'s disease or 
cholangiohepatitis. 
2. Trace perihepatic ascites and small left pleural effusion. 
  
RECOMMENDATION(S):   MRCP is recommended for further evaluation. 


V/Q Scan

IMPRESSION:  Low likelihood ratio for acute pulmonary embolism. 
  
By electronically signing this report, I, the attending 
physician, attest that I have  
reviewed the images associated with the above examination(s) and 
 
agree with the findings as documented above. 

Microbiology:
=========================
URINE CULTURE (Final ___:    NO GROWTH.
Blood Culture, Routine: Pending x3

Labs on discharge:
=========================
___ 07:15AM BLOOD WBC-5.3 RBC-2.89* Hgb-8.6* Hct-25.1* 
MCV-87 MCH-29.8 MCHC-34.3 RDW-12.6 RDWSD-40.1 Plt ___
___ 07:15AM BLOOD Glucose-151* UreaN-19 Creat-1.4* Na-135 
K-3.5 Cl-101 HCO3-23 AnGap-15
___ 07:15AM BLOOD Calcium-8.6 Phos-3.3 Mg-1.6
___ 07:15AM BLOOD ___ PTT-87.9* ___
 
Brief Hospital Course:
___ s/p renal transplant in ___ (unable to obtain IV dye), on 
immunosuppresion, s/p bilateral nephrectomies, afib on coumadin 
recently sub-therapeutic, who presents with ___ days of 
pleuritic chest pain under her left breast after 12 hours 
driving which resolved upon presentation. CP was of unclear 
cause. VQ scan was low probability. Patient notes some exercise 
recently and thinks this may have caused her pain. cardiac 
enzymes negative, EKG reassuring for ACS. patient was 
subtherapeutic on coumadin and has CHADS2 score of 3, and was 
treated with heparin gtt. Patient had fevers of unknown 
etiology, blood cultures were drawn which were pending at time 
of discharge.  The patient remained afebrile for 24 hours and 
was treated for presumed community acquired pneumonia given her 
subjective symptoms of pleuritic chest pain and pleural effusion 
on admission CXR.

# FEVERS -  Pt admitted for chest pain but spiked low grade 
fevers during admission. Initially placed on empiric vancomycin 
and zosyn, but continued spiking fevers without apparent source. 
 CXR showed minor pulmonary effusion on the R side. No 
localizing infectious symptoms, and fever resolved. Has 
reportedly had history of liver cyts which were again 
demonstrated on RUQ US without RUQ tenderness to palpation, thus 
not believed to be the source of intermittent fevers. The 
patient remained afebrile for 24 hours and was treated for 
presumed community acquired pneumonia given her subjective 
symptoms of pleuritic chest pain and pleural effusion on 
admission CXR without obvious localizing infectious signs, clear 
V/Q scan, and negative urine and blood cultures at the time of 
discharge.

# CP: The patient had an admission EKG and troponins reassuring 
for ACS, but reported pleuritic chest pain on admission.  Given 
a sub-therapeutic INR the patient was begun on a heparin drip, 
and with a recent history of travel and elevated d-dimer a V/Q 
scan was ordered which showed low probability of a pullmonary 
embolism. The patient's chest pain resolved completely by 
hospital day 2. Given that her only subjective complaint on 
admission was pleuritic chest pain, it was believed that her 
pain likely stemmed from a parapneumonic effusion and the 
patient was treated for community acquired pneumonia.  

TRANSITIONAL ISSUES:
# AFIB - ensure patient taking coumadin 2 mg. Follow up INR on 
___
# Liver cysts and sacular intrahepatic bile duct dilation - 
Noted on RUQ US to assess for possible fever source. Radiology 
recommended MRCP for further evaluation. Pls consider GI 
referral if needed. (note: pt with transplanted kidney)
# Please monitor INR closely given concurrent levofloxacin 
administration
# Code Status: Full code 
# Emergency Contact/HCP: ___ (husband) ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. PredniSONE 5 mg PO DAILY 
2. Mycophenolate Mofetil 250 mg PO BID 
3. Multivitamins 1 TAB PO DAILY 
4. Metoprolol Succinate XL 100 mg PO BID 
5. Losartan Potassium 25 mg PO DAILY 
6. Lorazepam 0.5 mg PO QHS:PRN anxiety 
7. GlipiZIDE XL 5 mg PO DAILY 
8. Furosemide 20 mg PO DAILY:PRN leg swelling 
9. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 
10. Diltiazem Extended-Release 120 mg PO DAILY 
11. Atorvastatin 10 mg PO QHS 
12. Ezetimibe 10 mg PO DAILY 
13. CycloSPORINE (Neoral) MODIFIED 25 mg PO Q12H 
14. Warfarin 1 mg PO DAILY16 
15. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral 2 tablets once a day 

 
Discharge Medications:
1. CycloSPORINE (Neoral) MODIFIED 25 mg PO Q12H 
2. Diltiazem Extended-Release 120 mg PO DAILY 
3. Ezetimibe 10 mg PO DAILY 
4. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 
5. Furosemide 20 mg PO DAILY:PRN leg swelling 
6. Lorazepam 0.5 mg PO QHS:PRN anxiety 
7. Metoprolol Succinate XL 100 mg PO BID 
8. Losartan Potassium 25 mg PO DAILY 
9. Multivitamins 1 TAB PO DAILY 
10. Mycophenolate Mofetil 250 mg PO BID 
11. PredniSONE 5 mg PO DAILY 
12. Levofloxacin 750 mg PO Q48H 
RX *levofloxacin 750 mg 1 tablet(s) by mouth every other day 
Disp #*3 Tablet Refills:*0
13. Atorvastatin 10 mg PO QHS 
14. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral 2 tablets once a day 
15. GlipiZIDE XL 5 mg PO DAILY 
16. Warfarin 1 mg PO DAILY16 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
Fevers
Chest pain
Commmunity acquired pneumonia

Secondary:
status post renal transplant
atrial fibrillation

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It has been a pleasure taking part in your care during your 
hospitalization at ___. You 
were admitted for left sided chest pain, and there was concern 
for a possible blood clot in your lungs. A study was performed 
that showed that it is unlikely that there was a clot in your 
lung. However, you had high fevers, and there was concern for 
infection given that you take immune suppressive medications. An 
ultrasound showed cysts in your liver, and bile duct dilation, 
which will need to get followed up with an outpatient 
gastroenterologist. You were treated empirically with broad 
antibiotics and these were changed to levofloxacin to treat for 
community acquired pneumonia. Please monitor your INR very 
closely given that it may fluctuate with your antibiotics.

Please follow up with the appointments as scheduled below. 
Please continue to take your medications, and take your coumadin 
daily unless instructed otherwise by your doctor. Again, it has 
been a pleasure taking part in your care, and we wish you the 
best.

Sincerely,

- Your ___ care team
 
Followup Instructions:
___
",MEDICINE
10005749-DS-17,Theresa Stutzman,10005749,24015009," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
High blood sugars, labs showing acute on chronic kidney injury
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ with a h/o renal transplant, CHF, AFib on 
Coumadin, DM who presented to the ED on ___ with 
hyperglycemia (600s) and worsening kidney function on routine 
tests at PCP. On ___, her blood glucose was 665, and her Hgb A1c 
was found to be 12.7. Her creatinine was 2.1, up from 1.4 in 
___ (most recent value). Had been taking her home 
Glipizide as prescribed. She had been urinating frequently and 
had a cold a few days prior to admission, but otherwise had no 
symptomatic complaints. 
 
Past Medical History:
ATRIAL FIBRILLATION  
CHRONIC KIDNEY DISEASE  
DIABETES TYPE II  
HYPERLIPIDEMIA  
HYPERTENSION  
GALLSTONE PANCREATITIS S/P SPHINCTEROTOMY  
S/P RENAL TRANSPANT  
SYSTOLIC CONGESTIVE HEART FAILURE EF ___  
SHINGLES - FOREHEAD  
DIABETES MELLITUS  
MITRAL REGURGITATION  
URINARY TRACT INFECTION  
RENAL TRANSPLANT ___  
BILATERAL NEPHRECTOMIES ___  
SPHINCTEROTOMY  
BREAST AUGMENTATION
 
Social History:
___
Family History:
Sister RENAL TRANSPLANT
Daughter POLYCYSTIC KIDNEYS
 
Physical Exam:
PHYSICAL EXAM upon admission:
Vitals:  97.4 PO, 160 / 55, 71, 20, 97 Ra 
Intake: 480, outs not recorded
General: alert, oriented, no acute distress  
HEENT: sclera anicteric, slightly dry mucus membranes, 
oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Irregularly irregular rhythm, normal S1 + S2, no murmurs, 
rubs, gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
GU: no foley  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: CNs2-12 intact, motor function grossly normal  

PHYSICAL EXAM upon discharge:
Vitals:  97.4 PO, 160 / 55, 71, 20, 97 Ra 
Intake: 480, outs not recorded
General: alert, oriented, no acute distress  
HEENT: sclera anicteric, slightly dry mucus membranes, 
oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: Irregularly irregular rhythm, normal S1 + S2, no murmurs, 
rubs, gallops  
Abdomen: soft, non-tender, non-distended, bowel sounds present, 
no rebound tenderness or guarding, no organomegaly  
GU: no foley  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema  
Neuro: CNs2-12 intact, motor function grossly normal 
 
Pertinent Results:
LABS UPON ADMISSION
___ 05:42PM BLOOD UreaN-46* Creat-2.1* Na-127* K-4.0 Cl-86* 
HCO3-22 AnGap-23*
___ 05:42PM BLOOD Glucose-665*
___ 05:42PM BLOOD WBC-7.9 RBC-3.54* Hgb-9.8* Hct-29.1* 
MCV-82 MCH-27.7 MCHC-33.7 RDW-14.1 RDWSD-41.6 Plt ___
___ 05:42PM BLOOD %HbA1c-12.7* eAG-318*

___ 12:15PM BLOOD Glucose-548* UreaN-47* Creat-1.9* Na-122* 
K-3.8 Cl-85* HCO3-21* AnGap-20
___ 12:15PM BLOOD WBC-11.2* RBC-3.64* Hgb-10.1* Hct-30.0* 
MCV-82 MCH-27.7 MCHC-33.7 RDW-14.1 RDWSD-41.8 Plt ___
___ 12:15PM BLOOD Neuts-90.2* Lymphs-6.1* Monos-2.1* 
Eos-0.2* Baso-0.2 Im ___ AbsNeut-10.14* AbsLymp-0.68* 
AbsMono-0.24 AbsEos-0.02* AbsBaso-0.02

LABS UPON DISCHARGE:
___ 11:19AM BLOOD Glucose-221* UreaN-42* Creat-1.8* Na-130* 
K-3.1* Cl-91* HCO3-22 AnGap-20
___ 05:56PM BLOOD Glucose-356* UreaN-43* Creat-1.9* Na-126* 
K-4.0 Cl-89* HCO3-23 AnGap-18
___ 11:19AM BLOOD WBC-11.4* RBC-3.64* Hgb-10.1* Hct-30.1* 
MCV-83 MCH-27.7 MCHC-33.6 RDW-14.1 RDWSD-41.7 Plt ___
___ 11:19AM BLOOD ___ PTT-35.5 ___

IMAGING:
RENAL US ___
IMPRESSION: 
1.  Patent renal transplant vasculature.
2.  Borderline to minimally elevated intrarenal resistive 
indices measuring up to 0.79 in the interpolar region.

CXR ___
IMPRESSION:  
Persistent small left and trace right pleural effusions and 
cardiomegaly.  No pulmonary edema.

 
Brief Hospital Course:
___ with a history of renal transplant, CHF, AFib on Coumadin, 
DM who was admitted on ___ after she was found to have 
hyperglycemia (600s) and worsening renal function on routine lab 
tests at PCP (Cr 2.1 on ___, up from most recent 1.4 on 
___.

# Hyperglycemia / T2DM: 
Pt presented with significant hyperglycemia with ___ and 
elevated serum osms (but not meeting criteria for HHS). Treated 
with insulin in ED and developed low K. Given her significantly 
elevated glucose and HbA1c, the patient requires insulin therapy 
for glucose control. ___ was consulted and recommended the 
following regimen: NPH 10 Units fixed dose in the morning and 
Humalog sliding scale at meals (see discharge paperwork for 
scale). Her electrolyte abnormalities resolved with repletion 
and intravenous fluids. Her home glipizide was held. 

# Acute on chronic kidney disease s/p renal transplant: She 
presented with Cr 2.1, though her Cr has been baseline 1.2-1.3 
for many years. Her acute presentation is likely due to 
hypovolemia in setting of hyperglycemia and gradual decline in 
kidney function. She was given intravenous fluids, and her 
creatinine was followed closely. Her Lasix and Losartan were 
held during admission due to her dehydration and ___. Her home 
cyclosporine, prednisone, and MMF were continued. Cr was not 
back to baseline upon discharge. Losartan and Lasix held at 
discharge.

# UTI: She was also found to have a urinalysis suggestive of 
UTI, culture pending. This infection likely developed in setting 
of acute on chronic hyperglycemia. Endorsed urinary sx. She was 
treated with ceftriaxone 1g IV once daily and transitioned to 
cefpoxodime 500mg twice a day for a 7 day course (last dose 
___. Urine cultures were pending at the time of discharge.

#Extensive discussions were had with patient and husband 
regarding discharge plan. We requested that the patient stay 
overnight given the elevated Cr, pending urine cultures, 
electrolyte abnormalities, and need for additional fluid 
repletion and patient education. Patient insisted on discharge 
and agreed to help ensure very close follow-up.

CHRONIC:
# A-fib
Continued home warfarin at 0.5 and 1mg alternating (note was 
just changed on ___ per ___ clinic because INR was high. 
Continued diltiazem, metoprolol and digoxin.

# CHF
ECHO ___ with normal regional/global systolic function. 
Mild-to-moderate mitral regurgitation. Moderate pulmonary 
hypertension. EF >55%. Per hx and exam, she was volume down. 
Lasix was held.

# Anxiety
Continued home lorazepam

# HTN
Losartan held in setting of ___. Furosemide held in setting of 
___.

# HLD
Continued home atorvastatin and zetia.

**TRANSITIONAL ISSUES**

NEW MEDICATIONS:
Insulin NPH 10 units at breakfast
Insulin sliding scale Humalog (see discharge medications)
Cefpodoxime 100 mg PO BID, end date ___

STOPPED MEDICATIONS:
Glipizide
Furosemide (Lasix)
Losartan

-Pt needs close f/u with PCP, ___, and ___. PCP is 
___. Discussed with patient and family
-Pt should have repeat labs on ___, chem 10 and INR. If her 
creatinine is improved and she does not appear hypovolemic, 
please restart her losartan and furosemide. 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. PredniSONE 5 mg PO DAILY 
2. Losartan Potassium 25 mg PO DAILY 
3. LORazepam 0.5 mg PO QHS:PRN anxiety 
4. Metoprolol Succinate XL 100 mg PO BID 
5. Diltiazem Extended-Release 120 mg PO DAILY 
6. Ezetimibe 10 mg PO DAILY 
7. Warfarin 1 mg PO EVERY OTHER DAY 
8. Atorvastatin 10 mg PO QPM 
9. CycloSPORINE (Neoral) MODIFIED 25 mg PO Q12H 
10. Mycophenolate Mofetil 250 mg PO BID 
11. Ferrous Sulfate 325 mg PO EVERY OTHER DAY 
12. Furosemide 60 mg PO BID 
13. Multivitamins 1 TAB PO DAILY 
14. GlipiZIDE XL 5 mg PO DAILY 
15. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral DAILY 
16. Warfarin 0.5 mg PO EVERY OTHER DAY 

 
Discharge Medications:
1.  Cefpodoxime Proxetil 100 mg PO Q12H Duration: 10 Days 
RX *cefpodoxime 100 mg 1 tablet(s) by mouth twice per day Disp 
#*18 Tablet Refills:*0 
2.  NPH 10 Units Breakfast
Insulin SC Sliding Scale using HUM Insulin 
3.  Atorvastatin 10 mg PO QPM  
4.  Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral DAILY  
5.  CycloSPORINE (Neoral) MODIFIED 25 mg PO Q12H  
6.  Diltiazem Extended-Release 120 mg PO DAILY  
7.  Ezetimibe 10 mg PO DAILY  
8.  Ferrous Sulfate 325 mg PO EVERY OTHER DAY  
9.  LORazepam 0.5 mg PO QHS:PRN anxiety  
10.  Metoprolol Succinate XL 100 mg PO BID  
11.  Multivitamins 1 TAB PO DAILY  
12.  Mycophenolate Mofetil 250 mg PO BID  
13.  PredniSONE 5 mg PO DAILY  
14.  Warfarin 1 mg PO EVERY OTHER DAY  
15.  Warfarin 0.5 mg PO EVERY OTHER DAY  
16. HELD- Furosemide 60 mg PO BID  This medication was held. Do 
not restart Furosemide until you see your PCP or your kidney 
doctor
17. HELD- Losartan Potassium 25 mg PO DAILY  This medication was 
held. Do not restart Losartan Potassium until you see your PCP 
or kidney doctor
18.Outpatient Lab Work
Chem 10, ___
fax to:
___, MD
___, MD
___

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS: 
HYPERGLYCEMIA
Acute kidney injury on chronic kidney injury
Complicated urinary tract infection
Hyponatremia
Hypokalemia
SECONDARY DIAGNOSIS: 
Atrial fibrillation
Renal transplant
Congestive heart failure
Anxiety
Hypertension

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___, 

You came to the hospital because you had very high blood sugar 
and bloodwork showing that your kidneys were not working as 
well.

While you were in the hospital, you were given insulin and 
intravenous fluids. Your Lasix and Losartan medications were 
held because you were very dehydrated. Your electrolyte levels 
were abnormal, which were repleted. You were also found to have 
a urinary tract infection, which was treated with antibiotics. 

Since your blood sugars were so high, it is very important that 
you take insulin every day, as prescribed. When you leave the 
hospital, you will also need to continue taking antibiotics 
(cefpodoxime 100 mg PO twice per day for 10 days) with last dose 
on ___. 

NEW MEDICATIONS:
Insulin NPH 10 units at breakfast
Insulin sliding scale Humalog (see discharge medications)(we 
have provided you with a chart that)
Cefpodoxime 100 mg PO twice a day through ___

STOPPED MEDICATIONS:
Glipizide 
Furosemide (Lasix)
Losartan

MAKE AN APPOINTMENT WITH YOUR NEPHROLOGIST FOR WITHIN ONE WEEK - 
Dr. ___ AN APPOINTMENT WITH YOUR PRIMARY CARE DOCTOR - Call 
___
PLEASE ATTEND YOUR ___ APPOINTMENT

Please get your labs checked next ___.

It was a pleasure taking care of you.

Your ___ Team

 
Followup Instructions:
___
",MEDICINE
10005817-DS-12,Gerald Champagne,10005817,28661809," 
Name:  ___                   Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Penicillins
 
Attending: ___.
 
Chief Complaint:
weakness, hypoxia secondary to superior vena cava syndrome
 
Major Surgical or Invasive Procedure:
intubation ___
Left femoral line placement ___
R femoral line placement
Left chest tube placement
Radiation Therapy
Left PICC placement
 
History of Present Illness:
___ h/o COPD, CAD s/p CABG, pAfib on xarelto, CKD, HTN, HLD, L 
supraclaviular mass dx as neuroendocrine tumor, who presented to 
___ on ___ for dehydration and failure to thrive. He did 
report scapular pain and dyspnea on exertion x 4 weeks starting 
about 2 months prior to presentation. Outpatient CT showed 
mediastinal lymphadenopathy and a supraclavicular mass. Biopsy 
on ___ showed poorly differentiated neuroendocrine tumor. 
Initial plan was to start chemotherapy of etoposide and 
carbaplantiunum x 3 days, as well as additioning to PET scan to 
___, however patient was unable to tolerate lying flat and PET 
scan was not performed. The patient was sent by his outpatient 
oncologist to ___ on ___ for failure to thrive and 
hypotension with SBPs in the ___. CT scan on ___ showed 
mediastinal adenopathy and SVC compromise and rec'd radiation 
but this was not done due to clinical decompensation. However, 
once the disease is staged, if the patient has no sign of 
metastatic disease, than chemotherapy would be curative. 

During his time at ___, his hospital course was notable for 
increased upper extremity swelling, facial swelling, and 
increased hypoxia. RUE ultrasound was negative for DVT. He had 
an increasing oxygen requirement from 2L to 7L. Given concern 
for airway compromise, the patient was transferred to the 
___ ICU on ___. Due to lack of surgical backup at 
___, the patient was not intubated at ___ and 
subsequently transferred here for further airway evaluation. 

Of note, the patient had a recent admission at ___ on 
___ for pneumonia, at which time he was treated with 
levaquin.

Vital signs at the time of transfer were 97.6 80 160/76 19 96% 
on high flow NC 8L.
Physical exam notable for facial flushing, able to speak in full 
sentences, RUE swelling.
Labs prior to transfer notable for a WBC of 12.6, H/H ___, 
platelets WNL. VBG 7.40/___. Cr 1.7.  Lactate 3.8 -> 2.2. 
Procalcitonin <0.05 (undetectable).

On arrival to the MICU, the patient was hemodynamically stable 
with pulse of 76 are blood pressure of 127/64. He had an 
increased work of breathing using his abdominal muscles. He was 
sitting upright, unable to tolerate laying flat.
 
Past Medical History:
- Coronary artery disease w/LAD stent; now s/p CABG x3:
Left internal mammary artery to left anterior descending artery,
saphenous vein graft to diagonal and obtuse marginal arteries
- Chronic obstructive pulmonary disease
- hypertension
- Congestive heart failure EF 40-45%.
- Diabetes mellitus
- Rectal Cancer ___ - treated w Chemo/ Rad followed by a 
surgical
procedure to remove residual tumor via the rectum
- Post traumatic stress disorder (pt is ___ veteran)
- atrial fibrillation
- CKD

 
Social History:
___
Family History:
FAMILY HISTORY:  No premature coronary artery disease, or 
neuroendocrine carcinomas
 
Physical Exam:
MICU ADMISSION 
============================
Vitals: T 97.7 HR 76 BP 127/64 R 20 93% 6L NC
GENERAL: fatigued, no acute distress
HEENT: Sclera anicteric, noted ___ swelling with 
rightsided facial fullness. Difficult to visualize posterior 
oropharynx
___: Regular without murmurs
RESP: Increased work of breathing with abnormal muscles. No 
stridor. RLL crackles
ABD: Non-tender, non-distended
EXT: Warm, no edema ___, Mild edema RUE
NEURO: CN II-XII intact. Strength ___ UE and ___ b/l

DEATH EXAM ___ - ___)
============================
Pupils non-reactive to light
No cardiac sounds auscultated
No respiratory effort seen
Telemetry without cardiac electrical activity
 
Pertinent Results:
ADMISSION LABS: 
==============================
___ 10:30PM   WBC-12.1*# RBC-3.67*# HGB-10.9*# HCT-33.4* 
MCV-91 MCH-29.7 MCHC-32.6 RDW-14.0 RDWSD-46.3
___ 10:30PM   PLT COUNT-359#
___ 10:30PM   GLUCOSE-190* UREA N-48* CREAT-1.6* SODIUM-138 
POTASSIUM-4.5 CHLORIDE-101 TOTAL CO2-23 ANION GAP-19
___ 10:51PM   freeCa-1.11*
___ 10:30PM   CALCIUM-9.0 PHOSPHATE-3.1 MAGNESIUM-2.4 URIC 
ACID-8.3*
___ 10:51PM   LACTATE-2.3*

DISCHARGE LABS: 
==============================
___ 01:02PM BLOOD WBC-9.8 RBC-3.06* Hgb-8.9* Hct-26.2* 
MCV-86 MCH-29.1 MCHC-34.0 RDW-14.6 RDWSD-44.7 Plt ___
___ 05:00AM BLOOD ___ PTT-67.6* ___
___ 11:14AM BLOOD Glucose-161* UreaN-102* Creat-2.7* 
Na-131* K-3.9 Cl-89* HCO3-28 AnGap-18
___ 05:00AM BLOOD ALT-27 AST-55* LD(LDH)-925* AlkPhos-93 
TotBili-0.4
___ 11:14AM BLOOD Calcium-7.0* Phos-6.0* Mg-1.8

MICROBIOLOGY: 
==============================
___ FLUID RECEIVED IN BLOOD CULTURE BOTTLES 
Fluid Culture in Bottles-PRELIMINARY INPATIENT 
___ PLEURAL FLUID GRAM STAIN-FINAL; FLUID 
CULTURE-FINAL; ANAEROBIC CULTURE-PRELIMINARY INPATIENT 
___ URINE URINE CULTURE-FINAL INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-PENDING 
INPATIENT 
___ SPUTUM GRAM STAIN-FINAL; RESPIRATORY 
CULTURE-FINAL {YEAST} INPATIENT 
___ URINE URINE CULTURE-FINAL INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
INPATIENT 
___ STOOL C. difficile DNA amplification 
assay-FINAL INPATIENT 
___ BRONCHOALVEOLAR LAVAGE GRAM STAIN-FINAL; 
RESPIRATORY CULTURE-FINAL {YEAST}; POTASSIUM HYDROXIDE 
PREPARATION-FINAL; FUNGAL CULTURE-PRELIMINARY {YEAST} INPATIENT 
___ MRSA SCREEN MRSA SCREEN-FINAL {STAPH AUREUS 
COAG +} INPATIENT 
___ PLEURAL FLUID GRAM STAIN-FINAL; FLUID 
CULTURE-FINAL; ANAEROBIC CULTURE-FINAL 

PATHOLOGY: 
===============================
PLEURAL FLUID, LATERALITY NOT SPECIFIED:
POSITIVE FOR MALIGNANT CELLS.
Consistent with metastatic poorly-differentiated non-small cell 
neuroendocrine carcinoma.
A few small groups of and scattered single atypical epithelioid 
cells are seen on the cell block
preparation. Immunohistochemical stains show the atypical cells 
to be focally, weakly positive for
synaptophysin, and CK5/6. No immunoreactive cells for 
chromogranin are seen. The patient's prior
slides of lymph node biopsy (___) were not available for 
comparison. Drs. ___ and ___ were informed of the diagnosis via e-mail by Dr. ___ 
on ___

STUDIES: 
===============================
+ TTE ___: The left atrium is mildly dilated. There is 
mild symmetric left ventricular hypertrophy. The left 
ventricular cavity size is normal. Due to suboptimal technical 
quality, a focal wall motion abnormality cannot be fully 
excluded. Overall left ventricular systolic function is normal 
(LVEF = 65%). Right ventricular chamber size and free wall 
motion are normal. The diameters of aorta at the sinus, 
ascending and arch levels are normal. The aortic valve is not 
well seen. There is no aortic valve stenosis. No aortic 
regurgitation is seen. The mitral valve leaflets are mildly 
thickened. Trivial mitral regurgitation is seen. The left 
ventricular inflow pattern suggests impaired relaxation. There 
is mild pulmonary artery systolic hypertension. There is a small 
pericardial effusion. There are no echocardiographic signs of 
tamponade.  
 
Brief Hospital Course:
Mr. ___ is a ___ year-old man with recently-diagnosed 
metastatic poorly-differentiated high-grade neuroendocrine 
carcinoma (likely of pulmonary origin), with bulky 
retroperitoneal/common iliac/mediastinal lymphadenopathy 
concerning for metastatic disease, who was admitted to ___ on 
___ with progressive dyspnea and hypoxemia thought to be at 
least partially related to ___ syndrome from an enlarging 
chest/neck mass, which was treated with external radiotherapy.  
Hospital course was been complicated by hypoxemic respiratory 
failure requiring prolonged mechanical intubation, sepsis ___ 
obstructive pneumonia, acute kidney injury ___ acute tubular 
necrosis, malignant pleural effusions requiring bilateral chest 
tube placement and hemodynamically unstable atrial fibrillation. 
Mr. ___ was followed closely by numerous consulting services 
(Heme-Onc, Pulmonary, Radiation Oncology, Nephrology, Infectious 
Disease). He developed progressive multi-system organ failure 
despite aggressive supportive care. Given his progressive 
decline and based on family wishes, his care was transitioned to 
a comfort focus and he was extubated with family at the bedside 
in accordance with his goals of care. He expired soon thereafter 
with official time of death being ___ @ 18:36. Autopsy was 
deferred. 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Atorvastatin 80 mg PO QPM 
2. Carvedilol 12.5 mg PO BID 
3. Diltiazem Extended-Release 240 mg PO DAILY 
4. Docusate Sodium 100 mg PO BID 
5. Fenofibrate 160 mg PO DAILY 
6. Levothyroxine Sodium 50 mcg PO DAILY 
7. Multivitamins 1 TAB PO DAILY 
8. Rivaroxaban 15 mg PO DAILY 
9. SAXagliptin 2.5 mg oral DAILY 
10. GlipiZIDE XL 10 mg PO QAM 
11. GlipiZIDE XL 5 mg PO QPM 
12. LamoTRIgine 100 mg PO DAILY 
13. Omeprazole 20 mg PO DAILY 
14. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain 
- Moderate 
15. QUEtiapine Fumarate 25 mg PO QHS 
16. Fentanyl Patch 75 mcg/h TD Q72H 
17. Midodrine 5 mg PO TID 

 
Discharge Medications:
patient expired
 
Discharge Disposition:
Expired
 
Discharge Diagnosis:
- Superior Vena Cava Syndrome
- Poorly differentiated neuroendocrine tumor  
- Acute Hypoxemic Respiratory failure 
- Healthcare associated pneumonia
- Malignant Pleural Effusions
- Acute tubular necrosis  
- Tumor lysis syndrome
- New onset atrial fibrillation/flutter with rapid ventricular 
response.
 
Discharge Condition:
Patient expired

 
Discharge Instructions:
Patient expired
 
Followup Instructions:
___
",MEDICINE
10005858-DS-16,Anna Bridges,10005858,29569314," 
Name:  ___.                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Aspirin / Adhesive Tape / Percocet / Erythromycin Base / Bee 
Sting Kit / adhesive bandage / Caffeine
 
Attending: ___.
 
Chief Complaint:
20 lb weight gain, DOE
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ year old F w/ history of hypertension,
obesity, osteoarthritis, hypothyroidism, and sarcoidosis
presenting for evaluation of a 20 lb weight gain in 1 week, DOE,
and lower extremity edema. She was seen by Cognitive Neurology
today who sent her in for evaluation. She reports that she woke
up approximately 3 days before admission with new lower 
extremity
swelling, DOE, bendopnea, and orthopnea. She also endorses chest
pain while walking that stops with slowing down. On ___, she 
was
265 pounds and today her weight is 293. She denies any chest
pain. She also has had three weeks of rhinorrhea, sore throat,
and a productive cough. 

In the ED, initial vital signs were T 99 HR 87 BP 135/106 RR 22
SPO2 96% RA. Her exam was notable for volume overload with
bilateral crackles and lower extremity edema. proBNP was only
221. TSH was normal. Hgb was newly decreased to 10.7. Urine
alb/Cr ratio was high at 109 and she had a low total protein of
5.8. ECG was unchanged from prior with sinus rhythm and
borderline LVH. Bedside cardiac ultrasound reportedly performed,
but not documented anywhere. CXR in the ED showed pulmonary
vascular congestion, so she was given 40 mg IV Lasix. 

Upon arrival to the floor, the patient reports the above story.
She is currently chest pain free, although notes dyspnea with
walking to the bathroom. Her legs feel lighter than before since
she received IV Lasix. This reminds her exactly of when she had
strep-induced nephritis at ___ years old. 

REVIEW OF SYSTEMS:
==================
Cardiac review of systems is notable for absence of paroxysmal
nocturnal dyspnea, palpitations, syncope, or presyncope. On
further review of systems, denies any prior history of stroke,
TIA, deep venous thrombosis, pulmonary embolism, bleeding at the
time of surgery, myalgias, hemoptysis, black stools or red
stools. Denies exertional buttock or calf pain. Denies recent
fevers, chills or rigors. All of the other review of systems 
were
negative.
 
Past Medical History:
1. CARDIAC RISK FACTORS
- Hypertension
- Obesity 

2. CARDIAC HISTORY
- CABG: None
- PERCUTANEOUS CORONARY INTERVENTIONS: None
- PACING/ICD: None
- Mitral valve prolapse 

3. OTHER PAST MEDICAL HISTORY
- Hypothyroidism, s/p partial thyroidectomy for multinodular
goiter 
- Sarcoidosis
- Acute nephritis diagnosed at age ___
- Urinary incontinence
- Spinal stenosis, lumbar region with neurogenic claudication,
s/p 3. Laminectomy lumbar L2-5, fusion I3-I5, instrumentation,
bone
graft, ___ S.viridans PJI of right knee (___)
- Chronic bilateral knee pain s/p bilateral total knee
replacement, ___
- Cerebral aneurysm s/p clips    
- Pulmonary nodule  
- Irritable bowel syndrome  
- Hx of CCY, APPY, TAH/RSO  
- S/p remote CTS release  
 
Social History:
___
Family History:
Mother - breast cancer
Brother - type ___ DM, CAD s/p CABG
Father - CAD s/p CABG, iCM 
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
VS: 98.7 PO 154 / 84 74 20 92 ra 
GENERAL: Obese elderly woman sitting up in bed in no acute
distress
HEENT: PERRL, EOMI, anicteric sclera, MMM, no oropharyngeal
erythema or exudates, no rhinorrhea 
NECK: supple, no LAD, JVP @ 12 cm
CV: RRR, S1/S2, no murmurs, gallops, or rubs
PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles
GI: abdomen obese, soft, multiple surgical scar, nontender in 
all
quadrants, no rebound/guarding, no hepatosplenomegaly
EXTREMITIES: no cyanosis or clubbing. 1+ pitting ___ to knees.
Bruising on knees  
PULSES: 1+ radial pulses bilaterally
BACK: Buffalo hump present 
NEURO: Alert although sometimes forgetful when asked questions,
CN intact, strength ___ x4 extremities, sensation to LT intact 
DERM: warm and well perfused, no excoriations or lesions, no
rashes

DISCHARGE PHYSICAL EXAM:
========================
VS: 24 HR Data (last updated ___ @ 722)
    Temp: 97.7 (Tm 98.3), BP: 124/63 (117-142/63-75), HR: 64
(64-75), RR: 16 (___), O2 sat: 96% (92-98), O2 delivery: RA,
Wt: 264.33 lb/119.9 kg  
GENERAL: Obese elderly woman, NAD
HEENT: anicteric sclera
NECK: supple, JVP not appreciated
CV: RRR, S1/S2, no murmurs, gallops, or rubs
PULM: CTAB, no increased work of breathing
GI: abdomen obese, soft, nontender
EXTREMITIES: No ___ edema
PULSES: palpable distal pulses
BACK: Buffalo hump present 
NEURO: alert, moves all four extremities with purpose
DERM: warm and well perfused, no excoriations or lesions, no
rashes
 
Pertinent Results:
ADMISSION LABS:
===============
___ 03:00PM BLOOD WBC-9.6 RBC-4.07 Hgb-10.7* Hct-35.6 
MCV-88 MCH-26.3 MCHC-30.1* RDW-16.4* RDWSD-52.0* Plt ___
___ 03:00PM BLOOD Neuts-77.9* Lymphs-12.4* Monos-7.1 
Eos-1.6 Baso-0.4 Im ___ AbsNeut-7.47* AbsLymp-1.19* 
AbsMono-0.68 AbsEos-0.15 AbsBaso-0.04
___ 03:00PM BLOOD ___ PTT-28.2 ___
___ 03:00PM BLOOD Glucose-97 UreaN-18 Creat-0.9 Na-147 
K-4.6 Cl-110* HCO3-29 AnGap-8*
___ 03:00PM BLOOD ALT-13 AST-20 AlkPhos-97 TotBili-0.2
___ 03:00PM BLOOD cTropnT-<0.01 proBNP-221
___ 03:00PM BLOOD Albumin-3.5 Calcium-9.1 Phos-3.4 Mg-2.0 
Cholest-188
___ 03:00PM BLOOD VitB12-713
___ 03:00PM BLOOD Triglyc-114 HDL-71 CHOL/HD-2.6 LDLcalc-94
___ 03:00PM BLOOD TSH-0.84

MICROBIOLOGY:
=============
___ 3:00 pm SEROLOGY/BLOOD

                            **FINAL REPORT ___

   RAPID PLASMA REAGIN TEST (Final ___: 
      NONREACTIVE. 
      Reference Range: Non-Reactive. 

INTERVAL LABS:
==============
___ C1 ESTERASE INHIBITOR PROTEIN, Result 34, Ref ___ 
mg/dL
___ COMPLEMENT, TOTAL (CH50), Result >60 H, Ref ___ U/mL

___ 06:18AM BLOOD cTropnT-<0.01
___ 01:18AM BLOOD %HbA1c-5.3 eAG-105
___ 03:10PM BLOOD C3-134 C4-28

IMAGING AND REPORTS:
====================
CHEST (PA & LAT) ___
Pulmonary vascular congestion without overt edema or focal 
consolidation.

Transthoracic Echo Report ___
The left atrial volume index is mildly increased. The right 
atrium is moderately enlarged. There is no evidence for an 
atrial septal defect by 2D/color Doppler
. The estimated right atrial pressure is ___ mmHg. There is mild 
symmetric left ventricular hypertrophy with a normal cavity 
size. There is normal regional and global left ventricular 
systolic function. Quantitative biplane left ventricular 
ejection fraction is 56 %.
There is no resting left ventricular outflow tract gradient. No 
ventricular septal defect is seen. Diastolic parameters are 
indeterminate. Normal right ventricular cavity size with mild 
global free wall hypokinesis. The aortic sinus diameter is 
normal for gender with normal ascending aorta diameter for 
gender
. The aortic arch diameter is normal. There is no evidence for 
an aortic arch coarctation. The aortic valve leaflets (3) are 
mildly thickened. There is no aortic valve stenosis. There is
no aortic regurgitation. The mitral valve leaflets are mildly 
thickened with no mitral valve prolapse.
There is trivial mitral regurgitation. The tricuspid valve 
leaflets appear structurally normal. There is physiologic 
tricuspid regurgitation. The estimated pulmonary artery systolic 
pressure is borderline elevated. There is a trivial pericardial 
effusion.
IMPRESSION: Biatrial enlargement. Mild symmetric left 
ventricular hypertrophy
. Preserved biventricular systolic function. Borderline 
pulmonary hypertension.
Compared with the prior TTE ___, the findings are similar
.

DISCHARGE LABS:
===============
___ 08:14AM BLOOD WBC-7.6 RBC-4.39 Hgb-11.6 Hct-38.5 MCV-88 
MCH-26.4 MCHC-30.1* RDW-16.5* RDWSD-52.8* Plt ___
___ 08:14AM BLOOD Glucose-98 UreaN-34* Creat-1.0 Na-143 
K-4.3 Cl-100 HCO3-32 AnGap-11
___ 08:14AM BLOOD Calcium-9.7 Phos-4.1 Mg-2.2
 
Brief Hospital Course:
Ms. ___ is a ___ year old F w/ history of hypertension,
obesity, osteoarthritis, hypothyroidism, and sarcoidosis
who presented for evaluation of a 20 lb weight gain in 1 week, 
DOE,
and lower extremity edema which improved after diuresis.

ACUTE PROBLEMS:
===============
# HFpEF
# Volume overload
Patient with 20 lb weight gain in one week, new ___ edema, DOE,
orthopnea, and bendopnea. TTE w/ LVEF 56% and biatrial 
enlargement. Diastolic parameters were indeterminate, but 
clinical suspicion is for diastolic failure likely ___ obesity. 
Diastolic CHF likely given her symptoms. Renal disease or DI 
unlikely with unremarkable studies. Unlikely hypothyroidism 
given normal TSH, or liver disease given normal LFTs and no 
stigmata on exam. Euvolemic and back to baseline weight s/p 
Lasix diuresis. Transitioned to Lasix 20 mg PO.
Admission Weight: 133.6 kg, 294.53 lb.
Discharge Weight: 119.9 kg, 264.33 lb

# Chest pain
Patient endorsed exertional chest pain. Unclear if this is
similar to pain she has had in the past when she had stress
tests. ECG unchanged and trops negative x1. ___ be stable angina
vs. severe DOE vs. pulmonary HTN vs. MSK. No evidence of
myocarditis or active ischemia. CP resolved. Should consider 
pMIBI.

# Acute normocytic anemia
___ be secondary to dilution from acute volume overload. No
history of bleeding. Hgb increased with diuresis.

CHRONIC PROBLEMS:
=================
# Hypothyroidism
Continued levothyroxine.

# Hx of spinal hardware infection
Continued home suppressive minocycline.

# Memory loss
Seeing Cognitive Neurology for poor short term memory. B12 and
TSH normal. RPR negative. Continued topiramate.

# GERD
Continued omeprazole.

# Restless legs
Continued Pramipexole.

# Insomnia
Continued trazodone, venlafaxine.

# Dry Eyes
Held home restasis; substituted for artificial tears.

# Urinary urgency
Held home mirabegron and trospium given non-formulary

TRANSITIONAL ISSUES:
====================
[] Consider pMIBI to further evaluate etiology of her chest 
pain.
[] Started on Lasix 20 mg PO on discharge. Titrate as needed and 
please ensure the patient monitors her weight.
[] Consider initiation of a statin.
[] Please weigh yourself every day in the morning. Call your 
doctor at if your weight goes up by more than 3 lbs. PCP: Dr. 
___ ___.
[] Discharge Weight: 119.9 kg, 264.33 lb
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Calcium Carbonate 1000 mg PO BID 
2. L-Lysine (lysine) 500 mg oral BID 
3. Multivitamins 1 TAB PO DAILY 
4. Restasis 0.05 % ophthalmic (eye) BID 
5. Minocycline 100 mg PO Q12H 
6. Omeprazole 20 mg PO BID 
7. Pramipexole 0.25 mg PO TID 
8. Topiramate (Topamax) 50 mg PO BID 
9. TraZODone 100 mg PO QHS 
10. trospium 60 mg oral DAILY 
11. Venlafaxine 200 mg PO QHS 
12. mirabegron 25 mg oral DAILY 
13. Levothyroxine Sodium 50 mcg PO DAILY 

 
Discharge Medications:
1.  Furosemide 20 mg PO DAILY 
RX *furosemide 20 mg 1 tablet(s) by mouth once a day Disp #*90 
Tablet Refills:*2 
2.  Calcium Carbonate 1000 mg PO BID  
3.  L-Lysine (lysine) 500 mg oral BID  
4.  Levothyroxine Sodium 50 mcg PO DAILY  
5.  Minocycline 100 mg PO Q12H  
6.  mirabegron 25 mg oral DAILY  
7.  Multivitamins 1 TAB PO DAILY  
8.  Omeprazole 20 mg PO BID  
9.  Pramipexole 0.25 mg PO TID  
10.  Restasis 0.05 % ophthalmic (eye) BID  
11.  Topiramate (Topamax) 50 mg PO BID  
12.  TraZODone 100 mg PO QHS  
13.  trospium 60 mg oral DAILY  
14.  Venlafaxine 200 mg PO QHS  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Heart failure with preserved ejection fraction

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at ___ 
___. 

WHY WAS I ADMITTED TO THE HOSPITAL?
- You were admitted to the hospital for rapid weight gain and 
leg swelling.

WHAT HAPPENED WHILE I WAS IN THE HOSPITAL?
- You were given medication to remove fluid from your body. You 
should continue to take this medication after you leave the 
hospital.
- You got imaging of your heart. The study showed normal pumping 
function but part of the results were indeterminate. You should 
follow-up with your PCP and cardiologist to review these 
results.

WHAT SHOULD I DO WHEN I GO HOME?
- You should continue to take your medications as prescribed. 
- You should attend the appointments listed below. 
- Please weigh yourself every day in the morning. Call your 
doctor at ___ if your weight goes up by more than 3 
lbs.  

We wish you the best!
Your ___ Care Team 
 
Followup Instructions:
___
",MEDICINE
10005866-DS-16,Joseph Bryant,10005866,22589518," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Tylenol / Neurontin
 
Attending: ___
 
Chief Complaint:
RUQ abdominal pain, vomiting, diarrhea
 
Major Surgical or Invasive Procedure:
-diagnostic para ___

 
History of Present Illness:
Mr ___ is a ___ year old man with cirrhosis (EtOH/HCV 
untreated, genotype 3)Child Class C, complicated by esophageal 
varices, ascites, and encephalopathy, chronic abdominal pain and 
multiple prior abdominal surgeries, presenting with 3 days of 
more severe RUQ pain, vomiting, and diarrhea.  

After a several month stay in rehab in ___ following his 
last ___ hospitalization in ___, the patient has been doing 
well at home. In his usual state of health, he has chronic RUQ 
abdominal pain, and is followed by his PCP and hepatologist; 
patient states that his pain has been attributed to possibly 
scar tissue from his several abdominal surgeries. He was 
previously on fentanyl patch for this but is now on oxycodone 
10mg QID. ___ checked ___. Last filled oxycodone 10mg 30 
day supply (120 pills) ___.  

He has Child's class C cirrhosis but overall his ascites and 
hepatic encephalopathy are well controlled with 
Lasix/spironolactone and lactulose. Prior paracentesis was 
""Several years ago.""  

He developed his present symptoms 3 days ago, with the subacute 
onset of worsening RUQ pain (stabbing, constant with waves of 
more severe pain, worse with vomiting, no change with 
eating/position/movement). For the past 3 days he has also had 
___ episodes per day of vomiting (clear/yellow fluid, no blood 
or coffee-ground emesis), and has been unable to tolerate food, 
or fluids, and thinks he has also vomited pills (although has 
been trying to stay compliant with his regimen). He has also 
been having multiple episodes per day of watery/yellow fluid 
diarrhea (no blood or melena).  

His ROS is positive for chills/sweats, and fatigue. His 
abdominal distention is moderate but stable. But he denies 
fevers, myalgia/arthralgias, HA, URI symptoms, visual complaint, 
chest pain/pressure, dyspnea, cough, rash, bruising, lower 
extremity edema. No recent travel, sick contacts, or recent 
raw/uncooked/spoiled food.

He presented to the ED for further evaluation.  

In the ED, initial vitals were: Temp. 98.0, HR 82, BP 157/82, RR 
22, 100% RA  
- Exam notable for: RUQ tenderness to palpitation, abdomen 
distended but soft  
--Bedside abdominal ultrasound showed small volume of ascites 
without a pocket amenable to paracentesis.  

- Labs notable for:  
--WBC 5.4, Hgb 14.0, plt 181  
--Na 130, K 4.8, HCO3 15, creatinine 0.8, glucose 144, BUN 9  
--ALT 32, AST 127, alk phos 145, Tbili 4.7, albumin 2.8  
--lactate 2.6, repeat lactate 1.7  
--INR 1.4, PTT 38.7  

- Imaging was notable for:  
CT abdomen ___:  
1. Cirrhosis with evidence of portal hypertension with moderate 
volume ascites partially loculated in the right upper quadrant, 
extensive portosystemic varices. ***Partially occlusive thrombus 
in the main portal vein. *** 
2. Small bowel distention without obstruction may reflect ileus. 
Mild thickening of the proximal colon may reflect portal 
colopathy.  
3. Trace right pleural effusion with chronic appearing 
atelectasis in the right lower lung.  
4. Extensive atherosclerotic disease of the aorta.  
 
Liver US ___:  
1. There is a new nonocclusive thrombus within the main portal 
vein with extension into the left and right portal vein 
branches. There is normal hepatopetal flow within the main 
portable vein and evidence of sluggish flow within the left and 
right portal vein branches.  
2. Large volume ascites.  
3. Worsening splenomegaly measuring 13.7 cm today, previously 
measuring 12 cm ___.
4. New 1.6 cm focus within the right hepatic lobe is 
incompletely characterized. Follow-up MR for further evaluation 
is recommended.

- Patient was given:  
--morphine 4mg IV x2  
--ondansetron 4mg IV  
--1L normal saline  
--started on heparin drip  

Upon arrival to the floor, patient reports continued abdominal 
pain in the RUQ, and being very thirsty and a little hungry.  

REVIEW OF SYSTEMS:  
 (+) Per HPI  
 (-) 10 point ROS reviewed and negative unless stated above in 
HPI
 
Past Medical History:
 - Hepatitis C (genotype 3)  
 - Cirrhosis, Child's Class C due EtOH and HCV d/b hepatic 
encephalopathy, portal hypertension with ascites and esophageal 
varices, portal hypertensive gastropathy  
 - Gastric & Duodenal ulcers  
 - Insomnia  
 - Umbilical hernia  
 - Sacral osteoarthritis  
 
Past Surgical History:  
 - Umbilical hernia repair (___)  
 -SBO requiring Ex lap & repair of ruptured umbilical hernia 
with lysis of adhesions (___)
 - Abdominal Hematoma evacuation (___)  
 - Abdominal incision opened, wound vac placed (___) 
 
Social History:
___
Family History:
Sister and brother both with ""collapsed lungs."" No family 
history of liver disease.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
==============================
VITAL SIGNS: BP 115 / 77 hr 64 RR18 SPO2 98 Ra  
GENERAL: chronically ill appearing man, resting in bed in 
moderate discomfort. Able to move around in bed without obvious 
increase in pain. Alert, fully conversant, very pleasant.  
HEENT: NCAT. Dry oral mucosa. No scleral icterus. Conjunctivae 
white. No JVD.  
NECK: full ROM, no masses  
CARDIAC: RRR, no murmurs, no lower extremity edema  
LUNGS: CTAB, unlabored breathing on ambient air  
ABDOMEN: moderately distended, but soft. Moderately tender in 
RUQ. Umbilical hernia site intact, non-tender. Dull to 
percussion, no fluid wave. Normal bowel sounds. Collateral 
vessels faintly visible in abdominal wall  
EXTREMITIES: warm, no edema. No asterixis  
NEUROLOGIC: alert, fully oriented. CN exam normal. 
Strength/sensation intact. Gait not tested. No asterixis or 
tremor.  
SKIN: no rashes, no jaundice  

DISCHARGE PHYSICAL EXAM:
==============================
VS: 98.1 PO 106 / 68 R Lying 68 18 96 Ra  
GENERAL: chronically ill appearing man, resting in bed in 
moderate discomfort.  
HEENT: NCAT. MMM. No scleral icterus
CARDIAC: RRR, no murmurs, no lower extremity edema  
LUNGS: CTAB, unlabored breathing on ambient air  
ABDOMEN: moderately distended, but soft. Moderately tender in 
RUQ. Umbilical hernia site intact, non-tender.  Normal bowel 
sounds. Collateral vessels faintly visible in abdominal wall  
EXTREMITIES: warm, no edema. No asterixis  
NEUROLOGIC: alert, fully oriented. CN exam normal. 
Strength/sensation intact. Gait not tested. No asterixis or 
tremor.  
SKIN: no rashes, no jaundice
 
Pertinent Results:
ADMISSION LABS:
==========================
___ 09:36AM BLOOD WBC-5.4 RBC-3.97* Hgb-14.0 Hct-42.2 
MCV-106* MCH-35.3* MCHC-33.2 RDW-14.2 RDWSD-56.4* Plt ___
___ 09:36AM BLOOD Neuts-65.3 ___ Monos-10.4 Eos-1.9 
Baso-1.7* Im ___ AbsNeut-3.51 AbsLymp-1.08* AbsMono-0.56 
AbsEos-0.10 AbsBaso-0.09*
___ 11:21AM BLOOD ___ PTT-38.7* ___
___ 09:36AM BLOOD Glucose-144* UreaN-9 Creat-0.8 Na-130* 
K-4.8 Cl-101 HCO3-15* AnGap-19
___ 09:36AM BLOOD ALT-32 AST-127* AlkPhos-145* TotBili-4.7*
___ 09:36AM BLOOD Albumin-2.8*
___ 05:00AM BLOOD Calcium-7.7* Phos-2.9 Mg-1.4*
___ 09:44AM BLOOD Lactate-2.6*

DISCHARGE LABS:
==========================
___ 04:46AM BLOOD WBC-5.1 RBC-3.46* Hgb-12.3* Hct-37.0* 
MCV-107* MCH-35.5* MCHC-33.2 RDW-14.2 RDWSD-55.5* Plt ___
___ 04:46AM BLOOD ___ PTT-36.8* ___
___ 04:46AM BLOOD Glucose-93 UreaN-9 Creat-0.9 Na-133 K-4.2 
Cl-99 HCO3-26 AnGap-12
___ 04:46AM BLOOD ALT-21 AST-63* AlkPhos-159* TotBili-2.3*
___ 04:46AM BLOOD Albumin-2.4* Calcium-8.0* Phos-3.6 Mg-1.6

PERTINENT RESULTS:
==========================
___ 01:55PM ASCITES TNC-64* RBC-650* Polys-1* Lymphs-48* 
Monos-6* Mesothe-2* Macroph-43* Other-0
___ 01:55PM ASCITES TotPro-1.7 Glucose-103 LD(LDH)-104 
Albumin-0.7 Cholest-19
___ 08:58PM STOOL NoroGI-NEGATIVE NoroGII-NEGATIVE

MICROBIOLOGY:
==========================
___ 1:55 pm FLUID RECEIVED IN BLOOD CULTURE BOTTLES
      PERITONEAL FLUID. 

   Fluid Culture in Bottles (Preliminary):    NO GROWTH.

___ 1:48 pm PERITONEAL FLUID      PERITONEAL FLUID. 

                            **FINAL REPORT ___

   GRAM STAIN (Final ___: 
      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR 
LEUKOCYTES. 
      NO MICROORGANISMS SEEN. 
      This is a concentrated smear made by cytospin method, 
please refer to
      hematology for a quantitative white blood cell count.

IMAGING:
==========================
___
IMPRESSION:
1. Cirrhosis with new partially occlusive thrombus within the 
main portal 
vein.
2. Large volume ascites. 
3. Worsening splenomegaly measuring 13.7 cm today, previously 
measuring 12 cm ___.
4. New 1.6 cm focus within the right hepatic lobe is 
incompletely characterized.  Follow-up MR for further evaluation 
is recommended.

___
IMPRESSION:
Tiny right pleural effusion, otherwise unremarkable exam.

___
IMPRESSION:
1. Cirrhosis with evidence of portal hypertension with moderate 
volume ascites partially loculated in the right upper quadrant, 
extensive portosystemic varices.  Partially occlusive thrombus 
in the main portal vein.
2. Small bowel distention without obstruction may reflect ileus. 
 Mild thickening of the proximal colon may reflect portal 
colopathy.
3. Trace right pleural effusion with chronic appearing 
atelectasis in the right lower lung.
4. Extensive atherosclerotic disease of the aorta.
 
Brief Hospital Course:
___ year old man with cirrhosis (EtOH/HCV untreated, genotype 3) 
Child Class C, complicated by esophageal varices, ascites, and 
encephalopathy, chronic abdominal pain and multiple prior 
abdominal surgeries, presenting with 3 days of acute on chronic 
RUQ pain, vomiting, and diarrhea likely ___ viral 
gastroenteritis. C.diff negative, norovorius negative. 
Diagnostic para w/ no e/o SBP. Stool Cx pending at time of 
discharge. Patient was given IV fluids with spontaneous 
resolution (though persistent chronic RUQ pain).

Hospital course complicated by new non-occlusive PVT, lactate 
slightly elevated on initial presentation normalized with IVF 
less c/f ischemia. Outpatient hepatologist (Dr. ___ was 
contacted who recommended against anticoagulation given 
non-occlusive, and concerns with patient compliance.

Otherwise no changes to home medications.

======================
ACUTE ISSUES
======================

#Abdominal pain, vomiting, diarrhea: presented with 3 days of 
acute on chronic RUQ pain, vomiting, and diarrhea likely ___ 
viral gastroenteritis. C.diff negative, norovorius negative. 
Diagnostic para w/ no e/o SBP. Stool Cx pending at time of 
discharge. Patient was given IV fluids with spontaneous 
resolution (though persistent chronic RUQ pain). Of note RUQ U/S 
and CT A/P w/ e/o non-occlusive PVT, though unlikely explanation 
for presentation as non-occlusive w/ down-trending lactate. 

#Partially occlusive portal vein thrombosis: iso decompensated 
cirrhosis; RUQ ultrasound and CT abdomen with contrast 
demonstrated partially occlusive portal vein thrombus, new since 
___ ultrasound. Lactate slightly elevated on initial 
presentation normalized with IVF less c/f ischemia. Outpatient 
hepatologist (Dr. ___ was contacted who recommended against 
anticoagulation given non-occlusive, and concerns with patient 
compliance.
  

#Hyponatremia : Admitted w/ serum sodium 130. Per history, 
multiple days of low fluid intake, diarrhea, vomiting, while 
continuing to take diuretics suggested he was intravascularly 
depleted. Resolved s/p 1L IVF, and resolution of gastroenteritis 
w/ improved PO intake. Home diuretics restarted upon discharge.

#Cirrhosis: Child's Class C, complicated by ascites, hepatic 
encephalopathy, prior SBP, esophageal varices. 
 -volume: home Lasix/spironolactone initially held iso n/v/d, 
resumed upon discharge.
 -hepatic encephalopathy - cont home lactulose after resolution 
of diarrhea
 -SBP ppx - cont home Bactrim 
 -esophageal varices - last EGD in ___ no evidence of bleeding 
on this presentation;

Transitional Issues:
==========================
-On RUQ U/S: There is a 1.6 cm echogenic focus within the mid 
right hepatic lobe, peripherally, for which follow-up MR for 
further evaluation is recommended.
-Patient w/ new non-occlusive PVT. Would recommend f/u CT in 3 
months to eval for progression of PVT thrombus.
-Stool cultures pending at time of discharge, please follow up

 # CODE: full 
 # CONTACT: sister/HCP ___ ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Furosemide 20 mg PO DAILY 
2. Lactulose 30 mL PO TID 
3. Spironolactone 50 mg PO DAILY 
4. Famotidine 20 mg PO Q12H 
5. OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN Pain - 
Moderate 
6. Multivitamins 1 TAB PO DAILY 
7. Potassium Chloride 10 mEq PO DAILY 
8. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 
9. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral DAILY 
10. Polyethylene Glycol 17 g PO DAILY:PRN constipation 

 
Discharge Medications:
1.  Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral DAILY  
2.  Famotidine 20 mg PO Q12H  
3.  Furosemide 20 mg PO DAILY  
4.  Lactulose 30 mL PO TID  
5.  Multivitamins 1 TAB PO DAILY  
6.  OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN Pain - 
Moderate 
RX *oxycodone 10 mg 1 tablet(s) by mouth every six (6) hours 
Disp #*8 Tablet Refills:*0 
7.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  
8.  Potassium Chloride 10 mEq PO DAILY 
Hold for K >  
9.  Spironolactone 50 mg PO DAILY  
10.  Sulfameth/Trimethoprim SS 1 TAB PO DAILY  
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
=======================
-viral gastroenteritis

Secondary Diagnosis:
======================
-ETOH/HCV Cirrhosis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr ___,

It was a pleasure being involved in your care.

Why you were here:
-You came in for nausea/vomiting/diarrhea.

What we did while you were here :
-We gave you some fluids through your IV because you were 
dehydrated. We believe that you had a viral illness, which 
cleared on its own.
-We also took some fluid out of your abdomen to make sure you 
were not having an infection, and this was negative for any 
infection.

Your next steps:
-please take all your medications as indicated below
-please keep all of your appointments

We wish you well,
Your ___ Care Team
 
Followup Instructions:
___
",MEDICINE
10005866-DS-19,Joseph Bryant,10005866,21636229," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Tylenol / Neurontin
 
Attending: ___.
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ man presents for evaluation of abdominal pain. 
Patient recently hospitalized for acute exacerbation of his
chronic abdominal pain, likely partial bowel obstruction. 
Discharged yesterday after undergoing conservative management of
likely partial bowel obstruction; of note at the time of
discharge he was pain-free and tolerating a regular diet, as 
well
as having bowel function.  Also had repeat ultrasound of liver
which showed resolution of prior portal vein partially occlusive
thrombus. Patient reports arriving to his daughter's home, 
having
a cup of tea and dinner without issue.  However overnight his
abdominal pain recurred and he decided to come back in for
evaluation.  He denies any nausea or vomiting, has not had a
bowel movement since leaving the hospital yesterday.  Denies any
fevers, chills, dysuria, chest pain, shortness of breath,
numbness, tingling.  Transplant surgery is consulted to evaluate
for surgical causes of recurrent abdominal pain.

ROS:
(+) per HPI

 
Past Medical History:
 - Hepatitis C (genotype 3)  
 - Cirrhosis, Child's Class C due EtOH and HCV d/b hepatic 
encephalopathy, portal hypertension with ascites and esophageal 
varices, portal hypertensive gastropathy  
 - Gastric & Duodenal ulcers  
 - Insomnia  
 - Umbilical hernia  
 - Sacral osteoarthritis  
 
Past Surgical History:  
 - Umbilical hernia repair (___)  
 -SBO requiring Ex lap & repair of ruptured umbilical hernia 
with lysis of adhesions (___)
 - Abdominal Hematoma evacuation (___)  
 - Abdominal incision opened, wound vac placed (___) 
 
Social History:
___
Family History:
Sister and brother both with ""collapsed lungs."" No family 
history of liver disease.
 
Physical Exam:
Admission Exam:
==================
VITAL SIGNS:  97.9 65 165/75 16 99% RA 
GENERAL: AAOx3 NAD
HEENT: NCAT, EOMI, PERRLA, No scleral icterus, mucosa moist, no 
LAD
CARDIOVASCULAR: R/R/R
PULMONARY: CTA ___, No crackles or rhonchi
GASTROINTESTINAL: protuberant, soft, more distended than usual,
tender to palpation in right hemi-abdomen, left hemi-abdomen
mildly tender, No guarding, rebound, or peritoneal signs.
EXT/MS/SKIN: No C/C/E; Feet warm. Good perfusion.
NEUROLOGICAL: Reflexes, strength, and sensation grossly intact
.
Discharge Exam:
===================
VS: 97.8 123/72 70 18 98% RA  
GENERAL: NAD, patient appears chronically ill, sunken temples,
A&Ox3   
HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,
adentulous
NECK: supple, no JVD  
HEART: RRR, S1/S2, no murmurs, gallops, or rubs  
LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably
without use of accessory muscles  
ABDOMEN: protuberant abdomen, not tense, decreased bowel sounds.
Tender to moderate palpation, mostly on R side. Multiple 
surgical
scars appearing c/d/i.
EXTREMITIES: no cyanosis, clubbing or edema, moving all 4
extremities with purpose  
PULSES: 2+ DP pulses bilaterally  
NEURO: CN II-XII intact  
SKIN: warm and well perfused, no excoriations or lesions, no
rashes
 
Pertinent Results:
Labs on admission:
========================
___ 07:00AM BLOOD WBC-5.7 RBC-3.43* Hgb-11.5* Hct-35.6* 
MCV-104* MCH-33.5* MCHC-32.3 RDW-14.9 RDWSD-57.2* Plt ___
___ 07:45AM BLOOD WBC-5.9 RBC-3.49* Hgb-11.7* Hct-36.4* 
MCV-104* MCH-33.5* MCHC-32.1 RDW-14.7 RDWSD-57.0* Plt ___
___ 07:00AM BLOOD ___ PTT-35.6 ___
___ 07:45AM BLOOD ___
___ 04:42AM BLOOD Glucose-90 UreaN-4* Creat-0.7 Na-136 
K-4.6 Cl-102 HCO3-26 AnGap-8*
___ 04:42AM BLOOD ALT-17 AST-50* AlkPhos-110 TotBili-2.4*
.
Microbiology:
========================
 
___ 7:31 am PERITONEAL FLUID      PERITONEAL FLUID. 

   GRAM STAIN (Final ___: 
      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
      NO MICROORGANISMS SEEN. 
      This is a concentrated smear made by cytospin method, 
please refer to
      hematology for a quantitative white blood cell count.. 

   FLUID CULTURE (Final ___:    NO GROWTH. 

   ANAEROBIC CULTURE (Preliminary):    NO GROWTH. 
.

___ 07:31AM ASCITES TNC-37* RBC-92* Polys-1* Lymphs-30* 
Monos-8* Basos-1* Macroph-60*
___ 07:31AM ASCITES TotPro-0.4 Glucose-101
.
.
Reports/imaging:
========================
RUQ ultrasound:
IMPRESSION: 
1. Cirrhotic liver, without evidence of focal lesion. 
2. Mild to moderate ascites and a right pleural effusion. 
3. Patent main and right portal vein with appropriate direction 
of flow. 
.
Abdominal XR:
IMPRESSION:  
Borderline diameter of a single loop of small bowel with a few 
small 
nonspecific small bowel air-fluid levels and air seen in the 
colon.  Findings are nonspecific, but a very early/very mild 
partial small bowel obstruction is not entirely excluded in the 
appropriate clinical setting. 
.
CT abd and pelvis with contrast
IMPRESSION: 
1. Redemonstration cirrhotic liver with sequela of portal 
hypertension.  New branching hypoattenuation in segments VIII 
and ___ may be due to periportal edema or inflammation along 
intrahepatic biliary ducts, the latter possibly related to 
cholangitis.  The main portal vasculature is patent. 
2. Moderate amount of ascites, as on prior.  Mild peritoneal 
enhancement 
without free air or drainable fluid collections, could represent 
peritonitis or secondary to recent paracentesis. 
.
Labs on discharge:
========================
___ 06:32AM BLOOD WBC-6.6 RBC-2.84* Hgb-9.8* Hct-29.5* 
MCV-104* MCH-34.5* MCHC-33.2 RDW-14.2 RDWSD-54.1* Plt ___
___ 06:32AM BLOOD Glucose-109* UreaN-7 Creat-0.7 Na-133* 
K-4.3 Cl-100 HCO3-24 AnGap-9*
___ 06:32AM BLOOD ALT-17 AST-50* AlkPhos-104 Amylase-110* 
TotBili-1.7*
___ 07:00AM BLOOD Lipase-42
___ 06:32AM BLOOD Lipase-32
___ 06:32AM BLOOD Calcium-7.6* Phos-2.8 Mg-1.___ with Cirrhosis, Child's Class C due EtOH and HCV d/b hepatic 
encephalopathy, portal hypertension with ascites and esophageal 
varices, portal hypertensive gastropathy; hx numerous abdominal 
surgeries with suspected frozen abdomen, chronic abdominal pain 
with subacute worsening. Patient had recent admission with small 
bowel obstruction that was treated conservatively with NG tube 
and bowel rest and resolved, who went home with decreased pain 
med regimen, and who is now returning with worsening abdominal 
pain. 
.
#Abdominal pain
CT abd pain pelvis showed no obstruction or extravasation of 
contrast. Patient was first placed on home pain regiment (oxy 
10mg q6hr) with improvement of pain, but given increased pain at 
4hours after oxy dose, chronic pain service recommended a 
regimen of 7.5mg oxy every 4 hours, which better controlled 
pain. Lidocaine patch attempted for back pain but without 
noticeable change. Patient was eating regular diet and with 
ongoing ___ pain but appearing comfortable, walking, 
eating and passing soft stool.
.
#Cirrhosis
With regards to cirrhosis, Child's Class C due EtOH and HCV, 
with past hepatic
encephalopathy, portal hypertension with ascites and esophageal 
varices, portal hypertensive gastropathy. No evidence of 
decompensation during this hospitalization. Para was done that 
did not show SBP.
.
TRANSITIONAL ISSUES:
[] CHANGED oxycodone 10mg q6hr to 7.5mg q4hr with improvement in 
pain control
[] STARTED miralax, thiamine
[] Please consider outpatient pain consult if worsening pain
[] CONTACT: ___ (HCP, sister) ___

 

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Famotidine 20 mg PO BID 
2. Furosemide 20 mg PO DAILY 
3. OxyCODONE (Immediate Release) 10 mg PO Q6H:PRN pain 
4. Spironolactone 50 mg PO DAILY 
5. Sulfameth/Trimethoprim SS 1 TAB PO DAILY SBP prophylaxis 
6. Simethicone 40-80 mg PO TID:PRN gas pain 
7. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral DAILY 
8. Lactulose 30 mL PO QID 
9. Multivitamins 1 TAB PO DAILY 
10. Potassium Chloride 20 mEq PO DAILY 
11. Bisacodyl ___AILY:PRN constipation 

 
Discharge Medications:
1.  Polyethylene Glycol 17 g PO DAILY 
RX *polyethylene glycol 3350 [ClearLax] 17 gram/dose 1 scoop 
powder(s) by mouth daily Disp #*1 Package Refills:*0 
2.  Simethicone 40-80 mg PO TID:PRN gas pain  
3.  Thiamine 100 mg PO DAILY 
RX *thiamine HCl (vitamin B1) 100 mg 1 tablet(s) by mouth daily 
Disp #*30 Tablet Refills:*0 
4.  OxyCODONE (Immediate Release) 7.5 mg PO Q4H:PRN Pain - 
Moderate 
RX *oxycodone [Oxaydo] 7.5 mg 1 tablet(s) by mouth every 4 hours 
Disp #*42 Tablet Refills:*0 
5.  Bisacodyl ___AILY:PRN constipation  
6.  Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral DAILY  
7.  Famotidine 20 mg PO BID  
8.  Furosemide 20 mg PO DAILY  
9.  Lactulose 30 mL PO QID 
Titrate to ___ bowel movements daily  
10.  Multivitamins 1 TAB PO DAILY  
11.  Potassium Chloride 20 mEq PO DAILY  
12.  Spironolactone 50 mg PO DAILY  
13.  Sulfameth/Trimethoprim SS 1 TAB PO DAILY SBP prophylaxis  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary:
=============
Cirrhosis
Intermittent abdominal pain of unknown origin
Intraabdominal bowel adhesions
.
Secondary:
=============
History of multiple abdominal surgeries

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear. Mr. ___,
.
It was a pleasure taking part in your care at ___ 
___. You were seen for increasing abdominal 
pain. A number of tests, including laboratory and a CT scan were 
reassuring. You were initially on the surgical service, but the 
surgical team did not feel there was any problem requiring 
surgery. You were seen by the chronic pain service that made an 
adjustment to the dose and timing of your pain medication. 
Please take this new dose as prescribed. Please take the new 
medications as prescribed.
.
Please call the surgery doctor, ___ office at 
___ if you are having increasing abdominal pain, 
inability to tolerate diet, not passing gas or having bowel 
movements, nausea, vomiting or any other concerning GI 
complaints.
.
You are likely to be having intermittent abdominal pain. Please 
work with your primary care physician regarding your pain 
management strategies.
.
No driving if taking narcotic pain medication.
.
Try to eat small frequent meals, using no additional salt, stay 
hydrated.
.
We wish you the best,
Your ___ care team

 
Followup Instructions:
___
",MEDICINE
10005866-DS-20,Joseph Bryant,10005866,20364112," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Neurontin
 
Attending: ___.
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
___ Exploratory laparotomy
___ EGD
___ EGD nasojejeunal placed and bridled (removed ___ CT-guided placement of an ___ pigtail catheter into 
the lesser sac collection. (removed ___
PICC placement. 

 
History of Present Illness:
___ man with multiple recent admissions for waxing
and waning abdominal pain, history of EtOH/hep C cirrhosis, now
presents with 24 hours of acutely worsening epigastric pain
associated with multiple episodes of emesis and dark stools. 
Patient states that his abdominal pain was at its baseline
yesterday at which point he noticed an acute worsening of his
pain that he describes as sharp and in his upper abdomen.  He
also had several episodes of emesis, reporting his vomit as 
being
dark brown in character.  Decided to re-present to ED for
reevaluation of abdominal pain given acute worsening status. 
Most recently presented to the ED over the weekend where he got 
a
CT abdomen pelvis that did not show any acute interval changes
compared to prior scans.  Was discharged home with expectant
management, transplant surgery was not consulted at that time. 
Now, underwent repeat CT scan showing free air and fluid in the
lesser sac concerning for gastric perforation.  Transplant
surgery is consulted for surgical management of this disease.

ROS:
(+) per HPI

 
Past Medical History:
 - Hepatitis C (genotype 3)  
 - Cirrhosis, Child's Class C due EtOH and HCV d/b hepatic 
encephalopathy, portal hypertension with ascites and esophageal 
varices, portal hypertensive gastropathy  
 - Gastric & Duodenal ulcers  
 - Insomnia  
 - Umbilical hernia  
 - Sacral osteoarthritis  
 
Past Surgical History:  
 - Umbilical hernia repair (___)  
 -SBO requiring Ex lap & repair of ruptured umbilical hernia 
with lysis of adhesions (___)
 - Abdominal Hematoma evacuation (___)  
 - Abdominal incision opened, wound vac placed (___) 
 
Social History:
___
Family History:
Sister and brother both with ""collapsed lungs."" No family 
history of liver disease.
 
Physical Exam:
Admission Physical Exam:
=========================
Vitals: T 97.8 HR 96 BP 145/79 RR 20 100 RA
GEN: A&O, uncomfortable appearing
HEENT: No scleral icterus, mucus membranes moist
CV: RRR
PULM: No respiratory distress
ABD: Firm, tender to percussion in the epigastric region,
guarding present, moderately distended, no fluid wave 
DRE: Deferred
Neuro: CSM grossly intact x 4
Ext: No ___ edema, UE and ___ warm and well perfused bilat

Discharge Physical Exam:
=========================
VS:97.5  95/56 65 18 99 Ra 
GENERAL: cachectic appearing older male, sitting up in bed, more
conversant and interactive today. 
HEENT: anicteric sclera, temporal muscle wasting 
Neck: supple 
HEART: irregular rhythm, no m/r/g
LUNGS: CTAB on anterior exam 
ABDOMEN: protuberant but soft, +BS, tenderness to palpation
in right upper quadrant, midline surgical incision with staples
removed, well healed, dressing over RLQ with drain place 
draining
dark brown serosanguineous fluid 
EXTREMITIES: no lower extremity edema, no clubbing or cyanosis
SKIN: no jaundice, warm and dry 
NEURO: alert, oriented, no asterixis, moving all extremities 

 
Pertinent Results:
Admission Labs: ___ 02:35AM 
================
WBC-15.9*# RBC-3.39* Hgb-11.7* Hct-35.5* MCV-105* MCH-34.5* 
MCHC-33.0 RDW-14.7 RDWSD-56.3* Plt ___ PTT-29.5 ___
Glucose-122* UreaN-15 Creat-0.5 Na-134* K-4.3 Cl-97 HCO3-22 
AnGap-15
ALT-24 AST-63* AlkPhos-92 TotBili-2.5*
Lipase-24
Calcium-6.8* Phos-3.7 Mg-1.7
Triglyc-36

Microbiology
============
Blood Culture, Routine (Final ___:    NO GROWTH. 
HELICOBACTER PYLORI ANTIBODY TEST (Final ___:  NEGATIVE BY 
EIA.(Reference Range-Negative). 
 
___ 7:44 pm PERITONEAL FLUID      PERITONEAL FLUID. 

   GRAM STAIN (Final ___: 
      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
      NO MICROORGANISMS SEEN. 

   FLUID CULTURE (Final ___:    NO GROWTH. 

   ANAEROBIC CULTURE (Preliminary):    NO GROWTH. 

Imaging:
=========
CT Abdomen Pelvis ___
IMPRESSION: 
1. Free air and increased fluid within the lesser sac concerning 
for 
perforated viscus, which could be from the stomach based on 
location. 
2. Mildly dilated small bowel bowel a transition point.  This 
could represent ileus versus partial small bowel obstruction.  
No initial in of the bowel or pneumatosis. 
3. Cirrhotic liver with findings of portal hypertension 
including varices and ascites. 

Upper GI Contrast Study: ___
IMPRESSION: Leak of contrast from the posterior antrum of the 
stomach. 

CXR: ___
COMPARISON:  ___ 
IMPRESSION:  Pulmonary edema has slightly worsened.  
Cardiomediastinal silhouette is stable.  Left-sided PICC line is 
unchanged the NG tube projects below the left hemidiaphragm.  
Small bilateral effusions left greater than right are  
unchanged.  No pneumothorax is seen 

CT Abdomen Pelvis ___
IMPRESSION:
1. A 8.5 x 5.9 cm loculated fluid collection with rim 
enhancement in the 
lesser sac is identified.  Compared to ___, the fluid 
collection 
demonstrates thicker and more discrete wall. 
2. Small ascites and peritonitis is similar to before. 
3. Liver cirrhosis with mild splenomegaly and portosystemic 
shunt. 
4. Small bilateral pleural effusions.
 
CT Abdomen for Interventional Procedure: ___
IMPRESSION: Successful CT-guided placement of an ___ 
pigtail catheter into the lesser sac collection.  Samples were 
sent for microbiology evaluation. 

Abdominal Ultrasound ___:
IMPRESSION:  No fluid pocket amenable to percutaneous sampling.  
A diagnostic paracentesis was not performed. 
  

Transfer Labs: ___ 06:32AM
===============
WBC-5.0 RBC-2.99* Hgb-9.7* Hct-31.0* MCV-104* MCH-32.4* 
MCHC-31.3* RDW-17.1* RDWSD-64.6* Plt ___ PTT-28.8 ___
Glucose-108* UreaN-15 Creat-0.5 Na-137 K-4.5 Cl-106 HCO3-24 
AnGap-7*
ALT-18 AST-58* AlkPhos-194* TotBili-1.2
Albumin-2.2* Calcium-7.3* Phos-2.6* Mg-1.8

Discharge Labs: ___ 05:55AM
===============
WBC-4.2 RBC-2.72* Hgb-9.0* Hct-28.7* MCV-106* MCH-33.1* 
MCHC-31.4* RDW-16.6* RDWSD-65.1* Plt ___
Glucose-97 UreaN-14 Creat-0.5 Na-136 K-4.8 Cl-105 HCO3-21* 
AnGap-10
ALT-19 AST-59* AlkPhos-198* TotBili-1.2
Albumin-2.1* Calcium-7.3* Phos-2.6* Mg-1.8

 
Brief Hospital Course:
Summary: 
---------
Mr ___ is a ___ man with alcoholic and hepatitis C 
cirrhosis who presented with abdominal pain, and was found to 
have a perforated inoperable duodenal and stomach ulcer.  

Active Issues:
--------------
# DUODENAL AND GASTRIC ULCERS with
# ___ GUIDED DRAINAGE OF LESSER SAC COLLECTION:
The patient presented to the ___ Emergency Department with 
abdominal pain. There was evidence of perforated ulcer on both 
CT abdomen and upper GI series (posterior antral leak to lesser 
sac). Initially he was kept NPO with IV hydration and placed on 
broad-spectrum antibiotics with pip-tazo and fluconazole from 
___. 
He underwent EGD on ___ with the following finding: large 
ulcer measuring approximately 5-6cm was seen in the first part 
of the duodenum.  There was likely perforation around the edge 
of the ulcer measuring 2-3cm -This appeared contained. The 
perforation was too large for endoscopic intervention. There was 
also moderate to severe esophagitis in the distal esophagus with 
portal hypertensive gastropathy seen. H. pylori was negative. He 
was put on the maximum dose of PPI.  A NG was in place. 
He underwent exploratory laparotomy by Dr. ___, but 
was found to have a frozen abdomen thus unable to see perforated 
stomach. Postop, he was transferred to the SICU for management 
as he was hypotensive and hematocrit had decreased. He was given 
albumin and 4 units of PRBC. Hct stabilized, but on ___, he 
had brief episode of SVT with rate of 160 without blood pressure 
drop; afib with intermittent RVR that was treated with 
metoprolol IV x 2 with decrease in BP. The patient required 
pressors and amiodarone was started (please see #Afib below). 

He transferred out of the SICU and was started on TPN. Afib was 
managed with metoprolol. Metoprolol dose was increased and he 
was given intermittent doses of Lasix for volume control and 
pulmonary edema seen on CXR. 

His diet was initially advanced to clears then full liquids. 
However, he did not tolerate advancement to a regular diet. He 
experienced a lot of abdominal pain. Diet was changed to just 
sips of clears and pain was managed with a Dilaudid PCA.  His 
diet was eventually changed to tube feeds and then regular diet 
as per an initial goals of care discussion. An abdominal CT 
___ an 8cm loculated fluid collection in lesser 
sac. He then underwent ___ placement of a drain in the 
fluid collection. Microbiology evaluation of the fluid 
collection did not grow any organisms, so antibiotics were 
discontinued on ___.  ___ continued to follow the drain until 
output was < 5cc for 2 consecutive days, at which point the 
drain was pulled.  Diet was advanced slowly for comfort, with 
supplemental nutrition from nasogastric tube feeds.  After a 
goals of care meeting on ___, Pt endorsed a desire to 
transition towards measures that would improve his comfort.  In 
light of this, his NGT was pulled ___ and he was permitted a 
regular PO diet, which he tolerated well. Patient was continued 
on sucralfate for continued gastric coating and comfort.  PPI 
and other unnecessary medicines were held.

# GOALS OF CARE DISCUSSION:
Pt with poor prognosis due to his perforated viscus, surgically 
frozen abdomen, and non-transplant candidacy.  A goals of care 
meeting was held on ___ with the patient and his friend, as 
well as newly-chosen HCP, ___.  At this meeting, Pt 
acknowledged the severity of his illness and endorsed a 
willingness to transition his course more towards 
comfort-focused care.  Medicines that would not contribute to 
his comfort were discontinued.  Unnecessary tubes and lines, 
including his NGT and PICC line, were removed prior to 
discharge.  Patient was discharged to a ___ facility for 
housing and further titration of his care.

# ETOH/HCV CIRRHOSIS with
# ASCITES and
# NEED FOR SBP PPX:
Previously complicated by hepatic encephalopathy, ascites, grade 
I esophageal varices.  Pt without significant hepatic 
encephalopathy or large ascites during his hospital stay; he was 
initially put on oral diuretics to minimize the ascites and risk 
of wound dehiscence, but these were held in the setting of 
significant weight loss while on tube feeds and overall hypo- to 
euvolemic appearance on exam.  Patient was continued on Bactrim 
for SBP prophylaxis.  He was continued on lactulose to keep his 
mental status clear.  Given goals of care discussion as above, 
vitamins such as thiamine and multivitamin were discontinued.

# ATRIAL FIBRILLATION:
Had one episode of Afib on ___, for which he was amiodarone 
loaded and started on amio gtt.  He was stable on PO metoprolol 
in-house, though sometimes limited due to soft blood pressures.  
He had a CHADS-VASC of 0.  Given his goals of care discussion at 
discharge, PO metoprolol was discontinued.  Anticoagulation was 
deferred given recent surgery as well as goals of care 
discussion as above.

# NUTRITION:
Initially requiring TPN, then tube feeds by ___.  He 
continued to lose muscle mass despite optimal nutrition on TF's. 
 After goals of care discussion ___, patient was provided with 
a regular diet - which he tolerated well.  

TRANSITIONAL ISSUES:
--------------------
# CODE STATUS:  DNR/DNI, CMO, Do not Hospitalize
# CONTACT:  Friend/HCP, ___ (___)

[ ] GOALS OF CARE:
- Pt transitioned to DNR/DNI and comfort measures only, given 
his poor prognosis and lack of surgical alternatives for his 
medical conditions.

[ ] PAIN MANAGEMENT:
- If patient is requiring more than 3 daily doses of oxycodone 
for breakthrough pain, consider uptitrating his TID oxyconTIN 
for further long-lasting pain relief.

[ ] MEDICATION CHANGES:
- Added:  Oxycodone 10mg PO q2h:PRN breakthrough pain, 
acetaminophen 500mg Q6H, Bactrim DS 1 tab daily, lidocaine 
patch, oxyconTIN 20mg PO TID, sucralfate 1gm PO QID, 
polyethylene glycol 17g daily
- Changed:  Lactulose (QID -> TID), Bactrim (1 SS tab -> 1 DS 
tab for SBP Ppx)
- Stopped: Metoprolol, Vitamins, furosemide, lansoprazole
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Famotidine 20 mg PO BID 
2. Furosemide 20 mg PO DAILY 
3. Lactulose 30 mL PO QID 
4. Spironolactone 50 mg PO DAILY 
5. Sulfameth/Trimethoprim SS 1 TAB PO DAILY SBP prophylaxis 
6. Polyethylene Glycol 17 g PO DAILY 
7. Bisacodyl ___AILY:PRN constipation 
8. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral DAILY 
9. Multivitamins 1 TAB PO DAILY 
10. Potassium Chloride 20 mEq PO DAILY 
11. Simethicone 40-80 mg PO TID:PRN gas pain 
12. Thiamine 100 mg PO DAILY 
13. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - 
Moderate 

 
Discharge Medications:
1.  Acetaminophen 500 mg NG Q6H  
2.  Lidocaine 5% Patch 1 PTCH TD QAM 
apply to abdomen
remove in pm  
3.  OxyCODONE SR (OxyconTIN) 20 mg PO TID abdominal pain 
RX *oxycodone 5 mg/5 mL 20 mL by mouth three times a day 
Refills:*0 
4.  Simethicone 40-80 mg PO TID:PRN gas pain  
5.  Sucralfate 1 gm PO QID  
6.  Sulfameth/Trimethoprim DS 1 TAB PO/NG DAILY  
7.  OxyCODONE (Immediate Release) 10 mg PO Q2H:PRN BREAKTHROUGH 
PAIN 
RX *oxycodone 5 mg/5 mL 10 mL by mouth every 2 hours Refills:*0 
8.  Bisacodyl ___AILY:PRN constipation  
9.  Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 
mg(1,500mg) -400 unit oral DAILY  
10.  Lactulose 30 mL PO TID  
11.  Multivitamins 1 TAB PO DAILY  
12.  Polyethylene Glycol 17 g PO DAILY  
13.  Thiamine 100 mg PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
PRIMARY DIAGNOSES:
Gastric perforation, frozen abdomen.
Duodenal ulcer
Esophagitis

SECONDARY DIAGNOSES:
portal hypertensive gastropathy
anemia
malnutrition
Cirrhosis

 
Discharge Condition:
Mental Status: Confused - sometimes.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
Dear Mr. ___,

WHY WAS I ADMITTED TO THE HOSPITAL?
- You were having pain in your abdomen. 

WHAT HAPPENED WHILE I WAS IN THE HOSPITAL?
- You were found to have a hole in your intestine (perforated 
ulcer), that could not be repaired due to scarred down tissue in 
your abdomen (frozen abdomen)
- You were given antibiotics to prevent infection
- You had a temporary drain placed in your abdomen to drain an 
infection, and this was removed. 
- You initially were given a feeding tube to bypass the hole, 
but as it healed from the inside, you were able to eat regular 
food. 
- Because you were so sick and there was no cure for your 
advance liver disease and holes in your stomach and intestines, 
you chose hospice care. 

WHAT SHOULD I DO WHEN I GO HOME
-Take medications to help your pain
-Eat for comfort

Thank you for letting us be a part of your care!

Your ___ Team

 
Followup Instructions:
___
",MEDICINE
10005991-DS-13,Carl Houston,10005991,20355325," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
EGD with biopsies

 
History of Present Illness:
PCP: Dr. ___

___ year-old man with abdominal pain that started the morning of 
admission.  The episodes last ___ minutes, 8 out of 10 in 
severity, sharp in quality, diffuse, but most severe in upper 
abdomen, and occurred 4 times prior to presentation.  He had 
black, loose stools x 4 episodes on morning of ___ with stool 
urgency, but no stool incontinence.  He had nausea without 
vomiting. He drinks ___ beers each weekend, but has been 
cutting down.  He used Ibuprofen 600mg once one week prior to 
admission for a headache.  Otherwise, the patient has loose 
stools once or twice weekly, but not black-colored.  Denies 
constipation.  No current fever or chills.  His diet typically 
consists of pizza, burritos, and beer.  Currently states that 
his pain is 7 out of 10 in the umbilical area.

Denies ever having alcohol withdrawal symptoms.

Review of Systems:
(+) Per HPI
(-) Denies night sweats, weight change, visual changes, oral 
ulcers, bleeding nose or gums, chest pain, shortness of breath, 
palpitations, orthopnea, PND, lower extremity edema, cough, 
hemoptysis, dysuria, hematuria, easy bruising, skin rash, 
myalgias, joint pain, back pain, numbness, weakness, dizziness, 
vertigo, headache, confusion, or depression.  All other review 
of systems negative.
 
Past Medical History:
Anxiety, sees a psychiatrist, Dr. ___
 
Social History:
___
Family History:
Mother with history of heart attack. Father healthy.
 
Physical Exam:
VS: 96.3, 138/88, 49, 20, 99% on room air
Pain 7 out of 10 in umbilical area
GEN: NAD
HEENT: EOMI, anicteric sclerae, MMM, no oral lesions
NECK: Supple
CHEST: CTAB
CV: RRR, normal S1 and S2, no murmurs
ABD: Soft, nontender, nondistended, bowel sounds present
SKIN: No rashes or other lesions
EXT: No lower extremity edema
NEURO: Alert, oriented x3, CN ___ intact, sensory intact 
throughout, strength ___ BUE/BLE, fluent speech, normal 
coordination
PSYCH: Calm, appropriate
 
Pertinent Results:
Admission Labs: ___ 09:40AM 
WBC-11.6* Hgb-17.1 Hct-48.4 MCV-85 RDW-13.7 Plt-331
Glu-111* BUN-20 Cr-1.0 Na-140 K-4.4 Cl-105 HCO3-22
ALT-36 AST-46* AlkPhos-74 Amylase-36 TotBili-0.5  Lipase-27

H. Pylori antibody: Negative

CXR ___: No acute process

CT Abdomen and Pelvis ___: No acute intra-abdominal pathology 
to explain the patient's pain. Specifically, normal appendix. 

EGD: Erythema in the antrum compatible with gastritis (biopsy 
normal); erythema in the duodenal bulb compatible with 
duodenitis

Discharge Labs: 
___ 07:20PM WBC-4.3# RBC-4.80 Hgb-13.9*# Hct-40.0 MCV-83 
Plt ___
___ 07:25AM Hct-39.1*

 
Brief Hospital Course:
___ year-old man with heavy alcohol use and poor diet presents 
with severe abdominal pain and black loose stools (guaiac 
positive) concerning for a GI bleed. 

# Gastrointestinal bleed: Guaiac positive in ED, with a decrease 
in his Hct from 48 to 40. Patient had no further bowel movements 
while in the hospital, and subsequent Hct was stable at 39. He 
underwent EGD which was notable for duodenitis and gastritis, 
biopsies of which were within normal limits. H.pylori antibody 
was negative. It was felt his duodenitis and gastritis were 
secondary to heavy alcohol use, and patient was advised to 
abstain from alcohol. He was started on a twice daily proton 
pump inhibitor, which he should continue until follow-up with 
___ gastroenterology. The patient continued to complain 
of pain following his EGD, and was advised to avoid NSAIDs given 
the gastritis noted on EGD. He was prescribed Tylenol and a 
limited supply of Ultram and advised to follow-up with his PCP 
if his pain persists. He tolerated a full regular diet prior to 
discharge with no change in his level of pain.

# Anxiety disorder: Mood remained stable on Sertraline and 
Lorazepam.

 
Medications on Admission:
Sertraline 150 mg PO daily
Lorazepam 1 mg PO BID prn anxiety
Zolpidem 10 mg PO QHS prn insomnia 
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Gastritis
Duodenitis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital with abdominal pain and black 
stools concerning for bleeding from your GI tract. You underwent 
a procedure called an EGD which found inflammation in your 
stomach (gastritis) and in the first part of your small 
intestine (duodenitis). For this you are being prescribed an 
acid suppressing medication which you will need to take twice a 
day for a month. You will also need to follow-up with ___ 
in Gastroenterology.

Due to ongoing abdominal pain you are being prescribed a 
medication called Ultram. However, this medication can interact 
with medications you are already taking and is not a good 
long-term option. You are being given a one day supply of this 
medication, and will need to discuss your pain control further 
with your primary care physician ___.

It is very important that you stop drinking, as this can worsen 
the inflammation in your stomach. It is also important that you 
avoid medications such as Ibuprofen, Motrin, Advil, Naproxen, 
and Alleve, as these can also worsen the inflammation. You can 
use Tylenol as needed for pain.
 
Followup Instructions:
___
",MEDICINE
10005991-DS-14,Carl Houston,10005991,24856862," 
Name:  ___               Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Abdominal Pain, distension
 
Major Surgical or Invasive Procedure:
Esophagogastroduodenoscopy
Colonoscopy

 
History of Present Illness:
Mr. ___ is a ___ y/o M with past medical history 
significant for Anxiety, and abdominal pain. Of note he had 
recent hospitilization in early ___ for abdominal pain, was 
evaluated by GI who was consulted for concern for upper GI 
bleed, an EGD was performed which showed gastritis and 
duodenitis with normal biopsies. It was believed at that time 
that his gastritis and duodenitis were due to heavy alcohol use. 
He was started on a PPI twice daily. He was negative for H. 
Pylori.
.
Today he is s/p EGD and colonoscopy for further evaluation of 
abdominal pain. He had an MRCP two days ago, which was 
essentially negative.  After his colonoscopy patient continued 
to have abdominal pain, gas, distension and was admitted for 
further monitoring overnight. 
.
Per history patient said that he has been daily with mainly 
epigastric pain, has not had any N/V recently. Pain is 
aggravated by eating, and alcohol intake (patient still reports 
drinking ___ drinks/week). Denies any recent Fevers/Chills, 
hematochezia, melena. He reports on average ___ BM's per day, 
with diarrhea on and off. He was not taking a PPI prior to 
admission due to insurance issues with ""prior authorization"".
.
On the floor patient's vitals were 97.8, 148/81, 62, 20, 97%RA. 
After his colonoscopy/EGD today patient currently reports that 
he has ___ pain, mainly in the LLQ, RLQ, and constant, 
non-radiating. He reports passing gas, has not had BM yet. Has 
taken clear liquids, does not currently report nausea (had 1 
episode of emesis after his procedure today).  
.  
.  
Review of sytems:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, sinus tenderness, rhinorrhea or 
congestion. Denied cough, shortness of breath. Denied chest pain 
or tightness, palpitations. No recent change in bowel or bladder 
habits. No dysuria. Denied arthralgias or myalgias.  

 
Past Medical History:
-Anxiety, sees a psychiatrist, Dr. ___, Duodenitis
-s/p bilateral inguinal hernia repair as child, denies other 
surgeries
 
Social History:
___
Family History:
-Mother with history of heart attack (believed to be in her 
___, patient denies other medical issues. 
-Father healthy.
-Uncle with ___ Lymphoma
-Denies family history of GI issues
 
Physical Exam:
Vitals: 97.8, 148/81, 62, 20, 97%RA 
General: Alert, oriented, no acute distress 
HEENT: Sclera anicteric, MMM, oropharynx clear  
Neck: supple, JVP not elevated, no LAD  
Lungs: Clear to auscultation bilaterally, no wheezes, rales, 
ronchi  
CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, 
gallops  
Abdomen: soft, obese, ttp in RLQ, LLQ, no rebound or gaurding, 
no organomegaly   
GU: no foley  
Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or 
edema
Neuro: CNs2-12 intact, motor function grossly normal  
 
Pertinent Results:
Labs during Observation:
___ 06:05AM BLOOD WBC-6.4 RBC-4.68 Hgb-13.6* Hct-39.4* 
MCV-84 MCH-29.1 MCHC-34.5 RDW-13.5 Plt ___
___ 06:05AM BLOOD Glucose-87 UreaN-15 Creat-1.1 Na-136 
K-4.2 Cl-103 HCO3-24 AnGap-13
___ 06:05AM BLOOD Calcium-9.1 Phos-3.3 Mg-2.6
.
___ EGD:
Impression: Grade 1 esophagitis in the lower third of the 
esophagus
Erythema and congestion in the antrum compatible with gastritis 
(biopsy)
Granularity, erythema, congestion and nodularity in the duodenal 
bulb compatible with duodenitis (biopsy). Otherwise normal EGD 
to third part of the duodenum.
.
___ Colonoscopy:
Impression: Polyps in the rectum and transverse colon 
(polypectomy, polypectomy, endoclip, epinephrine injection). 
Diverticulosis of the sigmoid colon. Otherwise normal 
colonoscopy to cecum.
 

 
Brief Hospital Course:
Mr. ___ is a ___ year old male with past medical history 
significant for anxiety with noted gastritis, duodenitis per 
previous EGD in ___, who presented s/p Colonoscopy/EGD with 
abdominal pain, distension and kept overnight for observation.
.  
#Abdominal Pain/Gastritis/Duodenitis: Patient s/p 
EGD/Colonoscopy. Likely source of abdominal pain is from 
distension, gas from colonoscopy. Patient discussed with GI, low 
risk for perforation. Patient remained afebrile throughout stay. 
He did not exhibit any signs of nausea/vomiting. He had a 
previous MRCP on ___ without evidence of pancreatitis, or 
cholestasis. Patient was started on pantoprazole BID which he 
will continue as an outpatient. He was given simethicone to help 
with his distension, and pain control with oxycodone 5mg PRN and 
tylenol. He was started on a regular diet and tolerated this 
well prior to discharge. Patient has scheduled follow-up with 
his GI doctor within the next month. 
.
#Anxiety: Patient followed by psychiatrist as outpatient. He was 
continued on his lorazepam and zoloft home dose.
.
#Insomnia: Patient continued on home zolpidem.
.
TRANSITIONAL ISSUES:
1) Patient to follow up with his GI doctor in ___ month
2) Patient has scheduled follow up with PCP

 
___ on ___:
Sertraline 150 mg PO daily
Lorazepam 1 mg PO BID prn anxiety
Zolpidem 10 mg PO QHS prn insomnia
 
Discharge Medications:
1. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One 
(1) Tablet, Delayed Release (E.C.) PO twice a day.  
2. zolpidem 10 mg Tablet Sig: One (1) Tablet PO at bedtime as 
needed for insomnia.  
3. lorazepam 1 mg Tablet Sig: One (1) Tablet PO twice a day as 
needed for anxiety.  
4. sertraline 50 mg Tablet Sig: Three (3) Tablet PO DAILY 
(Daily).  
5. oxycodone 5 mg Tablet Sig: One (1) Tablet PO every ___ hours 
as needed for pain for 5 doses.
Disp:*5 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis: Gastritis, Duodenitis
Secondary Diagnosis: Anxiety

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___. You were admitted 
to the hospital for observation after your EGD and Colononscopy 
for abdominal pain. Your pain improved overnight with pain 
medications, and with a medication to control gas. 

MEDICATION CHANGES:
START Pantoprazole 40mg tab two times a day (Dr. ___ has 
requested prior authorization for this, if you can not obtain 
then please take omeprazole instead)
START Oxycodone 5mg as needed for abdominal pain every 4 to 6 
hours. Do not operate machinery, or drive while taking this 
medication. Can cause drowsiness.
Avoid taking aspirin,ibuprofen, motrin, or other 
anti-inflammatory medications known as (NSAIDS)

Recommendations to help with heartburn: Avoid chocolate, 
peppermint, alcohol, caffeine, onions, aspirin. Elevate the head 
of the bed 3 inches. Go to bed with an empty stomach.

Please follow-up with your PCP and GI as below.
 
Followup Instructions:
___
",MEDICINE
10006029-DS-15,Robert Bowman,10006029,29107716," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___
 
Chief Complaint:
anbormal lfts
 
Major Surgical or Invasive Procedure:
ERCP ___

 
History of Present Illness:
PRIMARY ONCOLOGIST: Dr ___ 
___: Metastatic clear cell renal cell carcinoma 
TREATMENT: ___, randomized to sunitinib 50 mg PO daily x 4
weeks followed by 2 weeks off. Dose reduced sunitinib to 37.5 mg
daily. Cycle 25, Week 1.
CHIEF COMPLAINT: Abnormal LFTs 

HISTORY OF PRESENT ILLNESS:
Mr. ___ is a pleasant ___ w/ ID-T2DM, HTN, DL, BPH, and
metastatic clear cell RCC, s/p radical L nephrectomy in ___,
found to have pulmonary, mediastinal, and hilar mets ___, now
on ___, randomized to sunitinib, dose-reduced, currently 2
weeks off sunitinib per protocol, who is directly admitted from
clinic for abnormal LFTs found on routine lab screening. 

He feels tired but has no localizing symptoms. He did not have
any F/C, no abd pain, no N/V. Appeared mildly lethargic today
after he took his Ativan today for anxiety related coming into
___. His family reported ___ episodes of confusion since his
last clinic visit. He states he's had greasy foods lately 
without
any n/v, no abd pain. He drinks a couple beers a week during his
weeks off sunitinib. No new meds. No apap/nsaids. No recent
travel. No camping. 

REVIEW OF SYSTEMS:
10 point ROS reviewed in detail and negative except for what is
mentioned above in HPI

 
Past Medical History:
PAST ONCOLOGIC HISTORY (per OMR):
-___: presented with acute onset of gross hematuria
accompanied with some mild flank pain. During his workup, he was
found to have a 4.8 cm mass on a CAT scan dated ___,
specifically the scan describes a left renal mass with internal
enhancement measuring 4.1 x 4.8 cm in size in the mid and upper
pole of the left kidney. Also described was the fat-containing
left inguinal hernia and left perinephric stranding. There was 
no
adenopathy or other suspicious lesions. There is also an old
sclerotic right ilial lesion and left sacral lesion. 
-___: underwent a laparoscopic hand assisted radical right
nephrectomy by Dr. ___ pathology showed a 
renal
cell carcinoma, clear cell type, ___ grade II/IV measuring 4
cm extending but not invading through the renal capsule or
Gerota's fascia margins were questionably positive at the renal
vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the 
renal
vein margin. A background of global glomerulosclerosis is
described. Overall, this was a T3bNxMx lesion. Postoperative
imaging on ___ which was a CT torso showed no evidence of
recurrent or metastatic disease.
-___: CT chest showed interval increase in prominence of
mediastinal lymph nodes and minimal interval increase in 
multiple
b/l pulmonary nodules, concerning for progression
-___: Fine needle aspirate of 11R and 11L lymph nodes, which
was consistent with metastatic RCC
-___: CT Torso - mediastinal and hilar nodes and pulmonary
lesions increased in size. No definite intra-abdominal sites of
disease 
-___: C1D1 ___, randomized to sunitinib
-___: Multiple grade ___ adverse events including
thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 
2;
WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1;
elevated at baseline), elevated ALT (grade 1), and 
hypothyroidism
(grade 1). Mild symptoms with treatment. Continued sunitinib at
50mg daily per protocol.
-___: CT Torso: Response of mediastinal lymphadenopathy,
bilateral hilar lymphadenopathy, and numerous parenchymal
metastases. Stable disease by RECIST (decrease 19.1% from
baseline).
-___: Sunitinib reduced to 37.5 mg daily due to erythematous
rash and blistering on palms and sole of right foot.
-___: CT Torso: Decrease in pulmonary and mediastinal
lesions. Stable disease by RECIST 1.1 (decrease 22.5% from
baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
39.8% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
46.3% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease 
40.3%
from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
42.6% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
47.7% from baseline).
-___: CT torso: Ongoing partial response comments: No
significant change compared to prior scan. No new lesions. 
-___: CT Torso: PR by RECIST 1.1 
-___: CT Torso: PR by RECIST 1.1: -54.22% change from
baseline and -10.29% change from last scan. 
-___: CT Torso:  partial response: -57.79% from baseline,
-7.79% from nadir
-___: CT Torso shows continued partial response, no
significant change compared to prior

PAST MEDICAL HISTORY (per OMR):
1. Clear cell kidney cancer as above.
2. Benign prostatic hypertrophy.
3. Diabetes mellitus.
4. Hypertension.
5. Hyperlipidemia.
6. History of anxiety.

 
Social History:
___
Family History:
Mother: Died of rectal/colon cancer.
Father: No cancers, history of diabetes.
Other: He has a sister with ovarian cancer diagnosed at age ___
and a brother with liver cancer at age ___ and another brother
with hairy cell leukemia, which is in remission.
 
Physical Exam:
VITAL SIGNS: 97.5 PO 160 / 89 R Sitting 71 18 99 ra
General:  NAD, Resting in bed comfortably with daughter at 
bedside 
___:  MMM, no OP lesions, no cervical/supraclavicular
adenopathy, no icterus
CV:  RR, NL S1S2 no S3S4 No MRG
PULM:  CTAB, No C/W/R, No respiratory distress
ABD:  BS+, soft, NTND, no palpable masses or HSM
LIMBS: WWP, trace b/l pitting edema at the distal ___, no tremors
SKIN:  No rashes on the extremities
NEURO:  Grossly normal, speech clear, AOx3
ACCESS: No port
 
Pertinent Results:
___ 06:55AM BLOOD WBC-3.9* RBC-3.12* Hgb-10.5* Hct-33.5* 
MCV-107* MCH-33.7* MCHC-31.3* RDW-16.8* RDWSD-65.9* Plt ___
___ 07:25AM BLOOD WBC-3.0* RBC-3.03* Hgb-10.2* Hct-32.2* 
MCV-106* MCH-33.7* MCHC-31.7* RDW-16.9* RDWSD-66.0* Plt ___
___ 11:30AM BLOOD WBC-3.6* RBC-3.21* Hgb-10.8* Hct-34.9* 
MCV-109* MCH-33.6* MCHC-30.9* RDW-17.0* RDWSD-68.3* Plt ___
___ 06:55AM BLOOD Glucose-121* UreaN-14 Creat-1.2 Na-147 
K-4.5 Cl-106 HCO3-27 AnGap-14
___ 07:25AM BLOOD Glucose-204* UreaN-18 Creat-1.3* Na-140 
K-4.3 Cl-103 HCO3-25 AnGap-12
___ 11:30AM BLOOD UreaN-19 Creat-1.4* Na-139 K-5.3 Cl-101
___ 06:55AM BLOOD ALT-101* AST-47* LD(___)-239 AlkPhos-188* 
TotBili-1.5 DirBili-0.7* IndBili-0.8
___ 09:45PM BLOOD ALT-123* AST-57* LD(LDH)-274* CK(CPK)-106 
AlkPhos-241* TotBili-2.3*
___ 11:30AM BLOOD ALT-133* AST-71* LD(___)-289* 
AlkPhos-259* Amylase-210* TotBili-3.0* DirBili-1.8* IndBili-1.2
___ 09:45PM BLOOD cTropnT-<0.01
___ 11:30AM BLOOD Lipase-252*
___ 06:55AM BLOOD Lipase-63*
___ 06:55AM BLOOD Albumin-3.7 Calcium-9.3 Phos-3.7 Mg-2.0
___ 09:45PM BLOOD calTIBC-306 VitB12-356 Folate->20 
___ Ferritn-597* TRF-235
___ 09:45PM BLOOD Triglyc-207* HDL-30* CHOL/HD-4.7 
LDLcalc-70
___ 11:30AM BLOOD Free T4-1.2
___ 09:45PM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG
___ 09:45PM BLOOD Smooth-NEGATIVE
___ 09:45PM BLOOD ___
___ 09:45PM BLOOD IgG-666* IgA-165 IgM-120
___ 09:45PM BLOOD HCV Ab-NEG
___ 09:46PM BLOOD Lactate-0.7
___ 11:30AM BLOOD FREE T3-Test      
___ 11:30AM BLOOD Free T4-1.2
 
Brief Hospital Course:
IMAGING: 

RUQ US ___: 
1. Biliary sludge without evidence of gallbladder-wall 
thickening
or intrahepatic biliary dilatation. 
2. No evidence of focal liver lesions

MRCP ___:
1. Moderate intra and extrahepatic biliary ductal dilatation 
with
duct penetrating sign suggestive of inflammatory rather than
neoplastic stricture. Correlation with ERCP may be considered. 
No
evidence of choledocholithiasis or definite obstructing mass. 2.
Short-segment (11 mm) eccentric filling defect within the main
portal vein, suspicious for nonocclusive thrombus. 3. Sludge
within the gallbladder lumen. 4. Status post left nephrectomy
with stable soft tissue within the left nephrectomy bed. 5.
Multiple pancreatic cystic lesions, likely small side branch
IPMNs, measuring up to 10 mm.

ASSESSMENT AND PLAN:
___ w/ ID-T2DM, HTN, DL, BPH, and metastatic clear cell RCC, s/p
radical L nephrectomy in ___, found to have pulmonary,
mediastinal, and hilar mets ___, now on ___, randomized 
to
sunitinib, dose-reduced, currently 2 weeks off sunitinib per
protocol, who is directly admitted from clinic for abnormal LFTs
found on routine lab screening. 

# Elevated LFTs
Non-specific elevations. US did not reveal any focal lesions nor
any biliary dilatation nor stones. Lipase elevated at 252 but in
absence of any abd pain, unlikely pancreatitis. Unlikely
sunitinib effect per oncology. Pt did appear to be lethargic per
oncologist but is AOx3 and no asterixis, but cannot rule out 
some
element of encephalopathy. Found on MRCP to have moderate
intra/extrahepatic biliary ductal dilatation suggestive of
stricture. Hepto wnl and anemia stable, so unlikely hemolysis.
SPEP largely wnl.  

ERCP on ___ revealed stricture in bile duct and had plastic 
biliary
stent placed. He tolerated procedure well. Had no infectious 
symptoms
nor any signs of post-ercp pancreatitis. He was advanced to full 
diet 
and instructed to f/u with oncology for the results of the 
brushings 
done during ERCP. Their team will coordinate a repeat ERCP in 4 
wks. 

# Portal Vein THrombus
MRCP revealed a small non-occlusive filling defect within the
main portal vein suspicious for thrombus. Due to risk of 
progression,
patient was started on once daily dosing lovenox at 1.5 mg/kg.
Due to sphincterotomy during the ERCP, patient was instructed to 

wait 5 days after ercp to start the lovenox. He was provided 
teaching
on how to inject and warning signs while he was here.

# Pancreatic cysts 
Found on MRCP, per radiology, felt to be to be small side branch
Intraductal papillary mucinous neoplasm. 
- f/u in ___ year

# ___
CT scans from ___ revealed partial response to sunitinib. 
- sunitinib is currently on hold
- will f/u w/ Dr ___ 

# Macrocytic Anemia
Chronic and at baseline. TSH WNL as well as VIt B12, Folate,
spep, and ferritin/TIBC.

# Depressed mood/anxiety
- hold cariprazine ___ lfts
- cont fluoxetine

# T2DM: cont home insulin, glipizide 
# HTN: cont amlodipine, atenolol, lisinopril
# DL: hold statin/fibrate
# CKD: cr baseline 
# Hypothyroidism: cont levothyroxine (TSH WNL)
# BPH: cont flomax

FEN: Regular low fat diabetic diet
DVT PROPHYLAXIS: HSQ
ACCESS: PIV 
CODE STATUS: Full code, presumed
PCP: ___, MD
DISPO: Home w/o services
BILLING: 45 min spent coordinating care for discharge
________________
___, D.O.
Heme/Onc Hospitalist
p: ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY 
2. Atenolol 100 mg PO DAILY 
3. cariprazine 1.5 mg oral DAILY 
4. Fenofibrate 48 mg PO DAILY 
5. FLUoxetine 20 mg PO DAILY 
6. Gabapentin 100 mg PO DAILY 
7. GlipiZIDE 2.5 mg PO BID 
8. Lantus Solostar U-100 Insulin (insulin glargine) ___ units 
subcutaneous QPM 
9. Levothyroxine Sodium 100 mcg PO DAILY 
10. LORazepam 0.5 mg PO DAILY:PRN anxiety 
11. Ondansetron 4 mg PO Q8H:PRN nausea 
12. Prochlorperazine 5 mg PO Q8H:PRN nausea 
13. Simvastatin 40 mg PO QPM 
14. Tamsulosin 0.4 mg PO QHS 
15. Ascorbic Acid ___ mg PO DAILY 
16. Vitamin D 5000 UNIT PO DAILY 
17. Omeprazole 20 mg PO DAILY 
18. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry 
eyes 
19. Lisinopril 40 mg PO DAILY 

 
Discharge Medications:
1.  Enoxaparin Sodium 120 mg SC DAILY 
Start: Future Date - ___, First Dose: First Routine 
Administration Time 
RX *enoxaparin 120 mg/0.8 mL 120 mg sc daily Disp #*30 Syringe 
Refills:*0 
2.  amLODIPine 10 mg PO DAILY  
3.  Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry 
eyes  
4.  Ascorbic Acid ___ mg PO DAILY  
5.  Atenolol 100 mg PO DAILY  
6.  cariprazine 1.5 mg oral DAILY  
7.  FLUoxetine 20 mg PO DAILY  
8.  Gabapentin 100 mg PO DAILY  
9.  GlipiZIDE 2.5 mg PO BID  
10.  Lantus Solostar U-100 Insulin (insulin glargine) ___ 
units subcutaneous QPM  
11.  Levothyroxine Sodium 100 mcg PO DAILY  
12.  Lisinopril 40 mg PO DAILY  
13.  LORazepam 0.5 mg PO DAILY:PRN anxiety  
14.  Omeprazole 20 mg PO DAILY  
15.  Ondansetron 4 mg PO Q8H:PRN nausea  
16.  Prochlorperazine 5 mg PO Q8H:PRN nausea  
17.  Tamsulosin 0.4 mg PO QHS  
18.  Vitamin D 5000 UNIT PO DAILY  
19. HELD- Fenofibrate 48 mg PO DAILY  This medication was held. 
Do not restart Fenofibrate until discussed with your oncologist
20. HELD- Simvastatin 40 mg PO QPM  This medication was held. Do 
not restart Simvastatin until discussed with your oncologist

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Biliary Stricture
Portal Vein Thrombus

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___

___ were admitted to the hospital because ___ had abnormal liver 
enzymes. MRI of your liver (MRCP) revealed a narrowing in your 
bile duct, also known as a stricture. ___ had an ERCP (endoscopy 
and a camera into your bile duct) which confirmed a stricture. 
These improved after ___ had an ERCP. ___ had a plastic stent 
placed in your bile duct and ___ tolerated this well. Your liver 
enzymes are already improving. ERCP team will call ___ to 
schedule another ERCP in 4 weeks or so to possibly remove the 
stent. ___ will follow up on the biopsy results with your 
oncology team. ___ were also found to have a clot in one of your 
veins (portal vein) which will need to be treated with a blood 
thinner. ___ will start this ___. Call your oncology team if 
there are any issues or questions. 

Regards,
Your ___ team
 
Followup Instructions:
___
",MEDICINE
10006029-DS-16,Robert Bowman,10006029,27104518," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___.
 
Chief Complaint:
Fatigue
 
Major Surgical or Invasive Procedure:
___: ERCP and EUS
 
History of Present Illness:
Mr. ___ is a ___ male with IDDM, HTN, BPH,
and clear cell RCC s/p radical L nephrectomy (___) metastatic 
to
the lungs, mediastinum, and hilum currently on chemotherapy
(experimental trial; on sunitinib), with recent admission
(___) for biliary stricture s/p ERCP with plastic stent
placement (CBD brushing cytology non-diagnostic) and
non-occlusive portal vein thrombus started on enoxaparin who
presented to the ED with fever, jaundice, and confusion.

The CBD brushing cytology from his prior admission was
non-diagnostic. His imaging was reviewed at multidisciplinary
pancreas conference and no mass lesion was visualized in the 
head
of the pancreas but there was some peripancreatic stranding
around the head of the pancreas noted. There was some concern 
for
a potential primary pancreatobiliary tumor (rather than rare RCC
metastasis to pancreas), so he was planned for a repeat ERCP and
EUS in ___ weeks (planned for the week of ___ off sunatinib).

He last followed up in ___ clinic with Dr. ___ on 
___.
He was complaining of a week of increased fatigue, nausea, and
poor PO intake. His sunatinib was held due to concern for side
effects. Over the past week since then, he has had worsening
jaundice and fatigue. Last night, he developed chills,
restlessness, mild confusion, and fevers to 101, which prompted
his wife to bring him to ___. He was
transferred from there to the ___ ED.

Right now, he feels ok, just a little tired. He feels like his
thinking is foggy. No fevers/chills since he presented to the
hospital. No nausea, vomiting, abdominal pain. He has had loose
stools, which he associates with the sunatinib. No bloody, 
black,
or ___ stools. His urine has been ""tea colored."" He has
had poor appetite. No chest pain, shortness of breath, or
palpitations. 

ED COURSE:
VS: Tmax 98.6, HR ___, BP 100s-110s/60s, RR 16, SpO2 98-100%
on RA
Labs: WBC 3.4, AST/ALT 71/97, AP 214, Tbili 7.6, lipase 148,
lactate 1.4
Exam: jaundiced, abdomen benign, guaiac negative brown stool
Imaging: RUQ US: persistent left intrahepatic biliary dilation,
persistent GB sludge
Interventions: None

ROS: Pertinent positives and negatives as noted in the HPI.  All
other systems were reviewed and are negative. 
 
Past Medical History:
PAST ONCOLOGIC HISTORY (per OMR):
-___: presented with acute onset of gross hematuria
accompanied with some mild flank pain. During his workup, he was
found to have a 4.8 cm mass on a CAT scan dated ___,
specifically the scan describes a left renal mass with internal
enhancement measuring 4.1 x 4.8 cm in size in the mid and upper
pole of the left kidney. Also described was the fat-containing
left inguinal hernia and left perinephric stranding. There was 
no
adenopathy or other suspicious lesions. There is also an old
sclerotic right ilial lesion and left sacral lesion. 
-___: underwent a laparoscopic hand assisted radical right
nephrectomy by Dr. ___ pathology showed a 
renal
cell carcinoma, clear cell type, ___ grade II/IV measuring 4
cm extending but not invading through the renal capsule or
Gerota's fascia margins were questionably positive at the renal
vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the 
renal
vein margin. A background of global glomerulosclerosis is
described. Overall, this was a T3bNxMx lesion. Postoperative
imaging on ___ which was a CT torso showed no evidence of
recurrent or metastatic disease.
-___: CT chest showed interval increase in prominence of
mediastinal lymph nodes and minimal interval increase in 
multiple
b/l pulmonary nodules, concerning for progression
-___: Fine needle aspirate of 11R and 11L lymph nodes, which
was consistent with metastatic RCC
-___: CT Torso - mediastinal and hilar nodes and pulmonary
lesions increased in size. No definite intra-abdominal sites of
disease 
-___: C1D1 ___, randomized to sunitinib
-___: Multiple grade ___ adverse events including
thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 
2;
WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1;
elevated at baseline), elevated ALT (grade 1), and 
hypothyroidism
(grade 1). Mild symptoms with treatment. Continued sunitinib at
50mg daily per protocol.
-___: CT Torso: Response of mediastinal lymphadenopathy,
bilateral hilar lymphadenopathy, and numerous parenchymal
metastases. Stable disease by RECIST (decrease 19.1% from
baseline).
-___: Sunitinib reduced to 37.5 mg daily due to erythematous
rash and blistering on palms and sole of right foot.
-___: CT Torso: Decrease in pulmonary and mediastinal
lesions. Stable disease by RECIST 1.1 (decrease 22.5% from
baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
39.8% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
46.3% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease 
40.3%
from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
42.6% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
47.7% from baseline).
-___: CT torso: Ongoing partial response comments: No
significant change compared to prior scan. No new lesions. 
-___: CT Torso: PR by RECIST 1.1 
-___: CT Torso: PR by RECIST 1.1: -54.22% change from
baseline and -10.29% change from last scan. 
-___: CT Torso:  partial response: -57.79% from baseline,
-7.79% from nadir
-___: CT Torso shows continued partial response, no
significant change compared to prior

PAST MEDICAL HISTORY (per OMR):
1. Clear cell kidney cancer as above.
2. Benign prostatic hypertrophy.
3. Diabetes mellitus.
4. Hypertension.
5. Hyperlipidemia.
6. History of anxiety.

 
Social History:
___
Family History:
Colorectal cancer - mother
___ cancer - sister (dx at age ___
Liver cancer - brother
___ cell leukemia - brother
___ - father

 
Physical ___:
ADMISSION EXAM:
VITALS: T 97.6, HR 68, BP 115/76, RR 16, SpO2 98% on RA
___: Alert, NAD, breathing room air comfortably
EYES: Icteric sclera, PERRL
ENT: MMM, sublingual jaundice, OP clear
CV: NR/RR, no m/r/g
RESP: CTAB, no wheezes, crackles, or rhonchi
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel
sounds present.  No HSM.
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: Jaundiced
NEURO: Alert, oriented to hospital, city, date; able to recite
the days of the week backwards, face symmetric, gaze conjugate
with EOMI, speech fluent, moves all limbs
PSYCH: pleasant, appropriate affect

DISCHARGE EXAM:
T 97.9, HR 70, BP 143/79, RR 18, SpO2 97% on RA
___: Alert, NAD, breathing room air comfortably
EYES: Icteric sclera
ENT: MMM, OP clear
CV: NR/RR, no m/r/g
RESP: CTAB, no wheezes, crackles, or rhonchi
GI: Abdomen soft, non-distended, non-tender to palpation.  Bowel
sounds present.
MSK: Neck supple, moves all extremities, strength grossly full
and symmetric bilaterally in all limbs
SKIN: Jaundiced (but improved)
NEURO: Alert, oriented, face symmetric, gaze conjugate with 
EOMI, speech fluent, moves all limbs
PSYCH: pleasant, appropriate affect
 
Pertinent Results:
ADMISSION LABS:
___ 05:43AM BLOOD WBC-3.4* RBC-2.48* Hgb-8.4* Hct-24.9* 
MCV-100* MCH-33.9* MCHC-33.7 RDW-16.8* RDWSD-61.6* Plt ___
___ 05:43AM BLOOD Glucose-95 UreaN-24* Creat-1.5* Na-138 
K-4.4 Cl-106 HCO3-18* AnGap-14
___ 05:55AM BLOOD Albumin-2.5* Calcium-8.1* Phos-3.5 Mg-1.9 
Iron-18*
___ 05:43AM BLOOD Albumin-2.8*
___ 05:55AM BLOOD calTIBC-160* Hapto-230* Ferritn-990* 
TRF-123*
___ 05:43AM BLOOD ALT-97* AST-71* AlkPhos-214* TotBili-7.6* 
DirBili-5.6* IndBili-2.0

MICRO:
BCx ___: NGTD
Blood culture (___):
STREPTOCOCCUS ANGINOSUS (___) GROUP
                             |   
CEFTRIAXONE-----------   0.5 S
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.12 S
PENICILLIN G----------<=0.06 S
VANCOMYCIN------------   0.5 S

PATHOLOGY/CYTOLOGY:
Biliary mass biopsy (___): Minute fragment of highly 
atypical cells with sclerotic stroma consistent with 
adenocarcinoma
Common bile duct stricture brushings (___):
POSITIVE FOR MALIGNANT CELLS. - Adenocarcinoma.

IMAGING:
RUQ US (___):
IMPRESSION: 
1. Persistent mild left intrahepatic biliary dilation in 
presence
of a partially visualized CBD stent raises concern for stent
malfunction.  Compared to the prior ultrasound, the degree of
intrahepatic biliary dilation has not changed significantly. 
2. Persistent gallbladder sludge. 

ERCP ___:
removal of the old stent and placement of a new stent over a 2cm 
malignant-appearing stricture
of the distal CBD. Cytology brushings were sampled.

EUS ___:
1.8 x 1.1 cm ill-defined hypoechoic area around the distal CBD. 
FNB was performed x3

CT torso ___:
IMPRESSION: 
Non obstructive pneumonia, left upper lobe.
Minimal residual pulmonary edema and pleural effusions 
attributable to heart failure.
Atherosclerotic coronary calcification.
Left PICC line ends just above the superior cavoatrial junction.
IMPRESSION:
1. No evidence of local recurrence or metastatic disease in the 
abdomen and
pelvis.
2. Mild intrahepatic and extrahepatic biliary ductal dilatation, 
with CBD
stent in place.
3. Known nonocclusive main portal vein thrombus appears 
increased in size,
though difficult to directly compare to MR due to differences in 
imaging
technique.

ERCP ___: Biliary plastic stent removed with a snare. A 
metal stent was placed over 2cm long malignant appearing 
stricture in the distal CBD. 

TTE ___:
IMPRESSION: Adequate image quality. Mild symmetric left 
ventricular hypertrophy with normal cavity size and 
regional/global left ventricular systolic function. No 2D 
echocardiographic evidence for endocarditis. If clinically 
suggested, the absence of a discrete vegetation on 
echocardiography does not exclude the diagnosis of endocarditis.

 
Brief Hospital Course:
SUMMARY/ASSESSMENT:   
Mr. ___ is a ___ male with IDDM, HTN, BPH, and 
metastatic clear cell RCC s/p radical L nephrectomy (___) on 
chemotherapy (sunitinib), with recent admission (___) for 
biliary stricture s/p ERCP with plastic stent placement (CBD 
brushing cytology non-diagnostic) and non-occlusive portal vein 
thrombus started on enoxaparin who presented to the ED with 
fever, jaundice, and confusion, found to have persistent 
intrahepatic biliary dilation and gallbladder sludge on ___ US 
s/p ERCP x2 with placement of plastic, then metal biliary stent 
and EUS with pathology from FNB of CBD mass consistent with new 
pancreatobiliary adenocardinoma. 

ACUTE/ACTIVE PROBLEMS:
# Cholangitis
# Strep spp. (likely Enterococcus) bacteremia
# Adenocarcinoma pancreaticobiliary origin
He presented with fever, jaundice, and mental status changes. 
RUQ US also showed persistent left intrahepatic biliary dilation 
and gallbladder sludge despite the presence of CBD stent, 
suggesting that the stent was non-functioning/occluded or there 
was some other source of obstruction. The CBD brushing cytology 
from his prior ERCP was non-diagnostic. He had no apparent mass 
in the head of the pancreas on imaging but there remained some 
concern for a primary pancreatobiliary tumor so he was planned 
to have a repeat ERCP and EUS the week he was admitted.
Blood culture at ___ is growing Strep spp. He was treated with 
Unasyn for cholangitis as well as Strep bacteremia. BCx here 
grew Strep anginosus. He had an ERCP on ___ with removal of the 
old stent and placement of a new stent over a 2cm 
malignant-appearing stricture of the distal CBD. Cytology 
brushings were sampled. EUS was completed on which they 
visualized a 1.8 x 1.1 cm ill-defined hypoechoic area around the 
distal CBD. FNB was performed x3. Pathology was consistent with 
adenocarcinoma.  
After the plastic stent placement, his LFTs did not improve and 
bilirubin continued to rise. A repeat ERCP was done on ___ with 
removal of the plastic stent and placement of a metal stent. 
After this, his LFTs started to improve. His Unasyn was changed 
to ceftriaxone and metronidazole for ease of dosing to complete 
a 2 week course ___ - ___. A PICC was placed prior to 
discharge. TTE did not show evidence of endocarditis.

# ___ on CKD
Cr peaked at 1.8 from baseline 1.2. Most likely this was 
prerenal in the setting of cholangitis. It improved after ERCP, 
antibiotics, and fluid resuscitation. 

# PVT
He was found to have a non-occlusive portal vein thrombus on 
MRCP during his recent hospital admission and was started on 
enoxaparin. HIs home enoxaparin was initially held for ERCP, 
then resumed. 

# Macrocytic anemia
Macrocytic anemia is chronic. Baseline H/H appears to be ___, 
so he is lower than baseline. He had no signs of bleeding.  
Recent TSH, folate, B12, ferritin, and TIBC were wnl. Bilirubin 
is predominantly direct, so less likely hemolysis. Other 
hemolysis labs were not consistent with hemolysis. Acute on 
chronic anemia is perhaps ___ bone marrow suppression from 
sepsis. He was given 1 unit pRBCs for Hgb 7.6. 

# Metastatic clear cell RCC on chemotherapy
He is followed at ___ by Dr. ___. He was diagnosed in 
___ in workup of gross hematuria and flank pain. He underwent a 
laparoscopic radical right nephrectomy in ___. He was found 
to have metastases to the lungs, mediastinal lymph nodes, and 
hilar lymph nodes in ___. In ___ he was enrolled in an 
experimental trial and started on sunatinib. His most recent CT 
showed clinical response. He is currently in his regularly
scheduled two weeks off on sunatinib. He had a surveillance CT 
on ___ which showed  no evidence of local recurrence of 
metastatic disease in the abdomen/pelvis. 

# LUL pneumonia
He was found to have LUL opacity on CT chest ordered for 
surveillance. He was also complaining of cough. He was on Unasyn 
while inpatient, then transitioned to ceftriaxone and 
metronidazole for 2 weeks total, which should cover him for 
pneumonia.

# HTN
Initially his home atenolol dose was halved due to concern for 
cholangitis/impending sepsis. His home amlodipine 10 mg and 
lisinopril 40 mg daily were also initially held. These were 
resumed prior to or at discharge. 

# Insulin-dependent DM type II
At home he takes glargine 16 units qhs if his FSBG is <170 and 
he takes 18 units qhs if his FBSG is >170. While inpatient, he 
was given glaring 8 units qhs as he was not taking much PO as 
well as lispro SSI. 

CHRONIC/STABLE PROBLEMS:
# Hypothyroidism - continued home levothyroxine

# Depression and anxiety - continued home fluoxetine; held home
cariprazine as it is non-formulary

Mr. ___ is clinically stable for discharge. The total time 
spent today on discharge planning, counseling and coordination 
of care was greater than 30 minutes.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Enoxaparin Sodium 120 mg SC DAILY 
Start: ___, First Dose: Next Routine Administration Time 
2. amLODIPine 10 mg PO DAILY 
3. Ascorbic Acid ___ mg PO DAILY 
4. Atenolol 100 mg PO DAILY 
5. cariprazine 1.5 mg oral DAILY 
6. FLUoxetine 20 mg PO DAILY 
7. Gabapentin 100 mg PO BID 
8. GlipiZIDE 2.5 mg PO BID 
9. Glargine 16 Units Bedtime
10. Levothyroxine Sodium 100 mcg PO DAILY 
11. Lisinopril 40 mg PO DAILY 
12. LORazepam 0.5 mg PO DAILY:PRN anxiety 
13. Omeprazole 20 mg PO DAILY 
14. Ondansetron 4 mg PO Q8H:PRN nausea 
15. Prochlorperazine 5 mg PO Q8H:PRN nausea 
16. Tamsulosin 0.4 mg PO QHS 
17. Vitamin D 5000 UNIT PO DAILY 
18. Multivitamins 1 TAB PO DAILY 
19. Fenofibrate 48 mg PO DAILY 

 
Discharge Medications:
1.  CefTRIAXone 2 gm IV Q24H 
RX *ceftriaxone in dextrose,iso-os 2 gram/50 mL 2 gm IV once a 
day Disp #*9 Intravenous Bag Refills:*0 
2.  MetroNIDAZOLE 500 mg PO Q8H 
RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8) 
hours Disp #*27 Tablet Refills:*0 
3.  Glargine 16 Units Bedtime 
4.  amLODIPine 10 mg PO DAILY  
5.  Ascorbic Acid ___ mg PO DAILY  
6.  Atenolol 100 mg PO DAILY  
7.  cariprazine 1.5 mg oral DAILY  
8.  Enoxaparin Sodium 120 mg SC DAILY 
Start: ___, First Dose: Next Routine Administration Time  
9.  Fenofibrate 48 mg PO DAILY  
10.  FLUoxetine 20 mg PO DAILY  
11.  Gabapentin 100 mg PO BID  
12.  GlipiZIDE 2.5 mg PO BID  
13.  Levothyroxine Sodium 100 mcg PO DAILY  
14.  Lisinopril 40 mg PO DAILY  
15.  LORazepam 0.5 mg PO DAILY:PRN anxiety  
16.  Multivitamins 1 TAB PO DAILY  
17.  Omeprazole 20 mg PO DAILY  
18.  Ondansetron 4 mg PO Q8H:PRN nausea  
19.  Prochlorperazine 5 mg PO Q8H:PRN nausea  
20.  Tamsulosin 0.4 mg PO QHS  
21.  Vitamin D 5000 UNIT PO DAILY  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___ Diagnosis:
Cholangitis 
Bacteremia 
Adenocarcinoma 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were admitted to the hospital after you were found to have a 
blockage of your bile ducts causing a serious infection called 
cholangitis. You were also found to have bacteria in your blood 
stream.  You underwent an ERCP with a plastic stent placed. 
After the procedure your bilirubin continued to rise and you 
underwent a second ERCP to place a metal stent. 

For your serious infection you were started on IV antibiotics 
and will need to continue this for two weeks. 

This blockage in the bile duct was caused by a stricture. 
Samples of the stricture were taken and found to be cancer 
(adenocarcinoma). You were seen by the oncology team and have 
follow up with them in a few days to talk about treatment 
options. 

It was a pleasure caring for you,
Your ___ Team 
 
Followup Instructions:
___
",MEDICINE
10006029-DS-17,Robert Bowman,10006029,20850584," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
___
 
Attending: ___
 
Chief Complaint:
Hypotension, ___ on CKD
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
Mr. ___ is a ___ male with history metastatic
RCC, locally advanced cholangiocarcinoma s/p six months of
gemcitabine and cisplatin, and recent diagnosis of pancreatic
acinar cell carcinoma receiving liposomal irinotecan and
___ who presents with hypotension and acute on
chronic renal failure.

He reports that he checks his blood pressure using a machine at
home every morning. His BP this morning was 79/44 about 15
minutes after taking amlodipine, atenolol, and lisinopril. This
was associated with dizziness. Later in the morning repeat check
was 110/70. He notes decreased appetite. He had one loose small
bowel movement yesterday but otherwise no diarrhea.

He presented to clinic for follow-up His vitals were Temp 97.3,
BP 125/58, HR 72, RR 16, and O2 sat 100% RA. Labs were notable
for Cr 2.7 from baseline Cr 1.7-1.8. He was given 2L NS and
referred for direct admission to 11 ___.

On arrival to the floor, patient reports shortness of breath 
with
exertion, mild nausea without vomiting, and tingling in his
hands. He denies fevers/chills, night sweats, headache, vision
changes, weakness, cough, hemoptysis, chest pain, palpitations,
abdominal pain, nausea/vomiting, hematemesis,
hematochezia/melena, dysuria, hematuria, and new rashes.

REVIEW OF SYSTEMS: A complete 10-point review of systems was
performed and was negative unless otherwise noted in the HPI.

PAST ONCOLOGIC HISTORY:
- ___: Presented with acute onset of gross hematuria
accompanied with some mild flank pain. During his workup, he was
found to have a 4.8 cm mass on a CAT scan dated ___,
specifically the scan describes a left renal mass with internal
enhancement measuring 4.1 x 4.8 cm in size in the mid and upper
pole of the left kidney. Also described was the fat-containing
left inguinal hernia and left perinephric stranding. There was 
no
adenopathy or other suspicious lesions. There is also an old
sclerotic right ilial lesion and left sacral lesion.  
- ___: Underwent a laparoscopic hand assisted radical right
nephrectomy by Dr. ___ pathology showed a 
renal
cell carcinoma, clear cell type, ___ grade II/IV measuring 4
cm extending but not invading through the renal capsule or
Gerota's fascia margins were questionably positive at the renal
vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the 
renal
vein margin. A background of global glomerulosclerosis is
described. Overall, this was a T3bNxMx lesion. Postoperative
imaging on ___ which was a CT torso showed no evidence of
recurrent or metastatic disease.
- ___: CT chest showed interval increase in prominence of
mediastinal lymph nodes and minimal interval increase in 
multiple
b/l pulmonary nodules, concerning for progression
- ___: Fine needle aspirate of 11R and 11L lymph nodes, 
which
was consistent with metastatic RCC
- ___: CT Torso - mediastinal and hilar nodes and pulmonary
lesions increased in size. No definite intra-abdominal sites of
disease 
- ___: C1D1 ___, randomized to sunitinib
- ___: Multiple grade ___ adverse events including
thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 
2;
WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1;
elevated at baseline), elevated ALT (grade 1), and 
hypothyroidism
(grade 1). Mild symptoms with treatment. Continued sunitinib at
50mg daily per protocol.
- ___: CT Torso: Response of mediastinal lymphadenopathy,
bilateral hilar lymphadenopathy, and numerous parenchymal
metastases. Stable disease by RECIST (decrease 19.1% from
baseline).
- ___: Sunitinib reduced to 37.5 mg daily due to 
erythematous
rash and blistering on palms and sole of right foot.
- ___: CT Torso: Decrease in pulmonary and mediastinal
lesions. Stable disease by RECIST 1.1 (decrease 22.5% from
baseline).
- ___: CT Torso: Partial response by RECIST 1.1 (decrease
39.8% from baseline).
- ___: CT Torso: Partial response by RECIST 1.1 (decrease
46.3% from baseline).
- ___: CT Torso: Partial response by RECIST 1.1 (decrease
40.3% from baseline).
- ___: CT Torso: Partial response by RECIST 1.1 (decrease
42.6% from baseline).
- ___: CT Torso: Partial response by RECIST 1.1 (decrease
47.7% from baseline).
- ___: CT torso: Ongoing partial response comments: No
significant change compared to prior scan. No new lesions. 
- ___: CT Torso: PR by RECIST 1.1 
- ___: CT Torso: PR by RECIST 1.1: -54.22% change from
baseline and -10.29% change from last scan. 
-___: CT Torso: Partial response: -57.79% from baseline,
-7.79% from nadir
- ___: CT Torso shows continued partial response, no
significant change compared to prior
- ___: C25D1 held, admitted for biliary stricture
- ___: Resumed cycle 25 day 1
- ___: Admitted for biliary stricture and
cholangitis, diagnosed with pancreatobiliary adenocarcinoma and
taken off study. ERCP x2 with placement of plastic, then metal
biliary stent. EUS/biopsy of CBD mass showed new 
pancreatobiliary
adenocardinoma. 
- ___: C1D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: C2D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: C3D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: CT torso showed stable disease 
- ___: C4D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: C5D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 D1,___: MR liver showed ongoing inoperable disease but
stable
- ___: C6D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 
D1,15
dose modified for low counts
- ___: CT torso showed stable disease
- ___: C7D1 Gemcitabine 1000mg/m2 Cisplatin 25 mg/m2 
D1,15

- ___: C8D1 Gemcitabine 1000mg/m2 Cisplatin 18.75 mg/m2
D1,15 reduced for CKD
- ___: CT torso showed possible liver lesion and
pancreatic lesion. Biopsy of liver lesion suggests poorly
differentiated carcinoma. Biopsy of pancreas lesion suggests
acinar cell carcinoma.
- ___: C1D1 nanoliposomal irinotecan / ___ / leucovorin
___ I)

 
Past Medical History:
PAST ONCOLOGIC HISTORY (per OMR):
-___: presented with acute onset of gross hematuria
accompanied with some mild flank pain. During his workup, he was
found to have a 4.8 cm mass on a CAT scan dated ___,
specifically the scan describes a left renal mass with internal
enhancement measuring 4.1 x 4.8 cm in size in the mid and upper
pole of the left kidney. Also described was the fat-containing
left inguinal hernia and left perinephric stranding. There was 
no
adenopathy or other suspicious lesions. There is also an old
sclerotic right ilial lesion and left sacral lesion. 
-___: underwent a laparoscopic hand assisted radical right
nephrectomy by Dr. ___ pathology showed a 
renal
cell carcinoma, clear cell type, ___ grade II/IV measuring 4
cm extending but not invading through the renal capsule or
Gerota's fascia margins were questionably positive at the renal
vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the 
renal
vein margin. A background of global glomerulosclerosis is
described. Overall, this was a T3bNxMx lesion. Postoperative
imaging on ___ which was a CT torso showed no evidence of
recurrent or metastatic disease.
-___: CT chest showed interval increase in prominence of
mediastinal lymph nodes and minimal interval increase in 
multiple
b/l pulmonary nodules, concerning for progression
-___: Fine needle aspirate of 11R and 11L lymph nodes, which
was consistent with metastatic RCC
-___: CT Torso - mediastinal and hilar nodes and pulmonary
lesions increased in size. No definite intra-abdominal sites of
disease 
-___: C1D1 ___, randomized to sunitinib
-___: Multiple grade ___ adverse events including
thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 
2;
WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1;
elevated at baseline), elevated ALT (grade 1), and 
hypothyroidism
(grade 1). Mild symptoms with treatment. Continued sunitinib at
50mg daily per protocol.
-___: CT Torso: Response of mediastinal lymphadenopathy,
bilateral hilar lymphadenopathy, and numerous parenchymal
metastases. Stable disease by RECIST (decrease 19.1% from
baseline).
-___: Sunitinib reduced to 37.5 mg daily due to erythematous
rash and blistering on palms and sole of right foot.
-___: CT Torso: Decrease in pulmonary and mediastinal
lesions. Stable disease by RECIST 1.1 (decrease 22.5% from
baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
39.8% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
46.3% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease 
40.3%
from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
42.6% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
47.7% from baseline).
-___: CT torso: Ongoing partial response comments: No
significant change compared to prior scan. No new lesions. 
-___: CT Torso: PR by RECIST 1.1 
-___: CT Torso: PR by RECIST 1.1: -54.22% change from
baseline and -10.29% change from last scan. 
-___: CT Torso:  partial response: -57.79% from baseline,
-7.79% from nadir
-___: CT Torso shows continued partial response, no
significant change compared to prior

PAST MEDICAL HISTORY (per OMR):
1. Clear cell kidney cancer as above.
2. Benign prostatic hypertrophy.
3. Diabetes mellitus.
4. Hypertension.
5. Hyperlipidemia.
6. History of anxiety.

 
Social History:
___
Family History:
Colorectal cancer - mother
___ cancer - sister (dx at age ___
Liver cancer - brother
___ cell leukemia - brother
___ - father

 
Physical ___:
ADMISSION PHYSICAL EXAM:
VS: Temp 97.9, BP 150/74, HR 71, RR 20, O2 sat 100% RA.
GENERAL: Pleasant man, in no distress, lying in bed comfortably.
HEENT: Anicteric, PERLL, OP clear.
CARDIAC: RRR, normal s1/s2, no m/r/g.
LUNG: Appears in no respiratory distress, clear to auscultation
bilaterally, no crackles, wheezes, or rhonchi.
ABD: Soft, non-tender, non-distended, normal bowel sounds.
EXT: Warm, well perfused, no lower extremity edema.
NEURO: A&Ox3, good attention and linear thought, CN II-XII
intact. Gross strength and sensation intact.
SKIN: No significant rashes.
ACCESS: Right chest wall port without erythema.

DISCHARGE PHYSICAL EXAM:
VS: ___ 1623 Temp: 98.1 PO BP: 148/78 HR: 76 RR: 18 O2 sat: 
97% O2 delivery: RA 
GENERAL: Pleasant man, in no distress, lying in bed comfortably.
HEENT: Anicteric, PERLL, OP clear.
CARDIAC: RRR, normal s1/s2, no m/r/g.
LUNG: Appears in no respiratory distress, clear to auscultation 
bilaterally, no crackles, wheezes, or rhonchi.
ABD: Soft, non-tender, non-distended, normal bowel sounds.
EXT: Warm, well perfused, no lower extremity edema.
NEURO: A&Ox3, good attention and linear thought, CN II-XII 
intact. Gross strength and sensation intact.
SKIN: No significant rashes.
ACCESS: Right chest wall port without erythema.
 
Pertinent Results:
ADMISSION LABS:
___ 12:45PM BLOOD WBC-5.6 RBC-3.04* Hgb-9.1* Hct-28.6* 
MCV-94 MCH-29.9 MCHC-31.8* RDW-14.6 RDWSD-49.4* Plt ___
___ 12:45PM BLOOD Neuts-72.3* Lymphs-17.0* Monos-8.0 
Eos-2.0 Baso-0.2 Im ___ AbsNeut-4.05 AbsLymp-0.95* 
AbsMono-0.45 AbsEos-0.11 AbsBaso-0.01
___ 12:45PM BLOOD Plt ___
___ 12:45PM BLOOD UreaN-48* Creat-2.7* Na-135 K-4.7 Cl-102 
HCO3-18* AnGap-15
___ 12:45PM BLOOD ALT-24 AST-31 LD(LDH)-667* AlkPhos-173* 
TotBili-0.4
___ 12:45PM BLOOD Albumin-3.9 Calcium-9.4 Phos-3.1 Mg-2.1
___ 05:54AM BLOOD Hapto-271*
___ 10:41PM URINE Color-Straw Appear-Clear Sp ___
___ 10:41PM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG
___ 10:41PM URINE Hours-RANDOM Creat-78 Na-34

DISCHARGE LABS:
___ 05:47AM BLOOD WBC-5.2 RBC-2.74* Hgb-8.3* Hct-26.1* 
MCV-95 MCH-30.3 MCHC-31.8* RDW-14.6 RDWSD-49.2* Plt ___
___ 05:47AM BLOOD Plt ___
___ 05:47AM BLOOD Glucose-120* UreaN-26* Creat-1.7* Na-141 
K-4.9 Cl-106 HCO3-23 AnGap-12
___ 05:47AM BLOOD Calcium-9.0 Phos-3.9 Mg-2.0

PERTINENT STUDIES:
Radiology Report RENAL U.S. Study Date of ___ 8:18 AM 
COMPARISON:  CT abdomen and pelvis ___ 
  
FINDINGS:  
  
The left kidney is surgically absent.  A cortical defect is 
re-demonstrated in 
the interpolar region of the right kidney.  There is a 1.3 cm 
exophytic simple 
cyst arising from the lower pole of the right kidney, stable 
from the prior 
CT.  There is no hydronephrosis or stones bilaterally.  Normal 
cortical 
echogenicity and corticomedullary differentiation are seen 
bilaterally. 
Right kidney: 11.5 cm 
  
The bladder is moderately well distended and normal in 
appearance. 
  
IMPRESSION:  
  
No hydronephrosis.  Normal cortical echogenicity and 
corticomedullary 
differentiation within the remaining right kidney. 

Radiology Report CHEST (PORTABLE AP) Study Date of ___ 
7:22 ___ 
COMPARISON:  CT is available from ___. 
  
FINDINGS:  
  
Port terminates in the mid superior vena cava.  Cardiac, 
mediastinal and hilar 
contours appear stable.  There is no pleural effusion or 
pneumothorax.  Lungs 
appear clear. 
  
IMPRESSION:  
  
No evidence of acute cardiopulmonary process.

MICROBIOLOGY:
___ 10:41 pm URINE      Source: ___. 

                            **FINAL REPORT ___

URINE CULTURE (Final ___:    NO GROWTH. 

 
Brief Hospital Course:
Brief hospital summary:
=======================
Mr. ___ is a ___ male with history metastatic 
RCC, locally advanced cholangiocarcinoma s/p six months of 
gemcitabine and cisplatin, and recent diagnosis of pancreatic 
acinar cell carcinoma receiving liposomal irinotecan and 
___ who presents with hypotension and acute on 
chronic renal failure. Hypotension and ___ resolved with IVFs 
and holding BP medications. He was discharged in stable 
condition. 

Transitional issues:
==============
[] Hgb on discharge 8.3.
[] Held home lisinopril, atenolol, and amlodipine given concern 
for dehydration and hypotension. BPs improved during course of 
hospital stay.
[] Please titrate BP medications on outpatient basis as 
clinically indicated 
[] Cr on discharge 1.7 (baseline appears to be 1.4-1.7). Please 
recheck BMP within one week of discharge to trend Cr.
[] Glipizide held on discharge due to increase risk of 
hypoglycemia. Would consider d/c vs restart based on renal 
function

Acute issues:
==========
# Hypotension: Likely combination of poor PO intake and 
dehydration in setting of poor appetite and nausea from new 
chemotherapy regimen while continuing multiple home BP 
medications. Given IVF and held BP medications with resolution 
of hypotension. Orthostatics prior to discharge unremarkable. 

# ___ on CKD: Likely prerenal in setting of poor PO intake. FeNa 
<1% consistent with diagnosis. Held lisinopril which we will 
continue to hold upon discharge. Renal ultrasound without 
evidence of hydronephrosis. 

# Anemia: Likely secondary to chemotherapy and malignancy. 
Hemolysis labs reassuring. No clinical evidence of bleeding. Hgb 
on discharge 8.3.

Chronic issues:
===============
# Fatigue: Likely from anemia and chemotherapy side effect. 
Stable during course of hospitalization

# Pancreatic Acinar Cell Carcinoma:
# Cholangiocarcinoma:
# Secondary Neoplasm of Liver: Currently on palliative liposomal 
___. Follow-up with Dr. ___

# Metastatic Renal Cell Carcinoma:
# Secondary Neoplasm of Lung: He is on a treatment hold due to 
the management of his cholangiocarcinoma and now pancreatic 
cancer.

# Portal Vein Thrombus: continued home rivaroxaban

# BPH: continued home Flomax

# Hypothyroidism: continued home levothyroxine

# Diabetes: continued home lantus, started humalog ISS, and held 
home glipizide while in house and on discharge.

# Anxiety: continued home citalopram

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. amLODIPine 10 mg PO DAILY 
2. Ascorbic Acid ___ mg PO DAILY 
3. Atenolol 50 mg PO DAILY 
4. Levothyroxine Sodium 100 mcg PO DAILY 
5. LORazepam 0.5 mg PO DAILY:PRN anxiety/insomnia 
6. Multivitamins 1 TAB PO DAILY 
7. Omeprazole 20 mg PO DAILY 
8. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
9. Prochlorperazine 5 mg PO Q8H:PRN nausea/vomiting 
10. Tamsulosin 0.4 mg PO QHS 
11. Vitamin D 5000 UNIT PO DAILY 
12. GlipiZIDE 2.5 mg PO BID 
13. Lisinopril 10 mg PO DAILY 
14. Fenofibrate 48 mg PO DAILY 
15. Amoxicillin ___ mg PO PREOP 
16. Citalopram 20 mg PO DAILY 
17. Glargine 16 Units Bedtime
18. Rivaroxaban 10 mg PO DAILY 
19. Acetaminophen ___ mg PO Q8H:PRN Pain - Mild/Fever 
20. Cyanocobalamin 1000 mcg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen ___ mg PO Q8H:PRN Pain - Mild/Fever  
2.  Ascorbic Acid ___ mg PO DAILY  
3.  Citalopram 20 mg PO DAILY  
4.  Cyanocobalamin 1000 mcg PO DAILY  
5.  Fenofibrate 48 mg PO DAILY  
6.  Glargine 16 Units Bedtime 
7.  Levothyroxine Sodium 100 mcg PO DAILY  
8.  LORazepam 0.5 mg PO DAILY:PRN anxiety/insomnia  
9.  Multivitamins 1 TAB PO DAILY  
10.  Omeprazole 20 mg PO DAILY  
11.  Ondansetron 8 mg PO Q8H:PRN nausea/vomiting  
12.  Prochlorperazine 5 mg PO Q8H:PRN nausea/vomiting  
13.  Rivaroxaban 10 mg PO DAILY  
14.  Tamsulosin 0.4 mg PO QHS  
15.  Vitamin D 5000 UNIT PO DAILY  
16. HELD- amLODIPine 10 mg PO DAILY  This medication was held. 
Do not restart amLODIPine until you discuss with your primary 
care doctor.
17. HELD- Atenolol 50 mg PO DAILY  This medication was held. Do 
not restart Atenolol until you discuss with your primary care 
doctor.
18. HELD- GlipiZIDE 2.5 mg PO BID  This medication was held. Do 
not restart GlipiZIDE until you follow up with your PCP.
19. HELD- Lisinopril 10 mg PO DAILY  This medication was held. 
Do not restart Lisinopril until you discuss with your primary 
care doctor.

 
Discharge Disposition:
Home With Service
 
Facility:
___ 
 
Discharge Diagnosis:
Acute Issues:
==========
Hypotension
Acute on chronic CKD

Secondary Issues:
=============
Hypertension
CKD

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
======================  
DISCHARGE INSTRUCTIONS  
======================  
Dear Mr. ___,
 
It was a pleasure caring for you at ___ 
___.  
 
WHY WAS I IN THE HOSPITAL?  
 - You were admitted for low blood pressures 
 
WHAT HAPPENED TO ME IN THE HOSPITAL?  
 - We gave you fluids through an IV, and we held your blood 
pressure medications. Your blood pressures eventually improved 
to normal range. 
 -  We monitored your kidney function which improved with fluids 
and holding your blood pressure medications. 

WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  
 - Continue to take all your medicines and keep your 
appointments.  
 - Do not take any of your blood pressure medications until you 
discuss with your primary care doctor.

We wish you the best!  
 
Sincerely,  
Your ___ Team 
 
Followup Instructions:
___
",MEDICINE
10006029-DS-18,Robert Bowman,10006029,25426298," 
Name:  ___                     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
mirtazapine
 
Attending: ___.
 
Chief Complaint:
Nausea and vomiting
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Mr. ___ is a pleasant ___ w/ ID-T2DM, HTN, DL, BPH, and 
three concurrent cancers (1) metastatic clear cell RCC, s/p 
radical L nephrectomy in ___, found to have pulmonary, 
mediastinal, and hilar mets ___ (now off sunitinib w/o 
disease progression), (2) metastatic cholangiocarcinoma s/p 6 
months gem/cisplatin, who subsequently had new (3) acinar cell 
carcinoma of the pancreas, now on ___ I regimen of liposomal 
irinotecan and ___, last dose ___, p/w nausea/vomiting that 
started last evening. 

Patient was interviewed with his daughter at bedside and she 
helped provide collateral. 

They note that he has had n/v the past few weeks, especially 
with chemo. He had poor appetite as well since chemo. The 
vomiting seemed to be intermittent, sometimes able to tolerate 
PO. Last night he developed abdominal pain and vomiting. He had 
regular bowel movements last night.  This morning he had 
diarrhea but no further episodes of vomiting and his abdominal 
pain improved and nausea improved. He had special K cereal with 
skim milk today and tolerated it well. 

He called into his ___ clinic where he was seen this am. There 
he had 2L NS and obtained a KUB which suggested SBO. He is only 
a little tender in the epigastrium on exam. He was then admitted 
to 12R to the oncology service.

 
Past Medical History:
PAST ONCOLOGIC HISTORY (per OMR):
-___: presented with acute onset of gross hematuria
accompanied with some mild flank pain. During his workup, he was
found to have a 4.8 cm mass on a CAT scan dated ___,
specifically the scan describes a left renal mass with internal
enhancement measuring 4.1 x 4.8 cm in size in the mid and upper
pole of the left kidney. Also described was the fat-containing
left inguinal hernia and left perinephric stranding. There was 
no
adenopathy or other suspicious lesions. There is also an old
sclerotic right ilial lesion and left sacral lesion. 
-___: underwent a laparoscopic hand assisted radical right
nephrectomy by Dr. ___ pathology showed a 
renal
cell carcinoma, clear cell type, ___ grade II/IV measuring 4
cm extending but not invading through the renal capsule or
Gerota's fascia margins were questionably positive at the renal
vein and otherwise negative. On review of pathology here at ___, the margins are described as negative including the 
renal
vein margin. A background of global glomerulosclerosis is
described. Overall, this was a T3bNxMx lesion. Postoperative
imaging on ___ which was a CT torso showed no evidence of
recurrent or metastatic disease.
-___: CT chest showed interval increase in prominence of
mediastinal lymph nodes and minimal interval increase in 
multiple
b/l pulmonary nodules, concerning for progression
-___: Fine needle aspirate of 11R and 11L lymph nodes, which
was consistent with metastatic RCC
-___: CT Torso - mediastinal and hilar nodes and pulmonary
lesions increased in size. No definite intra-abdominal sites of
disease 
-___: C1D1 ___, randomized to sunitinib
-___: Multiple grade ___ adverse events including
thrombocytopenia (grade 2; platelet 52,000), leukopenia (grade 
2;
WBC 2.9), elevated lipase (grade 1), elevated amylase (grade 1;
elevated at baseline), elevated ALT (grade 1), and 
hypothyroidism
(grade 1). Mild symptoms with treatment. Continued sunitinib at
50mg daily per protocol.
-___: CT Torso: Response of mediastinal lymphadenopathy,
bilateral hilar lymphadenopathy, and numerous parenchymal
metastases. Stable disease by RECIST (decrease 19.1% from
baseline).
-___: Sunitinib reduced to 37.5 mg daily due to erythematous
rash and blistering on palms and sole of right foot.
-___: CT Torso: Decrease in pulmonary and mediastinal
lesions. Stable disease by RECIST 1.1 (decrease 22.5% from
baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
39.8% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
46.3% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease 
40.3%
from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
42.6% from baseline).
-___: CT Torso: Partial response by RECIST 1.1 (decrease
47.7% from baseline).
-___: CT torso: Ongoing partial response comments: No
significant change compared to prior scan. No new lesions. 
-___: CT Torso: PR by RECIST 1.1 
-___: CT Torso: PR by RECIST 1.1: -54.22% change from
baseline and -10.29% change from last scan. 
-___: CT Torso:  partial response: -57.79% from baseline,
-7.79% from nadir
-___: CT Torso shows continued partial response, no
significant change compared to prior

PAST MEDICAL HISTORY (per OMR):
1. Clear cell kidney cancer as above.
2. Benign prostatic hypertrophy.
3. Diabetes mellitus.
4. Hypertension.
5. Hyperlipidemia.
6. History of anxiety.

 
Social History:
___
Family History:
Colorectal cancer - mother
___ cancer - sister (dx at age ___
Liver cancer - brother
___ cell leukemia - brother
___ - father

 
Physical ___:
ADMISSION EXAM:
VITAL SIGNS: 98.4 PO 112 / 71 89 18 97 Ra
General:  NAD, Resting in bed comfortably with daughter at 
bedside
___: + xerostomia, + healing dried cold sore the L lower lip
CV:  RR, NL S1S2 no S3S4 No MRG
PULM:  CTAB, No C/W/R, No respiratory distress
ABD: scant bowel sounds, mostly tympanic, soft, minimally tender 
in epigastrium, no peritoneal signs, no significant distention
LIMBS: WWP, no ___, no tremors
SKIN:  No notable rashes on trunk nor extremities
NEURO: Face symmetric, speech clear and fluent, strength b/l 
___ intact
PSYCH: Thought process logical, linear, future oriented
ACCESS: R Chest port site intact w/o overlying erythema, 
accessed and dressing C/D/I 

DISCHARGE EXAM:
___ 0910 Temp: 97.4 PO BP: 136/89 HR: 102 RR: 18 O2 sat: 
95%
O2 delivery: RA FSBG: 269 
___ 0918 Pain Score: ___ 
GENERAL: appears uncomfortable, weaker and pale.
EYES: Anicteric
ENT: MMM, no lesions noted
CV: RRR, no murmur. Right chest port.
RESP: anterior exam, quiet lungs, normal respiratory effort.
GI: Abdomen soft, mild distention, G-tube in place.
MSK: no edema or swelling
NEURO: sleepy, but awakens with gentle touch, face symmetric, 
speech fluent, moves all limbs, answers all questions, fully
oriented.
PSYCH: Pleasant, appropriate affect
 
Pertinent Results:
ADMISSION LABS:
___ 01:15PM BLOOD WBC-3.5* RBC-2.83* Hgb-8.4* Hct-26.9* 
MCV-95 MCH-29.7 MCHC-31.2* RDW-17.2* RDWSD-58.1* Plt ___
___ 01:15PM BLOOD Neuts-74* Lymphs-12* Monos-13 Eos-0* 
___ Metas-1* AbsNeut-2.59 AbsLymp-0.42* AbsMono-0.46 
AbsEos-0.00* AbsBaso-0.00*
___ 05:41AM BLOOD ___ PTT-25.9 ___
___ 01:15PM BLOOD UreaN-26* Creat-1.8* Na-132* K-4.4 Cl-95* 
HCO3-22 AnGap-15
___ 01:15PM BLOOD ALT-20 AST-28 LD(___)-861* AlkPhos-150* 
TotBili-0.4
___ 01:15PM BLOOD Albumin-3.3* Calcium-9.1 Phos-3.9 Mg-2.2
=======================
DISCHARGE LABS:
___ 06:25AM BLOOD WBC-19.0* RBC-3.27* Hgb-9.4* Hct-31.4* 
MCV-96 MCH-28.7 MCHC-29.9* RDW-17.6* RDWSD-59.2* Plt ___
___ 06:25AM BLOOD Glucose-176* UreaN-35* Creat-1.5* Na-141 
K-4.8 Cl-100 HCO3-22 AnGap-19*
___ 06:25AM BLOOD ALT-24 AST-79* LD(LDH)-1713* AlkPhos-184* 
TotBili-0.8
___ 06:25AM BLOOD Calcium-9.0 Phos-4.0 Mg-2.1
=======================
MICROBIOLOGY:
___ 3:07 am STOOL     CONSISTENCY: LOOSE      Source: 
Stool. 
                            **FINAL REPORT ___
   C. difficile PCR (Final ___: 
      NEGATIVE. 
___ 3:07 am STOOL     CONSISTENCY: LOOSE      Source: 
Stool. 
   FECAL CULTURE - R/O E.COLI 0157:H7 (Pending): 
=======================
ABDOMINAL X-RAY ___:
FINDINGS: 
There are multiple centrally located distended loops of small 
bowel, concerning for small bowel obstruction. There is no free 
intraperitoneal air. Osseous structures are unremarkable. 
Re-demonstrated is a common bile duct extent in grossly 
unchanged position compared to the prior study given differences 
in techniques. Two small linear
hyperdensities noted over the midline adjacent to the biliary 
stent, likely surgical clips.
IMPRESSION: Imaging findings concerning for small-bowel 
obstruction.  Further evaluation with CT abdomen and pelvis, 
with iv contrast, is recommended.

CT ABDOMEN/PELVIS WITH ORAL CONTRAST ___:
1. Interval increase in size of pancreatic head mass, now 
measuring up to 8.0 cm, previously 6.0 cm.
2. Numerous metastatic lesions throughout the liver, increased 
in size and number.
3. Interval worsening of retroperitoneal lymphadenopathy.
4. Wall thickening of an approximately 20 cm segment of distal 
and terminal ileum with adjacent fat stranding, compatible with 
infectious or inflammatory ileitis.  No small bowel obstruction. 
 Oral contrast is seen to the rectum.
5. New 3 mm pulmonary nodule in the left lower lobe.

 
Brief Hospital Course:
Mr. ___ is a ___ year old male with type 2 diabetes, 
hypertension, hyperlipidemia, BPH, and three concurrent cancers: 
(1) metastatic clear cell renal cell carcinoma, s/p radical L 
nephrectomy in ___, found to have pulmonary,
mediastinal, and hilar metastases ___ (now off sunitinib 
without disease progression), (2) metastatic cholangiocarcinoma 
s/p 6 months gem/cisplatin, who subsequently had new (3) acinar 
cell carcinoma of the pancreas, now on ___ I regimen of 
liposomal irinotecan and ___, last dose ___, who went to 
___ clinic with nausea, vomiting, abdominal pain and was 
found to have possible SBO on KUB.  This led to direct admission 
for workup.  CT abdomen/pelvis with oral contrast showed no 
evidence of bowel obstruction, but showed findings of ileitis, 
as well as increasing pancreatic mass size and new hepatic 
lesions all concerning for progression of his cancer.  While 
hospitalized, he developed recurrent symptoms of nausea, 
vomiting after an initial improvement, and then developed signs 
and symptoms of frank obstruction likely related to his 
pancreatic mass or peritoneal carcinomatosis.  No further 
imaging was pursued.  An NG tube was placed for decompression 
and he had significant improved symptoms.  He subsequently 
underwent palliative venting G-tube is a transition to hospice.

ACUTE/ACTIVE PROBLEMS:
# Abdominal pain
# Nausea and vomiting, with malignant obstruction, in setting of 
progressive acinar cell cancer, and large pancreatic mass
# Acinar cell pancreatic cancer
He has been off sutinib as his other cancers are being managed 
and his pulm/hepatic mets have been stable. He is not yet due 
for restaging imaging. He is due for
___, LV, liposomal irinotecan. His oncologists are Dr ___ 
___ Dr ___ seen on ___.  CT abdomen/pelvis showed 
increased size of pancreatic head mass (from 6.0 to 8.0 cm), 
numerous metastatic liver lesions (increased in size and 
number), interval worsening of retroperitoneal lymphadenopathy, 
and new 3 mm pulmonary nodule in the left lower lobe.  He had 
been having nausea and vomiting likely related to chemo for 
several weeks, but then developed diarrhea, vomiting, and 
abdominal pain the night prior to presentation. His symptoms 
have resolved.  He had 2 watery bowel movements after admission. 
 KUB had showed multiple centrally located distended loops of 
small bowel, concerning for small bowel obstruction.  He has not 
had prior bowel obstruction.  Since he has only 1 kidney with a 
Cr of 1.6, initial CT was done without IV contrast.  CT 
abdomen/pelvis with oral contrast showed no evidence of bowel 
obstruction, but showed wall thickening of distal and terminal 
ileum with adjacent fat stranding, compatible with infectious or 
inflammatory ileitis.  Since he was afebrile with improved 
symptoms, empiric antibiotics were not started.  C. difficile 
was negative as was ecoli.   He was initially treated with bowel 
rest and IV fluids, then diet was advanced.  The CT scan also 
showed increasing size of pancreatic mass, enlarging and new 
hepatic lesions, new left lung nodule, worsening retroperitoneal 
lymphadenopathy, all concerning for progression of disease.   
Given this new complication of his pancreatic cancer, family 
meeting was held on ___, with a decision to pursue hospice 
care at home given no other therapeutic options.  His prognosis 
was given as weeks.  He was transitioned to liquid concentrated 
morphine for pain, as well as lorazepam for anxiety, and 
dexamethasone for nausea.  Oral medications were given after his 
PEG was placed, with clear instructions on how to take them.  
This included dexamethasone, concentrated morphine, and 
olanzapine.  Other home medications were continued at this time, 
with decisions to stop these medications going forward to occur 
with hospice services and Dr. ___, patient's 
oncologist.  MOLST form was completed.

# Acute on chronic anemia: Baseline hemoglobin is ___.  
Hemoglobin was low at 6.7 on ___, so he was transfused 1 unit 
PRBCs with improvement to 8.3.  He had no obvious signs of acute 
blood loss anemia and stool has not appeared grossly bloody or 
signs of melena evident.  His blood count remained stable.  Labs 
were not checked after goals of care were changed.

CHRONIC/STABLE PROBLEMS:
# Chronic kidney disease: Creatinine is 1.4-1.6 at baseline.  He 
had recent ___ with Cr of 2.2 on ___ and 1.8 on admission, 
likely due to dehydration. Renal function returned to baseline 
after getting IV fluids then rose after he likely developed 
recurrent dehydration.  As stated above labs were not rechecked 
after goals of care change.

# History of Portal Vein Thrombus: He was continued on home 
Rivaroxaban 10mg daily, except for initially being held while 
NPO.  This was continued for now, but should be stopped if 
decided not consistent with comfort going forward.

# Severe protein-calorie malnutrition: He has low albumin and 
reported low oral intake due to nausea, vomiting, and abdominal 
pain, which has been ongoing off/on for weeks, likely due to 
chemo and his known cancers.  Consulted nutrition who 
recommended low fiber diet with Ensure Clear early in 
hospitalization, but given transition to hospice, he was 
recommended to have diet as tolerated.

# Type 2 diabetes: His glargine was initially decreased while 
NPO on IV D5LR, then stopped and treated with sliding scale 
insulin only and Glipizide was held.  On discharge, glipizide 
was continued.

TRANSITIONS OF CARE
-------------------
# Follow-up: patient is being discharged to hospice.  Dr. ___ 
___ be the physician responsible for decisions going 
forward.

# Code status: DNR/DNI, comfort-focused care

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen ___ mg PO Q8H:PRN Pain - Mild/Fever 
2. Citalopram 20 mg PO DAILY 
3. Levothyroxine Sodium 100 mcg PO DAILY 
4. LORazepam 0.5 mg PO DAILY:PRN anxiety/insomnia 
5. Multivitamins 1 TAB PO DAILY 
6. Omeprazole 20 mg PO DAILY 
7. Prochlorperazine 5 mg PO Q8H:PRN nausea/vomiting 
8. Rivaroxaban 10 mg PO DAILY 
9. Tamsulosin 0.4 mg PO QHS 
10. Vitamin D 5000 UNIT PO DAILY 
11. Ascorbic Acid ___ mg PO DAILY 
12. Cyanocobalamin 1000 mcg PO DAILY 
13. Fenofibrate 48 mg PO DAILY 
14. Ondansetron 8 mg PO Q8H:PRN nausea/vomiting 
15. GlipiZIDE 2.5 mg PO BID 
16. Abreva (docosanol) 10 % topical ___ times daily prn cold 
sore 

 
Discharge Medications:
1.  Dexamethasone 4 mg PO DAILY 
RX *dexamethasone 4 mg 1 tablet(s) by mouth once a day Disp #*5 
Tablet Refills:*0 
2.  Morphine Sulfate (Concentrated Oral Solution) 20 mg/mL ___ 
mg PO Q2H:PRN Breakthrough pain 
RX *morphine concentrate 100 mg/5 mL (20 mg/mL) 0.25-0.75 ml by 
mouth q2h Refills:*0 
3.  OLANZapine (Disintegrating Tablet) 5 mg PO BID:PRN nausea 
not addressed by ondansetron 
RX *olanzapine 5 mg 1 tablet(s) by mouth twice a day Disp #*10 
Tablet Refills:*0 
4.  Abreva (docosanol) 10 % topical ___ times daily prn cold 
sore  
5.  Acetaminophen ___ mg PO Q8H:PRN Pain - Mild/Fever  
6.  Ascorbic Acid ___ mg PO DAILY  
7.  Citalopram 20 mg PO DAILY  
8.  Cyanocobalamin 1000 mcg PO DAILY  
9.  Fenofibrate 48 mg PO DAILY  
10.  Levothyroxine Sodium 100 mcg PO DAILY  
11.  LORazepam 0.5 mg PO DAILY:PRN anxiety/insomnia  
12.  Multivitamins 1 TAB PO DAILY  
13.  Omeprazole 20 mg PO DAILY  
14.  Ondansetron 8 mg PO Q8H:PRN nausea/vomiting  
15.  Prochlorperazine 5 mg PO Q8H:PRN nausea/vomiting  
16.  Rivaroxaban 10 mg PO DAILY  
17.  Tamsulosin 0.4 mg PO QHS  
18. HELD- GlipiZIDE 2.5 mg PO BID  This medication was held. Do 
not restart GlipiZIDE until someone tells you to

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
___ Diagnosis:
Abdominal pain
Nausea with vomiting
Diarrhea
Ileitis
Metastatic cholangiocarcinoma
Acinar cell pancreatic cancer
Metastatic renal cell carcinoma

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

You were hospitalized with abdominal pain.  Despite the fact 
that you initially improved, you subsequently worsened and the 
symptoms were all related to progressive cancer.  We talked 
about the meaning of this with you and your family and you are 
opting to go home with hospice care.  We put a gastric tube in 
to help alleviate any symptoms of obstruction.  You should keep 
the gastric tube hooked up to low suction overnight and when you 
are not doing anything during the day.  When you are active, and 
for ___ minutes after taking oral medications, you should 
clamp the tube.

You were continued on most of your oral medications that you 
take at home.  Over time, you may decide to discontinue these 
medications if they are not necessary for your comfort (for 
instance, your vitamin supplements), and can discuss this with 
your hospice team.

The hospice team will help you manage your symptoms at home.

We wish you the best of luck going forward. 

Thanks,

Your ___ Team

 
Followup Instructions:
___
",MEDICINE
10006053-DS-10,Matthew Riedl,10006053,22942076," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Chief Complaint:  GIB
Reason for MICU transfer:  active GIB

 
Major Surgical or Invasive Procedure:
EGD with banding
TIPS

 
History of Present Illness:
Mr. ___ is a ___ y/o man with h/o EtOH cirrhosis, currently 
drinking, c/b recurrent ascites requiring weekly taps, 
encephalopathy, and esophageal varices who presented to OSH 
intoxicated with BRBPR and hematemesis yesterday. Initially 
stabilized with 2 units pRBCs. hct 24, plt 96, INR 1.8. Alcohol 
level 0.195. GI performed EGD under concious sedation and saw 
fresh blood in stomach and esophagus, banded 3 varices. 
Ocreotide and protonix drips started. RUQ showed only ascites 
and cirrhotic liver, PV not mentioned. After endoscope, started 
having active hematemasis and was then intubated. Repeat EGD saw 
again lots of blood but did not believe varices had new 
bleeding. Injected sodium tetradisusulfate into the varix. GI 
recommended transfer. 

As patient prepped for transfer, he started having active 
bleeding from multiple orfices including mouth, rectum, and 
nose. Started on 2 additional pressors to include vasopressin, 
levophen, and neo and ___ was placed. NGT 800 cc prior to 
___. Additional pRBC, platelets and FFP were given for 
total of 15 units pRBC, 10 units FFP, 6 units platelets.

On arrival to the MICU, initials vitals were AF 114 110/62 32 
100% on ventilator set at Vt 480 RR 24 FiO2 80% PEEP 12. He was 
actively bleeding at the mouth. Intial ABG showed pH 
7.04/53/137, lactate 11.9. hct 24, plt 71, INR 1.9, Fibrinogen 
72. Given 1 unit cryo. GI and ___ were consulted and came to 
bedside for evaluation.

 
Past Medical History:
EtOH cirrhosis
alcohol abuse
h/o hypokalemia and hypomag

 
Social History:
___
Family History:
non-contributory
 
Physical Exam:
ADMISSION EXAM
===============

GENERAL: intubated, sedated 
HEENT: Sclera icteric, MMM, oropharynx clear, blood at 
oropharynx, ___ tube in place
NECK: supple, no LAD  
LUNGS: Clear to auscultation bilaterally, no wheezes, rales, 
rhonchi  
CV: tachycardic, normal S1 S2, no murmurs, rubs, gallops  
ABD: soft, distended, caput madusae visible, bowel sounds 
present
EXT: Warm, well perfused, 2+ pulses, trace edema  bilaterally 
NEURO:  intubated and sedated

DEATH NOTE
===========

Cardiac sounds absent. Lung sounds absent without chest rise. 
Neuro exam without withdrawal to painful stimuli and absent 
corneal reflexes.
 
Pertinent Results:
ADMISSION LABS
===============

___ 11:36PM BLOOD WBC-9.7 RBC-2.57* Hgb-7.8* Hct-24.0* 
MCV-94 MCH-30.2 MCHC-32.3 RDW-14.9 Plt Ct-71*
___ 11:36PM BLOOD Neuts-82.6* Lymphs-7.4* Monos-8.6 Eos-1.2 
Baso-0.2
___ 11:36PM BLOOD ___ PTT-71.7* ___
___ 11:36PM BLOOD Fibrino-72*
___ 11:36PM BLOOD Glucose-201* UreaN-12 Creat-1.7* Na-147* 
K-6.3* Cl-110* HCO3-14* AnGap-29*
___ 11:36PM BLOOD ALT-115* AST-729* LD(LDH)-1168* 
CK(CPK)-1391* AlkPhos-36* Amylase-117* TotBili-2.0* DirBili-0.5* 
IndBili-1.5
___ 11:36PM BLOOD CK-MB-42* MB Indx-3.0 cTropnT-0.02*
___ 11:36PM BLOOD Albumin-2.0* Calcium-8.2* Phos-9.3* 
Mg-1.8
___ 08:41AM BLOOD Hapto-<5*
___ 11:36PM BLOOD TSH-0.96
___ 11:55PM BLOOD ___ Temp-35.6 pO2-137* pCO2-53* 
pH-7.04* calTCO2-15* Base XS--17
___ 11:55PM BLOOD Glucose-179* Lactate-11.9* K-6.1*
___ 11:55PM BLOOD freeCa-0.71*

IMAGING STUDIES
===============

CXR ___:
Tube is projecting over the mid mediastinum and might 
potentially represent ___ tube.  Heart size and 
mediastinum are grossly within normal limits.  The ET tube tip 
is approximately 4.5 cm above the carina.  Left basal 
consolidation is most likely associated with pleural effusion.  
Right lung is essentially clear. 

TIPS ___:
IMPRESSION:  
  
Successful intrahepatic portosystemic shunt placement with 
decrease in 
porto-systemic pressure gradient from 24 to 6 mm Hg. 
  
Removal of 5 L of ascites. 
  
Placement of a left internal jugular triple-lumen catheter. 
  
Placement of a right internal jugular trauma line (triple 
lumen). 
  
RECOMMENDATION:  If esophageal bleeding continues, consider 
further treatment with ___ embolization of esophageal varices. 

___ LIVER OR GALLBLADDER US -
1. Patent TIPS shunt. 
2. Cirrhotic appearing liver with right pleural effusion and 
moderate ascites. 

___ CHEST (PORTABLE AP) -
 As compared to the previous radiograph, the patient has 
received a 
___ device.  The endotracheal tube as well as the left and 
right central venous access lines are constant.  Mildly 
increasing bilateral pleural effusions and signs of 
mild-to-moderate fluid overload.  Moderate cardiomegaly is 
constant.  No pneumothorax. 
 
Brief Hospital Course:
___ with h/o EtOH cirrhosis, currently drinking, c/b recurrent 
ascites requiring weekly taps, encephalopathy, and esophageal 
varices who presented to an outside hospital intoxicated with 
BRBPR and hematemesis requiring transfusion and EGD with 
significant esophageal variceal bleeding requiring ___ 
pressure balloon placement. On arrival, his bleeding temporarily 
stabilized and then subsequently resumed with impending DIC and 
multiorgan failure. Unfortunately he expired despite our 
resuscitation efforts.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. This patient is not taking any preadmission medications

 
Discharge Medications:
Not applicable.
 
Discharge Disposition:
Expired
 
Discharge Diagnosis:
Not applicable.
 
Discharge Condition:
Not applicable.
 
Discharge Instructions:
Not applicable.
 
Followup Instructions:
___
",MEDICINE
10006131-DS-14,Mark Martinez,10006131,27849136," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
ASA overdose
 
Major Surgical or Invasive Procedure:
HD 
 
History of Present Illness:
Initial history and physical is as per ICU team
.
This is a ___ year-old male with a history of previous suicide 
attempt who is transferred to ___ from ___ after presenting 
there following aspirin overdose.  He took 200 pills of ASA 
325mg in a suicide attempt and then called his brother.  He was 
taken to ___.  ASA level on presentation to OSH was 
21.7 and then rose to 51. Bicarb gtt was initiated.  Reports 
that this was a suicide attempt sparked by the poor economy, 
rising gas prices, etc.  He currently denies SI/HI and states 
that he wants to live.
.
In the ED, initial vital were T: 98.2 BP: 139/107 HR: 103 RR: 20 
O2sat: 98%RA.  Urine and serum tox screens were negative.  
Repeat aspirin level here was 105.  Creatinine was elevated to 
1.3.  VBG was 7.43/35/48.  Bicarb drip was continued.  Renal was 
consulted who recommended hemodialysis and HD line was placed by 
renal team upon presentation to the FICU.
.  
ROS: + Tinnitus.  He currently denies fevers/chills.  He is 
diaphoretic and feels antsy.  He denies LH/dizziness.  No 
changes in vision.  No CP/SOB, no cough.  No abdominal pain/N/V. 
 No dysuria/urinary frequentcy.  No rahses.  

 
Past Medical History:
Previous suicide attempt appox ___ yrs ago
 
Social History:
___
Family History:
Non contributory
 
Physical Exam:
Tmax: 36.1 C (96.9 F)Tcurrent: 35.9 C (96.7 F)
HR: 96 (96 - 132) bpm BP: 103/41(53) {93/41(53) - 146/89(98)} 
mmHg
RR: 27 (19 - 27) insp/min SpO2: 97% 
Heart rhythm: SR (Sinus Rhythm)Height: 67 Inch
GEN: Diaphoretic, jittery, anxious
HEENT: EOMI, PERRL, sclera anicteric, no epistaxis or 
rhinorrhea, MMM, OP Clear  
NECK: No JVD, carotid pulses brisk, no bruits, no cervical 
lymphadenopathy, trachea midline  
COR: Sinus tachycardia, no M/G/R, normal S1 S2, radial pulses +2 
 
PULM: Lungs clear anteriorly, no W/R/R  
ABD: Soft, NT, ND, +BS, no HSM, no masses  
EXT: No C/C/E, no palpable cords 
NEURO: alert, oriented to person, place, and time. CN II  XII 
grossly intact. Moves all 4 extremities. Strength and sensation 
to soft touch grossly intact.
SKIN: No jaundice, cyanosis, or gross dermatitis. No ecchymoses. 
 

 
Pertinent Results:
On admission:

___ 09:45PM BLOOD WBC-8.1 RBC-5.30 Hgb-16.6 Hct-46.1 MCV-87 
MCH-31.4 MCHC-36.1* RDW-13.9 Plt ___
___ 09:45PM BLOOD Glucose-126* UreaN-14 Creat-1.3* Na-141 
K-4.2 Cl-101 HCO3-22 AnGap-22
___ 09:45PM BLOOD ALT-29 AST-26 LD(LDH)-193 CK(CPK)-182* 
AlkPhos-70 TotBili-0.2
___ 09:45PM BLOOD Albumin-4.9* Calcium-9.1 Phos-3.7 Mg-2.4
___ 09:45PM BLOOD ASA-105* Ethanol-NEG Acetmnp-NEG 
Bnzodzp-NEG Barbitr-NEG Tricycl-NEG
___ 03:03AM BLOOD HCV Ab-NEGATIVE
 
Brief Hospital Course:
This is a ___ year-old male without significant PMH who presents 
following suicide attempt with aspirin overdose.  
.  
# Aspirin overdose/suicide attempt: Pt had no signs or symptoms 
of bleed and remain afebrile from time of admission until 
transfer out of the unit. ASA level on admission was 105 and 
trended down to 15 at time of transfer to the floor. Pt 
initially had AG met acidosis with compensatory resp alkalosis. 
He was initially placed on a bicarb gtt but this was d/c'd 
___. Toxicology and renal were consulted and pt had HD line 
placed followed by HD on ___.  HD line is to be removed by 
renal on ___.
Psych was consulted and recommended inpatient psychiatry unit 
placement.  He was watched a 1:1 sitter on the floor. At time of 
transfer to the inpatieent floor, he denied any SI or other 
thoughts of hurting himself.  He remaineed medically stable and 
will be transferred to ___ 4 for further psychiactric 
care.
.
# ARF:  Cr was 1.6 at admission.  ASA can cause interstitial 
nephritis, papillary necrosis, proteinuria.  Creatinine now down 
to 1.0 from 1.3 on admission, within normal range
.
# FEN:  Regular diet.  
.
# Code:  FULL.  

# Dispo:  transfer to inpatient psychiatry unit
 

 
Medications on Admission:
None
 
Discharge Medications:
1. Nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr 
Transdermal DAILY (Daily).  
2. Polyethylene Glycol 3350 100 % Powder Sig: One (1) dose PO 
daily prn as needed for constipation.  
3. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
4. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed.  
5. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 

 
Discharge Disposition:
Extended Care
 
Discharge Diagnosis:
Aspirin Overdose, suicide attempt

 
Discharge Condition:
Good

 
Discharge Instructions:
-Transfer to inpatient psychiatric unit for further care
-Follow up with PCP after discharge.
 
Followup Instructions:
___
",MEDICINE
10006269-DS-16,Michael Anderson,10006269,27357430," 
Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Major Surgical or Invasive Procedure:
EGD
Colonoscopy
Biopsy during colonoscopy
Lumbar puncture

attach
 
Pertinent Results:
ADMISSION LABS:
___ 11:00AM   WBC-10.0 RBC-4.66 HGB-8.4* HCT-30.9* MCV-66* 
MCH-18.0* MCHC-27.2* RDW-20.1* RDWSD-45.3
___ 11:00AM   NEUTS-85.1* LYMPHS-6.6* MONOS-7.7 EOS-0.0* 
BASOS-0.2 IM ___ AbsNeut-8.47* AbsLymp-0.66* AbsMono-0.77 
AbsEos-0.00* AbsBaso-0.02
___ 11:00AM   PLT COUNT-225
___ 11:00AM   GLUCOSE-111* UREA N-15 CREAT-1.0 SODIUM-128* 
POTASSIUM-4.6 CHLORIDE-95* TOTAL CO2-18* ANION GAP-15
___ 11:00AM   ALT(SGPT)-13 AST(SGOT)-20 ALK PHOS-80 TOT 
BILI-1.0
___ 11:00AM   ALBUMIN-4.9
___ 07:20AM BLOOD Hypochr-1+* Anisocy-1+* Macrocy-1+* 
Microcy-1+* Polychr-1+* Tear Dr-1+* RBC Mor-SLIDE REVI

___ 11:42AM BLOOD Ret Aut-3.1* Abs Ret-0.13*
___ 07:20AM BLOOD calTIBC-371 VitB12-293 Folate-8 
Ferritn-5.6* TRF-285
___ 11:42AM BLOOD Hapto-208*
___ 07:20AM BLOOD TSH-1.1
___ 07:20AM BLOOD 25VitD-17*
___ 03:30AM BLOOD IgA-162

___ 03:40PM CEREBROSPINAL FLUID (CSF)  TNC-146* RBC-7* 
POLYS-1 ___ MONOS-12 BASOS-1 OTHER-0
___ 03:40PM CEREBROSPINAL FLUID (CSF)  TNC-141* RBC-2 
POLYS-1 ___ MONOS-3 OTHER-0
___ 03:40PM CEREBROSPINAL FLUID (CSF)  PROTEIN-100* 
GLUCOSE-57
___ 11:00AM   Lyme Ab-NEG
___ 04:45PM BLOOD Trep Ab-NEG
___ 07:20AM BLOOD HIV Ab-NEG
___ 03:05PM BLOOD Parst S-NEGATIVE
 
MICRO:
___ 3:40 pm CSF;SPINAL FLUID     
Site: LUMBAR PUNCTURE
      TUBE #3. 
   GRAM STAIN (Final ___: 
      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 
      NO MICROORGANISMS SEEN.  

   FLUID CULTURE (Final ___:    NO GROWTH. 

HSV CSF HSV2 + low positive

IMAGING:
CT head w/o acute intracranial process

Discharge Labs:

___ 06:00AM BLOOD WBC-5.6 RBC-3.79* Hgb-7.2* Hct-27.1* 
MCV-72* MCH-19.0* MCHC-26.6* RDW-22.1* RDWSD-56.4* Plt ___
___ 06:00AM BLOOD Glucose-80 UreaN-12 Creat-0.8 Na-143 
K-3.9 Cl-111* HCO3-21* AnGap-11
___ 06:00AM BLOOD Calcium-8.2* Phos-4.5 Mg-1.7
___ 05:45AM BLOOD Hapto-126
___ 07:20AM BLOOD TSH-1.1
___ 05:50AM BLOOD CEA-1.9
___ 03:30AM BLOOD IgA-162

Colonoscopy:
Circumferential mass of malignant appearance was found in the 
distal rectum completely encircling the rectal verge. There were 
local ulcerations in the 12 o'clock position. Multiple cold 
forceps biopsies were performed for histology in the rectal 
mass.

EGD:
Normal erythema in the whole esophagus. Erythema in the antrum 
with gastritis. Erythema in the duodenum compatible with 
duodenitis.
 
Brief Hospital Course:
Hospital Medicine Attending Progress Note

Time patient seen and examined today

HPI on Admission:
Mr. ___ is a ___ male with a PMHX of partial aortic 
dissection, HTN, who presents w/ HA & fever x2d concerning for 
meningitis.

Patient reports that 3 days ago, he developed malaise and 
terrible headache: constant, dull, diffuse. The following day, 
headache was relenting ___ pain. Also had fever of 102 and 
took tylenol/ibuprofen without relief of symptoms. He reports 
nausea and decreased PO intake. Denies vision changes, 
sensitivity to light, syncope, URI sx, chest pain, shortness of 
breath, abd pain, diarrhea/constipation, sick contacts. Has mild 
neck stiffness as well. He lives in ___, does a lot of
yardwork. Has had exposure to ticks, mosquitoes, but none he 
memorably recalls recently. No recent travel hx. No rash. He was 
feeling entirely well prior to onset of these symptoms. Given 
terrible headache and fever, he presented to the ED. 

Hospital Course to Date:

The pt was admitted for acute onset headache and fever. LP 
showed a cell count of 141 with lymphocytic predominance and 
elevated protein to 100. He was initially started on bacterial 
meningitis coverage, then narrowed to acyclovir based on 
negative CSF stain and cultures. Doxycycline was added to cover 
potential lyme
meningitis. The pt's CSF came back positive for HSV PCR. Per ID 
recommendations from ___: ""Would recommend continuing on 
Acyclovir for now but when safe for discharge can change to 
Valtrex 1 gram po three times per day to complete 14 day course.
In setting of only low positive HSV 2 PCR and extensive outdoor 
activity would also complete 14 day course of doxycycline even 
though lyme is less likely."" The pt improved dramatically. His 
headache resolved. Throughout his hospitalization, he had no 
confusion or neurologic deficits. He was transitioned to oral 
acyclovir the day before discharge and discharged on PO 
acyclovir + PO doxycycline for a total 14 day course.

Of note, the pt was incidentally found to have an abnormally low 
Hb on admission. He required 1u PRBC transfusion ___. He denies 
any known bleeding. GI was consulted and recommended EGD + 
colonoscopy, performed ___. EGD showed diffuse erythema of 
the mucosa with no bleeding noted in the antrum, consistent with 
gastritis. Colonoscopy showed a circumferential mass of 
malignant appearance in the distal rectum completely encircling 
the rectal verge. There were local ulcerations in the 12:00 
position. Colorectal surgery was consulted. They recommended 
follow up at the colorectal cancer clinic. Follow up was 
arranged prior to discharge and the pt was aware of the 
diagnosis and need for follow up. The clinic and colorectal 
surgery asked for a baseline CEA which was normal. They asked 
for a staging MRI pelvis which did not show any spread of the 
presumed cancer. Pathology was sent by GI. Initial pathology 
showed superficial fragments of tubulovillous adenoma. This was 
pending at the time of discharge, though initial reports had 
shown the same diagnosis, so the pt was instructed to follow up 
with GI. The GI phone number was shared with the patient and he 
was instructed to call them directly if he did not hear from the 
clinic within 24 hours. The pt received a total of 2u PRBCs this 
hospitalization. Hb was 7.2 on the morning of discharge and the 
pt received 1u PRBCs (the second unit this stay) on the day of 
discharge after the Hb of 7.2 in order to ensure that his Hb did 
not drop below 7.0 at home. Close follow up was arranged prior 
to discharge. The pt had no active bleeding at the time of 
discharge. Return to ER precautions such as dizziness and 
increased bleeding were reviewed with the patient.

The pt's BP meds were held on admission but restarted prior to 
discharge.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. TraZODone 50 mg PO QHS:PRN insomnia 
2. Citalopram 20 mg PO DAILY 
3. Lisinopril 20 mg PO DAILY 
4. Metoprolol Succinate XL 50 mg PO DAILY 

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q6H:PRN Pain - Mild/Fever  
2.  Doxycycline Hyclate 100 mg PO Q12H 
RX *doxycycline hyclate 100 mg 1 capsule(s) by mouth twice a day 
Disp #*12 Capsule Refills:*0 
3.  Pantoprazole 40 mg PO DAILY 
RX *pantoprazole 40 mg 1 tablet(s) by mouth once a day Disp #*30 
Tablet Refills:*0 
4.  ValACYclovir 1000 mg PO TID 
RX *valacyclovir [Valtrex] 1,000 mg 1 tablet(s) by mouth three 
times a day Disp #*18 Tablet Refills:*0 
5.  Citalopram 20 mg PO DAILY  
6.  Lisinopril 20 mg PO DAILY  
7.  Metoprolol Succinate XL 50 mg PO DAILY  
8.  TraZODone 50 mg PO QHS:PRN insomnia  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Viral meningitis ___ HSV
Iron deficiency anemia
Rectal cancer

 
Discharge Condition:
Stable for outpatient follow up

 
Discharge Instructions:
Dear ___,

You came to the hospital with severe headache and fevers.  You 
were found to have a viral meningitis with testing showing 
herpes simplex virus to be the cause.  Please continue taking 
Valtrex and doxycycline until ___ to treat this infection.

When you were in the hospital, you were found to have iron 
deficiency anemia.  You were seen by the Gastroenterologists.  
You underwent an EGD and a colonoscopy. The EGD showed a little 
stomach irritation. Avoid ibuprofen, higher dose aspirin, and 
naproxen. Take pantoprazole to help with the irritation. There 
was no cancer found in the stomach. The colonoscopy showed a 
rectal cancer. Please follow up as instructed with 
gastroenterology for a better pathology sample and with the 
multi-disciplinary colorectal cancer team as instructed.

Your appointment with the multi-disciplinary team has already 
been set up.

Call the ___ clinic to set up an appointment 
with them, in order for them to get a better sample of the 
tumor. This is needed for the pathologists and oncologists. If 
you do not hear from the office within 48 hours, call them at: 
___.

We wish you the best in your recovery.
-- Your medical team
 
Followup Instructions:
___
",MEDICINE
10006277-DS-18,Thomas Blakemore,10006277,25610553," 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Patient recorded as having No Known Allergies to Drugs
 
Attending: ___.
 
Chief Complaint:
___
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
Pt is an ___ yo male w/ h/o afib on ___ transferred from 
___ with ___. His symptoms began one month ago, 
when he could not remember the day or the time.  Two days ago, 
he fell out of a chair to the floor and was unable to pick 
himself up.  He has no history of head injury or loss of 
consciousness.  He phoned a neighbor who found him on the ground 
and he was brought to an OSH hospital.   

At ___ his vital signs were stable, BPs ranged 
from 100-120 systolic, HR ___, maintaining O2 sats on 2LNC.  
Laboratory data notable for absense of leukocytosis, normal 
renal function, INR 4.3.  A RLE ultrasound was negative for DVT 
given Right knee swelling.  A XR of the knee showed DJD with 
effusion.  CXR showed interstitial edema.  Head CT and MRI which 
showed small R frontal and R temporal SDHs and a small R 
occipital intraperitoneal hemorrhage.  He was given 2 units of 
FFP and Vitamin K to reverse his supratherapeutic INR (4.3) on 
coumadin and sent to ___ for evlauation and management by 
neurosurgery managment. 

In the ED vital signs were 97.4   187/100   74   20   2L NC
ROS obtained was positive for generalized weakness.  He denied 
headache.  CXR was obtained which showed signs of volume 
overload and insterstitial lung disease.  He was given 40mg IV 
lasix and transferred to the ICU. 

On the floor, he was tired and unable to provide a history or 
review of systems.  

 
Past Medical History:
Atrial fibrillation
HTN
h/o anemia
h/o osteoarthritis
 
Social History:
___
Family History:
reviewed and no pertinent ___
 
Physical Exam:
VITAL SIGNS:  
T=98.1 BP=136/77 HR=74 ___ O2=94% ___ NC  
    
GENERAL: Asleep, arousable to voice. NAD. Alternating periods of 
apnea and rapid breathing.  
HEENT: Normocephalic, atraumatic. conjunctival pallor. No 
scleral icterus. Dry MM.  
CARDIAC: irregular rhythm, normal rate. Normal S1, S2. ___ 
systolic murmur at RUSB radiating to axilla. ___ blowing 
holosystolic murmur at apex radiating to axilla ___  
LUNGS: Clear anteriorly  
ABDOMEN: NABS. Soft, NT, ND. No HSM  
EXTREMITIES: R knee edema.  
SKIN: No rashes/lesions, ecchymoses.  
NEURO: Deferred given complete neuro exam by neurosurgery an hr 
ago.  
  
As per NS:
Neurological Exam:
Mental status: Awake, year - ___, month - ___, hospital -
___.  Fluent speech with some phonemic paraphasias 
Difficulty naming hammock, stethoscope.  

Cranial Nerves:
I: Not tested
II: PERRL, 4-->2mm with light. 
III, IV, VI: EOMI. no nystagmus.
V, VII: facial sensation intact, facial strength
IX, X: Palatal elevation symmetrical.
XII: Tongue midline without fasciculations.

Motor: Normal bulk. Normal tone. No pronator drift.

     Delt Tri Bi IP  Ham PF 
     C5   C7  C6          
RT:   4    5-  ___  5   
LEFT: 4+   5-  4+  ___    

Sensation: intact to pinprick, light touch.

Toes downgoing bilaterally

 
Pertinent Results:
Admission Labs ___:
BLOOD:
WBC-8.3 Hgb-11.6* Hct-35.4* MCV-75* Plt ___
Neuts-75.1* Lymphs-16.2* Monos-6.9 Eos-1.3 Baso-0.5
___ PTT-32.0 ___
Glucose-110* UreaN-17 Creat-0.9 Na-138 K-5.0 Cl-101 HCO3-26 
AnGap-16
Calcium-8.9 Phos-3.3 Mg-2.1
URINE:
Color-Yellow Appear-Clear Sp ___
Blood-SM Nitrite-NEG Protein-  Glucose-NEG Ketone-NEG 
Bilirub-NEG Urobiln-4* pH-6.5 Leuks-NEG
___ Bacteri-OCC Yeast-NONE ___
   
ABG ___
pO2-199* pCO2-32* pH-7.54* calTCO2-28 Base XS-5 AADO2-484 
   
URINE ___
Color-Yellow Appear-Hazy Sp ___
Blood-MOD Nitrite-NEG Protein-100 Glucose-NEG Ketone-NEG 
Bilirub-SM  Urobiln-8* pH-6.5 Leuks-MOD
   
MICROBIOLOGY:
URINE Cx ___ & ___:
ENTEROCOCCUS SP.
AMPICILLIN------------   <=2 S
NITROFURANTOIN--------  <=16 S
TETRACYCLINE----------  =>16 R
VANCOMYCIN------------   <=1 S
  
BLOOD Cx ___: No growth to date
  
IMAGING:
CXR ___: 
Stable cardiomegaly and moderate pulmonary edema with a small 
right pleural 
effusion. A chest x-ray following diuresis is recommended 
  
CT head ___:
1. No significant interval change in bilateral subdural 
hematomas, as well as a rounded hemorrhagic focus within the 
right occipital lobe, which may also be extraaxial. 
2. Punctate foci of layering hemorrhage within the occipital 
horns of lateral ventricles, unchanged. 
3. No new hemorrhage identified 
  
CT C-spine ___: 
1. No fracture identified. 
2. Severe multilevel degenerative changes, with a grade 1 
anterolisthesis of C5 on 6, of indeterminate chronicity. 
However, clinical correlation is 
suggested. If there is a high clinical concern for ligamentous 
or cord 
injury, an MRI is suggested 
   
ECHO ___:
Mild left ventricular hypertrophy with mildly depressed global 
systolic function. Severe diastolic dysfunction. Severe aortic 
stenosis. Severe pulmonary artery systolic hypertension
   
CT head ___:
1. No significant change in the subdural hemorrhages, noted, in 
the right 
frontal, right parietal and the left tentorial as well as along 
the 
cerebral convexity based on both sides compared to the most 
recent study. 
Follow up as clinically indicated. 
  
CT Spine ___:
1. No acute fracture within the limitation of severe osteopenia. 

2. Large lesion at S2 level, expanding and indenting S2, likely 
large sacral Tarlov cyst. Underlying soft tissue component can 
not be excluded and a MRI may be helpful in further evaluation. 
3. Degenerative changes as described above. 
4. Scattered areas of ground-glass opacity in bilateral lungs as 
well as areas of atelectasis and small right pleural effusion. 
Dedicated chest CT can be obtained for further evaluation if 
clinically warranted. 
5. Tortuous and dilated left iliac artery, 2.1cm 
max.inadequately assessed. Color doppler study may be helpful 
   
CT head ___:
No significant interval change from ___.
   
MRI brain ___:
No acute infarcts seen. Previously noted bilateral subdurals and 

subarachnoid hemorrhage as well as right sided intraventricular 
blood products are identified. No significant new abnormalities 
are seen 
  
DISCHARGE LABS ___:
WBC-9.5 Hgb-11.8* Hct-37.3* MCV-76* Plt ___ PTT-26.7 ___
Glucose-103 UreaN-19 Creat-0.7 Na-135 K-5.6* Cl-100 HCO3-23 
AnGap-18 (moderately hemolyzed sample)
Calcium-8.5 Phos-3.5 Mg-2.0
 
Brief Hospital Course:
Mr. ___ is an ___ yo male w/ PMHx sig for atrial fibrillation 
on
___ transferred from ___ with R frontal and 
temporal DHs and R occipital IPH in the setting of 
supratheraputic INR, thought to be related from unknown trauma 
vs hypertension.  

# Subdural hematomas: The patient was found to have R frontal 
and temporal subdurals and R occipital IPH in the setting of 
supratherapeutic INR.  This was reversed with Vitamin K and FFP. 
  He was followed by NS, who determined that no surgical 
intervention was needed at this time and recommended that Keppra 
be started for seizure prophylaxis.  They had initially 
recommended restarting ASA, but given the extent of his bleeds 
and discussion with his family, it was decided to hold 
anticoagulation until further evaluation with NSG in 1 month.  
The patient continued to have L sided weakness and L hemineglect 
on transfer to the floor, so Neurology was consulted. A repeat 
MRI revealed no evidence of acute infarct and stable size of his 
bleeds.  They felt that his bleeds could explain his previous 
hemineglect.  On repeat examination, Neurology felt his hemi 
neglect had and did not feel further intervention was needed.

He is scheduled for NSG follow up in 1 month with repeat CT 
scan.
    
# Atrial fibrillation: The patient has a h/o afib, for which he 
was on Coumadin and Toprol 25mg PO daily. He had an episode of 
afib with RVR on ___, which responded well to Diltiazem 
10mg IV. His Toprol dose was increased to 50mg PO daily with 
good effect. HR on discharge 88.

# UTI: The patient had a UCx that showed infection with 
Enterococcus. The patient was started on a 14 day course of 
Ampicillin. He has 10 days remaining in his course.
   
# Severe AS/Pulm HTN: The patient had an ECHO, which showed 
severe aortic stenosis with valve area 0.8-1.0 cm2 and severe 
pulm HTN. He will need close follow up by his outpatient 
cardiologist, Dr. ___, ___ 
   

 
Medications on Admission:
Metoprolol succinate 25mg daily  
Coumadin 3mg daily  
Lasix 20mg daily 
 
Discharge Medications:
1. Levetiracetam 250 mg Tablet Sig: Three (3) Tablet PO BID (2 
times a day): please take this medication until your appointment 
with neurosurgery.  
2. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 
hours) as needed for fever, pain.  
3. Metoprolol Succinate 50 mg Tablet Sustained Release 24 hr 
Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  
4. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day) as needed for constipation.  
5. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day) as needed for constipation.  
6. Ampicillin 250 mg Capsule Sig: Two (2) Capsule PO Q6H (every 
6 hours) for 10 days.  
7. Sodium Chloride 0.9%  Flush 3 mL IV Q8H:PRN line flush 
Peripheral line: Flush with 3 mL Normal Saline every 8 hours and 
PRN. 

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary: Subdural hematomas, Urinary Tract Infection

Secondary:  Atrial fibrillation

 
Discharge Condition:
Improved, subdural hematomas are stable, neuro exam improved - 
no longer has left hemineglect

 
Discharge Instructions:
You were admitted to the hospital for a bleed in your brain.  
You were monitored closely in the MICU.  The neurosurgery team 
came and evaluated you and determined there was no need for a 
surgical intervention at this time.  CT scans showed no 
progression of your bleed.  You were transferred to the general 
medicine floor on ___ and did well.  The neurology team also 
came and evaluated you and requested an MRI which showed no new 
strokes and the previous bleeds were stable. 

The following changes were made to your medications
1.  Hold Coumadin and other blood thinners until your visit with 
Neurosurgery in 4 weeks.
2.  Start Keppra 750mg by mouth twice daily to prevent seizures 
until your visit with Neurosurgery
3.  Take Ampicillin 500mg by mouth every 6 hours for the next ___ 
days for a urinary tract infection
4.  Tylenol ___ by mouth every 6 hours as needed for pain
5.  Increase Metoprolol succinate from 25mg to 50mg by mouth 
daily
6.  Discontinue Lasix 20mg until re-evaluation by your primary 
care physician.
   
If you experience worsening headache, increased weakness, 
difficulty speaking or slurring your speech, bowel or bladder 
incontinence, shortness of breath, chest pain, fevers, chills, 
or any other concerning symptoms, please call your primary care 
physician or return to the emergency department.
   
It was a pleasure meeting you and taking part in your care.
 
Followup Instructions:
___
",MEDICINE
10006368-DS-16,Ellen Pohl,10006368,28366563," 
Name:  ___             Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
atropine eyedrops
 
Attending: ___.
 
Chief Complaint:
post-polypectomy bleed 
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ year old woman without significant past medical history who 
is s/p colonoscopy and polypectomy on ___, presenting with 
blood per rectum. On colonoscopy, a sessile 8mm benign-appearing 
polyp and sessile 2cm multilobular poly were completely removed 
from the proximal transverse and mid -ascending colon 
respectively. After the colonoscopy she had two episodes ""like 
flowing blood"", slept through the night, and then at 8 am on day 
of presentation had two bloody BMs within 30 minutes where the 
blood was noticeably darker.  She has had occasional dizzininess 
and weakness recently.  

In the ED, initial vitals: 97.2 84 114/72 16 94% RA.  She was 
asymptomatic in the ED and no gross rectal bleeding was noted. 
Guaiac positive with brown/black stools. GI evaluated her and 
recommended observation for continued bleed and and Hct 
monitoring q6h.  Her admission Hct was 38.9, dropped down to 
34.5 over 12 hours.  She was admitted due to this Hct drop.  At 
time of admission to medicine, her Hct was 37.8.  Vitals prior 
to transfer:  98.0 72 133/70 16 98%.  

Currently, the patient reports feeling ""good"" and has not had 
any bowel movements over night. She was curious why she was 
admitted after no episodes of rectal bleeding while under 
observation. 
 
ROS: per HPI, denies fever, chills, night sweats, headache, 
vision changes, rhinorrhea, congestion, sore throat, cough, 
shortness of breath, chest pain, abdominal pain, nausea, 
vomiting, diarrhea, constipation, dysuria, hematuria.  
 
 
Past Medical History:
Hpylori (started on Pylera ___, not filled script yet), CAD 
and hypertension.

 
Social History:
___
Family History:
Father with CAD and an abnormal prostate. Mother died of colon 
cancer at age ___.  Her siblings are all well.
 
Physical Exam:
ADMISSION EXAM
---------------
98.0 72 133/70 16 98% 
Gen: NAD, AOx3
HEENT: normocephalic / atraumatic. Conjunctiva clear, sclera 
anicteric.  PERRL, EOM intact. 
Pulm: Clear to auscultation bilaterally, anteriorly and 
posteriorly.  
Card:  RRR. Normal S1/S2. No MRG. 
Abd: Normoactive bowel sounds.  Soft, NT/ND w/o masses or HSM.  
Ext: No swelling or deformity. Extremities WWP. Mild bilateral 
nonpitting edema.  
Skin: Skin warm and w/o rash, pigmented lesions, petechiae, or 
ecchymoses.

DISCHARGE EXAM
---------------
Afebrile, vital signs stable 
Gen: NAD, AOx3
HEENT: normocephalic / atraumatic. Conjunctiva clear, sclera 
anicteric.  PERRL, EOM intact. 
Pulm: Clear to auscultation bilaterally, anteriorly and 
posteriorly.  
Card:  RRR. Normal S1/S2. No MRG. 
Abd: Normoactive bowel sounds.  Soft, NT/ND w/o masses or HSM.  
Ext: No swelling or deformity. Extremities WWP. Mild bilateral 
non-pitting edema.  
Skin: Skin warm and w/o rash, pigmented lesions, petechiae, or 
ecchymoses.
 
Pertinent Results:
ADMISSION LABS
--------------
___ 12:55PM BLOOD WBC-6.7 RBC-4.46 Hgb-13.2 Hct-38.9 MCV-87 
MCH-29.7 MCHC-34.0 RDW-13.4 Plt ___
___ 06:45PM BLOOD Hct-38.0
___ 01:50AM BLOOD Hct-34.5*
___ 06:55AM BLOOD WBC-6.3 RBC-4.43 Hgb-13.4 Hct-37.8 MCV-85 
MCH-30.2 MCHC-35.4* RDW-13.4 Plt ___
___ 12:55PM BLOOD Neuts-52.1 ___ Monos-4.6 Eos-1.5 
Baso-0.7
___ 06:55AM BLOOD Neuts-45.9* Lymphs-46.1* Monos-4.2 
Eos-3.1 Baso-0.7
___ 12:55PM BLOOD Plt ___
___ 01:04PM BLOOD ___ PTT-26.6 ___
___ 06:55AM BLOOD Plt ___
___ 12:55PM BLOOD Glucose-85 UreaN-21* Creat-0.9 Na-142 
K-5.7* Cl-106 HCO3-26 AnGap-16
___ 06:58PM BLOOD K-3.6

DISCHARGE LABS
--------------
same as above, same day discharge and no new labs drawn 

MICROBIOLOGY
-----------
none

IMAGING
-------
none

 
Brief Hospital Course:
___ year old woman who underwent colonoscopy with polypectomy two 
days prior to presentation, admitted with blood in stools and 
hematocrit drop; resolved upon admission. 

ACTIVE ISSUES
-------------
#. Rectal Bleeding/Hematocrit drop:  Patient with likely mild 
post-polypectomy bleed 1 day following colonoscopy.  She was 
observed in the ED for 24 hours without bleeding, but was 
admitted to medicine for further monitoring in light of a 4 
point HCT drop (39 to 34). On admission to medicine, HCT 
improved to 37. The patient had no abdominal pain, cramping, or 
evidence of bleeding. She was able to tolerate a regular diet. 
She was discharged to home with PCP and gastroenterology 
___.

INACTIVE ISSUES
---------------
#.Hypertension: Blood pressure was stable. She was not taking 
her prescribed metoprolol succinate or aspirin prior to 
admission.  These were not given in the hospital. Her home dose 
of valsartan was continued.  The patient should follow up with 
her PCP for further management of her hypertension.  

#.Hyperlipidemia: PRAVASTATIN 80 mg was continued. 

#.H. pylori: No upper gastrointestinal symptoms during 
admission. She had not started her Pylera treatment yet and this 
was deferred to outpatient so that she may complete her full 
course withut interruptions.  

TRANSITIONAL ISSUES
-------------------
___: PCP and ___ follow up appointments were 
scheduled 
Code status: Full
Contact: daughter ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Metoprolol Succinate XL 25 mg PO DAILY 
2. Pravastatin 80 mg PO DAILY 
3. Valsartan 80 mg PO DAILY 
hold for SBP < 110 
4. Aspirin 81 mg PO DAILY 
5. Vitamin D 1000 UNIT PO DAILY 
6. Glucosamine *NF* (glucosamine sulfate) 500 mg Oral daily 
7. Multivitamins 1 TAB PO DAILY 

 
Discharge Medications:
1. Multivitamins 1 TAB PO DAILY 
2. Pravastatin 80 mg PO DAILY 
3. Valsartan 80 mg PO DAILY 
4. Vitamin D 1000 UNIT PO DAILY 
5. Glucosamine *NF* (glucosamine sulfate) 500 mg Oral daily 
6. Aspirin 81 mg PO DAILY 
hold for ___ days following discharge 
7. Metoprolol Succinate XL 25 mg PO DAILY 
You were not taking this prior to admission.  Please discuss 
with your PCP whether to resume it.   

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
post-polypectomy bleed

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___, 

You were admitted to the hospital with a small amount of 
bleeding after a colonoscopy.  Your blood counts initially went 
down in the emergency department, but then returned to your 
normal blood counts.  You had no abdominal pain and no evidence 
of bleeding for 24 hours when admitted to the medical floor.  
You were able to tolerate a regular diet and were discharged to 
home.  

Follow up with your primary care physician and gastroenterology 
for routine care.
 
Followup Instructions:
___
",MEDICINE
